CUI,Canonical Name,Keyword,Aliases,Frequency
C0011854,"Diabetes Mellitus, Insulin-Dependent",insulin,"Diabetes, type 1; DIABETES MELLITUS, INSULIN DEPENDENT; diabetes mellitus type 1; Insulin-dependent diabetes; Diabetes Mellitus, Insulin Dependent; Insulin-Dependent Diabetes Mellitus 1; Diabetes mellitus, growth onset type; INSULIN-DEPENDENT DIABETES MELLITUS 1; Insulin-Dependent Diabetes Mellitus; diabetes type i; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Type I; Juvenile diabetes mellitus; Diabetes Mellitus, Insulin-Dependent, 1; Diabetes Mellitus, Juvenile-Onset; DIABETES MELLITUS, TYPE 1; Diabetes mellitus type 1 (disorder); type 1 diabetes mellitus; IDDM1; Insulin Dependent Diabetes Mellitus 1; Diabetes mellitus, Type 1; Sudden-Onset Diabetes Mellitus; juvenile-onset diabetes mellitus; Type 1 Diabetes; JUVENILE ONSET DIABETES MELLITUS; JOD; Insulin-dependent diabetes mellitus; IDDM; Juvenile-Onset Diabetes Mellitus; type I diabetes mellitus; DIABETES MELLITUS INSULIN DEPENDENT; insulin dependent diabetes mellitus; diabetes, type i; type i diabetes; DIABETES MELLITUS (JUVENILE ONSET); TYPE 1 DIABETES MELLITUS; Insulin dependent diabetes mellitus; Diabetes mellitus, type I; Juvenile diabetes; Type 1 Diabetes Mellitus; Diabetes Mellitus, Sudden-Onset; Diabetes mellitus Type I; Type 1 diabetes mellitus; Diabetes, Juvenile-Onset; Diabetes Mellitus, Juvenile Onset; diabetes mellitus type i; Diabetes mellitus, insulin-dependent; DIABETES MELLITUS, INSULIN-DEPENDENT; Diabetes mellitus, juvenile onset type; T1DM - type 1 diabetes mellitus; diabetes type 1; Type I Diabetes Mellitus; Diabetes mellitus type I; T1D; Juvenile Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Insulin-Dependent; type 1 diabetes; insulin dependent diabetes; Insulin Dependent Diabetes Mellitus; Insulin-dependent diabetes mellitus (type I); Diabetes Type 1; Type I diabetes mellitus; Juvenile-Onset Diabetes; Type 1 diabetes; jodm; juvenile diabetes mellitus; Diabetes mellitus, type 1; DIABETES MELLITUS, INSULIN-DEPENDENT, 1; Insulin Dependent Diabetes; Type I diabetes; Diabetes, Type 1; Type I Diabetes; juvenile onset diabetes mellitus; IDD; type i diabetes mellitus; iddm; Diabetes mellitus type 1; Juvenile Onset Diabetes; T1d; Diabetes Mellitus, Sudden Onset; JUVENILE-ONSET DIABETES",0
C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",insulin,"MATURITY-ONSET DIABETES; Diabetes mellitus type 2; type II diabetes mellitus; AODM; Diabetes, Maturity-Onset; non-insulin dependent diabetes; type 2 diabetes mellitus; Noninsulin-dependent diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, NON-INSULIN DEPENDENT; Maturity onset diabetes; DIABETES, KETOSIS RESISTANT; Diabetes Mellitus, Maturity Onset; DIABETES MELLITUS, NONINSULIN-DEPENDENT; Type II diabetes mellitus; diabetes mellitus type ii; T2DM - diabetes mellitus type 2; NIDDM; Non-Insulin Dependent Diabetes; DIABETES MELLITUS NON INSULIN-DEP; Type II Diabetes; Diabetes mellitus (NIDDM); diabetes type 2; NCDMM; Maturity-Onset Diabetes; Noninsulin-dependent diabetes mellitus; Diabetes mellitus, type 2; Diabetes Mellitus, Slow Onset; Diabetes Mellitus, Type II; Type 2 diabetes mellitus; diabetes, type ii; Non-insulin dependent diabetes mellitus; Diabetes mellitus Type II; Type II diabetes; Stable Diabetes Mellitus; Diabetes mellitus type 2 (disorder); non-insulin dependent diabetes mellitus; Diabetes Mellitus, Adult-Onset; Diabetes Mellitus, Non-Insulin-Dependent; ADULT ONSET DIABETES MELLITUS; Maturity Onset Diabetes; NONINSULIN-DEPENDENT DIABETES MELLITUS; maturity onset diabetes; aodm; Diabetes Mellitus, Adult Onset; adult onset diabetes; Diabetes mellitus, noninsulin-dependent; Non-Insulin Dependent Diabetes Mellitus; TYPE 2 DIABETES MELLITUS; Diabetes Mellitus, Noninsulin Dependent; Type 2 Diabetes; Diabetes Mellitus, Type 2; MODY; Type 2 Diabetes Mellitus; Type II Diabetes Mellitus; Diabetes Mellitus, Non Insulin Dependent; DIABETES MELLITUS, TYPE 2; Diabetes mellitus type II; Non-insulin-dependent diabetes; Diabetes, Type 2; Non-insulin dependent diabetes; noninsulin dependent diabetes mellitus; Slow-Onset Diabetes Mellitus; late onset diabetes; type II diabetes; Noninsulin Dependent Diabetes Mellitus; MOD; Diabetes mellitus, adult onset type; adult onset diabetes mellitus; DIABETES MELLITUS (ADULT ONSET); Diabetes Mellitus, Stable; diabetes type ii; Diabetes Mellitus, Maturity-Onset; ketosis resistant diabetes; DIABETES MELLITUS, TYPE II; Diabetes Type 2; DIABETES, ADULT ONSET; Diabetes Mellitus, Ketosis Resistant; Maturity-Onset Diabetes Mellitus; diabete type 2; type 2 diabetes; diabetes mellitus type 2; type ii diabetes mellitus; Noninsulin-Dependent Diabetes Mellitus; Maturity Onset Diabetes Mellitus; T2D; Adult-Onset Diabetes; Type 2 Diabetes Mellitus Non-Insulin Dependent; Diabetes mellitus, type II; DIABETES, MATURITY ONSET; Non-Insulin-Dependent Diabetes Mellitus; Diabetes mellitus, Type 2; Noninsulin dependent diabetes mellitus; T2DM - Type 2 Diabetes mellitus; niddm; Ketosis-Resistant Diabetes Mellitus; Type 2 diabetes; Diabetes Mellitus, Slow-Onset; Diabetes Mellitus, Ketosis-Resistant; Diabetes Mellitus, Noninsulin-Dependent; NIDDM diabetes mellitus",0
C0012155,Diet,regular,"Diet; Diets; Diet, NOS; regular diet?; diets; Dietary; Dietary finding (finding); DIETS; diet; Dietary finding",0
C0017132,Gastric Inhibitory Polypeptide,insulin,"Polypeptide, Gastric-Inhibitory; Glucose Dependent Insulinotropic Peptide; GIP - Glucose dependent insulinotropic peptide; Glucose dependent insulinotropic peptide; Gastric inhibitory peptide; Glucose-Dependent Insulinotropic Peptide; Gastric-Inhibitory Polypeptide; Gastric inhibitory polypeptide (GIP); Gastric Inhibitory Polypeptide; Inhibitory Polypeptide, Gastric; Peptide, Glucose-Dependent Insulin-Releasing; Glucose dependent insulinotropic peptide (substance); Glucose-Dependent Insulin-Releasing Peptide; Glucose Dependent Insulin Releasing Peptide; GIP - Gastric inhibitory peptide; Insulin-Releasing Peptide, Glucose-Dependent; Insulinotropic Peptide, Glucose-Dependent; GIP - Gastric inhibitory polypeptide; GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE; Gastric inhibitory polypeptide (substance); Polypeptide, Gastric Inhibitory; gastric inhibitory polypeptide; gastric inhibitory peptide; gastric inhibitory polypeptide (GIP); Gastric inhibitory polypeptide; Peptide, Glucose-Dependent Insulinotropic; GIP",0
C0020171,Humulin insulin,insulin,humulin; insulin humulin; humulin insulin,0
C0020258,"Hydrocephalus, Normal Pressure",NPH,"NPH (Normal Pressure Hydrocephalus); hydrocephalus normal pressure; NPHs (Normal Pressure Hydrocephalus); Hakim Syndromes; normal pressure hydrocephalus; Hydrocephalus, normal pressure; NORMAL PRESSURE HYDROCEPHALY; Hakim Syndrome; nph; Normal pressure hydrocephalus NOS; Hakims Syndrome; Hydrocephalus, low pressure; NPH; NORMAL PRESSURE HYDROCEPHALUS; Normal-pressure hydrocephalus; hydrocephalus normal nph pressure; hakim syndrome; normal-pressure hydrocephalus; Syndromes, Hakim's; NPH - Normal pressure hydrocephalus; Normal pressure hydrocephalus; Low pressure hydrocephalus; Normal pressure hydrocephalus (disorder); low pressure hydrocephalus; Syndromes, Hakim; Normal pressure hydrocephalus syndrome; Hakim's Syndromes; hydrocephalus pressure normal; Hydrocephalus, Normal Pressure; normal pressure hydrocephaly; Syndrome, Hakim's; Hydrocephalus, Normal-Pressure; Hakim's Syndrome; Syndrome, Hakim; normal pressure hydrocephalus (nph); Normal Pressure Hydrocephalus",0
C0020459,Hyperinsulinism,insulin,"Hyperinsulinaemia; Hyperinsulinemia; Hyperinsulinism; Hyperinsulinism (disorder); hyperinsulinemia; Hyperinsulinism syndrome; increased insulin; Hyperinsulinism NOS; hyperinsulism; HYPERINSULINEMIA; insulin high; INSULIN INCREASE; Elevated insulin level; high insulin; Increased insulin; hyperinsulinaemia; Hyperinsulinism, NOS; Elevated insulin levels; increasing insulin; hyperinsulinism",0
C0021641,Insulin,insulin,"Regular insulin preparation; Regular insulin; Product containing insulin (product); Soluble Insulin; insulins; Insulin (substance); Insulin regular; insulin regular; Insulin, Regular; Regular insulin (substance); Unmodified insulin preparation; INSULIN PREPARATIONS; regular insulin; Insulin, Soluble; Insulin-containing product; insulin preparation; insulin products; Insulin; insulin product; Insulin soluble; insulin preparations; Soluble insulin; Insulin preparation, NOS; insulin; Regular Insulin",0
C0021642,Insulin A Chain,insulin,,0
C0021643,Insulin Antagonists,insulin,"Antagonists, Insulin; insulin antagonist; Insulin antagonist; inhibitors insulin; Substance with insulin antagonist mechanism of action (substance); insulin inhibitor; Insulin Antagonists",0
C0021644,Insulin Antibodies,insulin,"antibody insulin; anti insulin antibodies; Insulin Antibodies; Insulin Antibody; anti-insulin antibody; Antibodies, Insulin; Insulin antibody; Anti-insulin antibody (substance); Anti-insulin antibody; insulin antibody; Insulin antibodies; insulin antibodies; Insulin Ab",0
C0021645,Insulin Coma,insulin,"coma insulin; Insulin coma; insulin shock; Insulin coma (disorder); Coma, Insulin; insulin coma; Insulin coma NOS; Insulin Coma",0
C0021646,Insulin shock therapy,insulin,"Insulin shock therapy; Insulin shock therapy (procedure); Insulin Shock Therapy; Shock therapy - insulin; Shock Therapy, Insulin; Therapy, Insulin Shock; insulin shock therapy",0
C0021648,Insulin Infusion Systems,insulin,"Systems, Insulin Infusion; Infusion Systems, Insulin; Infusion System, Insulin; System, Insulin Infusion; insulin infusion system; Insulin Infusion System",0
C0021655,Insulin Resistance,insulin,"insulin resistance; Insulin resistance (disorder); Insulin Resistance; Body fails to respond to insulin; INSULIN RESISTANCE; Resistance, Insulin; Insulin resistance; Drug resistance to insulin (disorder); Drug resistance to insulin",0
C0021657,"Insulin, Globin Zinc",insulin,,0
C0021658,insulin isophane,insulin,"insulin nph; Insulin, Isophane; Hagedorn Insulin, Protamine; Isophane insulin (substance); Isophane insulin; Protamine Hagedorn Insulin; Insulin NPH; insulin isophane; Neutral protamine hagedorn insulin; insulin, NPH; protamine hagedorn insulin; NPH insulin; Insulin Isophane; Insulin, NPH; nph insulin; Neutral Protamine Hagedorn Insulin; Product containing isophane insulin (medicinal product); nph isophane insulin; NPH (neutral protamine hagedorn) insulin; insulins nph; Isophane Insulin; Isophane Insulin, Regular; Isophane insulin-containing product; NPH Insulin; nph insulin isophane; isophane insulin; Regular Isophane Insulin",0
C0021659,Lente Insulin,insulin,"Zinc insulin (substance); Insulin, Lente; zinc insulin; lente insulin; Lente Insulin; Zinc insulin; insulin zinc; insulin lente; Insulin Lente",0
C0021662,"Insulin, Protamine Zinc",insulin,"Insulin, Protamine Zinc; protamine zinc insulin; PZI; Protamine Zinc Insulin; pzi; Zinc Insulin, Protamine; Protamine zinc insulin; Protamine zinc insulin (substance)",0
C0021663,"Insulin, Prompt Zinc",insulin,"Semilente Insulin; Prompt zinc insulin; Insulin semilente; Insulin, Semilente",0
C0021665,Insulin-Like Growth Factor I,insulin,Insulin-like growth factor 1; Somatomedin C; IGF-I; Insulin-like growth factor I; igf 1; insulin-like growth factor 1 (IGF-1); insulin-like growth factor i; SM-C; Insulin-Like Somatomedin Peptide I; Insulin Like Somatomedin Peptide I; insulin like growth factor i; Human somatomedin C; igf-i; somatomedin c; Somatomedin C (substance); IGF-I-SmC; igf i; insulin like growth factor 1; igf-1; Insulin Like Growth Factor I; IGF 1 - Insulin like growth factor 1; Insulin-like growth factor-I; SmC - Somatomedin C; IGF I; insulin-like growth factor 1; IGF-1; Insulin-Like Growth Factor I,0
C0021666,insulin-like growth factor 2,insulin,"IGF II; Insulin Like Growth Factor II; igf 2; IGF-II; Insulin-like growth factor-II; Multiplication-Stimulating Factor; igf-ii; insulin-like growth factor ii; igf-2; insulin-like growth factor 2; Insulin-Like Somatomedin Peptide II; SM-A; Insulin Like Somatomedin Peptide II; Insulin-Like Growth Factor II; Factor, Multiplication-Stimulating; Multiplication Stimulating Activity; Somatomedin A (substance); Somatomedin A; Multiplication Stimulating Factor; IGF-2; Somatomedin MSA; Insulin-like growth factor II; Multiplication-Stimulating Activity; Insulin-like growth factor 2; IGF 2 - Insulin-like growth factor 2",0
C0021669,Insulinase,insulin,"Enzyme, Insulin-Degrading; Insulin protease; Insulin Degrading Enzyme; Insulysin; Insulinase; Insulin-degrading enzyme; Insulysin (substance); Insulin-Degrading Enzyme; Protease, Insulin; Insulin Protease; Proteinase, Insulin; Insulin Proteinase",0
C0021670,insulinoma,insulin,"Pancreatic Insulinoma; Tumors, beta-Cell; Beta Cell Tumor of the Pancreas; Insulinoma (disorder); Insuloma; Insulin-Producing Islet Cell Neoplasm; Tumor, beta-Cell; Pancreatic Insulin Producing Tumor; insulinomas; islet cell insulinoma; Insulinoma syndrome; Beta Cell Neoplasm; PANCREAS, ISLET-CELL TUMOR, INSULIN-PRODUCING; beta Cell Tumor; Insulin-Producing Neoplasm of Islet Cells; insuloma; Pancreatic Insulin Producing Neoplasm; Insulin-Producing Neoplasm of the Islet Cells; Pancreatic Insulin-Producing Neuroendocrine Tumor; Pancreatic Insulin Producing NET; Pancreatic Beta Cell Tumor; Beta Cell Neoplasm of the Pancreas; INSULOMA; pancreatic insulinoma; Beta Cell Tumor of Pancreas; Beta Cell Neoplasm of Pancreas; Adenomas, beta-Cell; Beta-cell adenoma; INSULINOMA; Insulinoma; Insulomas; Adenoma, beta-Cell; Adenoma, beta Cell; Insulin-Producing Tumor of the Islet Cells; Insulinoma, NOS; insulinoma; Pancreatic insulinoma; Beta cell adenoma; beta-Cell Adenoma; beta-Cell Adenomas; Insulin-Producing Islet Cell Tumor; Insulinomas; beta-Cell Tumors; Insulin-Producing Tumor of Islet Cells; Beta Cell Tumor; beta-Cell Tumor",0
C0025323,Menorrhagia,regular,"HYPERMENORRHEA; heavy prolonged periods; Heavy Periods; heavy menstrual period; excessive menstrual flow; Profuse menstrual flow; Heavy Menstrual Bleeding; Hypermenorrhoea; Abnormally heavy periods; BLEEDING MENSTRUAL HEAVY; heavy menstrual bleeding; EXCESSIVE MENSES; heavy menstrual periods; Abnormally heavy bleeding during menstruation; Menorrhagia (finding); MENSES REGULAR WITH EXCESSIVE BLEEDING; MENSTRUAL FLOW EXCESSIVE; Heavy period; MENORRHAGIA; Menstruation excessive; Flooding during periods; Heavy menstruation; heavy periods; Hypermenorrhea; Menorrhagia; Heavy menstrual bleeding; hypermenorrhea; excessive menstruation; menorrhagia; Heavy Period; Menstrual Bleeding, Heavy; heavy period; Heavy periods; hypermenorrhoea",0
C0027442,Nasopharynx,NPH,"Nasopharyngeal; rhinopharyngeal; Nph; Nasopharyngeal (qualifier value); Rhinopharynges; Nasopharynx, NOS; Rhinopharyngeal; Rhinopharynx, NOS; rhinopharynges; nasopharynges; rhinopharynx; Nasopharynges; Rhinopharynx; Nasopharynxes; Nasopharyngeal structure; Nasopharyngo-; Nasopharyngeal structure (body structure); Pars nasalis pharyngis; Nasopharynx; NASOPHARYNX; Nasal part of pharynx; Rhinopharyngo-; nasopharyngeal; Rhinopharynxes; nasopharynx",0
C0028318,Nonsuppressible Insulin-Like Activity,insulin,"Activity, Nonsuppressible Insulin-Like; Nonsuppressible Insulinlike Activity; Nonsuppressible Insulin Like Activity; Insulin-Like Activity, Nonsuppressible; Insulinlike Activity, Nonsuppressible; NSILA; Non-suppressible insulin-like activity; Activity, Nonsuppressible Insulinlike",0
C0028467,Novolin,novolin,novolin; Novolin; NovoLIN,0
C0030281,Structure of beta Cell of islet,insulin,"pancreatic beta cell; Insulin-Secreting Cell; Pancreatic B Cell; Pancreatic beta Cells; Beta cell of pancreatic islet; Beta cell of islet; Insulin Secreting Cell; Cells, Insulin-Secreting; Pancreatic beta cells; pancreas beta cell; Cell, Insulin-Secreting; Insulin-secreting cell; B-cell of pancreatic islet; Type B pancreatic cell; B Cell, Pancreatic; Insulin-Secreting Cells; Structure of beta cell of islet (cell structure); Insulin Cell; Pancreatic beta Cell; pancreatic beta cells; Pancreatic beta cell; Pancreatic B-cell; Structure of beta cell of islet; Beta Cell; B Cells, Pancreatic; Type B enteroendocrine cell; Pancreatic B Cells; beta Cells, Pancreatic; Type B cell of pancreatic islet; beta Cell, Pancreatic; Beta cell; Insulin Secreting Cells; beta Cell of islet",0
C0032999,Pregnancy-Associated Plasma Protein-A,insulin,"IGFBP-4-Specific Proteinase; Pregnancy Associated alpha Plasma Protein; Pregnancy-Associated Plasma Protein-A; PAPP alpha; Pregnancy associated plasma protein A; papp a; Insulin Like Growth Factor Binding Protein 4 Protease; Insulin-Like-Growth Factor Binding Protein-4 Protease; Metalloproteinase, IGFBP-4; PAPP-A; Pregnancy Associated Plasma Protein A; IGFBP-4 Metalloproteinase; IGFBP 4 Metalloproteinase; PAPP-alpha; Pregnancy associated plasma protein A (substance); IGFBP-4 Protease; Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease; IGFBP 4 Protease; papp-a; Protease, IGFBP-4; Insulin Like Growth Factor Dependent IGF Binding Protein 4 Protease; Pregnancy-Associated alpha-Plasma Protein",0
C0033628,Glutathione-insulin transhydrogenase,insulin,"Thiol Protein Disulfide Oxidoreductase; Glutathione insulin transhydrogenase; Thiol-Protein Disulfide Oxidoreductase; Protein-disulfide reductase (glutathione); Glutathione-insulin transhydrogenase; protein disulfide reductase (glutathione); glutathione insulin oxidoreductase; Disulfide Oxidoreductase, Thiol-Protein; Glutathione Insulin Transhydrogenase; Protein-disulfide reductase (glutathione) (substance); Oxidoreductase, Thiol-Protein Disulfide; insulin reductase; Insulin reductase; Glutathione:protein-disulfide oxidoreductase; glutathione insulin transhydrogenase; Protein Disulfide Reductase (Glutathione); glutathione protein disulfide reductase; thiol protein disulfide oxidoreductase; Transhydrogenase, Glutathione Insulin; Insulin Transhydrogenase, Glutathione; Glutathione Protein Disulfide Oxidoreductase; glutathione protein disulfide oxidoreductase",0
C0034818,Insulin Receptor,insulin,"Insulin--Receptors; Insulin receptor (substance); Insulin Receptors; insulin receptor site; Insulin Receptor; Receptors, Insulin; insulin receptor sites; Insulin receptor site; insulin receptors; Insulin receptor; Insulin Receptor Protein-Tyrosine Kinase; Insulin Receptor Protein Tyrosine Kinase; insulin receptor; Receptor, Insulin; receptor insulin; Insulin-Dependent Tyrosine Protein Kinase",0
C0037520,Sodium Insulin,insulin,"Insulin, Sodium",0
C0037657,Somatomedins,insulin,"Somatomedin; Sulfation Factor; Insulin-like growth factor; Insulin-like growth peptide; insulin-like growth factor; Insulin Like Growth Factor; somatomedin; Factor, Insulin-Like Growth; IGF; insulin like growth factor; Somatomedin (substance); Factor, Sulfation; Insulin-Like Growth Factor; Somatomedin-containing product; factor growth insulin-like; somatomedins; insulinlike growth factor; Product containing somatomedin (medicinal product); insulin-like growth factors; Somatomedin, NOS; Somatomedins; insulin like growth factors; Insulin Like Growth Factors; Somatomedin preparation; Insulin-Like Growth Factors; Growth Factor, Insulin-Like; Growth Factors, Insulin-Like; Factors, Insulin-Like Growth",0
C0041616,Ultralente Insulin,insulin,"Crystalline zinc insulin preparation; Insulin ultralente; insulin ultralente; insulin zinc extended; Insulin Zinc Injectable Suspension; Insulin, Ultralente; Extended zinc insulin; ultralente insulin; Ultralente Insulin",0
C0046449,2-nitrophenylhydrazine,NPH,2-NPH; o-nitrophenylhydrazine,0
C0048080,"insulin, 4-azido-2-nitrophenyl-",insulin,4-azido-2-nitrophenylinsulin,0
C0050397,acceleratory factor from growth hormone,insulin,insulin potentiating fragments of growth hormone; acceleratory factor from growth hormone (AcG); acceleratory factor from growth hormone; AcG; acg,0
C0051301,alpha-2-macroglobulin-insulin complex,insulin,insulin-alpha 2-macroglobulin conjugate; alpha-2-MIC,0
C0056590,cupferron,NPH,N-nitroso-N-phenylhydroxylamine Ammonium Salt; azane; N-hydroxy-N-phenylnitrous amide; Inhibitor NPH; Ammonium N-hydroxy-N-nitrosobenzenamine; N-nitroso-N-phenylhydroxylamine ammonium salt; Cupferron,0
C0057819,"insulin, dicarbain(A7,B7)-",insulin,"A7,B7-dicarbainsulin",0
C0061420,glucose-insulin-potassium cardioplegic solution,insulin,GIK solution; GIKCS; glucose-insulin-potassium substrate,0
C0063610,insulin dimers,insulin,,0
C0063612,insulin proreceptor,insulin,"proreceptor, insulin; insulin pro-receptors; insulin proreceptors",0
C0063613,insulin resistance factor (uremia),insulin,insulin resistance activity (uremia); IRF (uremia),0
C0063614,insulin secretory granule membrane glycoprotein 110,insulin,SGM 110,0
C0063617,"insulin, 4-azidobenzoyl(B29)-",insulin,"insulin, N-monoazidobenzoyl(B29)-; Insulin, NB-(4-azidobenzoyl)-; B29-monoazidobenzoyl-insulin; B29-4-azidobenzoyl-insulin",0
C0063618,"insulin, 2,7-diaminosuberoyl, N(alpha)(A1), N(epsilon)(B29)-",insulin,"2,7-diaminosuberoyl-A1-N(alpha)-B29-N(epsilon)-insulin; A2sb insulin; Insulin, NA,29B-(2,7-diamino-1,8-dioxo-1,8-octanediyl)-",0
C0063624,"insulin, (2-nitro-4-trimethylammoniophenyl)(A1)-",insulin,"A1-(2-nitro-4-trimethylammoniophenyl)-insulin; Insulin, NA-(2-nitro-4-(trimethylammonio)phenyl)-",0
C0063626,"insulin, adipoyl-Arg(B22)-",insulin,"insulin, adipoylarginine(B22)-; B22-adipoyl-Arg-insulin",0
C0063627,"insulin, Ala(B0)-",insulin,"B0-alanine-insulin; insulin, alanine(B0)-; B0-Ala-insulin",0
C0063628,"insulin, Ala(A1)-",insulin,"Insulin, 1A-D-alanine-9A-glycine-; A1-Ala-insulin; A1-alanine-insulin; insulin, alanine(A1)-",0
C0063629,"insulin, Asp(B9)-Glu(B27)-",insulin,"B9-aspartyl-B27-glutamic acid-insulin; insulin, aspartyl(B9)-glutamic acid(B27)-; B9-Asp-B27-Glu-insulin",0
C0063630,"insulin, (2-nitro-4-azidophenylacetyl)(B2)-des-Phe(B1)-",insulin,"NAPA-INSULIN (B29); insulin, (2-nitro-4-azidophenylacetyl)(B2)-desphenylalanine(B1)-; Insulin, 1B-de-L-phenylalanine-2B-(N-((4-azido-2-nitrophenyl)acetyl)-L-valine)-; B2-(2-nitro-4-azidophenylacetyl)-B1-desphenylalanine-insulin; 2-nitro-4-azidophenylacetyl (B2)des-phenylalanyl (B1)insulin; NAPA-DP-insulin; B2-(2-nitro-4-azidophenylacetyl)-(B1)-des-Phe-insulin",0
C0063631,"insulin, (2-nitro-4-azidophenylacetyl) (B29)-",insulin,"B29NAPA-Ins; B29-(2-nitro-4-azidophenylacetyl)-insulin; Insulin, 29B-(N6-((4-azido-2-nitrophenyl)acetyl)-L-lysine)-",0
C0063632,"insulin, Arg(B29)-",insulin,"B29-Arg-insulin; B29-arginine-insulin; insulin, arginine(B29)-",0
C0063633,"insulin, biotinyl-",insulin,biotinylinsulin,0
C0063634,"insulin, citraconyl-",insulin,citraconyl insulin,0
C0063635,"insulin, depot-",insulin,depot-insulin,0
C0063636,"insulin, des(heptapeptide)(B24-B30)-",insulin,"insulin, desheptapeptide(B24-B30)-; desheptapeptide(B24-B30)-insulin; desheptapeptide(B24-B30)insulin; DHPI B24-B30",0
C0063637,"insulin, (B1)-des-Phe-",insulin,"Insulin, 1B-de-L-phenylalanine-; insulin, des-desphenylalanine(B1)-; insulin, desphenylalanine(B1)-; B1-desphenylalanine-insulin; B1-dephenylalanine-insulin; B1-des-Phe-insulin",0
C0063638,"insulin, desamido-",insulin,deamido-insulin; desamido-insulin,0
C0063639,"insulin, deshexapeptide(B25-B30)-",insulin,"deshexapeptide(B25-B30)-insulin; Insulin, 8A-L-threonine-10A-L-isoleucine-25B-de-L-phenylalanine-26B-de-L-tyrosine-27B-de-L-threonine-28B-de-L-proline-29B-de-L-lysine-30B-de-L-alanine-",0
C0063640,"insulin, desoctapeptide-",insulin,"insulin (ox), 8(A)-L-threonine-10(A)-L-isoleucine-23(B)-deglycine-24(B)-de-L-phenylalanine-25(B)-de-L-phenylalanine-26(B)-de-L-tyrosine-27(B)-de-L-threonine-28(B)-de-L-proline-29(B)-de-L-lysine-30(B)-de-L-alanine-; desoctapeptide (B23-30) insulin; desoctapeptide insulin",0
C0063641,"insulin, despentapeptide(B26-B30)-",insulin,"DPI-NH2; despentapeptide(B26-B30)-insulin; des(pentapeptide)(B26-30)insulin; insulin, des-pentapeptide(B26-B30)-",0
C0063645,"insulin, despentapeptide (B26-B30)-TyrNH2(B25)-",insulin,"Tyr-desP-insulinamide; DAT-insulin; insulin, despentapeptide(B26-B30)-tyrosinamide(B25)-; despentapeptide(B26-B30)-B25-tyrosinamide-insulin; (B26-B30)-despentapeptide-B25-tyrosinamide-insulin; despentapeptide(B26-B30)-B25-TyrNH2-insulin",0
C0063646,"insulin, dethiobiotinyl-",insulin,dethiobiotinylinsulin,0
C0063647,"insulin, fluorescein-isothiocyanated-",insulin,FITC-insulin; fluorescein-isothiocyanate-insulin,0
C0063648,"insulin, Gln(B13)-",insulin,"B13-glutamine-insulin; B13-Gln-insulin; insulin, glutamine(B13)-",0
C0063650,"insulin, glycosylated",insulin,glycosylated insulin,0
C0063651,"insulin, iodo-",insulin,iodoinsulin; iodo-insulin; monoiodoinsulin,0
C0063652,"insulin, 3-iodo-Tyr(A14)-",insulin,"A14-3-iodotyrosine-insulin; A14-3-iodo-Tyr-insulin; insulin, 3-iodotyrosine(A14)-",0
C0063653,"insulin, Leu(B24)-",insulin,"Insulin, 8A-L-threonine-10A-L-isoleucine-24B-L-leucine-30B-L-threonine-; insulin, leucine(B24)-; B24-leucine-insulin; B24-Leu-insulin",0
C0063654,"insulin, Leu(B25)-",insulin,"insulin Chicago; insulin, leucine(B25)-; Insulin, 8A-L-threonine-10A-L-isoleucine-25B-L-leucine-30B-L-threonine-; B25-leucine-insulin; B25-Leu-insulin",0
C0063655,"insulin, Leu(B30)-",insulin,"B30-Leu-insulin; insulin, leucine(B30)-; B30-leucine-insulin",0
C0063656,"insulin, Leu(A3)-",insulin,"A3-leucine-insulin; A3-Leu-insulin; insulin, leucine(A3)-",0
C0063657,"insulin, neutral",insulin,"insulin, neutral; Insulin, 8A-L-threonine-10A-L-isoleucine-; neutral insulin; Neutral insulin",0
C0063658,"insulin, Phe(A14)-",insulin,"A14-phenylalanine-insulin; insulin, phenylalanine(A14)-; Insulin, 8A-L-threonine-10A-L-isoleucine-14A-L-phenylalanine-; A14-Phe-insulin",0
C0063659,"insulin, Phe(A19)-",insulin,"Insulin, 8A-L-threonine-10A-L-isoleucine-19A-L-phenylalanine-; insulin, phenylalanine(A19)-; A19-phenylalanine-insulin; A19-Phe-insulin",0
C0063660,"insulin, Phe(B1)-",insulin,"B1-phenylalanine-insulin; insulin, phenylalanine(B1)-; B1-Phe-insulin",0
C0063662,"insulin, Ser(B25)-",insulin,"B25-Ser-insulin; B25-serine-insulin; insulin, serine(B25)-",0
C0063663,"insulin, single chain des-(B30)-",insulin,SCI des-(B30); single chain des-B30-insulin,0
C0063664,"insulin, Phe(B24)-",insulin,"B24-Phe-insulin; insulin, phenylalanine(B24)-",0
C0063665,"insulin, tri-Lys-",insulin,"tri-Lys-insulin; trilysine insulin; N(A)-L-lysyl-N(B)-L-lysyl-29(B)-(N(6)-L-lysyl-L-lysine)insulin (ox); insulin, trilysine-",0
C0063666,"insulin, Trp(B1)-",insulin,"B1-tryptophan-insulin; insulin, tryptophan(B1)-; B1-Trp-insulin",0
C0063667,"insulin, Trp(A19)-",insulin,"A19-Trp-insulin; insulin, tryptophan(A19)-; A19-tryptophan-insulin",0
C0063668,"insulin, Trp(A1)-",insulin,"insulin, tryptophan(A1)-; A1-Trp-insulin",0
C0063669,"Insulin, Ultratard",insulin,Ultratard Insulin,0
C0063672,insulin crosslinked to the catalytic fragment A of diphtheria toxin,insulin,insulin-diphtheria toxin A chimeric peptide,0
C0063673,insulin-glucagon liberin,insulin,,0
C0063674,"insulin-like growth factor 1, des-(1-3)-",insulin,"IGF-1, des(1-3)-; des-(1-3)-IGF-1; des(1-3)IGF-I",0
C0063675,insulin-like growth factor 1A prohormone (91-103),insulin,IGF-Ia prohormone; IGF-IA E PEPTIDE (91-103); EIa(91-103),0
C0063679,"insulin-like growth factor I, Thr(59)-",insulin,"threonine-59-insulin-like growth factor I; 59-Thr-IGF I; IGF I,threonine-59-",0
C0063681,insulin-related factor,insulin,insulin-related growth factor,0
C0063682,insulin-stimulated phosphoprotein pp105,insulin,insulin-stimulatable phosphoprotein pp105; IS-pp105,0
C0067840,N-benzyloxycarbonylarginine 4-nitrophenyl ester,NPH,N-(alpha)-carbobenzoxyarginine-p-nitrophenyl ester; Cbz-Arg-Nph,0
C0067842,N-benzyloxycarbonylglycine 4-nitrophenyl ester,NPH,Z-Gly-Nph; N-benzyloxycarbonylglycine para-nitrophenyl ester,0
C0067845,N-benzyloxycarbonyllysine 4-nitrophenyl ester,NPH,Z-Lys-Nph; N-(alpha)-carbobenzoxylysine-4-nitrophenyl ester; alpha-Cbz-lysine-p-nitrophenyl ester; CbzLNP,0
C0069060,NPH-peptide,NPH,"N-formyl-Nle-Leu-Phe-Nle-Tyr-N-epsilon-(6-(4'azido-2'-nitrophenylamino)hexanoyl)Lys; L-Lysine, N6-(6-((4-azido-2-nitrophenyl)amino)-1-oxohexyl)-N2-(N-(N-(N-(N-(N-formyl-L-norleucyl)-L-leucyl)-L-phenylalanyl)-L-norleucyl)-L-tyrosyl)-; N-formyl-norleucyl-leucyl-phenylalanyl-norleucyl-tyrosyl-N-epsilon-(6-(4'-azido-2'-nitrophenylamino)hexanoyl)lysine",0
C0071189,"IGFBP1 protein, human",insulin,"Alpha-Pregnancy-Associated Endometrial Globulin; Insulin-Like Growth Factor-Binding Protein 1; Binding Protein-25; Growth Hormone Independent-Binding Protein; IGFBP-1 protein, human; Placental Protein 12; IGFBP-1; PAMG-1 protein, human; IGF Binding Protein 1; IGFBP1 protein, human; placenta-specific protein 12, human; IGF-Binding Protein 1; Binding Protein-26; Insulin-Like Growth Factor Binding Protein 1; Amniotic Fluid Binding Protein; IGF-binding protein 1, human; placental protein 12, human; IGFBP1; Binding Protein-28; insulin-like growth factor binding protein 1, human; IBP-1 protein, human",0
C0074825,Insulin-Like Growth-Factor-Binding Proteins,insulin,"Insulin-like growth factor-binding proteins; igf binding protein; Binding Protein, IGF; Somatomedin Binding Protein; Insulin-Like Growth Factor-Binding Protein; IGF-Binding Proteins; Insulin Like Growth Factor Binding Protein; IGFBP; Insulin-Like Growth Factor Binding Protein; igf binding proteins; Protein, Somatomedin-Binding; Insulin-like growth factor binding proteins; Insulin-Like Growth Factor Binding Proteins; IGF-BP - Insulin-like growth factor binding protein; Insulin-like growth factor binding protein (substance); IGF-Binding Protein; Protein, IGF-Binding; igfbp; Somatomedin Binding Proteins; Insulin-like growth factor binding protein; Protein, IGF Binding; IGF Binding Protein; Somatomedin-Binding Protein; IGF binding protein; insulinlike growth factor binding protein; IGF Binding Proteins; Somatomedin-Binding Proteins",0
C0075309,"subtilisin inhibitor protein, Streptomyces",SSI,"SSI protease inhibitor, Streptomyces",0
C0076579,thymidine 5'-4-nitrophenyl phosphate,NPH,PNPpT; p-Nph-5'-TMP; p-nitrophenyl 5'-thymidine monophosphate,0
C0083014,"IEBP1 protein, rat",insulin,"insulin enhancer binding protein, IEBP1; insulin enhancer binding protein 1, rat",0
C0083015,insulin gene enhancer binding protein Isl-1,insulin,islet-1 protein,0
C0083016,insulin like growth factor I (1-27)-Gly-Gly-Gly-Gly-(38-70),insulin,"Gly4-IGF-I; IGF-I ((1-27),Gly4,(38-70)); (1-27,Gly4,38-70)IGF-I",0
C0083017,insulin receptor-related receptor,insulin,"INSRR; insulin receptor-related receptors; receptor, insulin receptor-related-; insulin receptor-related receptor (IRR); insulin receptor-related receptor; IRR",0
C0083018,"insulin, (2-nitro-4-azidophenyl)(A1)-",insulin,"A1NAP-Ins; Insulin, NA-(4-azido-2-nitrophenyl)-; A1-(2-nitro-4-azidophenyl)-insulin",0
C0083020,"insulin, 4-succinylamidophenylglucopyranoside-",insulin,4-succinylamidophenylglucopyranoside-insulin; SAPG-INS,0
C0083022,"insulin, Arg(B31,B32)-",insulin,"diarginylinsulin; B31,B32-Arg-insulin",0
C0083024,insulin-related neuropeptide,insulin,,0
C0084179,proinsulin-like growth factor II,insulin,pro-IGF-II; big insulin-like growth factor II,0
C0085500,"Gram-Positive Asporogenous Rods, Regular",regular,"Gram Positive Asporogenous Rods, Regular",0
C0086855,Implantable Programmable Insulin Pump,insulin,"Insulin Pump, Programmable Implantable; Pump, Programmable Implantable Insulin; Programmable Implantable Insulin Pump",0
C0101395,Actrapid insulin,insulin,,0
C0110610,connective tissue growth factor,insulin,Connective Tissue Growth Factor; connective tissue growth factor; IGF-BP 8 - Insulin-like growth factor binding protein 8; IGF-Binding Protein-Related Protein-2; IGF Binding Protein Related Protein 2; ctgf; Insulin Like Growth Factor Binding Protein 8; Connective tissue growth factor (substance); IGFBP-8; Hypertrophic Chondrocyte-Specific Protein 24; Connective tissue growth factor; CTGF; Insulin-like growth factor binding protein 8; Hypertrophic Chondrocyte Specific Protein 24; IGFBP-rP2; fisp12 protein; CCN2 Protein; Insulin-Like Growth Factor Binding Protein 8,0
C0113127,des-Ala B30 insulin,insulin,,0
C0114422,DKP-insulin,insulin,"aspartyl(B10)-lysyl(B28)-prolyl(B29)-insulin; insulin, Asp(B10)-Lys(B28)-Pro(B29)",0
C0121830,"IRS1 protein, human",insulin,"IRS1 protein, human; insulin receptor substrate 1 protein, human; IRS1; Insulin Receptor Substrate 1; IRS-1; IRS-1 protein, human; hIRS-1 protein",0
C0123256,Insulin-Like Growth-Factor Binding Protein 1,insulin,IGF-Binding Protein 1; Insulin-like growth factor binding protein 1; Insulin-Like Growth Factor Binding Protein 1; Insulin-like growth factor binding protein 1 (substance); IGFBP-1; IGF-BP 1 - Insulin-like growth factor binding protein BP 1; IGF Binding Protein 1; Insulin Like Growth Factor Binding Protein 1,0
C0123257,Insulin-Like Growth Factor Binding Protein 2,insulin,Insulin-like growth factor binding protein 2 (substance); Insulin Like Growth Factor Binding Protein 2; IGF-BP 2 - Insulin-like growth factor binding protein 2; IGF-Binding Protein 2; Insulin-Like Growth Factor Binding Protein 2; Insulin-like growth factor binding protein 2; IGFBP 2; IGFBP-2; IGF Binding Protein 2,0
C0123258,Insulin-Like Growth Factor Binding Protein 4,insulin,IGF-BP4 - Insulin-like growth factor binding protein 4; Insulin-Like Growth Factor Binding Protein 4; IGF-Binding Protein 4; Insulin-like growth factor binding protein 4; Insulin Like Growth Factor Binding Protein 4; IGF Binding Protein 4; Insulin-like growth factor binding protein 4 (substance); IGFBP-4,0
C0123259,Insulin-Like Growth Factor Binding Protein 5,insulin,Insulin Like Growth Factor Binding Protein 5; IGF-Binding Protein 5; IGF Binding Protein 5; IGF-BP 5 - Insulin-like growth factor binding protein 5; Insulin-Like Growth Factor Binding Protein 5; IGFBP-5; Insulin-like growth factor binding protein 5 (substance); Insulin-like growth factor binding protein 5,0
C0123651,insulin dependent activator,insulin,,0
C0123658,insulin receptor substrate 1 protein,insulin,Insulin Receptor Substrate 1 Protein; Insulin Receptor Substrate 1; Insulin Receptor Substrate-1; Insulin Receptor Substrate-1 Protein,0
C0123659,"irs1 protein, Xenopus",insulin,"insulin receptor substrate-1-like protein, Xenopus",0
C0123664,insulin Tochigi,insulin,,0
C0123665,insulin Wakayama,insulin,,0
C0123676,"insulin, Asp(B10)-",insulin,"B10-aspartyl-insulin; B10Asp insulin; ASPB(10); insulin B10Asp; insulin, aspartyl(B10)-; B10-Asp-insulin",0
C0123677,"insulin aspart, human",insulin,"Insulin Aspart; Insulin aspart; Aspart; Insulin X14; Insulin aspart-containing product; Insulin aspart soluble; Insulina asparta; Aspart Insulin; insulin aspart; Product containing insulin aspart (medicinal product); Insulin aspart (substance); insulin aspart recombinant; INSULIN ASPART; Insulin, aspart, human; insulin aspart, human; B28-Aspart-Insulin; Insulin Aspart Recombinant; INSULIN,ASPART,HUMAN/rDNA; Insulin aspart recombinant; Insulin aspart protamine recombinant",0
C0123682,"insulin, des-Ala-",insulin,"des-Ala-insulin; insulin, desalanine-; insulin, de-alanine-; desalanine insulin",0
C0123707,Insulin-Like Growth Factor Binding Protein 3,insulin,"insulin-like growth factor binding protein 3; IGF Binding Protein 3; Insulin-like growth factor binding protein 3 (substance); igfbp-3; Insulin-like growth factor binding protein 3; IGF-BP 3 - Insulin-like growth factor binding protein 3; IGFBP-3; IGF-Binding Protein 3; Protein 3, IGF-Binding; IGFBP3; 3 binding igf protein; Insulin-Like Growth Factor Binding Protein 3; igf binding protein 3",0
C0123715,insulin-maltose,insulin,,0
C0123716,insulin-maltotriose,insulin,,0
C0123717,insulin-mannotetrose,insulin,,0
C0123718,insulin-mannotriose,insulin,,0
C0123720,insulin-oligosaccharides,insulin,,0
C0123722,"insulin-related peptide II, Lymnaea",insulin,,0
C0132893,Novo MC insulin,insulin,,0
C0140079,Insulin-Like Growth Factor Receptor,insulin,"Somatomedin Receptors; Insulin Like Growth Factor Receptor; Receptors, Insulin Like Growth Factors; Insulin Like Growth Factor Receptors; Receptor, Somatomedin; Receptors, Somatomedin; Receptors, Insulin-Like Growth Factors; Insulin-Like Growth Factor Receptors; IGF Receptor; Somatomedin Receptor; Insulin-Like Growth Factor Receptor",0
C0140080,Insulin-Like-Growth Factor I Receptor,insulin,"Insulin-like growth factor-I receptor; Receptors, IGF 1; IGF Type 1 Receptor; IGF-I Receptor; IGF1R; IGF-1 Receptors; Receptors, Insulin-Like-Growth Factor I; Receptor, IGF I; insulin-like growth factor I receptor; Receptor, Insulin-Like Growth Factor I; IGF I Receptor; IGF 1 Receptor; Receptors, IGF-1; Receptor, Insulin-Like Growth Factor Type 1; Receptor, IGF Type 1; Receptor, IGF-1; IGF-1 Receptor; Receptor, IGF-I; Insulin Like Growth Factor I Receptor; Insulin-Like-Growth Factor I Receptor",0
C0140968,ribosomal protein S6 kinase 2,insulin,"insulin-stimulated protein kinase-1; ribosomal protein S6 kinase, 90kD, polypeptide 3; ribosomal S6 kinase 2; ribosomal protein S6 kinase II; RSK2 Kinase; MAPKAP kinase-1b; ribosomal protein S6 kinase alpha-3; MAP-kinase-activated protein kinase 1b; ribosomal protein S6 kinase 2; ribosomal protein S6 kinase alpha 3; RSK kinase II; ISPK-1; ribosomal protein S6 kinase, 90kDa, polypeptide 3",0
C0149658,CONTINUOUS INSULIN INFUSION PUMP,insulin,,0
C0152193,Regular astigmatism,regular,"Regular astigmatism; Astigmatism, regular; Regular astigmatism (disorder)",0
C0163070,Stoddard solvent,regular,Stoddard solvent; Regular mineral spirits; stoddard solvent; Stoddard solvent (substance); Mineral spirits Type I,0
C0165526,insulin secretory granule type II endopeptidase,insulin,,0
C0165638,molluscan insulin-related neuropeptide,insulin,MIP-V,0
C0166441,Glucose Transporter Type 4,insulin,"Insulin Responsive Glucose Transporter; Glucose Transporter Type 4; Glucose Transporter, Insulin-Responsive; Insulin-Responsive Glucose Transporter; Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein; GLUT 4 protein; GLUT4 Protein; GLUT-4 Protein; SLC2A4 Protein; GLUT 4 Protein",0
C0168250,"insulin, B1-(4-azidosalicyloyl)-(B1-biocytin,B2-lysine)-",insulin,"B1-(4-azidosalicyloyl)-(B1-biocytin,B2-lysin)insulin; B1-ASA-(BctB1,LysB2)insulin",0
C0169975,Insulin-Like Growth Factor Binding Protein 6,insulin,IGF Binding Protein 6; IGF-Binding Protein 6; Insulin Like Growth Factor Binding Protein 6; IGFBP-6; Insulin-Like Growth Factor Binding Protein 6,0
C0170857,"insulin-like growth factor binding protein, acid labile subunit",insulin,"insulin-like growth factor binding protein, acid labile subunit; acid-labile subunit, IGF; IGF acid-labile subunit; ALS-IGF",0
C0181334,Closed-loop insulin infusion system,insulin,"Infusion Systems, Insulin, Closed-Loop; Closed-loop insulin infusion system (physical object)",0
C0181364,Insulin Pens,insulin,insulin pens; insulin pen,0
C0181365,Insulin Pump Administration Sets,insulin,,0
C0184625,Normal diet,regular,"Normal diet (finding); Regular diet; Regular diet, NOS; Normal diet; normal diet; Normal diet, NOS; diet regular; Regular Diet; regular diet",0
C0199411,Complete infant care up to one year during regular office visit,regular,,0
C0199782,Administration of insulin,insulin,of insulin injection; Administration of insulin; insulin injection; injections insulin; Administration of insulin (procedure); insulin infusion; insulin administration; Injection of insulin; injection insulin; Infusion of insulin; administration insulin,0
C0201521,Insulin factor antibody measurement,insulin,Insulin factor antibody measurement (procedure); Insulin factor antibody measurement,0
C0202098,Insulin measurement,insulin,insulin level; insulin level test; Insulin Measurement; insulin test; Insulin level; Insulin measurement; insulin levels; insulin testing; Insulin measurement (procedure); insulin measurement,0
C0202099,Immunoreactive insulin measurement,insulin,Immunoreactive insulin measurement (procedure); Immunoreactive insulin measurement,0
C0202100,Insulin C-peptide measurement,insulin,Insulin C-peptide measurement (procedure); C-peptide level; C-peptide Measurement; insulin c-peptide measurement; c peptide levels; insulin c-peptide level test; Connecting peptide insulin measurement; C-peptide measurement; Insulin C-peptide measurement; Proinsulin C-peptide measurement; c-peptide level,0
C0202220,Somatomedin-C measurement,insulin,Insulin-like growth factor-I measurement; Insulin-like growth factor-1 measurement; Somatomedin-C measurement (procedure); Somatomedin-C measurement; Insulin Like Growth Factor-1 Measurement,0
C0204495,"Regular psychiatric visit, routine, established patient",regular,"Regular psychiatric visit, routine, established patient (procedure); Regular psychiatric visit, routine, established patient",0
C0205272,Regular,regular,Regular (qualifier value); Regularity; Regular; regular,0
C0208233,pitrilysin,insulin,Pitrilysin; Pitrilysin (substance); protease III; periplasmic insulin degrading protease; protease Pi; Protease Pi; pitrilysin; Coccus P proteinase; Sporotrichum proteinase II; Protease III; Staphyiokinase,0
C0209305,"insulin, despentapeptide (B26-B30)-PheNH2(B25)-",insulin,"despentapeptide(B26-B30)-B25-phenylalaninamide-insulin; DPPA-insulinamide; despentapeptide(B26-B30)-B25-PheNH2-insulin; (B26-B30)-despentapeptide-B25-phenylalaninamide-insulin; insulin, despentapeptide(B26-B30)-phenylalaninamide(B25)-; despentapeptide(B26-B30)-insulin-B25-amide",0
C0213702,B29-biotin insulin,insulin,BBpa insulin,0
C0214849,insulin-like growth factor binding protein-3 protease,insulin,IGFBP-3 protease,0
C0217461,insulin receptor serine kinase,insulin,IRS kinase,0
C0221887,"Syringes, Insulin, Shielded-Needle",insulin,,0
C0225333,Dense fibrous connective tissue,regular,Dense regular collagenous connective tissue; Structure of dense fibrous connective tissue; Dense fibrous connective tissue; Regular Dense Connective Tissue; Dense regular connective tissue; Dense regular collagenous tissue; Typus regularis (Textus connectivus collagenosus compactus); Structure of dense fibrous connective tissue (body structure),0
C0225346,Dense elastic connective tissue,regular,Structure of dense elastic connective tissue; Dense regular elastic connective tissue; Dense elastic connective tissue; Dense regular elastic tissue; Structure of dense elastic connective tissue (body structure),0
C0235409,INCREASED INSULIN REQUIREMENT,insulin,INSULIN REQUIREMENT INCREASE,0
C0235422,INSULIN VALUE INCREASED,insulin,,0
C0236287,Insulin tolerance test,insulin,ITT - Insulin tolerance test; insulin stress test; insulin tests tolerance; Insulin tolerance test (procedure); IST - Insulin stress test; Insulin stress test; tolerance test insulin; insulin tolerance test,0
C0240014,INSULIN REQUIREMENT DECREASE,insulin,,0
C0240016,Insulin used,insulin,insulin uses; use insulin; INSULIN USE; Insulin used (attribute); insulin use,0
C0245314,octadeutero-Phe(B1)-insulin,insulin,,0
C0246071,insulin enhancer factor 1,insulin,IEF1,0
C0248419,pancreatic and duodenal homeobox 1 protein,insulin,insulin promoter factor 1; somatostatin transactivating factor 1; pancreatic-duodenal homeobox factor-1; islet-duodenum homeobox-1 protein; pancreatic and duodenal homeobox gene-1; glucose-sensitive factor (GSF); pancreatic and duodenal homeobox 1 protein,0
C0249860,Leydig insulin-like protein,insulin,relaxin-like factor; Leydig insulin-like protein; INSL3 protein; Ley I-L protein; RLF (LEY I-L),0
C0250831,insulin fragment A(14-21)-B(17-30),insulin,insulin fragment A14-21-B17-30,0
C0251583,long R(3)-insulin-like growth factor-I,insulin,long-arginyl(3)-IGF-I; long-Arg(3)-IGF-I; longR(3)-IGF-I; long R(3) IGF-I,0
C0253017,"insulin, Arg(B31)-",insulin,Arg-B31 human insulin; ABHI; B31-Arg-insulin,0
C0254207,"insulin, octadeutero-Phe(B1)-octadeutero-Val(B2)-",insulin,"insulin, octadeuterophenylalanyl(B1)-octadeuterovalyl(B2)-; octadeutero-Phe(B1)-octadeutero-Val(B2)-insulin; B1-octadeutero-Phe-B2-octadeutero-Val-insulin",0
C0254260,"EIF4EBP1 protein, human",insulin,"4E-BP1; 4E-BP1, human; Phosphorylated Heat- and Acid-Stable Protein Regulated by Insulin 1; PHAS-I protein, human; EIF4EBP1 protein, human; eIF4E-Binding Protein 1; eIF4E-binding protein 1, human; PHAS-I; eukaryotic translation initiation factor 4E binding protein 1, human; Eukaryotic Translation Initiation Factor 4E-Binding Protein 1",0
C0254448,insulin-stimulated MEK kinase,insulin,I-MEKK; insulin-stimulated MEKK,0
C0256611,EPC-NPH,NPH,,0
C0256728,"insulin, His(B16)-",insulin,"insulin, histidine(B16)-; B16-histidine-insulin; His(B16)-insulin",0
C0261548,Failure in dosage in electroshock or insulin-shock therapy,insulin,,0
C0271636,Insulin dependent diabetes mellitus type 1A,insulin,Insulin dependent diabetes mellitus type IA; Insulin dependent diabetes mellitus type IA (disorder); Immune-mediated type 1 diabetes mellitus,0
C0271637,Insulin dependent diabetes mellitus type 1B,insulin,Insulin dependent diabetes mellitus type IB (disorder); Idiopathic type 1 diabetes mellitus; Primary autoimmune diabetes mellitus; Insulin dependent diabetes mellitus type IB,0
C0271658,Impaired glucose tolerance associated with insulin receptor abnormality,insulin,Impaired glucose tolerance associated with insulin receptor abnormality; Impaired glucose tolerance associated with insulin receptor abnormality (disorder),0
C0271687,Diabetes mellitus due to structurally abnormal insulin,insulin,"Insulinopathy, NOS; Diabetes mellitus due to structurally abnormal insulin (disorder); Insulinopathy; Diabetes mellitus due to abnormal insulin",0
C0271688,Insulin biosynthesis defect,insulin,"Insulin biosynthesis defect (disorder); Insulin biosynthesis defect, NOS",0
C0271689,"Insulin Receptor, Defect in",insulin,"Insulin receptor defect (disorder); Insulin receptor defect, NOS; INSULIN RECEPTOR, DEFECT IN; Insulin receptor defect",0
C0271690,Acanthosis nigricans due to type 2 diabetes mellitus,insulin,Acanthosis nigricans due to type 2 diabetes mellitus (disorder); Insulin-resistant diabetes mellitus and acanthosis nigricans; Type 2 diabetes mellitus with acanthosis nigricans; Insulin-resistant diabetes mellitus AND acanthosis nigricans,0
C0271691,"Extreme insulin resistance with acanthosis nigricans, hirsutism AND abnormal insulin receptors",insulin,"Extreme insulin resistance with acanthosis nigricans, hirsutism AND abnormal insulin receptors (disorder); Extreme insulin resistance with acanthosis nigricans, hirsutism and abnormal insulin receptors; Extreme insulin resistance type A",0
C0271692,"Extreme insulin resistance with acanthosis nigricans, hirsutism AND autoantibodies to the insulin receptors",insulin,"Extreme insulin resistance with acanthosis nigricans, hirsutism and autoantibodies to the insulin receptors; Extreme insulin resistance type B; Extreme insulin resistance with acanthosis nigricans, hirsutism AND autoantibodies to the insulin receptors (disorder)",0
C0271695,Rabson-Mendenhall Syndrome,insulin,"Pineal hyperplasia and diabetes mellitus syndrome; PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES; Mendenhall syndrome; MENDENHALL SYNDROME; Pineal Hyperplasia, Insulin-Resistant Diabetes Mellitus, And Somatic Abnormalities; Pineal hyperplasia, insulin-resistant diabetes mellitus and somatic abnormalities; Pineal hyperplasia AND diabetes mellitus syndrome (disorder); Rabson Mendenhall syndrome; Pineal hyperplasia AND diabetes mellitus syndrome; Syndrome, Rabson-Mendenhall; RABSON-MENDENHALL SYNDROME; Rabson Mendenhall Syndrome; Mendenhall Syndrome; Syndrome, Mendenhall; Rabson-Mendenhall syndrome; Rabson-Mendenhall Syndrome",0
C0271701,Diabetes mellitus due to insulin receptor antibodies,insulin,Diabetes mellitus caused by insulin receptor antibodies (disorder); DM due to insulin receptor ab; Diabetes mellitus due to insulin receptor antibodies; DM caused by insulin receptor ab; Diabetes mellitus caused by insulin receptor antibodies,0
C0274541,"Poisoning by insulin or antidiabetic agent, NOS",insulin,,0
C0274546,Poisoning by insulin,insulin,Poisoning by insulin; Poisoning caused by insulin (disorder); Insulin poisoning; Poisoning caused by insulin,0
C0279719,Pancreatic Beta Cell Adenoma,insulin,"adenoma, pancreatic beta islet cell; insulin producing adenoma; insulin secreting adenoma; beta islet cell adenoma, pancreatic; pancreatic beta islet cell adenoma; Pancreatic Beta Cell Adenoma; islet cell, beta, pancreatic adenoma",0
C0283258,"insulin, desamido (A21)-",insulin,A21-desamido-insulin; desamido-A21-insulin,0
C0285904,insulin-like growth factor I (57-70),insulin,IGF-1 (57-70); somatomedin C (57-70),0
C0291665,B-insulin,insulin,,0
C0291667,NBC-insulin,insulin,NalphaB1-(biotinyl-epsilon-aminocaproyl)insulin,0
C0293359,insulin lispro,insulin,"Insulin lispro recombinant; Insulin lispro (genetical recombination); Insulin lispro (rDNA origin); Insulin lispro; insulin lispro; Insulin,lispro,human/rDNA; LYSPRO; Lispro, Insulin; Insulin lispro-containing product; lispro insulin; Insulin, Lys(28B)-Pro(29B)-; Product containing insulin lispro (medicinal product); Insulin, Lysyl(28B)-Prolyl(28B)-; Insulin lispro protamine recombinant; INSULIN LISPRO; 28(B)-Lysine-29(B)-Prolineinsulin; insulin human lispro; Insulin lispro (substance); Lispro; lispro human insulin; Lispro insulin; Insulina lispro; lispro; Insulin Lispro; 28(B)-Lys-29(B)-Pro-Insulin; INSULIN,LISPRO,HUMAN/rDNA",0
C0294232,insulin-like growth factor I (24-41),insulin,IGF-I (24-41),0
C0294827,BSA-insulin-chlorin e(6) conjugate,insulin,BSA-insulin-chlorin e6,0
C0296855,amphioxus insulin-like peptide,insulin,amphioxus ILP,0
C0299594,"insulin-like growth factor I, Gln(3)-Ala(4)-Tyr(15)-Leu(16)-",insulin,(QAYL)IGF-I; (Q(3)A(4)Y(15)L(16))IGF-I; glutaminyl(3)-alanyl(4)-tyrosyl(15)-leucyl(16)-IGF-I,0
C0304866,"Insulin, Beef",insulin,"insulin bovine; insulin (beef); Insulin Beef; Beef insulin; Beef insulin-containing product; Insulin bovine; beef insulin; Insulin (beef); Insulin purified beef; Beef insulin, NOS; bovine insulin; Product containing beef insulin (product); Beef insulin (substance); Insulin beef; Bovine insulin",0
C0304869,"Intermediate-acting insulin, NOS",insulin,,0
C0304870,"Insulin, Long-Acting",insulin,"Long-Acting Insulin; long acting insulin; Long Acting Insulin; insulins long acting; Insulin, Long Acting; Long-acting insulin, NOS",0
C0304889,halibut liver oil,regular,Halibut liver oil-containing product; Product containing halibut liver oil (medicinal product); Halibut liver oil preparation; Halibut liver oil (substance); Halibut Liver Oil Regular; Halibut liver oil; Halibut Liver Oil; halibut liver oil,0
C0305086,"4-Way Fast Acting Nasal Spray, Regular",regular,,0
C0305257,Anacin-3 Regular Strength Acetaminophen Film Coated Tablets,regular,,0
C0305655,Clearasil Double Textured Pads - Regular Strength,regular,,0
C0305966,Doan's - Regular Strength Analgesic,regular,,0
C0306041,Ecotrin Enteric Coated Aspirin Regular Strength Caplets,regular,,0
C0306435,"Iletin I, Regular",regular,,0
C0306467,Insulatard NPH,NPH,,0
C0306468,Insulatard NPH Human,NPH,,0
C0306604,"lente insulin, pork",insulin,"insulin, lente, porcine; insulin zinc pork purified; insulin, lente, pork; Insulin Lente Pork; Lente Purified Pork Insulin; lente insulin, pork; INSULIN,LENTE,PORK/PURIFIED",0
C0306644,Listerine Antiseptic Lozenges Regular Strength,regular,,0
C0306906,NPH Iletin I,NPH,,0
C0306907,NPH Iletin II,NPH,Iletin II NPH Pork,0
C0307055,Norwich Regular Strength Aspirin,regular,,0
C0307068,NovoLIN 70/30,novolin,Novolin 70/30,0
C0307069,Novolin 70/30 PenFill Cartridges,novolin,,0
C0307070,NovoLIN L,novolin,Novolin L,0
C0307071,Novolin N,novolin,"Insulatard; Novolin N; novolin n; NovoLIN N; N, Novolin",0
C0307072,Novolin N PenFill Cartridges,novolin,,0
C0307073,Novolin R,novolin,novolin r; NovoLIN R; Novolin R,0
C0307074,Novolin R PenFill Cartridges,novolin,,0
C0307181,Oxy Clean Medicated Pads - Regular,regular,,0
C0307371,Primatene Tablets-Regular Formula,regular,,0
C0307460,Regular Iletin II,regular,,0
C0307462,Regular Strength Ascriptin Tablets,regular,,0
C0307463,Regular Strength Midol Multi-Symptom Menstrual Formula,regular,,0
C0307631,Sinutab Regular Strength Without Drowsiness Formula,regular,,0
C0307689,Stri-Dex Dual Textured Regular Strength Big Pads,regular,,0
C0307690,Stri-Dex Dual Textured Regular Strength Pads,regular,,0
C0307724,Sunkist Children's Chewable Multivitamins - Regular,regular,,0
C0308204,pHisoDerm Skin Cleanser and Conditioner - Regular and Oily,regular,,0
C0311125,Mechanical regular diet,regular,Mechanical regular diet; Mechanical regular diet (finding),0
C0311127,Regular wired jaw diet,regular,Regular wired jaw diet; Regular wired jaw diet (finding),0
C0334097,Epithelial proliferation,regular,"Epithelial proliferation; Proliferation, epithelial; Regular epithelial proliferation; Epithelial proliferation (morphologic abnormality)",0
C0336563,"Pancreas, Artificial",insulin,"Artificial pancreas; artificial pancreas; Artificial pancreas, device (physical object); pancreas artificial; Artificial Pancreas Device System; Artificial pancreas, device; Artificial Pancreas; Autonomous System for Glycemic Control; Automated Insulin Delivery System",0
C0337430,Insulin antibody measurement,insulin,Insulin antibody measurement (procedure); Insulin Antibody Measurement; Insulin antibody measurement; insulin antibody level test,0
C0339682,Corneal Astigmatism,regular,"Corneal astigmatism; Astigmatism, Corneal; Regular astigmatism - corneal (disorder); Regular astigmatism - corneal",0
C0339683,Lenticular Astigmatism,regular,"Regular astigmatism - lenticular; Astigmatism, Lenticular; Lenticular astigmatism; Regular astigmatism - lenticular (disorder)",0
C0342266,Insulin treated type 2 diabetes mellitus,insulin,Diabetes type 2 on insulin; Insulin treated type 2 diabetes mellitus (disorder); Insulin treated Type II diabetes mellitus,0
C0342278,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",insulin,"Hereditary benign acanthosis nigricans with insulin resistance; Insulin Receptor Defect with Insulin-Resistant Diabetes Mellitus and Acanthosis Nigricans; INSULIN RECEPTOR, DEFECT IN, WITH INSULIN-RESISTANT DIABETES MELLITUS AND ACANTHOSIS NIGRICANS; Insulin receptor defect with insulin-resistant diabetes mellitus and acanthosis nigricans; Hereditary benign acanthosis nigricans with insulin resistance (disorder); DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS, TYPE A; Insulin-resistant acanthosis nigricans type A; DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS; IRAN, TYPE A; Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans, Type A; IRAN, Type A",0
C0342284,Bangstad syndrome,insulin,"Bird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goiter, and primary gonadal insufficiency (disorder); Ataxia-diabetes-goiter-gonadal insufficiency syndrome; BANGSTAD SYNDROME; Bird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goiter, and primary gonadal insufficiency; Bangstad syndrome; Bird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goitre, and primary gonadal insufficiency; BIRD-HEADED DWARFISM WITH PROGRESSIVE ATAXIA, INSULIN-RESISTANT DIABETES, GOITER, AND PRIMARY GONADAL INSUFFICIENCY",0
C0342288,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,insulin,"XLAAD; POLYENDOCRINOPATHY, IMMUNE DYSFUNCTION, AND DIARRHEA, X-LINKED; Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome; IDDM-SECRETORY DIARRHEA SYNDROME; XPID; IPEX; X-linked immune dysregulation, polyendocrinopathy, enteropathy syndrome; IMMUNODEFICIENCY, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED, FORMERLY; X-Linked Autoimmunity-Allergic Dysregulation Syndrome; Immune Dysregulation, Polyendocrinopathy, and Enteropathy X-Linked Syndrome; Immunodysregulation, Polyendocrinopathy, and Enteropathy, X-Linked; IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; Diabetes Mellitus, Congenital Insulin-Dependent, with Fatal Secretory Diarrhea; DMSD; Enteropathy, Autoimmune, with Hemolytic Anemia and Polyendocrinopathy; X-LINKED AUTOIMMUNITY-ALLERGIC DYSREGULATION SYNDROME; Autoimmunity-Immunodeficiency Syndrome, X-Linked; Ipex Syndrome; AUTOIMMUNITY-IMMUNODEFICIENCY SYNDROME, X-LINKED; ENTEROPATHY, AUTOIMMUNE, WITH HEMOLYTIC ANEMIA AND POLYENDOCRINOPATHY; Diarrhea, Polyendocrinopathy, Fatal Infection Syndrome, X-Linked; Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome; Autoimmune enteropathy type 1; X-linked immune dysregulation, polyendocrinopathy, enteropathy syndrome (disorder); DIABETES MELLITUS, CONGENITAL INSULIN-DEPENDENT, WITH FATAL SECRETORY DIARRHEA; DIARRHEA, POLYENDOCRINOPATHY, FATAL INFECTION SYNDROME, X-LINKED; IDDM-Secretory Diarrhea Syndrome; Polyendocrinopathy, Immune Dysfunction, and Diarrhea, X-Linked",0
C0342305,pregnancy and insulin-dependent diabetes mellitus,insulin,iddm pregnancy,0
C0342323,Ectopic IGF hypoglycemia,insulin,Ectopic insulin-like growth factor hypoglycaemia; Ectopic insulin-like growth factor hypoglycemia; Ectopic insulin-like growth factor hypoglycemia (disorder); Ectopic IGF hypoglycaemia,0
C0342324,Ectopic IGF-1 hypoglycemia,insulin,Ectopic insulin-like growth factor-1 hypoglycemia; Ectopic insulin-like growth factor-1 hypoglycaemia; Ectopic insulin-like growth factor-1 hypoglycemia (disorder); Ectopic IGF-1 hypoglycaemia,0
C0342325,Ectopic IGF-2 hypoglycemia,insulin,Ectopic insulin-like growth factor-2 hypoglycaemia; Ectopic insulin-like growth factor-2 hypoglycemia (disorder); Ectopic insulin-like growth factor-2 hypoglycemia; Ectopic IGF-2 hypoglycaemia,0
C0342335,insulin resistance in diabetes,insulin,diabetes insulin resistance; insulin resistance diabetes,0
C0342336,Insulin resistance - type A,insulin,"Insulin resistance syndrome, type A; Insulin-resistance syndrome type A; Insulin resistance - type A (disorder); Type A insulin resistance; Insulin Resistant Diabetes Mellitus with Acanthosis Nigricans and Hyperandrogenism",0
C0342337,Insulin resistance - type B,insulin,"Insulin-resistance syndrome type B; Insulin resistance syndrome, type B; Insulin resistance - type B (disorder)",0
C0344170,Insulin-induced anaphylaxis,insulin,Insulin-induced anaphylaxis (disorder),0
C0348917,"Pre-existing diabetes mellitus, insulin-dependent",insulin,Pre-existing type 1 diabetes mellitus (disorder); Pre-existing type 1 diabetes mellitus,0
C0348921,"Pre-existing diabetes mellitus, non-insulin-dependent",insulin,Pre-existing type 2 diabetes mellitus; Pre-existing type 2 diabetes mellitus (disorder),0
C0356365,"Insulin, Short-Acting",insulin,"Short-Acting Insulin; Rapid-Acting Insulin; Rapid-acting insulin, NOS; Insulin, Rapid-Acting; Insulin, Rapid Acting; Insulin, Short Acting",0
C0356369,Biphasic Insulins,insulin,"Insulins, Biphasic; Biphasic Insulin; Insulins, Mixed; Insulin, Biphasic; Insulin Mixtures; Mixed Insulins",0
C0360493,mixtard insulin,insulin,insulin mixtard,0
C0362748,Insulin bovine Ab.IgE:ACnc:Pt:Ser:Qn,insulin,Insulin Bovine IgE Qn; Insulin bovine IgE Qn (S); Insulin bovine Antibody.immunoglobulin E:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative; Insulin bovine IgE Ab [Units/volume] in Serum,0
C0362749,Insulin human Ab.IgE:ACnc:Pt:Ser:Qn,insulin,Insulin human IgE Qn (S); Insulin human Antibody.immunoglobulin E:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative; Insulin Human IgE Qn; Insulin human IgE Ab [Units/volume] in Serum,0
C0362750,Insulin porcine Ab.IgE:ACnc:Pt:Ser:Qn,insulin,Insulin porcine Antibody.immunoglobulin E:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative; Insulin Porcine IgE Qn; Insulin porcine IgE Ab [Units/volume] in Serum; Insulin porcine IgE Qn (S),0
C0363494,Corticotropin^1.5H post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,ACTH 1.5h p Ins IV Plas-mCnc; Corticotropin [Mass/volume] in Plasma --1.5 hours post dose insulin IV; Corticotropin^1.5 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin 1.5 Hr post dose insulin IV (P) [Mass/Vol],0
C0363496,Corticotropin^1H post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin 1 Hr post dose insulin IV (P) [Mass/Vol]; ACTH 1h p Ins IV Plas-mCnc; Corticotropin^1 hour post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Mass/volume] in Plasma --1 hour post dose insulin IV,0
C0363499,Corticotropin^30M post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin 30 Min post dose insulin IV (P) [Mass/Vol]; ACTH 30M p Ins IV Plas-mCnc; Corticotropin [Mass/volume] in Plasma --30 minutes post dose insulin IV; Corticotropin^30 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative,0
C0363501,Corticotropin^45M post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin^45M post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV; Corticotropin 45 Min post dose insulin IV (P) [Mass/Vol]; ACTH 45M p Ins IV Plas-mCnc,0
C0363533,Cortisol^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn,insulin,Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting; Cortisol 1.5 Hr post 0.05-0.15 U insulin/kg IV 12 Hr fasting [Mass/Vol]; Cortisol^1.5 hours post 0.05-0.15 U insulin/kg Intravenous post 12 hours Calorie fast:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortis 1.5h p U/kg Ins IV SerPl-mCnc,0
C0363534,Cortisol^1.5H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Cortisol^1.5 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortis 1.5h p Ins IV SerPl-mCnc; Cortisol 1.5 Hr post dose insulin IV [Mass/Vol]; Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV,0
C0363535,Cortisol^1H post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn,insulin,Cortis 1h p U/kg Ins IV SerPl-mCnc; Cortisol^1 hour post 0.05-0.15 U insulin/kg Intravenous post 12 hours Calorie fast:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst; Cortisol 1 Hr post 0.05-0.15 U insulin/kg IV post 12H CFst [Mass/Vol],0
C0363540,Cortisol^1 hour post dose insulin Intravenous:Mass Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Cortisol^1H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn; Cortisol 1 Hr post dose insulin IV [Mass/Vol]; Cortisol^1 hour post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV; Cortis 1h p Ins IV SerPl-mCnc,0
C0363549,Cortisol^30M post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn,insulin,Cortisol 30 Min post 0.05-0.15 U insulin/kg IV post 12H CFst [Mass/Vol]; Cortisol^30 minutes post 0.05-0.15 U insulin/kg Intravenous post 12 hours Calorie fast:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortis 30M p U/kg Ins IV SerPl-mCnc; Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C0363554,Cortisol^30 minutes post dose insulin Intravenous:Mass Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Cortis 30M p Ins IV SerPl-mCnc; Cortisol^30 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol^30M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn; Cortisol 30 Min post dose insulin IV [Mass/Vol]; Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV,0
C0363558,Cortisol^45M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Cortisol 45 Min post dose insulin IV [Mass/Vol]; Cortis 45M p Ins IV SerPl-mCnc; Cortisol^45M post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV,0
C0363627,Glucose^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose 1.5 Hr post 0.05-0.15 U insulin/kg IV 12 Hr fasting [Mass/Vol]; Glucose^1.5 hours post 0.05-0.15 U insulin/kg Intravenous post 12 hours Calorie fast:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 1.5h p U/kg Ins IV SerPl-mCnc; Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting,0
C0363631,Glucose^1.5H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV; Glucose^1.5 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 1.5h p Ins IV SerPl-mCnc; Glucose 1.5 Hr post dose insulin IV [Mass/Vol],0
C0363634,Glucose^1H post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose 1h p U/kg Ins IV SerPl-mCnc; Glucose 1 Hr post 0.05-0.15 U insulin/kg IV post 12H CFst [Mass/Vol]; Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst; Glucose^1 hour post 0.05-0.15 U insulin/kg Intravenous post 12 hours Calorie fast:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0363644,Glucose^1 hour post dose insulin Intravenous:Mass Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose 1h p Ins IV SerPl-mCnc; Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV; Glucose^1 hour post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose^1H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn; Glucose 1 Hr post dose insulin IV [Mass/Vol],0
C0363656,Glucose^30M post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose 30M p U/kg Ins IV SerPl-mCnc; Glucose^30 minutes post 0.05-0.15 U insulin/kg Intravenous post 12 hours Calorie fast:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 30 Min post 0.05-0.15 U insulin/kg IV post 12H CFst [Mass/Vol]; Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C0363661,Glucose^30 minutes post dose insulin Intravenous:Mass Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose 30M p Ins IV SerPl-mCnc; Glucose^30M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn; Glucose 30 Min post dose insulin IV [Mass/Vol]; Glucose^30 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV,0
C0363668,Glucose^45M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose^45M post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 45 Min post dose insulin IV [Mass/Vol]; Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV; Glucose 45M p Ins IV SerPl-mCnc,0
C0363693,Insulin^1H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 1 Hr post 75 g glucose PO [Mass/Vol]; Insulin^1 hour post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1h p 75 g Glc PO SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO,0
C0363696,Insulin^2H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^2 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2 Hr post 75 g glucose PO [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO; Insulin 2h p 75 g Glc PO SerPl-mCnc,0
C0363699,Insulin^3H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 3h p 75 g Glc PO SerPl-mCnc; Insulin 3 Hr post 75 g glucose PO [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO; Insulin^3 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0363700,Insulin^4H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^4 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 4 Hr post 75 g glucose PO [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO; Insulin 4h p 75 g Glc PO SerPl-mCnc,0
C0363701,Insulin^5H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 5h p 75 g Glc PO SerPl-mCnc; Insulin 5 Hr post 75 g glucose PO [Mass/Vol]; Insulin^5 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO,0
C0363702,Insulin^baseline:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin baseline [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --baseline; Insulin^baseline:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin BS SerPl-mCnc,0
C0363705,Insulin^post 12H CFst:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin post 12 Hr fast [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --12 hours fasting; Insulin^post 12 hours Calorie fast:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin p 12h fast SerPl-mCnc,0
C0363758,Somatotropin^1.5H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^1.5 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 1.5h p Ins IV SerPl-mCnc; Somatotropin 1.5 Hr post dose insulin IV [Mass/Vol]; Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV,0
C0363760,Somatotropin^1H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,GH 1h p Ins IV SerPl-mCnc; Somatotropin^1 hour post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV; Somatotropin 1 Hr post dose insulin IV [Mass/Vol],0
C0363762,Somatotropin^30M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 30 Min post dose insulin IV [Mass/Vol]; GH 30M p Ins IV SerPl-mCnc; Somatotropin^30 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV,0
C0363764,Somatotropin^45M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV; Somatotropin^45M post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 45M p Ins IV SerPl-mCnc; Somatotropin 45 Min post dose insulin IV [Mass/Vol],0
C0364623,Insulin Ab:PrThr:Pt:Ser:Ord,insulin,Insulin Ab Ql (S); Insulin Antibody:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal; Insulin Ab [Presence] in Serum; Insulin Ab Ser Ql,0
C0364624,Insulin Ab:MCnc:Pt:Ser:Qn,insulin,Insulin Antibody:Mass Concentration:To identify measures at a point in time:Serum:Quantitative; Insulin Ab (S) [Mass/Vol]; Insulin Ab Ser-mCnc; Insulin Ab [Mass/volume] in Serum,0
C0364625,Insulin-like growth factor binding protein 3:MCnc:Pt:Ser/Plas:Qn,insulin,IGF BP3 SerPl-mCnc; Insulin-like growth factor binding protein 3 [Mass/Vol]; Insulin-like growth factor binding protein 3:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma,0
C0364626,Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma,insulin,Insulin-like growth factor-I [Mass/Vol]; Insulin-like growth factor-I:MCnc:Pt:Ser/Plas:Qn; Insulin-like growth factor-I:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma; IGF-I SerPl-mCnc,0
C0364627,Insulin-like growth factor-II:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-II [Mass/Vol]; Insulin-like growth factor-II [Mass/volume] in Serum or Plasma; IGF-II SerPl-mCnc; Insulin-like growth factor-II:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0365924,Insulin renal clearance (24H U) [Vol/Time],insulin,,0
C0365925,Insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/Vol]; Insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma,0
C0366511,Insulin Lente:Mass:Pt:Dose:Qn,insulin,Insulin Lente:Mass:To identify measures at a point in time:Dose:Quantitative; Insulin Lente Dose; Insulin Lente [Mass] of Dose; Insulin Lente (Dose) [Mass],0
C0366512,Insulin NPH:Mass:Pt:Dose:Qn,insulin,Insulin NPH [Mass] of Dose; Insulin NPH Dose; Insulin NPH (Dose) [Mass]; Insulin NPH:Mass:To identify measures at a point in time:Dose:Quantitative,0
C0366513,Insulin regular:Mass:Pt:Dose:Qn,insulin,Insulin regular (Dose) [Mass]; Insulin regular:Mass:To identify measures at a point in time:Dose:Quantitative; Insulin Regular Dose; Insulin regular [Mass] of Dose,0
C0366514,Insulin semilente:Mass:Pt:Dose:Qn,insulin,Insulin semilente [Mass] of Dose; Insulin semilente (Dose) [Mass]; Insulin semilente:Mass:To identify measures at a point in time:Dose:Quantitative; Insulin Semilente Dose,0
C0366515,Insulin ultralente:Mass:Pt:Dose:Qn,insulin,Insulin Ultralente Dose; Insulin ultralente:Mass:To identify measures at a point in time:Dose:Quantitative; Insulin ultralente (Dose) [Mass]; Insulin ultralente [Mass] of Dose,0
C0367432,Insulin Ab:ACnc:Pt:Ser:Qn:RIA,insulin,Insulin Antibody:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative:Radioimmunoassay; Insulin Ab Ser RIA-aCnc; Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA); Insulin Ab RIA Qn (S),0
C0369533,Insulin renal clearance,insulin,"Insulin renal clearance, function; Insulin renal clearance; Insulin renal clearance, function (observable entity)",0
C0373503,Glucagon tolerance panel; for insulinoma This panel must include the following: Glucose (82947 x 3) Insulin (83525 x 3),insulin,,0
C0373509,Insulin tolerance panel; for ACTH insufficiency This panel must include the following: Cortisol (82533 x 5) Glucose (82947 x 5),insulin,,0
C0373510,Insulin tolerance panel; for growth hormone deficiency This panel must include the following: Glucose (82947 x 5) Human growth hormone (HGH) (83003 x 5),insulin,,0
C0374422,"Rapid desensitization procedure, each hour (eg, insulin, penicillin, equine serum)",insulin,,0
C0375113,"Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled",insulin,"Adult-onset type diabetes mellitus or unspecified type, not stated as uncontrolled, without mention of complication; Type II diabetes mellitus or unspecified type, not stated as uncontrolled, without mention of complication; Non-insulin dependent type diabetes mellitus or unspecified type, not stated as uncontrolled, without mention of complication; NIDDM type or unspecified type, not stated as uncontrolled, without mention of complication; type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, without mention of complication",0
C0375114,"Diabetes mellitus without mention of complication, type I [juvenile type], not stated as uncontrolled",insulin,"Type I diabetes mellitus not stated as uncontrolled, without mention of complication; IDDM not stated as uncontrolled, without mention of complication; Insulin dependent type not stated as uncontrolled, without mention of complication; type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, without mention of complication; Juvenile type diabetes mellitus not stated as uncontrolled, without mention of complication",0
C0375115,"Diabetes mellitus without mention of complication, type II or unspecified type, uncontrolled",insulin,"type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, without mention of complication; Non-insulin dependent type diabetes mellitus or unspecified type, uncontrolled, without mention of complication; Type II diabetes mellitus or unspecified type, uncontrolled, without mention of complication; Adult-onset type diabetes mellitus or unspecified type, uncontrolled, without mention of complication; NIDDM type or unspecified type, uncontrolled, without mention of complication",0
C0375117,"Diabetes with ketoacidosis, type II or unspecified type, not stated as uncontrolled",insulin,"Non-insulin dependent type diabetes mellitus or unspecified type, not stated as uncontrolled, with ketoacidosis; Type II diabetes mellitus or unspecified type, not stated as uncontrolled, with ketoacidosis; type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, with ketoacidosis; Adult-onset type diabetes mellitus or unspecified type, not stated as uncontrolled, with ketoacidosis; NIDDM type or unspecified type, not stated as uncontrolled, with ketoacidosis",0
C0375118,"Diabetes with ketoacidosis, type I [juvenile type], not stated as uncontrolled",insulin,"Type I diabetes mellitus, not stated as uncontrolled, with ketoacidosis; Insulin dependent type diabetes mellitus, not stated as uncontrolled, with ketoacidosis; type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, with ketoacidosis; Juvenile type diabetes mellitus, not stated as uncontrolled, with ketoacidosis; IDDM, not stated as uncontrolled, with ketoacidosis",0
C0375119,"Diabetes with ketoacidosis, type II or unspecified type, uncontrolled",insulin,"NIDDM type or unspecified type, uncontrolled, with ketoacidosis; type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, with ketoacidosis; Adult-onset type diabetes mellitus or unspecified type, uncontrolled, with ketoacidosis; Non-insulin dependent type diabetes mellitus or unspecified type, uncontrolled, with ketoacidosis; Type II diabetes mellitus or unspecified type, uncontrolled, with ketoacidosis",0
C0375122,"Diabetes with hyperosmolarity, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus, NIDDM type or unspecified type with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, non-insulin dependent type or unspecified type with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, type II or unspecified type with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, adult-onset type or unspecified type with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type with hyperosmolarity, not stated as uncontrolled",0
C0375123,"Diabetes with hyperosmolarity, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus, juvenile type with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, type I with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, IDDM with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, insulin dependent type with hyperosmolarity, not stated as uncontrolled; Diabetes mellitus, type I [insulin dependent type] [IDDM] [juvenile type] with hyperosmolarity, not stated as uncontrolled",0
C0375124,"Diabetes with hyperosmolarity, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitustype II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type with hyperosmolarity, uncontrolled; Diabetes mellitus non-insulin dependent type or unspecified type with hyperosmolarity, uncontrolled; Diabetes mellitus NIDDM type or unspecified type with hyperosmolarity, uncontrolled; Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type with hyperosmolarity, uncontrolled; Diabetes mellitus adult-onset type or unspecified type with hyperosmolarity, uncontrolled; Diabetes mellitus type II or unspecified type with hyperosmolarity, uncontrolled",0
C0375126,"Diabetes with other coma, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus, adult-onset type or unspecified type, not stated as uncontrolled; Diabetes mellitus, type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled; Diabetes mellitus, NIDDM type or unspecified type, not stated as uncontrolled; Diabetes mellitus, non-insulin dependent type or unspecified type, not stated as uncontrolled; Diabetes mellitus, type II or unspecified type, not stated as uncontrolled",0
C0375127,"Diabetes with other coma, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus, juvenile type, not stated as uncontrolled; Diabetes mellitus, type I, not stated as uncontrolled; Diabetes mellitus, type I [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled; Diabetes mellitus, insulin dependent type, not stated as uncontrolled; Diabetes mellitus, IDDM, not stated as uncontrolled",0
C0375128,"Diabetes with other coma, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitus with other coma, type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled; Diabetes mellitus with other coma, non-insulin dependent type or unspecified type, uncontrolled; Diabetes mellitus with other coma, adult-onset type or unspecified type, uncontrolled; Diabetes mellitus with other coma, type II or unspecified type, uncontrolled; Diabetes mellitus with other coma, NIDDM type or unspecified type, uncontrolled",0
C0375130,"Diabetes with renal manifestations, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus NIDDM type or unspecified type, not stated as uncontrolled, with renal manifestations; Diabetes mellitus adult-onset type or unspecified type, not stated as uncontrolled, with renal manifestations; Diabetes mellitus type II or unspecified type, not stated as uncontrolled, with renal manifestations; Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, with renal manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, not stated as uncontrolled, with renal manifestations",0
C0375131,"Diabetes with renal manifestations, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus IDDM, not stated as uncontrolled, with renal manifestations; Diabetes mellitus juvenile type, not stated as uncontrolled, with renal manifestations; Diabetes mellitus insulin dependent type, not stated as uncontrolled, with renal manifestations; Diabetes mellitus type I, not stated as uncontrolled, with renal manifestations; Diabetes mellitus type I [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, with renal manifestations",0
C0375132,"Diabetes with renal manifestations, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitus NIDDM type or unspecified type, uncontrolled, with renal manifestations; Diabetes mellitus adult-onset type or unspecified type, uncontrolled, with renal manifestations; Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, with renal manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, uncontrolled, with renal manifestations; Diabetes mellitus type II or unspecified type, uncontrolled, with renal manifestations",0
C0375134,"Diabetes with ophthalmic manifestations, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus NIDDM type or unspecified type, not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus adult-onset type or unspecified type, not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus type II or unspecified type, not stated as uncontrolled, with ophthalmic manifestations",0
C0375135,"Diabetes with ophthalmic manifestations, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus insulin dependent type, not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus IDDM, not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus type I [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus type I, not stated as uncontrolled, with ophthalmic manifestations; Diabetes mellitus juvenile type, not stated as uncontrolled, with ophthalmic manifestations",0
C0375137,"Diabetes with neurological manifestations, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, with neurological manifestations; Diabetes mellitus type II or unspecified type, not stated as uncontrolled, with neurological manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, not stated as uncontrolled, with neurological manifestations; Diabetes mellitus adult-onset type or unspecified type, not stated as uncontrolled, with neurological manifestations; Diabetes mellitus NIDDM type or unspecified type, not stated as uncontrolled, with neurological manifestations",0
C0375138,"Diabetes with neurological manifestations, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus insulin dependent type, not stated as uncontrolled, with neurological manifestations; Diabetes mellitus type I [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, with neurological manifestations; Diabetes mellitus juvenile type, not stated as uncontrolled, with neurological manifestations; Diabetes mellitus type I, not stated as uncontrolled, with neurological manifestations; Diabetes mellitus IDDM, not stated as uncontrolled, with neurological manifestations",0
C0375139,"Diabetes with neurological manifestations, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, with neurological manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, uncontrolled, with neurological manifestations; Diabetes mellitus adult-onset type or unspecified type, uncontrolled, with neurological manifestations; Diabetes mellitus NIDDM type or unspecified type, uncontrolled, with neurological manifestations; Diabetes mellitus type II or unspecified type, uncontrolled, with neurological manifestations",0
C0375141,"Diabetes with peripheral circulatory disorders, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus non-insulin dependent type or unspecified type, not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus adult-onset type or unspecified type, not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus type II or unspecified type, not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus NIDDM type or unspecified type, not stated as uncontrolled, with peripheral circulatory disorders",0
C0375142,"Diabetes with peripheral circulatory disorders, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus type I [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus insulin dependent type, not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus juvenile type, not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus IDDM, not stated as uncontrolled, with peripheral circulatory disorders; Diabetes mellitus type I, not stated as uncontrolled, with peripheral circulatory disorders",0
C0375143,"Diabetes with peripheral circulatory disorders, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitus NIDDM type or unspecified type, uncontrolled, with peripheral circulatory disorders; Diabetes mellitus adult-onset type or unspecified type, uncontrolled, with peripheral circulatory disorders; Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, with peripheral circulatory disorders; Diabetes mellitus type II or unspecified type, uncontrolled, with peripheral circulatory disorders; Diabetes mellitus non-insulin dependent type or unspecified type, uncontrolled, with peripheral circulatory disorders",0
C0375145,"Diabetes with other specified manifestations, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, with other specified manifestations; Diabetes mellitus type II or unspecified type, not stated as uncontrolled, with other specified manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, not stated as uncontrolled, with other specified manifestations; Diabetes mellitus NIDDM type or unspecified type, not stated as uncontrolled, with other specified manifestations; Diabetes mellitus adult-onset type or unspecified type, not stated as uncontrolled, with other specified manifestations",0
C0375146,"Diabetes with other specified manifestations, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus type I [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, with other specified manifestations; Diabetes mellitus type I, not stated as uncontrolled, with other specified manifestations; Diabetes mellitus juvenile type, not stated as uncontrolled, with other specified manifestations; Diabetes mellitus IDDM, not stated as uncontrolled, with other specified manifestations; Diabetes mellitus insulin dependent type, not stated as uncontrolled, with other specified manifestations",0
C0375147,"Diabetes with other specified manifestations, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, with other specified manifestations; Diabetes mellitus NIDDM type or unspecified type, uncontrolled, with other specified manifestations; Diabetes mellitus adult-onset type or unspecified type, uncontrolled, with other specified manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, uncontrolled, with other specified manifestations; Diabetes mellitus type II or unspecified type, uncontrolled, with other specified manifestations",0
C0375149,"Diabetes with unspecified complication, type II or unspecified type, not stated as uncontrolled",insulin,"Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, not stated as uncontrolled, with unspecified complication; Diabetes mellitus adult-onset type or unspecified type, not stated as uncontrolled, with unspecified complication; Diabetes mellitus NIDDM type or unspecified type, not stated as uncontrolled, with unspecified complication; Diabetes mellitus non-insulin dependent type or unspecified type, not stated as uncontrolled, with unspecified complication",0
C0375150,"Diabetes with unspecified complication, type I [juvenile type], not stated as uncontrolled",insulin,"Diabetes mellitus type I, not stated as uncontrolled, with unspecified complication; Diabetes mellitus type I [insulin dependent type] [IDDM] [juvenile type], not stated as uncontrolled, with unspecified complication; Diabetes mellitus IDDM, not stated as uncontrolled, with unspecified complication; Diabetes mellitus insulin dependent type, not stated as uncontrolled, with unspecified complication; Diabetes mellitus juvenile type, not stated as uncontrolled, with unspecified complication",0
C0375151,"Diabetes with unspecified complication, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitus adult-onset type or unspecified type, uncontrolled, with unspecified complication; Diabetes mellitus type II or unspecified type, uncontrolled, with unspecified complication; Diabetes mellitus NIDDM type or unspecified type, uncontrolled, with unspecified complication; Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, with unspecified complication; Diabetes mellitus non-insulin dependent type or unspecified type, uncontrolled, with unspecified complication",0
C0375152,"Diabetes with unspecified complication, type I [juvenile type], uncontrolled",insulin,"Diabetes mellitus type I, uncontrolled, with unspecified complication; Diabetes mellitus type I [insulin dependent type] [IDDM] [juvenile type], uncontrolled, with unspecified complication; Diabetes mellitus insulin dependent type, uncontrolled, with unspecified complication; Diabetes mellitus IDDM, uncontrolled, with unspecified complication; Diabetes mellitus juvenile type, uncontrolled, with unspecified complication",0
C0376128,"Diabetes with ophthalmic manifestations, type II or unspecified type, uncontrolled",insulin,"Diabetes mellitus type II or unspecified type, uncontrolled, with ophthalmic manifestations; Diabetes mellitus type II [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type, uncontrolled, with ophthalmic manifestations; Diabetes mellitus adult-onset type or unspecified type, uncontrolled, with ophthalmic manifestations; Diabetes mellitus NIDDM type or unspecified type, uncontrolled, with ophthalmic manifestations; Diabetes mellitus non-insulin dependent type or unspecified type, uncontrolled, with ophthalmic manifestations",0
C0381451,Insulin Receptor Substrate-2 Protein,insulin,Insulin Receptor Substrate-2 Protein; Insulin Receptor Substrate 2 Protein; Insulin Receptor Substrate 2; Insulin Receptor Substrate-2,0
C0382607,insulin-like growth factor-1 D peptide,insulin,IGF-1 D peptide,0
C0383959,125I-(A14-tyrosyl)insulin,insulin,,0
C0383961,iodo(A14-tyrosyl)insulin,insulin,I(A14-Tyr)insulin,0
C0386280,insulin B (9-23),insulin,B9-23 peptide; insulin peptide B (9-23),0
C0388636,Crest Regular Dentifrice,regular,Crest Regular; Colgate regular dentifrice; Crest regular cavity protection,0
C0390374,"insulin, desamido (B-3)",insulin,B-3 monodesamidoinsulin; B-3DHI,0
C0393124,Continuous subcutaneous infusion of insulin,insulin,Continuous subcutaneous infusion of insulin (procedure),0
C0406603,Insulin lipohypertrophy,insulin,Insulin site lipohypertrophy; Insulin injection pad; Insulin lipohypertrophy (disorder),0
C0406607,Insulin lipoatrophy,insulin,"Insulin lipoatrophy (disorder); INSULIN, LIPODYSTROPHY",0
C0413591,Insulin adverse reaction,insulin,Insulin adverse reaction (disorder),0
C0418632,Failure in dose in insulin-shock therapy,insulin,Failure in dose in insulin-shock therapy (event),0
C0418673,"Insulin-shock therapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure",insulin,,0
C0418918,Regular washing and bathing education,regular,Instruction on regular washing and bathing; Regular washing and bathing education (procedure),0
C0418919,Regular change of sanitary pad education,regular,Regular change of sanitary pad education (procedure); Instruction on regular change of sanitary pad,0
C0419178,Dietary regime,regular,Food treatments and procedures; Dietary regime (regime/therapy); Regular diet care,0
C0421248,Diabetic on insulin,insulin,diabetics insulin; diabetic insulin; insulin diabetic; diabetic on insulin; Diabetic on insulin (finding),0
C0423251,Regular corneal stromal opacities,regular,Regular corneal stromal opacities (finding),0
C0423297,Pupil size and shape normal,regular,PRRE - Pupils round regular equal; Pupil size and shape normal (finding),0
C0425565,Pulse regular,regular,Pulse regular (finding),0
C0425569,Regular intermission in pulse,regular,Regular intermission in pulse (finding),0
C0425942,Regular periods,regular,periods regular; Regular periods (finding); Menstrual periods regular; regular periods; regular period; period regular,0
C0428356,Serum insulin - C-polypeptide measurement,insulin,Serum insulin - C-polypeptide measurement (procedure); Serum insulin - C-polypeptide measurement; Serum insulin - C-polypeptide level,0
C0428357,Serum insulin measurement,insulin,serum insulin level; serum insulin; insulin serum; insulin levels serum; Serum insulin measurement; Serum insulin measurement (procedure); Serum insulin level,0
C0428405,Insulin level result,insulin,insulin level; level insulin; insulin levels,0
C0430108,Insulin/thyrotrophin releasing hormone/gonadotrophin releasing hormone test,insulin,Insulin/TRH/LHRH test; TRH - Insulin/thyrotrophin releasing hormone/gonadotrophin releasing hormone test; Insulin/TRH/GnRH test; GnRH - Insulin/thyrotropin releasing hormone/gonadotropin releasing hormone test; LHRH - Insulin/thyrotropin releasing hormone/luteinizing hormone releasing hormone test; LHRH - Insulin/thyrotrophin releasing hormone/luteinising hormone releasing hormone test; Insulin/thyrotrophin releasing hormone/luteinizing hormone releasing hormone test; LHRH - Insulin/thyrotrophin releasing hormone/luteinizing hormone releasing hormone test; Insulin/thyrotropin releasing hormone/gonadotropin releasing hormone test; GnRH - Insulin/thyrotrophin releasing hormone/gonadotrophin releasing hormone test; Insulin/thyrotropin releasing hormone/luteinising hormone releasing hormone test; TRH - Insulin/thyrotropin releasing hormone/gonadotropin releasing hormone test; Insulin/thyrotrophin releasing hormone/luteinising hormone releasing hormone test; Insulin/thyrotropin releasing hormone/luteinizing hormone releasing hormone test; Insulin/thyrotrophin releasing hormone/gonadotrophin releasing hormone test (procedure); LHRH - Insulin/thyrotropin releasing hormone/luteinising hormone releasing hormone test,0
C0430109,Augmented insulin stress test,insulin,Augmented insulin stress test (procedure),0
C0430164,Insulin provocation test,insulin,hollander test; hollanders test; Hollander test; Insulin provocation test (procedure),0
C0430188,Insulin stimulation test,insulin,Insulin stimulation test (procedure); Insulin stimulation test,0
C0430191,Insulin suppression test,insulin,Insulin suppression test (procedure),0
C0443875,Insulin-like growth factor 1 antibody,insulin,Insulin-like growth factor 1 antibody (substance),0
C0443876,Insulin receptor antibody,insulin,Anti-insulin receptor antibody; Insulin receptor antibody (substance); Insulin receptor Antibody; Insulin receptor antibody; Insulin receptor Ab,0
C0451512,Stuttering severity instrument,SSI,Stuttering severity instrument (assessment scale); SSI - Stuttering severity instrument,0
C0454160,Regular volume implant,regular,Regular volume implant (physical object),0
C0455628,H/O: insulin therapy,insulin,History of insulin therapy (situation); History of insulin therapy,0
C0455633,H/O: regular medication,regular,History of regular medication; H/O: repeat medication; History of regular medication (situation),0
C0457592,types of insulin,insulin,Insulin type; insulin types; insulins types; insulin type,0
C0473936,Radiolabeled insulin study,insulin,Radiolabeled insulin study (procedure); Radiolabelled insulin study,0
C0474191,Insulin desensitization therapy,insulin,Insulin desensitisation therapy; Insulin desensitization therapy (regime/therapy),0
C0481899,Insulin and oral hypoglycemic [antidiabetic] drugs causing adverse effects in therapeutic use,insulin,,0
C0482466,Corticotropin^pre dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin pre dose insulin IV (P) [Mass/Vol]; Corticotropin^pre dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; ACTH pre Ins IV Plas-mCnc; Corticotropin [Mass/volume] in Plasma --pre dose insulin IV,0
C0482517,Cortisol^pre dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Cortisol^pre dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol pre dose insulin IV [Mass/Vol]; Cortis pre Ins IV SerPl-mCnc; Cortisol [Mass/volume] in Serum or Plasma --pre dose insulin IV,0
C0482536,Glucose^30M post 0.1 U/kg insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose 30M p 0.1 U/kg Ins SerPl-mCnc; Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.1 U/kg insulin; Glucose 30 Min post 0.1 U/kg insulin [Mass/Vol]; Glucose^30 minutes post 0.1 U/kg insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0482543,Glucose^pre dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose^pre dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose pre dose insulin IV [Mass/Vol]; Glucose pre Ins IV SerPl-mCnc; Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV,0
C0482546,Insulin^1.5H post dose TOLBUTamide IV:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^1.5 hours post dose TOLBUTamide Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.5M p TBM IV SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --1.5 hours post dose TOLBUTamide IV; Insulin 1.5 Hr post dose TOLBUTamide IV [Mass/Vol],0
C0482547,Insulin^1H post dose TOLBUTamide IV:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 1 Hr post dose TOLBUTamide IV [Mass/Vol]; Insulin^1 hour post dose TOLBUTamide Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --1 hour post dose TOLBUTamide IV; Insulin 1h p TBM IV SerPl-mCnc,0
C0482548,Insulin^2.5H post dose TOLBUTamide IV:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 2.5h p TBM IV SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --2.5 hours post dose TOLBUTamide IV; Insulin^2.5 hours post dose TOLBUTamide Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2.5 Hr post dose TOLBUTamide IV [Mass/Vol],0
C0482549,Insulin^2H post dose TOLBUTamide IV:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --2 hours post dose TOLBUTamide IV; Insulin^2 hours post dose TOLBUTamide Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2h p TBM IV SerPl-mCnc; Insulin 2 Hr post dose TOLBUTamide IV [Mass/Vol],0
C0482550,Insulin^30M post dose TOLBUTamide IV:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 30M p TBM IV SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --30 minutes post dose TOLBUTamide IV; Insulin^30 minutes post dose TOLBUTamide Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 30 Min post dose TOLBUTamide IV [Mass/Vol],0
C0482551,Insulin^3H post dose TOLBUTamide IV:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^3 hours post dose TOLBUTamide Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3h p TBM IV SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --3 hours post dose TOLBUTamide IV; Insulin 3 Hr post dose TOLBUTamide IV [Mass/Vol],0
C0482552,Insulin^pre dose TOLBUTamide IV:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^pre dose TOLBUTamide Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin pre dose TOLBUTamide IV [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --pre dose TOLBUTamide IV; Insulin pre TBM IV SerPl-mCnc,0
C0482553,Insulin^pre 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin pre 75 g Glc PO SerPl-mCnc; Insulin pre 75 g glucose PO [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --pre 75 g glucose PO; Insulin^pre 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0482567,Prolactin^1.5H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Prolactin 1.5 Hr post dose insulin IV [Mass/Vol]; Prolactin^1.5 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Prolactin 1.5h p Ins IV SerPl-mCnc; Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV,0
C0482570,Prolactin^1H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Prolactin 1 Hr post dose insulin IV [Mass/Vol]; Prolactin^1 hour post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV; Prolactin 1h p Ins IV SerPl-mCnc,0
C0482573,Prolactin^30 minutes post dose insulin Intravenous:Mass Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Prolactin^30M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn; Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV; Prolactin 30 Min post dose insulin IV [Mass/Vol]; Prolactin^30 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Prolactin 30M p Ins IV SerPl-mCnc,0
C0482575,Prolactin^45M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Prolactin 45 Min post dose insulin IV [Mass/Vol]; Prolactin^45M post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Prolactin 45M p Ins IV SerPl-mCnc; Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV,0
C0482578,Prolactin^pre dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Prolactin^pre dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Prolactin pre dose insulin IV [Mass/Vol]; Prolactin pre Ins IV SerPl-mCnc; Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV,0
C0482583,Somatotropin^pre dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin pre dose insulin IV [Mass/Vol]; GH pre Ins IV SerPl-mCnc; Somatotropin^pre dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV,0
C0484601,Insulin^30M post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 30 Min post 75 g glucose PO [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO; Insulin^30 minutes post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 30M p 75 g Glc PO SerPl-mCnc,0
C0484602,Insulin^6H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO; Insulin^6 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 6 Hr post 75 g glucose PO [Mass/Vol]; Insulin 6h p 75 g Glc PO SerPl-mCnc,0
C0484781,Insulin Ag:PrThr:Pt:Tiss:Ord:Immune stain,insulin,"Insulin Ag [Presence] in Tissue by Immune stain; Insulin Ag Immune stain Ql (Tiss); Insulin Antigen:Presence or Threshold:To identify measures at a point in time:Tissue, unspecified:Ordinal:Immune stain; Insulin Ag Tiss Ql ImStn",0
C0484942,Insulin.free:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin Free SerPl-aCnc; Insulin Free Qn; Insulin Free [Units/volume] in Serum or Plasma; Insulin.free:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0485848,Insulin Ab:ACnc:Pt:Ser:Qn,insulin,Insulin Antibody:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative; Insulin Ab [Units/volume] in Serum; Insulin Ab Ser-aCnc; Insulin Ab Qn (S),0
C0485849,Insulin bovine Ab:ACnc:Pt:Ser:Qn,insulin,Insulin bovine Ab [Units/volume] in Serum; Insulin bovine Antibody:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative; Insulin bovine Ab Qn (S); Insulin Bovine Ab Ser-aCnc,0
C0485850,Insulin human Ab:ACnc:Pt:Ser:Qn,insulin,Insulin human Antibody:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative; Insulin human Ab Qn (S); Insulin human Ab [Units/volume] in Serum; Insulin Human Ab Ser-aCnc,0
C0485851,Insulin porcine Ab:ACnc:Pt:Ser:Qn,insulin,Insulin porcine Ab Qn (S); Insulin Porcine Ab Ser-aCnc; Insulin porcine Ab [Units/volume] in Serum; Insulin porcine Antibody:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative,0
C0487013,insulin antigen,insulin,Insulin Antigen; aging insulin; Insulin Ag,0
C0487014,Bovine insulin antibody,insulin,Anti-bovine insulin antibody; Insulin bovine Ab; Bovine insulin antibody (substance); Insulin Bovine Antibodies; Insulin bovine Antibody,0
C0487015,Human insulin antibody,insulin,Insulin human Ab; Anti-human insulin antibody; Human insulin antibody (substance); Insulin Human Antibodies; Insulin human Antibody,0
C0487017,Free insulin,insulin,Free insulin (substance); Insulin Free; Free insulin; Insulin.free,0
C0490216,"RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN",insulin,,0
C0493352,"MONITOR, SKIN RESISTANCE/SKIN TEMPERATURE, FOR INSULIN REACTIONS",insulin,,0
C0494284,Type 1 diabetes mellitus without complication,insulin,Type I diabetes mellitus without complication; Insulin-dependent diabetes without complication; Type I diabetes mellitus without complication (disorder),0
C0496967,Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs,insulin,Poisoning by insulins and antidiabetic agents,0
C0497788,"Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)",insulin,,0
C0497790,"Infusion set for external insulin pump, non needle cannula type",insulin,,0
C0497791,"Infusion set for external insulin pump, needle type",insulin,,0
C0497792,"Syringe with needle for external insulin pump, sterile, 3 cc",insulin,,0
C0498515,"External ambulatory infusion pump, insulin",insulin,,0
C0498723,"Physician supervision of a nursing facility patient (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more",regular,,0
C0519204,"Physician supervision of a hospice patient (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes",regular,,0
C0520006,"Physician supervision of a patient under care of home health agency (patient not present) in home, domiciliary or equivalent environment (eg, Alzheimer's facility) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with other health care professionals and other non-physician professionals involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes",regular,,0
C0520007,"Physician supervision of a nursing facility patient (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes",regular,,0
C0520116,"Physician supervision of a patient under care of home health agency (patient not present) in home, domiciliary or equivalent environment (eg, Alzheimer's facility) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with other health care professionals and other non-physician professionals involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more",regular,,0
C0520117,"Physician supervision of a hospice patient (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more",regular,,0
C0522814,"Glucagon tolerance panel, for insulinoma, including glucose and insulin measurements",insulin,,0
C0522819,"Insulin-induced C-peptide suppression panel, including glucose, C-peptide and insulin measurement",insulin,,0
C0522820,"Insulin tolerance panel, for ACTH insufficiency, including cortisol and glucose measurements",insulin,,0
C0522821,"Insulin tolerance panel, for growth hormone deficiency, including glucose and HGH measurements",insulin,,0
C0523380,Insulin human antibody measurement,insulin,Insulin human antibody measurement (procedure); Insulin human antibody measurement,0
C0523381,Insulin bovine antibody measurement,insulin,Insulin bovine antibody measurement; Insulin bovine antibody measurement (procedure),0
C0523382,Insulin pork antibody measurement,insulin,Insulin pork antibody measurement (procedure); Insulin pork antibody measurement,0
C0523719,"Insulin, total measurement",insulin,"Insulin, total measurement; Insulin, total measurement (procedure)",0
C0523720,"Insulin, free measurement",insulin,"Insulin, free measurement; Free Insulin Measurement; Insulin, free measurement (procedure); free measurement of insulin; free insulin",0
C0523721,Insulin challenge tests,insulin,Insulin challenge tests (procedure); Insulin challenge tests,0
C0523722,Insulin-like growth factor binding protein 3 measurement,insulin,Insulin-like growth factor binding protein 3 measurement (procedure); Insulin-like growth factor binding protein 3 measurement; Insulin-Like Growth Factor Binding Protein 3 Measurement; Insulin-like growth factor binding protein 3 level,0
C0523893,Insulin-like growth factor-II measurement,insulin,Somatomedin A measurement; Insulin-like growth factor-II measurement (procedure); Insulin-like growth factor-II measurement,0
C0524160,Insulin renal clearance measurement,insulin,Insulin renal clearance measurement (procedure); Insulin renal clearance measurement,0
C0524620,Metabolic Syndrome X,insulin,"Metabolic Syndrome; metabolic syndromes; Syndrome, Metabolic X; Insulin resistance syndrome; Dysmetabolic syndrome X; reaven's syndrome; METABOLIC SYNDROME; Metabolic X Syndrome; Syndrome, Metabolic Cardiovascular; Metabolic syndrome X (disorder); metabolic syndrome; Syndrome X, Insulin Resistance; metabolic syndrome X; Reaven Syndrome X; Metabolic Cardiovascular Syndrome; syndrome x insulin resistance; Syndrome, Metabolic; X Syndrome, Metabolic; metabolic x syndrome; Reaven's syndrome; Metabolic syndrome; Syndrome X, Dysmetabolic; Metabolic Syndrome X; Cardiovascular Syndromes, Metabolic; metabolic syndrome x; METABOLIC SYNDROME X; Cardiometabolic Syndrome; dysmetabolic syndrome X; Metabolic syndrome X; Insulin Resistance Syndrome X; Dysmetabolic Syndrome X; Cardiovascular Syndrome, Metabolic; Syndrome X, Reaven; Equine metabolic syndrome; dysmetabolic syndrome x; Metabolic Syndromes; syndrome metabolic; Syndromes, Metabolic; Syndrome X, Metabolic; Syndrome X (Metabolic); Reaven syndrome X",0
C0528249,Humalog,humalog,humalog; HumaLOG; Humalog,0
C0529145,"INSL4 protein, human",insulin,"INSL4 protein, human; Placentin; insulin-like growth factor 4 protein, human; INSL4; EPIL peptide, human; early placenta insulin-like peptide, human; EPIL; insulin-like 4 (placenta) protein, human; Early Placenta Insulin-Like Peptide; placentin protein, human; insulin-like peptide 4, human; Insulin-Like Peptide 4",0
C0529318,"insulin, Ser(A6,A11)-",insulin,"A6-Ser-A11-Ser-insulin; insulin, seryl(A6,A11)-; (A6-Ser,A11-Ser)-insulin",0
C0532025,insulin-like growth factor binding protein-related protein 1,insulin,insulin-like growth factor binding protein-related protein 1; insulin like-growth factor binding protein-7; IGFBP-7; IGFBP-rP1,0
C0532130,insulin receptor (1293-1307),insulin,HC peptide,0
C0537270,insulin detemir,insulin,"Insulin detemir; Insulin Detemir; Insulina detemir; Basal Insulin Detemir; Insulin detemir-containing product; Detemir, Insulin; Product containing insulin detemir (medicinal product); Insulin Detemir, Basal; Detemir, Basal Insulin; INSULIN DETEMIR; Insulin detemir (substance); insulin detemir; Insulin detemir recombinant; Detemir",0
C0538990,leucyl-cystinyl aminopeptidase,insulin,insulin-regulated membrane aminopeptidase; insulin-responsive aminopeptidase; leucyl-cystinyl aminopeptidase; vesicle protein aminopeptidase vp165; IRAP enzyme,0
C0539906,"IMP3 protein, human",insulin,"IMP-3; K homology domain containing protein overexpressed in cancer, human; Koc protein, human; VICKZ Family Member 3; KH Domain Containing Protein Overexpressed In Cancer; hKOC; KOC1 Protein; insulin-like growth factor 2 messenger RNA binding protein 3, human; IGF-II mRNA-Binding Protein 3; IGF II mRNA Binding Protein 3; KH Domain-Containing Protein Overexpressed In Cancer; Insulin-Like Growth Factor 2 mRNA-Binding Protein 3; Cancer/Testis Antigen 98; IGF-II mRNA-binding protein 3, human; insulin like growth factor 2 mRNA binding protein 3, human; IGF2 mRNA-Binding Protein 3; IGF2BP3 protein, human; Koc1 protein, human; IGF2BP3; KOC1",0
C0540335,"SOCS1 protein, human",SSI,"STAT-induced STAT inhibitor-1 protein, human; Tec-interacting protein 3, human; cytokine inducible SH2-containing protein 1, human; SOCS-1 protein, human; SSI-1 protein, human; suppressor of cytokine signaling 1 protein, human; TIP3 protein, human",0
C0540340,"SOCS2 protein, human",SSI,"SSI-2; SOSC2 protein, human; Suppressor of Cytokine Signaling 2; CIS-2; suppressor of cytokine signaling 2 protein, human; hsSOCS-2 protein, human; STAT-induced STAT inhibitor 2, human; CIS2 protein, human; SOCS-2; Cytokine-Inducible SH2 Protein 2; SOCS2 protein, human; Suppressor of Cytokine Signaling-2; STAT-Induced STAT Inhibitor-2; STAT Induced STAT Inhibitor-2; STAT-Induced STAT Inhibitor 2",0
C0540345,"Socs3 protein, mouse",SSI,"mmSOCS-3 protein, mouse; SSI-3 protein, mouse; CIS3 protein, mouse; suppressor of cytokine signaling 3 protein, mouse; Cish3 protein, mouse; STAT-induced STAT inhibitor-3, mouse; SOCS-3 protein, mouse",0
C0542501,Insulin response test - vagus,insulin,Insulin response test - vagus (procedure); Hollander test (provocative test for vagotomy),0
C0544377,"Insulin, injectable",insulin,,0
C0546448,Plasma membrane receptor site for insulin,insulin,,0
C0546683,Intravenous insulin tolerance test,insulin,,0
C0546686,Insulin/gastrin stimulation test,insulin,,0
C0546704,"Insulin measurement, RIA",insulin,,0
C0547004,Regular intermenstrual bleeding,regular,Intermenstrual bleeding - regular; Regular intermenstrual bleeding; Intermenstrual bleeding - regular (finding),0
C0550007,Insulin-like growth factor-I^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF-I 1.5h p chal SerPl-mCnc; Insulin-like growth factor-I^1.5 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge; Insulin-like growth factor-I 1.5 Hr post Unsp challenge [Mass/Vol],0
C0550008,Insulin-like growth factor-I^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF-I 1h p chal SerPl-mCnc; Insulin-like growth factor-I 1 Hr post Unsp challenge [Mass/Vol]; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1 hour post XXX challenge; Insulin-like growth factor-I^1 hour post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550009,Insulin-like growth factor-I^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge; Insulin-like growth factor-I^30 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I 30 Min post Unsp challenge [Mass/Vol]; IGF-I 30M p chal SerPl-mCnc,0
C0550010,Insulin^3.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^3.5 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3.5 Hr post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge; Insulin 3.5h p chal SerPl-mCnc,0
C0550011,Insulin^10H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 10h p chal SerPl-mCnc; Insulin 10 Hr post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge; Insulin^10H post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550012,Insulin^11H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^11H post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge; Insulin 11 Hr post Unsp challenge [Mass/Vol]; Insulin 11h p chal SerPl-mCnc,0
C0550013,Insulin^12H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge; Insulin 12 Hr post Unsp challenge [Mass/Vol]; Insulin 12h p chal SerPl-mCnc; Insulin^12 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550014,Insulin^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 15M p chal SerPl-mCnc; Insulin^15 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge; Insulin 15 Min post Unsp challenge [Mass/Vol],0
C0550015,Insulin^19M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 19 Min post Unsp challenge [Mass/Vol]; Insulin^19M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge; Insulin 19M p chal SerPl-mCnc,0
C0550016,Insulin^22M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge; Insulin 22 Min post Unsp challenge [Mass/Vol]; Insulin 22M p chal SerPl-mCnc; Insulin^22M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550017,Insulin^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 2M p chal SerPl-mCnc; Insulin 2 Min post Unsp challenge [Mass/Vol]; Insulin^2 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge,0
C0550018,Insulin^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge; Insulin^2nd specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2nd specimen post Unsp challenge [Mass/Vol]; Insulin sp2 p chal SerPl-mCnc,0
C0550019,Insulin^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 3rd specimen post Unsp challenge [Mass/Vol]; Insulin^3rd specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp3 p chal SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge,0
C0550020,Insulin^4.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 4.5 Hr post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge; Insulin^4.5 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 4.5h p chal SerPl-mCnc,0
C0550021,Insulin^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 40 Min post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge; Insulin 40M p chal SerPl-mCnc; Insulin^40M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550022,Insulin^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 45M p chal SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge; Insulin 45 Min post Unsp challenge [Mass/Vol]; Insulin^45M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550023,Insulin^4M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 4M p chal SerPl-mCnc; Insulin 4 Min post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge; Insulin^4 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550024,Insulin^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 4th specimen post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge; Insulin sp4 p chal SerPl-mCnc; Insulin^4th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550025,Insulin^5.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 5.5h p chal SerPl-mCnc; Insulin^5.5 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge; Insulin 5.5 Hr post Unsp challenge [Mass/Vol],0
C0550026,Insulin^50M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 50 Min post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge; Insulin 50M p chal SerPl-mCnc; Insulin^50M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550027,Insulin^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^5th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp5 p chal SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge; Insulin 5th specimen post Unsp challenge [Mass/Vol],0
C0550028,Insulin^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^6th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp6 p chal SerPl-mCnc; Insulin 6th specimen post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge,0
C0550029,Insulin^7.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge; Insulin^7.5 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 7.5 Hr post Unsp challenge [Mass/Vol]; Insulin 7.5h p chal SerPl-mCnc,0
C0550030,Insulin^70M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 70 Min post Unsp challenge [Mass/Vol]; Insulin^70M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 70M p chal SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge,0
C0550031,Insulin^7H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 7h p chal SerPl-mCnc; Insulin 7 Hr post Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge; Insulin^7 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550032,Insulin^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge; Insulin 7th specimen post Unsp challenge [Mass/Vol]; Insulin^7th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp7 p chal SerPl-mCnc,0
C0550033,Insulin^8H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 8h p chal SerPl-mCnc; Insulin 8 Hr post Unsp challenge [Mass/Vol]; Insulin^8 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge,0
C0550034,Insulin^8M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge; Insulin 8M p chal SerPl-mCnc; Insulin^8 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 8 Min post Unsp challenge [Mass/Vol],0
C0550035,Insulin^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 8th specimen post Unsp challenge [Mass/Vol]; Insulin sp8 p chal SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge; Insulin^8th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550036,Insulin^9H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 9 Hr post Unsp challenge [Mass/Vol]; Insulin^9H post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge; Insulin 9h p chal SerPl-mCnc,0
C0550037,Insulin^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 9th specimen post Unsp challenge [Mass/Vol]; Insulin sp9 p chal SerPl-mCnc; Insulin^9th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge,0
C0550038,Insulin^15M pre XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^15 minutes pre XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 15M pre chal SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge; Insulin 15 Min pre Unsp challenge [Mass/Vol],0
C0550039,Insulin^30M pre XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^30 minutes pre XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 30M pre chal SerPl-mCnc; Insulin 30 Min pre Unsp challenge [Mass/Vol]; Insulin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge,0
C0550040,Insulin^pre XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^pre XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin pre Unsp challenge [Mass/Vol]; Insulin pre chal SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --pre XXX challenge,0
C0550041,Insulin^7H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 7 Hr post 75 g glucose PO [Mass/Vol]; Insulin^7 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO; Insulin 7h p 75 g Glc PO SerPl-mCnc,0
C0550400,Insulin-like growth factor binding protein 1:MCnc:Pt:Ser/Plas:Qn,insulin,IGF BP1 SerPl-mCnc; Insulin-like growth factor binding protein 1 [Mass/Vol]; Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma; Insulin-like growth factor binding protein 1:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0550401,Insulin-like growth factor binding protein 2:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma; Insulin-like growth factor binding protein 2 [Mass/Vol]; Insulin-like growth factor binding protein 2:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF BP2 SerPl-mCnc,0
C0550514,Deprecated Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma,insulin,Somatomedin C (S) [Mass/Vol],0
C0551300,Insulin Ab:Titr:Pt:Ser:Qn,insulin,Insulin Ab [Titer] in Serum; Insulin Ab (S) [Titer]; Insulin Antibody:Dilution Factor (Titer):To identify measures at a point in time:Serum:Quantitative; Insulin Ab Titr Ser,0
C0556338,Drinker,regular,Regular Drinker,0
C0557315,School attendance good,regular,School attendance good (finding); Regular attendance at school; Regular school attender,0
C0557364,In regular work,regular,In regular work (finding),0
C0557977,Sliding scale insulin regime,insulin,Sliding scale insulin regime (regime/therapy),0
C0557978,Insulin regime,insulin,Insulin regime (regime/therapy),0
C0558050,Checking patient regularly,regular,Quick check observation method; Checking patient regularly (regime/therapy); Regular checks,0
C0559174,Regular blood donor,regular,Regular blood donor (situation),0
C0562339,Regular daily routine,regular,Regular daily routine (finding); Set routine to day; Set pattern to day,0
C0566680,Time contractions became regular,regular,Time contractions became regular; Time contractions became regular (observable entity),0
C0566875,Regular fetal heart rhythm,regular,Regular fetal heart rhythm (finding); Regular foetal heart rhythm,0
C0567125,Regular uterine contractions,regular,Regular uterine contractions (finding); Regular Uterine Contraction,0
C0569145,Accidental insulin poisoning,insulin,Accidental insulin poisoning (disorder),0
C0569146,Intentional insulin poisoning,insulin,Intentional insulin poisoning (disorder),0
C0570208,Isophane insulin adverse reaction,insulin,Isophane insulin adverse reaction (disorder),0
C0570209,Protamine zinc insulin adverse reaction,insulin,Protamine zinc insulin adverse reaction (disorder),0
C0571622,Allergy to insulin,insulin,allergies insulin; Allergy to insulin (finding); allergy insulin; Insulin allergy; insulin allergy,0
C0571625,Allergy to zinc insulin,insulin,Insulin zinc suspension allergy; Allergy to zinc insulin (finding),0
C0571628,Allergy to isophane insulin,insulin,Allergy to isophane insulin (finding); Isophane insulin allergy,0
C0571629,Allergy to protamine zinc insulin,insulin,Protamine zinc insulin allergy; Allergy to protamine zinc insulin (finding),0
C0571631,Allergy to human insulin,insulin,Allergy to human insulin (finding),0
C0573713,Insulin overdose,insulin,Insulin overdose (disorder); insulin overdose,0
C0573714,Accidental insulin overdose,insulin,Accidental insulin overdose (disorder),0
C0573715,Intentional insulin overdose,insulin,Intentional insulin overdose (disorder),0
C0579065,Type 1 diabetes mellitus with ulcer,insulin,Type I diabetes mellitus with ulcer (disorder); Type I diabetes mellitus with ulcer; Insulin-dependent diabetes mellitus with ulcer,0
C0580930,Conversion to insulin,insulin,conversions insulin; Conversion to insulin (regime/therapy); insulin conversion; conversion to insulin,0
C0581383,Type 1 diabetes mellitus maturity onset,insulin,Type I diabetes mellitus maturity onset; Type I diabetes mellitus maturity onset (disorder); Insulin-dependent diabetes maturity onset,0
C0582191,Regular exercise (observable entity),regular,exercise regular; Regular exercise (observable entity); regular exercise; Regular exercise,0
C0582652,Perceived control of insulin-dependent diabetes,insulin,Perceived control of insulin-dependent diabetes (assessment scale),0
C0585282,Regular frequency,regular,Regular frequency (qualifier value),0
C0586328,Subcutaneous injection of insulin,insulin,Subcutaneous injection of insulin (procedure); Insulin injection; Subcutaneous injection of insulin,0
C0597296,protein bound insulin,insulin,,0
C0598703,insulin tolerance,insulin,,0
C0602919,"insulin, carboxymethyl-His-",insulin,"carboxymethylhisitidine insulin; insulin, carboxymethylhistidine-; carboxymethyl-His-insulin",0
C0604437,"insulin, Sar(9A)-",insulin,"9A-Sar-insulin; insulin, sarcosine(9A)-",0
C0604998,"insulin, hexamethylester-",insulin,hexamethylester insulin,0
C0605635,"insulin, trifluoroacetyl-",insulin,trifluoroacetylinsulin,0
C0605837,"insulin, tris(N-methylpyridinium)-",insulin,tris(N-methylpyridinium)insulin,0
C0605896,"insulin, Asp-imide(A21)-",insulin,"insulin, asparaginimide(A21)-; A21-asparaginimide-insulin; Insulin, 8A-L-threonine-10A-L-isoleucine-20A-(N-(2,5-dioxo-3-pyrrolidinyl)-L-cysteinamide)-21A-de-L-asparagine-, (S)-; A21-Asp-imide-insulin",0
C0607219,"insulin, triphthaloyl-",insulin,N(A)-(2-carboxybenzoyl)-N(B)-(2-carboxybenzoyl)- 29(B)-(N(6)-(2-carboxybenzoyl)-L-lysine)insulin (ox); triphthaloylinsulin,0
C0607815,"insulin, des(pentapeptide)(B1-B5)-",insulin,"Insulin, 1B-de-L-phenylalanine-2B-de-L-valine-3B-de-L-asparagine-4B-de-L-glutamine-5B-de-L-histidine-; des(pentapeptide)(B1-B5)-insulin",0
C0607817,"insulin, des(tetrapeptide)(B1-B4)-",insulin,"des(tetrapeptide)(B1-B4)-insulin; Insulin, 1B-de-L-phenylalanine-2B-de-L-valine-3B-de-L-asparagine-4B-de-L-glutamine-",0
C0609422,"insulin-like material, blowfly brain",insulin,,0
C0609900,"insulin, N,N-bis(methylsulfonylethoxycarbonyl)-",insulin,"N,N-bis(methylsulfonylethoxycarbonyl)insulin; Insulin, NA-((2-(methylsulfonyl)ethoxy)carbonyl)-NB-((2-(methylsulfonyl)ethoxy)carbonyl)-",0
C0610305,"insulin, des-Phe(B1)-des-Val(B2)-",insulin,"B1-de-Phe-B2-de-Val-insulin; B1-desphenylalaninyl-B2-desvaline-insulin; insulin, des-phenylalanyl(B1)-des-valine(B2)-; Insulin (ox), 1(B)-de-L-phenylalanine-2(B)-de-L-valine-",0
C0610312,"insulin, des-Gly(A1)-",insulin,"A1-des-Gly-insulin; insulin, des-glycine(A1)-; A1-desglycine-insulin; Insulin (ox), 1(A)-deglycine-",0
C0610317,"insulin, des-Gly(A1)-des-Phe(B1)-",insulin,"des-Gly-(A1)-des-Phe(B1)insulin; Insulin (ox), 1(A)-deglycine-1(B)-de-L-phenylalanine-; insulin, desglycyl(A1)-desphenylanine(B1)-; A1-de-Gly-(B1)Phe-insulin; A1-desglycyl-B1-desphenylanine-insulin",0
C0611569,"insulin, AsnNH2(A21)-",insulin,"insulin, asparaginamide(A21)-; A21-AsnNH2-insulin; Insulin, 9A-glycine-21A-L-aspartamide-; A21-asparaginamide-insulin",0
C0612342,"insulin, tetrakis(3-nitro-Tyr)-",insulin,"insulin, tetrakis(3-nitrotyrosine)-; Insulin, 14A-(3-nitro-L-tyrosine)-16B-(3-nitro-L-tyrosine)-19A-(3-nitro-L-tyrosine)-26B-(3-nitro-L-tyrosine)-; 3-nitroTyr-tetrakis-insulin; 3-nitro-Tyr-tetrakis-insulin; 3-nitrotyrosine-tetrakis-insulin; TNT-insulin",0
C0612378,"insulin, fluoresceinthiocarbamyl(B29)-",insulin,B29-fluoresceinthiocarbamyl-insulin; N(epsilonB29)-fluoresceinthiocarbamyl-insulin; FTC-insulin,0
C0612927,ATP-insulin conjugates,insulin,adenosine triphosphate-insulin conjugates; ATP-insulin conjugate; insulin ATP conjugate,0
C0613284,"insulin, Asn(B12)-",insulin,"Insulin, 12-L-asparagine-30-L-threonine-, 7,19-bis(hydrogen sulfate), ion(2-); B12-Asn-insulin; B12-asparagine-insulin; insulin, asparagine(B12)-",0
C0613591,"insulin, butyrimidylpyridine disulfide-",insulin,"BPDSI; butyrimidylpyridine disulfide insulin; Insulin, NA-(1-imino-4-(2-pyridinyldithio)butyl)-",0
C0614076,"insulin, Leu(B24,B25)-",insulin,"B24,B25-Leu-insulin; insulin, leucine (B24,B25)-; B24,B25-leucine-insulin",0
C0614165,"insulin, azoisobutyryl-",insulin,azoisobutyryl-insulin; AIB-insulin,0
C0614339,"insulin, Nle(A2)-",insulin,"insulin, norleucine(A2)-; A2-norleucine-insulin; A2-Nle-insulin; Insulin, 2A-L-norleucine-9A-glycine-",0
C0614343,"insulin, carbonyl-bis-Met,N(alphal),N(epsilon)(B29)-",insulin,"insulin, carbonyl-bis-(methionine)N(alphal),N(epsilon)(B29)-; OC(Met)2 insulin; Insulin, NA-L-methionyl-29B-(N6-L-methionyl-L-lysine)-, NA,29B-carbonyl deriv.; B29-carbonyl-bis-Met,N(alphal),N(epsilon)-insulin",0
C0614347,"insulin, des-Gly(1A)-N-((trimethylammonio)acetyl)Ile(2A)-",insulin,"NATMI; Insulin, 1A-deglycine-2A-(N-((trimethylammonio)acetyl)-L-isoleucine)-; 1A-des-Gly-2A-N-((trimethylammonio)acetyl)-Ile-insulin; insulin, desglycyl(1A)-N-((trimethylammonio)acetyl)isoleucine(2A)-",0
C0615244,"insulin, dihydroxycyclohexylene-",insulin,dihyroxycyclohexylene-insulin; DHCH-insulin,0
C0615784,"insulin, methoxy-",insulin,"insulin, methyl-d3 ether; methoxyinsulin",0
C0616080,N-methoxycarbonylphenylalanylglycine 4-nitrophenyl ester,NPH,"Glycine, N-(N-(methoxycarbonyl)-L-phenylalanyl)-, 4-nitrophenyl ester; N-methoxycarbonyl-Phe-Gly-4-nitrophenyl ester; N-methoxycarbony-L-phenylalanylglycine para-nitrophenyl ester; MeO-Phe-Gly-Nph",0
C0616797,"insulin, 4-(azidophenylacetyl)-2,4-diaminobutyric acid(A1)-",insulin,"APA-DAB-insulin; A1-4-azidophenylacetyl-2,4-diaminobutyric acid insulin; Insulin, 1A-(N4-((4-azidophenyl)acetyl)-D-2,4-diaminobutanoic acid)-8A-L-threonine-10A-L-isoleucine-",0
C0617005,"insulin, Ala(B24)-",insulin,"B24-Ala-insulin; B24-alanine-insulin; Insulin, 8A-L-threonine-10A-L-isoleucine-24B-L-alanine-; insulin, alanine(B24)-",0
C0617304,"insulin, disulfide-des-Ala(B30)-",insulin,"B30-disulfide-desalanine insulin; B30-des-Ala-insulin disulfide; B30-desalanine-insulin disulfide; Insulin, 30-de-L-alanine-, cyclic (7-19)-disulfide; insulin, disulfide-de-alanine(B30)-; insulin, disulfide-desalanine(B30)-",0
C0617638,"insulin, Arg(B22)-",insulin,"B22-Arg-insulin; insulin, arginine(B22)-; B22-arginine-insulin; Insulin, 8A-L-threonine-10A-L-isoleucine-22B-D-arginine-",0
C0617744,"insulin, (2-nitro-azidophenylacetyl)(B1)-",insulin,"B1-(2-nitro-4-azidophenylacetyl) insulin; B1NAPA-Ins; Insulin, NB-((4-azido-2-nitrophenyl)acetyl)-",0
C0618331,"insulin, N-methylpyridinium",insulin,"N-methylpyridinium insulin; Insulin, 19A-(O-(1-methylpyridinium-2-yl)-L-tyrosine)-, hydroxide, inner salt",0
C0618584,"insulin, bis(tert-butyloxycarbonyl)desoctapeptide-phenylhydrazide-",insulin,"insulin, di-Boc-DOP-phenylhydrazide-; bis(tert-butyloxycarbonyl)desoctapeptide insulin phenylhydrazide",0
C0618823,"insulin, 3,5-diiodo-Tyr(A19)-",insulin,"A19-3,5-diiodo-Tyr-insulin; Insulin, 8A-L-threonine-10A-L-isoleucine-19A-(3,5-diiodo-L-tyrosine)-; insulin, 3,5-diiodotyrosine(A19)-; A19-3,5-diiodotyrosine-insulin",0
C0619003,"insulin, des-Asn(A21)-des-Ala(B30)-",insulin,"insulin, de-asparaginyl(A21)-de-alanine(B30); A21-des-Asn-B30-des-Ala-insulin; insulin, desasparaginyl (A21)-desalanine (B30)-; A21-desasparaginyl-B30-desalanine-insulin",0
C0619541,insulin B (22-30),insulin,"insulin (B22-B30); L-Alanine, N-(N2-(1-(N-(N-(N-(N-(N-L-arginylglycyl)-L-phenylalanyl)-L-phenylalanyl)-L-tyrosyl)-L-threonyl)-L-prolyl)-L-lysyl)-",0
C0619608,"insulin, Pro(B21)-",insulin,"B21-proline-insulin; B21-Pro-insulin; insulin, proline(B21)-",0
C0619735,"insulin, polyethylene glycol(B1)-",insulin,"PEGylated insulin; B1-polyethylene-glycol-insulin; PEG insulin; insulin, PEG-",0
C0620337,"insulin, des(hexapeptide)(B25-30)-Ala(B23)-",insulin,"insulin, des(hexapeptide)(B25-30)-alanine(B23)-; deshexapeptide(B25-30)-Ala(B23)-insulin; dhex-Ala-insulin; des(hexapeptide)(B25-30)-B23-alanine-insulin",0
C0620404,"insulin, Nle(B17)-",insulin,"B17-Nle-insulin; insulin, norleucine(B17)-; Insulin, 8A-L-threonine-10A-L-isoleucine-17B-L-norleucine-, (+-)-; B17-norleucine-insulin",0
C0621499,"insulin, Asn(B10)-",insulin,"Insulin, 8A-L-threonine-10A-L-isoleucine-10B-L-asparagine-30B-L-threonine-, (1R-cis)-; B10-asparagine-insulin; B10-Asn-insulin; insulin, asparagine(B10)-",0
C0621732,insulin B (20-30),insulin,"L-Alanine, N-(N2-(1-(N-(N-(N-(N-(N-(N2-(N-glycyl-L-alpha-glutamyl)-L-arginyl)glycyl)-L-phenylalanyl)-L-phenylalanyl)-L-tyrosyl)-L-threonyl)-L-prolyl)-L-lysyl)-, (3aS-(3aalpha,4beta,6aalpha))-; insulin (B20-B30)",0
C0621734,insulin B (9-30),insulin,"Insulin, 1-de-L-phenylalanine-2-de-L-valine-3-de-L-asparagine-4-de-L-glutamine-5-de-L-histidine-6-de-L-leucine-7-de-L-cysteine-8-deglycine-, (+-)-; insulin (B9-B30)",0
C0621836,"insulin, (2-nitro-4-azidophenyl)-Gly(B29)-",insulin,"B29NAPGL-Ins; (2-nitro-4-azidophenyl)-B29-Gly-insulin; (2-nitro-4-azidophenyl)-B29-glycine-insulin; insulin, (2-nitro-4-azidophenyl)-glycine(B29)-",0
C0622744,"insulin, Gln(B30)-",insulin,"insulin, glutamine(B30)-; B30-glutamine-insulin; Insulin, 8A-L-threonine-10A-L-isoleucine-30B-L-glutamine-, (SP-4-1)-; B30-Gln-insulin",0
C0622930,"insulin, Leu(A19)-",insulin,"insulin, leucine(A19)-; A19-Leu-insulin; A19-leucine-insulin",0
C0623348,dextran-insulin complex,insulin,,0
C0623349,insulin-dextran,insulin,,0
C0624080,"insulin, N(alpha)(B1), biotinyl-epsilon-aminocaproyl-",insulin,"B1-N(alpha), biotinyl-epsilon-aminocaproyl-insulin; BAC-insulin",0
C0624860,4-azidobenzoyliodo-insulin-like growth factor II,insulin,4-azidobenzoyl-(125)I-IGF-II; 4-ABI-IGF-II,0
C0625128,"insulin, dicitraconyl Gly(A1)Phe(B1)-",insulin,"dicitraconylinsulin, glycine(A1)phenylalanine(B1)-; dicitraconylinsulin, Gly(A1)Phe(B1)-; A1-Gly-B1-Phe-dicitraconyl-insulin; DC-GP-insulin; A1-Gly-B1-Phe-dicitraconylinsulin",0
C0626113,"insulin, A(27)-B-insulin-like growth factor I",insulin,A(27) insulin-B-IGF-I,0
C0628009,"insulin-like growth factor I, Val(59)-",insulin,"59-Val-somatomedin C; IGF 1, valine-59; valine-59-insulin-like growth factor I; somatomedin C, 59-Val; 59-Val-IGF 1",0
C0628782,"insulin, 3-(N-phenylacetyl)-",insulin,"insulin, PA(3)-; 3-(N-phenylacetyl)insulin",0
C0629690,insulin covalent aggregate,insulin,,0
C0629769,"insulin, dodecoy(A1-B29)-",insulin,dodecoyl(A1-B29)-insulin,0
C0629771,"insulin, diacetyl(A1-B29)-",insulin,A1-B29-diacetyl-insulin,0
C0632718,"insulin, N-Me-Ile(2A)-",insulin,"2A-N-methyl-Ile-insulin; insulin, N-methyl-Ile(2A)-; 2A-N-methylisoleucine-insulin; 2A-N-Me-Ile-insulin",0
C0632723,"insulin, N-Me-Val(3A)-",insulin,"insulin, N-methylvaline(3A)-; 3A-N-Me-Val-insulin; insulin, N-methyl-Val(3A)-; 3A-N-methyl-Val-insulin",0
C0632755,"insulin, des-Asn(21)-CysNH2(20)(A)-",insulin,"DACA-insulin; insulin, desparagyl(21)-cysteinamide(20)(A)-; 21-des-asparagine-20-cysteinamide (A)insulin; A21-des-Asn-A20-CysNH2-insulin",0
C0632760,"insulin, des-Asn(21)-Cys(20)-isopropylamide(A)-",insulin,"21-des Asn-20-Cys-isopropylamide (A)insulin; insulin, 21-desasparaginyl-20-cysteine isopropylamide (A)-; DACIA-insulin; 21-des-asparaginyl-20-cysteine isopropylamide (A)insulin",0
C0632765,"insulin, Asn(21)-diethylamide(A)-",insulin,"insulin, asparagine(21)-diethylamide(A)-; A-21-asparagine-diethylamide-insulin; ADA-insulin; A-21-Asn-diethylamide-insulin",0
C0632770,"insulin, des-Asn(21)-Cys(20)-ethylamide(A)-",insulin,"21-des-asparaginyl-20-cysteine ethylamide (A)insulin; DACEA-insulin; 21-des-Asn-20-Cys-ethylamide (A)insulin; insulin, 21-deasparaginyl-20-cysteine ethylamide (A)-",0
C0632775,"insulin, des-Asn(21)-Cys(20)-2,2,2-trifluoroethylamide(A)-",insulin,"21-des-asparagine-20-cysteine 2,2,2-trifluoroethylamide(A)-insulin; insulin, desasparaginyl(21)-Cysteine(20)-2,2,2-trifluoroethylamide(A)-; DACTA-insulin; 21-des-Asn-20-Cys-2,2,2-trifluoroethylamide(A)-insulin",0
C0632877,"insulin, Gly(A1)-",insulin,"insulin, glycine(A1)-; A1-glycine-insulin; A1-Gly-insulin",0
C0633110,colloidal gold-insulin complex,insulin,insulin-colloidal gold complex,0
C0633788,acetylinsulin,insulin,acetyl insulin,0
C0634754,"insulin, (2,4,6-trinitrophenyl)sulfonyl(Al)-",insulin,"Al-TNPS-insulin; Al-(2,4,6-trinitrophenyl)sulfonyl-insulin",0
C0635017,insulin-binding peptide,insulin,Cys-Val-Glu-Glu-Ala-Ser,0
C0635370,glycerol-insulin,insulin,insulin-glycerol,0
C0636815,"insulin, 4-fluorophenylalanine(A19)-",insulin,"A19-(4-fluorophenylalanine)-insulin; A19-Phe(F)-insulin; insulin, 4-f-Phe(A19)-",0
C0638143,insulin B-chain tetrapeptide amide B22-B25,insulin,B chain insulin tetrapeptidamide (22-25); insulin B22-B25-NH2; Arg-Gly-Phe-Phe-NH2,0
C0638372,NovoSol Basal insulin,insulin,NovoSol Basal,0
C0638563,"insulin, despentapeptide (B26-B30)-HisNH2(B25)-",insulin,"insulin, despentapeptide(B26-B30)-histidinamide(B25)-; despentapeptide(B26-B30)-B25-HisNH2-insulin; (B26-B30)-despentapeptide-B25-histidinamide-insulin; His-desP-insulinamide; despentatpeptide(B26-B30)-B25-histidinamide-insulin",0
C0638972,"insulin-like growth factor I, N-methionyl-",insulin,N-Met-insulin-like growth factor I; N-methionyl-insulin-like growth factor I; Met-ILGF-I,0
C0643685,"insulin, 4-succinylamidophenylmannopyranoside-",insulin,SAPM-INS; 4-succinylamidophenylmannopyranoside-insulin,0
C0643688,"insulin, 4-succinylamidophenylarabinopyranoside-",insulin,4-succinylamidophenylarabinopyranoside-insulin; SAPA-INS,0
C0643945,"insulin-like growth factor II, Leu(27)-",insulin,"(Leu(27))ILGF-II; ILGF-II, Leu(27)-; IGF-II (Leu-27); insulin-like growth factor II, leucine(27)-; 27-Leu-insulin-like growth factor II",0
C0647224,"2,4-dinitrophenol-insulin A chain-fluorescein conjugate",insulin,DNP-insulin-fluorescein,0
C0648107,"insulin, Glu(21) B-chain-",insulin,"21-Glu insulin B chain; insulin, glutamic acid (21) B-chain-",0
C0648110,"insulin, Aib(21) B-chain-",insulin,"21-Aib insulin B-chain; insulin, aminoisobutyric acid(21) B-chain-",0
C0648113,"insulin, Aib(22) B-chain-",insulin,"22-Aib insulin B-chain; insulin, aminoisobutyric acid(22) B-chain-",0
C0648983,"2-(4-azidosalicylamido)ethyl-1,3-dithiopropionate insulin",insulin,ASDP-insulin,0
C0651293,human insulin-like-growth-factor-I (21-40),insulin,"IGF-I (21-40); insulin-like-growth-factor-I (21-40), human",0
C0652363,"insulin, W(B28),P(B29)-",insulin,"W(B28),P(B29)-insulin",0
C0653718,"Insulin, Sulfated, Beef",insulin,sulfated beef insulin,0
C0656814,"insulin, Ser(B24)-",insulin,"insulin Los Angeles; (Ser(B24))insulin; Insulin (ox), 8A-L-threonine-10A-L-isoleucine-24B-L-serine-30B-L-threonine-; B24-serine-insulin; insulin, serine(B24)-; B24-Ser-insulin",0
C0657329,"insulin-like growth factor I, N-Ala-Glu-",insulin,"insulin-like growth factor I, N-alanyl-glutamic acid-; N-Ala-Glu-IGF-I",0
C0657490,benzoylphenylalanine(B25)insulin,insulin,Bpa(B25)insulin,0
C0660794,insulin receptor peptide (1135-1156),insulin,GPBP2 (1135-1156),0
C0661523,insulin-like growth factor I-Pseudomonas exotoxin A (40),insulin,IGF-I-PE40,0
C0662186,"insulin, des(tetrapeptide)(B27-B30)-",insulin,des(tetrapeptide)(B27-B30)-insulin; des-(B27-B30)-insulin,0
C0662575,"insulin-related peptide III, Lymnaea",insulin,MIP III,0
C0664773,insulin receptor substrate 4 protein,insulin,Insulin Receptor Substrate 4 Protein; Insulin Receptor Substrate 4; Insulin Receptor Substrate-4; Insulin Receptor Substrate-4 Protein,0
C0667397,"Irs3 protein, mouse",insulin,"insulin receptor substrate-3 protein, mouse; IRS-3 protein, mouse; insulin receptor substrate 3 protein, mouse",0
C0668244,insulin-like growth factor binding protein 5 (201-218),insulin,IGFBP-5 (201-218),0
C0670667,insulin-related peptide I,insulin,"MIP I, lymnacea",0
C0673311,Seal Rite-Regular Viscosity,regular,,0
C0673450,"insulin, N(epsilon)-palmitoyl Lys(B29)-",insulin,"B29-N(epsilon)-palmitoyl-Lys-insulin; insulin, N(epsilon)-palmitoyllysyl(B29)-",0
C0678154,insulin sensitivity/resistance,insulin,,0
C0678290,regular AOD use,regular,regular Alcohol or Other Drugs use,0
C0678291,regular light AOD use,regular,regular light Alcohol or Other Drugs use,0
C0678292,regular moderate AOD use,regular,regular moderate Alcohol or Other Drugs use,0
C0678293,regular heavy AOD use,regular,regular heavy Alcohol or Other Drugs use,0
C0678383,regular beer,regular,,0
C0686860,Non-Sporing Gram Positive Rods,regular,"Subclass Regular Non-Sporing Gram Positive Rods; Non-Sporing Gram Positive Rods (organism); SUBCLASS REGULAR, NONSPORING GRAM-POSITIVE RODS",0
C0691084,acetaminophen 325 MG Oral Capsule,regular,"ACETAMINOPHEN 325 mg ORAL CAPSULE, LIQUID FILLED [Regular Strength Pain Relief]; ACETAMINOPHEN 325 mg ORAL CAPSULE, LIQUID FILLED; ACETAMINOPHEN 325 mg ORAL CAPSULE, GELATIN COATED [REGULAR STRENGTH PAIN RELIEF]; ACETAMINOPHEN 325 mg ORAL CAPSULE, LIQUID FILLED [Regular Strength Pain Reliever]; ACETAMINOPHEN 325 mg ORAL CAPSULE, LIQUID FILLED [ACETAMINOPHEN (RED)]; Acetaminophen 325 mg oral capsule; APAP 325 MG Oral Capsule; Paracetamol 325 mg oral capsule; acetaminophen 325 MG Oral Capsule; acetaminophen 325 mg oral capsule; ACETAMINOPHEN 325MG CAP; ACETAMINOPHEN 325 mg in 1570 mg ORAL CAPSULE [Naspen]; Product containing precisely paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)",0
C0691137,aspirin 325 MG Delayed Release Oral Tablet,regular,"ASPIRIN 325 mg ORAL TABLET, COATED [Regular Strength Aspirin EC]; ASPIRIN 325 mg ORAL TABLET, COATED [Enteric coated aspirin]; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET, COATED [Regular Strength Enteric coated aspirin]; ASPIRIN 325MG TAB,EC; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin regular strength]; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [aspirin pain relief]; ASPIRIN 325 mg ORAL TABLET [Aspirin Enteric Coated]; ASPIRIN 325MG EC TAB; ASPIRIN 325 mg ORAL TABLET, COATED [Health Mart Regular Strength Enteric Coated Aspirin]; ASPIRIN 325 ng ORAL TABLET, COATED; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Aspirin 325 mg]; aspirin 325 MG Enteric Coated Oral Tablet; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Enteric Coated Aspirin]; ASA 325 MG Delayed Release Oral Tablet; ASPIRIN 325 mg ORAL TABLET [Aspirin 325 mg]; ASPIRIN 325 mg in 325 ORAL TABLET, DELAYED RELEASE [Enteric Coated Aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [enteric coated aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin Safety Coated Enteric, Regular Strength]; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin 325]; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Pharbest Aspirin 325mg]; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Regular Strength Aspirin EC]; ASPIRIN 325 mg ORAL TABLET, COATED [Enteric coated aspirin Regular strength]; Product containing precisely aspirin 325 milligram/1 each gastro-resistant oral tablet (clinical drug); ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Enteric Aspirin]; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Aspirin Enteric Coated, Regular Strength]; Aspirin 325 mg gastro-resistant oral tablet; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin Safety Coated]; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin]; Aspirin, 325 mg oral delayed release tablet; aspirin 325 MG Delayed Release Oral Tablet; Aspirin Enteric Coated, 325 mg oral delayed release tablet; ASPIRIN 325 mg ORAL TABLET [Enteric Coated Aspirin]; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [VALUMEDS ASPIRIN]; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET, COATED [Enteric Coated Aspirin regular strength]; ASPIRIN 325 mg ORAL TABLET, FILM COATED; ASPIRIN 325 mg ORAL TABLET, COATED [Regular Strength Aspirin]; ASPIRIN 325 mg ORAL TABLET [ASPIRIN 325 MG EC]; ASPIRIN 325 mg ORAL TABLET; ASPIRIN 325 mg ORAL TABLET, DELAYED RELEASE [Enteric Coated Aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET, COATED; aspirin 325 mg oral delayed release tablet",0
C0691537,hydrocortisone 5 MG/ML Topical Cream,regular,"HYDROCORTISONE 5 mg in 1 g TOPICAL CREAM [Anti-Itch Regular Strength]; HYDROCORTISONE 5 mg in 1 g TOPICAL CREAM [ANTI-ITCH FEMININE CARE]; Hydrocortisone 0.5 g in 100 g TOPICAL CREAM; hydrocortisone 0.5 % Topical Cream; HYDROCORTISONE 5 mg in 1 g TOPICAL CREAM [AVON HeXashield Anti Itch Cream with Healing Aloe]; Hydrocortisone 5 mg/g cutaneous cream; HYDROCORTISONE 0.5% CREAM; HYDROCORTISONE 5 mg in 1 g TOPICAL CREAM [HeXashield Anti Itch Cream with Healing Aloe]; Product containing precisely hydrocortisone 5 milligram/1 gram conventional release cutaneous cream (clinical drug); Hydrocortisone-Aloe, 0.5% topical cream; Hydrocortisone, Topical, 0.5% topical cream; hydrocortisone topical 0.5% topical cream; Hydrocortisone 0.5 g in 100 g TOPICAL CREAM [Good Neighbor Pharmacy Hydrocortisone With Aloe for Sensitive Skin]; hydrocortisone 5 MG/ML Topical Cream; HYDROCORTISONE 0.51 g in 100 g TOPICAL CREAM [Regular Strength Hydrocortisone Cream]; HYDROCORTISONE 0.5% CREAM,TOP",0
C0692225,"Lente Insulin, Beef-Pork 100 UNT/ML Injectable Suspension",insulin,,0
C0694064,"sennosides, USP 15 MG Oral Tablet",regular,"Senna Lax, 15 mg oral tablet; SENNOSIDES 15 mg ORAL TABLET, COATED [Laxative Regular Strength]; SENNOSIDES 15 mg ORAL TABLET, SUGAR COATED [Stimulant Laxative]; sennosides 15 MG Oral Tablet; SENNOSIDES 15 mg ORAL TABLET [Regular Strength Laxative]; Product containing precisely senna 15 milligram/1 each conventional release oral tablet (clinical drug); SENNOSIDES 15 mg ORAL TABLET, SUGAR COATED [Laxative Regular Strength]; Senna 15 mg oral tablet; SENNOSIDES 15 mg ORAL TABLET, SUGAR COATED [Laxative]; senna 15 mg oral tablet; SENNOSIDES A AND B 15 mg ORAL TABLET, SUGAR COATED",0
C0694916,Glucose monitor supply for diabetic beneficiary not treated with insulin,insulin,,0
C0700907,Insulin Novo Monotard,insulin,"Novo Monotard, Insulin; Monotard, Insulin Novo",0
C0700908,"Insulin, Lente, Monocomponent",insulin,,0
C0700910,"Insulin, Monotard",insulin,Monotard Insulin,0
C0711152,acetaminophen 325 MG Oral Tablet [Tylenol],regular,"Tylenol Regular Strength, 325 mg oral tablet; APAP 325 MG Oral Tablet [Tylenol]; Tylenol, 325 mg oral tablet; Tylenol 325 MG Oral Tablet; Acetaminophen 325 mg ORAL TABLET [TYLENOL Regular Strength]; ACETAMINOPHEN 325 mg ORAL TABLET [TYLENOL Regular Strength]; ACETAMINOPHEN 325 mg ORAL TABLET, FILM COATED [TYLENOL Regular Strength]; Tylenol Regular Strength 325 MG Oral Tablet",0
C0711804,aspirin 325 MG Oral Tablet [Ascriptin],regular,Ascriptin Regular Strength 325 MG Oral Tablet; ASA 325 MG Oral Tablet [Ascriptin]; Ascriptin 325 MG Oral Tablet,0
C0711901,aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon],regular,"Gaviscon Regular Strength, 95 mg-358 mg/15 mL oral suspension; Gaviscon (aluminum hydroxide 95 MG / magnesium carbonate 358 MG) per 15 ML Oral Suspension; Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension; ALUMINUM HYDROXIDE 95 mg in 15 mL / MAGNESIUM CARBONATE 358 mg in 15 mL ORAL LIQUID [GAVISCON]; Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension",0
C0711956,calcium carbonate 500 MG Chewable Tablet [Tums],regular,"Tums Freshers 500 MG Chewable Tablet; Tums, 500 mg oral tablet, chewable; CALCIUM CARBONATE 500 mg ORAL TABLET [TUMS]; Tums 500 MG (as calcium 200 MG) Chewable Tablet; Tums 500 MG (Ca 200 MG) Chewable Tablet; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Tums Regular Strength]",0
C0713228,tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution,regular,"TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION [GoodSense Eye Drops Original Formula]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION/ DROPS [Meijer Redness Relief]; TETRAHYDROZOLINE HCL 0.05% OPH SOLN; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION [DG Original Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION/ DROPS [Preferred Plus Pharmacy Redness Relief Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION/ DROPS [Good Neighbor Pharmacy Eye Drops Original Formula]; tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution; Tetrahydrozoline Hydrochloride, 0.05% ophthalmic solution; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION/ DROPS [Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC LIQUID [Redness reliever]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION [TopCare Health Original Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [Equate Redness Reliever]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION/ DROPS [EYE DROPS]; tetrahydrozoline hydrochloride 0.05 % Eye Drops; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC LIQUID [Leader Original Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [Rite Aid Original Sterile Eye]; tetrahydrozoline HCl 0.05 % Ophthalmic Solution; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [Family Care Original Eye]; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC SOLUTION [DG Health Sterile Redness Relief]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC LIQUID [Winco Original Formula Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC SOLUTION [QUALITY CHOICE ORIGINAL EYE DROPS]; tetrahydrozoline hydrochloride 0.05 % Ophthalmic Solution; Eye Drops, 0.05% ophthalmic solution; TETRAHYDROZOLINE HCL 0.05% SOLN,OPH; Eye Drop, 0.05% ophthalmic solution; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC LIQUID [Equate Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC LIQUID [Sunmark Eye Drops Original Formula]; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL TOPICAL SOLUTION/ DROPS [Circle K Eye Drops Redness Reliever]; tetrahydrozoline ophthalmic 0.05% ophthalmic solution; Tetrahydrozoline Hydrochloride 0.5 mg in 1 mL TOPICAL LIQUID [Lil Drug Store Eye Drops Redness Reliever]; TETRAHYDROZOLINE HYDROCHLORIDE 0.5 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [Eye Drops Regular]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION [SK Original Eye Drops]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC SOLUTION/ DROPS [Rugby Tetrahydrozoline Ophthalmic Solution]; TETRAHYDROZOLINE HYDROCHLORIDE 0.05 g in 100 mL OPHTHALMIC LIQUID [Walgreens Eye Drops Original 15mL and twin pack]",0
C0713271,"Aveeno Regular Bath, topical powder",regular,,0
C0714615,aspirin 325 MG Oral Tablet,regular,"ASPIRIN 325 mg ORAL TABLET, FILM COATED [Equaline Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Pain Reliever]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Medique Aspirin]; Aspirin 325 mg oral tablet; ASPIRIN 325 mg ORAL TABLET, COATED [Unishield Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [MEDI-FIRST Aspirin]; ASPIRIN 325 mg ORAL TABLET [Lil Drug Store Aspirin 325]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [365 everyday value aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Sunmark Aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET [Aspirin Regular Strength]; aspirin buffered 325 mg oral tablet; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Buffered Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Medi-First Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Pain Relief Aspirin]; Product containing precisely aspirin 325 milligram/1 each conventional release oral tablet (clinical drug); Tri-Buffered Aspirin, buffered 325 mg oral tablet; ASPIRIN 325 mg ORAL TABLET, FILM COATED [health mart adult aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [sunmark adult aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Health Mart Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Crane Safety Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [good neighbor pharmacy aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Medi-First Plus Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [good sense aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Rapidol Aspirin Display 2x25]; ASPIRIN 325 mg ORAL TABLET [Aspirin 325mg]; ASPIRIN 325 mg ORAL TABLET, COATED [Geritrex Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [MEDIQUE ASPIRIN]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [equate aspirin]; ASPIRIN 325 mg ORAL TABLET [Aramark Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [rugby adult aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Travel Savvy Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [up and up aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [First Aid Only Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Equate Aspirin]; ASPIRIN 325 mg TOPICAL TABLET, FILM COATED [Medique Aspirin]; Aspirin, 325 mg oral tablet; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET [Circle K Aspirin 325]; ASPIRIN 325 mg ORAL TABLET [First Aid Direct Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [MooreBrand Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Aspirin Regular Strength]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [ULINE Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Aspirin NSAID]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Medique Products Aspirin]; ASPIRIN 325 mg ORAL TABLET; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Direct Safety Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED; ASPIRIN 325 mg ORAL TABLET, FILM COATED [signature care aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [McKesson Aspirin]; ASPIRIN 325 ORAL TABLET [ADVANCED ASPIRIN]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Henry Schein Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Tri-Buffered Aspirin]; ASA 325 MG Oral Tablet; ASPIRIN 325 mg ORAL TABLET [Aspirin 5 grain]; ASPIRIN 325 mg ORAL TABLET, COATED [Crane Safety Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Medi-First Plus Aspirin]; ASPIRIN 325 mg ORAL TABLET [Zee Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Good Sense Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Micro-Coated Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Coated Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [leader aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Medi-First Aspirin]; ASPIRIN 325MG BUFFERED TAB; ASPIRIN 325 mg ORAL TABLET [Aspirin]; ASPIRIN 325 mg ORAL TABLET [ASPIRIN 325 MG]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Berkley and Jensen Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Physicians Care Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Basic Care Aspirin]; Aspirin 325 mg ORAL TABLET; ASPIRIN 325 mg ORAL TABLET, COATED [Travel Savvy Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [careone aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [Physicians Care Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Up and Up aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Good Neighbor Pharmacy Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Unishield Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [MEDIQUE Aspirin]; ASPIRIN 325MG TAB,UD; ASPIRIN 325 mg ORAL TABLET, COATED [Direct Safety Aspirin]; ASPIRIN 325 mg ORAL TABLET, COATED [ULINE Aspirin]; aspirin 325 MG Oral Tablet; ASPIRIN 325MG TAB; ASPIRIN 325 mg ORAL TABLET, COATED [MICRO-COATED ASPIRIN 325 mg]; ASPIRIN 325 mg ORAL TABLET, COATED [Medique Products Aspirin]; aspirin 325 mg oral tablet; ASPIRIN 325 mg ORAL TABLET [Aspirin NSAID]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Moore Medical Aspirin]; Adult Aspirin, 325 mg oral tablet; ASPIRIN 325 mg ORAL TABLET, FILM COATED [365 Everyday Value Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [caring mill aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Medi First Plus Aspirin]; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Uline Aspirin]; ASPIRIN 325 mg ORAL TABLET [Pharbest Regular Strength Aspirin]; ASPIRIN 325MG TAB UD; ASPIRIN 325 mg ORAL TABLET, FILM COATED [Signature Care Aspririn]",0
C0714681,aspirin 325 MG Delayed Release Oral Tablet [Ecotrin],regular,"Ecotrin, 325 mg oral delayed release tablet; ASPIRIN 325 mg ORAL TABLET, COATED [Ecotrin Regular Strength]; ASA 325 MG Delayed Release Oral Tablet [Ecotrin]; Ecotrin 325 MG Delayed Release Oral Tablet",0
C0714962,benzocaine 50 MG/ML / resorcinol 20 MG/ML Vaginal Cream [Vagisil Original Formula],regular,"Vagisil Original Strength (benzocaine 5 % / resorcinol 2 % ) Vaginal Cream; Vagisil Original Strength 5 % / 2 % Vaginal Cream; BENZOCAINE 50 mg in 1 g / RESORCINOL 20 mg in 1 g TOPICAL CREAM [VAGISIL Anti-Itch Creme Regular Strength]; Vagisil, 5%-2% vaginal cream; Vagisil, Original Strength, Anti-Itch Topical Cream; Benzal Vagisil Creme Regular Strength (benzocaine 5 % / resorcinol 2 % ) Vaginal Cream",0
C0715671,phenylephrine hydrochloride 5 MG/ML Nasal Spray [Neo-Synephrine],regular,"Neo-Synephrine 0.5 % Nasal Spray; Neo-Synephrine Cold & Sinus Regular Strength 0.5 % Nasal Spray; Neo-Synephrine 5 MG/ML Nasal Spray; PHENYLEPHRINE HYDROCHLORIDE 0.5 g in 100 mL NASAL SPRAY [Neo-Synephrine Regular]; Neo-Synephrine Nasal, 0.5% nasal spray; phenylephrine hydrochloride 5 MG/ML Nasal Spray [Neo-Synephrine]",0
C0716043,"sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated]",regular,"SENNOSIDES 15 mg ORAL TABLET, CHEWABLE [EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE]; Ex-Lax Chocolated 15 MG Chewable Tablet; Ex-Lax Chocolated, 15 mg oral tablet, chewable; Ex-Lax Regular Strength Chocolated 15 MG Chewable Tablet",0
C0716044,"sennosides, USP 15 MG Oral Tablet [Ex-Lax Regular Strength Pills]",regular,Ex-Lax Regular Strength Pills 15 MG Oral Tablet; Ex-Lax Regular Strength 15 MG Oral Tablet; SENNOSIDES 15 mg ORAL TABLET [EX-LAX REGULAR STRENGTH STIMULANT LAXATIVE],0
C0716500,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]",insulin,"HumuLIN 70/30, human recombinant 70 units-30 units/mL subcutaneous suspension; HumuLIN 70/30 Injectable Suspension; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [HumuLIN]; INSULIN HUMULIN 70/30 (NPH/REG) INJ LILY; Insulin human 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humulin 70/30]; Humulin 70/30 Injectable Suspension; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]",0
C0716501,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin]",insulin,"Relion NovoLIN 70/30 Injectable Suspension; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [NovoLIN]; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin]; ReliOn/NovoLIN 70/30, human recombinant 70 units-30 units/mL subcutaneous suspension; NovoLIN 70/30 Injectable Suspension; INSULIN NOVOLIN 70/30 (NPH/REG) INJ NOVO; INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Novolin 70/30]; INSULIN HUMAN 100 [USP'U] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Novolin 70/30]; NovoLIN 70/30, human recombinant 70 units-30 units/mL subcutaneous suspension; Relion Novolin 70/30 Injectable Suspension; Novolin 70/30 Injectable Suspension",0
C0718746,Aveeno Regular Bath,regular,,0
C0720144,Ecotrin Regular,regular,,0
C0720325,Ex-Lax Regular Strength Pills,regular,Ex-Lax Regular Strength Pills,0
C0721036,Iletin II Regular Pork,regular,,0
C0721038,Iletin NPH,NPH,,0
C0721039,Iletin Regular,regular,,0
C0721077,Insulin Pork Mix,insulin,,0
C0723264,Selsun Blue-Regular,regular,,0
C0723357,Sinutab Regular Strength,regular,,0
C0723521,Sulfoxyl Regular,regular,,0
C0724030,Tylenol Regular Strength,regular,,0
C0724600,"insulin isophane, pork",insulin,"Insulin Purified NPH Pork; INSULIN,NPH,PORK/PURIFIED; Product containing porcine isophane insulin (medicinal product); Pork isophane insulin; insulin isophane, pork; insulin, NPH, porcine; isophane insulin, pork; insulin isophane pork; NPH insulin, pork; insulin, NPH, pork; Insulin isophane porcine; NPH insulin, porcine; Porcine isophane insulin; insulin, isophane, porcine; Porcine isophane insulin (substance); Porcine isophane insulin-containing product",0
C0724601,"insulin, regular, pork",insulin,"insulin pork regular; Insulin Purified Regular Pork; Insulin, Porcine; INSULIN,REGULAR,PORK/PURIFIED; Porcine insulin soluble; Porcine Insulin; Product containing porcine regular insulin (medicinal product); Insulin, Regular, Pork; Insulin, regular, pork; Insulin, Regular, Porcine; Porcine insulin soluble-containing product; INSULIN,REGULAR,PORK; Regular Purified Pork Insulin; Porcine regular insulin (substance); Porcine regular insulin; insulin, regular, pork; Porcine regular insulin-containing product",0
C0724603,"ultralente insulin, human",insulin,"insulin, ultralente, human; insulin zinc ext human recombinant; ultralente insulin, human; INSULIN,ULTRALENTE,HUMAN/rDNA; INSULIN,ULTRALENTE,HUMAN",0
C0724838,"Insulin Syringe 1cc 28g 1/2""",insulin,,0
C0725208,Attends Guard Regular,regular,,0
C0725212,Attends Undergarment Regular,regular,,0
C0725219,Autolet Regular Platform,regular,,0
C0725324,Beauty Glove While-U-Sleep Regular,regular,,0
C0725329,Belted Under Regular Absorbency,regular,,0
C0725428,Brief Liner Regular,regular,,0
C0725687,Compleat Formula Regular Can,regular,,0
C0725747,Coverlet Eye Occlusor Regular,regular,,0
C0725817,Depend Brief Fit Regular,regular,,0
C0725819,Depend Shield Regular,regular,,0
C0725821,DEPEND UNDERGARMENT REG ABSORB,regular,Depend Undergarment Regular Absorbent; DEPEND UNDERGARMENT REG ABSORB,0
C0726056,Enfamil Concentrate Liquid Regular,regular,,0
C0726063,Enfamil Liquid RTU Regular,regular,,0
C0726137,Entrust Plus Pad Regular Absorbent,regular,,0
C0726139,Entrust Plus Regular,regular,,0
C0726243,First Aid Kit Regular,regular,,0
C0726356,Glove Ladies/Men Dermal Regular,regular,,0
C0726410,Guards Regular Absorbency,regular,,0
C0726520,Hose T.E.D. Small Regular White,regular,,0
C0726524,Hose T.E.D. Small/Regular Calf,regular,,0
C0726647,Incontinent Undergarment Regular,regular,,0
C0726649,Incontinent Underpad Regular,regular,,0
C0726689,Instaject II Insulin Lancet,insulin,,0
C0726693,Insulin Carry Tote,insulin,,0
C0726694,Insulin Delivery Needle,insulin,,0
C0726695,Insulin Syringe 0.5cc 27g,insulin,,0
C0726700,Insulin Syringe 1cc,insulin,,0
C0726701,Insulin Syringe 1cc 25g,insulin,,0
C0726703,Insulin Syringe 1cc 27g,insulin,,0
C0726707,"Insulin Syringe 27g 1/2""",insulin,,0
C0726708,"Insulin Syringe 28g 1/2""",insulin,,0
C0726710,"Insulin Syringe 29g 1/2""",insulin,,0
C0727037,Microlet Endcap Regular,regular,,0
C0727136,BD Needle Regular Bevel 18g,regular,,0
C0727137,BD Needle Regular Bevel 20g,regular,,0
C0727138,BD Needle Regular Bevel 23g,regular,,0
C0727139,BD Needle Regular Bevel 25g,regular,,0
C0727140,BD Needle Regular Bevel 27g,regular,,0
C0727269,Oatmeal Bath Regular,regular,,0
C0727299,Opticlude Regular Size,regular,,0
C0727383,Pads Free and Active Regular,regular,,0
C0727388,Pant Dignity Regular Extra Large,regular,,0
C0727389,Pant Dignity Regular Large,regular,,0
C0727390,Pant Dignity Regular Medium,regular,,0
C0727391,Pant Dignity Regular Small,regular,,0
C0727773,Scandishake Regular Chocolate,regular,,0
C0727774,Scandishake Regular Strawberry,regular,,0
C0727775,Scandishake Regular Vanilla,regular,,0
C0727842,Shield Regular,regular,,0
C0728239,Insulin Syringe 0.25cc 29g,insulin,,0
C0728241,Insulin Syringe 29g x 0.3cc,insulin,,0
C0728243,Insulin Syringe 1cc 28g,insulin,Insulin Syringe 28g 1cc,0
C0728249,Insulin Syringe Monoject 0.3cc 29g,insulin,,0
C0728250,Insulin Syringe Monoject 0.5cc 28g,insulin,,0
C0728251,Insulin Syringe Monoject 0.5cc 29g,insulin,,0
C0728252,Insulin Syringe Monoject 1cc 28g,insulin,,0
C0728253,Insulin Syringe Monoject 1cc 29g,insulin,,0
C0728373,Thermakit Insulin Carry-All,insulin,,0
C0728487,Undergarment Regular Absorbency,regular,,0
C0728493,Underpad Regular,regular,,0
C0733228,Humalog Mix25,humalog,,0
C0738361,Regular connective tissue,regular,Regular connective tissue,0
C0745343,insulin treatment,insulin,insulin treatments,0
C0751464,Insulin Receptor alpha Subunit,insulin,Insulin Receptor alpha Chain,0
C0751465,Insulin Receptor beta Subunit,insulin,Insulin Receptor beta Chain,0
C0756359,2-aminobenzoylprolyl-arginyl-glycyl-4-nitrophenylhydrazine,NPH,Abz-Pro-Arg-Gly-Nph; APAGN,0
C0758536,"irs2-A protein, Xenopus",insulin,"IRS-u protein, Xenopus; insulin receptor substrate 2-A, Xenopus; xIRS-u protein, Xenopus",0
C0759350,"insulin, Arg(B0)-",insulin,B-chain-(L-arginine)-B0 insulin; (L-Arg)-B0 insulin,0
C0768288,"BAIAP2 protein, human",insulin,"BAI1-associated protein 2, human; IRS-58; Insulin Receptor Substrate p53/p58; IRSp53/58; BAIAP2; BAI-Associated Protein 2; IRSp53 protein, human; FLAF3; Insulin receptor substrate 53, human; Fas Ligand-Associated Factor 3; IRSp53; Brain-Specific Angiogenesis Inhibitor Binding Protein; Insulin Receptor Substrate Protein of 53 kDa; BAP2 protein, human; Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2; BAIAP2 protein, human; Insulin Receptor Substrate p53; Protein BAP2",0
C0769166,pro-insulin-like growth factor I,insulin,pro-IGF-I,0
C0769489,bis(9-fluorenylmethoxycarbonyl)insulin,insulin,(Fmoc)2insulin; (Fmoc)2-insulin,0
C0770201,"insulin, regular, beef-pork",insulin,"INSULIN,REGULAR,BEEF/PORK; insulin, regular, beef-pork; insulin, regular, bovine-porcine",0
C0770206,"insulin, pork",insulin,"Pork insulin; insulin pork; Insulin purified porcine; insulin (swine); INSULIN PORK; porcine insulin; Insulin purified pork; Insulin, porcine; pork insulin; Pork insulin, NOS; Insulin (pork); Pork insulin-containing product; Insulin porcine; Insulin Pork; insulin (pork); Pork insulin (substance); insulin, pork; Insulin pork; Product containing pork insulin (product); Porcine insulin",0
C0770209,"insulin, protamine zinc, beef",insulin,"insulin, protamine zinc, beef",0
C0770213,"insulin, protamine zinc, pork",insulin,"insulin, protamine zinc, pork",0
C0770221,"lente insulin, beef",insulin,"lente insulin, beef; INSULIN,LENTE,BEEF; insulin, lente, beef; INSULIN,LENTE,BEEF/PURIFIED",0
C0770226,"ultralente insulin, beef-pork",insulin,"ultralente insulin, beef-pork; INSULIN,ULTRALENTE,BEEF/PORK",0
C0770228,"ultralente insulin, beef",insulin,"INSULIN,ULTRALENTE,BEEF/PURIFIED; INSULIN,ULTRALENTE,BEEF; insulin, ultralente, beef; ultralente insulin, beef",0
C0770230,"insulin, prompt zinc, beef-pork",insulin,"INSULIN,SEMILENTE,BEEF/PORK; insulin, prompt zinc, beef-pork",0
C0770232,"insulin, prompt zinc, beef",insulin,"INSULIN,SEMILENTE,BEEF; insulin, prompt zinc, beef",0
C0770233,"insulin, prompt zinc, human",insulin,"insulin, prompt zinc, human",0
C0770234,"insulin, prompt zinc, pork",insulin,"INSULIN,SEMILENTE,PORK/PURIFIED; insulin, prompt zinc, pork",0
C0771946,"insulin, protamine zinc, human",insulin,"insulin, protamine zinc, human",0
C0773216,"Lente Insulin, human 100 UNT/ML Injectable Suspension",insulin,,0
C0773219,"Ultralente Insulin, Human 100 UNT/ML Injectable Suspension",insulin,,0
C0780404,insulin lispro 100 UNT/ML Injectable Solution,insulin,"INSULIN LISPRO 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Lispro]; Insulin lispro 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin lispro]; Product containing precisely insulin lispro 100 unit/1 milliliter conventional release solution for injection (clinical drug); insulin lispro 100 UNT/ML Injectable Solution; Insulin lispro 100 unit/mL solution for injection; Insulin Lispro, 100 units/mL injectable solution; INSULIN LISPRO 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin Lispro]; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Lispro]; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin lispro]; insulin, analog lispro 100 UNT/ML Injectable Solution; insulin lispro 100 units/mL injectable solution; Insulin lispro 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin Lispro]",0
C0782004,"insulin, protamine zinc, beef 100 UNT/ML Injectable Suspension",insulin,"insulin, protamine zinc, beef 100 UNT/ML Injectable Suspension; Product containing precisely bovine insulin protamine zinc 100 unit/1 milliliter conventional release suspension for injection (clinical drug); Bovine insulin protamine zinc 100 unit/mL suspension for injection",0
C0783228,benzocaine 50 MG/ML / resorcinol 20 MG/ML Vaginal Cream,regular,BENZOCAINE 5 g in 100 g / RESORCINOL 2 g in 100 g TOPICAL CREAM [Rite Aid Original Strength Vagicaine]; BENZOCAINE 5 g in 100 g / RESORCINOL 2 g in 100 g TOPICAL CREAM [Anti-Itch Regular Strength]; benzocaine-resorcinol topical 5%-2% vaginal cream; benzocaine 5 % / resorcinol 2 % Vaginal Cream; BENZOCAINE 0.05 g in 1 g / RESORCINOL 0.02 g in 1 g TOPICAL CREAM [Budpak Feminine Anti-Itch],0
C0785307,Disposable insulin syringe U-100 0.5 ML,insulin,,0
C0785308,Disposable insulin syringe U-100 1 ML,insulin,,0
C0785936,"insulin isophane, human 85 UNT/ML / insulin, regular, human 15 UNT/ML Injectable Suspension",insulin,Human isophane insulin 85 unit/mL and recombinant human regular insulin 15 unit/mL suspension for injection; Human isophane insulin 85 unit/mL and recombinant human soluble insulin 15 unit/mL suspension for injection; Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug),0
C0785937,"insulin isophane, human 50 UNT/ML / insulin, regular, human 50 UNT/ML Injectable Suspension",insulin,"insulin, human mixed 50/50 100 UNT/ML Injectable Suspension; Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug); Human isophane insulin 50 unit/mL and recombinant human soluble insulin 50 unit/mL suspension for injection; Human isophane insulin 50 unit/mL and recombinant human regular insulin 50 unit/mL suspension for injection",0
C0788619,"insulin isophane, human 90 UNT/ML / insulin, regular, human 10 UNT/ML Injectable Suspension",insulin,Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug); Human isophane insulin 90 unit/mL and recombinant human regular insulin 10 unit/mL suspension for injection; Human isophane insulin 90 unit/mL and recombinant human soluble insulin 10 unit/mL suspension for injection,0
C0788620,"insulin isophane, human 80 UNT/ML / insulin, regular, human 20 UNT/ML Injectable Suspension",insulin,Human isophane insulin 80 unit/mL and recombinant human regular insulin 20 unit/mL suspension for injection; Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug); Human isophane insulin 80 unit/mL and recombinant human soluble insulin 20 unit/mL suspension for injection,0
C0788621,"insulin isophane, human 60 UNT/ML / insulin, regular, human 40 UNT/ML Injectable Suspension",insulin,Human isophane insulin 60 unit/mL and recombinant human regular insulin 40 unit/mL suspension for injection; Human isophane insulin 60 unit/mL and recombinant human soluble insulin 40 unit/mL suspension for injection; Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug),0
C0788845,sulfur 25 MG/ML Medicated Shampoo,regular,"SULFUR 25 mg in 1 mL TOPICAL SUSPENSION [Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Oil Serum]; SULFUR 25 mg in 1 mL TOPICAL SUSPENSION [Glovers Dandruff Control Medicine, Regular]; sulfur 2.5 % Medicated Shampoo; SULFUR 25 mg in 1 mL TOPICAL SUSPENSION [Glovers Dandruff Control Med., Floral]",0
C0789897,Disposable insulin syringe U-100 0.3 ML,insulin,,0
C0790734,"lente insulin, pork 40 UNT/ML Injectable Suspension",insulin,,0
C0790951,"insulin, regular, human 500 UNT/ML Injectable Solution",insulin,"insulin regular human recombinant 500 units/mL subcutaneous solution; insulin, human regular 500 UNT/ML Injectable Solution; regular insulin, human (concentrated) 500 UNT/ML Injectable Solution",0
C0793005,"sennosides, USP 15 MG Chewable Tablet",regular,"Sennosides 15 mg ORAL TABLET, CHEWABLE [Laxative Regular Strength, chocolated stimulant laxative sennosides, Equaline]; senna 15 mg oral tablet, chewable; Sennosides 15 mg ORAL TABLET, CHEWABLE [Chocolated Laxative Regular Strength Sennosides Stimulant Laxative, Best Choice]; Sennosides 15 mg ORAL TABLET, CHEWABLE [Chocolated Laxative]; SENNOSIDES 15MG TAB,CHEWABLE; Sennosides 15 mg ORAL TABLET, CHEWABLE [Chocolated Laxative Regular Strength Sennosides Stimulant Laxative TopCare health]; Sennosides 15 mg ORAL TABLET, CHEWABLE [Chocolate Laxative Regular strength, Sennosides Stimulant Laxative, equate]; Sennosides 15 mg ORAL TABLET [Leader Regular Strength Chocolate Laxative sennosides]; SENNOSIDES 15MG CHEW TAB; SENNOSIDES 15 mg ORAL TABLET, CHEWABLE [Chocolated Laxative]; sennosides 15 MG Chewable Tablet",0
C0793278,diphenhydramine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Cream,regular,diphenhydramine-zinc acetate topical 1%-0.1% topical cream; DIPHENHYDRAMINE HYDROCHLORIDE 10 mg in 1 g / ZINC ACETATE 1 mg in 1 g TOPICAL CREAM [WinCo Original Strength Anti-Itch]; diphenhydrAMINE hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Cream; diphenhydrAMINE HCl 1 % / zinc acetate 0.1 % Topical Cream; DIPHENHYDRAMINE HYDROCHLORIDE 1 g in 100 g / ZINC ACETATE 0.1 g in 100 g TOPICAL CREAM [ANTI-ITCH]; diphenhydrAMINE hydrochloride 1 % / zinc acetate 0.1 % Topical Cream; diphenhydramine hydrochloride 1 % / zinc acetate 0.1 % Topical Cream; DIPHENHYDRAMINE HYDROCHLORIDE 10 mg in 1 g / ZINC ACETATE 1 mg in 1 g TOPICAL CREAM [Discount Drug Mart Regular Strength Itch Stopping]; DIPHENHYDRAMINE HYDROCHLORIDE 1 g in 100 g / ZINC ACETATE 0.1 g in 100 g TOPICAL CREAM [Walgreens Original Strength Anti Itch]; DIPHENHYDRAMINE HYDROCHLORIDE 10 mg in 1 g / ZINC ACETATE 1 mg in 1 g TOPICAL CREAM [CVS Regular Strength Itch Stopping],0
C0795633,"insulin isophane, human",insulin,"insulin nph human recombinant; NPH Insulin, Human; Human isophane insulin-containing product; Isophane Insulin, Human; insulin human isophane; Human NPH Insulin; insulin isophane; insulin nph human; isophane human insulin; INSULIN,NPH,HUMAN/SEMISYNTHETIC; Human Isophane Insulin; nph human insulin; Product containing human isophane insulin (medicinal product); Insulin, Human NPH; Human isophane insulin; insulin human nph; isophane insulin human; human insulin nph; INSULIN,NPH,HUMAN/rDNA; Insulin, NPH, Human; Protophane; Protophan; Isophane Insulin (Human); human isophane insulin; Insulin, Human Isophane; insulin isophane, human; human nph insulin; insulin isophane (NPH); Human isophane insulin (substance)",0
C0795635,"insulin, regular, human",insulin,"human regular insulin; insulin regular human recombinant; Insulina regular; Human insulin, NOS; Semisynthetic human insulin; High molecular weight insulin human; Human insulin soluble-containing product; Human insulin (substance); Insulin regular; Insulin (human); Insulin Human; INSULIN; Human insulin; Insulin, Regular, Human; Insulin Human Regular; INSULIN,REGULAR,HUMAN/rDNA; Insulin human regular (rDNA); Human insulin-containing product; insulin regular; Insulin, Regular; Insulin Human (Regular); insulin, regular, human; Human regular insulin (substance); insulin human; insulin (human); Insulin, human; human insulin; insulin, regular; Regular Insulin, human; Product containing human insulin (product); INSULIN HUMAN; Human regular insulin-containing product; insulin human regular; Product containing human regular insulin (medicinal product); Human insulin soluble; INSULIN,REGULAR,HUMAN/SEMISYNTHETIC; Insulin human; insulin; Human regular insulin",0
C0796116,pigmentary retinopathy-hypogonadism-mental retardation-nerve deafness-glucose intolerance syndrome,insulin,insulin-resistant diabetes-acanthosis nigricans-hypogonadism-pigmentary retinopathy-deafness-mental retardation syndrome,0
C0796799,Insulin^1.5H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^1.5 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.5h p 75 g Glc PO SerPl-mCnc; Insulin [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO; Insulin 1.5 Hr post 75 g glucose PO [Mass/Vol],0
C0796800,Insulin^2.5H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO; Insulin^2.5 hours post 75 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2.5 Hr post 75 g glucose PO [Mass/Vol]; Insulin 2.5h p 75 g Glc PO SerPl-mCnc,0
C0796823,Insulin receptor Ab:Titr:Pt:Ser:Qn,insulin,Insulin receptor Ab (S) [Titer]; Insulin receptor Antibody:Dilution Factor (Titer):To identify measures at a point in time:Serum:Quantitative; Insulin Recep Ab Titr Ser; Insulin receptor Ab [Titer] in Serum,0
C0796824,Insulin receptor Ab:PrThr:Pt:Ser:Ord,insulin,Insulin receptor Antibody:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal; Insulin Recep Ab Ser Ql; Insulin receptor Ab Ql (S); Insulin receptor Ab [Presence] in Serum,0
C0797085,Insulin-like growth factor-I:ACnc:Pt:Bld:Qn,insulin,Insulin-like growth factor-I Qn (Bld); Insulin-like growth factor-I:Arbitrary concentration:To identify measures at a point in time:Whole blood:Quantitative; IGF-I Bld-aCnc; Insulin-like growth factor-I [Units/volume] in Blood,0
C0797474,Insulin^baseline:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^baseline:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --baseline; Insulin BS SerPl-sCnc; Insulin baseline [Moles/Vol],0
C0797970,Insulin:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/Vol]; Insulin SerPl-sCnc; Insulin:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma,0
C0798959,Insulin bovine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,insulin,Insulin Bovine IgE RAST Ql; Insulin bovine Antibody.immunoglobulin E.RAST class:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal; Insulin bovine IgE Ab RAST class [Presence] in Serum; Insulin bovine IgE RAST class (S),0
C0798960,Insulin human Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,insulin,Insulin human IgE RAST class (S); Insulin Human IgE RAST Ql; Insulin human IgE Ab RAST class [Presence] in Serum; Insulin human Antibody.immunoglobulin E.RAST class:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal,0
C0798961,Insulin porcine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,insulin,Insulin porcine IgE RAST class (S); Insulin Porcine IgE RAST Ql; Insulin porcine Antibody.immunoglobulin E.RAST class:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal; Insulin porcine IgE Ab RAST class [Presence] in Serum,0
C0800147,Insulin^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge; Insulin 10 Min post Unsp challenge [Mass/Vol]; Insulin^10 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10M p chal SerPl-mCnc,0
C0800148,Insulin^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^20 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge; Insulin 20M p chal SerPl-mCnc; Insulin 20 Min post Unsp challenge [Mass/Vol],0
C0800149,Insulin-like growth factor-I^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF-I 2h p chal SerPl-mCnc; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2 hours post XXX challenge; Insulin-like growth factor-I^2 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I 2 Hr post Unsp challenge [Mass/Vol],0
C0801280,Insulin:PrThr:Pt:Unk sub:Ord,insulin,Insulin Usub Ql; Insulin Ql (Unknown substance); Insulin:Presence or Threshold:To identify measures at a point in time:Unknown substance:Ordinal; Insulin [Presence] in Unknown substance,0
C0803262,Insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin Qn; Insulin [Units/volume] in Serum or Plasma; Insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin SerPl-aCnc,0
C0806515,Insulin bovine Ab.IgE.RAST class,insulin,Insulin bovine Ab.IgE.RAST class; Insulin bovine Antibody.immunoglobulin E.RAST class,0
C0806516,Insulin human Ab.IgE.RAST class,insulin,Insulin human Antibody.immunoglobulin E.RAST class; Insulin human Ab.IgE.RAST class,0
C0806517,Insulin porcine Ab.IgE.RAST class,insulin,Insulin porcine Ab.IgE.RAST class; Insulin porcine Antibody.immunoglobulin E.RAST class,0
C0814560,regular involvement in church activities,regular,,0
C0815170,regular physical activity,regular,,0
C0851302,Hypoglycemic shock,insulin,Hypoglycemic shock; Hypoglycemic shock NOS; hypoglycemic shock; Hypoglycemic shock (disorder); Hypoglycaemic shock; Insulin shock; hypoglycaemic shock; SHOCK HYPOGLYCEMIC,0
C0852795,Increased insulin level,insulin,Increased insulin level (finding); Hyperinsulinemia; Hyperinsulinism; Increased insulin level; Serum insulin concentration increased above normal,0
C0853230,blood insulin,insulin,insulin blood,0
C0854110,Insulin-resistant diabetes mellitus,insulin,"Diabetes mellitus, insulin-resistant; DIABETES MELLITUS, INSULIN-RESISTANT; Insulin-resistant diabetes; diabetes insulin resistant; insulin resistant diabetes; Insulin-resistant diabetes mellitus; Insulin resistant diabetes; Insulin resistant diabetes mellitus; diabetes resistant insulin",0
C0854359,Insulin autoimmune syndrome,insulin,Insulin autoimmune syndrome (disorder); Hirata disease; Insulin autoimmune syndrome,0
C0855718,Blood insulin C-peptide abnormal result,insulin,,0
C0857690,plasma insulin,insulin,,0
C0858301,insulin normal,insulin,normal insulin,0
C0858734,insulin hypoglycemia,insulin,hypoglycemia insulin,0
C0861019,Insulin C-peptide abnormal result,insulin,,0
C0861023,insulin low,insulin,low insulin,0
C0865167,Non-diabetic insulin coma,insulin,,0
C0868214,Insulin causing adverse effects in therapeutic use,insulin,,0
C0872645,"insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Injectable Suspension",insulin,"insulin lispro protamine / insulin lispro 75/25 Injectable Suspension; Insulin lispro 25 unit/mL and insulin lispro protamine 75 unit/mL solution for injection; insulin lispro-insulin lispro protamine 25 units-75 units/mL subcutaneous suspension; insulin analog, lispro mixed 75/25 100 UNT/ML Injectable Suspension; Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)",0
C0875287,aspirin 325 MG Oral Tablet [Bufferin],regular,"aspirin 325 mg ORAL TABLET, COATED [Bufferin Regular Strength Pain Relief]; Bufferin 325 MG Oral Tablet; ASA 325 MG Oral Tablet [Bufferin]",0
C0875843,"Insulin Lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Injectable Suspension [Humalog Mix]",insulin,"HumaLOG Mix 50/50, 50 units-50 units/mL subcutaneous suspension; INSULIN,LISPRO,HUMAN 50/50 HUMALOG INJ; insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Injectable Suspension [Humalog Mix]; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humalog Mix50/50]; insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Injectable Suspension [HumaLOG Mix]; Humalog Mix 50/50 100 UNT/ML Injectable Suspension; HumaLOG Mix 50/50 Injectable Suspension; HumaLOG Mix 50/50 100 UNT/ML Injectable Suspension; INSULIN,LISPRO,HUMAN 50/50 INJ,HUMALOG",0
C0875931,Insulin lispro protamine- and insulin lispro-containing product,insulin,insulin lispro-insulin lispro protamine; Product containing insulin lispro and insulin lispro protamine (medicinal product),0
C0876055,Humalog Mix,humalog,humalog mix; HumaLOG Mix,0
C0876064,Lantus,lantus,"Solostar, Lantus; Lantus Solostar; lantus; Lantus",0
C0876372,Insulin Syringe 0.5cc 30g,insulin,,0
C0876417,Poise Feminine Pad Regular,regular,,0
C0876493,Insulin Syringe 0.5cc 29g,insulin,Insulin Syringe 29g 0.5cc,0
C0876496,Insulin Syringe 0.3cc 28g,insulin,,0
C0885447,"Insulinum, homeopathic preparation",insulin,"homeopathic preparation insulin; insulin, homeopathic drug",0
C0893188,"Relaxin-Insulin-like factor, RIF2",insulin,Insulin-like peptide 5; INSL5 protein; Relaxin-insulin-like factor 2,0
C0904505,mecasermin,insulin,Mechano growth factor; Recombinant human insulin-like growth factor 1; Recombinant IGF-I; Recombinant Insulin-Like Growth Factor 1; Mecasermin (substance); MECASERMIN; Recombinant human somatomedin c; Mecasermin-containing product; mecasermin; Product containing mecasermin (medicinal product); Recombinant human insulin-like growth factor I; Mecasermin recombinant; Mecasermin; mescamerin recombinant; Mecasermina,0
C0907402,insulin glargine,insulin,"Insulin glargine recombinant; insulin glargine; Insulin glargine (rDNA origin); INSULIN GLARGINE; Insulin glargine; Insulin glargine (substance); INSULIN,GLARGINE,HUMAN/rDNA; Insulin, Gly(A21)-Arg(B31,B32); Insulina glargina; Product containing insulin glargine (medicinal product); glargine insulin; A21-Gly-B31-Arg-B32-Arg-insulin; Insulin Glargine Recombinant; Glargine; glargine; Insulin Glargine; Insulin, Glycyl(A21)-Arginyl(B31,B32); Glargine, Insulin; insulin glargine recombinant; A21 Gly B31 Arg B32 Arg insulin; Insulin glargine-containing product; insulin glargine human",0
C0908993,"Insl5 protein, mouse",insulin,"RIF2 protein, mouse; insulin-like peptide 5, mouse; ZINS3 protein, mouse",0
C0909044,insulin-cleaving membrane proteinase,insulin,ICMP enzyme,0
C0909989,cholera toxin B-insulin conjugate,insulin,,0
C0914288,"IGF2-AS protein, human",insulin,"IGF2 Antisense RNA 1; IGF2AS; IGF2-AS protein, human; IGF2-AS; Insulin-Like Growth Factor 2, Antisense; insulin-like growth factor 2 antisense protein, human; IGF2AS protein, human; Insulin-Like Growth Factor 2 Antisense 1; PEG8 protein, human; IGF2 Antisense RNA; IGF2-AS lncRNA, human; PEG8; Insulin-Like Growth Factor 2 Antisense; long non-coding RNA IGF2-AS, human",0
C0915240,"RXFP3 protein, human",insulin,"GPCR135 protein, human; Somatostatin- and Angiotensin- Like Peptide Receptor, human; relaxin-insulin-like family peptide receptor 3, human; SALPR protein, human",0
C0915518,insulin receptor tyrosine kinase,insulin,insulin-induced receptor tyrosine kinase; IRTK enzyme,0
C0915897,((2-sulfo)-9-fluorenylmethoxycarbonyl)3-insulin,insulin,(FMS)3-insulin,0
C0919008,"PHYSICIAN SUPERVISION OF A PATIENT RECEIVING MEDICARE-COVERED SERVICES PROVIDED BY A PARTICIPATING HOME HEALTH AGENCY (PATIENT NOT PRESENT) REQUIRING COMPLEX AND MULTIDISCIPLINARY CARE MODALITIES INVOLVING REGULAR PHYSICIAN DEVELOPMENT AND/OR REVISION OF CARE PLANS, REVIEW OF SUBSEQUENT REPORTS OF PATIENT STATUS, REVIEW OF LABORATORY AND OTHER STUDIES, COMMUNICATION (INCLUDING TELEPHONE CALLS) WITH OTHER HEALTH CARE PROFESSIONALS INVOLVED IN THE PATIENT'S CARE, INTEGRATION OF NEW INFORMATION INTO THE MEDICAL TREATMENT PLAN AND/OR ADJUSTMENT OF MEDICAL THERAPY, WITHIN A CALENDAR MONTH, 30 MINUTES OR MORE",regular,Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans,0
C0919009,"PHYSICIAN SUPERVISION OF A PATIENT UNDER A MEDICARE-APPROVED HOSPICE (PATIENT NOT PRESENT) REQUIRING COMPLEX AND MULTIDISCIPLINARY CARE MODALITIES INVOLVING REGULAR PHYSICIAN DEVELOPMENT AND/OR REVISION OF CARE PLANS, REVIEW OF SUBSEQUENT REPORTS OF PATIENT STATUS, REVIEW OF LABORATORY AND OTHER STUDIES, COMMUNICATION (INCLUDING TELEPHONE CALLS) WITH OTHER HEALTH CARE PROFESSIONALS INVOLVED IN THE PATIENT'S CARE, INTEGRATION OF NEW INFORMATION INTO THE MEDICAL TREATMENT PLAN AND/OR ADJUSTMENT OF MEDICAL THERAPY, WITHIN A CALENDAR MONTH, 30 MINUTES OR MORE",regular,"Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more",0
C0919752,Anti-insulin antibody measurement,insulin,anti-insulin antibody test,0
C0920563,Insulin Sensitivity,insulin,"Sensitivity, Insulin; Insulin Sensitivity; insulin sensitivity",0
C0939412,NovoLog,novolog,NovoRapid; novorapid; novolog; Novolog; NovoLOG; NovoLog,0
C0939651,Insulin Glargine 100 UNT/ML Injectable Solution [Lantus],insulin,"INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Lantus]; insulin glargine 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Lantus]; insulin glargine 100 UNT/ML Injectable Solution [Lantus]; Lantus, 100 units/mL subcutaneous solution; Lantus 100 UNT/ML Injectable Solution",0
C0941585,Insulin.free:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin.free:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin Free SerPl-sCnc; Insulin Free [Moles/Vol]; Insulin Free [Moles/volume] in Serum or Plasma,0
C0941647,Insulin-like growth factor:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma; Insulin-like growth factor [Moles/Vol]; Insulin-like growth factor:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF SerPl-sCnc,0
C0941776,Insulin^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^10th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10th specimen post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge; Insulin sp10 p chal SerPl-sCnc,0
C0941777,Insulin^11th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^11th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 11th specimen post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge; Insulin sp11 p chal SerPl-sCnc,0
C0941778,Insulin^12th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge; Insulin^12th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp12 p chal SerPl-sCnc; Insulin 12th specimen post Unsp challenge [Moles/Vol],0
C0941779,Insulin^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^13th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge; Insulin 13th specimen post Unsp challenge [Moles/Vol]; Insulin sp13 p chal SerPl-sCnc,0
C0941780,Insulin^14th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^14th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp14 p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge; Insulin 14th specimen post Unsp challenge [Moles/Vol],0
C0941781,Insulin^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin sp1 p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge; Insulin^1st specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1st specimen post Unsp challenge [Moles/Vol],0
C0941782,Insulin^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin sp2 p chal SerPl-sCnc; Insulin 2nd specimen post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge; Insulin^2nd specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0941783,Insulin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^3rd specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3rd specimen post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge; Insulin sp3 p chal SerPl-sCnc,0
C0941784,Insulin^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^4th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp4 p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge; Insulin 4th specimen post Unsp challenge [Moles/Vol],0
C0941785,Insulin^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 5th specimen post Unsp challenge [Moles/Vol]; Insulin^5th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge; Insulin sp5 p chal SerPl-sCnc,0
C0941786,Insulin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge; Insulin 7th specimen post Unsp challenge [Moles/Vol]; Insulin^7th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp7 p chal SerPl-sCnc,0
C0941787,Insulin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin sp8 p chal SerPl-sCnc; Insulin 8th specimen post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge; Insulin^8th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0941837,Insulin-like growth factor^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge; IGF sp10 p chal SerPl-sCnc; Insulin-like growth factor^10th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor 10th specimen post Unsp challenge [Moles/Vol],0
C0941838,Insulin-like growth factor^11th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge; Insulin-like growth factor 11th specimen post Unsp challenge [Moles/Vol]; IGF sp11 p chal SerPl-sCnc; Insulin-like growth factor^11th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0941839,Insulin-like growth factor^12th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor 12th specimen post Unsp challenge [Moles/Vol]; IGF sp12 p chal SerPl-sCnc; Insulin-like growth factor^12th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge,0
C0941840,Insulin-like growth factor^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge; Insulin-like growth factor^13th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor 13th specimen post Unsp challenge [Moles/Vol]; IGF sp13 p chal SerPl-sCnc,0
C0941841,Insulin-like growth factor^14th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor^14th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF sp14 p chal SerPl-sCnc; Insulin-like growth factor [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge; Insulin-like growth factor 14th specimen post Unsp challenge [Moles/Vol],0
C0941842,Insulin-like growth factor^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge; Insulin-like growth factor^1st specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor 1st specimen post Unsp challenge [Moles/Vol]; IGF sp1 p chal SerPl-sCnc,0
C0941843,Insulin-like growth factor^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge; Insulin-like growth factor^3rd specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF sp3 p chal SerPl-sCnc; Insulin-like growth factor 3rd specimen post Unsp challenge [Moles/Vol],0
C0941844,Insulin-like growth factor^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor^4th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor 4th specimen post Unsp challenge [Moles/Vol]; IGF sp4 p chal SerPl-sCnc; Insulin-like growth factor [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge,0
C0941845,Insulin-like growth factor^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge; IGF sp5 p chal SerPl-sCnc; Insulin-like growth factor 5th specimen post Unsp challenge [Moles/Vol]; Insulin-like growth factor^5th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0941846,Insulin-like growth factor^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,IGF sp6 p chal SerPl-sCnc; Insulin-like growth factor [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge; Insulin-like growth factor^6th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor 6th specimen post Unsp challenge [Moles/Vol],0
C0941847,Insulin-like growth factor^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor^7th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF sp7 p chal SerPl-sCnc; Insulin-like growth factor [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge; Insulin-like growth factor 7th specimen post Unsp challenge [Moles/Vol],0
C0941848,Insulin-like growth factor^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor 9th specimen post Unsp challenge [Moles/Vol]; Insulin-like growth factor [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge; Insulin-like growth factor^9th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF sp9 p chal SerPl-sCnc,0
C0943142,Insulin^1.5H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 1.5 Hr post Unsp challenge Qn; Insulin 1.5h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge; Insulin^1.5 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0943179,Insulin^20M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge; Insulin 20M p chal SerPl-aCnc; Insulin^20 minutes post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 20 Min post Unsp challenge Qn,0
C0943183,Insulin^1H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^1 hour post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1h p chal SerPl-aCnc; Insulin 1 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --1 hour post XXX challenge,0
C0943236,Insulin^40M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 40 Min post Unsp challenge Qn; Insulin 40M p chal SerPl-aCnc; Insulin^40M post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge,0
C0943520,Insulin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 2 Hr post Unsp challenge Qn; Insulin 2h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --2 hours post XXX challenge; Insulin^2 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0943521,Insulin^3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^3 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --3 hours post XXX challenge; Insulin 3 Hr post Unsp challenge Qn; Insulin 3h p chal SerPl-aCnc,0
C0943522,Insulin^1H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --1 hour post 75 g glucose PO; Insulin 1h p 75 g Glc PO SerPl-aCnc; Insulin^1 hour post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1 Hr post 75 g glucose PO Qn,0
C0943523,Insulin^4th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge; Insulin 4th specimen post Unsp challenge Qn; Insulin sp4 p chal SerPl-aCnc; Insulin^4th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0943524,Insulin^7H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --7 hours post 75 g glucose PO; Insulin 7 Hr post 75 g glucose PO Qn; Insulin 7h p 75 g Glc PO SerPl-aCnc; Insulin^7 hours post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0943525,Insulin 1.5H p 75 g Glc PO SerPl-aCnc,insulin,Insulin^1.5 hours post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.5h p 75 g Glc PO SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO; Insulin 1.5 Hr post 75 g glucose PO Qn; Insulin^1.5H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,0
C0943541,Insulin^5H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 5 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --5 hours post XXX challenge; Insulin^5 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 5h p chal SerPl-aCnc,0
C0943549,Insulin^2H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --2 hours post 75 g glucose PO; Insulin 2h p 75 g Glc PO SerPl-aCnc; Insulin^2 hours post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2 Hr post 75 g glucose PO Qn,0
C0943550,Insulin^3H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 3 Hr post 75 g glucose PO Qn; Insulin [Units/volume] in Serum or Plasma --3 hours post 75 g glucose PO; Insulin^3 hours post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3h p 75 g Glc PO SerPl-aCnc,0
C0943551,Insulin^4H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 4h p 75 g Glc PO SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --4 hours post 75 g glucose PO; Insulin^4 hours post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 4 Hr post 75 g glucose PO Qn,0
C0943552,Insulin^2.5H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 2.5h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge; Insulin^2.5 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2.5 Hr post Unsp challenge Qn,0
C0943555,Insulin^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^7th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 7th specimen post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge; Insulin sp7 p chal SerPl-aCnc,0
C0943560,Insulin^6H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 6 Hr post 75 g glucose PO Qn; Insulin [Units/volume] in Serum or Plasma --6 hours post 75 g glucose PO; Insulin 6h p 75 g Glc PO SerPl-aCnc; Insulin^6 hours post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0943561,Insulin^post CFst:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin p fast SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --fasting; Insulin^post Calorie fast:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin post fast Qn,0
C0943562,Insulin^5th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^5th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge; Insulin sp5 p chal SerPl-aCnc; Insulin 5th specimen post Unsp challenge Qn,0
C0944722,Insulin:ACnc:Pt:Body fld:Qn,insulin,"Insulin [Units/volume] in Body fluid; Insulin Qn (Body fld); Insulin Fld-aCnc; Insulin:Arbitrary concentration:To identify measures at a point in time:Body fluid, unsp:Quantitative",0
C0944837,Insulin^4H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^4 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 4h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --4 hours post XXX challenge; Insulin 4 Hr post Unsp challenge Qn,0
C0944838,Insulin^6H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 6h p chal SerPl-aCnc; Insulin 6 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --6 hours post XXX challenge; Insulin^6 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C0945254,Insulin^7.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge; Insulin^7.5 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 7.5h p chal SerPl-sCnc; Insulin 7.5 Hr post Unsp challenge [Moles/Vol],0
C0945255,Insulin^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge; Insulin^9th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp9 p chal SerPl-sCnc; Insulin 9th specimen post Unsp challenge [Moles/Vol],0
C0945262,Insulin-like growth factor^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge; Insulin-like growth factor^2nd specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF sp2 p chal SerPl-sCnc; Insulin-like growth factor 2nd specimen post Unsp challenge [Moles/Vol],0
C0945263,Insulin-like growth factor^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,IGF sp8 p chal SerPl-sCnc; Insulin-like growth factor [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge; Insulin-like growth factor^8th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor 8th specimen post Unsp challenge [Moles/Vol],0
C0945542,Insulin^30M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 30 Min post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge; Insulin^30 minutes post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 30M p chal SerPl-aCnc,0
C0945547,Insulin^6th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^6th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge; Insulin sp6 p chal SerPl-aCnc; Insulin 6th specimen post Unsp challenge Qn,0
C0947216,Insulin^15th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --15th specimen post XXX challenge; Insulin sp15 p chal SerPl-sCnc; Insulin^15th specimen post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 15th specimen post Unsp challenge [Moles/Vol],0
C0956260,"des(hexapeptide)(B25-30)-Ala(B23)-insulin, D-Ala(B23)-isomer",insulin,,0
C0957077,"Trp(A1)-insulin, (L)-Trp-isomer",insulin,,0
C0957520,"des-Asn(21)-CysNH2(20)(A)-insulin, hydrochloride",insulin,,0
C0957521,"des-Asn(21)-Cys(20)-isopropylamide(A)-insulin, hydrochloride",insulin,,0
C0960400,N(epsilon)B29-(4-azidosalicyloyl) insulin,insulin,N(epsilon)B29-(4-A)insulin,0
C0960401,N(epsilon)B29-(4-azidotetrafluorobenzoyl-biocytinyl) insulin,insulin,N(epsilon)B29-(4-A-B)insulin,0
C0961403,"insulin, Lys(B29)-(N(epsilon)-myristoyl)-des(b30)",insulin,"LysB29-myristoyl, des(B30); LysB29-myristoyl, des(B30) insulin",0
C0962634,thyroxyl-insulin,insulin,,0
C0962635,NalphaB1 L-thyroxyl-insulin,insulin,B1-T4-Ins,0
C0964556,4-nitrophenyl-2-(4-O-methylglucopyranuronosyl)xylopyranoside,NPH,Nph-Xyl-MeGlcA,0
C0966894,Nalpha(Gly1)-(4-azidobenzoyl)-insulin-like growth factor-1,insulin,abG(1)IGF-1,0
C0966895,Nalpha(Gly1)-((2-6-(biotinamido)-2-(4-azidobenzamido)hexanoamido)ethyl-1.'-dithiopropionyl)-insulin-like growth factor-1,insulin,bedG(1)IGF-1,0
C0967881,"igf1 protein, zebrafish",insulin,"IGF-1a protein, zebrafish; IGF-1 Ea-2 protein, zebrafish; insulin-like growth factor 1 protein, zebrafish",0
C0969617,zea-mays insulin-like growth factor,insulin,ZmlGF,0
C0972641,Insulin Determination Reagents,insulin,"Reagents, Immunoassay, Diabetes, Insulin",0
C0973845,aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension,regular,"ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [exchange select antacid regular strength]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [Regular Strength Antacid Mint]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Equate antacid regular strength]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Antacid Regular Strength]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [ADVANCED REGULAR STRENGTH ANTACID]; aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension; aluminum hydroxide 400 MG / milk of magnesia 400 MG / dimethicone 40 MG per 10 ML Oral Suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [ADVANCED ANTACID MINT]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [GERI-LANTA ANTACID ANTIGAS]; Antacid Regular Strength Cool Mint, 200 mg-200 mg-20 mg/5 mL oral suspension; Geri-Lanta, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [careone antacid regular strength]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [ANTACID MINT]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [REGULAR STRENGTH ANTACID]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [REGULAR STRENGTH ANTACID ANTIGAS]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [ANTACID MINT]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [dg health antacid]; aluminum hydroxide 1200 MG / milk of magnesia 1200 MG / dimethicone 120 MG per 30 ML Oral Suspension; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL LIQUID [REGULAR STRENGTH ANTACID ANTIGAS]; Antacid Plus, 200 mg-200 mg-20 mg/5 mL oral suspension; MAGNESIUM HYDROXIDE 1200 mg in 30 mL / ALUMINUM HYDROXIDE 1200 mg in 30 mL / DIMETHICONE 120 mg in 30 mL ORAL SUSPENSION [Mag-Al Plus]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [REGULAR STRENGTH ANTACID/ANTIGAS]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL LIQUID [REGULAR STRENGTH ANTACID]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [ANTACID AND GASRELIEF]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [equaline antacid]; ALOH/MGOH/SIMETHICONE REGULAR STRENGTH LIQUID; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [Regular Strength Antacid Antigas]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [Antacid]; ALOH/MGOH/SIMTH REG STRENGTH LIQ,360ML; ALOH/MGOH/SIMTH REG STRENGTH LIQ; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [antacid]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [good sense antacid]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [Antacid antigas Regular Strength]; Mag-al Plus, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [REGULAR STRENGTH ANTACID]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Antacid regular strength]; AL OH 200MG/MG OH 200MG/SIMETHICONE 20MG/5ML LIQUID,360ML; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [GERI-MOX ANTACID ANTIGAS]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [Mag-AL Plus]; ALOH/MGOH/SIMETHICONE REGULAR STRENGTH LIQUID,30ML; Good Sense Advanced Antacid Regular Strength, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [Melox]; Aluminum Hydroxide/Magnesium Hydroxide/Simethicone, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [harris teeter antacid]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL LIQUID [Antacid]; ALOH/MGOH/SIMTH REG STRENGTH LIQ 30ML; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [Mag Al Plus]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Sunmark Antacid]; Geri-Mox, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Harris Teeter Antacid Regular Strength]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [antacid regular strength]; Good Sense Antacid Regular Strength, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Equaline Antacid regular strength]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Good Sense Antacid Regular Strength]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL LIQUID [ANTACID]; Antacid Anti-Gas, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [signature care antacid plus gas relief]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [Antacid Mint]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [Antacid Plus]; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL LIQUID [ADVANCED ANTACID REGULAR STRENGTH]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [REGULAR STRENGTH ANTACID MINT]; Antacid with Simethicone, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [Antacid Antigas]; ALUMINUM HYDROXIDE 1200 mg in 30 mL / MAGNESIUM HYDROXIDE 1200 mg in 30 mL / DIMETHICONE 120 mg in 30 mL ORAL SUSPENSION; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL LIQUID [REGULAR STRENGTH ANTACID]; aluminum hydroxide 200 MG / milk of magnesia 200 MG / dimethicone 20 MG per 5 ML Oral Suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Careone antacid]; Good Sense Antacid And Gas Relief Regular Strength, 200 mg-200 mg-20 mg/5 mL oral suspension; Advanced Antacid, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL LIQUID [GERI-LANTA ANTACID]; Antacid Regular Strength, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [Regular Strength antacid anti gas]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [health mart antacid]; aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG in 5 mL Oral Suspension; Al hydroxide/Mg hydroxide/simethicone 200 mg-200 mg-20 mg/5 mL oral suspension; Sunmark Antacid, 200 mg-200 mg-20 mg/5 mL oral suspension; ALUMINUM HYDROXIDE 200 mg in 5 mL / MAGNESIUM HYDROXIDE 200 mg in 5 mL / DIMETHICONE 20 mg in 5 mL ORAL SUSPENSION [REGULAR STRENGTH ANTACID AND GAS RELIEF]; ALUMINUM HYDROXIDE 400 mg in 10 mL / MAGNESIUM HYDROXIDE 400 mg in 10 mL / DIMETHICONE 40 mg in 10 mL ORAL SUSPENSION [REGULAR STRENGTH ANTACID MINT]",0
C0973846,Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 25 MG Chewable Tablet,regular,"ALOH/MGOH/SIMTH REG STRENGTH CHEW TAB; aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 25 MG Chewable Tablet; aluminum hydroxide 200 MG / milk of magnesia 200 MG / simethicone 25 MG Chewable Tab; Al hydroxide/Mg hydroxide/simethicone 200 mg-200 mg-25 mg oral tablet, chewable; ALOH/MGOH/SIMETHICONE REGULAR STRENGTH TAB,CHEWABLE",0
C0974997,bismuth subsalicylate 17.5 MG/ML Oral Suspension,regular,"BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief Original Strength]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL SUSPENSION [Peptic Relief Cherry]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [TopCare Regular Strength]; BISMUTH SUBSALICYLATE 66.2 mg in 3.785 L ORAL SUSPENSION [BISMUTH]; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID [GERI-PECTATE VANILLA FLAVOR]; Bismuth Subsalicylate 525 mg in 30 mL ORAL LIQUID [Stomach Lil Drug Store Products]; Bismuth subsalicylate 262 mg in 15 mL ORAL SUSPENSION [HEB Diarrhea Relief Vanilla Flavor]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Soothe]; bismuth subsalicylate 527 mg/30 mL oral suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [Kroger Regular Strength Pink Bismuth]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Equaline Stomach Relief]; bismuth subsalicylate 262 mg/15 mL oral suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Bismutina]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [meijer stomach relief regular strength]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief Cherry]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Circle K Stomach]; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID [GERI-PECTATE PEPPERMINT FLAVOR]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [WinCo FOODS Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief Original Formula]; bismuth subsalicylate 524 MG per 30 ML Oral Suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief Regular Strength]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Peptic Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [STOMACH RELIEF]; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID [Bismatrol]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [GNP Stomach Relief]; bismuth subsalicylate 525 MG per 30 ML Oral Suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Topcare Stomach Relief cherry]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief Regular Strength ReadyInCase]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [TopCare Stomach Relief Regular Strength]; bismuth subsalicylate 525 mg/30 mL oral suspension; BISMUTH SUBSALICYLATE 262 mg in 30 mL ORAL LIQUID [Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief regular strength]; bismuth subsalicylate 1.75 % Oral Suspension; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL SUSPENSION [MEDIQUE DIOTAME]; bismuth subsalicylate 525 MG in 30 mL Oral Suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [HEB Stomach Relief]; Stomach Relief, 527 mg/30 mL oral suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Pink Bismuth Regular Strength]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [HEB Stomach Relief Regular Strength]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [regular strength pink bismuth]; Bismuth subsalicylate 262 mg in 15 mL ORAL SUSPENSION [QC Quality Choice Pink Bismuth Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [GS Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [STOMACH RELIEF]; BISMUTH SUBSALICYLATE 262MG/15ML SUSP,ORAL; bismuth subsalicylate 262 MG per 15 ML Oral Suspension; Bismuth Subsalicyclate, 262 mg/15 mL oral suspension; bismuth subsalicylate 17.5 MG/ML Oral Suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Maximum strength Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [up and up digestive relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Digestive Relief Regular Strength]; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID; BISMUTH SUBSALICYLATE 17.5 g in 1 L Oral SUSPENSION [Bismuth Suspension]; Stomach Relief, 262 mg/15 mL oral suspension; Soothe Regular Strength, 262 mg/15 mL oral suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [Regular Strength Pink Bismuth]; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID [Pink-Bismuth]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [Stomach Relief Regular Strength]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [QC Stomach Relief Cherry Flavor]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Leader Stomach Relief]; Stomach Relief, 525 mg/30 mL oral suspension; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Stomach Relief - Regular Strength]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL SUSPENSION [STOMACH RELIEF Regular Strength]; Bismuth subsalicylate 262 mg in 15 mL ORAL SUSPENSION [QC Anti Diarrheal Vanilla Regular Flavor]; Bismuth subsalicylate 262 mg in 15 mL ORAL SUSPENSION [Premier Value Diarrhea Relief Vanilla Flavor]; BISMUTH SUBSALICYLATE 262MG/15ML SUSP; Bismuth subsalicylate 262 mg in 15 mL ORAL SUSPENSION [CVS Health Anti-Diarrheal Vanilla]",0
C0974999,bismuth subsalicylate 35 MG/ML Oral Suspension,regular,"BISMUTH SUBSALICYLATE 525MG/15ML SUSP; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL SUSPENSION [Stomach Relief Maximum Strength]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL LIQUID [Equaline Maximum Strength Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL SYRUP [L-Oral STOMACH RELIEF Syrup]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL SUSPENSION [ULTRA STRENGHT PINK BISMUTH]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL SUSPENSION [Stomach Relief, Ultra Strength]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL SUSPENSION [TopCare Stomach Relief Ultra Strength]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [Soothe Ultra Strength]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL SUSPENSION [Meijer Stomach Relief Regular Strength]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL SUSPENSION [HEB Stomach Relief Max Strength]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL LIQUID [Stomach Relief Maximum Strength]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL SUSPENSION [WinCo FOODS Ultra Strength Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 30 mL ORAL LIQUID [Topcare Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [Stomach Relief Ultra Strength]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL LIQUID [Leader Maximum Strength Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [Ultra Stomach Relief]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL LIQUID [Stomach Relief - Maximum Strength]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL SUSPENSION [Stomach Relief, Maximum Strength]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL SUSPENSION [STOMACH RELIEF Maximum Strength]; Stomach Relief Extra Strength, 525 mg/15 mL oral suspension; bismuth subsalicylate 1050 MG in 30 mL Oral Suspension; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [QC Stomach Relief Regular Strength]; bismuth subsalicylate 35 MG/ML Oral Suspension; bismuth subsalicylate 1050 MG per 30 ML Oral Suspension; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL SUSPENSION [DRx Choice Stomach Relief Regular Strength]; BISMUTH SUBSALICYLATE 525MG/15ML SUSP,ORAL; bismuth subsalicylate 525 MG per 15 ML Oral Suspension; bismuth subsalicylate 525 mg/15 mL oral suspension; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL LIQUID [Bismuth Maximum Strength]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [Ultra Bismuth]; BISMUTH SUBSALICYLATE 1050 mg in 30 mL ORAL LIQUID [Soothe Maximum Strength]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [Topcare Ultra Strength Stomach Relief]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [Stomach Relief Ultra]; BISMUTH SUBSALICYLATE 525 mg in 15 mL ORAL LIQUID [Stomach Relief Maximum Strength]",0
C0975164,calcium carbonate 500 MG Chewable Tablet,regular,"CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Good Neighbor Pharmacy Antacid Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Fast Acting Heartburn Relief Peppermint Flavor]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Leader Antacid Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Premier Value Extra Strength Chewable Antacid Assorted Berry]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Premier Value Chewable Antacid Ultra Strength Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [GERICARE Regular strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Best Choice Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [ANTACID]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Health Mart Regular Strength Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [BI-MART Regular Strength Antacid Peppermint]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [EQUALINE regular strength antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Plus Pharma Calcium Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Calcium Carbonate 500 mg]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [QC Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Meijer Regular Strength Peppermint Flavor]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Calcium Carbonate Assorted Flavors]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Antacid Relief]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Rugby]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Regular Strength Antacid Assorted Fruit]; calcium carbonate 500 MG Chewable Tablet; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Quality Choice Regular Strength Antacid Peppermint Regular strength Antacid Peppermint]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [HEB Regular Strength Peppermint Flavor]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [WinCo FOODS Antacid Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Publix Regular Strength Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [CALCIUM CARBONATE]; CALCIUM CARBONATE 500MG TAB,CHEWABLE; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Care One Calcium Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Publix Regular Strength Peppermint Flavor]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Quality Choice Regular Strength Peppermint Flavor]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Healthmart Regular Strength Antacid]; Antacid (Calcium Carbonate), base 500 mg oral tablet, chewable; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Topcare Antacid Calcium Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Guardian Regular Strength Alkums]; CALCIUM CARBONATE 500 mg ORAL TABLET [Bio V Antacid Fruit Flavors]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Quality Choice Antacid Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Quality Choice Chewable Antacid Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Quality Choice Regular Strength Antacid Regular strength Antacid]; CALCIUM CARB 500MG (CA 200MG) CHEW TAB; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Antacid Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Careone Regular Strength calcium Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Leader Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Major Regular Strength Assorted Flavors]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Regular Strength Antacid]; Antacid (Calcium Carbonate), 500 mg oral tablet, chewable; Antacid Long Lasting Fruit Flavor, 500 mg oral tablet, chewable; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Premier Value Chewable Antacid Extra Strength Tropical Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Careone Regular Strength Calcium Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Calcium Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [DG Health Regular Strength Antacid]; calcium carbonate 500 MG (Ca 200 MG) Chewable Tablet; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [DRx CHOICE Antacid Calcium Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Xpect Antacid]; calcium carbonate 500 mg oral tablet, chewable; CALCIUM CARBONATE 500 mg ORAL TABLET [DGH Antacid Regular Strength 500 (Fruit assorted), 150ct]; Calcium Carbonate, 500 mg oral tablet, chewable; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [HEB Regular strength Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Premier Value Chewable Antacid Extra Strength Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Premier Value Regular Strength Chewable Antacid Peppermint Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Regular strength Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Goodsense Regular Strength Antacid Peppermint]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Antacid Regular strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Sunmark Regular Strength Antacid]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [WinCo FOODS Antacid Regular strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Premier Value Smooth Antacid Extra Strength Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Topcare Antacid Calcium]; Calcium Antacid, 500 mg oral tablet, chewable; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Meijer Regular strength Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Best Choice Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Sunmark Regular Strength Antacid Peppermint]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [BI-MART Regular Strength Antacid]; calcium carbonate 500 MG (equivalent to calcium 200 MG) Chewable Tablet; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Antacid Peppermint Flavour Regular Strength]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Premier Value Chewable Antacid Assorted Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Regular Strength Tropical Fruit]; CALCIUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Whole Foods Market Regular Strength Peppermint Flavor]",0
C0977786,"insulin isophane, human 100 UNT/ML Injectable Suspension [Humulin N]",insulin,"HumuLIN N, human recombinant 100 units/mL subcutaneous suspension; Insulin human 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humulin N]; Humulin N 100 UNT/ML Injectable Suspension; insulin isophane, human 100 UNT/ML Injectable Suspension [Humulin N]; INSULIN NPH HUMAN 100 U/ML INJ HUMULIN N; INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humulin N]; insulin isophane, human 100 UNT/ML Injectable Suspension [HumuLIN N]; INSULIN NPH HUMAN 100 UNIT/ML HUMULIN N; HumuLIN N 100 UNT/ML Injectable Suspension",0
C0977787,"insulin isophane, human 100 UNT/ML Injectable Suspension [Novolin N]",insulin,"INSULIN NPH HUMAN 100 UNIT/ML NOVOLIN N; ReliOn/NovoLIN N, human recombinant 100 units/mL subcutaneous suspension; ReliOn Novolin N 100 UNT/ML Injectable Suspension; ReliOn NovoLIN N 100 UNT/ML Injectable Suspension; Novolin N 100 UNT/ML Injectable Suspension; NovoLIN N 100 UNT/ML Injectable Suspension; NovoLIN N, human recombinant 100 units/mL subcutaneous suspension; insulin isophane, human 100 UNT/ML Injectable Suspension [NovoLIN N]; INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Novolin N]; INSULIN NPH HUMAN 100 U/ML INJ NOVOLIN N; insulin isophane, human 100 UNT/ML Injectable Suspension [Novolin N]",0
C0977788,"insulin isophane, human 100 UNT/ML Injectable Suspension",insulin,"Human isophane insulin 100 unit/mL suspension for injection; insulin isophane (NPH), human 100 UNT/ML Injectable Suspension; insulin isophane (NPH), human 100 UNT/mL Injectable Suspension; insulin isophane (NPH) human recombinant 100 units/mL subcutaneous suspension; Product containing precisely human isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)",0
C0977793,"insulin, regular, human 100 UNT/ML Injectable Solution [Novolin R]",insulin,"insulin, regular, human 100 UNT/ML Injectable Solution [Novolin R]; INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Novolin R]; insulin, regular, human 100 UNT/ML Injectable Solution [NovoLIN R]; NovoLIN R 100 UNT/ML Injectable Solution; INSULIN REG HUMAN 100 UNIT/ML NOVOLIN R; ReliOn/NovoLIN R, human recombinant 100 units/mL injectable solution; Novolin R 100 UNT/ML Injectable Solution; INSULIN REG HUMAN 100 U/ML INJ NOVOLIN R; NovoLIN R, human recombinant 100 units/mL injectable solution",0
C0977794,"insulin, regular, human 100 UNT/ML Injectable Solution",insulin,"Human regular insulin 100 unit/mL solution for injection; insulin, human regular 100 UNT/ML Injectable Solution; insulin regular human recombinant 100 units/mL injectable solution; Human insulin soluble 100 unit/mL solution for injection; Product containing precisely human regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug); regular insulin, human 100 UNT/ML Injectable Solution",0
C0977796,"insulin, regular, human 100 UNT/ML Injectable Solution [Humulin R]",insulin,"insulin, regular, human 100 UNT/ML Injectable Solution [Humulin R]; HumuLIN R 100 UNT/ML Injectable Solution; INSULIN REG HUMAN 100 UNIT/ML HUMULIN R; insulin human 100 [iU] in 1 mL PARENTERAL INJECTION, SOLUTION [Humulin R]; Humulin R 100 UNT/ML Injectable Solution; HumuLIN R, human recombinant 100 units/mL injectable solution; insulin, regular, human 100 UNT/ML Injectable Solution [HumuLIN R]; INSULIN REG HUMAN 100 U/ML INJ HUMULIN R",0
C0977802,"insulin aspart, human 100 UNT/ML Injectable Solution",insulin,"INSULIN,ASPART,HUMAN 100 UNIT/ML INJ; Insulin Aspart, 100 units/mL injectable solution; insulin aspart 100 units/mL injectable solution; insulin aspart, human 100 UNT/ML Injectable Solution; INSULIN,ASPART,HUMAN 100 UNT/ML INJ; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Aspart]; insulin analog, aspart 100 UNT/ML Injectable Solution; INSULIN ASPART 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin Aspart]; insulin aspart 100 UNT/ML Injectable Solution",0
C0977804,Insulin Glargine 100 UNT/ML Injectable Solution,insulin,"Insulin glargine 100 unit/mL solution for injection; INSULIN,GLARGINE,HUMAN 100 UNT/ML INJ; Insulin Glargine, 100 units/mL subcutaneous solution; INSULIN,GLARGINE,HUMAN 100 UNIT/ML INJ; Product containing precisely insulin glargine 100 unit/1 milliliter conventional release solution for injection (clinical drug); INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Glargine]; insulin analog, glargine 100 UNT/ML Injectable Solution; insulin glargine 100 units/mL subcutaneous solution; insulin glargine 100 UNT/ML Injectable Solution",0
C0977809,insulin lispro 100 UNT/ML Injectable Solution [Humalog],insulin,"HumaLOG 100 UNT/ML Injectable Solution; INSULIN LISPRO 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog]; insulin lispro 100 UNT/ML Injectable Solution [HumaLOG]; insulin lispro 100 UNT/ML Injectable Solution [Humalog]; HumaLOG, 100 units/mL injectable solution; INSULIN LISPRO HUMAN 100 UNIT/ML HUMALOG; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog]; Insulin lispro 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Humalog]; INSULIN LISPRO 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Humalog]; INSULIN,LISPRO,HUMAN 100 UNT/ML INJ,HUMALOG; Humalog 100 UNT/ML Injectable Solution",0
C0977811,"Insulin Lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Injectable Suspension [Humalog Mix]",insulin,"HumaLOG Mix 75/25 Injectable Suspension; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humalog Mix75/25]; INSULIN,LISPRO,HUMAN 75/25 HUMALOG INJ; HumaLOG Mix 75/25, 25 units-75 units/mL subcutaneous suspension; INSULIN,LISPRO,HUMAN 75/25 INJ,HUMALOG; HumaLOG Mix 75/25; insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Injectable Suspension [Humalog Mix]; Humalog Mix 75/25 Injectable Suspension; insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Injectable Suspension [HumaLOG Mix]",0
C0977813,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension",insulin,"Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug); Human isophane insulin 70 unit/mL and recombinant human soluble insulin 30 unit/mL solution for injection; Human isophane insulin 70 unit/mL and recombinant human regular insulin 30 unit/mL solution for injection; insulin isophane-insulin regular human recombinant 70 units-30 units/mL subcutaneous suspension; insulin, human mixed 70/30 100 UNT/ML Injectable Suspension; insulin, human isophane / insulin regular 70/30 Injectable Suspension",0
C0977820,"insulin isophane, pork 100 UNT/ML Injectable Suspension",insulin,Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug); Porcine isophane insulin 100 unit/mL suspension for injection,0
C0977821,"Insulin, Protamine Zinc, Beef-Pork 100 UNT/ML Injectable Suspension",insulin,,0
C0977824,"insulin, regular, beef-pork 100 UNT/ML Injectable Solution",insulin,,0
C0977826,"insulin, regular, beef 100 UNT/ML Injectable Solution",insulin,"Bovine insulin soluble 100 unit/mL solution for injection; Bovine regular insulin 100 unit/mL solution for injection; insulin, regular, beef (as bovine insulin soluble) 100 UNT/ML Injectable Solution; Product containing precisely bovine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug)",0
C0977828,"Insulin, Regular, Pork 100 UNT/ML Injectable Solution",insulin,"Porcine insulin soluble 100 unit/mL solution for injection; Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug); Porcine regular insulin 100 unit/mL solution for injection; insulin, regular, pork 100 UNT/ML Injectable Solution",0
C0978406,menthol 0.02 MG/MG / methyl salicylate 0.1 MG/MG Topical Ointment,regular,MENTHOL 2 g in 100 g / METHYL SALICYLATE 10 g in 100 g TOPICAL OINTMENT [La Vaquita New Regular]; menthol 2 % / methyl salicylate 10 % Topical Ointment,0
C0978677,minoxidil 20 MG/ML Topical Solution,regular,"MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Bosley MD Regular Strength for Women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [GROW GIRL]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [minoxidil for women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [basic care hair regrowth treatment]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [EXT Hair Regrowth Treatment for Men 2%]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Keranique 2% Hair Regrowth Treatment for Women]; Product containing precisely minoxidil 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug); MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [hair regrowth treatment]; MINOXIDIL 20 mg in 1 mL TOPICAL LIQUID [BOSLEY PROFESSIONAL STRENGTH HAIR REGROWTH TREATMENT Regular Strength For Women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Minoxidil Regular Strength for Men]; MINOXIDIL 2% (FOR WOMEN) SOLN,TOP; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [equate hair regrowth treatment]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Minoxidil For Women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [EXT Hair Regrowth Treatment for Women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [hers minoxidil]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Navi Hair Solutions Womens Hair Regrowth Treatment]; minoxidil 2 % Topical Solution; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Daniel Alain Hair Regrowth Treatment for Women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION/ DROPS [AXELOFEIN]; Minoxidil 20 mg/mL cutaneous solution; MINOXIDIL 2% (FOR MEN) TOP SOLN; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [up and up hair regrowth treatment for women]; minoxidil topical 2% topical solution; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Minoxidil]; minoxidil 2 GM per 100 ML Topical Solution; Minoxidil, Topical, 2% topical solution; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Rootly Hair Regrowth Treatment for Women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Core Values Minoxidil]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [hair regrowth treatment for women]; MINOXIDIL 2% (FOR MEN) SOLN,TOP; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [GROFULLY Womens Hair Regrowth Treatment]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [harmon face values minoxidil]; MINOXIDIL 20 g in 1 mL TOPICAL SOLUTION; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [equate hair regrowth treatment for women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [MDhair hair regrowth treatment for women]; MINOXIDIL 20 mg in 1 mL TOPICAL SOLUTION [Nutrastim Hair Regrowth Treatment For Women]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [core values minoxidil]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [Loesch Hair Regrowth Formula Unscented Topical Solution Regular-Strength for Men and Women]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [minoxidil]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [minoxidil topical]; MINOXIDIL 2 g in 100 mL TOPICAL SOLUTION [ScalpMED for Women - Vitadil-2A Hair Regrowth Treatment 2%]; MINOXIDIL 20 mg in 1 mL TOPICAL LIQUID [Womens Minoxidil Hair Growth System]; MINOXIDIL 20 mg in 1 mL TOPICAL LIQUID [KERANIQUE For Women Hair Regrowth Treatment]; MINOXIDIL 2% (FOR WOMEN) TOP SOLN",0
C0978678,minoxidil 50 MG/ML Topical Solution,regular,"MINOXIDIL 50 mg in 1 mL TOPICAL LIQUID [BOSLEY PROFESSIONAL STRENGTH HAIR REGROWTH TREATMENT Regular Strength For Men]; MINOXIDIL 5% TOP SOLN; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [GOOD GUY Mens Hair Regrowth Treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [5% Minoxidil Topical Solution]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [kirkland signature minoxidil]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Kirkland Signature Minoxidil]; Minoxidil 50 mg/mL cutaneous solution; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Good Sense Hair Regrowth Treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [equate hair regrowth treatment]; MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Nutrastim Hair Regrowth Treatment Unscented For Men]; MINOXIDIL 50 mg in 1 mL TOPICAL LIQUID [Capillus Hair Regrowth Treatment]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [EXT Hair Regrowth Treatment for Men 5%]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [Equaline hair regrowth treatment for men]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [up and up hair regrowth treatment for men]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [bourn Hair Regrowth Treatment for Men]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [Basic Care Hair Regrowth]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [Hair Regrowth Treatment Extra Strength for Men]; Product containing precisely minoxidil 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug); MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Club Roots - Topical Solution Hair Regrowth Treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Mens pura dor Hair Loss MD]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Rootly Extra Strength Hair Regrowth Treatment for Men]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [minoxidil]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Daniel Alain Extra Strength Hair Regrowth Treatment for Men]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Roots Professional - Topical Solution Hair Regrowth Treatment]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [minoxidil for men]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [Hair regrowth treatment for men]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION/ DROPS [AZELOMAX FORTE]; MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Minoxidil Extra Strength for Men]; MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [MENS alopexy]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Bosley MD Extra Strength for Men]; MINOXIDIL 5% SOLN,TOP; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [just for men minoxidil]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [Core Values Minoxidil]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [MDhair Extra Strength hair regrowth treatment for Men]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [uElixir Hair Growth Serum]; Hair Regrowth Treatment For Men, 5% topical solution; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [GROFULLY Mens Extra Strength Hair Regrowth Treatment]; MINOXIDIL 5 g in 100 mL TOPICAL LIQUID [BUNEE Hair Growth Serum]; minoxidil 3 GM per 60 ML Topical Solution; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [up and up hair regrowth treatment for men]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [signature care hair regrowth treatment]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [hims minoxidil]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [ScalpMED for Men - VITADIL-5A Hair Regrowth Treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Hair Regrowth Treatment]; minoxidil 50 MG/ML Topical Solution; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [equate hair regrowth treatment for men]; Minoxidil, Topical, 5% topical solution; MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Mens Minoxidil Hair Growth System]; MINOXIDIL 50 mg in 1 mL TOPICAL LIQUID [Regenpure Precision]; MINOXIDIL 5 g in 100 mL TOPICAL LIQUID [ELEVATE BEARD GROWTH SERUM]; minoxidil 5 % Topical Solution; minoxidil 5 GM per 100 ML Topical Solution; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Navi Hair Solutions Mens Hair Regrowth Treatment]; minoxidil topical 5% topical solution; MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Minoxidil For Men extra strength]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [hair regrowth treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [myhair hair regrowth treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Mens Intelligent Hair Regrowth Treatment]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [hair regrowth treatment]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [keeps minoxidil topical]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [signature care hair regrowth treatment]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [Loesch Hair Regrowth Formula Unscented Topical Solution Extra-Strength for Men]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [hims hair regrowth treatment]; MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Hair Regrowth Treatment Extra Strength for Men]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [basic care hair regrowth treatment]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [Good Sense Hair Regrowth Treatment for Men]; MINOXIDIL 3 g in 60 mL TOPICAL SOLUTION [members mark hair regrowth treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Minoxidil Extra Strength for Men]; MINOXIDIL 5 g in 100 mL TOPICAL LIQUID [ELEVATE HAIR GROWTH SERUM]; MINOXIDIL 50 mg in 1 mL TOPICAL LIQUID [GETTIK Hair Regrowth Treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [Mens SPECTRAL UHP EXTRA STRENGTH HAIR REGROWTH TREATMENT]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [members mark hair regrowth treatment]; MINOXIDIL 5 g in 100 mL TOPICAL SOLUTION [kirkland signature minoxidil]",0
C0980141,"sennosides, USP 8.6 MG Oral Tablet",regular,"Sennosides 8.6 mg ORAL TABLET, COATED [Laxative Senna]; SENNOSIDES A AND B 8.6 mg ORAL TABLET, FILM COATED [Senna-Lax]; sennosides 8.6 MG Oral Tablet; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Senna-Lax]; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Vegetable Laxative]; SENNOSIDES A AND B 8.6 mg ORAL TABLET [Leader Senna Laxative]; SENNOSIDES 8.6 mg ORAL TABLET [CAREMOTION]; Senna, 8.6 mg oral tablet; SENNOSIDES 8.6MG TAB; SENNOSIDES A AND B 8.6 mg ORAL TABLET, COATED [Senna Natural Vegetable]; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Senna-Tabs]; SENNOSIDES 8.6 mg ORAL TABLET [NATURAL SENNA LAXATIVE]; SENNOSIDES 8.6MG TAB UD; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED; SENNOSIDES 8.6 mg ORAL TABLET [Natural Vegetable Laxative]; SENNOSIDES A AND B 8.6 mg ORAL TABLET, FILM COATED [Senna Laxative]; SENNOSIDES 8.6 mg ORAL TABLET [Kroger Senna Laxative Regular Strength]; SENNOSIDES 8.6 mg ORAL TABLET [Senna-Lax]; SENNOSIDES 8.6 mg ORAL TABLET [Geri-kot]; SENNOSIDES 8.6MG TAB,UD; SENNOSIDES 8.6 mg ORAL TABLET [Sennosides Natural Laxative]; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Plus Pharma Senna Standardized Senna Concentrate 8.6 mg Sennosides Each]; SENNOSIDES 8.6 mg ORAL TABLET [Senna Lax]; sennosides A and B 8.6 MG Oral Tablet; SENNOSIDES 8.6 mg ORAL TABLET [Senna laxative Regular Strength]; SENNOSIDES 8.6 mg ORAL TABLET [Senna]; sennosides a and b 8.6 mg ORAL TABLET [CAREALL Sennosides]; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Senna]; Geri-kot, 8.6 mg oral tablet; SENNOSIDES 8.6 mg ORAL TABLET; SENNOSIDES 8.6 mg ORAL TABLET [Senna laxative]; SENNOSIDES 8.6 mg ORAL TABLET [Vegetable Laxative]; Senna Lax, 8.6 mg oral tablet; SENNOSIDES A AND B 8.6 mg ORAL TABLET, COATED; SENNOSIDES 8.6 mg ORAL TABLET [Senna Laxative]; Natural Laxative, 8.6 mg oral tablet; SENNOSIDES A AND B 8.6 mg ORAL TABLET; sennosides, USP 8.6 MG Oral Tablet; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Natural Vegetable Laxative]; SENNOSIDES A AND B 8.6 mg ORAL TABLET [SENNA LAXATIVE]; SENNOSIDES 8.6 mg ORAL TABLET [HEALTH SENSE SENNO]; SENNOSIDES A AND B 8.6 mg ORAL TABLET, COATED [SENNA]; SENNOSIDES 8.6 mg ORAL TABLET [SENNA LAXATIVE]; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Natural Laxative]; SENNOSIDES A AND B 8.6 mg ORAL TABLET, FILM COATED [Senna Tabs]; SENNOSIDES 8.6 mg ORAL TABLET [Meijer Senna Laxative Regular Strength]; SENNOSIDES 8.6 mg ORAL TABLET [Exchange select]; SENNOSIDES A AND B 8.6 mg ORAL TABLET [Senna]; SENNOSIDES 8.6 mg ORAL TABLET [SENNA]; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Preferred Plus Senna Gentle Natural Vegetable Laxative]; SENNOSIDES A AND B 8.6 mg ORAL TABLET [Senna Laxative]; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [Senna Standardized Senna Concentrate 8.6 mg Sennosides Each]; senna 8.6 mg oral tablet; SENNOSIDES 8.6 mg ORAL TABLET, FILM COATED [VALUMEDS NATURAL LAXATIVE]",0
C0981193,acetaminophen 325 MG Oral Tablet,regular,"ACETAMINOPHEN 325 mg ORAL TABLET, COATED [MEDI-FIRST Non-Aspirin]; ACETAMINOPHEN 325 mg ORAL TABLET [Medline Acetaminophen]; ACETAMINOPHEN 325 mg ORAL TABLET [Equate Acetaminophen]; acetaminophen 325 MG Oral Tablet; ACETAMINOPHEN 325 mg ORAL TABLET [Acetaminophen Regular Strength]; Pain Relief, 325 mg oral tablet; ACETAMINOPHEN 325 mg ORAL TABLET, FILM COATED [Travel Savvy Non-Aspirin]; ACETAMINOPHEN 325 mg ORAL TABLET [Pain Relief Regular Strength, Aspirin Free]; ACETAMINOPHEN 325 mg ORAL TABLET; ACETAMINOPHEN 325MG TAB UD; Pain Reliever, 325 mg oral tablet; ACETAMINOPHEN 325 mg ORAL TABLET [Aphen]; Product containing precisely paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug); ACETAMINOPHEN 325 mg ORAL TABLET [ACETAMINOPHEN Pain Reliever,Fever Reducer]; ACETAMINOPHEN 325 mg ORAL TABLET [Pain Reliever]; ACETAMINOPHEN 325 mg ORAL TABLET, FILM COATED [Direct Safety Aspirin Free]; ACETAMINOPHEN 325 mg ORAL TABLET [Acetaminophen 325mg RS]; ACETAMINOPHEN 325 mg ORAL TABLET [Regular Strength Acetaminophen]; ACETAMINOPHEN 325 mg ORAL TABLET [PAIN RELIEF Regular Strength]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED [Medi First Plus Non-Aspirin]; ACETAMINOPHEN 325 mg ORAL TABLET [basic care acetaminophen]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED; Non-Aspirin, 325 mg oral tablet; Medique APAP (Acetaminophen), 325 mg oral tablet; ACETAMINOPHEN 325 mg ORAL TABLET [Pain Reliever Regular Strength]; ACETAMINOPHEN 325 mg ORAL Tablet [ACETAMINOPHEN]; ACETAMINOPHEN 325 mg ORAL TABLET [Pain Relief]; ACETAMINOPHEN 325 mg ORAL TABLET [Regular Strength Pain Relief]; ACETAMINOPHEN 325 mg ORAL TABLET [Rugby Acetaminophen]; Paracetamol 325 mg oral tablet; ACETAMINOPHEN 325 mg ORAL TABLET [NON-ASPIRIN]; ACETAMINOPHEN 325MG TAB,UD; ACETAMINOPHEN 325 mg ORAL TABLET [Acetaminophen Regular strength]; ACETAMINOPHEN 325 mg ORAL TABLET [Plus Pharma Pain Reliever,Fever Reducer]; ACETAMINOPHEN 325 mg ORAL TABLET [good sense pain relief]; ACETAMINOPHEN 325 mg ORAL TABLET [Acetaminophen 325 mg Round]; ACETAMINOPHEN 325 mg ORAL TABLET, FILM COATED [Pain Reliever]; ACETAMINOPHEN 325 mg ORAL TABLET [pain relief]; Acetaminophen, 325 mg oral tablet; ACETAMINOPHEN 325 mg ORAL TABLET [Aypanal Non-Aspirin]; ACETAMINOPHEN 325 mg ORAL TABLET [Acetaminophen 325mg]; ACETAMINOPHEN 325 mg ORAL TABLET [Pain Relief Regular Strength]; ACETAMINOPHEN 325 mg ORAL TABLET [Aurophen Regular Strength]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED [Acetaminophen Regular Strength]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED [McKesson Acetaminophen 325]; acetaminophen 325 mg oral tablet; ACETAMINOPHEN 325 mg ORAL TABLET [ACETAMINOPHEN 325 MG]; APAP 325 MG Oral Tablet; ACETAMINOPHEN 325 mg ORAL TABLET [dg health pain relief]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED [Travel Savvy Non-Aspirin]; Acetaminophen 325 mg ORAL TABLET [Acetaminophen 325mg RS]; ACETAMINOPHEN 325 mg ORAL TABLET [Rugby Regular Strength Acetaminophen]; ACETAMINOPHEN 325 mg ORAL TABLET, FILM COATED [Moore Medical Non Aspirin]; Acetaminophen 325 mg oral tablet; ACETAMINOPHEN 325 mg ORAL TABLET [leader acetaminophen]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED [MEDIQUE APAP]; ACETAMINOPHEN 325 mg ORAL TABLET, FILM COATED [Henry Schein Acetaminophen]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED [Dover Aminophen]; Acetaminophen 325 mg ORAL TABLET [CareALL Acetaminophen]; ACETAMINOPHEN 325 mg ORAL TABLET, COATED [Medique at Home APAP]; ACETAMINOPHEN 325MG TAB; ACETAMINOPHEN 325 mg ORAL TABLET, FILM COATED [MEDIQUE APAP]; ACETAMINOPHEN 325 mg ORAL TABLET [Clear Choice Regular Strength Pain Reliever]; ACETAMINOPHEN 325 mg ORAL TABLET [up and up acetaminophen]",0
C0981717,simethicone 80 MG Chewable Tablet,regular,"DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [SIMETHICONE]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Rugby Gas relief]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Antiflatulent]; Gas Relief, 80 mg oral tablet, chewable; simethicone 80 mg oral tablet, chewable; SIMETHICONE 80MG TAB,CHEW; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Gas Relief]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [CVS PHARMACY Gas relief]; SIMETHICONE 80MG CHEW TAB; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [GNP Regular Strength Gas Relief]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Leader Gas relief]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [PlusPHARMA]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Simethicone 80 mg]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [GAS RELIEF]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Gas Relief Mint Flavor]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE; simethicone 80 MG Chewable Tablet; Simethicone, 80 mg oral tablet, chewable; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Gas relief]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [QC Gas Relief Mint Flavor]; DIMETHICONE 80 mg ORAL TABLET, CHEWABLE [Gas Relief Regular Strength]",0
C0982217,"lente insulin, beef-pork",insulin,"lente insulin, beef-pork; INSULIN,LENTE,BEEF/PORK",0
C0982219,"lente insulin, human",insulin,"lente insulin, human; Lente human insulin; INSULIN,LENTE,HUMAN/SEMISYNTHETIC; insulin zinc human recombinant; INSULIN,LENTE,HUMAN/rDNA; insulin, lente, human; Lente human insulin (substance)",0
C0982221,"insulin lispro protamine, human",insulin,"Insulin lispro protamine (substance); Insulin lispro protamine crystallized; insulin lispro protamine, human; Insulin,lispro,protamine/rDNA; Insulin lispro protamine crystallised; insulin lispro protamine; INSULIN,LISPRO,PROTAMINE/rDNA; Insulin lispro protamine",0
C0982224,"insulin, protamine zinc, beef-pork",insulin,"insulin, protamine zinc, beef-pork; insulin, protamine zinc, bovine-porcine",0
C0982226,"insulin, regular, beef",insulin,"INSULIN,REGULAR,BEEF/PURIFIED; insulin, regular, beef",0
C0991832,"insulin isophane, beef",insulin,"Product containing bovine isophane insulin (medicinal product); NPH insulin, beef; Bovine isophane insulin; isophane insulin, beef; INSULIN,NPH,BEEF/PURIFIED; insulin isophane, beef; Bovine isophane insulin-containing product; insulin, NPH, beef; isophane insulin, bovine; Bovine isophane insulin (substance); INSULIN,NPH,BEEF",0
C0993223,"insulin isophane, beef-pork",insulin,"insulin, NPH, beef-pork; insulin isophane, beef-pork; isophane insulin, bovine-porcine; isophane insulin, beef-pork; insulin, isophane, beef-pork; NPH insulin, beef-pork; INSULIN,NPH,BEEF/PORK",0
C0994195,"Insulin syringes (100 syringes, any size)",insulin,,0
C0994230,"Home infusion therapy, continuous insulin infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",insulin,,0
C1099171,"insulin, Glu(A8)-",insulin,"A8-Glu-insulin; insulin, glutamyl(A8)-",0
C1099172,"insulin, Gln(A8)-",insulin,"insulin, glutaminyl(A8)-; A8-Gln-insulin",0
C1113715,Insulin-like growth factor-I:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I [Moles/Vol]; Insulin-like growth factor-I [Moles/volume] in Serum or Plasma; IGF-I SerPl-sCnc,0
C1114132,Insulin^15M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 15M p chal SerPl-aCnc; Insulin 15 Min post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge; Insulin^15 minutes post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1114133,Insulin^45M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 45M p chal SerPl-aCnc; Insulin 45 Min post Unsp challenge Qn; Insulin^45M post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge,0
C1114134,Insulin^1.3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^1.3 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --1.3 hours post XXX challenge; Insulin 1.3h p chal SerPl-aCnc; Insulin 1.3 Hr post Unsp challenge Qn,0
C1114135,Insulin^1.6H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^1.6 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.6 Hr post Unsp challenge Qn; Insulin 1.6h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --1.6 hours post XXX challenge,0
C1114136,Insulin^2.3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --2.3 hours post XXX challenge; Insulin 2.3h p chal SerPl-aCnc; Insulin 2.3 Hr post Unsp challenge Qn; Insulin^2.3 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1114137,Insulin^2.6H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --2.6 hours post XXX challenge; Insulin 2.6h p chal SerPl-aCnc; Insulin 2.6 Hr post Unsp challenge Qn; Insulin^2.6 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1114138,Insulin^3.3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^3.3 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3.3h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --3.3 hours post XXX challenge; Insulin 3.3 Hr post Unsp challenge Qn,0
C1114139,Insulin^3.6H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^3.6 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3.6 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --3.6 hours post XXX challenge; Insulin 3.6h p chal SerPl-aCnc,0
C1114224,Insulin^30M post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --30 minutes post 75 g glucose PO; Insulin 30M p 75 g Glc PO SerPl-aCnc; Insulin 30 Min post 75 g glucose PO Qn; Insulin^30 minutes post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1114225,Insulin^post 12H CFst:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^post 12 hours Calorie fast:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --12 hours fasting; Insulin post 12 Hr fast Qn; Insulin p 12h fast SerPl-aCnc,0
C1114880,Insulin^3.5H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --3.5 hours post XXX challenge; Insulin^3.5 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3.5h p chal SerPl-aCnc; Insulin 3.5 Hr post Unsp challenge Qn,0
C1121443,"NOV protein, human",insulin,"NOV protein, human; IGFBP9; CCN3 protein, human; nov proto-oncogene protein, human; Nephro Blastoma-Overexpressed Gene Protein Homolog; NovH; IGF-Binding Protein 9; Insulin-Like Growth Factor Binding Protein 9; NOV; Insulin-Like Growth Factor-Binding Protein-9; Cellular Communication Network Factor 3; Protein NOV Homolog; IGFBP-9; CCN Family Member 3; NOVH protein, human; CCN3; Insulin-Like Growth Factor-Binding Protein 9; nephroblastoma overexpressed protein, human; Nephroblastoma-Overexpressed Gene Protein Homolog; IBP-9",0
C1122005,"Atp5md protein, rat",insulin,"upregulated during skeletal muscle growth 5 protein, rat; Usmg5 protein, rat; diabetes-associated protein in insulin-sensitive tissues, rat; Dapit protein, rat",0
C1137456,"CYR61 protein, human",insulin,"cysteine-rich protein 61, human; Cysteine-Rich Heparin-Binding Protein 61; Cysteine-Rich Angiogenic Inducer 61; Cellular Communication Network Factor 1; Protein GIG1; Protein CYR61; CCN Family Member 1; IGF-Binding Protein 10; IGFBP-10; IGFBP10 protein, human; cysteine-rich, angiogenic inducer, 61, human; IBP-10; CCN1 protein, human; CYR61 protein, human; Cysteine-Rich Protein 61; Insulin-Like Growth Factor-Binding Protein 10; CCN1; IGFBP-10 protein, human",0
C1137457,"CTGF protein, human",insulin,"Connective Tissue Growth Factor; IGFBP-8; connective tissue growth factor, human; Hcs24 protein, human; CTGF protein, human; IBP-8; IGFBP8 protein, human; Hypertrophic Chondrocyte-Specific Protein 24; hypertrophic chondrocyte-specific protein 24, human; CTCF; cellular communication network factor 2 protein, human; CCN2; IGFBP-rP2 protein, human; Cellular Communication Network Factor 2; Insulin-Like Growth Factor-Binding Protein 8; CCN Family Member 2; IGF-Binding Protein 8; IGFBP-8 protein, human; CCN2 protein, human",0
C1139189,Insulin-Like Growth Factor Binding Protein 1 (IGFBP-1) Determination Reagents,insulin,"IGFBP-1 (Insulin-Like Growth Factor Binding Protein 1) Determination Reagents; Reagents, Immunoassay, Endocrine, Insulin-Like Growth Factor Binding Protein 1",0
C1139577,"Growth Factor II Determination Reagents, Insulin-Like",insulin,"Reagents, Immunoassay, Endocrine Hormone, Insulin-Like Growth Factor II; Insulin-Like Growth Factor II (IGF-II) Determination Reagents; IGF-II (Insulin-Like Growth Factor II) Determination Reagents",0
C1139583,Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3) Determination Reagents,insulin,"Reagents, Immunoassay, Endocrine, Insulin-Like Growth Factor Binding Protein 3; IGFBP-3 (Insulin-Like Growth Factor Binding Protein 3) Determination Reagents",0
C1139605,"Premature Ruptured Fetal Membrane Determination Reagents, Rapid Test",insulin,"Reagents, Immunoassay, Rapid Test, Pregnancy, Premature Ruptured Fetal Membrane; IGFBP-1 (Insulin-like Growth Factor Binding Protein) Determination Reagents; Insulin-Like Growth Factor Binding Protein (IGFBP-1) Determination Reagents",0
C1139664,Insulin Antibody Determination Reagents,insulin,"Insulin Auto-Antibody (IAA) Determination Reagents; Reagents, Immunoassay, Autoimmune, Diabetes, Insulin Autoantibody; IAA (Insulin Auto-Antibody) Determination Reagents",0
C1139793,"Syringes, Plunger, Insulin, Luer Slip",insulin,,0
C1139794,"Syringes, Plunger, Insulin, Protective, Luer Slip",insulin,,0
C1139795,"Syringes, Plunger, Insulin, Luer Lock",insulin,,0
C1139796,"Syringes, Plunger, Insulin, Protective, Luer Lock",insulin,,0
C1139797,"Syringes, Plunger, Insulin, Fixed Needle",insulin,,0
C1139798,"Syringes, Plunger, Insulin, Protective, Fixed Needle",insulin,,0
C1139828,"Syringes, Cartridge, Insulin",insulin,,0
C1139829,"Syringes, Cartridge, Insulin, Penlike",insulin,,0
C1139832,"Injectors, Medication/Vaccine, Syringe, Insulin",insulin,,0
C1139940,"Reagents, Immunoassay, Endocrine Hormone, Insulin-Like Growth Factor I",insulin,,0
C1140609,Insulin pump,insulin,"Pumps, Insulin; Insulin pumps; Insulin Pumps; insulin pump; PUMP, INFUSION, INSULIN; Insulin pump, NOS; insulin infusion pump; Insulin pump, device (physical object); insulin pumps; Infusion Pumps, Insulin; Insulin pump, device",0
C1141032,"insulin, regular, pork 100 UNT/ML",insulin,,0
C1141084,"insulin, protamine zinc, beef 100 UNT/ML",insulin,,0
C1141095,"insulin, regular, human 100 UNT/ML",insulin,,0
C1141096,"insulin, regular, human 40 UNT/ML",insulin,,0
C1141097,"insulin, regular, human 500 UNT/ML",insulin,,0
C1144205,"RLN3 protein, rat",insulin,"Insulin-like peptide 7, rat; relaxin-3, rat; R3 relaxin, rat; INSL7 protein, rat; relaxin-3 protein, rat",0
C1145198,"INJECTION, INSULIN, PER 5 UNITS",insulin,"Injection, insulin, per 5 units",0
C1145199,"Insulin for administration through dme (i.e., insulin pump) per 50 units",insulin,,0
C1145338,"Insulin pump initiation, instruction in initial use of pump (pump not included)",insulin,,0
C1145751,insulin activity,insulin,,0
C1145789,insulin lispro 100 UNT/ML,insulin,,0
C1145792,"insulin isophane, human 70 UNT/ML",insulin,,0
C1145793,"insulin isophane, pork 100 UNT/ML",insulin,,0
C1145794,"insulin isophane, pork 70 UNT/ML",insulin,,0
C1145795,"insulin, regular, beef 100 UNT/ML",insulin,,0
C1145796,"insulin, regular, human 30 UNT/ML",insulin,,0
C1145797,"insulin, regular, pork 30 UNT/ML",insulin,,0
C1145821,"insulin isophane, human 100 UNT/ML",insulin,,0
C1145950,"insulin aspart, human 100 UNT/ML",insulin,,0
C1145970,insulin glargine 100 UNT/ML,insulin,,0
C1146005,"insulin isophane, human 50 UNT/ML",insulin,,0
C1146006,"insulin, regular, human 50 UNT/ML",insulin,,0
C1146014,"insulin lispro protamine, human 50 UNT/ML",insulin,,0
C1146015,insulin lispro 25 UNT/ML,insulin,,0
C1146016,"insulin lispro protamine, human 75 UNT/ML",insulin,,0
C1146283,"insulin isophane, human 90 UNT/ML",insulin,,0
C1146284,"insulin isophane, human 85 UNT/ML",insulin,,0
C1146285,"insulin isophane, human 80 UNT/ML",insulin,,0
C1146451,"lente insulin, pork 40 UNT/ML",insulin,,0
C1146501,insulin lispro 50 UNT/ML,insulin,,0
C1147124,Insulin receptor Ab:ACnc:Pt:Ser:Qn,insulin,Insulin receptor Antibody:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative; Insulin Recep Ab Ser-aCnc; Insulin receptor Ab [Units/volume] in Serum; Insulin receptor Ab Qn (S),0
C1147707,Insulin-like growth factor-I:MCnc:Pt:Bld:Qn,insulin,IGF-I Bld-mCnc; Insulin-like growth factor-I [Mass/volume] in Blood; Insulin-like growth factor-I:Mass Concentration:To identify measures at a point in time:Whole blood:Quantitative; Insulin-like growth factor-I (Bld) [Mass/Vol],0
C1148044,Insulin^10M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^10 minutes post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10 Min post Unsp challenge Qn; Insulin 10M p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge,0
C1149301,insulin-like growth factor binding,insulin,IGF binding,0
C1149501,insulin receptor binding,insulin,,0
C1149502,insulin-like growth factor receptor binding activity,insulin,IGF receptor binding; insulin-like growth factor receptor binding,0
C1150623,insulin receptor activity,insulin,insulin-activated receptor activity; insulin receptor activity,0
C1150624,insulin-like growth factor receptor activity,insulin,insulin-like growth factor receptor activity; IGF-activated receptor activity; IGF receptor activity; insulin-like growth factor-activated receptor activity,0
C1151602,glutathione-insulin transhydrogenase activity,insulin,"glutathione--insulin transhydrogenase activity; thiol:protein-disulfide oxidoreductase activity; reductase, protein disulfide (glutathione); insulin reductase activity; thiol-protein disulphide oxidoreductase activity; protein disulfide transhydrogenase activity; protein-disulfide isomerase/oxidoreductase activity; protein-disulphide reductase (glutathione) activity; glutathione-protein disulfide oxidoreductase activity; GSH-insulin transhydrogenase activity; glutathione:protein-disulfide oxidoreductase activity; protein-disulfide reductase (glutathione) activity; protein disulfide reductase (glutathione); glutathione-insulin transhydrogenase activity",0
C1153021,insulin-activated sodium/amino acid transporter activity,insulin,insulin-activated sodium:amino acid symporter activity; insulin-activated sodium:amino acid transporter activity,0
C1154418,negative regulation of insulin secretion,insulin,down-regulation of insulin secretion; down regulation of insulin secretion; downregulation of insulin secretion,0
C1155394,insulin-like growth factor receptor signaling pathway,insulin,IGF receptor signalling pathway; IGF receptor signaling pathway,0
C1155395,insulin receptor signaling pathway,insulin,insulin receptor signalling pathway,0
C1155396,regulation of insulin receptor signaling pathway,insulin,regulation of insulin receptor signalling pathway,0
C1155397,negative regulation of insulin receptor signaling pathway,insulin,down-regulation of insulin receptor signaling pathway; down regulation of insulin receptor signaling pathway; negative regulation of insulin receptor signalling pathway; downregulation of insulin receptor signaling pathway,0
C1155398,positive regulation of insulin receptor signaling pathway,insulin,positive regulation of insulin receptor signalling pathway; up regulation of insulin receptor signaling pathway; upregulation of insulin receptor signaling pathway; up-regulation of insulin receptor signaling pathway,0
C1158354,insulin processing,insulin,,0
C1161041,Insulin administration education,insulin,Teach insulin injection; Insulin administration education (procedure),0
C1167145,insulin control element activator complex,insulin,insulin control element activator complex location; ICE activator complex location; ICE activator complex,0
C1167226,insulin receptor complex,insulin,insulin receptor complex location,0
C1167389,insulin-like growth factor binding protein complex,insulin,IGF binding protein complex location; insulin-like growth factor binding protein complex location; IGF binding protein complex,0
C1167390,insulin-like growth factor binary complex,insulin,IGF binary complex location; insulin-like growth factor binary complex location; IGF binary complex,0
C1167391,insulin-like growth factor ternary complex,insulin,IGF ternary complex location; insulin-like growth factor ternary complex location; IGF ternary complex,0
C1168864,"insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension",insulin,"Insulin Aspart-Insulin Aspart Protamine, 30 units-70 units/mL subcutaneous suspension; insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension; insulin aspart-insulin aspart protamine 30 units-70 units/mL subcutaneous suspension; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Insulin Aspart Protamine and Insulin Aspart Mix 70/30]; insulin analog, aspart mixed 70/30 100 UNT/ML Injectable Suspension; insulin aspart protamine / insulin aspart 70/30 Injectable Suspension",0
C1169459,"insulin, regular, human 500 UNT/ML Injectable Solution [Humulin R]",insulin,"HumuLIN R (concentrated) 500 UNT/ML Injectable Solution; HumuLIN R (Concentrated), human recombinant 500 units/mL subcutaneous solution; Insulin human 500 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humulin R U-500]; INSULIN CONCENTRATE REG HUMAN 500 UNT/ML; INSULIN,REGULAR,HUMAN CONCENTRATED 500 UNIT/ML INJ HUMULIN R; insulin, regular, human 500 UNT/ML Injectable Solution [HumuLIN R]; Humulin R 500 UNT/ML Injectable Solution; HumuLIN R 500 UNT/ML Injectable Solution",0
C1169461,HumaLOG Pen,humalog,humalog pens; humalog pen,0
C1169512,HumaLOG Mix 75/25 Pen,humalog,,0
C1169537,"insulin aspart, human 100 UNT/ML Injectable Solution [NovoLog]",insulin,"insulin aspart, human 100 UNT/ML Injectable Solution [NovoLog]; insulin aspart, human 100 UNT/ML Injectable Solution [NovoLOG]; NovoLOG 100 UNT/ML Injectable Solution; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [NOVOLOG]; NovoLOG, 100 units/mL injectable solution; Relion NovoLOG, 100 units/mL injectable solution; INSULIN ASPART 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [NOVOLOG]; NovoLog 100 UNT/ML Injectable Solution",0
C1169967,"insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension [NovoLog Mix]",insulin,"INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [NovoLog Mix 70/30]; NovoLOG Mix 70/30 Injectable Suspension; Relion NovoLOG Mix 70/30, 30 units-70 units/mL subcutaneous suspension; insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension [NovoLOG Mix]; insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension [NovoLog Mix]; INSULIN,ASPART,HUMAN 70/30 INJ,NOVOLOG; NovoLOG Mix 70/30, 30 units-70 units/mL subcutaneous suspension; NovoLog Mix 70/30 Injectable Suspension; INSULIN,ASPART,HUMAN 70/30 NOVOLOG INJ",0
C1170011,"insulin aspart protamine, human",insulin,"insulin aspart protamine; Insulin, aspart protamine, human; Insulin,aspart protamine; Insulin aspart protamine crystallised; insulin aspart protamine, human; Insulin aspart protamine; Insulin aspart protamine (substance); Insulin aspart protamine crystallized; INSULIN,ASPART PROTAMINE",0
C1170142,Cepacol Regular Strength,regular,,0
C1170320,HumaLOG Mix 50/50,humalog,,0
C1170447,NovoLog Mix 70/30,novolog,NovoMix 30; NovoLog Mix 70:30; NovoLOG Mix 70/30,0
C1171259,"insulin aspart protamine, human 70 UNT/ML",insulin,,0
C1172008,"INSIG2 protein, human",insulin,"Insig-2 protein, human; insulin induced gene 2 protein, human",0
C1175526,"RXFP2 protein, human",insulin,"G-protein-coupled receptor affecting testis descent, human; GREAT protein, human; LGR8 protein, human; leucine-rich repeat-containing G protein-coupled receptor 8, human; relaxin-insulin-like family peptide receptor 2, human",0
C1175776,hexyl-insulin monoconjugate 2,insulin,HIM2 compound,0
C1176449,"insulin isophane, pork 70 UNT/ML / insulin, regular, pork 30 UNT/ML Injectable Suspension",insulin,Porcine isophane insulin 70 unit/mL and porcine regular insulin 30 unit/mL suspension for injection; Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug); Porcine insulin soluble 30 unit/mL and porcine isophane insulin 70 unit/mL suspension for injection,0
C1176743,"insulin isophane, human 60 UNT/ML",insulin,,0
C1177285,"insulin, regular, human 15 UNT/ML",insulin,,0
C1177286,"insulin, regular, human 10 UNT/ML",insulin,,0
C1177287,"insulin, regular, human 20 UNT/ML",insulin,,0
C1178545,"insulin aspart, human 30 UNT/ML",insulin,,0
C1180382,Regular cardiac myocyte,regular,Regular cardiac muscle cell; Regular cardiac myocyte; Regular cardiac muscle fiber,0
C1183487,Regular intercellular matrix,regular,Regular intercellular matrix,0
C1186705,Milk proper,regular,Milk proper; Regular milk,0
C1186899,"insulin isophane, human 75 UNT/ML",insulin,,0
C1186900,"insulin, regular, human 25 UNT/ML",insulin,,0
C1236501,insulin glargine Injectable Solution [Lantus],insulin,,0
C1236539,"insulin, regular, human Injectable Solution [Humulin R]",insulin,"insulin, regular, human Injectable Solution [HumuLIN R]",0
C1237151,"insulin, regular, human Injectable Solution [Novolin R]",insulin,"insulin, regular, human Injectable Solution [NovoLIN R]",0
C1239530,insulin isophane Injectable Suspension [Novolin N],insulin,insulin isophane Injectable Suspension [NovoLIN N],0
C1239630,"insulin isophane / insulin, regular, human Injectable Suspension [Novolin]",insulin,"insulin isophane / insulin, regular, human Injectable Suspension [NovoLIN]",0
C1239635,insulin isophane Injectable Suspension [Humulin N],insulin,insulin isophane Injectable Suspension [HumuLIN N],0
C1239637,"insulin isophane / insulin, regular, human Injectable Suspension [Humulin]",insulin,"insulin isophane / insulin, regular, human Injectable Suspension [HumuLIN]",0
C1242297,"sennosides, USP Oral Tablet [Ex-Lax Regular Strength Pills]",regular,,0
C1251111,"insulin, regular, human Injectable Solution",insulin,,0
C1251112,"insulin, regular, pork Injectable Solution",insulin,,0
C1253202,insulin lispro Injectable Solution,insulin,,0
C1253204,"insulin, regular, beef Injectable Solution",insulin,,0
C1253218,"insulin isophane / insulin, regular, human Injectable Suspension",insulin,,0
C1253219,"insulin isophane / insulin, regular, pork Injectable Suspension",insulin,,0
C1253225,insulin glargine Injectable Solution,insulin,,0
C1253281,"insulin aspart, human Injectable Solution",insulin,,0
C1253297,insulin isophane Injectable Suspension,insulin,insulin isophane Injectable Suspension,0
C1253321,"lente insulin, pork Injectable Suspension",insulin,,0
C1253340,"insulin lispro / insulin lispro protamine, human Injectable Suspension",insulin,,0
C1253386,"insulin, protamine zinc, beef Injectable Suspension",insulin,,0
C1253387,"insulin, protamine zinc, human Injectable Suspension",insulin,,0
C1253439,"insulin aspart protamine, human / insulin aspart, human Injectable Suspension",insulin,,0
C1254218,NovoLOG PenFill,novolog,,0
C1254219,"insulin aspart, human Injectable Solution [NovoLog]",insulin,"insulin aspart, human Injectable Solution [NovoLOG]",0
C1254221,NovoLIN 70/30 PenFill,novolin,,0
C1255139,Serum Anti-Insulin Antibody Test,insulin,,0
C1255308,General Serum Insulin Antibodies Test,insulin,,0
C1255309,Intravascular Insulin Test,insulin,,0
C1255355,Serum Beef Insulin Antibody Test,insulin,,0
C1255356,Serum Human Insulin Antibody Test,insulin,,0
C1255357,Serum Pork Insulin Antibody Test,insulin,,0
C1255475,Intravascular Insulin-Like Growth Factor Binding Protein 3 Test,insulin,,0
C1256369,Insulin Secretion,insulin,"insulin secretion; Secretion, Insulin",0
C1256831,"nonsuppressible insulin-like carrier protein, human",insulin,"NSILA carrier protein, human",0
C1258519,Lys(B29)(N-carboxynonadecanoyl)-des(B30) human insulin,insulin,Lys(B29)(N(epsilon)-omega-carboxynonadecanoyl)-des(B30) human insulin; O346 human insulin,0
C1260459,Insulin pump status,insulin,,0
C1260460,Fitting and adjustment of insulin pump,insulin,Fitting and adjustment of insulin pump Insulin pump titration,0
C1260472,Encounter for insulin pump training,insulin,,0
C1261415,Serum insulin result,insulin,serum insulin level; insulin serum; serum insulin; insulin levels serum,0
C1261416,Serum insulin - C-polypeptide level result,insulin,,0
C1269958,"insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Injectable Suspension",insulin,"Insulin lispro 50 unit/mL and insulin lispro protamine 50 unit/mL solution for injection; insulin lispro-insulin lispro protamine 50 units-50 units/mL subcutaneous suspension; Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug); insulin lispro protamine / insulin lispro 50/50 Injectable Suspension; insulin analog, lispro mixed 50/50 100 UNT/ML Injectable Suspension",0
C1270253,Insulin (bovine) specific IgE antibody measurement,insulin,Insulin (bovine) specific immunoglobulin E antibody measurement (procedure); Insulin (bovine) specific IgE antibody measurement; Insulin (bovine) specific immunoglobulin E antibody measurement; Bovine insulin RAST test; c71 specific IgE antibody measurement; Insulin (bovine) RAST,0
C1270254,Insulin (human) specific IgE antibody measurement,insulin,c73 specific IgE antibody measurement; Insulin (human) RAST; Insulin (human) specific immunoglobulin E antibody measurement; Human insulin RAST test; Insulin (human) specific IgE antibody measurement; Insulin (human) specific immunoglobulin E antibody measurement (procedure),0
C1270255,Insulin (porcine) specific IgE antibody measurement,insulin,Insulin (porcine) specific immunoglobulin E antibody measurement (procedure); Insulin (porcine) RAST; c70 specific IgE antibody measurement; Insulin (porcine) specific IgE antibody measurement; Insulin (porcine) specific immunoglobulin E antibody measurement,0
C1270389,Insulin (bovine) specific immunoglobulin E,insulin,Insulin (bovine) specific IgE; Insulin (bovine) specific immunoglobulin E; Insulin (bovine) specific immunoglobulin E (substance); Insulin bovine Ab.IgE; Insulin bovine Antibody.immunoglobulin E; Insulin bovine IgE,0
C1270390,Insulin (human) specific immunoglobulin E,insulin,Insulin (human) specific immunoglobulin E (substance); Insulin human IgE; Insulin (human) specific immunoglobulin E; Insulin human Ab.IgE; Insulin human Antibody.immunoglobulin E; Insulin (human) specific IgE,0
C1270392,Insulin (porcine) specific immunoglobulin E,insulin,Insulin porcine IgE; Insulin (porcine) specific immunoglobulin E; Insulin (porcine) specific immunoglobulin E (substance); Insulin porcine Ab.IgE; Insulin (porcine) specific IgE; Insulin porcine Antibody.immunoglobulin E,0
C1271041,Other regular care provider,regular,,0
C1272306,Diabetic on insulin and oral treatment,insulin,Diabetic on insulin and oral treatment (finding),0
C1272417,Insulin administration assessment,insulin,Assess insulin injection; Insulin administration assessment (procedure),0
C1272418,Insulin administration management,insulin,Insulin administration management (procedure); Manage insulin injection,0
C1273270,Insulin aspart protamine- and insulin aspart-containing product,insulin,Product containing insulin aspart and insulin aspart protamine (medicinal product); insulin aspart-insulin aspart protamine; Insulin Aspart-Insulin Aspart Protamine,0
C1273452,Insulin IgE antibody level,insulin,Insulin immunoglobulin E antibody level; Insulin immunoglobulin E antibody level (procedure),0
C1273453,Insulin IgG antibody level,insulin,Insulin immunoglobulin G antibody level (procedure); Insulin immunoglobulin G antibody level,0
C1273708,Nuclear pleomorphism: small regular nuclei (score=1),regular,Nuclear pleomorphism: small regular nuclei (score=1) (finding),0
C1275890,Anti-insulin autoantibody,insulin,Anti-insulin autoantibody (substance); insulin autoantibody; Insulin autoantibody; autoantibodies insulin; Anti-insulin autoantibody,0
C1276042,Plasma insulin measurement,insulin,Plasma insulin level; Plasma insulin measurement (procedure),0
C1278021,Plasma IGF 1 measurement,insulin,Plasma IGF 1 level; Plasma insulin-like growth factor 1 measurement (procedure); Plasma insulin-like growth factor 1 measurement,0
C1278022,Plasma IGF 2 measurement,insulin,Plasma insulin-like growth factor 2 measurement (procedure); Plasma IGF 2 level; Plasma insulin-like growth factor 2 measurement,0
C1278024,Serum insulin-like growth factor 1 measurement,insulin,Serum insulin-like growth factor 1 level; Serum insulin-like growth factor 1 measurement (procedure),0
C1278025,Serum Insulin-like growth factor 2 measurement,insulin,Serum Insulin-like growth factor 2 level; Serum Insulin-like growth factor 2 measurement (procedure),0
C1279187,Diabetes mellitus insulin-glucose infusion in acute myocardial infarction,insulin,DIGAMI - diabetes mellitus insulin-glucose infusion in acute myocardial infarction; Diabetes mellitus insulin-glucose infusion in acute myocardial infarction (procedure),0
C1279306,Type 1 diabetes mellitus with arthropathy,insulin,Insulin dependent diabetes mellitus with arthropathy; Type I diabetes mellitus with arthropathy; Arthropathy due to type 1 diabetes mellitus (disorder); Arthropathy due to type 1 diabetes mellitus,0
C1292059,Anti-pork insulin antibody,insulin,Insulin Pork Antibodies; Insulin porcine Antibody; Anti-pork insulin antibody (substance); Insulin porcine Ab,0
C1294992,Measurement of insulin receptor antibody,insulin,Insulin receptor antibody assay; Measurement of insulin receptor antibody (procedure),0
C1295163,Insulin-like growth factor binding protein 2 measurement,insulin,Insulin-like growth factor binding protein 2 measurement (procedure); Insulin-like growth factor binding protein 2 measurement; IGFBP2 Measurement; Insulin-Like Growth Factor Binding Protein 2 Measurement,0
C1295164,Insulin-like growth factor binding protein 1 measurement,insulin,Insulin-like growth factor binding protein 1 measurement (procedure); Insulin-like growth factor binding protein 1 measurement; IGFBP1 Measurement; Insulin-Like Growth Factor Binding Protein 1 Measurement,0
C1295676,Decreased insulin level,insulin,Decreased insulin level (finding),0
C1302942,"insulin isophane, human 75 UNT/ML / insulin, regular, human 25 UNT/ML Injectable Suspension",insulin,Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug); Human isophane insulin 75 unit/mL and recombinant human soluble insulin 25 unit/mL suspension for injection; Human isophane insulin 75 unit/mL and recombinant human regular insulin 25 unit/mL suspension for injection,0
C1303121,Plasma insulin C-peptide level,insulin,Plasma insulin C-peptide level (procedure),0
C1305108,"Addison's disease, struma lymphomatosa and insulin-dependent diabetes mellitus",insulin,"Addison's disease with struma lymphomatosa; Addison's disease, toxic diffuse goitre and insulin-dependent diabetes mellitus; Addison's disease, toxic diffuse goiter and insulin-dependent diabetes mellitus; Addison's disease, struma lymphomatosa and insulin-dependent diabetes mellitus",0
C1305435,Human insulin analog product,insulin,,0
C1307286,"LIRP protein, Locusta migratoria",insulin,"insulin-related peptide, Locusta migratoria",0
C1309497,"wortmannin-sensitive and insulin-sensitive protein kinase, rat",insulin,"WISK protein, rat",0
C1309542,"IBP protein, Spodoptera frugiperda",insulin,"27-kDa IBP, Spodoptera frugiperda; insulin-related peptide-binding protein, Spodoptera frugiperda",0
C1311477,B27 Lys destripeptide insulin,insulin,B27 Lys DtrI; B27 lysine DtrI,0
C1313386,"insulin glulisine, human",insulin,"Insulina glulisina; Insulin Glulisine (recombinant DNA origin); Insulin glulisine (substance); INSULIN GLULISINE; insulin, lysyl(B3)-glutamyl(B29)-; insulin glulisine, human; Product containing insulin glulisine (medicinal product); insulin, Lys(B3)-Glu(B29)-; Insulin glulisine-containing product; B3-lysyl-B29-glutamylinsulin; Insulin Glulisine; glulisine insulin; Insulin glulisine recombinant; INSULIN,GLULISINE,HUMAN; insulin glulisine; Insulin glulisine",0
C1314431,"Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each",insulin,,0
C1314585,"Insulin, rapid onset, 5 units",insulin,,0
C1314586,"Insulin, most rapid onset (lispro or aspart); 5 units",insulin,,0
C1314587,"Insulin, intermediate acting (nph or lente); 5 units",insulin,,0
C1314588,"Insulin, long acting; 5 units",insulin,,0
C1314589,"Insulin delivery device, reusable pen; 1.5 ml size",insulin,,0
C1314590,"Insulin delivery device, reusable pen; 3 ml size",insulin,,0
C1314591,Insulin cartridge for use in insulin delivery device other than pump; 150 units,insulin,,0
C1314592,Insulin cartridge for use in insulin delivery device other than pump; 300 units,insulin,,0
C1314593,"Insulin delivery device, disposable pen (including insulin); 1.5 ml size",insulin,,0
C1314594,"Insulin delivery device, disposable pen (including insulin); 3 ml size",insulin,,0
C1314782,Levemir,levemir,levemir; Levemir,0
C1316004,Influenza virus A+B Ag:PrThr:Pt:Nph:Ord,NPH,Influenza virus A+B Ag [Presence] in Nasopharynx; Influenza virus A+B Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal; FLUAV+FLUBV Ag Nph Ql; FLUAV+FLUBV Ag Ql (Nph),0
C1316118,Insulin-like growth factor binding protein 3^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 1 Hr post Unsp challenge [Mass/Vol]; IGF BP3 1h p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1 hour post XXX challenge; Insulin-like growth factor binding protein 3^1 hour post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1316122,Insulin-like growth factor binding protein 3^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 2 Hr post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3^2 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2 hours post XXX challenge; IGF BP3 2h p chal SerPl-mCnc,0
C1316272,Insulin-like growth factor binding protein 3:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 [Moles/volume] in Serum or Plasma; Insulin-like growth factor binding protein 3 [Moles/Vol]; Insulin-like growth factor binding protein 3:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF BP3 SerPl-sCnc,0
C1316273,Insulin^10th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^10th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10th specimen post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge; Insulin sp10 p chal SerPl-aCnc,0
C1316274,Insulin^11th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --11th specimen post XXX challenge; Insulin^11th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 11th specimen post Unsp challenge Qn; Insulin sp11 p chal SerPl-aCnc,0
C1316275,Insulin^12th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --12th specimen post XXX challenge; Insulin 12th specimen post Unsp challenge Qn; Insulin sp12 p chal SerPl-aCnc; Insulin^12th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1316276,Insulin^13th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin sp13 p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --13th specimen post XXX challenge; Insulin^13th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 13th specimen post Unsp challenge Qn,0
C1316277,Insulin^14th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^14th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --14th specimen post XXX challenge; Insulin 14th specimen post Unsp challenge Qn; Insulin sp14 p chal SerPl-aCnc,0
C1316278,Insulin^15th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^15th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 15th specimen post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --15th specimen post XXX challenge; Insulin sp15 p chal SerPl-aCnc,0
C1316279,Insulin^1st specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge; Insulin 1st specimen post Unsp challenge Qn; Insulin^1st specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp1 p chal SerPl-aCnc,0
C1316280,Insulin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^2nd specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge; Insulin 2nd specimen post Unsp challenge Qn; Insulin sp2 p chal SerPl-aCnc,0
C1316281,Insulin^3rd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin sp3 p chal SerPl-aCnc; Insulin 3rd specimen post Unsp challenge Qn; Insulin^3rd specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge,0
C1316282,Insulin^8th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge; Insulin sp8 p chal SerPl-aCnc; Insulin 8th specimen post Unsp challenge Qn; Insulin^8th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1316283,Insulin^9th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^9th specimen post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge; Insulin sp9 p chal SerPl-aCnc; Insulin 9th specimen post Unsp challenge Qn,0
C1316523,Glucose^pre or post dose insulin:SCnc:Pt:Ser/Plas:Qn,insulin,Glucose pre or post dose insulin [Moles/Vol]; Glucose pre/p Ins SerPl-sCnc; Glucose [Moles/volume] in Serum or Plasma --pre or post dose insulin; Glucose^pre or post dose insulin:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1316527,Somatotropin^pre or post dose insulin:MCnc:Pt:Ser/Plas:Qn,insulin,GH pre/p Ins SerPl-mCnc; Somatotropin^pre or post dose insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin pre or post dose insulin [Mass/Vol]; Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose insulin,0
C1316619,Insulin.bound:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin Bnd SerPl-aCnc; Insulin.bound:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin.bound Qn; Insulin.bound [Units/volume] in Serum or Plasma,0
C1317461,Bound insulin,insulin,Insulin.bound; Bound insulin (substance),0
C1318662,Serum pro-insulin level,insulin,Serum pro-insulin level (procedure); Serum pro-insulin measurement,0
C1319510,Regular monitoring discussed with patient,regular,Regular monitoring discussed with patient (finding),0
C1319579,Serum 32-33 split pro-insulin level,insulin,Serum 32-33 split pro-insulin level (procedure),0
C1319762,Needle-free insulin delivery system,insulin,Needle-free insulin delivery system (physical object),0
C1322699,Insulin Delivery Systems,insulin,,0
C1322705,Insulin Dosers,insulin,,0
C1322777,Insulin Needles,insulin,,0
C1323032,"Syringes, Plunger, Insulin, Protective",insulin,,0
C1325802,insulin-like growth factor binding protein location,insulin,,0
C1325895,regulation of insulin secretion,insulin,,0
C1328726,Insulin-like growth factor measurement,insulin,,0
C1329419,bismuth subsalicylate 17.5 MG/ML Oral Suspension [Kaopectate Reformulated Aug 2006],regular,"Kaopectate, 262 mg/15 mL oral suspension; BISMUTH SUBSALICYLATE 17.47 mg in 1 mL ORAL LIQUID [Kaopectate Regular Strength Peppermint Flavor Anti Diarrheal]; Bismuth Subsalicylate 262 mg in 15 mL ORAL LIQUID [Kaopectate Vanilla Flavor Anti Diarrheal]; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID [Kaopectate Regular Strength Vanilla Flavor Anti Diarrheal]; Bismuth Subsalicylate 262 mg in 15 mL ORAL LIQUID [Kaopectate Cherry Flavor Anti Diarrheal]; Kaopectate 262 MG per 15 ML Oral Suspension, Reformulated Aug 2006; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID [Kaopectate Regular Strength Cherry Flavor]; Kaopectate 262 MG in 15 mL Oral Suspension, Reformulated Aug 2006; bismuth subsalicylate 17.5 MG/ML Oral Suspension [Kaopectate Reformulated Aug 2006]; BISMUTH SUBSALICYLATE 262 mg in 15 mL ORAL LIQUID [Kaopectate Peppermint Flavor Anti Diarrheal]; Kaopectate Reformulated Aug 2006 17.5 MG/ML Oral Suspension",0
C1330322,Gaviscon Regular Strength,regular,,0
C1330431,NovoLOG FlexPen,novolog,,0
C1330432,NovoLIN 70/30 Innolet,novolin,,0
C1330433,NovoLIN N Innolet,novolin,,0
C1330434,NovoLIN N PenFill,novolin,,0
C1330435,NovoLOG Mix 70/30 PenFill,novolog,,0
C1330500,Regular Strength Sinus Medication Caplet,regular,Medicament Pour Les Sinus Reg Caplet,0
C1330501,Regular Strength Tylenol Sinus Caplet,regular,,0
C1330533,Sinu Nondrowsy Regular Strength,regular,,0
C1330759,"Heelboot Laundry Bag, Regular",regular,,0
C1330761,"Heelboot Replacement Liner, Regular",regular,,0
C1330792,Monoject Insulin Syringe 0.5cc 28g 0.5,insulin,,0
C1330895,"Insulin Syringe 0.5cc 29g 1/2""",insulin,,0
C1330896,"Insulin Syringe 0.5cc 30g 1/2""",insulin,,0
C1330900,"Insulin Syringe 0.3cc 30g 5/16""",insulin,,0
C1332378,BAIAP2 gene,insulin,WASP and MIM like; BAI1-ASSOCIATED PROTEIN 2; WAML; BAI1 associated protein 2; BAP2; BAI1-Associated Protein 2 Gene; BAR/IMD domain containing adaptor protein 2; IRSp53; INSULIN RECEPTOR SUBSTRATE p53; BAIAP2 gene; IRSP53; insulin receptor substrate of 53 kDa; BAIAP2 Gene; BAIAP2,0
C1332743,CDX2 gene,insulin,INSULIN-REGULATING TRANSCRIPTION FACTOR CDX3; CDX2 Gene; CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 3; CDX2; CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 2; Caudal Type Homeobox 2 Gene; caudal type homeo box transcription factor 2; CDX3; CDX2 gene; caudal type homeobox 2,0
C1332802,CTLA4 gene,insulin,"CELIAC3; Cytotoxic T-Lymphocyte-Associated Protein 4 Gene; CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; insulin-dependent diabetes mellitus 12; CTLA4; CTLA-4; celiac disease 3; CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4, SOLUBLE ISOFORM; CD152; IDDM12; CD; cytotoxic T-lymphocyte associated protein 4; CTLA4 Gene; CTLA4 gene; GSE",0
C1334088,IGF1R gene,insulin,IGFR; IGF1R Gene; JTK13; CD221; insulin-like growth factor 1 receptor; insulin like growth factor 1 receptor; IGFIR; IGF1R gene; MGC18216; Insulin Like Growth Factor 1 Receptor Gene; INSULIN-LIKE GROWTH FACTOR I RECEPTOR; IGF1R,0
C1334089,IGF1 gene,insulin,IGF1; IGF-I; IGF; INSULIN-LIKE GROWTH FACTOR I; somatomedin C; IGF1 Gene; IGF I; IGFI; insulin like growth factor 1; SOMATOMEDIN C; insulin-like growth factor 1 (somatomedin C); Insulin-Like Growth Factor 1 (Somatomedin C) Gene; IGF1A; IGF1 gene,0
C1334090,IGF2R gene,insulin,"IGF2R Gene; insulin like growth factor 2 receptor; IGF2R; IGF2R gene; M6P-R; MANNOSE 6-PHOSPHATE RECEPTOR, CATION-INDEPENDENT; CI-M6PR; Insulin-Like Growth Factor 2 Receptor Gene; insulin-like growth factor 2 receptor; INSULIN-LIKE GROWTH FACTOR II RECEPTOR; CIMPR; MPR1; CD222; cation-independent mannose-6 phosphate receptor; MPRI; CI-MPR; MPR300",0
C1334091,IGF2 gene,insulin,insulin-like growth factor 2; C11orf43; chromosome 11 open reading frame 43; IGF2 gene; SOMATOMEDIN A; IGF2 Gene; preptin; FLJ44734; IGF-II; IGF2; INSULIN-LIKE GROWTH FACTOR II; somatomedin A; Insulin-Like Growth Factor 2 (Somatomedin A) Gene; insulin like growth factor 2,0
C1334092,IGFBP1 gene,insulin,IBP1; IGFBP1 Gene; AFBP; amniotic fluid binding protein; hIGFBP-1; Insulin-Like Growth Factor Binding Protein 1 Gene; PLACENTAL PROTEIN 12; binding protein-25; insulin-like growth factor binding protein 1; insulin like growth factor binding protein 1; IGFBP1 gene; binding protein-28; alpha-pregnancy-associated endometrial globulin; IGF-BP25; placental protein 12; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1; IGF-binding protein 1; IGFBP1; binding protein-26; growth hormone independent-binding protein; PP12,0
C1334093,IGFBP2 gene,insulin,"IGFBP2; Insulin-Like Growth Factor Binding Protein 2, 36kDa Gene; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; insulin-like growth factor binding protein 2 (36kD); IGFBP2 Gene; IGF-BP53; insulin like growth factor binding protein 2; insulin-like growth factor binding protein 2, 36kDa; insulin-like growth factor binding protein 2; IGFBP2 gene; IBP2",0
C1334094,IGFBP3 gene,insulin,IGFBP3 gene; insulin-like growth factor binding protein 3; insulin like growth factor binding protein 3; IGF-binding protein 3; BP-53; growth hormone-dependent binding protein; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IBP3; binding protein 53; IGFBP3 Gene; binding protein 29; Insulin-Like Growth Factor Binding Protein 3 Gene; IGFBP3; acid stable subunit of the 140 K IGF complex,0
C1334095,IGFBP4 gene,insulin,insulin like growth factor binding protein 4; IGF-binding protein 4; IGFBP4 Gene; IGFBP4 gene; IBP4; HT29-IGFBP; IGFBP4; Insulin-Like Growth Factor Binding Protein 4 Gene; insulin-like growth factor binding protein 4; BP-4; insulin-like growth factor-binding protein 4; IGFBP-4; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 4,0
C1334096,IGFBP5 gene,insulin,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; IBP5; IGFBP5 Gene; insulin like growth factor binding protein 5; IGFBP5; insulin-like growth factor binding protein 5; Insulin-Like Growth Factor Binding Protein 5 Gene; IGFBP5 gene,0
C1334114,IL2RA gene,insulin,"CD25; IL2R; IL2 RECEPTOR; interleukin 2 receptor subunit alpha; IL2RA gene; insulin-dependent diabetes mellitus 10; T-CELL GROWTH FACTOR RECEPTOR; IL2RA; INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA Gene; Interleukin 2 Receptor, Alpha Gene; TCGFR; interleukin 2 receptor, alpha; TAC ANTIGEN; IL2R, ALPHA CHAIN; IDDM10",0
C1334133,INSR gene,insulin,INSR gene; Insulin Receptor Gene; INSR; CD220; insulin receptor; INSULIN RECEPTOR; INSR Gene,0
C1334140,IRS1 gene,insulin,IRS1 gene; HIRS-1; IRS1; Insulin Receptor Substrate 1 Gene; insulin receptor substrate 1; INSULIN RECEPTOR SUBSTRATE 1; IRS1 Gene,0
C1334141,IRS2 gene,insulin,IRS2 gene; insulin receptor substrate 2; INSULIN RECEPTOR SUBSTRATE 2; IRS2 Gene; Insulin Receptor Substrate 2 Gene; IRS2,0
C1334142,IRS4 gene,insulin,Insulin Receptor Substrate 4 Gene; IRS4 Gene; IRS-4; IRS4; IRS4 gene; PY160; insulin receptor substrate 4; INSULIN RECEPTOR SUBSTRATE 4,0
C1334189,"IGF2R protein, human",insulin,"CD222 Antigen; CI Man-6-P Receptor; IGF2R protein, human; 300 kDa Mannose 6-Phosphate Receptor; insulin like growth factor 2 receptor protein, human; M6P/IGF2R; Cation-Independent Mannose-6 Phosphate Receptor; Insulin-Like Growth Factor 2 Receptor; IGF2R; M6P/IGF2 Receptor; M6PR; MPR 300; IGF-II Receptor; Insulin-Like Growth Factor II Receptor; Antigen CD222; CD222; CI-M6PR protein, human; CI-MPR",0
C1334191,"IRS2 protein, human",insulin,"Insulin Receptor Substrate 2; IRS-2 protein, human; IRS-2; insulin receptor substrate 2, human; IRS2; IRS2 protein, human",0
C1336533,Suppressor of Cytokine Signaling Family Gene,SSI,CIS Family Gene; Cytokine-Induced STAT Inhibitor Family Gene; SOCS Family Gene; STAT-Induced STAT Inhibitor Family Gene; SSI Family Gene,0
C1337112,INS gene,insulin,IDDM2; insulin-dependent diabetes mellitus 2; Insulin Gene; INS-IGF2 SPLICED READ-THROUGH TRANSCRIPTS; INS; INSULIN; IDDM1; INSIGF; PROINSULIN; INS Gene; INS gene; insulin,0
C1349489,menthol 0.05 MG/MG Medicated Patch,regular,"Menthol, Unspecified Form 50 mg TOPICAL PATCH [Bengay Ultra Strength Large Size]; MENTHOL 5 g TOPICAL PATCH [Extra Strength Cold-Hot Medicated Patches]; MENTHOL 5 g in 100 g TOPICAL PATCH [Hot and Cold Medicated Patch]; MENTHOL, UNSPECIFIED FORM 5 g in 100 g TOPICAL PATCH [Thritex]; MENTHOL 5 mg TOPICAL PATCH [Pain Relief Patches]; MENTHOL 5 g in 100 g TOPICAL PATCH [Good Sense Hot and Cold Medicated Patch Small]; MENTHOL 50 mg in 1 mL TOPICAL PATCH [GeriGentle FrostyHeat Pain Relief Patch Back]; MENTHOL 0.85 g in 17 g TOPICAL PATCH [SINSINPAS COLD]; MENTHOL 50 mg TOPICAL PATCH [Family Wellness Cold Hot]; MENTHOL 5 mg in 100 mg TOPICAL PATCH [Assured Cold N Hot Pain Relief Menthol]; MENTHOL, UNSPECIFIED FORM 240 mg TOPICAL PATCH [Cold and Hot Medicated]; MENTHOL 285 mg in 5700 mg TOPICAL PATCH [Hot/Cold Medicated Patch]; MENTHOL 5 g in 100 g TOPICAL PATCH [cold hot patch]; MENTHOL 428.50 mg TOPICAL PATCH [Icy Hot Back and Large Areas]; Icy Hot Extra Strength Back and Large Areas, 5% topical pad; MENTHOL 50 mg in 1 mL TOPICAL PATCH [IceQuake Coldn Hot Medicated]; Icy Hot Extra Strength, 5% topical pad; MENTHOL, UNSPECIFIED FORM 205.5 mg TOPICAL PATCH [Icy Hot Medicated]; MENTHOL, UNSPECIFIED FORM 428.5 mg TOPICAL PATCH [Icy Hot Medicated, Back]; MENTHOL, UNSPECIFIED FORM 500 mg TOPICAL PATCH [Cold and Hot Medicated]; MENTHOL 5 g in 100 g TOPICAL PATCH [Extra Large Cool and Heat Patch]; MENTHOL 5 g TOPICAL PATCH [Meijer Large Cold-Hot Medicated Patches]; MENTHOL 5 g in 100 g TOPICAL PATCH [Thera Care Pain Relief Menthol Patchs]; MENTHOL, UNSPECIFIED FORM 5 g in 100 g TOPICAL PATCH [Cycle]; MENTHOL 875 mg TOPICAL PATCH [Cold and Hot Medicated Pain Relief Large]; MENTHOL 5 g TOPICAL PATCH [Back and Large Extra Strength Cold-Hot Medicated Patches]; Menthol, unspecified form 50 mg TOPICAL PATCH [Bengay Ultra Strength Regular Size]; MENTHOL 400 mg TOPICAL PATCH [Cold and Hot Pain Relief]; MENTHOL 5 g in 100 g TOPICAL PATCH [Hempvana Cold As Ice Pain Relief Gel-Patch]; MENTHOL 750 mg TOPICAL PATCH [Extra Strength Pain Relief Therapy]; MENTHOL, UNSPECIFIED FORM 5 g in 100 g TOPICAL PATCH [Rugby Menthol Hot Cold Patch]; MENTHOL 5 g TOPICAL PATCH [Meijer Small Cold-Hot Medicated Patches]; MENTHOL 5 g in 100 g TOPICAL PATCH [Cycle]; MENTHOL 5 g in 100 g TOPICAL PATCH [Relief]; MENTHOL 5 g in 100 g TOPICAL PATCH [Dollar General Cold-Hot Medicated Patches]; MENTHOL 0.05 g in 1 g TOPICAL PATCH [OVERNIGHT RELIEF Gel-Patch]; MENTHOL, UNSPECIFIED FORM 600 mg TOPICAL PATCH [Menthol 5% Hydrogel]; MENTHOL 550 mg TOPICAL PATCH [Cold and Hot Medicated Pain Relief Large]; MENTHOL 5 g in 100 g TOPICAL PATCH [Kroger Hot and Cold Medicated Patch]; Menthol, Unspecified Form 0.3 g in 6 g TOPICAL PATCH [Biofreeze Overnight Relief]; MENTHOL 50 mg TOPICAL PATCH [Topcare Cold and Hot Medicated]; MENTHOL 5% PATCH; MENTHOL, UNSPECIFIED FORM 750 mg TOPICAL PATCH [Icy Hot Medicated, XL]; MENTHOL 5 g TOPICAL PATCH [Dollar General Cold-Hot Medicated Patches]; MENTHOL 5 g in 100 g TOPICAL PATCH [Thera Care Hot and Cold Medicated Patch]; MENTHOL 5 mg in 1 g TOPICAL PATCH [Coralite Cold and Hot Medicated]; MENTHOL, UNSPECIFIED FORM 428.5 mg TOPICAL PATCH [Cold and Hot Medicated Large]; MENTHOL 50 mg in 1 g TOPICAL PATCH [Coralite Cold and Hot Medicated]; MENTHOL 5 g in 100 g TOPICAL PATCH [Good Sense Hot and Cold Medicated Patch]; MENTHOL 5 g in 100 g TOPICAL PATCH [Thera Care Cold Hot Medicated Patch]; MENTHOL, UNSPECIFIED FORM 205.5 mg TOPICAL PATCH [Cold and Hot Medicated Patch]; MENTHOL 428.5 mg TOPICAL PATCH [Medicated Pain Relief]; menthol 5 % Medicated Patch; MENTHOL 400 mg TOPICAL PATCH [Soundbody Cold and Hot Pain Relief]; MENTHOL 5 g in 100 g TOPICAL PATCH [Walgreens Cold Therapy Pain Relief Patch]; MENTHOL 205.50 mg TOPICAL PATCH [Icy Hot Arm Neck Leg and Small Areas]; MENTHOL 50 mg TOPICAL PATCH [CVS Cold and Hot]; MENTHOL, UNSPECIFIED FORM 50 mg TOPICAL PATCH [Equate Cool and Heat Extra Strength]; MENTHOL, UNSPECIFIED FORM 5 g TOPICAL PATCH [MediRelief Ultra]; MENTHOL 50 mg TOPICAL PATCH [Goodsense Extra Strength Cold and Hot Medicated]; MENTHOL 50 mg TOPICAL PATCH [Up and Up Cold and Hot Medicated]; Menthol Cold/Hot, 5% topical pad; MENTHOL 750.00 mg TOPICAL PATCH [Icy Hot XL Back and Large Areas]; MENTHOL 50 mg TOPICAL PATCH [Winco Cold and Hot Medicated Patch Large]; MENTHOL 0.05 g in 1 g TOPICAL PATCH [MENTHOL PAIN RELIEF Gel-Patch]; MENTHOL 750 mg TOPICAL PATCH [CVS COLD AND HOT MEDICATED XL]; MENTHOL, UNSPECIFIED FORM 5 g in 100 g TOPICAL PATCH [Extra Strength Cold and Hot Menthol Patch]; MENTHOL, UNSPECIFIED FORM 500 mg TOPICAL PATCH [Signature Care Cold and Hot Medicated]; MENTHOL 50 mg in 1 mL TOPICAL PATCH [GeriGentle FrostyHeat Pain Relief Patch Arm and Neck]; MENTHOL 750 mg TOPICAL PATCH [Major Extra Strength Cold and Hot Pain Relief Therapy]; MENTHOL 428.5 mg TOPICAL PATCH [Health Mart Extra Strength Pain Relief]; MENTHOL, UNSPECIFIED FORM 50 g TOPICAL PATCH [Rite Aid Cold and Hot Medicated]; MENTHOL, UNSPECIFIED FORM 50 mg TOPICAL PATCH [Equate Menthol Pain Relieving]; MENTHOL, UNSPECIFIED FORM 440 mg TOPICAL PATCH [Menthol 5%]; Menthol 375 mg TOPICAL PATCH [Toplast Cool Menthol 5percent]",0
C1367148,IGFBP6 gene,insulin,IGFBP6 gene; IGFBP6; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; Insulin-Like Growth Factor Binding Protein 6 Gene; IGFBP6 Gene; insulin-like growth factor binding protein 6; IBP6; insulin like growth factor binding protein 6,0
C1369575,Chlamydia trachomatis Ag:PrThr:Pt:Nph:Ord,NPH,Chlamydia trachomatis Ag [Presence] in Nasopharynx; C. trachomatis Ag Ql (Nph); C trach Ag Nph Ql; Chlamydia trachomatis Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal,0
C1371675,Decreased Insulin Secretion,insulin,Decreased Insulin Secretion [PE],0
C1372360,Increased Insulin Secretion,insulin,Increased Insulin Secretion [PE],0
C1373083,Insulin Receptor Interactions,insulin,Insulin Receptor Interactions [MoA],0
C1373092,Insulin Receptor Agonists,insulin,Insulin Receptor Agonists [MoA],0
C1373105,Insulin Receptor Antagonists,insulin,Insulin Receptor Antagonists [MoA],0
C1385356,Insulin pump present,insulin,Insulin pump present (finding),0
C1392869,Drug-induced insulin coma in nondiabetic,insulin,Drug-induced insulin coma in nondiabetic (disorder),0
C1413668,CPE gene,insulin,CPE; CPE gene; carboxypeptidase E; carboxypeptidase H; CARBOXYPEPTIDASE E; enkephalin convertase; Carboxypeptidase E Gene; insulin granule-associated carboxypeptidase; CARBOXYPEPTIDASE H; cobalt-stimulated chromaffin granule carboxypeptidase; CPE Gene,0
C1413791,CCN2 gene,insulin,cellular communication network factor 2; Cellular Communication Network Factor 2 Gene; CONNECTIVE TISSUE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 8; connective tissue growth factor; CCN2; IGFBP8; CTGF; CCN2 Gene; CELLULAR COMMUNICATION NETWORK FACTOR 2; CCN2 gene,0
C1413896,CCN1 gene,insulin,"GIG1; CCN FAMILY, MEMBER 1; IGFBP10; CELLULAR COMMUNICATION NETWORK FACTOR 1; CCN1 gene; CYR61; CCN1 Gene; cysteine rich angiogenic inducer 61; CYSTEINE-RICH, ANGIOGENIC INDUCER, 61; cellular communication network factor 1; CCN1; Cellular Communication Network Factor 1 Gene; CYSTEINE-RICH PROTEIN 61, MOUSE, HOMOLOG OF; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 10",0
C1414352,EIF4EBP1 gene,insulin,Eukaryotic Translation Initiation Factor 4E Binding Protein 1 Gene; eukaryotic translation initiation factor 4E binding protein 1; phosphorylated heat- and acid-stable protein regulated by insulin 1; 4EBP1; 4E-BP1; EIF4EBP1 Gene; EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 1; EIF4EBP1; PHAS-I; EIF4EBP1 gene,0
C1415875,IDE gene,insulin,INSULIN-DEGRADING ENZYME; INSULYSIN; INSULINASE; insulin-degrading enzyme; IDE gene; insulysin; IDE; Insulin-Degrading Enzyme Gene; IDE Gene; insulin degrading enzyme,0
C1415932,IGFBP7 gene,insulin,IGFBP7 Gene; MAC25; PROSTACYCLIN-STIMULATING FACTOR; insulin like growth factor binding protein 7; PSF; Insulin-Like Growth Factor Binding Protein 7 Gene; AGM; IGFBPRP1; IGFBP7 gene; IGF-BINDING PROTEIN-RELATED PROTEIN 1; ANGIOMODULIN; IGFBP7; IGFBP-7; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7; insulin-like growth factor binding protein 7; FSTL2,0
C1416450,INSIG1 gene,insulin,"INSIG1 gene; INSIG-1 membrane protein; CL6, RAT, HOMOLOG OF; INSULIN-INDUCED GENE 1; insulin induced gene 1; CL-6; INSIG1; MGC1405",0
C1416453,INSL3 gene,insulin,"INSULIN-LIKE 3; INSL3 gene; relaxin-like factor; RELAXIN-LIKE FACTOR; MGC119819; RLF; prepro-INSL3; INSL3; MGC119818; insulin-like 3 (Leydig cell); INSULIN-LIKE PEPTIDE, LEYDIG CELL-SPECIFIC; insulin like 3; RLNL",0
C1416454,INSL4 gene,insulin,INSL4; PLACENTIN; EPIL; EARLY PLACENTA INSULIN-LIKE PEPTIDE; INSL4 gene; insulin-like 4 (placenta); Insulin Like 4 Gene; INSL4 Gene; insulin like 4; INSULIN-LIKE 4,0
C1416455,INSL5 gene,insulin,INSULIN-LIKE 5; prepro-INSL5; insulin-like 5; INSL5; insulin like 5; INSL5 gene,0
C1416456,INSL6 gene,insulin,RELAXIN/INSULIN-LIKE FACTOR 1; INSL6 gene; INSULIN-LIKE 6; RIF1; insulin-like 6; INSL6; insulin like 6; relaxin/insulin-like factor 1,0
C1416459,INSRR gene,insulin,INSRR Gene; INSRR; INSULIN RECEPTOR-RELATED RECEPTOR; Insulin Receptor-Related Receptor Gene; INSRR gene; insulin receptor related receptor; IRR,0
C1416889,LMX1A gene,insulin,"LIM HOMEOBOX TRANSCRIPTION FACTOR 1, ALPHA; LMX1A; LMX1A gene; LIM homeobox transcription factor 1 alpha; INSULIN-REGULATING TRANSCRIPTION FACTOR LMX1; LIM HOMEOBOX TRANSCRIPTION FACTOR 1; LMX1; LMX1.1; LIM homeobox transcription factor 1, alpha",0
C1416891,LNPEP gene,insulin,"placental leucine aminopeptidase; LEUCYL-CYSTINYL AMINOPEPTIDASE; PLAP; INSULIN-RESPONSIVE AMINOPEPTIDASE, MOUSE, HOMOLOG OF; P-LAP; LNPEP gene; CAP; leucyl/cystinyl aminopeptidase; OXYTOCINASE; leucyl and cystinyl aminopeptidase; cystinyl aminopeptidase; LNPEP; LEUCINE AMINOPEPTIDASE OF PLACENTA; IRAP",0
C1418224,P4HB gene,insulin,"PO4DB; THYROID HORMONE-BINDING PROTEIN p55, CELLULAR; procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (protein disulfide isomerase; thyroid hormone binding protein p55); prolyl 4-hydroxylase, beta polypeptide; PROTEIN DISULFIDE ISOMERASE/OXIDOREDUCTASE; procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide; PROLYL 4-HYDROXYLASE, BETA SUBUNIT; collagen prolyl 4-hydroxylase beta; prolyl 4-hydroxylase subunit beta; P4Hbeta; ERBA2L; PDIA1; PO4HB; P4HB; protein disulfide isomerase-associated 1; PHDB; PROHB; PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 1; PDI; PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, BETA SUBUNIT; protein disulfide isomerase family A, member 1; DSI; P4HB gene; GLUTATHIONE-INSULIN TRANSHYDROGENASE; procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (protein disulfide isomerase-associated 1); GIT; DISULFIDE ISOMERASE",0
C1420175,SLC2A4 gene,insulin,"SLC2A4 gene; GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE; SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 4; GLUT4; GLUCOSE TRANSPORTER 4; SLC2A4 Gene; Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 4 Gene; solute carrier family 2 member 4; SLC2A4; solute carrier family 2 (facilitated glucose transporter), member 4",0
C1422385,IGF2-AS gene,insulin,"IGF2AS; IGF2-AS; IGF2 antisense RNA 1 (non-protein coding); INSULIN-LIKE GROWTH FACTOR II, ANTISENSE; IGF2 antisense RNA; insulin-like growth factor 2 antisense 1 (non-protein coding); IGF2-AS gene; IGF2-AS1; IGF2 antisense RNA (non-protein coding); IGF2 Antisense RNA Gene; PEG8; IGF2, ANTISENSE; insulin-like growth factor 2, antisense; IGF2-AS Gene",0
C1424898,RXFP2 gene,insulin,RXFP2 gene; RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 2; RXFPR2; HORNS IN SHEEP; GREAT; INSL3R; relaxin/insulin like family peptide receptor 2; leucine-rich repeat-containing G protein-coupled receptor 8; LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 8; RXFP2; LGR8; HO; relaxin family peptide receptor 2; GPR106,0
C1426207,SOCS2 gene,SSI,SOCS2; SSI-2; SOCS2 gene; STAT-induced STAT inhibitor-2; CIS2; SOCS2 Gene; STATI2; Cish2; suppressor of cytokine signaling 2; CYTOKINE-INDUCIBLE SH2 PROTEIN 2; SOCS-2; SUPPRESSOR OF CYTOKINE SIGNALING 2; SSI2; Suppressor of Cytokine Signaling 2 Gene; STAT-INDUCED STAT INHIBITOR 2,0
C1426208,SOCS1 gene,SSI,TIP3; JAB; CISH1; suppressor of cytokine signaling 1; SUPPRESSOR OF CYTOKINE SIGNALING 1; SOCS1 Gene; TEC-INTERACTING PROTEIN 3; Cish1; SSI1; CYTOKINE-INDUCIBLE SH2 PROTEIN 1; Suppressor of Cytokine Signaling 1 Gene; SSI-1; CIS1; JAK-BINDING PROTEIN; SOCS1 gene; SOCS-1; STAT-INDUCED STAT INHIBITOR 1; SOCS1,0
C1426212,SOCS3 gene,SSI,SSI-3; SUPPRESSOR OF CYTOKINE SIGNALING 3; suppressor of cytokine signaling 3; Suppressor of Cytokine Signaling 3 Gene; CIS3; SOCS-3; STAT-INDUCED STAT INHIBITOR 3; Cish3; SSI3; SOCS3 Gene; SOCS3 gene; CYTOKINE-INDUCIBLE SH2 PROTEIN 3; SOCS3,0
C1426946,INSIG2 gene,insulin,INSULIN-INDUCED GENE 2; INSIG2; insulin induced gene 2; INSIG2 gene,0
C1429011,ATP5MK gene,insulin,"upregulated during skeletal muscle growth 5 homolog (mouse); ATP5MD; ATP5MK gene; ATP5MK; ATP synthase membrane subunit DAPIT; ATP SYNTHASE MEMBRANE SUBUNIT DAPIT; Diabetes Associated Protein in Insulin-sensitive Tissues; UPREGULATED DURING SKELETAL MUSCLE GROWTH 5, MOUSE, HOMOLOG OF; DIABETES-ASSOCIATED PROTEIN IN INSULIN-SENSITIVE TISSUES; up-regulated during skeletal muscle growth 5 homolog (mouse); USMG5; AGP; bA792D24.4; DAPIT; upregulated during skeletal muscle growth 5; MGC14697; ATP synthase membrane subunit k",0
C1429267,"insulin-dependent cytoplasmic regulator protein, rat",insulin,"cytoplasmic glycoprotein, rat",0
C1429362,"insulin-stimulating peptide, human",insulin,"H-ISP protein, human; insulin-stimulating protein, human",0
C1429668,"Ahsg protein, rat",insulin,"alpha-2-HS-glycoprotein, rat; pp63 protein, rat; IRTK inhibitor protein, rat; insulin receptor tyrosine kinase inhibitor protein, rat",0
C1429722,"insulin response element binding protein, human",insulin,"IRE-ABP protein, human",0
C1430275,"GRB10 protein, human",insulin,"growth factor receptor-bound protein 10 , human; GRB10; Growth Factor Receptor-Bound Protein 10; GRB10 Adaptor Protein; Insulin Receptor-Binding Protein Grb-IR; GRB10 Adapter Protein; Grb-10; Grb-IR protein, human; GRB10 protein, human",0
C1432092,"PHOT2 protein, Arabidopsis",NPH,"NPH-like 1 protein, Arabidopsis; CAV1 protein, Arabidopsis; NPL1 protein, Arabidopsis",0
C1433390,"RLN3 protein, human",insulin,"relaxin 3 protein, human; Insulin-like peptide 7, human; relaxin 3, human; INSL7 protein, human; relaxin-3 protein, human",0
C1433391,"RXFP4 protein, human",insulin,"relaxin-insulin-like family peptide receptor 4 protein, human; RLN3R2 protein, human; GPR100 protein, human; relaxin 3 receptor 2, human; GPCR142 protein, human; G protein-coupled receptor 100, human",0
C1433598,"Sh2b2 protein, mouse",insulin,"insulin receptor substrate 5 protein, mouse; Aps protein, mouse; SH2B adaptor protein 2, mouse; adaptor protein with pleckstrin homology and src, mouse",0
C1433807,"insulin-like protein 6-kDa, Panulirus argus",insulin,"6-kDa insulin-like protein, P. argus",0
C1434775,"SOCS3 protein, human",SSI,"SOCS-3 protein, human; CIS3 protein, human; suppressor of cytokine signaling 3 protein, human; SSI-3 protein, human; STAT-induced STAT inhibitor-3, human; SSI3 protein, human",0
C1435702,"insulin response element binding protein, rat",insulin,"IRE-ABP protein, rat",0
C1438043,"InR protein, Drosophila",insulin,"Insulin-like receptor protein, Drosophila",0
C1438873,"IGF2BP1 protein, human",insulin,"insulin like growth factor 2 mRNA binding protein 1, human; CRD-BP protein, human; coding region determinant-binding protein, human; IGF-II mRNA-binding protein 1, human; IMP-1 protein, human; IMP1 protein, human; IGF2 mRNA binding protein 1, human",0
C1439325,"IGFALS protein, human",insulin,"IGFALS protein, human; Insulin-Like Growth Factor Binding Protein Complex Acid Labile Chain; Insulin Like Growth Factor Binding Protein Acid Labile Subunit; Acid-Labile Subunit; insulin-like growth factor binding protein acid-labile subunit, human; Insulin-Like Growth Factor-Binding Protein Complex Acid Labile Subunit",0
C1439395,1.5 hours post 0.05-0.15 U insulin/kg IV post 12 hours CFst,insulin,1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C1439408,1.5 hours post dose insulin IV,insulin,1.5H post dose insulin IV,0
C1439481,1 hour post 0.05-0.15 U insulin/kg IV post 12 hours CFst,insulin,1H post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C1439506,1 hour post dose insulin IV,insulin,1H post dose insulin IV,0
C1439512,1 hour post dose U/kg insulin IV,insulin,1H post dose U/kg insulin IV,0
C1439637,30 minutes post 0.05-0.15 U insulin/kg IV post 12 hours CFst,insulin,30M post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C1439638,30 minutes post 0.1 U/kg insulin,insulin,30M post 0.1 U/kg insulin,0
C1439659,30 minutes post dose insulin IV,insulin,30M post dose insulin IV,0
C1439665,30 minutes post dose U/kg insulin IV,insulin,30M post dose U/kg insulin IV,0
C1439726,45 minutes post dose insulin IV,insulin,45M post dose insulin IV,0
C1439914,pre dose insulin IV,insulin,pre dose insulin IV,0
C1439931,pre or post dose insulin,insulin,pre or post dose insulin,0
C1442822,"IGFBP6 protein, human",insulin,IGFBP6; IBP-6; IGF Binding Protein 6; IGF-Binding Protein 6; Insulin-Like Growth Factor-Binding Protein 6; IGFBP-6; Insulin-Like Growth Factor Binding Protein 6,0
C1442932,PAPPA gene,insulin,"PAPPALYSIN 1; aspecific BCL2 ARE-binding protein 2; DIPLA1; pregnancy-associated plasma protein A, pappalysin 1; insulin-like growth factor-dependent IGF binding protein-4 protease; pappalysin 1; IGFBP-4ase; differentially placenta 1 expressed protein; PAPPA gene; PAPP-A; PAPPA1; Pregnancy-Associated Plasma Protein A, Pappalysin 1 Gene; IGFBP4 PROTEASE; PAPA; PAPPA Gene; PAPPA; DIFFERENTIALLY EXPRESSED IN PLACENTA 1; PREGNANCY-ASSOCIATED PLASMA PROTEIN A; ASBABP2",0
C1444314,Dietary regime assessment,regular,Assess regular diet; Dietary regime assessment (procedure),0
C1444316,Dietary regime management,regular,Dietary management treatment; Manage regular diet; Dietary regime management (procedure),0
C1445779,"insulin glulisine, human 100 UNT/ML Injectable Solution",insulin,"insulin glulisine 100 UNT/ML Injectable Solution; insulin analog, glulisine 100 UNT/ML Injectable Solution; Product containing precisely insulin glulisine 100 unit/1 milliliter conventional release solution for injection (clinical drug); INSULIN,GLULISINE,HUMAN 100 UNIT/ML INJ; Insulin glulisine 100 unit/mL solution for injection; insulin glulisine 100 units/mL injectable solution",0
C1446598,Recombinant human regular insulin,insulin,Recombinant human regular insulin (substance); Insulin recombinant human; Insulin recombinant purified human; Recombinant human soluble insulin,0
C1447572,"INSIG1 protein, human",insulin,"CL-6 protein, human; Insig-1 protein, human; insulin induced gene 1 protein, human",0
C1447753,"igf2bp3 protein, zebrafish",insulin,"decapentaplegic and Vg-related 1, RNA binding protein, zebrafish; insulin-like growth factor 2 mRNA binding protein 3, zebrafish; insulin-like growth factor 2 mRNA-binding protein 3, zebrafish; Vg1-RBP protein, zebrafish; dvr1rbp protein, zebrafish",0
C1447796,"IGF2BP2 protein, human",insulin,"VICKZ Family Member 2; IGF2BP2 protein, human; IMP-2; IGF2BP2; insulin-like growth factor 2 mRNA binding protein 2, human; IGF-II mRNA-Binding Protein 2; IGF2 mRNA-Binding Protein 2; Hepatocellular Carcinoma Autoantigen p62; IGF-II mRNA binding protein p62, human; IGF II mRNA Binding Protein 2; IGF-II mRNA-binding protein 2, human; IMP-2 protein, human; Insulin-Like Growth Factor 2 mRNA Binding Protein 2",0
C1447797,"Igf2bp3 protein, mouse",insulin,"Igf2 mRNA-binding protein3, mouse; IGF-II mRNA-binding protein 3, mouse; insulin-like growth factor 2, binding protein 3, mouse",0
C1448132,"INSR protein, human",insulin,"INSR; Insulin Receptor; CD220 Antigen; INSR protein, human; Antigen CD220; IR; CD220 antigen, human; insulin receptor, human; EC 2.7.10.1; CD220",0
C1448550,"regular S-layer protein, bacteria",regular,,0
C1449053,"Igf2bp1 protein, rat",insulin,"tumor stroma and activated macrophage protein DLM-1, rat; ZBP1 protein, rat; zipcode-binding protein 1, rat; Dlm1 protein, rat; DLM-1 protein, rat; Imp1 protein, rat; ZBP-1 protein, rat; insulin-like growth factor 2, binding protein 1 protein, rat",0
C1449899,Vasocon Regular,regular,"Pensa, Vasoconstrictor; Vasocon Regular; Vasoconstrictor Pensa",0
C1450557,"IGFBP7 protein, human",insulin,"Angiomodulin; IGFBP-rP1; IGF-Binding Protein-Related Protein 1; IGFBP7 protein, human; Prostacyclin-Stimulating Factor; Tumor-Derived Adhesion Factor; PGI2-Stimulating Factor; TAF; IBP-7; IGFBP-7; IGF-Binding Protein 7; insulin-like growth factor binding protein 7, human; Insulin-Like Growth Factor Binding Protein 7; MAC25 protein, human; MAC25 Protein; Insulin-Like Growth Factor-Binding Protein 7",0
C1450558,"Igfbp7 protein, mouse",insulin,"insulin-like growth factor binding protein 7, mouse; mac25 protein, mouse",0
C1450894,"insulin, long-acting, beef",insulin,,0
C1450895,"insulin, long-acting, human",insulin,,0
C1451294,"Igfals protein, mouse",insulin,"insulin-like growth factor binding protein, acid labile subunit, mouse",0
C1451295,"Igfals protein, rat",insulin,"insulin-like growth factor binding protein, acid labile subunit, rat",0
C1452091,"Isl2 protein, mouse",insulin,"insulin related protein 2 (islet 2), mouse; islet-2 protein, mouse",0
C1453476,"Insig1 protein, rat",insulin,"insulin induced gene 1 protein, rat; CL-6 protein, rat",0
C1455599,"IRS4 protein, rat",insulin,"insulin receptor substrate 4 protein, rat; IRS-4 protein, rat",0
C1455600,"Irs4 protein, mouse",insulin,"insulin receptor substrate 4 protein, mouse; IRS-4 protein, mouse",0
C1455979,Encounter for long-term (current) use of insulin,insulin,Encounter for long-term (current) use of insulin; Long-term (current) use of insulin,0
C1456383,IGFALS gene,insulin,"ALS; insulin like growth factor binding protein acid labile subunit; IGFALS Gene; IGFALS gene; IGFALS; Insulin Like Growth Factor Binding Protein Acid Labile Subunit Gene; IGFBP, SOLUBLE; ACID-LABILE SUBUNIT; insulin-like growth factor binding protein, acid labile subunit; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT",0
C1504974,"ELAPOR1 protein, human",insulin,"KIAA1324 protein, human; endosome-lysosome associated apoptosis and autophagy regulator 1 protein, human; EIG121 protein, human; IIR protein, human; insulin inhibitory receptor protein, human; maba1protein, human",0
C1505029,"Irs1 protein, mouse",insulin,"IRS-1 protein, mouse; insulin receptor substrate 1 protein, mouse",0
C1505030,"Irs1 protein, rat",insulin,"insulin receptor substrate 1 protein, rat; Irs-1 protein, rat",0
C1505031,"SLC2A4 protein, human",insulin,"GLUT4 protein, human; solute carrier family 2 (facilitated glucose transporter), member 4 protein, human; Glucose Transporter Type 4, Insulin-Responsive; Solute Carrier Family 2, Facilitated Glucose Transporter Member 4; GLUT-4; SLC2A4 protein, human",0
C1505053,"HtrA1 protein, mouse",insulin,"Prss11 protein, mouse; protease, serine, 11 protein, mouse; insulin-like growth factor binding protein 5 protease, mouse; HtrA serine peptidase 1, mouse",0
C1505565,"Irs3 protein, rat",insulin,"insulin receptor substrate 3 protein, rat; insulin receptor substrate protein pp60, rat; insulin receptor substrate protein pp60; IRS-3 protein, rat",0
C1505566,"IRS3P protein, human",insulin,"IRS3L protein, human; insulin receptor substrate 3-like protein, human; insulin receptor substrate 3, pseudogene protein, human; IRS3 protein, human",0
C1505661,"CDX2 Protein, human",insulin,"caudal type homeo box transcription factor 2 protein, human; CDX2 protein, human; CDX2; Caudal-Type Homeo Box Transcription Factor 2; CDX3; Insulin-Regulating Transcription Factor CDX3; CDX2 Protein; Caudal Type Homeobox Transcription Factor 2; Homeobox Protein CDX2; CDX-3; Caudal-Type Homeobox Protein 2; Caudal-Type Homeo Box Transcription Factor 3; Homeobox Protein CDX-2",0
C1507585,Herpes simplex virus identified:Prid:Pt:Nph:Nom:Organism specific culture,NPH,HSV identified Org specific cx Nom (Nph); HSV Nph Cult; Herpes simplex virus identified:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Organism specific culture; Herpes simplex virus identified in Nasopharynx by Organism specific culture,0
C1507856,Adenovirus Ag:PrThr:Pt:Nph:Ord,NPH,HAdV Ag Nph Ql; Adenovirus Ag [Presence] in Nasopharynx; Adenovirus Ag Ql (Nph); Adenovirus Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal,0
C1507887,Chlamydia sp rRNA:PrThr:Pt:Nph:Ord:Probe,NPH,Chlamydia sp rRNA Probe Ql (Nph); Chlamydia rRNA Nph Ql Probe; Chlamydia sp ribosomal ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe; Chlamydia sp rRNA [Presence] in Nasopharynx by Probe,0
C1508128,Bordetella parapertussis Ag:PrThr:Pt:Nph:Ord:IF,NPH,Bordetella parapertussis Ag [Presence] in Nasopharynx by Immunofluorescence; B parapert Ag Nph Ql IF; B. parapertussis Ag IF Ql (Nph); Bordetella parapertussis Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence,0
C1508129,Bordetella pertussis Ag:PrThr:Pt:Nph:Ord:IF,NPH,Bordetella pertussis Ag [Presence] in Nasopharynx by Immunofluorescence; B pert Ag Nph Ql IF; Bordetella pertussis Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence; B. pertussis Ag IF Ql (Nph),0
C1512802,"Insulin, 70/30",insulin,,0
C1512803,Insulin Resistance Pathway,insulin,,0
C1512804,Insulin Signaling Pathway,insulin,Insulin Signaling Pathway,0
C1522214,Endocrine Pancreas - Islet Cell of Langerhans - Beta Cell (MMHCC),insulin,Mouse Beta Cell; Mouse Pancreatic Beta Cell; Mouse Insulin Cell; Mouse Insulin Secreting Cell,0
C1522567,Recombinant Insulin-Like Growth Factor,insulin,Rh Insulin Like Growth Factor; Recombinant Insulin-Like Growth Factor; Somatomedin,0
C1524723,Parainfluenza virus 1 Ag:PrThr:Pt:Nph:Ord:IF,NPH,Parainfluenza virus 1 Ag [Presence] in Nasopharynx by Immunofluorescence; Parainfluenza virus 1 Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence; HPIV1 Ag Nph Ql IF; Parainfluenza virus 1 Ag IF Ql (Nph),0
C1526490,Insulin bovine Ab:Titr:Pt:Ser:Qn,insulin,Insulin bovine Ab (S) [Titer]; Insulin Bovine Ab Titr Ser; Insulin bovine Ab [Titer] in Serum; Insulin bovine Antibody:Dilution Factor (Titer):To identify measures at a point in time:Serum:Quantitative,0
C1526491,Insulin porcine Ab:Titr:Pt:Ser:Qn,insulin,Insulin porcine Antibody:Dilution Factor (Titer):To identify measures at a point in time:Serum:Quantitative; Insulin porcine Ab [Titer] in Serum; Insulin porcine Ab (S) [Titer]; Insulin Porcine Ab Titr Ser,0
C1526492,Insulin-like growth factor binding protein 3.acid labile:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3.acid labile [Mass/volume] in Serum or Plasma; Insulin-like growth factor binding protein 3.acid labile [Mass/Vol]; IGF BP3 AL SerPl-mCnc; Insulin-like growth factor binding protein 3.acid labile:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1526493,Insulin-like growth factor-I:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I Qn; IGF-I SerPl-aCnc; Insulin-like growth factor-I [Units/volume] in Serum or Plasma; Insulin-like growth factor-I:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1527283,"Coma Therapy, Insulin",insulin,"Therapy, Insulin Coma; Coma Therapy, Insulin; Coma Therapies, Insulin; Insulin Coma Therapies; Insulin Coma Therapy; Insulin coma therapy; insulin coma therapy; Therapies, Insulin Coma",0
C1527401,Insulin Shock,insulin,"INSULIN SHOCK; SHOCK INSULIN; Insulin Reaction; Shock, Insulin; Insulin shock; Insulin Shock",0
C1527557,"Socs3 protein, rat",SSI,"suppressor of cytokine signaling 3 protein, rat; Socs-3 protein, rat; cytokine inducible SH2-containing protein 3, rat; Cish3 protein, rat; Ssi-3 protein, rat; Ssi3 protein, rat",0
C1528563,"PDX1 protein, human",insulin,"MODY4 protein, human; IUF1 protein, human; PDX-1; Pancreas/Duodenum Homeobox Protein 1; IPF1 protein, human; Somatostatin Transcription Factor 1; PDX-1 protein, human; Insulin Promoter Factor 1; IUF-1; Insulin Upstream Factor 1; Pancreatic-Duodenal Homeobox Factor 1; Somatostatin-Transactivating Factor 1; PDX1 protein, human; IDX-1 protein, human; Glucose-Sensitive Factor; IDX-1; insulin promoter factor 1, homeodomain transcription factor protein, human; Islet/Duodenum Homeobox-1; Homeodomain Transcription Factor IPF1; GSF; STF-1",0
C1528564,"Pdx1 protein, mouse",insulin,"insulin promoter factor 1, homeodomain transcription factor protein, mouse; pdx-1 protein, mouse; Ipf1 protein, mouse",0
C1528842,CPD2 insulin mimetic,insulin,,0
C1532971,insulin detemir 100 UNT/ML Injectable Solution,insulin,"insulin detemir 100 UNT/ML Injectable Solution; insulin detemir 100 units/mL subcutaneous solution; insulin analog, detemir 100 UNT/ML Injectable Solution; INSULIN,DETEMIR,HUMAN 100 UNIT/ML INJ",0
C1533581,Therapeutic Insulin,insulin,therapeutic insulin; Recombinant Insulin; Therapeutic Insulin; Insulin,0
C1535396,"3 ML insulin aspart, human 100 UNT/ML Cartridge",insulin,"INSULIN,ASPART 100UNIT/ML PENFILL 3ML; insulin, aspart, human 100 UNT/ML per 3 ML Cartridge; 3 ML insulin aspart, human 100 UNT/ML Cartridge; insulin aspart 100 UNT/ML in 3 ML Cartridge; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Aspart]; Insulin Aspart PenFill, 100 units/mL injectable solution; INSULIN,ASPART,HUMAN 100 UNIT/ML INJ,PENFILL,3ML; INSULIN ASPART 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin Aspart]",0
C1537401,IGFBPL1 gene,insulin,insulin like growth factor binding protein-like 1; IGFBPL1 gene; bA113O24.1; insulin-like growth factor binding protein-like 1; IGFBPL1; insulin like growth factor binding protein like 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-LIKE 1; IGFBPRP4; IGFBP-RELATED PROTEIN 4,0
C1538314,BAIAP2L1 gene,insulin,BAI1 associated protein 2 like 1; IRTKS; insulin receptor tyrosine kinase substrate; BAIAP2L1 Gene; BAI1-Associated Protein 2-Like 1 Gene; BAIAP2L1 gene; BAIAP2L1; INSULIN RECEPTOR TYROSINE KINASE SUBSTRATE; BAI1-ASSOCIATED PROTEIN 2-LIKE 1; BAR/IMD domain containing adaptor protein 2 like 1,0
C1539897,SUMO4 gene,insulin,small ubiquitin like modifier 4; SUMO4 gene; SUMO4; IDDM5; dJ281H8.4; insulin-dependent diabetes mellitus 5; SMALL UBIQUITIN-LIKE MODIFIER 4; SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae); SMT3H4; SMT3 suppressor of mif two 3 homolog 4 (yeast),0
C1539904,SYCN gene,insulin,FLJ27441; SYCN; SYL; insulin synthesis associated 1; SYCN gene; INSSA1; syncollin,0
C1544264,Insulin^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^30 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 30M p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge; Insulin 30 Min post Unsp challenge [Moles/Vol],0
C1544265,Insulin^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 1 Hr post Unsp challenge [Moles/Vol]; Insulin^1 hour post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1h p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge,0
C1544266,Insulin^1.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge; Insulin^1.5 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.5 Hr post Unsp challenge [Moles/Vol]; Insulin 1.5h p chal SerPl-sCnc,0
C1544267,Insulin^2H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 2h p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge; Insulin 2 Hr post Unsp challenge [Moles/Vol]; Insulin^2 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1544268,Insulin^2.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 2.5h p chal SerPl-sCnc; Insulin^2.5 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2.5 Hr post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge,0
C1544269,Insulin^3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 3h p chal SerPl-sCnc; Insulin^3 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge; Insulin 3 Hr post Unsp challenge [Moles/Vol],0
C1550158,Regular Production,regular,,0
C1554860,"Injection, insulin pump",insulin,"Injection, insulin pump",0
C1562292,Incretins,insulin,"Hormone, Glucose-Dependent Insulin-Releasing; Incretin (substance); Insulin-Releasing Hormone, Glucose-Dependent; incretin; Glucose Dependent Insulin Releasing Hormone; Glucose-Dependent Insulin-Releasing Hormone; incretins; incretin hormone; Incretin; Incretins",0
C1562789,Bovine regular insulin-containing product,insulin,Product containing bovine regular insulin (medicinal product); Bovine regular insulin (substance); Bovine insulin soluble-containing product; Bovine regular insulin; Bovine insulin soluble,0
C1562921,Bovine insulin protamine zinc,insulin,Bovine insulin protamine zinc-containing product; Bovine insulin protamine zinc (substance); Product containing bovine insulin protamine zinc (medicinal product),0
C1564682,Suppressor of Cytokine Signaling Proteins,SSI,STAT-Induced STAT Inhibitor Family Protein; SSI Family Protein; Suppressor of Cytokine Signaling Family Protein; SOCS Proteins; Cytokine-Induced STAT Inhibitor Family Protein; SOCS Family Protein; SOCS Protein; Suppressors of Cytokine Signaling Proteins; CIS Family Protein,0
C1568024,"INSL3 protein, human",insulin,"insulin-like 3 (Leydig cell) protein, human; Ley-I-L protein, human; RLNL protein, human; relaxin-like factor protein, human",0
C1568025,"Insl3 protein, mouse",insulin,"Leydig insulin-like protein, mouse; relaxin-like factor protein, mouse; Ley-I-L protein, mouse; Insulin-like 3 protein, mouse",0
C1568026,"Insl3 protein, rat",insulin,"Insulin-like 3 protein, rat; relaxin-like factor protein, rat; Ley-I-L protein, rat",0
C1569730,"insulin-like growth factor 2, human",insulin,"Somatomedin A; IGF-2; insulinlike growth factor II, human; Somatomedin-A; IGF2 protein, human; Insulin-Like Growth Factor 2; somatomedin A protein, human; IGF-II protein, human; Insulin-Like Growth Factor II; IGF-II; IGF2; insulin-like growth factor 2, human; INSULIN-LIKE GROWTH FACTOR-2",0
C1570375,"IGFBPL1 protein, human",insulin,"insulin-like growth factor binding protein-like 1 protein, human; IGFBP-rP4 protein, human; insulin-like growth factor binding related protein-4, human",0
C1570874,"INSL6 protein, human",insulin,"insulin-like 6 protein, human; relaxin-insulin-like factor 1 protein, human",0
C1570875,"Insl6 protein, mouse",insulin,"insulin-like 6 protein, mouse; relaxin-insulin-like factor 1 protein, mouse",0
C1571494,"DAF-2 protein, C elegans",insulin,"insulin-like receptor subunit beta, C elegans",0
C1572076,NOVOLIN PEN INSULIN DELIVERY SYSTEM 1.5ML,insulin,NOVOLIN PEN INSULIN SYSTEM 1.5ML,0
C1572135,"AUTOLET PLATFORM,AMES REGULAR",regular,"AUTOLET PLATFORM,AMES REGULAR",0
C1572137,"BEDPAN,REGULAR,PLASTIC,DISPOSABLE",regular,"BEDPAN,REGULAR,PLASTIC,DISPOSABLE",0
C1572269,"CUNNINGHAM CLAMP,REGULAR,BARD #004053",regular,CUNNINGHAM CLAMP REGULAR BARD #004053,0
C1572478,"UNDERGARMENT REGULAR ABSORBENCY,ONE SIZE FITS ALL",regular,"UNDERGARMENT REG ABSORBENT,ONE SIZE/ALL",0
C1572854,ATTENDS REGULAR BRIEF SMALL,regular,ATTENDS REGULAR BRIEF SMALL; Attends Brief Small,0
C1572891,"BRIEF,NU-FIT REGULAR FQP #NU-016",regular,"BRIEF,NU-FIT REGULAR FQP #NU-016",0
C1572895,"BRIEF,PER-FIT REGULAR FQP #PF-016",regular,"BRIEF,PER-FIT REGULAR FQP #PF-016",0
C1572906,"BRIEF,REGULAR FQP #IB-016",regular,"BRIEF,REGULAR FQP #IB-016",0
C1572907,"BRIEF,REGULAR FQP #IBF-016",regular,"BRIEF,REGULAR FQP#IBF-016",0
C1572908,"BRIEF,REGULAR,PROMISE #63202",regular,"BRIEF,REGULAR,PROMISE #63202",0
C1572947,DEPEND W/STRAP REGULAR #19690-50,regular,DEPEND W/STRAP REGULAR #19690-50,0
C1573130,INCONTINENCE DEVICE MALE C3 REGULAR ENDOCARE,regular,INCONT DEVICE MALE C3 REGULAR ENDOCARE,0
C1574699,"FACEPLATE,RUBBER,REGULAR CONVEX 3 5/8IN,TORBOT #TT131",regular,"FACEPLATE,RUBBER CONVEX TORBOT #TT131",0
C1574799,INSULIN SYRINGE 1ML 27G 5/8IN,insulin,INSULIN SYRINGE 1ML 27G 5/8IN,0
C1575920,"SET,INFUSION INSULIN CHRONIMED #2652-999001",insulin,"SET,INFUSION INSULIN CHRONIMED #52999001",0
C1576071,"TAPE STRIP,REGULAR ADHERING NU-HOPE#2330",regular,"TAPE STRIP,REGULAR ADHERING NU-HOPE#2330",0
C1577146,"insulin glulisine, human 100 UNT/ML",insulin,,0
C1577147,"insulin glulisine, human Injectable Solution",insulin,,0
C1579054,Insulin response test,insulin,,0
C1579433,Insulin [EPC],insulin,Insulin-class Agent; Insulin [EPC]; Insulin,0
C1586289,"lente insulin, pork 40 UNT/ML Injectable Suspension [Vetsulin]",insulin,insulin pork 40 [iU] in 1 mL SUBCUTANEOUS INJECTION [Vetsulin]; Vetsulin 40 UNT/ML Injectable Suspension,0
C1589410,"lente insulin, pork 40 UNT/ML [Vetsulin]",insulin,,0
C1590066,sodium monofluorophosphate 0.0076 MG/MG Toothpaste,regular,"SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [WHITE GLO BIO-ENZYME]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [SparkleFresh]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Freshmint Anticavity Fluoride]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g DENTAL PASTE [Ipana Wintergreen Fluoride]; SODIUM MONOFLUOROPHOSPHATE 76 mg in 1 g DENTAL PASTE [FreshMax Fluoride Minty Flavor]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL GEL, DENTIFRICE [Colgate Sparkling White Mint Zing]; SODIUM MONOFLUOROPHOSPHATE 1.0 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Baking Soda and Peroxide Whitening Oxygen Bubbles Frosty Mint]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Medpride]; SODIUM MONOFLUOROPHOSPHATE 1.0 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Essentials]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE [Natural Adult Fluoride]; WHITE GLO CHARCOAL KIT; SODIUM MONOFLUOROPHOSPHATE 1.3 mg in 1 mL DENTAL PASTE, DENTIFRICE [PERIOSCIENCES HYDRATING AO Pro]; sodium monofluorophosphate 0.76 % (fluoride ion 0.13 % )Toothpaste; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Stain Prevention]; Sodium Monofluorophosphate 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Cavity Protection Spearmint Fights cavities Fresh Breath]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [White Glo 2in1 Tooth w Mouthwash]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [Gerigentle-Good morning]; SODIUM MONOFLUOROPHOSPHATE 0.13 g in 100 g ORAL PASTE, DENTIFRICE [GO SMILE LUXURY AM]; SODIUM MONOFLUOROPHOSPHATE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Baking Soda Cavity Protection Peppermint Fights cavities / Fresh Breath]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g ORAL GEL [Jason Sea Fresh Anticavity Deep Sea Spearmint]; Biotene Dry Mouth Toothpaste, oral paste; White Glo Mouthwash Protection KIT; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [HEB Brilliant White]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Freshenup Fluoride Cool Mint]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE [White Glo Charcoal Deep Stain Remover Tooth]; Sodium monofluorophosphate 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Hello Naturally Whitening]; sodium monofluorophosphate 0.0076 MG/MG Toothpaste; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [WHITE GLO PROFESSIONAL CHOICE]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Freshenup Fluoride Mint]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Sparkling]; WHITE GLO BIO-ENZYME KIT; SODIUM MONOFLUOROPHOSPHATE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Hello Whitening]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE [UNIVERSAL ADVANCED WHITENING ANTI-CAVITY FLUORIDE]; Sodium Monofluorophosphate 0.76 g in 100 g ORAL PASTE, DENTIFRICE [Finefra Silver]; SODIUM MONOFLUOROPHOSPHATE 0.0014 g in 1 g DENTAL PASTE, DENTIFRICE [Wicked Cool Anticavity - LMFT51 MRT]; SODIUM MONOFLUOROPHOSPHATE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate ULTRA BRITE Baking Soda and Peroxide Whitening]; SODIUM MONOFLUOROPHOSPHATE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Whole Care Wintermint fights cavities / whitening / fresh breath / helps fight tartar / no artificial dyes or sweeteners]; Sodium monofluorophosphate 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Hello Activated Charcoal]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Anticavity]; Sodium Monofluorophosphate 0.758 g in 100 g ORAL GEL, DENTIFRICE [Teen Toothpast e Peach Leaf Flavor]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Meijer Whole Care with Fluoride]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Kosette Salt Tooth]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [White Glo 2 in 1 with Mouthwash]; SODIUM MONOFLUOROPHOSPHATE 0.0014 g in 1 g DENTAL PASTE, DENTIFRICE [Silly Strawberry Anticavity - BFT51 MRT]; RON 2 KIT; SODIUM MONOFLUOROPHOSPHATE 1.0 mg in 1 g DENTAL PASTE, DENTIFRICE [COLGATE Great Regular Flavor]; SODIUM MONOFLUOROPHOSPHATE 1.4 mg in 1 g ORAL PASTE, DENTIFRICE [Supersmile]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Lucky Super Soft Anti Cavity]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [WHITE GLO MICELLAR]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 mL DENTAL PASTE, DENTIFRICE [Oral7 Dry Mouth Moisturizing]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Lucky Super Soft Whitening Anti Cavity with Free Toothbrush]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [COLGATE Great Regular Flavor]; SODIUM MONOFLUOROPHOSPHATE 0.7581 g in 100 g DENTAL PASTE, DENTIFRICE [Dr. Zenni Natural WhiteToothpaste]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [White Glo Coffee Tea Drinkers Formula]; White Glo Instant White KIT; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [United Airlines Business Class Kit]; Sodium Monofluorophosphate 0.91 g in 120 g ORAL PASTE, DENTIFRICE [Need For You Limpio Tooth]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Business Class Kit]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Baking Soda and Peroxide Whitening Oxygen Bubbles Frosty Mint]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [White Glo Smokers Formula]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g ORAL GEL [Jason Powersmile Anticavity Whitening Peppermint]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE [ADVANCED WHITENING ANTI CAVITY FLUORIDE]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE [Colgate]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Kiss My Face Kids Fluoride - Berry Smart]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Anticavity]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Advanced Icy Fresh]; SODIUM MONOFLUOROPHOSPHATE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Anticavity]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE [ANTI CAVITY FLUORIDE]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [WHITE GLO CHARCOAL]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g ORAL PASTE, DENTIFRICE [Go Smile RELAX]; Colgate 5g Toothbrush Kit KIT; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE [UNIVERSAL ANTI-CAVITY FLUORIDE]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Lucky Super Soft Whitening Anti Cavity]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Freshenup Fluoride Fresh Mint]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [White Glo Mouthwash Protection]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g ORAL GEL [Jason Healthy Mouth Anticavity Tartar Control Tea Tree Cinnamon]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [White Glo Maximum White Charcoal]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [Curetech-Good morning]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Renewal Lasting Fresh]; sodium monofluorophosphate 0.76 % Toothpaste; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Freshenup Fluoride Double Mint]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Kroger Company Radiant White]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE [AP-24 Whitening]; Sodium Monofluorophosphate 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Whole Care Cinnamon Clove fights cavities whitening fresh breath helps fight tartar]; Sodium Monofluorophosphate 1.3 mg in 1 g ORAL GEL, DENTIFRICE [Listerine Essential Care]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [White Glo Professional Choice]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g TOPICAL PASTE, DENTIFRICE [Charm-Tex FLUORIDE]; SODIUM MONOFLUOROPHOSPHATE 0.0014 g in 1 g DENTAL CREAM [Toms Childrens Wild Blueberry Anticavity BLUE]; WHITE GLO MICELLAR KIT; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [SparkleFresh Flouride Toothpaste]; SODIUM MONOFLUOROPHOSPHATE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Pro Series Stain Prevention]; SODIUM MONOFLUOROPHOSPHATE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Wicked Fresh Spearmint Ice fresh breath / cavity protection]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [Ancalima-Good morning]; sodium monofluorophosphate 0.76 % (fluoride ion 0.14 % )Toothpaste; SODIUM MONOFLUOROPHOSPHATE 0.0014 g in 1 g DENTAL PASTE, DENTIFRICE [Outrageous Orange Anticavity - OFT51 MRT]; sodium monofluorophosphate 0.76 % (fluoride ion 0.15 % )Toothpaste; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE [White Glo 2in1 with Mouthwash]; Sodium Monofluorophosphate 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Nature Mint Anticavity]; Sodium monofluorophosphate 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Tom Whole Care Peppermint fights cavities whitening fresh breath helps fight tartar]; SODIUM MONOFLUOROPHOSPHATE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Hello Charcoal]; Sodium monofluorophosphate 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Whole Care Spearmint fights cavities whitening fresh breath helps fight tartar]; SODIUM MONOFLUOROPHOSPHATE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Wicked Fresh Cool Peppermint fresh breath / cavity protection]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Kids Strawberry FTP]; SODIUM MONOFLUOROPHOSPHATE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Hello Bye Bye Bacteria Fluoride]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Renewal High Impact White]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Brush Buddies Value 2 pack Whitening]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Natures Promise Childrens Fluoride Strawberry]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g ORAL PASTE, DENTIFRICE [Charm Tex]; SODIUM MONOFLUOROPHOSPHATE 0.7581 g in 100 g DENTAL PASTE, DENTIFRICE [Dr. Zenni Natural OrthodonticToothpaste]; WHITE GLO PROFESSIONAL CHOICE KIT; sodium monofluorophosphate 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Hello activated charcoal plus matcha green tea epic whitening fluoride]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Anticavity Kit]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [COLGATE Baking Soda and Peroxide Whitening Brisk Mint]; SODIUM MONOFLUOROPHOSPHATE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White ProSeries Vividly Fresh]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Kids Silly Strawberry TP]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Platinum Stain-Less]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Charm Tex]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [MediChoice Fluoride]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [365 Everyday Value Cavity Fighting and Whitening]; Sodium Monofluorophosphate 0.758 g in 100 g ORAL GEL, DENTIFRICE [Teen Toothpast e Eucalyptus Flavor]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Rembrandt]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g DENTAL PASTE [FIREFLY Pediatric]; Sodium Monofluorophosphate 0.76 g in 100 g TOPICAL PASTE, DENTIFRICE [Finefra Clinic Tooth 100g]; sodium monofluorophosphate 0.76 % (fluoride ion 0.12 % )Toothpaste; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Simple Truth Kids Flouride]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [COLGATE ANTICAVITY]; White Glo Maximum White Charcoal KIT; SODIUM MONOFLUOROPHOSPHATE 76 mg in 1 g ORAL PASTE [Morning Fresh]; SODIUM MONOFLUOROPHOSPHATE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Supersmile]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [Weekend White TP]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE, DENTIFRICE [365 Everyday Value Kids Flouride]; SODIUM MONOFLUOROPHOSPHATE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Watermelon Save the Animals]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE [Idodent Flouride Mint]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE, DENTIFRICE [Colgate Optic White Advanced Sparkling White]; SODIUM MONOFLUOROPHOSPHATE 1.3 mg in 1 g ORAL GEL, DENTIFRICE [Listerine Essential Care]; SODIUM MONOFLUOROPHOSPHATE 1.4 mg in 1 g DENTAL CREAM [BLUE Save the Animals]; Sodium Monofluorophosphate 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Whole Care Wintermint - WWT4]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [First Class Kit]; Murchison Hume Dental Kit KIT; SODIUM MONOFLUOROPHOSPHATE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Toms Fresh and Bright]; SODIUM MONOFLUOROPHOSPHATE 7.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Lucky Super Soft Anti Cavity with Free Toothbrush]; SODIUM MONOFLUOROPHOSPHATE 0.15 g in 100 g DENTAL PASTE, DENTIFRICE [Handy Solutions Colgate Cavity Protection]; SODIUM MONOFLUOROPHOSPHATE 76 mg in 1 g DENTAL PASTE [FreshMax Fluoride Regular Flavor]; SODIUM MONOFLUOROPHOSPHATE 0.1 g in 100 g DENTAL PASTE [Ipana Bucky Beaver Bubble Gum Childrens Fluoride]; SODIUM MONOFLUOROPHOSPHATE 0.76 g in 100 g DENTAL PASTE [IODENT tooth]; Sodium Monofluorophosphate 1.02 g in 135 g TOPICAL PASTE, DENTIFRICE [Finefra Clinic Tooth 135g]",0
C1592792,insulin glargine 100 UNT/ML [Lantus],insulin,,0
C1592865,"insulin isophane, human 100 UNT/ML [Humulin N]",insulin,"insulin isophane, human 100 UNT/ML [HumuLIN N]",0
C1592866,"insulin isophane, human 100 UNT/ML [Novolin N]",insulin,"insulin isophane, human 100 UNT/ML [NovoLIN N]",0
C1592870,"insulin, regular, human 100 UNT/ML [Novolin R]",insulin,"insulin, regular, human 100 UNT/ML [NovoLIN R]",0
C1592872,"insulin, regular, human 100 UNT/ML [Humulin R]",insulin,"insulin, regular, human 100 UNT/ML [HumuLIN R]",0
C1592875,insulin lispro 100 UNT/ML [Humalog],insulin,insulin lispro 100 UNT/ML [HumaLOG],0
C1593346,"insulin, regular, human 500 UNT/ML [Humulin R]",insulin,"insulin, regular, human 500 UNT/ML [HumuLIN R]",0
C1593394,"insulin aspart, human 100 UNT/ML [NovoLog]",insulin,"insulin aspart, human 100 UNT/ML [NovoLOG]",0
C1607199,"sennosides, USP 15 MG [Ex-Lax Regular Strength Pills]",regular,,0
C1607522,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML [Humulin]",insulin,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML [HumuLIN]",0
C1607523,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML [Novolin]",insulin,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML [NovoLIN]",0
C1609008,"Individual physician supervision of a patient (patient not present) in home, domiciliary or rest home (eg, assisted living facility) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more",regular,,0
C1609559,"Individual physician supervision of a patient (patient not present) in home, domiciliary or rest home (eg, assisted living facility) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (eg, legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes",regular,,0
C1609904,"INSAF protein, human",insulin,"insulin activator factor (insulin control element-binding transcription factor), human",0
C1610583,"Syringes, Plunger, Insulin",insulin,"Insulin Syringe; Insulin Syringes; insulin syringe; Syringes, Insulin; insulin syringes; syringe injection insulin",0
C1611336,"insulin-like growth factor binding proteinase, human",insulin,"IGFBPase, human",0
C1611968,"Baiap2 protein, rat",insulin,"brain-specific angiogenesis inhibitor 1-associated protein 2, rat; IRSp53 protein, rat; BAI1-associated protein 2, rat; insulin receptor substrate p53, rat",0
C1622199,insulin-like growth factor II binding,insulin,IGF-II binding,0
C1623303,insulin-like growth factor I binding,insulin,IGF-I binding,0
C1623509,positive regulation of insulin-like growth factor receptor signaling pathway,insulin,up-regulation of insulin-like growth factor receptor signaling pathway; positive regulation of IGF receptor signalling pathway; up regulation of insulin-like growth factor receptor signaling pathway; positive regulation of insulin-like growth factor receptor signalling pathway; upregulation of insulin-like growth factor receptor signaling pathway; positive regulation of IGF receptor signaling pathway,0
C1623517,insulin binding,insulin,,0
C1623518,insulin receptor substrate binding,insulin,insulin receptor substrate [protein] binding; IRS binding; IRS [protein] binding,0
C1624604,regulation of insulin-like growth factor receptor signaling pathway,insulin,regulation of IGF receptor signaling pathway; regulation of insulin-like growth factor receptor signalling pathway; regulation of IGF receptor signalling pathway,0
C1625152,negative regulation of insulin-like growth factor receptor signaling pathway,insulin,negative regulation of IGF receptor signaling pathway; negative regulation of IGF receptor signalling pathway; downregulation of insulin-like growth factor receptor signaling pathway; negative regulation of insulin-like growth factor receptor signalling pathway; down-regulation of insulin-like growth factor receptor signaling pathway; down regulation of insulin-like growth factor receptor signaling pathway,0
C1625232,Insulin-like growth factor-I receptor Ag:PrThr:Pt:Tiss:Ord:Immune stain,insulin,"Insulin-like growth factor-I receptor Ag Immune stain Ql (Tiss); Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain; Insulin-like growth factor-I receptor Antigen:Presence or Threshold:To identify measures at a point in time:Tissue, unspecified:Ordinal:Immune stain; IGF-IR Ag Tiss Ql ImStn",0
C1626833,Insulin-like growth factor-I receptor Ag,insulin,Insulin-like growth factor-I receptor Ag; Insulin-like growth factor-I receptor Antigen,0
C1627320,Insulin^pre 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --pre 100 g glucose PO; Insulin^pre 100 g glucose Oral:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin pre 100 g Glc PO SerPl-mCnc; Insulin pre 100 g glucose PO [Mass/Vol],0
C1627399,Insulin delivery device panel,insulin,Insulin delivery device panel,0
C1627400,Insulin name + ID,insulin,Insulin name + ID; Insulin Name+ID,0
C1631789,Insulin delivery device panel:-:Point in time:^Patient:-,insulin,Insulin delivery device panel:-:Pt:^Patient:-; Insulin delivery device panel; Insulin Delivery Device Pnl; Insulin delivery device panel:-:To identify measures at a point in time:^Patient:-,0
C1632382,Class:Type:Pt:Insulin delivery device:Nom,insulin,Class:Type:To identify measures at a point in time:Insulin delivery device:Nominal; Type of Insulin delivery device; Insulin Delivery Device Class,0
C1637295,Teach regular diet,regular,,0
C1639204,benzocaine 0.1 MG/MG Oral Gel [Anbesol],regular,Anbesol 0.1 MG/MG Oral Gel; Anbesol 10 % Oral Gel; Anbesol Regular Strength 10 % Oral Gel,0
C1640721,Take at regular intervals. Complete the prescribed course unless otherwise directed,regular,Take at regular intervals. Complete the prescribed course unless otherwise directed (qualifier value),0
C1641060,Bordetella parapertussis DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Bordetella parapertussis deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; B. parapertussis DNA NAA+probe Ql (Nph); B parapert DNA Nph Ql NAA+probe; Bordetella parapertussis DNA [Presence] in Nasopharynx by NAA with probe detection,0
C1644749,Equaline Insulin Syringe 31g x 0.5cc,insulin,,0
C1644754,Kroger Insulin Syringe 29g x 0.5cc,insulin,,0
C1644755,Kroger Insulin Syringe 30g x 1cc,insulin,,0
C1645623,Kroger Insulin Syringe 30g x 0.5cc,insulin,,0
C1645661,NovoLIN R PenFill,novolin,,0
C1645996,Small Insulin Syringe 0.3cc 31g,insulin,,0
C1646083,Small Insulin Syringe 0.5cc 31g,insulin,,0
C1646084,Small Insulin Syringe 1cc 31g,insulin,,0
C1646086,Medic Insulin Syringe 29g x 0.5cc,insulin,,0
C1646212,Equaline Insulin Syringe 31g x 0.3cc,insulin,,0
C1646215,Kroger Insulin Syringe 29g x 0.3cc,insulin,,0
C1646273,Regular Strength Calcium Antacid,regular,,0
C1647177,Kroger Insulin Syringe 30g x 0.3cc,insulin,,0
C1647265,Equaline Insulin Syringe 31g x 1cc,insulin,,0
C1647269,Kroger Insulin Syringe 29g x 1cc,insulin,,0
C1647308,Family Pharmacy Insulin Syringe 29g x 1cc,insulin,,0
C1649259,Medic Insulin Syringe 30g x 0.3cc,insulin,,0
C1649581,Regular Strength Orajel,regular,Orajel Regular Strength,0
C1650401,Medicine Shoppe Insulin Syringe 31g x 0.5cc,insulin,,0
C1650469,Sunmark Insulin Syringe 30g x 0.5cc,insulin,,0
C1650879,Insulin delivery device,insulin,Insulin delivery device,0
C1650885,Insulin type:Type:Pt:Medication.current:Nom,insulin,"Current medication, Insulin type; Insulin type:Type:To identify measures at a point in time:Medication.current:Nominal",0
C1650892,Vendor software version:ID:Pt:Insulin delivery device:Nom,insulin,Insulin delivery device Vendor software version; Insulin Delivery Device Software vers; Vendor software version:Identifier:To identify measures at a point in time:Insulin delivery device:Nominal,0
C1650895,Vendor device model code:ID:Pt:Insulin delivery device:Nom,insulin,Insulin delivery device Vendor model code; Insulin Delivery Device Model Cd; Vendor device model code:Identifier:To identify measures at a point in time:Insulin delivery device:Nominal,0
C1651020,Levemir FlexPen,levemir,,0
C1652059,Medicine Shoppe Insulin Syringe 31g x 1cc,insulin,,0
C1652060,Medicine Shoppe Insulin Syringe 31g x 0.3cc,insulin,,0
C1652065,Insulin Syringe 29g x 1cc,insulin,,0
C1652066,"Insulin Syringe 1cc 29g 1/2""",insulin,"Insulin Syringes - 29G, 1cc, 1/2""",0
C1652143,Vendor device name:ID:Pt:Insulin delivery device:Nom,insulin,Insulin delivery device Vendor name; Vendor device name:Identifier:To identify measures at a point in time:Insulin delivery device:Nominal; Insulin Delivery Device Vendor name,0
C1652478,WD Medic Insulin Syringe 29g x 0.5cc,insulin,,0
C1652654,Vendor serial number:ID:Pt:Insulin delivery device:Nom,insulin,Insulin Delivery Device Serial #; Vendor serial number:Identifier:To identify measures at a point in time:Insulin delivery device:Nominal; Insulin delivery device Vendor serial number,0
C1652655,Insulin name + ID:ID:Pt:Medication.current:Nom,insulin,"Insulin name + ID:Identifier:To identify measures at a point in time:Medication.current:Nominal; Current medication, Insulin Name+ID",0
C1653532,Brite Life Insulin Syringe 29g x 1cc,insulin,,0
C1653546,WD Medic Insulin Syringe 29g x 1cc,insulin,,0
C1653547,WD Medic Insulin Syringe 30g x 0.5cc,insulin,,0
C1654064,WD Medic Insulin Syringe 29g x 0.3cc,insulin,,0
C1654795,"Ultiguard Insulin Syringe 29g x 1/2"" 0.5cc",insulin,,0
C1654796,"Ultiguard Insulin Syringe 30g x 5/16"" 1cc",insulin,,0
C1655161,"Ultiguard Insulin Syringe 29g x 1/2"" 1cc",insulin,,0
C1655163,"Ultiguard Insulin Syringe 30g x 5/16"" 0.5c",insulin,,0
C1655346,Lantus OptiClik Cartridge,lantus,,0
C1656493,Brite Life Insulin Syringe 28g x 1cc,insulin,,0
C1656697,Midol Regular,regular,,0
C1656773,Brite Life Insulin Syringe 28g x 0.5cc,insulin,,0
C1656785,Sunmark Insulin Syringe 30g x 0.3cc,insulin,,0
C1656865,Family Pharmacy Insulin Syringe 28g x 1cc,insulin,,0
C1656868,Family Pharmacy Insulin Syringe 31g x 0.3cc,insulin,,0
C1656870,Good Neighbor Insulin Syringe 28g x 1cc,insulin,,0
C1656871,Good Neighbor Insulin Syringe 28g x 0.5cc,insulin,,0
C1656872,Good Neighbor Insulin Syringe 30g x 0.3cc,insulin,,0
C1657036,Quality Choice Insulin Syringe 29g x 0.3cc,insulin,,0
C1657037,Quality Choice Insulin Syringe 30g x 1cc,insulin,,0
C1657168,Brite Life Insulin Syringe 29g x 0.5cc,insulin,,0
C1657169,Brite Life Insulin Syringe 29g x 0.3cc,insulin,,0
C1657178,Sunmark Insulin Syringe 29g x 1cc,insulin,,0
C1657359,Family Pharmacy Insulin Syringe 29g x 0.5cc,insulin,,0
C1657360,Family Pharmacy Insulin Syringe 30g x 0.5cc,insulin,,0
C1657361,Family Pharmacy Insulin Syringe 30g x 0.3cc,insulin,,0
C1657675,insulin detemir 100 UNT/ML,insulin,,0
C1657883,Brite Life Insulin Syringe 30g x 0.5cc,insulin,,0
C1658021,Family Pharmacy Insulin Syringe 30g x 1cc,insulin,,0
C1658024,Good Neighbor Insulin Syringe 30g x 1cc,insulin,,0
C1658025,Good Neighbor Insulin Syringe 30g x 0.5cc,insulin,,0
C1658078,Relion NovoLIN 70/30 Innolet,novolin,,0
C1658169,Quality Choice Insulin Syringe 29g x 1cc,insulin,,0
C1658373,Medic Insulin Syringe 29g x 1cc,insulin,,0
C1658446,Brite Life Insulin Syringe 30g x 1cc,insulin,,0
C1658447,Brite Life Insulin Syringe 30g x 0.3cc,insulin,,0
C1658451,Sunmark Insulin Syringe 30g x 1cc,insulin,,0
C1658496,Maalox Antacid Antigas Regular Strength,regular,,0
C1658528,Family Pharmacy Insulin Syringe 28g x 0.5cc,insulin,,0
C1658530,Family Pharmacy Insulin Syringe 29g x 0.3cc,insulin,,0
C1658531,Good Neighbor Insulin Syringe 29g x 1cc,insulin,,0
C1658532,Good Neighbor Insulin Syringe 29g x 0.5cc,insulin,,0
C1658533,Good Neighbor Insulin Syringe 29g x 0.3cc,insulin,,0
C1658702,calcium carbonate 550 MG / magnesium hydroxide 110 MG Chewable Tablet [Rolaids Reformulated Aug 2006],regular,"Rolaids REGULAR Strength 550 MG (Ca 220 MG) / 110 MG Chewable Tablet, Reformulated Aug 2006; Rolaids Reformulated Aug 2006 (calcium carbonate 550 MG / magnesium hydroxide 110 MG) Chewable Tablet; Rolaids, 550 mg-110 mg oral tablet, chewable; CALCIUM CARBONATE 550 mg / MAGNESIUM HYDROXIDE 110 mg ORAL TABLET, CHEWABLE [Rolaids Regular Strength Mint]",0
C1658848,Levemir PenFill,levemir,,0
C1658880,insulin detemir Injectable Solution,insulin,,0
C1659409,NovoLIN R Innolet,novolin,,0
C1660494,Levemir InnoLet,levemir,,0
C1668134,"insulin-related peptide, Crassostrea gigas",insulin,"insulin-related peptide, C gigas",0
C1669500,glycated insulin,insulin,,0
C1682359,"Insig2 protein, mouse",insulin,"insulin induced gene 2 protein, mouse; Insig-2 protein, mouse",0
C1690449,"Insig1 protein, mouse",insulin,"Insig-1 protein, mouse; insulin induced gene 1 protein, mouse",0
C1693555,insulin detemir 100 UNT/ML Injectable Solution [Levemir],insulin,"Levemir 100 UNT/ML Injectable Solution; insulin detemir 100 UNT/ML Injectable Solution [Levemir]; INSULIN DETEMIR 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Levemir]; Levemir 14.2 MG/ML Injectable Solution; Levemir, 100 units/mL subcutaneous solution",0
C1695598,Sunmark Insulin Syringe 28g x 1cc,insulin,,0
C1695675,Sunmark Insulin Syringe 29g x 0.3cc,insulin,,0
C1695676,Sunmark Insulin Syringe 31g x 1cc,insulin,,0
C1695677,Sunmark Insulin Syringe 31g x 0.5cc,insulin,,0
C1695970,"insulin human, rDNA origin",insulin,"Insulin human [rDNA origin]; insulin human, rDNA origin; Insulin human, rDNA origin; human insulin (rDNA)",0
C1696547,mecasermin rinfabate,insulin,Mecasermin rinfabate recombinant; Mecasermin rinfabate (substance); Mecasermin Rinfabate; MECASERMIN RINFABATE; mecasermin rinfabate; Binary complex of recombinant human insulin-like growth factor I and insulin-like growth factor binding protein 3; Mecasermin rinfabate; rhIGF-I/rhIGFBP-3,0
C1696835,Sunmark Insulin Syringe 28g x 0.5cc,insulin,,0
C1696836,Sunmark Insulin Syringe 29g x 0.5cc,insulin,,0
C1696837,Sunmark Insulin Syringe 31g x 0.3cc,insulin,,0
C1698151,18FB-AHx-insulin,insulin,,0
C1698737,"insulin, 6-(4-fluorobenzoyl)aminohexanoylphenylalanyl(B1)-",insulin,insulin-FB-AHxPhe(B1)-; FB-AHx-insulin,0
C1700198,"insulin inhalation, rapid acting",insulin,,0
C1701284,Regular Strength Cold Medication,regular,,0
C1702411,insulin detemir Injectable Solution [Levemir],insulin,,0
C1703413,insulin detemir 100 UNT/ML [Levemir],insulin,,0
C1703761,ethanol 0.62 ML/ML Topical Solution,regular,ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [United Airlines Clean Plus Clorox]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Purenique Hygiene Solutions Hand Sanitizer]; Safety 1st Oh Sh t Kit KIT; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Antibacterial Hand Sanitizer]; ALCOHOL 146.94 mL in 237 mL TOPICAL LIQUID [skin protectant Sweet Pea]; alcohol 62 mL in 100 mL TOPICAL SOLUTION [Living Concepts Hand Sanitizer advanced aloe vera]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Hand Sanitizer with Vitamin E]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Endure 320 Advanced Care]; ALCOHOL 146.94 mL in 237 mL TOPICAL LIQUID [skin protectant Aloe Vera]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Health Smart Instant Hand Sanitizer with aloe vera and vitamin e peach]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Hand Sanitizer]; ALCOHOL 17.98 mL in 29 mL TOPICAL LIQUID [FRESH SCENT HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Hand Sanitizer Lemon]; ALCOHOL 620 mL in 1000 mL TOPICAL LIQUID [Stream2Sea Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [XtraCare instant Hand Sanitizer Original]; ALCOHOL 17.57 g in 30 mL TOPICAL LIQUID [Red Hot Cinnamon Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [BIOMEDISUN HAND SANITIZER]; ALCOHOL 620 mL in 1000 mL TOPICAL LIQUID [Hand Sanitizer]; ALCOHOL 620 mL in 1000 mL TOPICAL LIQUID [Foaming Alcohol Instant Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [BLUE CROSS LABORATORIES HAND RX]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Clean Skin Sanitizer]; ALCOHOL 620 mg in 1 mL TOPICAL SOLUTION [Ecolab]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [HAND SANITIZER]; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Laughing Linen]; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Fresh Breeze]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Walgreens Hand Sanitizer Coastal Breeze]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Common Sense]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Persani Instant Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Walgreens Hand Sanitizer Vitamin E]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Alcohol Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Alcohol Antispetic 62% Topical Solution Hand Sanitizer]; ALCOHOL 62 g in 100 g TOPICAL LIQUID [KidzStuff Hand Sanitizer]; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Frisky Cinnamon]; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Pretty Punch]; ALCOHOL 62 g in 100 mL TOPICAL LIQUID [anti-bacterial Hand Cleanser]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Hand Rx Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Magnet Hand Sanitizer]; ALCOHOL 62 g in 100 mL TOPICAL LIQUID [Lacura Moisturizing Hand Sanitizer]; ALCOHOL 620 mg in 1 mL TOPICAL LIQUID [Pro Advantage Instant Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Harmon Face Values Warm Vanilla Sugar Scent Hand Sanitizer]; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Foxy Citrus]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [EAAE Hand Sanitizer]; ALCOHOL 0.62 mL in 1 mL TOPICAL LIQUID [Foam San Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Safety 1st hand sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Foaming Alcohol Hand Sanitizer]; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Citrus Sunshine]; Alcohol 0.62 mL in 1 mL TOPICAL LIQUID [Sanix Alcohol Hand Rub]; ALCOHOL 0.62 mL in 1 mL TOPICAL LIQUID [HydraGen Pro Barrier Hand Sanitizer]; ALCOHOL 37 g in 60 g TOPICAL LIQUID [XtraCare Instant Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [whole health Hand Sanitizer Lavender Scent]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [whole health Hand Sanitizer Regular]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [RESTORE ANTIBACTERIAL HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Benchmark Shield]; ALCOHOL 31 mL in 50 mL TOPICAL LIQUID [MEDIFENSE CLEAN HAND SERUM GREENERY BOUQUET]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Harmon Face Values Cucumber Melon Scent Hand Sanitizer]; ALCOHOL 146.94 mL in 237 mL TOPICAL LIQUID [skin protectant Original]; ALCOHOL 31 mL in 50 mL TOPICAL LIQUID [MEDIFENSE CLEAN HAND SERUM TROPICAL FRUIT]; ethanol 62 % Topical Solution; ALCOHOL 62 mg in 1 mL TOPICAL LIQUID; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Love You Berry Much]; ALCOHOL 17.57 g in 30 mL TOPICAL LIQUID [Rainbow Berry Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Hand Sanitizer Lavender]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Freeman Packaging Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Clinishield Instant Hand Sanitizer]; ALCOHOL 146.32 mL in 236 mL EXTRACORPOREAL LIQUID; ALCOHOL 17.57 g in 30 mL TOPICAL LIQUID [Laughing Linen Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Blue Devil Hand Sanitizer]; ALCOHOL 0.62 mL in 1 mL TOPICAL LIQUID [Baby Bum Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [SWEET STRAWBERRY SCENTED HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Health Smart Instant Hand Sanitizer with aloe vera and vitamin e cucumber melon]; ALCOHOL 26.36 g in 44 mL TOPICAL LIQUID [Coconut Lime]; ALCOHOL 0.62 mL in 1 mL TOPICAL LIQUID [Mr. Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Handy Solutions Instant Hand Sanitizer with Aloe and Vitamin E]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Harmon Face Values Pomegranate Scent Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Walgreens Hand Sanitizer Aloe Vitamin E]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [BEST ACCESSORY GROUP COTTON CANDY SCENTED HAND SANITIZER]; ALCOHOL 0.62 mL in 1 mL TOPICAL LIQUID [Brittanies Thyme Lavender and Peppermint Hand Sanitizer]; ethanol 0.62 ML/ML Topical Solution; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [COTTON CANDY SCENTED HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [BEST ACCESSORY GROUP SWEET STRAWBERRY SCENTED HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [CrocodileCloth Hand Sanitizer]; ALCOHOL 62 g in 100 g TOPICAL LIQUID; ALCOHOL 146.94 mL in 237 mL TOPICAL LIQUID [skin protectant Lavender]; ALCOHOL 62 mL in 100 L TOPICAL LIQUID [Handi Sani]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Harmon Face Values Cherry Blossom Scent Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Live Clean Unscented]; ALCOHOL 62 mL TOPICAL LIQUID [2PACK 2OZ HAND SANITIZER- CLASSIC]; ALCOHOL 310 mL in 500 mL TOPICAL LIQUID [OH MY CLEAN THE PURE SANITIZER MIST]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Health Smart Instant Hand Sanitizer with aloe vera and vitamin e sweet pea]; Alcohol 0.62 mL in 1 mL TOPICAL LIQUID [Germ Attack Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Paw Patrol Hand Sanitizer]; ALCOHOL 17.98 mL in 29 mL TOPICAL LIQUID [Sunny Tropicolada HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Mellow 59ml instant hand sanitizer 01]; ALCOHOL 74.4 mL in 120 mL TOPICAL LIQUID [skin protectant]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Hand Sanitizer Eucalyptus]; ALCOHOL 0.62 mL in 1 mL TOPICAL SOLUTION [Mrs. Meyers Clean Day Hand Sanitizer Basil Scent]; ALCOHOL 62 mL TOPICAL LIQUID [2PK 2OZ HAND SANITIIZER-ALOE VERA]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Symmetry Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Handy Solutions Instant Hand Sanitizer With Aloe And Vitamin E]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [1904 HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [whole health Hand Sanitizer Aloe]; ALCOHOL 0.62 mL in 1 mL TOPICAL LIQUID [Sun Bum Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Nozin Nasal Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Visibly Clean Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Walgreens Hand Sanitizer Crisp Apple]; ALCOHOL 17.57 g in 30 mL TOPICAL LIQUID [Thumbs-Up Lime Hand Sanitizer]; Alcohol 620 mg in 1 mL TOPICAL SOLUTION [Facilipro]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [SOL ON THE GO]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL SOLUTION [Altra Hand Sanitizer with Aloe and Vitamin E]; ALCOHOL 17.98 mL in 29 mL TOPICAL LIQUID [Purrfect Cherry HAND SANITIZER]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Afassco Hand Sanitizer]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Squeeky Clean]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Lucky Instant Hand Sanitizer with Vitamin E and Moisturizers]; ethyl alcohol 62 % Topical Solution; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Antibacterial Hnad Sanitizer]; ALCOHOL 0.62 mL in 1 mL TOPICAL SOLUTION [Mrs. Meyers Clean Day Hand Sanitizer Lavender Scent]; ALCOHOL 62 mL in 100 mL TOPICAL LIQUID [Minions Hand Sanitizer],0
C1704984,IRS1 wt Allele,insulin,IRS1 wt Allele; Insulin Receptor Substrate 1 wt Allele; HIRS-1,0
C1704985,IRS2 wt Allele,insulin,Insulin Receptor Substrate 2 wt Allele; IRS2 wt Allele,0
C1705021,INS wt Allele,insulin,Insulin wt Allele; INS wt Allele; INS,0
C1705345,IGFBP6 wt Allele,insulin,Insulin-Like Growth Factor Binding Protein 6 wt Allele; IBP-6; IGFBP6 wt Allele; IBP6; IGFBP-6,0
C1705350,IGF1R wt Allele,insulin,IGFR; JTK13; CD221; IGFIR; IGF1R wt Allele; Insulin Like Growth Factor 1 Receptor wt Allele; IGF1R,0
C1705351,IGFBP3 wt Allele,insulin,IGFBP3 wt Allele; IBP3; Insulin-Like Growth Factor Binding Protein 3 wt Allele; IGFBP3,0
C1705677,IGFBP1 wt Allele,insulin,IBP1; hIGFBP-1; IGF-BP25; Insulin-Like Growth Factor Binding Protein 1 wt Allele; IGFBP1 wt Allele; PP12; AFBP; IGFBP1,0
C1705678,IGFBP2 wt Allele,insulin,"IBP2; IGFBP2 wt Allele; IGF-BP53; BP2; Insulin-Like Growth Factor Binding Protein 2, 36kDa wt Allele; IGFBP2",0
C1705679,IGFBP4 wt Allele,insulin,Insulin-Like Growth Factor Binding Protein 4 wt Allele; IBP4; HT29-IGFBP; IGFBP4; IGFBP4 wt Allele; BP-4; IGFBP-4,0
C1705680,IGFBP5 wt Allele,insulin,IBP5; IGFBP5 wt Allele; Insulin-Like Growth Factor Binding Protein 5 wt Allele; IGFBP5,0
C1705859,IGF2BP3 wt Allele,insulin,CT98; VICKZ3; IMP3; IMP-3; KOC; IGF-II mRNA-Binding Protein 3 Gene; IGF2BP3 wt Allele; Insulin-Like Growth Factor 2 mRNA Binding Protein 3 wt Allele; KOC1,0
C1705861,INSR wt Allele,insulin,INSR; Insulin Receptor wt Allele; INSR wt Allele; CD220; HHF5,0
C1705933,INSL4 wt Allele,insulin,INSL4; INSL4 wt Allele; PLACENTIN; Insulin-Like 4 (Placenta) Gene; Insulin-Like 4 Gene; EPIL; Insulin Like 4 wt Allele,0
C1705973,CCN3 wt Allele,insulin,NOVh; IGFBP-9; IGFBP9; Insulin-Like Growth Factor Binding Protein-9 Gene; Nephroblastoma Overexpressed Gene; CCN3; Cellular Communication Network Factor 3 wt Allele; IBP-9; NOV; Oncogene NOV; CCN3 wt Allele,0
C1706038,CDX2 wt Allele,insulin,Caudal-Type Homeobox Protein 2 Gene; CDX3 Gene; Insulin-Regulating Transcription Factor CDX3 Gene; CDX2; Caudal-Type Homeo Box Transcription Factor 2 Gene; Homeobox Protein CDX-2 Gene; CDX-3 Gene; Caudal Type Homeobox 2 wt Allele; CDX2 wt Allele; Caudal-Type Homeo Box Transcription Factor 3 Gene,0
C1706330,INSRR wt Allele,insulin,Insulin Receptor-Related Receptor wt Allele; IRR; INSRR wt Allele,0
C1708414,IGF1 wt Allele,insulin,Insulin-Like Growth Factor 1A Gene; IGF1 wt Allele; IBP1; IGF-I; Insulin-Like Growth Factor 1B Gene; IGFI; IGF1A; Insulin-Like Growth Factor 1 (Somatomedin C) wt Allele,0
C1708415,IGF2R wt Allele,insulin,IGF2R wt Allele; Insulin-Like Growth Factor 2 Receptor wt Allele; CIMPR; CD222; MPRI; M6P-R,0
C1708416,IGF2 wt Allele,insulin,C11orf43; IGF2 wt Allele; Chromosome 11 Open Reading Frame 43 Gene; IGF-II; PP9974; Insulin-Like Growth Factor 2 (Somatomedin A) wt Allele,0
C1708452,IRS4 wt Allele,insulin,PY160; IRS4 wt Allele; Insulin Receptor Substrate 4 wt Allele; IRS-4,0
C1708521,Insulin Aspart,insulin,"Insulin Aspart; B28-Asp-Insulin; Insulin-Aspart; B28 Asp Insulin; Insulin, Aspartic Acid(B28)-; B28asp, Insulin; aspart insulin; Aspart, Insulin; Insulin B28asp",0
C1712375,"Health Care America Insulin Syringe 29gx1/2""",insulin,,0
C1712376,"Health Care America Insulin Syringe 29gx3/8""",insulin,,0
C1712377,"Health Care America Insulin Syringe 30gx1/2""",insulin,,0
C1712378,"Health Care America Insulin Syringe 30gx3/8""",insulin,,0
C1712379,"Health Care America Insulin Syringe 31gx3/8""",insulin,,0
C1712394,Kinray Preferred Plus Insulin Syringe 31g,insulin,,0
C1712401,BD Insulin Syringe 0.3cc Ultrafine,insulin,,0
C1712402,BD Insulin Syringe 0.5cc,insulin,,0
C1712403,BD Insulin Syringe 0.5cc 28g,insulin,,0
C1712406,BD Insulin Syringe 1cc,insulin,,0
C1712408,"BD Insulin Syringe 1cc 27g 1/2""",insulin,,0
C1712452,Medic Insulin Syringe 29g x 0.3cc,insulin,,0
C1712453,Medic Insulin Syringe 30g x 0.5cc,insulin,,0
C1712454,Medic Insulin Syringe 30g x 1cc,insulin,,0
C1712468,Insulin Syringe 0.3cc,insulin,,0
C1712469,"Insulin Syringe 0.3cc 29g 1/2""",insulin,,0
C1712470,Insulin Syringe 0.3cc 30g,insulin,Insulin Syringe 30g 0.3cc,0
C1712471,"Insulin Syringe 0.3cc 30g x 1/2""",insulin,,0
C1712473,Insulin Syringe 0.5cc,insulin,,0
C1712474,Insulin Syringe 0.5cc 28g,insulin,Insulin Syringes 0.5cc 28g; Insulin Syringe 28g 0.5cc,0
C1712477,Insulin Syringe 1cc 30g,insulin,,0
C1712478,"Insulin Syringe 1cc 30g x 1/2""",insulin,,0
C1712486,Insulin Syringe 29g 0.3cc,insulin,,0
C1712487,Insulin Syringe 29g x 0.5cc,insulin,,0
C1712488,"Insulin Syringe, 31g x 0.5cc",insulin,,0
C1712489,"Insulin Syringe, 31g x 1cc",insulin,,0
C1712497,WD Medic Insulin Syringe 30g x 0.3cc,insulin,,0
C1712498,WD Medic Insulin Syringe 30g x 1cc,insulin,,0
C1714127,"BD Insulin Syringe 27g 1/2""",insulin,,0
C1714179,"Health Care America Insulin Syringe 31gx1/2""",insulin,,0
C1714190,"Insulin Syringe 1cc 30g 5/16""",insulin,"Insulin Syringes - 30G, 1cc, 5/16""",0
C1714532,Glucose/Insulin:MRto:Pt:Ser/Plas:Qn,insulin,Glucose/Insulin [Mass Ratio] in Serum or Plasma; Glucose/Insulin SerPl; Glucose/Insulin [Mass ratio]; Glucose/Insulin:Mass Ratio:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1714585,Bacteria identified:Prid:Pt:Nph:Nom:Culture,NPH,Bacteria identified Cx Nom (Nph); Bacteria identified in Nasopharynx by Culture; Bacteria Nph Cult; Bacteria identified:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Culture,0
C1714766,Bacteria identified:Prid:Pt:Nph:Nom:Aerobic culture,NPH,Bacteria identified in Nasopharynx by Aerobe culture; Bacteria Nph Aerobe Cult; Bacteria identified Aer cx Nom (Nph); Bacteria identified:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Aerobic culture,0
C1714832,Insulin porcine Ab:PrThr:Pt:Ser:Ord,insulin,Insulin porcine Antibody:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal; Insulin porcine Ab [Presence] in Serum; Insulin porcine Ab Ql (S); Insulin Porcine Ab Ser Ql,0
C1714833,Insulin.bound:PrThr:Pt:Ser/Plas:Ord,insulin,Insulin.bound:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal; Insulin.bound [Presence] in Serum or Plasma; Insulin.bound Ql; Insulin Bnd SerPl Ql,0
C1714986,Adenovirus Ag:PrThr:Pt:Nph:Ord:IF,NPH,Adenovirus Ag [Presence] in Nasopharynx by Immunofluorescence; Adenovirus Ag IF Ql (Nph); Adenovirus Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence; HAdV Ag Nph Ql IF,0
C1715184,Bordetella parapertussis:PrThr:Pt:Nph:Ord:Organism specific culture,NPH,Bordetella parapertussis:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Organism specific culture; B parapert Nph Ql Cult; Bordetella parapertussis [Presence] in Nasopharynx by Organism specific culture; B. parapertussis Org specific cx Ql (Nph),0
C1715198,Influenza virus B Ag:PrThr:Pt:Nph:Ord,NPH,Influenza virus B Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal; FLUBV Ag Ql (Nph); Influenza virus B Ag [Presence] in Nasopharynx; FLUBV Ag Nph Ql,0
C1715214,Bordetella pertussis DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,B. pertussis DNA NAA+probe Ql (Nph); Bordetella pertussis deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection; B pert DNA Nph Ql NAA+probe,0
C1715232,Insulin.free:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin.free:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin Free SerPl-mCnc; Insulin Free [Mass/Vol]; Insulin Free [Mass/volume] in Serum or Plasma,0
C1715627,Insulin:PrThr:Pt:Ser/Plas:Ord,insulin,Insulin Ql; Insulin SerPl Ql; Insulin:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal; Insulin [Presence] in Serum or Plasma,0
C1715628,Insulin bovine Ab:PrThr:Pt:Ser:Ord,insulin,Insulin bovine Ab [Presence] in Serum; Insulin bovine Antibody:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal; Insulin Bovine Ab Ser Ql; Insulin bovine Ab Ql (S),0
C1715685,Insulin.free+Bound:PrThr:Pt:Ser/Plas:Ord,insulin,Insulin Free+Bound [Presence] in Serum or Plasma; Insulin Free+Bnd SerPl Ql; Insulin Free+Bound Ql; Insulin.free+Bound:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal,0
C1715773,Influenza virus A Ag:PrThr:Pt:Nph:Ord:IF,NPH,Influenza virus A Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence; FLUAV Ag Nph Ql IF; FLUAV Ag IF Ql (Nph); Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence,0
C1715841,Influenza virus B Ag:PrThr:Pt:Nph:Ord:IF,NPH,FLUBV Ag IF Ql (Nph); Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence; FLUBV Ag Nph Ql IF; Influenza virus B Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence,0
C1716242,Chlamydia trachomatis rRNA:PrThr:Pt:Nph:Ord:Probe,NPH,C trach rRNA Nph Ql Probe; Chlamydia trachomatis ribosomal ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe; Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe; C. trachomatis rRNA Probe Ql (Nph),0
C1716243,Chlamydia trachomatis DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Chlamydia trachomatis deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; C. trachomatis DNA NAA+probe Ql (Nph); Chlamydia trachomatis DNA [Presence] in Nasopharynx by NAA with probe detection; C trach DNA Nph Ql NAA+probe,0
C1716247,Chlamydia trachomatis Ag:PrThr:Pt:Nph:Ord:IA,NPH,C. trachomatis Ag IA Ql (Nph); Chlamydia trachomatis Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immunoassay; C trach Ag Nph Ql IA; Chlamydia trachomatis Ag [Presence] in Nasopharynx by Immunoassay,0
C1716251,Chlamydia trachomatis:PrThr:Pt:Nph:Ord:Organism specific culture,NPH,Chlamydia trachomatis [Presence] in Nasopharynx by Organism specific culture; C. trachomatis Org specific cx Ql (Nph); Chlamydia trachomatis:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Organism specific culture; C trach Nph Ql Cult,0
C1716256,Chlamydia sp identified:Prid:Pt:Nph:Nom:Organism specific culture,NPH,Chlamydia sp identified in Nasopharynx by Organism specific culture; Chlamydia sp identified Org specific cx Nom (Nph); Chlamydia Nph Cult; Chlamydia sp identified:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Organism specific culture,0
C1716283,Chlamydia sp Ag:PrThr:Pt:Nph:Ord:IF,NPH,Chlamydia sp Ag IF Ql (Nph); Chlamydia Ag Nph Ql IF; Chlamydia sp Ag [Presence] in Nasopharynx by Immunofluorescence; Chlamydia sp Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence,0
C1716284,Chlamydia sp Ag:PrThr:Pt:Nph:Ord:IA,NPH,Chlamydia sp Ag IA Ql (Nph); Chlamydia sp Ag [Presence] in Nasopharynx by Immunoassay; Chlamydia Ag Nph Ql IA; Chlamydia sp Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immunoassay,0
C1716403,Bordetella bronchiseptica DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Bordetella bronchiseptica DNA [Presence] in Nasopharynx by NAA with probe detection; B. bronchiseptica DNA NAA+probe Ql (Nph); B bronch DNA Nph Ql NAA+probe; Bordetella bronchiseptica deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C1716463,Proinsulin/Insulin:Ratio:Pt:Ser/Plas:Qn,insulin,Proinsulin/Insulin [Ratio]; Proinsulin/Insulin SerPl-Rto; Proinsulin/Insulin:Ratio:To identify measures at a point in time:Serum/Plasma:Quantitative; Proinsulin/Insulin [Ratio] in Serum or Plasma,0
C1716512,Influenza virus A Ag:PrThr:Pt:Nph:Ord:IA,NPH,FLUAV Ag Nph Ql IA; FLUAV Ag IA Ql (Nph); Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay; Influenza virus A Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immunoassay,0
C1716513,Influenza virus B Ag:PrThr:Pt:Nph:Ord:IA,NPH,Influenza virus B Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immunoassay; FLUBV Ag Nph Ql IA; FLUBV Ag IA Ql (Nph); Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay,0
C1716727,Bowel elimination pattern regular - at least one movement every three D:Find:Pt:^Patient:Ord:MDS,regular,Bowel elimination pattern regular - at least one movement every three days [Minimum Data Set]; Bowel elimination pattern regular - at least one movement every three D:Finding:To identify measures at a point in time:^Patient:Ordinal:MDS,0
C1716814,Regular or repetitive complaints of hunger:Find:Pt:^Patient:Ord:MDS,regular,Regular or repetitive complaints of hunger [Minimum Data Set]; Regular or repetitive complaints of hunger:Finding:To identify measures at a point in time:^Patient:Ordinal:MDS,0
C1717251,Insulin human Ab:PrThr:Pt:Ser:Ord,insulin,Insulin human Ab Ql (S); Insulin human Ab [Presence] in Serum; Insulin Human Ab Ser Ql; Insulin human Antibody:Presence or Threshold:To identify measures at a point in time:Serum:Ordinal,0
C1717286,Influenza virus A Ag:PrThr:Pt:Nph:Ord,NPH,Influenza virus A Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal; FLUAV Ag Nph Ql; FLUAV Ag Ql (Nph); Influenza virus A Ag [Presence] in Nasopharynx,0
C1717291,Bordetella pertussis Ag:PrThr:Pt:Nph:Ord,NPH,Bordetella pertussis Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal; Bordetella pertussis Ag [Presence] in Nasopharynx; B. pertussis Ag Ql (Nph); B pert Ag Nph Ql,0
C1717373,Insulin dependent diabetes mellitus:PrThr:Pt:^Patient:Ord,insulin,Insulin dependent diabetes mellitus [Presence]; Insulin dependent diabetes mellitus Ql; IDDM Patient Ql; Insulin dependent diabetes mellitus:Presence or Threshold:To identify measures at a point in time:^Patient:Ordinal,0
C1717394,Chlamydia sp Ag:PrThr:Pt:Nph:Ord,NPH,Chlamydia sp Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal; Chlamydia sp Ag Ql (Nph); Chlamydia Ag Nph Ql; Chlamydia sp Ag [Presence] in Nasopharynx,0
C1717966,Insulin.free+Bound,insulin,Insulin.free+Bound; Insulin Free+Bound,0
C1718242,Proinsulin/Insulin,insulin,Proinsulin/Insulin,0
C1719133,Glucose/Insulin,insulin,Glucose/Insulin,0
C1719668,Unspecified adverse effect of insulin,insulin,,0
C1720281,Human insulin zinc suspension crystalline,insulin,Human insulin zinc suspension crystalline (substance); Human insulin zinc suspension crystalline-containing product; Product containing human insulin zinc suspension crystalline (medicinal product),0
C1720660,Product containing human insulin zinc suspension mixed (medicinal product),insulin,,0
C1721248,"Lnpep protein, rat",insulin,"insulin-regulated membrane aminopeptidase IRAP, rat; vp165 protein, rat",0
C1721314,"insulin receptor alpha subunit, human",insulin,,0
C1721315,"Insulin receptor beta subunit, human",insulin,,0
C1724222,Soothe Regular Strength,regular,,0
C1724991,BD Insulin Syringe Integra 1cc 29g,insulin,,0
C1725049,"BD Insulin Syringe 0.3cc 30g 1/2"" (UF)",insulin,,0
C1725258,"{90 (insulin human, rDNA origin 1 MG/ACTUAT Inhalant Powder [Exubera]) / 90 (insulin human, rDNA origin 3 MG/ACTUAT Inhalant Powder [Exubera]) } Pack [Exubera Combination Pack 12]",insulin,,0
C1725260,"{180 (insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]) } Pack [Exubera Kit]",insulin,"Exubera Kit; Exubera Inhalation Powder Pack - 180 (1 MG), 90 (3 MG); {180 (insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]) } Pack [Exubera Kit]; Exubera Combination Pack 15; EXUBERA Combination Pack 15",0
C1725406,Soothe Regular Strength Cherry,regular,,0
C1738209,"Irs2 protein, rat",insulin,"insulin receptor substrate 2, rat",0
C1740193,"ins protein, zebrafish",insulin,"insulin-a protein, zebrafish; preproinsulin protein, zebrafish",0
C1741594,"Irs2 protein, mouse",insulin,"insulin receptor substrate 2 protein, mouse; IRS-2 protein, mouse",0
C1742153,"Insb protein, zebrafish",insulin,"insulin-b protein, zebrafish; preproinsulin b protein, zebrafish",0
C1742762,"Ins1 protein, mouse",insulin,"Ins-1, mouse; insulin I, mouse; Ins1, mouse",0
C1743122,B22 Glu des-B30 insulin,insulin,,0
C1749413,insulin receptor ligand,insulin,,0
C1749414,insulin-like growth factor receptor ligand,insulin,,0
C1753359,insulin-like growth factor activity,insulin,insulin-like growth factor,0
C1764795,Deprecated Insulin [Units/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO,insulin,Insulin 1.5 Hr post 75 g glucose PO Qn,0
C1812639,RXFP3 gene,insulin,G PROTEIN-COUPLED RECEPTOR 135; RLN3 RECEPTOR 1; SOMATOSTATIN- AND ANGIOTENSIN-LIKE PEPTIDE RECEPTOR; SALPR; RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 3; relaxin family peptide receptor 3; RXFP3; RXFP3 gene; RELAXIN 3 RECEPTOR 1; GPCR135; relaxin 3 receptor 1; relaxin/insulin like family peptide receptor 3; RXFPR3; RLN3R1,0
C1814346,OSTEO BI-FLEX REGULAR STRENGTH CAP/TAB,regular,OSTEO BI-FLEX REGULAR STRENGTH CAP/TAB,0
C1814966,"Insulin Syringe, 30g",insulin,,0
C1814967,"{180 (insulin human, rDNA origin 1 MG Inhalation Powder) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder) } Pack",insulin,"regular insulin, human, rDNA origin 270 Inhalation Powder Pack - 180 (1 MG), 90 (3 MG)",0
C1815692,INCONT LINER CAPRI REGULAR,regular,INCONT LINER CAPRI REGULAR,0
C1815716,"CARTRIDGE,ANIMAS INSULIN",insulin,"CARTRIDGE,ANIMAS INSULIN",0
C1815806,"INSULIN,DETEMIR,HUMAN",insulin,"Insulin,detemir,human",0
C1815827,OPTICLIK INSULIN DELIVERY SYSTEM,insulin,OPTICLIK INSULIN DELIVERY SYSTEM,0
C1818873,positive regulation of insulin secretion,insulin,upregulation of insulin secretion; up-regulation of insulin secretion; up regulation of insulin secretion,0
C1823201,C1QTNF12 gene,insulin,"C1q DOMAIN-CONTAINING PROTEIN 2; ADIPOSE-DERIVED INSULIN-SENSITIZING FACTOR; MGC105127; adipolin; FAMILY WITH SEQUENCE SIMILARITY 132, MEMBER A; C1QDC2; family with sequence similarity 132 member A; adipose-derived insulin-sensitizing factor; C1q domain containing 2; FAM132A; C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 12; C1QTNF12; ADIPOLIN; C1q and TNF related 12; CTRP12; C1QTNF12 gene; C1q and tumor necrosis factor related protein 12; family with sequence similarity 132, member A",0
C1824100,AQP12B gene,insulin,AQP12B gene; INSSA3; aquaporin 12B; AQP12B; insulin synthesis associated 3,0
C1825576,IGF2BP1 gene,insulin,"IGF2BP1 gene; ZIPCODE-BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 1; IGF2 mRNA-BINDING PROTEIN 1; CRDBP; IGF II mRNA binding protein 1; insulin like growth factor 2 mRNA binding protein 1; CODING REGION DETERMINANT-BINDING PROTEIN, MOUSE, HOMOLOG OF; IGF2BP1; insulin-like growth factor 2 mRNA binding protein 1; IMP1; ZBP1; IMP-1",0
C1825577,IGF2BP2 gene,insulin,INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 2; Insulin-Like Growth Factor 2 mRNA Binding Protein 2 Gene; P62; insulin like growth factor 2 mRNA binding protein 2; IMP-2; IGF2BP2; insulin-like growth factor 2 mRNA binding protein 2; IGF2 mRNA-BINDING PROTEIN 2; IGF II mRNA binding protein 2; IGF2BP2 Gene; IGF2BP2 gene; IMP2; p62,0
C1825578,IGF2BP3 gene,insulin,IGF2BP3 Gene; CT98; IGF2 mRNA-BINDING PROTEIN 3; VICKZ3; IMP3; IGF II mRNA binding protein 3; cancer/testis antigen 98; insulin-like growth factor 2 mRNA binding protein 3; IMP-3; insulin like growth factor 2 mRNA binding protein 3; KH DOMAIN CONTAINING PROTEIN OVEREXPRESSED IN CANCER; INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 3; IGF2BP3 gene; IGF2BP3; Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Gene; KOC1,0
C1826562,PDX1 gene,insulin,"PDX-1; PANCREAS/DUODENUM HOMEOBOX PROTEIN 1; Islet/duodenum homeobox-1; Pancreatic and Duodenal Homeobox 1 Gene; IUF-1; SOMATOSTATIN TRANSCRIPTION FACTOR 1; MODY4; PDX1 gene; IDX-1; somatostatin transcription factor 1; pancreatic and duodenal homeobox 1; PDX1 Gene; STF1; INSULIN PROMOTER FACTOR 1; insulin upstream factor 1; Glucose-sensitive factor; IPF1; IDX1; HOMEODOMAIN TRANSCRIPTION FACTOR IPF1; PANCREATIC AND DUODENAL HOMEOBOX 1; GSF; STF-1; PDX1; insulin promoter factor 1, homeodomain transcription factor",0
C1826958,RXFP1 gene,insulin,RXFP1; LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 7; LGR7; relaxin/insulin like family peptide receptor 1; leucine-rich repeat-containing G protein-coupled receptor 7; relaxin family peptide receptor 1; RXFPR1; RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 1; RXFP1 gene,0
C1826959,RXFP4 gene,insulin,relaxin/insulin like family peptide receptor 4; G PROTEIN-COUPLED RECEPTOR 142; GPR100; RLN3R2; GPCR142; RXFP4; RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 4; relaxin family peptide/INSL5 receptor 4; G protein-coupled receptor 100; RXFP4 gene; RELAXIN 3 RECEPTOR 2; relaxin 3 receptor 2; RLN3 RECEPTOR 2; relaxin family peptide receptor 4; RXFPR4; G PROTEIN-COUPLED RECEPTOR 100,0
C1829491,1.5 hours post dose arginine+insulin,insulin,1.5H post dose arginine+insulin,0
C1829498,1.75 hours post dose arginine+insulin,insulin,1.75H post dose arginine+insulin,0
C1829507,15 minutes post dose arginine+insulin,insulin,15M post dose arginine+insulin,0
C1829510,15 minutes post dose insulin IV,insulin,15M post dose insulin IV,0
C1829525,2.25 hours post dose arginine+insulin,insulin,2.25H post dose arginine+insulin,0
C1829531,2 hours post dose arginine+insulin,insulin,2H post dose arginine+insulin,0
C1829537,2 hours post dose insulin IV,insulin,2H post dose insulin IV,0
C1829544,30 minutes post dose arginine+insulin,insulin,30M post dose arginine+insulin,0
C1829560,45 minutes post dose arginine+insulin,insulin,45M post dose arginine+insulin,0
C1829568,5 minutes post dose arginine+insulin,insulin,5M post dose arginine+insulin,0
C1829593,pre dose arginine+insulin,insulin,pre dose arginine+insulin,0
C1830292,Cortisol^2H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Cortisol [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV; Cortis 2h p Ins IV SerPl-mCnc; Cortisol^2 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol 2 Hr post dose insulin IV [Mass/Vol],0
C1830293,Somatotropin^2H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,GH 2h p Ins IV SerPl-mCnc; Somatotropin 2 Hr post dose insulin IV [Mass/Vol]; Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV; Somatotropin^2 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1830661,"Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances:Find:Pt:^Patient:Ord:RFC assessment",regular,"Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances:Finding:To identify measures at a point in time:^Patient:Ordinal:RFC assessment; Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances [RFC]",0
C1830662,"Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances",regular,"Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances",0
C1832392,"DIABETES MELLITUS, INSULIN-DEPENDENT, 12",insulin,"Diabetes Mellitus, Insulin-Dependent, 12; INSULIN-DEPENDENT DIABETES MELLITUS 12; DIABETES MELLITUS, INSULIN-DEPENDENT, 12; TYPE 1 DIABETES MELLITUS 12; T1D12; Insulin-Dependent Diabetes Mellitus 12; IDDM12",0
C1832474,"DIABETES MELLITUS, INSULIN-DEPENDENT, 13",insulin,"Diabetes Mellitus, Insulin-Dependent, 13; DIABETES MELLITUS, INSULIN-DEPENDENT, 13; IDDM13; Insulin-Dependent Diabetes Mellitus 13; T1D13; INSULIN-DEPENDENT DIABETES MELLITUS 13; TYPE 1 DIABETES MELLITUS 13",0
C1832605,"DIABETES MELLITUS, INSULIN-DEPENDENT, 11",insulin,"T1D11; INSULIN-DEPENDENT DIABETES MELLITUS 11; TYPE 1 DIABETES MELLITUS 11; DIABETES MELLITUS, INSULIN-DEPENDENT, 11; Diabetes Mellitus, Insulin-Dependent, 11; IDDM11; Insulin-Dependent Diabetes Mellitus 11",0
C1833060,Decreased or normal plasma insulin,insulin,,0
C1833218,"DIABETES MELLITUS, INSULIN-DEPENDENT, 8",insulin,"T1D8; TYPE 1 DIABETES MELLITUS 8; IDDM8; Diabetes Mellitus, Insulin-Dependent, 8; Insulin-Dependent Diabetes Mellitus 8; DIABETES MELLITUS, INSULIN-DEPENDENT, 8; INSULIN-DEPENDENT DIABETES MELLITUS 8",0
C1835379,Insulin-resistant diabetes mellitus (onset around puberty),insulin,,0
C1837475,Insulin-Like Growth Factor I Deficiency,insulin,"IGF-1 deficiency; Growth delay-deafness-intellectual disability syndrome; GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION; IGF1 Deficiency; IGF1 DEFICIENCY; Growth Retardation with Sensorineural Deafness and Mental Retardation; Growth delay, deafness, intellectual disability syndrome; Growth delay due to insulin-like growth factor type 1 deficiency (disorder); Growth delay due to insulin-like growth factor type 1 deficiency; Primary insulin-like growth factor deficiency; Insulin Growth Factor I Deficiency; Growth delay-hearing loss-intellectual disability syndrome; IGF-I Deficiency; IGF-1 (insulin-like growth factor 1) deficiency; INSULIN-LIKE GROWTH FACTOR I DEFICIENCY",0
C1837476,Decreased serum insulin-like growth factor-1 (IGF1),insulin,Decreased serum insulin-like growth factor 1 (IGF1),0
C1837792,Insulin-resistant diabetes mellitus at puberty,insulin,Insulin-resistant diabetes mellitus at puberty,0
C1838259,"DIABETES MELLITUS, INSULIN-DEPENDENT, 7",insulin,"T1D7; TYPE 1 DIABETES MELLITUS 7; INSULIN-DEPENDENT DIABETES MELLITUS 7; IDDM7; Insulin-Dependent Diabetes Mellitus 7; DIABETES MELLITUS, INSULIN-DEPENDENT, 7; Diabetes Mellitus, Insulin-Dependent, 7",0
C1838260,"DIABETES MELLITUS, INSULIN-DEPENDENT, 5",insulin,"Insulin-Dependent Diabetes Mellitus 5; TYPE 1 DIABETES MELLITUS 5; Diabetes Mellitus, Insulin-Dependent, 5; INSULIN-DEPENDENT DIABETES MELLITUS 5; IDDM5; DIABETES MELLITUS, INSULIN-DEPENDENT, 5; T1D5",0
C1838261,"DIABETES MELLITUS, INSULIN-DEPENDENT, 4",insulin,"Diabetes Mellitus, Insulin-Dependent, 4; INSULIN-DEPENDENT DIABETES MELLITUS 4; DIABETES MELLITUS, INSULIN-DEPENDENT, 4; T1D4; IDDM4; TYPE 1 DIABETES MELLITUS 4; Insulin-Dependent Diabetes Mellitus 4",0
C1838262,"DIABETES MELLITUS, INSULIN-DEPENDENT, 3",insulin,"Diabetes Mellitus, Insulin-Dependent, 3; IDDM3; DIABETES MELLITUS, INSULIN-DEPENDENT, 3; Insulin-Dependent Diabetes Mellitus 3; T1D3; TYPE 1 DIABETES MELLITUS 3; INSULIN-DEPENDENT DIABETES MELLITUS 3",0
C1838655,Pancreatic beta cell agenesis with neonatal diabetes mellitus,insulin,PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS; Congenital absence of insulin-producing beta cells with diabetes mellitus,0
C1840136,"DIABETES MELLITUS, INSULIN-DEPENDENT, SUSCEPTIBILITY TO",insulin,,0
C1840176,INSULIN-RELATED DNA POLYMORPHISM,insulin,INS VNTR; IRDN; ILPR; INSULIN-RELATED VNTR; INSULIN-LINKED POLYMORPHIC REGION; INSULIN MINISATELLITE,0
C1840226,"INSULIN RECEPTORS, FAMILIAL INCREASE IN",insulin,,0
C1842248,No insulin-dependent diabetes mellitus,insulin,,0
C1842404,Insulin-dependent but ketosis-resistant diabetes,insulin,Insulin-dependent but ketosis-resistant diabetes,0
C1843997,"Deficient growth hormone response to insulin, arginine, or levodopa",insulin,,0
C1848042,"TYPE 1 DIABETES MELLITUS, X-LINKED, SUSCEPTIBILITY TO",insulin,"INSULIN-DEPENDENT DIABETES MELLITUS, X-LINKED, SUSCEPTIBILITY TO; DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO; IDDMX; T1DX",0
C1849157,Resistance to Insulin-Like Growth Factor I,insulin,"Growth delay due to insulin-like growth factor I resistance (disorder); IGF-1 (insulin-like growth factor 1) resistance; Growth delay due to insulin-like growth factor I resistance; SOMATOMEDIN, END-ORGAN INSENSITIVITY TO; IGF-I Resistance; Somatomedin C, Resistance To; SOMATOMEDIN-C, RESISTANCE TO; IGF-I RESISTANCE; Insulin Growth Factor I Resistance; Insulin-Like Growth Factor I, Resistance To; Growth delay due to insulin-like growth factor 1 resistance; INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; Resistance to IGF-1; IGF1RES; Somatomedin, End-Organ Insensitivity To; Somatomedin C resistance",0
C1849158,"Insulin-Like Growth Factor I, Resistance to, due to Increased Binding Protein",insulin,"INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO, DUE TO INCREASED BINDING PROTEIN",0
C1849166,"Increased serum insulin-like growth factor-1 (IGF1, 147740)",insulin,,0
C1849401,"Retinitis Pigmentosa, Deafness, Mental Retardation, and Hypogonadism",insulin,"RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM; INSULIN-RESISTANT DIABETES WITH ACANTHOSIS NIGRICANS, HYPOGONADISM, PIGMENTARY RETINOPATHY, DEAFNESS, AND MENTAL RETARDATION",0
C1849404,Decreased insulin receptor binding,insulin,,0
C1849529,"Decreased serum insulin-like growth factor-1 (IGF1, 147440)",insulin,,0
C1850546,Insulin deficiency (may develop later in life),insulin,,0
C1852091,"INSULIN RESISTANCE, SUSCEPTIBILITY TO",insulin,"INSULIN RESISTANCE, SUSCEPTIBILITY TO",0
C1852092,"DIABETES MELLITUS, INSULIN-DEPENDENT, 2",insulin,"IDDM2; DIABETES MELLITUS, INSULIN-DEPENDENT, 2; Diabetes Mellitus, Insulin-Dependent, 2; Insulin-Dependent Diabetes Mellitus 2; INSULIN-DEPENDENT DIABETES MELLITUS 2; T1D2; TYPE 1 DIABETES MELLITUS 2",0
C1854125,"DIABETES MELLITUS, INSULIN-DEPENDENT, 18",insulin,"INSULIN-DEPENDENT DIABETES MELLITUS 18; Insulin-Dependent Diabetes Mellitus 18; DIABETES MELLITUS, INSULIN-DEPENDENT, 18; Diabetes Mellitus, Insulin-Dependent, 18; TYPE 1 DIABETES MELLITUS 18; IDDM18; T1D18",0
C1854174,"HYPERTENSION, INSULIN RESISTANCE-RELATED, SUSCEPTIBILITY TO",insulin,,0
C1855518,Elevated plasma insulin,insulin,,0
C1855519,Absent anti-insulin receptor antibodies,insulin,,0
C1856903,Insulin-dependent diabetes mellitus (onset in infancy),insulin,,0
C1857808,"DIABETES MELLITUS, INSULIN-DEPENDENT, 19 (disorder)",insulin,"T1D19; DIABETES MELLITUS, INSULIN-DEPENDENT, 19; Diabetes Mellitus, Insulin-Dependent, 19; IDDM19; TYPE 1 DIABETES MELLITUS 19",0
C1864068,"DIABETES MELLITUS, INSULIN-DEPENDENT, 17",insulin,"Diabetes Mellitus, Insulin-Dependent, 17; Insulin-Dependent Diabetes Mellitus 17; DIABETES MELLITUS, INSULIN-DEPENDENT, 17; INSULIN-DEPENDENT DIABETES MELLITUS 17; TYPE 1 DIABETES MELLITUS 17; TID17; IDDM17",0
C1864445,Histiocytosis with joint contractures and sensorineural deafness,insulin,"SLC29A3 spectrum disorder; Histiocytosis with joint contractures and sensorineural deafness; Faisalabad histiocytosis; SHML; H syndrome; Histiocytosis-lymphadenopathy plus syndrome (disorder); Pigmented Hypertrichosis With Insulin-Dependent Diabetes Mellitus Syndrome; HISTIOCYTOSIS AND LYMPHADENOPATHY WITH OR WITHOUT CUTANEOUS, CARDIAC, AND/OR ENDOCRINE FEATURES, JOINT CONTRACTURES, AND/OR DEAFNESS; HYPERPIGMENTATION, CUTANEOUS, WITH HYPERTRICHOSIS, HEPATOSPLENOMEGALY, HEART ANOMALIES, AND HYPOGONADISM WITH OR WITHOUT HEARING LOSS; Histiocytosis-lymphadenopathy plus syndrome; SINUS HISTIOCYTOSIS AND MASSIVE LYMPHADENOPATHY; FAISALABAD HISTIOCYTOSIS; Hyperpigmentation, Cutaneous, with Hypertrichosis, Hepatosplenomegaly, Heart Anomalies, and Hypogonadism With or Without Hearing Loss; PHID; HISTIOCYTOSIS WITH JOINT CONTRACTURES AND SENSORINEURAL DEAFNESS; ROSAI-DORFMAN DISEASE, FAMILIAL; HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME; PIGMENTED HYPERTRICHOSIS WITH INSULIN-DEPENDENT DIABETES MELLITUS; H SYNDROME; HJCD",0
C1864570,Insulin insensitivity,insulin,Insulin insensitivity,0
C1864905,Pyruvate-induced insulin secretion,insulin,,0
C1864954,Fasting hyperinsulinemia,insulin,"High blood insulin levels while fasting; Hyperinsulinemia, fasting",0
C1864955,Elevated serum insulin-to-C-peptide ratio,insulin,,0
C1865284,Pseudoacromegaly with Severe Insulin Resistance,insulin,PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE,0
C1865291,"Diabetes mellitus, insulin-dependent, late onset",insulin,,0
C1866040,"DIABETES MELLITUS, INSULIN-DEPENDENT, 10",insulin,"TYPE 1 DIABETES MELLITUS 10; Insulin-Dependent Diabetes Mellitus 10; Diabetes Mellitus, Insulin-Dependent, 10; INSULIN-DEPENDENT DIABETES MELLITUS 10; DIABETES MELLITUS, INSULIN-DEPENDENT, 10; T1D10; IDDM10",0
C1866041,"DIABETES MELLITUS, INSULIN-DEPENDENT, 6",insulin,"TYPE 1 DIABETES MELLITUS 6; IDDM6; Insulin-Dependent Diabetes Mellitus 6; DIABETES MELLITUS, INSULIN-DEPENDENT, 6; Diabetes Mellitus, Insulin-Dependent, 6; INSULIN-DEPENDENT DIABETES MELLITUS 6; T1D6",0
C1866503,ACUTE INSULIN RESPONSE,insulin,AIR; ACUTE INSULIN RESPONSE,0
C1866519,"DIABETES MELLITUS, INSULIN-DEPENDENT, 15",insulin,"TYPE 1 DIABETES MELLITUS 15; IDDM15; INSULIN-DEPENDENT DIABETES MELLITUS 15; DIABETES MELLITUS, INSULIN-DEPENDENT, 15; T1D15; Insulin-Dependent Diabetes Mellitus 15; Diabetes Mellitus, Insulin-Dependent, 15",0
C1868448,"Attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise",insulin,,0
C1870033,"CRD-BP protein, mouse",insulin,"Igf2bp1 protein, mouse; insulin-like growth factor 2 binding protein 1, mouse",0
C1872103,"IGFBP3 protein, human",insulin,"IGF Binding Protein 3; Acid Stable Subunit of The 140 k IGF Complex; IGFBP-3 protein, human; insulin-like growth factor binding protein 3, human; IGFBP3 protein, human; Binding Protein 29; Growth Hormone-Dependent Binding Protein; IGFBP-3; IGF-Binding Protein 3; IGFBP3; Binding Protein 53; Insulin-Like Growth Factor-Binding Protein 3; IBP-3; Insulin-Like Growth Factor Binding Protein 3",0
C1873795,Lofthouse Regular Fisherman's Friend,regular,,0
C1875298,INSULIN MAGNIFIER,insulin,,0
C1875548,NOVOLIN PEN,novolin,,0
C1875641,PERNOX,regular,Pernox Regular; Pernox Lemon,0
C1875812,"SYRINGES,INSULIN,INJECTION",insulin,,0
C1879342,Insulin-Like Growth Factor I (IGF-I) Determination Reagents,insulin,"Somatomedin C Determination Reagents; IGF-I (Growth Factor I, Insulin-Like) Determination Reagents; Growth Factor I, Insulin-Like (IGF-I) Determination Reagents",0
C1897133,Adelges kitamiensis,NPH,Adelges sp. CNC-HEM053415; Adelges sp. A NPH-2007,0
C1897134,Adelges sp. B NPH-2007,NPH,Adelges sp. CNC-HEM054837; Adelges sp. CNC-HEM053359; Adelges sp. CNC-HEM054241,0
C1949165,calcium citrate 1190 MG / cholecalciferol 0.005 MG Oral Tablet,regular,"CALCIUM CITRATE 250MG/VIT D 200 UNIT TAB; CALCIUM CITRATE 250MG/VITAMIN D 200UNT TAB; calcium-vitamin D 250 mg-5 mcg oral tablet; calcium-vitamin D (as carbonate and lactate) 200 mg-6.25 mcg oral tablet; calcium citrate 1190 MG (calcium 250 MG) / vitamin D3 200 UNT Oral Tablet; calcium 250 MG / cholecalciferol 0.005 MG (200 UNT) Oral Tablet, as calcium citrate; Citracal Regular, 250 mg-5 mcg oral tablet",0
C1949389,ReliOn/NovoLIN R,novolin,,0
C1949541,ReliOn/NovoLIN 70/30,novolin,,0
C1949544,Novolin 70/30 Penfill Suspension for Injection,novolin,,0
C1949545,ReliOn/NovoLIN N,novolin,,0
C1949780,BD Insulin Syringe 1cc Slip Tip,insulin,,0
C1949809,BD MF Insulin Syringe 0.3cc,insulin,,0
C1949812,BD MF Insulin Syringe 1cc,insulin,,0
C1949822,BD Insulin Syringe 0.3cc (UF),insulin,,0
C1949824,BD Insulin Syringe 1cc (UF),insulin,,0
C1950220,Maalox Regular Strength,regular,,0
C1951355,Regular Strength Acetaminophen,regular,,0
C1952521,Disposable insulin safety needles,insulin,,0
C1952627,Insulin^6M post dose glucagon:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 6 Min post dose glucagon Qn; Insulin^6 minutes post dose glucagon:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --6 minutes post dose glucagon; Insulin 6M p Gc SerPl-aCnc,0
C1952628,Insulin^pre dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^pre dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --pre dose glucose; Insulin pre Glc SerPl-aCnc; Insulin pre dose glucose Qn,0
C1952629,Insulin^pre dose glucagon:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin pre Gc SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --pre dose glucagon; Insulin^pre dose glucagon:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin pre dose glucagon Qn,0
C1952630,Insulin^pre-meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^pre-meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --pre-meal; Insulin pre-meal Qn; Insulin pre-meal SerPl-aCnc,0
C1952644,Insulin^5M pre dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 5 Min pre dose glucose Qn; Insulin^5 minutes pre dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 5M pre Glc SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --5 minutes pre dose glucose,0
C1952675,Somatotropin^1H post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine+insulin; Somatotropin^1 hour post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 1 Hr post dose arginine+insulin Qn; GH 1h p Arg+Ins SerPl-aCnc,0
C1952764,Somatotropin^15M pre dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine+insulin; GH 15M pre Arg+Ins SerPl-aCnc; Somatotropin^15 minutes pre dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 15 Min pre dose arginine+insulin Qn,0
C1952766,Somatotropin^15M pre dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 15 Min pre dose insulin IV Qn; Somatotropin^15 minutes pre dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose insulin IV; GH 15M pre Ins IV SerPl-aCnc,0
C1952894,Insulin^10M post dose glucagon:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 10M p Gc SerPl-aCnc; Insulin^10 minutes post dose glucagon:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucagon; Insulin 10 Min post dose glucagon Qn,0
C1952895,Insulin^10M post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^10 minutes post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10 Min post dose glucose Qn; Insulin 10M p Glc SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucose,0
C1952896,Insulin^15M post dose glucagon:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 15M p Gc SerPl-aCnc; Insulin^15 minutes post dose glucagon:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon; Insulin 15 Min post dose glucagon Qn,0
C1952897,Insulin^1M post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 1 Min post dose glucose Qn; Insulin 1M p Glc SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --1 minute post dose glucose; Insulin^1 minute post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1952898,Insulin^1H post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 1 Hr post dose glucose Qn; Insulin 1h p Glc SerPl-aCnc; Insulin^1 hour post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --1 hour post dose glucose,0
C1952899,Insulin^1.5H post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose; Insulin^1.5 hours post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.5 Hr post dose glucose Qn; Insulin 1.5h p Glc SerPl-aCnc,0
C1952900,Insulin^2H post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --2 hours post dose glucose; Insulin 2h p Glc SerPl-aCnc; Insulin 2 Hr post dose glucose Qn; Insulin^2 hours post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1952901,Insulin^2.5H post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 2.5h p Glc SerPl-aCnc; Insulin 2.5 Hr post dose glucose Qn; Insulin^2.5 hours post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --2.5 hours post dose glucose,0
C1952902,Insulin^20M post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^20 minutes post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 20M p Glc SerPl-aCnc; Insulin 20 Min post dose glucose Qn; Insulin [Units/volume] in Serum or Plasma --20 minutes post dose glucose,0
C1952903,Insulin^3H post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 3 Hr post dose glucose Qn; Insulin^3 hours post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3h p Glc SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --3 hours post dose glucose,0
C1952904,Insulin^30M post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 30M p Glc SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --30 minutes post dose glucose; Insulin 30 Min post dose glucose Qn; Insulin^30 minutes post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1952905,Insulin^3M post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --3 minutes post dose glucose; Insulin 3 Min post dose glucose Qn; Insulin 3M p Glc SerPl-aCnc; Insulin^3 minutes post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1952906,Insulin^5M post dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^5 minutes post dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 5 Min post dose glucose Qn; Insulin 5M p Glc SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --5 minutes post dose glucose,0
C1952999,Somatotropin^1.5H post dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^1.5 hours post dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 1.5h p Ins IV SerPl-aCnc; Somatotropin 1.5 Hr post dose insulin IV Qn; Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose insulin IV,0
C1953005,Somatotropin^15M post dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^15 minutes post dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose insulin IV; Somatotropin 15 Min post dose insulin IV Qn; GH 15M p Ins IV SerPl-aCnc,0
C1953008,Somatotropin^1H post dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 1 Hr post dose insulin IV Qn; Somatotropin^1 hour post dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 1h p Ins IV SerPl-aCnc; Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose insulin IV,0
C1953070,Somatotropin^2H post dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,GH 2h p Ins IV SerPl-aCnc; Somatotropin^2 hours post dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 2 Hr post dose insulin IV Qn; Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose insulin IV,0
C1953074,Somatotropin^30M post dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,GH 30M p Ins IV SerPl-aCnc; Somatotropin 30 Min post dose insulin IV Qn; Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose insulin IV; Somatotropin^30 minutes post dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1953077,Somatotropin^45M post dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose insulin IV; GH 45M p Ins IV SerPl-aCnc; Somatotropin^45M post dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 45 Min post dose insulin IV Qn,0
C1953081,Somatotropin^pre dose insulin IV:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^pre dose insulin Intravenous:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH pre Ins IV SerPl-aCnc; Somatotropin pre dose insulin IV Qn; Somatotropin [Units/volume] in Serum or Plasma --pre dose insulin IV,0
C1953184,Insulin^post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin p meal SerPl-aCnc; Insulin^post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --post meal; Insulin post meal Qn,0
C1953208,Somatotropin^1.5H post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,GH 1.5h p Arg+Ins SerPl-aCnc; Somatotropin^1.5 hours post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 1.5 Hr post dose arginine+insulin Qn; Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin,0
C1953211,Somatotropin^1.75H post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 1.75 Hr post dose arginine+insulin Qn; Somatotropin [Units/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin; GH 1.75h p Arg+Ins SerPl-aCnc; Somatotropin^1.75H post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1953213,Somatotropin^15M post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 15 Min post dose arginine+insulin Qn; Somatotropin^15 minutes post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine+insulin; GH 15M p Arg+Ins SerPl-aCnc,0
C1953221,Somatotropin^2.25H post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 2.25 Hr post dose arginine+insulin Qn; GH 2.25h p Arg+Ins SerPl-aCnc; Somatotropin^2.25H post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Units/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin,0
C1953224,Somatotropin^2H post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine+insulin; GH 2h p Arg+Ins SerPl-aCnc; Somatotropin 2 Hr post dose arginine+insulin Qn; Somatotropin^2 hours post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1953232,Somatotropin^30M post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 30 Min post dose arginine+insulin Qn; Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine+insulin; Somatotropin^30 minutes post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 30M p Arg+Ins SerPl-aCnc,0
C1953242,Somatotropin^45M post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^45M post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine+insulin; GH 45M p Arg+Ins SerPl-aCnc; Somatotropin 45 Min post dose arginine+insulin Qn,0
C1953248,Somatotropin^5M post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^5 minutes post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose arginine+insulin; Somatotropin 5 Min post dose arginine+insulin Qn; GH 5M p Arg+Ins SerPl-aCnc,0
C1953256,Somatotropin^pre dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine+insulin; GH pre dose Arg+Ins SerPl-aCnc; Somatotropin pre dose arginine+insulin Qn; Somatotropin^pre dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1953463,Somatotropin^2.5H post dose arginine+insulin:ACnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 2.5 Hr post dose arginine+insulin Qn; Somatotropin^2.5 hours post dose arginine+insulin:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin; GH 2.5h p Arg+Ins SerPl-aCnc,0
C1953523,Insulin^10M pre dose glucose:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 10M pre Glc SerPl-aCnc; Insulin^10 minutes pre dose glucose:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --10 minutes pre dose glucose; Insulin 10 Min pre dose glucose Qn,0
C1954195,Insulin.free & Insulin.total panel:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin.free+total Pnl SerPl-aCnc; Insulin.free & Insulin.total panel:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma; Insulin.free and Insulin.total panel Qn,0
C1954196,Insulin.free & Insulin.total panel,insulin,Insulin.free and Insulin.total panel; Insulin.free & Insulin.total panel,0
C1954210,Insulin-like growth factor binding protein 3:PrThr:Pt:Urine:Ord,insulin,Insulin-like growth factor binding protein 3 [Presence] in Urine; Insulin-like growth factor binding protein 3:Presence or Threshold:To identify measures at a point in time:Urine:Ordinal; IGF BP3 Ur Ql; Insulin-like growth factor binding protein 3 Ql (U),0
C1954370,Bordetella pertussis:PrThr:Pt:Nph:Ord:Organism specific culture,NPH,B. pertussis Org specific cx Ql (Nph); B pert Nph Ql Cult; Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture; Bordetella pertussis:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Organism specific culture,0
C1955091,15 minutes pre dose arginine+insulin,insulin,15M pre dose arginine+insulin,0
C1955094,15 minutes pre dose insulin IV,insulin,15M pre dose insulin IV,0
C1955098,1 hour post dose arginine+insulin,insulin,1H post dose arginine+insulin,0
C1955101,2.5 hours post dose arginine+insulin,insulin,2.5H post dose arginine+insulin,0
C1955116,Arginine+Insulin,insulin,Arginine+Insulin,0
C1956798,"insulin-like growth factor-1, mouse",insulin,"Igf1 protein, mouse; Igf-1 protein, mouse",0
C1956934,"IGFBPL-1 protein, mouse",insulin,"insulin-like growth factor binding protein-like 1 protein, mouse",0
C1957875,Lys(B29)-N(epsilon)-lithocholoyl-gamma-Glu des(b30) insulin,insulin,"insulin, Lys(B29)-N(epsilon)-lithocholoyl-gamma-Glu des(b30)",0
C1962462,Lantus Solostar Pen,lantus,,0
C1963745,HAIR-AN syndrome,insulin,"Hyperandrogenic, insulin-resistant acanthosis nigricans syndrome; Hyperandrogenism, Insulin Resistance, Acanthosis Nigricans Syndrome; Hyperandrogenism (HA), insulin resistance (IR), and acanthosis nigricans (AN)",0
C1965649,"insulin lispro / insulin lispro protamine, human Injectable Suspension [Humalog Mix]",insulin,"insulin lispro / insulin lispro protamine, human Injectable Suspension [HumaLOG Mix]",0
C1965655,"insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML [Humalog Mix]",insulin,"insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML [HumaLOG Mix]",0
C1966505,"BD MF Insulin Syringe 0.3cc 28g 1/2""",insulin,"BD Insulin Syringe 0.3cc 28g 1/2"" (MF)",0
C1966506,BD MF Insulin Syringe 0.5cc 28g,insulin,,0
C1966509,BD MF Insulin Syringe 1cc 28g,insulin,,0
C1966514,"BD Insulin Syringe 0.3cc 31g 5/16"" (UF II)",insulin,"BD Insulin Syringe 0.3cc 31g 5/16"" 0.5u(UFII)",0
C1966516,"BD Insulin Syringe 0.5cc 31g 5/16"" (UF II)",insulin,,0
C1966517,"BD Insulin Syringe 1cc 31g 5/16"" (UF II)",insulin,,0
C1966518,BD UF Insulin Syringe 0.3cc 29g,insulin,,0
C1966519,BD UF Insulin Syringe 0.5cc 29g,insulin,BD Insulin Syringe 0.5cc 29g (UF),0
C1966521,"BD UF Insulin Syringe 29g 1/2""",insulin,,0
C1971395,"External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories",insulin,,0
C1976721,Bowel elimination pattern regular - at least one movement every three D,regular,Bowel elimination pattern regular - at least one movement every three D; Bowel elimination pattern regular - at least one movement every three days,0
C1976731,Regular or repetitive complaints of hunger,regular,Regular or repetitive complaints of hunger,0
C1976983,Insulin-like growth factor-I^baseline:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --baseline; Insulin-like growth factor-I^baseline:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF-I BS SerPl-mCnc; Insulin-like growth factor-I baseline [Mass/Vol],0
C1977768,Insulin^pre XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^pre XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin pre Unsp challenge Qn; Insulin pre chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --pre XXX challenge,0
C1978315,Cortisol^30M pre dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Cortis 30M pre Ins IV SerPl-mCnc; Cortisol [Mass/volume] in Serum or Plasma --30 minutes pre dose insulin IV; Cortisol^30 minutes pre dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol 30 Min pre dose insulin IV [Mass/Vol],0
C1978316,Cortisol^20M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Cortisol [Mass/volume] in Serum or Plasma --20 minutes post dose insulin IV; Cortis 20M p Ins IV SerPl-mCnc; Cortisol^20 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Cortisol 20 Min post dose insulin IV [Mass/Vol],0
C1978375,Insulin^1st specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^1st specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp1 SerPl-aCnc; Insulin spec 1 Qn; Insulin [Units/volume] in Serum or Plasma --1st specimen,0
C1978376,Insulin^2nd specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin spec 2 Qn; Insulin sp2 SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --2nd specimen; Insulin^2nd specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1978377,Insulin^3rd specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^3rd specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp3 SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --3rd specimen; Insulin spec 3 Qn,0
C1978378,Insulin^4th specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin spec 4 Qn; Insulin sp4 SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --4th specimen; Insulin^4th specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1978379,Insulin^5th specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin sp5 SerPl-aCnc; Insulin 5th specimen Qn; Insulin [Units/volume] in Serum or Plasma --5th specimen; Insulin^5th specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1978380,Insulin^6th specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 6th specimen Qn; Insulin [Units/volume] in Serum or Plasma --6th specimen; Insulin^6th specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin sp6 SerPl-aCnc,0
C1978381,Insulin^7th specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 7th specimen Qn; Insulin sp7 SerPl-aCnc; Insulin^7th specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --7th specimen,0
C1978382,Insulin^8th specimen:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^8th specimen:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --8th specimen; Insulin 8th specimen Qn; Insulin sp8 SerPl-aCnc,0
C1978654,Insulin XXX challenge panel:-:Pt:Ser:Qn,insulin,Insulin Unsp challenge panel (S); Insulin XXX challenge Pnl Ser; Insulin XXX challenge panel - Serum; Insulin XXX challenge panel:-:To identify measures at a point in time:Serum:Quantitative,0
C1978655,Insulin XXX challenge panel,insulin,Insulin XXX challenge panel,0
C1978755,Glucose^15M post 0.1 U/kg insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose^15 minutes post 0.1 U/kg insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 15 Min post 0.1 U/kg insulin [Mass/Vol]; Glucose [Mass/volume] in Serum or Plasma --15 minutes post 0.1 U/kg insulin; Glucose 15M p 0.1 U/kg Ins SerPl-mCnc,0
C1978756,Cortisol^15M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Cortis 15M p Ins IV SerPl-mCnc; Cortisol 15 Min post dose insulin IV [Mass/Vol]; Cortisol [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV; Cortisol^15 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1978757,Somatotropin^15M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 15 Min post dose insulin IV [Mass/Vol]; Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV; GH 15M p Ins IV SerPl-mCnc; Somatotropin^15 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C1978908,Insulin:SCnc:Pt:Body fld:Qn,insulin,"Insulin [Moles/volume] in Body fluid; Insulin (Body fld) [Moles/Vol]; Insulin Fld-sCnc; Insulin:Substance Concentration:To identify measures at a point in time:Body fluid, unsp:Quantitative",0
C1979450,Insulin^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin pre or post Unsp challenge [Moles/Vol]; Insulin pre/p chal SerPl-sCnc; Insulin^pre or post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge,0
C1979520,15 minutes post 0.1 U/kg insulin,insulin,15M post 0.1 U/kg insulin,0
C1979532,20 minutes post dose insulin IV,insulin,20M post dose insulin IV,0
C1979541,30 minutes pre dose insulin IV,insulin,30M pre dose insulin IV,0
C1995426,INSULIN SYRINGE 1ML SLIP TIP,insulin,INSULIN SYRINGE 1ML SLIP TIP,0
C1995853,"insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML [Humalog Mix]",insulin,"insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML [HumaLOG Mix]",0
C1997301,Palpitations with regular rhythm,regular,Palpitations with regular rhythm (finding),0
C1999661,"BAIAP2L1 protein, human",insulin,"BAR-IMD domain containing adaptor protein 2 like 1 protein, human; BAI1-associated protein 2-like 1 protein, human; IRTKS protein, human; insulin receptor tyrosine kinase substrate protein, human",0
C2002841,"RPS6KA3 protein, human",insulin,"Mitogen-Activated Protein Kinase-Activated Protein Kinase 1b; MAPKAP Kinase 1b; p90RSK3; ISPK-1; ribosomal protein S6 kinase, 90kDa, polypeptide 3, human; p90-RSK 3; Insulin-Stimulated Protein Kinase 1; Ribosomal Protein S6 Kinase 2; EC 2.7.11.1; pp90RSK2; S6K-Alpha 3; RPS6KA3 protein, human; Ribosomal Protein S6 Kinase Alpha-3; Ribosomal Protein S6 Kinase A3; MAPKAPK1B; MAP Kinase-Activated Protein Kinase 1b; RSK-2; 90 kDa Ribosomal Protein S6 Kinase 3; RPS6KA3; MAPKAPK-1b; S6K-Alpha-3; MAPK-Activated Protein Kinase 1b",0
C2003521,"insulin aspart, insulin aspart protamine drug combination 30:70",insulin,BIAsp 30; biphasic insulin aspart 30:70; BIAsp30; insulin aspart - insulin aspart protamine (30:70); biphasic insulin aspart 30,0
C2047218,"insulin lispro / insulin lispro protamine, human",insulin,,0
C2054149,History of taking medication for diabetes long-term use of insulin,insulin,,0
C2077427,insulin tolerance panel (lab test),insulin,,0
C2228890,Mechanical complication due to insulin pump,insulin,Complications due to insulin pump,0
C2241035,"BD Insulin Syringe 1cc 30g 1/2"" (UF)",insulin,,0
C2241735,Humalog Kwikpen,humalog,"HumaLOG KwikPen; Kwikpen, Humalog",0
C2242121,"insulin human, rDNA origin 1 MG Inhalation Powder",insulin,"insulin human, rDNA origin 1 MG Inhalation Powder",0
C2242122,"insulin human, rDNA origin 3 MG Inhalation Powder",insulin,"insulin human, rDNA origin 3 MG Inhalation Powder",0
C2242125,"insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]",insulin,"Exubera 1 MG/ACTUAT Inhalation Powder; insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]",0
C2242126,"insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]",insulin,"Exubera 3 MG/ACTUAT Inhalation Powder; insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]",0
C2242697,Anti-insulin receptor antibody (lab procedure),insulin,,0
C2243091,regular exercise (therapy),regular,,0
C2243092,Insulin Autoantibody Measurement,insulin,Insulin Autoantibody Measurement,0
C2245392,activation of insulin secretion,insulin,,0
C2245393,stimulation of insulin secretion,insulin,,0
C2245793,insulin-responsive compartment,insulin,IRC; GLUT4 storage compartment; insulin-responsive compartment; GSC,0
C2246187,response to insulin,insulin,response to insulin stimulus,0
C2246188,cellular response to insulin stimulus,insulin,,0
C2248584,activation of insulin-like growth factor receptor signaling pathway,insulin,,0
C2248585,stimulation of insulin-like growth factor receptor signaling pathway,insulin,,0
C2248588,inhibition of insulin-like growth factor receptor signaling pathway,insulin,,0
C2250287,inhibition of insulin receptor signaling pathway,insulin,,0
C2250288,activation of insulin receptor signaling pathway,insulin,,0
C2250289,stimulation of insulin receptor signaling pathway,insulin,,0
C2250323,inhibition of insulin secretion,insulin,,0
C2250882,insulin-glutathione transhydrogenase activity,insulin,protein-disulfide reductase activity; protein disulphide reductase activity; protein disulfide reductase (NAD(P)H) activity; protein-disulphide reductase activity; disulfide reductase activity; protein disulphide oxidoreductase activity; insulin-glutathione transhydrogenase activity; protein-disulfide reductase (NAD(P)) activity; protein disulfide oxidoreductase activity; NAD(P)H:protein-disulfide oxidoreductase activity; protein disulfide-oxidoreductase activity; protein disulfide reductase activity; peptide disulfide oxidoreductase activity; peptide disulphide oxidoreductase activity,0
C2262316,insulin-responsive hydrogen:glucose symporter activity,insulin,insulin-responsive hydrogen:glucose symporter activity; transepithelial hydrogen/glucose transporter activity; insulin-responsive glucose:proton symporter activity; insulin-responsive hydrogen:glucose transporter activity,0
C2323654,Dense regular collagenous tissue of tendon,regular,,0
C2324407,Dense regular collagenous tissue of left cornea,regular,,0
C2325541,Fibroblast of dense regular elastic tissue,regular,,0
C2329620,Regular interatrial cardiac myocyte,regular,,0
C2330081,Dense regular collagenous tissue of cornea,regular,,0
C2331147,Dense regular collagenous tissue of right cornea,regular,,0
C2331714,Regular interventricular cardiac myocyte,regular,,0
C2333269,Dense regular elastic tissue of lamina propria of esophagus,regular,,0
C2333348,Dense regular collagenous tissue of submucosa of esophagus,regular,,0
C2334000,Dense regular collagenous tissue of skeletal ligament,regular,,0
C2334101,Regular atrial cardiac myocyte,regular,Regular atrial cardiac muscle cell; Regular atrial cardiac muscle fiber; Regular cardiac muscle cell of atrium; Atrial myocyte,0
C2335139,Dense regular collagenous tissue of fibrous capsule of spleen,regular,,0
C2335584,Dense regular elastic tissue of pectinate muscle,regular,,0
C2339371,Regular ventricular cardiac myocyte,regular,Ventricular myocyte; Regular ventricular cardiac muscle fiber; Regular cardiac muscle cell of ventricle; Regular ventricular cardiac muscle cell,0
C2342951,SINUS RINSE NEILMED REGULAR KIT,regular,SINUS RINSE NEILMED REGULAR KIT,0
C2343558,Insulin Diluting Medium for NovoLOG,insulin,,0
C2344515,acetaminophen 325 MG Oral Tablet [Tactinal],regular,Tactinal 325 MG Oral Tablet; APAP 325 MG Oral Tablet [Tactinal]; ACETAMINOPHEN 325 mg ORAL TABLET [HEALTH SENSE TACTINAL Regular Strength],0
C2346322,HumaLOG Cartridge,humalog,,0
C2346451,IGFBP7 wt Allele,insulin,MAC25; IGFBP-7v; PSF; TAF; AGM; IGFBPRP1; IGFBP7 wt Allele; RAMSVPS; Insulin-Like Growth Factor Binding Protein 7 wt Allele; IBP-7; IGFBP-7; FSTL2,0
C2349379,Secondary diabetes mellitus with insulin coma NOS,insulin,,0
C2350409,Insulin Receptor Substrate Proteins,insulin,IRS Signaling Adaptor Proteins,0
C2350410,Insulin Receptor Substrate-3 Protein,insulin,Insulin Receptor Substrate 3; Insulin Receptor Substrate 3 Protein; Insulin Receptor Substrate-3,0
C2352518,"insulin-like peptide 7, Drosophila",insulin,"ILP7, Drosophila",0
C2356249,"insulin glulisine, human 100 UNT/ML [Apidra]",insulin,,0
C2356250,"insulin glulisine, human Injectable Solution [Apidra]",insulin,,0
C2356251,"insulin glulisine, human 100 UNT/ML Injectable Solution [Apidra]",insulin,"Apidra 100 UNT/ML Injectable Solution; INSULIN GLULISINE 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Apidra]; Apidra, 100 units/mL injectable solution; insulin glulisine, human 100 UNT/ML Injectable Solution [Apidra]; INSULIN GLULISINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Apidra]",0
C2356407,"BELT,OSTOMY REGULAR PERMA TYPE #C116R000",regular,"BELT,OSTOMY REGULAR PERMA TYPE #C116R000",0
C2362594,"IRS4 protein, human",insulin,"IRS-4; IRS4; 160 kDa Phosphotyrosine Protein; PY160; Phosphoprotein of 160 kDa; IRS-4 protein, human; Insulin Receptor Substrate 4; IRS4 protein, human; pp160; insulin receptor substrate 4 protein, human; PY160 protein, human",0
C2363249,Insulin-Like growth factor-I [Mass or Molecules/volume] in Serum or Plasma,insulin,Insulin-like growth factor-I:Mass or Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF-I SerPl-msCnc; Insulin-like growth factor-I [Mass or Moles/volume] in Serum or Plasma; Insulin-like growth factor-I [Mass or moles/Vol]; Insulin-like growth factor-I:MSCnc:Pt:Ser/Plas:Qn,0
C2363710,Pen-Like Insulin Syringes,insulin,"Pen-Like Syringes, Insulin",0
C2369890,CVS Belted Undergarment Regular,regular,,0
C2370251,"BRIEF,PREVAIL REGULAR #IBF016",regular,"BRIEF,PREVAIL REGULAR #IBF016",0
C2452913,"Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ Hormone @ Insulin,0
C2452954,"Introduction of Insulin into Peripheral Vein, Open Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Peripheral Vein @ Open @ Hormone @ Insulin,0
C2452984,"Introduction of Insulin into Peripheral Vein, Percutaneous Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Peripheral Vein @ Percutaneous @ Hormone @ Insulin,0
C2453012,"Introduction of Insulin into Central Vein, Open Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Central Vein @ Open @ Hormone @ Insulin,0
C2453040,"Introduction of Insulin into Central Vein, Percutaneous Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Central Vein @ Percutaneous @ Hormone @ Insulin,0
C2453068,"Introduction of Insulin into Peripheral Artery, Open Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Peripheral Artery @ Open @ Hormone @ Insulin,0
C2453096,"Introduction of Insulin into Peripheral Artery, Percutaneous Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Peripheral Artery @ Percutaneous @ Hormone @ Insulin,0
C2453124,"Introduction of Insulin into Central Artery, Open Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Central Artery @ Open @ Hormone @ Insulin,0
C2453152,"Introduction of Insulin into Central Artery, Percutaneous Approach",insulin,Administration @ Physiological Systems and Anatomical Regions @ Introduction @ Central Artery @ Percutaneous @ Hormone @ Insulin,0
C2585401,Initiation of first time insulin therapy,insulin,Initiation of first time insulin therapy (regime/therapy),0
C2586365,MiniMed Insulin Pump Reservoir 3 mL,insulin,,0
C2586612,"BRIEF,PROTECTION PLUS REGULAR #MSC94400A",regular,"BRIEF,PROTECTION PLUS REGULAR #MSC94400A",0
C2599506,1.3 hours post dose insulin IV,insulin,1.3H post dose insulin IV,0
C2599520,2.5 hours post dose insulin IV,insulin,2.5H post dose insulin IV,0
C2599537,3 hours pre dose insulin IV,insulin,3H pre dose insulin IV,0
C2607839,Insulin^pre or post dose glucose:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^pre or post dose glucose:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin pre or post dose glucose [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --pre or post dose glucose; Insulin pre/p Glc SerPl-sCnc,0
C2675472,"Diabetes Mellitus, Insulin-Dependent, 23",insulin,"DIABETES MELLITUS, INSULIN-DEPENDENT, 23; TYPE 1 DIABETES MELLITUS 23; T1D23; IDDM23",0
C2675864,"DIABETES MELLITUS, INSULIN-DEPENDENT, 22 (disorder)",insulin,"IDDM22; Diabetes Mellitus, Insulin-Dependent, 22; TYPE 1 DIABETES MELLITUS 22; T1D22; DIABETES MELLITUS, INSULIN-DEPENDENT, 22",0
C2675865,"DIABETES MELLITUS, INSULIN-DEPENDENT, 21 (disorder)",insulin,"DIABETES MELLITUS, INSULIN-DEPENDENT, 21; TYPE 1 DIABETES MELLITUS 21; Diabetes Mellitus, Insulin-Dependent, 21; T1D21; IDDM21",0
C2675866,"DIABETES MELLITUS, INSULIN-DEPENDENT, 20 (disorder)",insulin,"T1D20; DIABETES MELLITUS, INSULIN-DEPENDENT, 20; Diabetes Mellitus, Insulin-Dependent, 20; IDDM20; TYPE 1 DIABETES MELLITUS 20",0
C2676198,Increased serum insulin-like growth factor 1,insulin,Increased serum IGF1; Increased serum insulin-like growth factor 1; Elevated serum IGF1,0
C2676369,FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1,insulin,FIQTL1,0
C2677129,"Insulin resistance, variable",insulin,,0
C2683543,"3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Humulin]",insulin,"3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Humulin]; INSULIN HUMULIN 70/30 INJ PEN 3ML; Insulin human 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humulin 70/30 KwikPen]; 3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [HumuLIN]; Humulin 70/30 per 3 ML KwikPen; INSULIN HUMULIN 70/30 (NPH/REG) INJ PEN,3ML; HumuLIN 70/30 KwikPen; HumuLIN 70/30 per 3 ML KwikPen; HumuLIN 70/30 in 3 ML Pen Injector; HumuLIN 70/30 KwikPen, human recombinant 70 units-30 units/mL subcutaneous suspension",0
C2683545,Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL,insulin,,0
C2683547,"3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]",insulin,"INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [NovoLog Mix 70/30]; 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]; NovoLOG Mix 70/30 per 3 ML Pen Injector; Relion NovoLOG Mix 70/30 FlexPen, 30 units-70 units/mL subcutaneous suspension; NovoLog Mix 70/30 per 3 ML Pen Injector; NovoLOG Mix 70/30 in 3 ML Pen Injector; INSULIN,ASPART 70/30 NOVOLOG FLEXPEN 3ML; 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLOG Mix]; INSULIN,ASPART,HUMAN 70/30 INJ,NOVOLOG,FLEXPEN,3ML; NovoLOG Mix 70/30 FlexPen, 30 units-70 units/mL subcutaneous suspension",0
C2683552,"3 ML insulin isophane, human 100 UNT/ML Pen Injector [Humulin N]",insulin,"3 ML Humulin N 100 UNT/ML Pen Injector; 3 ML HumuLIN N 100 UNT/ML Pen Injector; 3 ML insulin isophane, human 100 UNT/ML Pen Injector [HumuLIN N]; Insulin human 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humulin N]; HumuLIN N (insulin isophane (NPH), human) 100 UNT/ML per 3 ML KwikPen; 3 ML insulin isophane, human 100 UNT/ML Pen Injector [Humulin N]; HumuLIN N 100 UNT/ML in 3 ML Pen Injector; INSULIN NPH HUMULIN-N 100 U/ML INJ PEN 3ML; Humulin N (insulin isophane (NPH), human) 100 UNT/ML per 3 ML KwikPen; HumuLIN N KwikPen, human recombinant 100 units/mL subcutaneous suspension; INSULIN NPH HUMULIN-N 100UNIT/ML PEN 3ML",0
C2683557,"3 ML insulin, regular, human 100 UNT/ML Prefilled Syringe [Novolin R]",insulin,,0
C2683559,3 ML insulin lispro 100 UNT/ML Cartridge,insulin,"insulin lispro 100 UNT/ML in 3 ML Cartridge; insulin lispro 100 UNT/ML per 3 ML Cartridge; INSULIN,LISPRO,HUMAN 100 UNIT/ML INJ,CARTRIDGE,3ML; INSULIN LISPRO HUMAN 100UNIT/ML CART 3ML",0
C2683561,3 ML Insulin Lispro 100 UNT/ML Cartridge [Humalog],insulin,"HumaLOG 100 UNT/ML per 3 ML Cartridge; HumaLOG Cartridge, 100 units/mL injectable solution; 3 ML HumaLOG 100 UNT/ML Cartridge; 3 ML Humalog 100 UNT/ML Cartridge; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog]; Insulin lispro 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Humalog]; HumaLOG 100 UNT/ML in 3 ML Cartridge; 3 ML insulin lispro 100 UNT/ML Cartridge [HumaLOG]; 3 ML insulin lispro 100 UNT/ML Cartridge [Humalog]; Humalog 100 UNT/ML per 3 ML Cartridge",0
C2683563,"3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector",insulin,"INSULIN,LISPRO,HUMAN 50/50 3ML PEN INJ; insulin lispro protamine / insulin lispro 50/50 in 3 ML Pen Injector; INSULIN,LISPRO,HUMAN 50/50 INJ,PEN,3ML; INSULIN,LISPRO,HUMAN 50/50 INJ,KWIKPEN,3ML; insulin lispro protamine 150 UNT / insulin lispro 150 UNT per 3 ML Pen Injector; INSULIN,LISPRO,HUMAN 50/50 3ML KWIKPEN",0
C2683565,"3 ML Insulin Lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]",insulin,"HumaLOG Mix 50/50 KwikPen, 50 units-50 units/mL subcutaneous suspension; Humalog Mix 50/50 300 UNT per 3 ML KwikPen; Humalog Mix 50/50 300 UNT per 3 ML Prefilled Pen; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humalog Mix50/50 KwikPen]; HumaLOG Mix 50/50 KwikPen; 3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]; 3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [HumaLOG Mix]; HumaLOG Mix 50/50 in 3 ML Pen Injector; HumaLOG Mix 50/50 300 UNT per 3 ML Prefilled Pen; HumaLOG Mix 50/50 300 UNT per 3 ML KwikPen; HumaLOG Mix 50/50 Pen",0
C2683584,3 ML insulin glargine 100 UNT/ML Pen Injector [Lantus],insulin,"Lantus 100 UNT/ML in 3 ML Pen Injector; insulin glargine 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Lantus Solostar]; Lantus 300 UNT per 3 ML OptiClik Pen; Lantus 300 UNT per 3 ML SoloStar Pen; 3 ML Lantus 100 UNT/ML Pen Injector; 3 ML insulin glargine 100 UNT/ML Pen Injector [Lantus]; Lantus Solostar Pen, 100 units/mL subcutaneous solution; Lantus 300 UNT per 3 ML Pen Injector; INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Lantus Solostar]",0
C2683592,3 ML insulin detemir 100 UNT/ML Pen Injector [Levemir],insulin,"Levemir 100 UNT/ML 3 ML PenFill; 3 ML insulin detemir 100 UNT/ML Pen Injector [Levemir]; Levemir 100 UNT/ML 3 ML FlexTouch; INSULIN DETEMIR 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Levemir]; Levemir 100 UNT/ML in 3 ML Pen Injector; 3 ML Levemir 100 UNT/ML Pen Injector; Levemir 100 UNT/ML 3 ML FlexPen; Levemir FlexTouch, 100 units/mL subcutaneous solution",0
C2683601,"3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector",insulin,"INSULIN,LISPRO,HUMAN 75/25 INJ,KWIKPEN,3ML; insulin lispro protamine 75 UNT/ML / insulin lispro 25 UNT/ML per 3 ML Pen Injector; INSULIN,LISPRO,HUMAN 75/25 3ML KWIKPEN; Insulin Lispro Protamine-Insulin Lispro Mix75/25 KwikPen, 25 units-75 units/mL subcutaneous suspension; INSULIN,LISPRO,HUMAN 75/25 3ML PEN INJ; insulin lispro protamine / insulin lispro 75/25 in 3 ML Pen Injector; INSULIN,LISPRO,HUMAN 75/25 INJ,PEN,3ML; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen]",0
C2683603,"3 ML Insulin Lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [Humalog Mix]",insulin,"HumaLOG Mix 75/25 300 UNT per 3 ML KwikPen; Humalog Mix 75/25 300 UNT per 3 ML Pen; HumaLOG Mix 75/25 KwikPen, 25 units-75 units/mL subcutaneous suspension; 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [HumaLOG Mix]; HumaLOG Mix 75/25 KwikPen; HumaLOG Mix 75/25 UNT in 3 ML Pen Injector; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humalog Mix75/25 KwikPen]; 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [Humalog Mix]; HumaLOG Mix 75/25 300 UNT per 3 ML Pen; Humalog Mix 75/25 300 UNT per 3 ML KwikPen",0
C2683609,"3 ML insulin glulisine, human 100 UNT/ML Pen Injector [Apidra]",insulin,"3 ML insulin glulisine, human 100 UNT/ML Pen Injector [Apidra]; Apidra SoloStar Pen, 100 units/mL injectable solution; 3 ML Apidra 100 UNT/ML Pen Injector; Apidra 100 UNT/ML in 3 ML Pen Injector; Apidra 100 UNT/ML per 3 ML SoloSTAR Pen; INSULIN GLULISINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Apidra SoloStar]",0
C2683612,"3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog]",insulin,"NovoLOG 100 UNT/ML in 3 ML Cartridge; 3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLOG]; 3 ML NovoLOG 100 UNT/ML Cartridge; NovoLOG PenFill, 100 units/mL injectable solution; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [NOVOLOG]; INSULIN ASPART 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [NOVOLOG]; 3 ML NovoLog 100 UNT/ML Cartridge; 3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog]",0
C2683621,"1.5 ML insulin isophane, human 100 UNT/ML Prefilled Syringe [Humulin N]",insulin,,0
C2697754,Insulin Like Growth Factor-2 Measurement,insulin,Insulin Like Growth Factor-2 Measurement,0
C2700448,Novolin 70/30 includes 1.5 ML & 3 ML Prefilled Syringe,novolin,,0
C2706778,Insulin-like growth factor binding protein 1^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma --pre or post XXX challenge; Insulin-like growth factor binding protein 1^pre or post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF BP1 pre/p chal SerPl-mCnc; Insulin-like growth factor binding protein 1 pre or post Unsp challenge [Mass/Vol],0
C2706820,Glucose^pre dose insulin IV:SCnc:Pt:Ser/Plas:Qn,insulin,Glucose^pre dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose pre Ins IV SerPl-sCnc; Glucose pre dose insulin IV [Moles/Vol]; Glucose [Moles/volume] in Serum or Plasma --pre dose insulin IV,0
C2706821,Glucose^2 hours post dose insulin Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose^2H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn; Glucose 2 Hr post dose insulin IV [Moles/Vol]; Glucose [Moles/volume] in Serum or Plasma --2 hours post dose insulin IV; Glucose 2h p Ins IV SerPl-sCnc; Glucose^2 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2706822,Glucose^2 1/2 hours post dose insulin Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose^2.5 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 2.5h p Ins IV SerPl-sCnc; Glucose 2.5 Hr post dose insulin IV [Moles/Vol]; Glucose^2.5H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn; Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose insulin IV,0
C2706823,Glucose^15 minutes post dose insulin Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose insulin IV; Glucose 15M p Ins IV SerPl-sCnc; Glucose^15M post dose insulin IV:SCnc:Pt:Ser/Plas:Qn; Glucose^15 minutes post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 15 Min post dose insulin IV [Moles/Vol],0
C2706824,Glucose^15M pre dose insulin IV:SCnc:Pt:Ser/Plas:Qn,insulin,Glucose^15 minutes pre dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose insulin IV; Glucose 15 Min pre dose insulin IV [Moles/Vol]; Glucose 15M pre Ins IV SerPl-sCnc,0
C2706825,Glucose^3H pre dose insulin IV:SCnc:Pt:Ser/Plas:Qn,insulin,Glucose 3 Hr pre dose insulin IV [Moles/Vol]; Glucose 3h pre Ins IV SerPl-sCnc; Glucose^3 hours pre dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose [Moles/volume] in Serum or Plasma --3 hours pre dose insulin IV,0
C2706826,Glucose^30 minutes post dose insulin Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose 30M p Ins IV SerPl-sCnc; Glucose 30 Min post dose insulin IV [Moles/Vol]; Glucose^30M post dose insulin IV:SCnc:Pt:Ser/Plas:Qn; Glucose^30 minutes post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose insulin IV,0
C2706827,Glucose^45M post dose insulin Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose^45M post dose insulin IV:SCnc:Pt:Ser/Plas:Qn; Glucose^45M post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 45M p Ins IV SerPl-sCnc; Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose insulin IV; Glucose 45 Min post dose insulin IV [Moles/Vol],0
C2706828,Glucose^1 hour post dose insulin Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Glucose [Moles/volume] in Serum or Plasma --1 hour post dose insulin IV; Glucose^1 hour post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose^1H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn; Glucose 1 Hr post dose insulin IV [Moles/Vol]; Glucose 1h p Ins IV SerPl-sCnc,0
C2706829,Glucose^1.3H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn,insulin,Glucose 1.3h p Ins IV SerPl-sCnc; Glucose 1.3 Hr post dose insulin IV [Moles/Vol]; Glucose^1.3 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose insulin IV,0
C2706830,Glucose^1.5H post dose insulin IV:SCnc:Pt:Ser/Plas:Qn,insulin,Glucose 1.5 Hr post dose insulin IV [Moles/Vol]; Glucose 1.5h p Ins IV SerPl-sCnc; Glucose^1.5 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose insulin IV,0
C2708622,Insulin^5M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^5 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 5M p chal SerPl-sCnc; Insulin 5 Min post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge,0
C2708623,Insulin^10M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^10 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10M p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge; Insulin 10 Min post Unsp challenge [Moles/Vol],0
C2708624,Insulin^3M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 3 Min post Unsp challenge [Moles/Vol]; Insulin^3 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge; Insulin 3M p chal SerPl-sCnc,0
C2708625,Insulin^15M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 15 Min post Unsp challenge [Moles/Vol]; Insulin 15M p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge; Insulin^15 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2708626,Insulin^2M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^2 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2 Min post Unsp challenge [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge; Insulin 2M p chal SerPl-sCnc,0
C2708627,Insulin^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^45M post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge; Insulin 45M p chal SerPl-sCnc; Insulin 45 Min post Unsp challenge [Moles/Vol],0
C2708628,Insulin^4H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 4h p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --4 hours post XXX challenge; Insulin 4 Hr post Unsp challenge [Moles/Vol]; Insulin^4 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2708629,Insulin^5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --5 hours post XXX challenge; Insulin 5h p chal SerPl-sCnc; Insulin^5 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 5 Hr post Unsp challenge [Moles/Vol],0
C2708630,Insulin^6H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --6 hours post XXX challenge; Insulin^6 hours post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 6 Hr post Unsp challenge [Moles/Vol]; Insulin 6h p chal SerPl-sCnc,0
C2708631,Insulin^4M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --4 minutes post XXX challenge; Insulin 4 Min post Unsp challenge [Moles/Vol]; Insulin^4 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 4M p chal SerPl-sCnc,0
C2708632,Insulin^1M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 1M p chal SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge; Insulin^1 minute post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1 Min post Unsp challenge [Moles/Vol],0
C2708703,Insulin^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 20 Min post Unsp challenge [Moles/Vol]; Insulin^20 minutes post XXX challenge:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge; Insulin 20M p chal SerPl-sCnc,0
C2708759,Insulin^7M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --7 minutes post dose glucose IV; Insulin 7M p Glc IV SerPl-sCnc; Insulin^7 minutes post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 7 Min post dose glucose IV [Moles/Vol],0
C2708760,Insulin^5M pre dose glucose:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose; Insulin 5 Min pre dose glucose [Moles/Vol]; Insulin^5 minutes pre dose glucose:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 5M pre Glc SerPl-sCnc,0
C2708761,Insulin^10M pre dose glucose:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^10 minutes pre dose glucose:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10 Min pre dose glucose [Moles/Vol]; Insulin 10M pre Glc SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --10 minutes pre dose glucose,0
C2708762,Insulin^4H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^4 hours post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 4 Hr post dose glucose IV [Moles/Vol]; Insulin 4h p Glc IV SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --4 hours post dose glucose IV,0
C2708763,Insulin^1.5H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 1.5h p Glc IV SerPl-sCnc; Insulin^1.5 hours post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.5 Hr post dose glucose IV [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose IV,0
C2708764,Insulin^10M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 10M p Glc IV SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --10 minutes post dose glucose IV; Insulin^10 minutes post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 10 Min post dose glucose IV [Moles/Vol],0
C2708765,Insulin^1 hour post dose glucose Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucose IV; Insulin^1H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn; Insulin 1 Hr post dose glucose IV [Moles/Vol]; Insulin^1 hour post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1h p Glc IV SerPl-sCnc,0
C2708766,Insulin^1M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^1 minute post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1M p Glc IV SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --1 minute post dose glucose IV; Insulin 1 Min e post dose glucose IV [Moles/Vol],0
C2708767,Insulin^2 1/2 hours post dose glucose Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Insulin 2.5h p Glc IV SerPl-sCnc; Insulin 2.5 Hr post dose glucose IV [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose IV; Insulin^2.5H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn; Insulin^2.5 hours post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2708768,Insulin^1H post dose glucagon:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucagon; Insulin 1h p Gc SerPl-sCnc; Insulin^1 hour post dose glucagon:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1 Hr post dose glucagon [Moles/Vol],0
C2708769,Insulin^1.5H post dose glucagon:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^1.5 hours post dose glucagon:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucagon; Insulin 1.5h p Gc SerPl-sCnc; Insulin 1.5 Hr post dose glucagon [Moles/Vol],0
C2708770,Insulin^45M post dose glucagon:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^45M post dose glucagon:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 45 Min post dose glucagon [Moles/Vol]; Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucagon; Insulin 45M p Gc SerPl-sCnc,0
C2708771,Insulin^2H post dose glucagon:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 2 Hr post dose glucagon [Moles/Vol]; Insulin 2h p Gc SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucagon; Insulin^2 hours post dose glucagon:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2708772,Insulin^30 minutes post dose glucose Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Insulin^30M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn; Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucose IV; Insulin 30 Min post dose glucose IV [Moles/Vol]; Insulin 30M p Glc IV SerPl-sCnc; Insulin^30 minutes post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2708773,Insulin^3H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --3 hours post dose glucose IV; Insulin 3 Hr post dose glucose IV [Moles/Vol]; Insulin 3hp Glc IV SerPl-sCnc; Insulin^3 hours post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2708774,Insulin^5M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 5M p Glc IV SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --5 minutes post dose glucose IV; Insulin^5 minutes post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 5 Min post dose glucose IV [Moles/Vol],0
C2708775,Insulin^45M post dose glucose Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Insulin 45 Min post dose glucose IV [Moles/Vol]; Insulin^45M post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin^45M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn; Insulin 45M p Glc IV SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucose IV,0
C2708776,Insulin^2 hours post dose glucose Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucose IV; Insulin 2 Hr post dose glucose IV [Moles/Vol]; Insulin^2 hours post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2h p Glc IV SerPl-sCnc; Insulin^2H post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,0
C2708777,Insulin^3M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --3 minutes post dose glucose IV; Insulin^3 minutes post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3 Min post dose glucose IV [Moles/Vol]; Insulin 3M p Glc IV SerPl-sCnc,0
C2708778,Insulin^7M pre dose glucose:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 7M pre Glc SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --7 minutes pre dose glucose; Insulin 7 Min pre dose glucose [Moles/Vol]; Insulin^7 minutes pre dose glucose:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2708779,Insulin^15 minutes post dose glucose Intravenous:Substance Concentration:Point in time:Serum/Plasma:Quantitative,insulin,Insulin^15 minutes post dose glucose Intravenous:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --15 minutes post dose glucose IV; Insulin 15M p Glc IV SerPl-sCnc; Insulin^15M post dose glucose IV:SCnc:Pt:Ser/Plas:Qn; Insulin 15 Min post dose glucose IV [Moles/Vol],0
C2708780,Insulin^30M post dose glucagon:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 30M p Gc SerPl-sCnc; Insulin^30 minutes post dose glucagon:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucagon; Insulin 30 Min post dose glucagon [Moles/Vol],0
C2709840,ATTENDS REGULAR BRIEF X-LARGE,regular,ATTENDS REGULAR BRIEF X-LARGE,0
C2711433,Does rotate site of insulin injection,insulin,Does rotate site of insulin injection (finding),0
C2713141,Deprecated Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV,insulin,Cortisol 1 Hr post dose U/kg insulin IV (P) [Mass/Vol],0
C2713142,Deprecated Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV,insulin,Cortisol 30 Min post dose U/kg insulin IV (P) [Mass/Vol],0
C2713143,Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV,insulin,Glucose 1 Hr post dose U/kg insulin IV (P) [Mass/Vol],0
C2713144,Deprecated Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV,insulin,Glucose 30 Min post dose U/kg insulin IV (P) [Mass/Vol],0
C2715235,"Baiap2 protein, mouse",insulin,"insulin receptor substrate p53, mouse; IRSp53 protein, mouse; brain-specific angiogenesis inhibitor 1-associated protein 2, mouse",0
C2717409,"ILP3 protein, Drosophila",insulin,"insulin-like peptide 3, Drosophila",0
C2717492,"3,4-dihydroxybenzaldehyde-4-nitrophenylhydrazone",NPH,"3,4-DHB-NPH cpd",0
C2717493,"2,4-dihydroxybenzaldehyde-4-nitrophenylhydrazone",NPH,"2,4-DHB-NPH cpd",0
C2718211,Deprecated Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV,insulin,Prolactin 30 Min post dose U/kg insulin IV (P) [Mass/Vol],0
C2722426,Maalox Advanced,regular,Maalox Advanced Regular Strength,0
C2722833,insulin lispro Injectable Solution [Humalog],insulin,insulin lispro Injectable Solution [HumaLOG],0
C2726710,Jobst Anti Embolism Thigh High Small Regular,regular,,0
C2726712,Jobst Anti Embolism Thigh High Large Regular,regular,,0
C2726732,"SANITARY NAPKIN,REGULAR",regular,"SANITARY NAPKIN,REGULAR",0
C2729798,sodium fluoride 0.00243 MG/MG Toothpaste,regular,"SODIUM FLUORIDE 130 mg in 100 g DENTAL PASTE [Plak Smacker Mint Blast]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [CVS Pharmacy Dry Mouth]; SODIUM FLUORIDE 0.00243 g in 1 g DENTAL PASTE, DENTIFRICE [Toms Luminous White Fluoride Clean Mint cavity protection / whitening]; sodium fluoride 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Hello]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Whitening Therapy]; SODIUM FLUORIDE 0.243 g in 100 mL DENTAL PASTE, DENTIFRICE [WHITENING ALL VARIANTS]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Auraglow Daily]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Kids Cavity Protection]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Whitening Therapy Enamel Care]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Luxe Diamond Strong]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Cavity Protection Regular]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [HEB Gleaming White Arctic Mint]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Advanced Triple Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Tartar Protection Fresh Mint Gel]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi-Benefit Whitening Plus Scope]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi-Benefit Whitening plus Cinnamon Expressions]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [PERIOE Microbiome Whitening Cool Mint]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [ARC Whitening]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Up and UP Anticavity Toothpaste Whitening Plus Mouthwash]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Fresh and White]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [Dentalux total care]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [PERIOE Microbiome Total Care Strong Mint]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Native Whitening]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Charcoal Mint Medley]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Blue Bubble Gum]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Glamorous White]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Enamel care]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Premium Plus Scope Outlast Active Foam]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Brilliance Blast]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Theory Enamel Care Wild Peppermint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Premium Plus Advanced Whitening Active Foam]; SODIUM FLUORIDE 2.43 mg in 1 g ORAL PASTE, DENTIFRICE [Dr Tichenors With Extra Whitening and Tartar Control]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [dentalux kids bubble gum]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [ARC WHITENING]; sodium fluoride 0.243 % Toothpaste; SODIUM FLUORIDE 1.5 mg in 1 g ORAL PASTE, DENTIFRICE [Brisa Luminous Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Splash]; SODIUM FLUORIDE 1.1 mg in 1 g ORAL PASTE, DENTIFRICE [Dentisse]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Whitening Baking Soda and Peroxide with scope Outlast Freshness]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Mystic Magical Bubblegum]; sodium fluoride 0.243 % (fluoride ion 0.15 % ) Toothpaste; SODIUM FLUORIDE 1.1 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Complete Multi-Benefit Whitening Plus Cinnamon Expressions]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [HEB Gleaming White Fresh Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Whitening Therapy Deep Clean Charcoal]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Strawberry]; SODIUM FLUORIDE 0.15 g in 100 g ORAL PASTE, DENTIFRICE [Handy Solutions Crest Complete MULTI-BENEFIT WHITENING plus Scope]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Minty Breeze]; SODIUM FLUORIDE 1.1 mg in 1 g ORAL PASTE, DENTIFRICE [Beam]; Humble Brush Bamboo with FRESH MINT FLOURIDE KIT; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Theory Freshness Care Essential Mint]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Enamel Protect]; SODIUM FLUORIDE 24.3 mg in 1 g ORAL PASTE, DENTIFRICE [Rembrandt Intense Stain]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi Benefit Whitening plus Scope Minty Fresh Gel]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Brillianc]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [PERIOE Whitening Essentials 10X Charcoal Black Clean Mint]; SODIUM FLUORIDE 1.1 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Complete Multi-Benefit Plus Scope]; SODIUM FLUORIDE 1.1 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Complete Multi-benefit Tartar Control Whitening Plus Scope]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Tartar Protection Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 4in1]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Freshmint Premium Anticavity Gel]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi-Benefit Whitening plus Scope]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Deep Clean plus Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Luminous Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Whitening Therapy Gentle Care Coconut Oil]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Arctic Fresh]; SODIUM FLUORIDE 0.15 g in 100 g DENTAL PASTE, DENTIFRICE [MintBlast Cool Mint Flavor Anti Cavity Fluoride Tooth]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [The Humble Co. Anticavity FRESH MINT]; Airline Dental Products with Crest and Manual Toothbrush KIT; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [GLEEM Whitening]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [The Natural Dentist Groovy Grape]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Complete Plus 3 in 1]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [Natural White Radiant White]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [Rite Aid Radiant White Arctic Mint]; SODIUM FLUORIDE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Dentisse]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Premium Plus Scope Dual Blast Active Foam]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest 3D White Whitening Therapy Gentle Clean Charcoal with Hemp Seed Oil]; Sodium fluoride 0.00243 g in 1 g DENTAL PASTE, DENTIFRICE [Natural Fluoride Fresh Mint cavity protection whitening fresh breath]; SODIUM FLUORIDE 2.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Complete Care Tartar Control Plus Whitening Baking Soda and Peroxide]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Brilliance]; sodium fluoride 0.243 % (fluoride ion 0.13 % ) Toothpaste; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Ultra]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Charcoal]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [PERIOE Whitening Essentials Fresh Aloe Green Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [The Humble Co Fresh Mint Fluoride]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Simply Clean]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Anti-Cavity Regular]; sodium fluoride 0.243 % (fluoride ion 0.16 % ) Toothpaste; SODIUM FLUORIDE 0.00243 g in 1 g DENTAL PASTE, DENTIFRICE [Toms Natural Enamel Strength Peppermint strengthens enamel / whitening / fights cavities / freshens breath / no artificial dyes or sweeteners]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi Benefit Whitening plus Scope Outlast]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [AVON Whitening Essentials Blanc Charcoal Fresh Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest 3D White Whitening Therapy Charcoal with Coconut Oil]; SODIUM FLUORIDE 1.5 mg in 1 g ORAL PASTE, DENTIFRICE [Crest 3D White Stain Eraser Polishing Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Whitening Herbal Mint Expressions]; sodium fluoride 0.00243 MG/MG Toothpaste; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Deep Clean]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [BreathRx with Zytex]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Complete Plus Scope Outlast]; SODIUM FLUORIDE 2.43 mg in 1 g ORAL PASTE, DENTIFRICE [Tanners Tasty Vanilla Bling]; SODIUM FLUORIDE 2.43 mg in 1 g ORAL PASTE, DENTIFRICE [Tanners Tasty Ooh La La Orange]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Extra Whitening with Tartar Protection]; SODIUM FLUORIDE 0.243 g in 100 g ORAL PASTE, DENTIFRICE [Peppermint Twist]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest complete plus Whitening Deep Clean]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [The Humble Co. Anticavity CHARCOAL]; SODIUM FLUORIDE 0.243 mg in 1 g DENTAL PASTE, DENTIFRICE [Truly Radiant Bright and Strong]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Native Charcoal]; SODIUM FLUORIDE 0.11 g in 100 g TOPICAL PASTE, DENTIFRICE [Oral Fusion Anticavity]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest 3D White Whitening Therapy Charcoal with Ginger Oil]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi-Benefit Whitening Scope Outlast]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Kids Crest Cavity Protection Sparkle Fun]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Pure Gentle Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Plus Active Fresh plus Whitening Scope]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Whitening plus Scope Outlast]; SODIUM FLUORIDE 0.26244 g in 108 g TOPICAL PASTE [Whitening Tooth Polish]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Bubblegum]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Plus Scope Outlast Ultra]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest 3D White Whitening Therapy Charcoal with Tea Tree Oil]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White]; SODIUM FLUORIDE 0.243 mg in 1 g DENTAL PASTE, DENTIFRICE [Truly Radiant Rejuvenating Whitening]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [AVON Whitening Essentials Original Cool Mint]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Whitening Scope Candy Cane]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Auraglow Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Whitening Cinnamon Expressions]; SODIUM FLUORIDE 2.43 mg in 1 g ORAL PASTE, DENTIFRICE [Tanners Tasty Cha Cha Chocolate]; Sodium fluoride 0.00243 g in 1 g DENTAL PASTE, DENTIFRICE [Toms Luminous White - Spearmint fights cavities whitening]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [HEB Dry Mouth]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi-Benefit Whitening plus Baking Soda and Peroxide with Tartar Protection]; SODIUM FLUORIDE 0.2430 g in 100 g DENTAL PASTE, DENTIFRICE [The Natural Dentist Peppermint Twist]; SODIUM FLUORIDE 2.4 mg in 1 g ORAL PASTE, DENTIFRICE [Orthocare]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Mystic Enchanted Strawberry]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Stain Eraser Icy Clean Mint]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [Whitening Plus]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Whitening plus Scope]; SODIUM FLUORIDE 0.15 g in 100 g DENTAL PASTE [UNIVERSAL CHARCOAL WITH ALOE VERA ANTI-CAVITY FLUORIDE]; SODIUM FLUORIDE 0.243 g in 100 g DENTAL PASTE, DENTIFRICE [dentalux kids mixed berry]; SODIUM FLUORIDE 1.1 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Complete Multi-Benefit Tartar Control Whitening Plus Scope]; Sodium fluoride 0.00243 g in 1 g DENTAL PASTE, DENTIFRICE [Whole Care Spearmint]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Stain Shield]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Premium Plus Deep Clean Active Foam]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Kids Crest Bubblegum Flavor]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Clean and Fresh]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Charcoal Peppermint]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [AVON Whitening Essentials 10X Charcoal Black Clean Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Brilliance Charcoal]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi-benefit Whitening plus Scope]; SODIUM FLUORIDE 1.5 mg in 1 g ORAL PASTE, DENTIFRICE [Brisa Awaken Refreshed]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Extra White]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Kids Strawberry Splash]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL GEL, DENTIFRICE [Crest Cavity Protection Cool Mint Gel]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Up and Up Anticavity Toothpaste Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Enamel Renewal]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [Freshmint Premium Anticavity]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees for Kids]; Sodium fluoride 0.243 g in 100 g DENTAL GEL, DENTIFRICE [BIO SPECTRA ATTITUDE]; SODIUM FLUORIDE 1.5 mg in 1 g ORAL PASTE, DENTIFRICE [Handy Solutions Crest Cavity Protection FLUORIDE ANTICAVITY]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Native Whitening Candy Cane]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE, DENTIFRICE [MediChoice Premium Anticavity Fluoride]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Premium Plus Active Foam Whitening scope]; Sodium fluoride 0.00243 g in 1 g DENTAL PASTE, DENTIFRICE [Simply White Clean Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Kids Crest Bubblegum Rush]; SODIUM FLUORIDE 1.3 mg in 1 g DENTAL PASTE, DENTIFRICE [Burts Bees Extra White Zen Peppermint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Kids Crest Pure Strawberry]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Tartar Protection]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Advanced Whitening]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Kids Crest Strawberry Rush]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White High Speed White]; SODIUM FLUORIDE 2.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Orthocare]; SODIUM FLUORIDE 1.5 mg in 1 g ORAL PASTE, DENTIFRICE [Brisa Tropical Fresh]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Brilliance Ultra]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Ultra Vivid Mint]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Pure All Around Clean]; SODIUM FLUORIDE 1.6 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Baking Soda and Peroxide Whitening with Tartar Protection]; SODIUM FLUORIDE 2.43 mg in 1 g DENTAL PASTE [MINTBLAST]; SODIUM FLUORIDE 1.1 mg in 1 g DENTAL PASTE, DENTIFRICE [Beam]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest 3D White Radiant Mint]; SODIUM FLUORIDE 2.43 mg in 1 g ORAL PASTE, DENTIFRICE [Dr. Sheffield Fluoride Anticavity]; SODIUM FLUORIDE 1.4 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete plus Whitening Intense Freshness]; SODIUM FLUORIDE 1.5 mg in 1 g DENTAL PASTE, DENTIFRICE [Crest Complete Multi-Benefit Extra Whitening plus Scope Advanced Freshness]",0
C2732238,Maternal history of insulin dependence,insulin,Maternal history of insulin dependence (situation),0
C2732268,Insertion of insulin pump,insulin,Insertion of insulin pump (procedure),0
C2732278,Removal of insulin pump,insulin,Removal of insulin pump (procedure),0
C2733770,Insulin porcine Ab.IgG4:MCnc:Pt:Ser:Qn,insulin,Insulin Porcine IgG4-mCnc; Insulin porcine IgG4 Ab [Mass/volume] in Serum; Insulin porcine IgG4 (S) [Mass/Vol]; Insulin porcine Antibody.IgG4:Mass Concentration:To identify measures at a point in time:Serum:Quantitative,0
C2733771,Insulin porcine Ab.IgG4,insulin,Insulin porcine Ab.IgG4; Insulin porcine IgG4; Insulin porcine Antibody.IgG4,0
C2733777,Insulin^16H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin^16H post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --16 hours post XXX challenge; Insulin 16 Hr post Unsp challenge [Mass/Vol]; Insulin 16h p chal SerPl-mCnc,0
C2733778,Insulin^20H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge; Insulin 20H p chal SerPl-mCnc; Insulin^20H post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 20 Hr post Unsp challenge [Mass/Vol],0
C2733779,Insulin^1D post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin 1D p chal SerPl-mCnc; Insulin^1 day post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Mass/volume] in Serum or Plasma --1 day post XXX challenge; Insulin 1 day post Unsp challenge [Mass/Vol],0
C2734188,Insulin bovine Ab.IgG4:MCnc:Pt:Ser:Qn,insulin,Insulin Bovine IgG4-mCnc; Insulin bovine IgG4 Ab [Mass/volume] in Serum; Insulin bovine Antibody.IgG4:Mass Concentration:To identify measures at a point in time:Serum:Quantitative; Insulin bovine IgG4 (S) [Mass/Vol],0
C2734189,Insulin bovine Ab.IgG4,insulin,Insulin bovine Ab.IgG4; Insulin bovine Antibody.IgG4; Insulin bovine IgG4,0
C2734341,Insulin human Ab.IgG4:MCnc:Pt:Ser:Qn,insulin,Insulin Human IgG4-mCnc; Insulin human Antibody.IgG4:Mass Concentration:To identify measures at a point in time:Serum:Quantitative; Insulin human IgG4 (S) [Mass/Vol]; Insulin human IgG4 Ab [Mass/volume] in Serum,0
C2734342,Insulin human Ab.IgG4,insulin,Insulin human IgG4; Insulin human Ab.IgG4; Insulin human Antibody.IgG4,0
C2734576,Insulin^baseline:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --baseline; Insulin BS SerPl-aCnc; Insulin^baseline:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin baseline Qn,0
C2734586,Insulin^6M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 6M p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --6 minutes post XXX challenge; Insulin^6 minutes post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 6 Min post Unsp challenge Qn,0
C2734615,Insulin-like growth factor-I^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I 15 Min post Unsp challenge [Mass/Vol]; IGF-I 15M p chal SerPl-mCnc; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge; Insulin-like growth factor-I^15 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2734616,Insulin-like growth factor-I^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF-I 45M p chal SerPl-mCnc; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge; Insulin-like growth factor-I 45 Min post Unsp challenge [Mass/Vol]; Insulin-like growth factor-I^45M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2734625,Insulin Ab.IgG:ACnc:Pt:Ser:Qn,insulin,Insulin IgG Ab [Units/volume] in Serum; Insulin IgG Ser-aCnc; Insulin IgG Qn (S); Insulin Antibody.immunoglobulin G:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative,0
C2734626,Insulin Ab.IgG,insulin,Insulin Ab.IgG; Insulin IgG; Insulin Antibody.immunoglobulin G,0
C2734639,Insulin Ab:ACnc:Pt:Ser:Qn:IA,insulin,Insulin Ab Ser IA-aCnc; Insulin Ab [Units/volume] in Serum by Immunoassay; Insulin Antibody:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative:Immunoassay; Insulin Ab IA Qn (S),0
C2734747,Insulin^12M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 12 Min post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --12 minutes post XXX challenge; Insulin^12M post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 12M p chal SerPl-aCnc,0
C2734772,Insulin-like growth factor-I^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF-I 10M p chal SerPl-mCnc; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge; Insulin-like growth factor-I^10 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I 10 Min post Unsp challenge [Mass/Vol],0
C2734773,Insulin-like growth factor-I^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF-I 20M p chal SerPl-mCnc; Insulin-like growth factor-I 20 Min post Unsp challenge [Mass/Vol]; Insulin-like growth factor-I^20 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge,0
C2734933,Insulin-like growth factor binding protein 3^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF BP3 10M p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge; Insulin-like growth factor binding protein 3 10 Min post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3^10 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2734934,Insulin-like growth factor binding protein 3^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3^20 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge; IGF BP3 20M p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 20 Min post Unsp challenge [Mass/Vol],0
C2735008,Insulin^28H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 28h p chal SerPl-aCnc; Insulin^28H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 28 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --28 hours post XXX challenge,0
C2735009,Insulin^32H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 32 Hr post Unsp challenge Qn; Insulin 32h p chal SerPl-aCnc; Insulin^32H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --32 hours post XXX challenge,0
C2735010,Insulin^36H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --36 hours post XXX challenge; Insulin 36h p chal SerPl-aCnc; Insulin 36 Hr post Unsp challenge Qn; Insulin^36H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2735224,Insulin^8H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 8h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --8 hours post XXX challenge; Insulin^8 hours post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 8 Hr post Unsp challenge Qn,0
C2735225,Insulin^64H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 64h p chal SerPl-aCnc; Insulin 64 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --64 hour post XXX challenge; Insulin^64H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2735226,Insulin^68H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --68 hour post XXX challenge; Insulin 68 Hr post Unsp challenge Qn; Insulin^68H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 68h p chal SerPl-aCnc,0
C2735230,Insulin^3D post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^3 days post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 3 days post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --3 days post XXX challenge; Insulin 3D p chal SerPl-aCnc,0
C2735231,Insulin^56H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^56H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 56h p chal SerPl-aCnc; Insulin 56 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --56 hours post XXX challenge,0
C2735232,Insulin^2D post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --2 days post XXX challenge; Insulin 2D p chal SerPl-aCnc; Insulin 2 days post Unsp challenge Qn; Insulin^2 days post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2735233,Insulin^60H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --60 hour post XXX challenge; Insulin^60H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 60H p chal SerPl-aCnc; Insulin 60 Hr post Unsp challenge Qn,0
C2735234,Insulin^44H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 44 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --44 hour post XXX challenge; Insulin 44h p chal SerPl-aCnc; Insulin^44H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2735235,Insulin^40H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 40H p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --40 hours post XXX challenge; Insulin^40H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 40 Hr post Unsp challenge Qn,0
C2735276,Insulin^52H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --52 hours post XXX challenge; Insulin 52h p chal SerPl-aCnc; Insulin 52 Hr post Unsp challenge Qn; Insulin^52H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2735573,Neisseria gonorrhoeae DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,N. gonorrhoeae DNA NAA+probe Ql (Nph); Neisseria gonorrhoeae DNA [Presence] in Nasopharynx by NAA with probe detection; N gonorrhoea DNA Nph Ql NAA+probe; Neisseria gonorrhoeae deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C2735715,Chlamydia trachomatis rRNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,C trach rRNA Nph Ql NAA+probe; Chlamydia trachomatis ribosomal ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Chlamydia trachomatis rRNA [Presence] in Nasopharynx by NAA with probe detection; C. trachomatis rRNA NAA+probe Ql (Nph),0
C2735716,Neisseria gonorrhoeae rRNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Neisseria gonorrhoeae ribosomal ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; N. gonorrhoeae rRNA NAA+probe Ql (Nph); N gonorrhoea rRNA Nph Ql NAA+probe; Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by NAA with probe detection,0
C2735753,Insulin^5M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 5 Min post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --5 minutes post XXX challenge; Insulin 5M p chal SerPl-aCnc; Insulin^5 minutes post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2736416,Insulin-like growth factor^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor 1st specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge; Insulin-like growth factor^1st specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF sp1 p chal SerPl-mCnc,0
C2736626,Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment,insulin,Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D:Number=Count/Time:7 days:^Patient:Quantitative:CMS Assessment; Number of days insulin injections were received in last 7 days or since admission/reentry if less than 7 days [CMS Assessment],0
C2736627,Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D,insulin,Number of days insulin injections were received in last 7 days or since admission/reentry if less than 7 days; Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D,0
C2736628,Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment,insulin,Number of days the physician changed the resident's insulin orders in last 7 days or since admission/reentry if less than 7 days [CMS Assessment]; Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D:Number=Count/Time:7 days:^Patient:Quantitative:CMS Assessment,0
C2736629,Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D,insulin,Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D; Number of days the physician changed the resident's insulin orders in last 7 days or since admission/reentry if less than 7 days,0
C2739803,Insulin:-:Point in time:^Patient:-,insulin,Insulin:-:To identify measures at a point in time:^Patient:-:CMS Assessment; Insulin:-:Pt:^Patient:-:CMS Assessment; Insulin [CMS Assessment],0
C2741671,Time contractions became regular:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative,regular,Time contractions became regular; Time contractions became regular:Time Stamp-Date and Time:To identify measures at a point in time:^Patient:Quantitative; Time contractions became regular:TmStp:Pt:^Patient:Qn,0
C2743577,"ILP2 protein, Drosophila",insulin,"Insulin-like peptide 2 protein, Drosophila; Dilp2 protein, Drosophila; CG8167 protein, Drosophila",0
C2744282,"Ilp6 protein, Drosophila",insulin,"Insulin-like peptide 6 protein, Drosophila; Dilp6 protein, Drosophila; Drosophila insulin-like protein 6",0
C2746219,"Chemo Gown, Regular",regular,,0
C2746231,Insulin Syringe 1cc 29g,insulin,Insulin Syringe 29g 1cc,0
C2746251,BD Insulin Syringe 0.3cc,insulin,,0
C2746253,BD Insulin Syringe 0.5cc (UF),insulin,,0
C2746254,"BD Insulin Syringe 0.5cc 28g 1/2"" (MF)",insulin,"BD MF Insulin Syringe 0.5cc 28g 1/2""; BD MF Insulin Syringe 0.5cc 28gx1/2""",0
C2746256,"BD Insulin Syringe 0.5cc 29g 1/2"" (UF)",insulin,,0
C2746259,"BD Insulin Syringe 1cc 28g 1/2"" (MF)",insulin,,0
C2746261,"BD Insulin Syringe 1cc 29g 1/2"" (UF)",insulin,,0
C2746457,ethanol 0.65 ML/ML Topical Gel,regular,"ALCOHOL 65 mL in 100 mL TOPICAL LIQUID [GelSanitizerLav]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Dailycare hand sanitizer Ocean Breeze Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Bubble Gum]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Raspberry Cooler Scented Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Fresh Lemon Scented with vitamin E and Moisturizers]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [BODYCOLOGY CUCUMBER MELON HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Lavender Scented with Vitamin E and Aloe Vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Strawberry]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [P.O.V. Vitamin E Hand Sanitizer]; ALCOHOL 65 g in 100 mL TOPICAL GEL [marshmallow scented anti-bacterial hand gel]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Lemongrass Scented With Vitamin E and Aloe Vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Puppicorn Strawberry Scented Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Hand Sanitizer Lemongrass and Sweet Orange]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [A2A Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Coconut Scented With Vitamin E and Aloe Vera]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [P b pure Antibacterial Hand Sanitizer Cucumber Melon Scented]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Handy Antibac Antiseptic Instant Gel Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [1.8oz Armstrong Hand Sanitizer with Aloe Vera and Vitamin E]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Fresh Kiwi Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Premium Nature Instant hand sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Lavnder Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [ALOE VERA CENTER HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [You Are My Sunshine Antibacterial Hand Sanitizer Cotton Candy Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Hand Sanitizer Lavender and Chamomile]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [scented antibacterial hand sanitizer]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Art Naturals Hand Sanitizer]; ALCOHOL 65 g in 100 mL TOPICAL GEL [lollipop scented anti-bacterial hand gel]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Vanilla Ice Cream Scented Hand Sanitizer]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Instant Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [BORN BASIC. ANTI-BAC HAND SANITIZER 65 PERCENT]; ethanol 65 % Topical Gel; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Olika Hydrating Hand Sanitizer, Noble Fir]; ALCOHOL 65 g in 100 g TOPICAL GEL [Hand Sanitizer with Aloe]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Artnaturals Scent Free Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Unicorn Antibacterial Hand Sanitizer Fruit Punch scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Lavender Frost Scented Antibacterial Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [RBX Hand Sanitizer Lemon Scented Alloe Vera and Vitamin E]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Orange Blossom Lilac and Jasmine Hand Sanitizer]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Berkley Jensen Instant Hand Sanitizer]; Alcohol 65 mL in 100 mL TOPICAL GEL [Soft N Sure Antiseptic Hand]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Cherry Blossom Scented with vitamin E and aloe vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [SCENTFUL LOVE HAND SANITIZER 65 PERCENT]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Careone Vitamin E Hand sanitizer]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Careone Aloe Vitamin E Hand sanitizer]; ALCOHOL 65 g in 100 mL TOPICAL GEL [cupcake scented anti-bacterial hand gel]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Girls Rule The World Antibacterial Hand Sanitizer Berry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [My Beauty Spot Hand Sanitizer Wild Berries Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Anti-Bac Hand Sanitizer Mixed Berries Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Serene Clean and Pure Hand Sanitizer Gel]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Lemongrass Scented with vitamin E and aloe vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [LATHER HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [bioXterminate Hand Sanitizer Gel]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Prosecco Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [BODYCOLOGY CHERRY BLOSSOM HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Daily essentials antibacterial hand sanitizer Aloe Vera Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Follow the Rainbow Antibacterial Hand Sanitizer Watermelon Ice Pop scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [mermaid vibes Antibacterial Hand Sanitizer Blueberry shake scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [You Are A Magical Unicorn Antibacterial Hand Sanitizer Cotton Candy Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Lemon Lime Fizzer Scented]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Natural Concepts]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Scentia Pro Care and Sanitizer]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [P.O.V. Aloe Vera Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [LATHER - HAND SANITIZER WITH MOISTURIZING ALOE]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [NUVALU HAND SANITIZER SWEET PEA BLUE 1OZ]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [P b pure Antibacterial Hand Sanitizer Sweet Pea Scented]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Shopko Beauty Hand Sanitizer with Vitamin E]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [You Are A Magical Unicorn Antibacterial Hand Sanitizer Watermelon Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [My Beauty Spot Antibacterial Hand Sanitizer French Lavnder Scented with vitamin E and aloe vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [My Beauty Spot Hand Sanitizer Cool Fall Breeze Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Vanilla Ice Cream Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Hand Sanitizer Easy Klean]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Cool Mint Scented Antibacterial Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Girls Rule The World Antibacterial Hand Sanitizer Cotton Candy Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Keep Your Hands Clean Antibacterial Hand Sanitizer Berry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Dailycare Antibacterial Hand Sanitizer Original Unscented]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Full Clean Hand Sanitizer]; ethyl alcohol 65 % Topical Gel; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Natural Concepts Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Water Melon Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Santorini Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [mermaid squad Antibacterial Hand Sanitizer Strawberry cake scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Unscented Antibacterial Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [SCENTFUL SELF LOVE CLUB HAND SANITIZER 65 PERCENT]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Rasp Berry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Keep Your Hands Clean Antibacterial Hand Sanitizer Watermelon Scented]; ALCOHOL 65 g in 100 mL TOPICAL GEL [cotton candy scented anti-bacterial hand gel]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Ethyl Alcohol]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Germaphobe Black Tea Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Lemon, Verbena and Cedar Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Anti-Bac Hand Sanitizer Strawberry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [TRADER JOES HAND SANITIZER WITH MOISTURIZERS AND VITAMIN E]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Vanilla Almond scented With Vitamin E and Aloe Vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Follow the Rainbow Antibacterial Hand Sanitizer Sweet Berries scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Spector and Co Hand Sanitizer Gel with Coconut Scent]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Liebers Hand Sanitizer Advanced Regular]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [DOP Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [mermaid vibes Antibacterial Hand Sanitizer cotton candy scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Juicy Orange Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Unicorn Antibacterial Hand Sanitizer cotton candy scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Peppermint Scented with vitamin E and aloe vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Sweet Heart Antibacterial Hand Sanitizer Tropical Fruit Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Sweet Heart Antibacterial Hand Sanitizer Strawberry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [RBX Hand Sanitizer Unscented Alloe Vera and Vitamin E]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Natural Concepts Vitamin E Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Coconut Scented with vitamin E and aloe vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [You Are My Sunshine Antibacterial Hand Sanitizer Watermelon Scented]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Prince and Spring Moisturizing Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hydrel]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Luxury Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Puppicorn Cotton Candy Scented Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Follow the Rainbow Antibacterial Hand Sanitizer Coconut Milk scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [mermaid vibes Antibacterial Hand Sanitizer mint chocolate scented]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [P b pure Antibacterial Hand Sanitizer Ocean Breeze Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Straw Berry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Fresh Lemons Antibacterial Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Blueberry]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Cherry Blossom scented With Vitamin E and Aloe Vera]; ethanol 0.65 ML/ML Topical Gel; ALCOHOL 650 mg in 1 mL TOPICAL GEL [TD Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Ocean Citron Hand Sanitizer]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [ALCOHOL]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Laura Ashley Antibacterial Hand Sanitizer Aloe Vera Scented with vitamin E and aloe vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [LOS POBLANOS LAVENDER HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [My Beauty Spot Hand Sanitizer Lavender Frost Scented]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Guard Hand Sanitizer]; Hand Sanitizer KIT; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Spector and Co Antiseptic Hand Sanitizer Gel with Kiwi Scent]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Unicorn Antibacterial Hand Sanitizer Strawberry scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Candy Apple Scented Antibacterial Hand Sanitizer]; ALCOHOL 65 L in 100 L TOPICAL GEL [PFP POLYclean Hand Sanitizer - Gel 65]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Unicorn Antibacterial Hand Sanitizer mint chocolate scented]; ALCOHOL 65 L in 100 L TOPICAL GEL [ANTISEPTIC HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Antibacterial Hand Sanitizer Lavnder Scented with vitamin E and aloe vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Fragrance Free Antibacterial Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Original UnScented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Laura Ashley Antibacterial Hand Sanitizer Cotton Blossom Scented with vitamin E and aloe vera]; ALCOHOL 325 mL in 500 mL TOPICAL GEL [LAVINNA FIRST HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [65% alcohol hand sanitizer (no water)]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Mango Papaya Popcicle Scented]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Liebers Hand Sanitizer Advanced Aloe]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Coconut Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [BC3 Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Lemon Verbena Scented vitamin E and Moisturizers]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [RBX Hand Sanitizer Ocean Scented Alloe Vera and Vitamin E]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Cotton Candy]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [GELRITE]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [BODYCOLOGY SWEET PETALS HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Live Love Travel Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [GIR The Guardian Gel Sanitize]; ALCOHOL 65 g in 112 mL TOPICAL GEL; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Daily essentials antibacterial hand sanitizer Lavender Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [SOMBRA ANTIBACTERIAL HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [LECHAT]; ALCOHOL .65 mL in 100 L TOPICAL GEL [Waterless Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Laura Ashley Antibacterial Hand Sanitizer Pink Peony Scented with vitamin E and aloe vera]; ALCOHOL 65 g in 100 mL TOPICAL GEL [candy apple scented anti-bacterial hand gel]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [PURE ESSENTIAL MINERALS ANTIBACTERIAL HAND SANITIZER]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Blue Berries Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Hand Sanitizer Wild Rasp Berry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Birthday Cake Anti-Bacterial Scented Hand Sanitizer]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Equate Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [NUVALU HAND SANITIZER SWEET PEA 1OZ]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Discount Drug Mart Prebiotic Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Cotton Candy Scented Antibacterial Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [dailycare Antibacterial hand sanitizr unscented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Antibacterial Hand Sanitizer Hawaiian Coconut Scented With Vitamin E and Aloe Vera]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Kills Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Sweet Heart Antibacterial Hand Sanitizer Cotton Candy Scented]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Bee Safe Hand Sanitizer With Manuka Honey and Lemongrass]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [SANIRUS HAND SANITIZER]; ALCOHOL 650 mg in 1 mL TOPICAL GEL [Hand Sanitizer]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Keep Your Hands Clean Antibacterial Hand Sanitizer Strawberry Scented]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [Aromatherapy Hand Sanitizer English Rose and Hemp]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [ENCHANTMENT HAND SANITIZER]; ALCOHOL 0.65 mL in 1 mL TOPICAL GEL [Luxury Hand Sanitizer Aloe]; ALCOHOL 65 mL in 100 mL TOPICAL GEL [SCENTFUL GOOD VIBES ONLY HAND SANITIZER 65 PERCENT]",0
C2747665,"insulin, protamine zinc, human 40 UNT/ML",insulin,,0
C2747666,"insulin, protamine zinc, human 40 UNT/ML Injectable Suspension",insulin,"insulin, protamine zinc, human 40 UNT in 1 mL Injectable Suspension; insulin, protamine zinc, human 40 UNT per 1 ML Injectable Suspension",0
C2747668,"insulin, protamine zinc, human 40 UNT/ML [ProZinc]",insulin,,0
C2747669,"insulin, protamine zinc, human Injectable Suspension [ProZinc]",insulin,,0
C2747670,"insulin, protamine zinc, human 40 UNT/ML Injectable Suspension [ProZinc]",insulin,ProZinc 40 UNT/ML Injectable Suspension; ProZinc 40 UNT in 1 mL Injectable Suspension; INSULIN HUMAN 40 [iU] in 1 mL SUBCUTANEOUS INJECTION [ProZinc]; ProZinc 40 UNT per 1 ML Injectable Suspension,0
C2751697,"Diabetes Mellitus, Insulin-Dependent, 24",insulin,"IDDM24; DIABETES MELLITUS, INSULIN-DEPENDENT, 24; T1D24; TYPE 1 DIABETES MELLITUS 24",0
C2756220,ReliOn Insulin Syringe,insulin,,0
C2825028,Insulin Analog [EPC],insulin,Insulin Analog [EPC]; Insulin Analog; Insulin Analogue,0
C2825234,Non-insulin Hypoglycemic,insulin,,0
C2826381,Anti-Insulin-Like Growth Factor 1/2 Monoclonal Antibody MEDI-573,insulin,"Anti-IGF 1/2 Monoclonal Antibody MEDI-573; anti-insulin-like growth factor 1/2 monoclonal antibody MEDI-573; anti-IGF1/2 monoclonal antibody MEDI-573; Immunoglobulin G2, Anti-(Human Insulin-like Growth Factor I/Insulin-like Growth Factor II); Human Monoclonal MEDI-573 gamma Heavy Chain (134-216')-Disulfide with Human Monoclonal MEDI-573 lambda Light Chain Dimer (222-222'':223-223'':226-226'':229-229'')-Tetrakisdisulfide",0
C2827418,IGF1R Immunohistochemical Expression,insulin,Insulin-Like Growth Factor 1 Receptor Immunohistochemical Expression; Insulin-Like Growth Factor 1 Receptor Immunohistochemical Expression Analysis; IGF1R Immunohistochemical Expression Analysis,0
C2874124,Diabetes mellitus due to genetic defect in insulin action,insulin,Diabetes mellitus due to genetic defect in insulin action (disorder),0
C2881354,Regular astigmatism of right eye,regular,Regular astigmatism of right eye (disorder),0
C2881355,Regular astigmatism of left eye,regular,Regular astigmatism of left eye (disorder),0
C2881356,Bilateral regular astigmatism,regular,Regular astigmatism of both eyes; Regular astigmatism of bilateral eyes; Regular astigmatism of bilateral eyes (disorder),0
C2891174,"Displacement of insulin pump, initial encounter",insulin,,0
C2891175,"Displacement of insulin pump, subsequent encounter",insulin,,0
C2891176,"Displacement of insulin pump, sequela",insulin,,0
C2891189,"Leakage of insulin pump, initial encounter",insulin,,0
C2891190,"Leakage of insulin pump, subsequent encounter",insulin,,0
C2891191,"Leakage of insulin pump, sequela",insulin,,0
C2911829,"insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML [NovoLog Mix]",insulin,"insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML [NovoLOG Mix]",0
C2911831,"insulin aspart protamine, human / insulin aspart, human Injectable Suspension [NovoLog Mix]",insulin,"insulin aspart protamine, human / insulin aspart, human Injectable Suspension [NovoLOG Mix]",0
C2912234,Metamucil Original Texture Regular,regular,,0
C2923157,Insulin-like growth factor binding protein 3^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 45 Min post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge; IGF BP3 45M p chal SerPl-mCnc; Insulin-like growth factor binding protein 3^45M post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2923337,Insulin-like growth factor binding protein 3^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge; IGF BP3 15M p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 15 Min post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3^15 minutes post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2923569,Insulin^post CFst:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^post Calorie fast:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --fasting; Insulin p fast SerPl-sCnc; Insulin post fast [Moles/Vol],0
C2924119,105 minutes post dose insulin IV,insulin,105M post dose insulin IV,0
C2924150,3 hours post dose insulin IV,insulin,3H post dose insulin IV,0
C2924162,75 minutes post dose insulin IV,insulin,75M post dose insulin IV,0
C2926280,Corticotropin^1.5H post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin 1.5 Hr post dose insulin IV (P) [Moles/Vol]; Corticotropin^1.5 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; ACTH 1.5h p Ins IV Plas-sCnc; Corticotropin [Moles/volume] in Plasma --1.5 hours post dose insulin IV,0
C2926285,Corticotropin^105M post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin 105 Min post dose insulin IV (P) [Mass/Vol]; Corticotropin [Mass/volume] in Plasma --105 minutes post dose insulin IV; Corticotropin^105M post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; ACTH 105M p Ins IV Plas-mCnc,0
C2926286,Corticotropin^105M post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin [Moles/volume] in Plasma --105 minutes post dose insulin IV; Corticotropin^105M post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin 105 Min post dose insulin IV (P) [Moles/Vol]; ACTH 105M p Ins IV Plas-sCnc,0
C2926289,Corticotropin^15M post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin [Mass/volume] in Plasma --15 minutes post dose insulin IV; Corticotropin^15 minutes post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin 15 Min post dose insulin IV (P) [Mass/Vol]; ACTH 15M p Ins IV Plas-mCnc,0
C2926290,Corticotropin^15M post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin^15 minutes post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Moles/volume] in Plasma --15 minutes post dose insulin IV; Corticotropin 15 Min post dose insulin IV (P) [Moles/Vol]; ACTH 15M p Ins IV Plas-sCnc,0
C2926293,Corticotropin^15M pre dose insulin IV:MCnc:Pt:Plas:Qn,insulin,ACTH 15M pre Ins IV Plas-mCnc; Corticotropin^15 minutes pre dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin 15 Min pre dose insulin IV (P) [Mass/Vol]; Corticotropin [Mass/volume] in Plasma --15 minutes pre dose insulin IV,0
C2926294,Corticotropin^15M pre dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin [Moles/volume] in Plasma --15 minutes pre dose insulin IV; Corticotropin 15 Min pre dose insulin IV (P) [Moles/Vol]; Corticotropin^15 minutes pre dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; ACTH 15M pre Ins IV Plas-sCnc,0
C2926300,Corticotropin^1H post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin 1 Hr post dose insulin IV (P) [Moles/Vol]; Corticotropin^1 hour post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Moles/volume] in Plasma --1 hour post dose insulin IV; ACTH 1h p Ins IV Plas-sCnc,0
C2926307,Corticotropin^2.5H post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin^2.5 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin 2.5 Hr post dose insulin IV (P) [Mass/Vol]; ACTH 2.5h p Ins IV Plas-mCnc; Corticotropin [Mass/volume] in Plasma --2.5 hours post dose insulin IV,0
C2926308,Corticotropin^2.5H post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin 2.5 Hr post dose insulin IV (P) [Moles/Vol]; Corticotropin [Moles/volume] in Plasma --2.5 hours post dose insulin IV; ACTH 2.5h p Ins IV Plas-sCnc; Corticotropin^2.5 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative,0
C2926318,Corticotropin^2H post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin^2 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Mass/volume] in Plasma --2 hours post dose insulin IV; Corticotropin 2 Hr post dose insulin IV (P) [Mass/Vol]; ACTH 2h p Ins IV Plas-mCnc,0
C2926319,Corticotropin^2H post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,ACTH 2h p Ins IV Plas-sCnc; Corticotropin 2 Hr post dose insulin IV (P) [Moles/Vol]; Corticotropin^2 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Moles/volume] in Plasma --2 hours post dose insulin IV,0
C2926327,Corticotropin^30M post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin^30 minutes post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Moles/volume] in Plasma --30 minutes post dose insulin IV; Corticotropin 30 Min post dose insulin IV (P) [Moles/Vol]; ACTH 30M p Ins IV Plas-sCnc,0
C2926333,Corticotropin^30M pre dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin [Moles/volume] in Plasma --30 minutes pre dose insulin IV; Corticotropin^30 minutes pre dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; ACTH 30M pre Ins IV Plas-sCnc; Corticotropin 30 Min pre dose insulin IV (P) [Moles/Vol],0
C2926340,Corticotropin^3H post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin [Mass/volume] in Plasma --3 hours post dose insulin IV; Corticotropin^3 hours post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin 3 Hr post dose insulin IV (P) [Mass/Vol]; ACTH 3h p Ins IV Plas-mCnc,0
C2926341,Corticotropin^3H post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,Corticotropin 3 Hr post dose insulin IV (P) [Moles/Vol]; ACTH 3h p Ins IV Plas-sCnc; Corticotropin^3 hours post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Moles/volume] in Plasma --3 hours post dose insulin IV,0
C2926348,Corticotropin^45M post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,ACTH 45M p Ins IV Plas-sCnc; Corticotropin 45 Min post dose insulin IV (P) [Moles/Vol]; Corticotropin^45M post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Moles/volume] in Plasma --45 minutes post dose insulin IV,0
C2926354,Corticotropin^75M post dose insulin IV:MCnc:Pt:Plas:Qn,insulin,Corticotropin 75 Min post dose insulin IV (P) [Mass/Vol]; Corticotropin^75M post dose insulin Intravenous:Mass Concentration:To identify measures at a point in time:Plasma:Quantitative; ACTH 75M p Ins IV Plas-mCnc; Corticotropin [Mass/volume] in Plasma --75 minutes post dose insulin IV,0
C2926355,Corticotropin^75M post dose insulin IV:SCnc:Pt:Plas:Qn,insulin,ACTH 75M p Ins IV Plas-sCnc; Corticotropin^75M post dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative; Corticotropin [Moles/volume] in Plasma --75 minutes post dose insulin IV; Corticotropin 75 Min post dose insulin IV (P) [Moles/Vol],0
C2926368,Corticotropin^pre dose insulin IV:SCnc:Pt:Plas:Qn,insulin,ACTH pre Ins IV Plas-sCnc; Corticotropin pre dose insulin IV (P) [Moles/Vol]; Corticotropin [Moles/volume] in Plasma --pre dose insulin IV; Corticotropin^pre dose insulin Intravenous:Substance Concentration:To identify measures at a point in time:Plasma:Quantitative,0
C2928106,"insulin aspart protamine, human / insulin aspart, human",insulin,,0
C2928209,"insulin, prompt zinc, human / ultralente insulin, human",insulin,,0
C2928327,"insulin, prompt zinc, human / lente insulin, human",insulin,,0
C2929405,"insulin isophane / insulin, regular, human",insulin,Human isophane insulin- and recombinant human soluble insulin-containing product; Human isophane insulin- and recombinant human regular insulin-containing product; Product containing human isophane insulin and recombinant human regular insulin (medicinal product); Insulin Human Regular/ Isophane Insulin,0
C2929413,"insulin isophane / insulin, regular, pork",insulin,Isophane insulin- and porcine insulin soluble-containing product; Product containing isophane insulin and porcine regular insulin (medicinal product); Isophane insulin- and porcine regular insulin-containing product,0
C2930363,"Insupen Insulin Pen Needle Ultrafine, 31g",insulin,,0
C2931279,"Growth Factors, Combined Defect of",insulin,"Combined insulin, insulin-like growth factor 1 and epidermal growth factor deficiency; INSULIN, INSULIN-LIKE GROWTH FACTOR I, AND EPIDERMAL GROWTH FACTOR DEFICIENCY; Combined insulin, insulin-like growth factor 1 (IGF1) and epidermal growth factor (EGF) deficiency; GROWTH FACTORS, COMBINED DEFECT OF; Hoepffner-Dreyer-Reimers syndrome; Werner-Like Syndrome due to Combined Growth Factor Deficiency; Lipodystrophy due to peptidic growth factors deficiency; Hoepffner Dreyer Reimers syndrome; Lipodystrophy due to peptidic growth factors deficiency (disorder); Peptide growth factors deficiency; Insulin, Insulin-Like Growth Factor I, and Epidermal Growth Factor Deficiency; Peptidic growth factors deficiency; WERNER-LIKE SYNDROME DUE TO COMBINED GROWTH FACTOR DEFICIENCY; Werner-like syndrome due to combined growth factor deficiency; Hoepffner dreyer reimers syndrome",0
C2933444,"insulin-like growth factor-1, rat",insulin,"Igf-1 protein, rat; Igf1 protein, rat",0
C2937673,"Top Care Ultra Comfort Insulin Syringes, 31g,",insulin,,0
C2939509,Precise Heat Patch Regular,regular,,0
C2948845,"INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Humalog 70/30]",insulin,,0
C2954523,sodium monofluorophosphate 0.008 MG/MG Toothpaste,regular,"SODIUM MONOFLUOROPHOSPHATE 0.8 g in 100 g DENTAL PASTE [Orbitol Fluoride Whitening Toothpaste]; SODIUM MONOFLUOROPHOSPHATE 0.8 g in 100 g DENTAL PASTE [Orbitol Alpine Fresh Fluoride Whitening Toothpaste]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE [Dental Plus Whitening]; sodium monofluorophosphate 0.0081 MG/MG Toothpaste; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE [Dental plus Extra Mint]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE [Dental Plus Regular Flavor]; sodium monofluorophosphate 0.8 % Toothpaste; Sodium Monofluorophosphate 1 mg in 1 g DENTAL PASTE, DENTIFRICE [SmartMouth Advance Clinical Formula]; SODIUM MONOFLUOROPHOSPHATE 1 mg in 1 g DENTAL PASTE [Dental Plus Fresh Mint Flavor]",0
C2955623,PADIMATE O 15 mg in 1 g / PETROLATUM 450 mg in 1 g TOPICAL STICK [Walgreens Chap Aid Cherry Lip Balm],regular,PADIMATE O 15 mg in 1 g / PETROLATUM 450 mg in 1 g TOPICAL STICK [Walgreens Chap Aid Regular Lip Balm],0
C2959223,"Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration",insulin,,0
C2959938,Change in insulin dose,insulin,Change in insulin dose (procedure),0
C2962412,aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet [Gaviscon Chewable],regular,"Gaviscon, 80 mg-14.2 mg oral tablet, chewable; Gaviscon Chewable 80/14.2 (aluminum hydroxide / magnesium trisilicate) Chewable Tablet; Gavsicon Regular Strength (aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG) Chewable Tablet; Gavsicon Regular Strength 80 MG / 14.2 MG Chewable Tablet; Gaviscon Chewable 80/14.2 Chewable Tablet",0
C2963237,"About how often did you eat beef or pork hot dogs, regular fat, in past 12Mo",regular,"About how often did you eat beef or pork hot dogs, regular-fat, in past 12 months; About how often did you eat beef or pork hot dogs, regular fat, in past 12Mo",0
C2963238,"About how often did you eat cheese or cheese spread, regular fat, in past 12Mo",regular,"About how often did you eat cheese or cheese spread, regular fat, in past 12Mo; About how often did you eat cheese or cheese spread, regular fat, in past 12 months",0
C2963245,"About how often did you eat mayonnaise, regular fat, in past 12Mo",regular,"About how often did you eat mayonnaise, regular-fat, in past 12 months; About how often did you eat mayonnaise, regular fat, in past 12Mo",0
C2963247,"About how often did you eat salad dressings, regular fat, in past 12Mo",regular,"About how often did you eat salad dressings, regular-fat, in past 12 months; About how often did you eat salad dressings, regular fat, in past 12Mo",0
C2963248,"About how often did you eat sausage or bacon, regular fat, in past 12Mo",regular,"About how often did you eat sausage or bacon, regular fat, in past 12Mo; About how often did you eat sausage or bacon, regular-fat, in past 12 months",0
C2963637,"How many Y did you take regular one a day type, centrum or thera type multiple vitamins",regular,"How many years did you take Regular One-a-Day type, Centrum or Thera-type multiple vitamins; How many Y did you take regular one a day type, centrum or thera type multiple vitamins",0
C2963703,"How often did you drink regular colas and root beer (caffeine free, not diet)",regular,"How often did you drink regular colas and root beer (caffeine free, not diet)",0
C2963704,"How often did you drink regular colas and root beer (with caffeine, not diet)",regular,"How often did you drink regular colas and root beer (with caffeine, not diet)",0
C2963705,"How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30D",regular,"How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30D; How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30 days",0
C2963755,"How often did you take regular one a day type, centrum or thera type multiple vitamins",regular,"How often did you take regular one a day type, centrum or thera type multiple vitamins; How often did you take regular One-a-day type, Centrum or Thera-type multiple vitamins",0
C2963858,I could get up from a regular toilet in past 7D,regular,I could get up from a regular toilet in past 7D; I could get up from a regular toilet in past 7 days,0
C2964073,I was satisfied with my ability to do regular personal and household responsibilities in past 7D,regular,I was satisfied with my ability to do regular personal and household responsibilities in past 7 days; I was satisfied with my ability to do regular personal and household responsibilities in past 7D,0
C2964182,Lipoprotein insulin resistance score,insulin,Lipoprotein insulin resistance score,0
C2964578,"What is your serving size for regular colas and root beer (caffeine free, not diet)",regular,"What is your serving size for regular colas and root beer (caffeine free, not diet)",0
C2964579,"What is your serving size for regular colas and root beer (with caffeine, not diet)",regular,"What is your serving size for regular colas and root beer (with caffeine, not diet)",0
C2966769,Insulin Ab:SCnc:Pt:Ser:Qn,insulin,Insulin Ab Ser-sCnc; Insulin Ab (S) [Moles/Vol]; Insulin Antibody:Substance Concentration:To identify measures at a point in time:Serum:Quantitative; Insulin Ab [Moles/volume] in Serum,0
C2966811,Insulin-like growth factor-I^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge; Insulin-like growth factor-I 2nd specimen post Unsp challenge [Mass/Vol]; IGF-I sp2 p chal SerPl-mCnc; Insulin-like growth factor-I^2nd specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2966812,Insulin-like growth factor-I^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I 1st specimen post Unsp challenge [Mass/Vol]; IGF-I sp1 p chal SerPl-mCnc; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge; Insulin-like growth factor-I^1st specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2969919,Insulin-like growth factor binding protein 3^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 8th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3^8th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF BP3 sp8 p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge,0
C2969920,Insulin-like growth factor binding protein 3^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF BP3 sp7 p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 7th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge; Insulin-like growth factor binding protein 3^7th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2969921,Insulin-like growth factor binding protein 3^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 6th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3^6th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge; IGF BP3 sp6 p chal SerPl-mCnc,0
C2969922,Insulin-like growth factor binding protein 3^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF BP3 sp5 p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge; Insulin-like growth factor binding protein 3 5th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3^5th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2969923,Insulin-like growth factor binding protein 3^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3^4th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge; Insulin-like growth factor binding protein 3 4th specimen post Unsp challenge [Mass/Vol]; IGF BP3 sp4 p chal SerPl-mCnc,0
C2969924,Insulin-like growth factor binding protein 3^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 3rd specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge; IGF BP3 sp3 p chal SerPl-mCnc; Insulin-like growth factor binding protein 3^3rd specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2969925,Insulin-like growth factor binding protein 3^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3^2nd specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor binding protein 3 2nd specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge; IGF BP3 sp2 p chal SerPl-mCnc,0
C2969926,Insulin-like growth factor binding protein 3^baseline:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3 baseline [Mass/Vol]; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --baseline; IGF BP3 BS SerPl-mCnc; Insulin-like growth factor binding protein 3^baseline:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C2969927,Insulin-like growth factor binding protein 3^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor binding protein 3^1st specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF BP3 sp1 p chal SerPl-mCnc; Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge; Insulin-like growth factor binding protein 3 1st specimen post Unsp challenge [Mass/Vol],0
C2969928,Insulin-like growth factor-I^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I^8th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; IGF-I sp8 p chal SerPl-mCnc; Insulin-like growth factor-I 8th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge,0
C2969929,Insulin-like growth factor-I^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I^7th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge; IGF-I sp7 p chal SerPl-mCnc; Insulin-like growth factor-I 7th specimen post Unsp challenge [Mass/Vol],0
C2969930,Insulin-like growth factor-I^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I^6th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge; IGF-I sp6 p chal SerPl-mCnc; Insulin-like growth factor-I 6th specimen post Unsp challenge [Mass/Vol],0
C2969931,Insulin-like growth factor-I^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I^5th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I 5th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge; IGF-I sp5 p chal SerPl-mCnc,0
C2969932,Insulin-like growth factor-I^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,IGF-I sp4 p chal SerPl-mCnc; Insulin-like growth factor-I 4th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor-I^4th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge,0
C2969933,Insulin-like growth factor-I^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge; IGF-I sp3 p chal SerPl-mCnc; Insulin-like growth factor-I^3rd specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I 3rd specimen post Unsp challenge [Mass/Vol],0
C2970472,"About how often did you eat sausage or bacon, regular fat, in past 12Mo:Find:12Mo:^Patient:Ord:PhenX",regular,"How often sausage bacon in 12Mo PhenX; About how often did you eat sausage or bacon, regular-fat, in past 12 months [PhenX]; About how often did you eat sausage or bacon, regular fat, in past 12Mo:Finding:12 months:^Patient:Ordinal:PhenX",0
C2970684,Insulin porcine Ab.IgE/IgE.total:AFr:Pt:Ser:Qn,insulin,Insulin Porcine IgE/IgE total %; Insulin porcine IgE/Total IgE (S) [%]; Insulin porcine Antibody.immunoglobulin E/immunoglobulin E.total:Arbitrary fraction:To identify measures at a point in time:Serum:Quantitative; Insulin porcine IgE Ab/IgE total in Serum,0
C2973050,"How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30D:Find:30D:^Patient:Ord:PhenX",regular,"How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30D:Finding:30 days:^Patient:Ordinal:PhenX; How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30 days [PhenX]; Carb soda w sugar in 30D PhenX",0
C2973077,"How often did you drink regular colas and root beer (caffeine free, not diet):Find:Pt:^Patient:Ord:PhenX",regular,"How often did you drink regular colas and root beer (caffeine free, not diet):Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX; Reg cola caffeine free PhenX; How often did you drink regular colas and root beer (caffeine free, not diet) [PhenX]",0
C2973078,"What is your serving size for regular colas and root beer (caffeine free, not diet):Find:Pt:^Patient:Ord:PhenX",regular,"What is your serving size for regular colas and root beer (caffeine free, not diet) [PhenX]; Size reg cola caffeine free PhenX; What is your serving size for regular colas and root beer (caffeine free, not diet):Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",0
C2973079,"How often did you drink regular colas and root beer (with caffeine, not diet):Find:Pt:^Patient:Ord:PhenX",regular,"How often did you drink regular colas and root beer (with caffeine, not diet) [PhenX]; How often did you drink regular colas and root beer (with caffeine, not diet):Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX; Regular cola w caffeine PhenX",0
C2973080,"What is your serving size for regular colas and root beer (with caffeine, not diet):Find:Pt:^Patient:Ord:PhenX",regular,"What is your serving size for regular colas and root beer (with caffeine, not diet) [PhenX]; Size reg cola w caffeine PhenX; What is your serving size for regular colas and root beer (with caffeine, not diet):Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",0
C2973103,"How often did you take regular one a day type, centrum or thera type multiple vitamins:Find:Pt:^Patient:Ord:PhenX",regular,"How often did you take regular one a day type, centrum or thera type multiple vitamins:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX; Regular multiple vit PhenX; How often did you take regular One-a-day type, Centrum or Thera-type multiple vitamins [PhenX]",0
C2973104,"How many Y did you take regular one a day type, centrum or thera type multiple vitamins:Time:Pt:^Patient:Qn:PhenX",regular,"Years regular multiple vit PhenX; How many Y did you take regular one a day type, centrum or thera type multiple vitamins:Time:To identify measures at a point in time:^Patient:Quantitative:PhenX; How many years did you take Regular One-a-Day type, Centrum or Thera-type multiple vitamins [PhenX]",0
C2973135,"About how often did you eat beef or pork hot dogs, regular fat, in past 12Mo:Find:12Mo:^Patient:Ord:PhenX",regular,"About how often did you eat beef or pork hot dogs, regular fat, in past 12Mo:Finding:12 months:^Patient:Ordinal:PhenX; Freq beef pork hot dog in 12Mo PhenX; About how often did you eat beef or pork hot dogs, regular-fat, in past 12 months [PhenX]",0
C2973136,"About how often did you eat cheese or cheese spread, regular fat, in past 12Mo:Find:12Mo:^Patient:Ord:PhenX",regular,"How often cheese reg fat in 12Mo PhenX; About how often did you eat cheese or cheese spread, regular fat, in past 12Mo:Finding:12 months:^Patient:Ordinal:PhenX; About how often did you eat cheese or cheese spread, regular fat, in past 12 months [PhenX]",0
C2973139,"About how often did you eat mayonnaise, regular fat, in past 12Mo:Find:12Mo:^Patient:Ord:PhenX",regular,"How often mayo reg fat 12Mo PhenX; About how often did you eat mayonnaise, regular fat, in past 12Mo:Finding:12 months:^Patient:Ordinal:PhenX; About how often did you eat mayonnaise, regular-fat, in past 12 months [PhenX]",0
C2973140,"About how often did you eat salad dressings, regular fat, in past 12Mo:Find:12Mo:^Patient:Ord:PhenX",regular,"About how often did you eat salad dressings, regular-fat, in past 12 months [PhenX]; Freq salad drsing reg fat in 12Mo PhenX; About how often did you eat salad dressings, regular fat, in past 12Mo:Finding:12 months:^Patient:Ordinal:PhenX",0
C2973177,Lipoprotein insulin resistance score:Score:Pt:Ser/Plas:Qn,insulin,LP-IR score SerPl; Lipoprotein insulin resistance score:Score:To identify measures at a point in time:Serum/Plasma:Quantitative; Lipoprotein insulin resistance score [Score]; Lipoprotein insulin resistance score in Serum or Plasma,0
C2975281,"insulin-like growth factor II, des(37-40)",insulin,des(37-40)IGF-II; vesiculin peptide,0
C2976311,humalog Mix 50,humalog,,0
C2978756,"BD Insulin Syringe 1cc 25g 5/8""",insulin,,0
C2978760,"BD Insulin Syringe 1cc 27g 5/8""",insulin,,0
C2978761,"BD Insulin Syringe U100 1cc 25g 1""",insulin,,0
C2978763,BD Insulin Syringe U-100 1 mL,insulin,,0
C2978806,"BD Insulin Syringe 1cc 29g 1/2"" (Safety Lok)",insulin,,0
C2978817,"BD Insulin Syringe 0.5cc 30g 1/2"" (UF)",insulin,,0
C2980632,ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 16 g in 100 g TOPICAL STICK [Sure Original Solid Powder],regular,ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 16 g in 100 g TOPICAL STICK [Sure Original Solid Unscented]; ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 16 g in 100 g TOPICAL STICK [Sure Original Solid Regular],0
C2980635,ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Sure Invisible Solid Regular],regular,ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Sure Invisible Solid Powder Scent]; ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Sure Invisible Solid Unscented],0
C2982408,"Sushi, Nidogen and EGF-Like Domain-Containing Protein 1",insulin,"SNED1; Sushi, Nidogen and EGF-Like Domains Protein 1; IRE-BP1; Stromal Nidogen Extracellular Matrix Protein; Insulin-Responsive Sequence DNA-Binding Protein 1; Sushi, Nidogen and EGF-Like Domain-Containing Protein 1",0
C2982484,SLC2A4 wt Allele,insulin,"GLUT4; Insulin-Responsive Glucose Transporter Type 4 Gene, Glucose Transporter 4 Gene; SLC2A4 wt Allele; Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 4 wt Allele",0
C2984182,EIF4EBP1 wt Allele,insulin,4E-BP1; 4EBP1; MGC4316; EIF4EBP1 wt Allele; BP-1; Eukaryotic Translation Initiation Factor 4E Binding Protein 1 wt Allele; PHAS-I; Phosphorylated Heat- and Acid-Stable Protein Regulated by Insulin 1 Gene,0
C2984300,Insulin/Insulin Receptor Signaling Pathway,insulin,Insulin/Insulin Receptor Signaling Pathway,0
C2984416,IGF1 Pathway,insulin,Somatomedin C Signaling Pathway; Insulin-Like Growth Factor 1 Signaling Pathway,0
C2984427,Insulin Pathway,insulin,,0
C2984428,Insulin-Mediated Glucose Transport Pathway,insulin,,0
C2984582,PAPPA wt Allele,insulin,"PAPP-A; PAPPA wt Allele; PAPPA1; Pregnancy-Associated Plasma Protein A, Pappalysin 1 wt Allele; Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease Gene; Differentially Placenta 1 Expressed Protein Gene; PAPA; IGFBP-4ase; Aspecific BCL2 ARE-Binding Protein 2 Gene; DIPLA1; ASBABP2",0
C2984583,Pappalysin-1,insulin,Pappalysin-1; Insulin-Like Growth Factor-Dependent IGF-Binding Protein 4 Protease; PAPP-A; EC 3.4.24.79; PAPPA; IGF-Dependent IGFBP-4 Protease; Pregnancy-Associated Plasma Protein A; IGFBP-4ase,0
C3147672,IRS3P gene,insulin,"insulin receptor substrate 3-like; insulin receptor substrate 3, pseudogene; IRS3P gene; IRS3L; IRS3P",0
C3153813,"ALUMINUM CHLOROHYDRATE 246 mg in 1 g TOPICAL AEROSOL, SPRAY [ARRID EXTRA EXTRA DRY XX]",regular,"ALUMINUM CHLOROHYDRATE 246 mg in 1 g TOPICAL AEROSOL, SPRAY [ARRID EXTRA DRY Regular]; ALUMINUM CHLOROHYDRATE 246 mg in 1 g TOPICAL AEROSOL, SPRAY [ARRID EXTRA EXTRA DRY XX Morning Clean]",0
C3155708,regulation of insulin secretion involved in cellular response to glucose stimulus,insulin,regulation of insulin secretion in response to glucose,0
C3155709,negative regulation of insulin secretion involved in cellular response to glucose stimulus,insulin,negative regulation of insulin secretion involved in cellular response to glucose,0
C3155710,negative regulation of insulin secretion in response to glucose,insulin,,0
C3158960,insulin secretion involved in cellular response to glucose stimulus,insulin,insulin secretion involved in cellular response to glucose,0
C3158961,positive regulation of insulin secretion involved in cellular response to glucose stimulus,insulin,positive regulation of insulin secretion in response to glucose,0
C3159351,camphor 0.11 MG/MG / menthol 0.08 MG/MG Topical Ointment,regular,"Camphor (Synthetic) 110 mg in 1 g / Menthol, Unspecified Form 80 mg in 1 g TOPICAL OINTMENT [Tiger Balm White Regular Strength]; Camphor (Synthetic) 110 mg in 1 g / Menthol, unspecified form 80 mg in 1 g TOPICAL OINTMENT [Tiger Balm White Regular Strength]; Tiger Balm, topical ointment; camphor 11 % / menthol 8 % Topical Ointment",0
C3159446,"Insulin Syringe, Ultiguard 0.3cc 30g X5/16""",insulin,,0
C3162838,docusate sodium 100 MG Oral Capsule,regular,"DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Laxa-basic 100]; docusate sodium 100 mg oral capsule; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [stool softener]; DOCUSATE NA 100MG CAP,UD; DOCUSATE SODIUM 100 mg ORAL CAPSULE [Stool Softener Gentle Relief]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Betr stool softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, GELATIN COATED [DQZATE STOOL SOFTENER]; DOCUSATE SODIUM 100 mg ORAL CAPSULE [CVS Health Stool Softener Clear]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Docusate Sodium - Stool Softener Laxative]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Stool Softener Regular Strength]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Stool Softener Laxative]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [DOCUSATE SODIUM 100mg Two-Tone]; DOCUSATE SODIUM 100 mg ORAL CAPSULE [Docusate Sodium]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Gentle Stool Softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE [Stool Softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [STOOL SOFTNER]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [good sense stool softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Docusate Sodium]; Stool Softener, sodium 100 mg oral capsule; Product containing precisely docusate sodium 100 milligram/1 each conventional release oral capsule (clinical drug); DOCUSATE SODIUM 100 mg ORAL CAPSULE, GELATIN COATED [Gentle Relief Stool Softner]; Docu Soft, sodium 100 mg oral capsule; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [DOCUSATE SODIUM 100mg]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Quality Choice Stool Softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, GELATIN COATED; Docusate Sodium 100 mg ORAL CAPSULE [Docusate Sodium]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [basic care stool softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE; DSS, sodium 100 mg oral capsule; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [STOOL SOFTENER]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Winco Stool Softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Stool Softener]; DOSS Sodium 100 MG Oral Capsule; Docusate Sodium 100 mg ORAL CAPSULE, LIQUID FILLED; docusate sodium 100 MG Oral Capsule; DOCUSATE SODIUM 100 mg ORAL CAPSULE, GELATIN COATED [Stool Softener Docusate Sodium]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Good Neighbor Stool Softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Topcare Stool Softener]; DOCUSATE SODIUM 100 mg ORAL CAPSULE, LIQUID FILLED [Harris Teeter Stool Softener]; DOCUSATE NA 100MG CAP; Docusate Sodium, sodium 100 mg oral capsule; Docusate sodium 100 mg oral capsule; DOCUSATE SODIUM 100 mg ORAL CAPSULE [Stool Softener Laxative]; DOCUSATE NA 100MG CAP UD",0
C3162847,Antacid Regular Strength,regular,,0
C3165688,PhenX - fasting serum insulin protocol,insulin,PhenX - fasting serum insulin protocol 141301,0
C3166018,PhenX measure - fasting serum insulin,insulin,PhenX measure - fasting serum insulin,0
C3166528,Was insulin your first diabetes medicine,insulin,Was insulin your first diabetes medicine,0
C3166790,"While your child sleeps, have you seen repeated kicks or jerks of the legs at regular intervals - about every 20 to 40S",regular,"While your child sleeps, have you seen repeated kicks or jerks of the legs at regular intervals - about every 20 to 40S",0
C3166796,Why did you stop regular use of pain-relieving medication,regular,Why did you stop regular use of pain-relieving medication,0
C3169305,"At what age did you begin to drink regularly - that is, drinking at least once a month for 6Mo or more:Time:Pt:^Patient:Qn:SSAGA II",regular,"At what age did you begin to drink regularly - that is, drinking at least once a month for 6 months or more [SSAGA II]; Regular drinking age SSAGA II; At what age did you begin to drink regularly - that is, drinking at least once a month for 6Mo or more:Time:To identify measures at a point in time:^Patient:Quantitative:SSAGA II",0
C3169500,Glucose/Insulin:Ratio:Pt:Ser/Plas:Qn,insulin,Glucose/Insulin SerPl-Rto; Glucose/Insulin [Ratio]; Glucose/Insulin [Ratio] in Serum or Plasma; Glucose/Insulin:Ratio:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C3171772,PhenX measure - fasting serum insulin:-:Point in time:^Patient:-:PhenX,insulin,,0
C3171773,PhenX - fasting serum insulin protocol:-:Point in time:^Patient:-:PhenX,insulin,PhenX - fasting serum insulin protocol 141301; PhenX - fasting serum insulin protocol 141301:-:To identify measures at a point in time:^Patient:-:PhenX; PhenX - fasting serum insulin protocol 141301:-:Pt:^Patient:-:PhenX; Fasting serum insulin proto,0
C3173331,Did you stop the regular use of pain-relieving medication during past 3Y:Find:3Y:^Patient:Ord:California Teachers Study,regular,Stop regular use pain med past 3Y 3Y CTS; Did you stop the regular use of pain-relieving medication during past 3Y:Finding:3 years:^Patient:Ordinal:California Teachers Study; Did you stop the regular use of pain-relieving medication during past 3Y 3 years [CA Teachers],0
C3173332,Did you stop the regular use of pain-relieving medication during past 3Y,regular,Did you stop the regular use of pain-relieving medication during past 3Y,0
C3173333,Why did you stop regular use of pain-relieving medication:Find:Pt:^Patient:Nom:California Teachers Study,regular,Why did you stop regular use of pain-relieving medication [CA Teachers]; Why did you stop regular use of pain-relieving medication:Finding:To identify measures at a point in time:^Patient:Nominal:California Teachers Study; Stop reg use pain med past 3Y why CTS,0
C3174117,"While your child sleeps, have you seen repeated kicks or jerks of the legs at regular intervals - about every 20 to 40S:Find:Pt:^Patient:Ord:PhenX",regular,"While your child sleeps, have you seen repeated kicks or jerks of the legs at regular intervals - about every 20 to 40S:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX; Child legs repeated kicks PhenX; While your child sleeps, have you seen repeated kicks or jerks of the legs at regular intervals - about every 20 to 40S [PhenX]",0
C3175928,"How many H and M does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning:Time:Pt:^Patient:Qn:PhenX",regular,"How many hours and minutes does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning [PhenX]; How many H and M does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning:Time:To identify measures at a point in time:^Patient:Quantitative:PhenX; Time to wake up PhenX",0
C3175929,"How many H and M does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning",regular,"How many hours and minutes does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning; How many H and M does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning",0
C3175949,"How often do you remember your dreams - that is, dreams that occur during your regular sleep and not while napping:NRat:Pt:^Patient:Ord:PhenX",regular,"Remember dreams PhenX; How often do you remember your dreams - that is, dreams that occur during your regular sleep and not while napping:Number=Count/Time:To identify measures at a point in time:^Patient:Ordinal:PhenX; How often do you remember your dreams - that is, dreams that occur during your regular sleep and not while napping [PhenX]",0
C3175968,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next:Find:Pt:^Patient:Ord:PhenX,regular,Prefer regular sleep schedule PhenX; Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX; Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next [PhenX],0
C3175969,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next,regular,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next,0
C3175970,"If you do not keep your regular sleep schedule, how much do you feel off - not your regular self, the next day:Find:Pt:^Patient:Ord:PhenX",regular,"No sleep schedule feel off PhenX; If you do not keep your regular sleep schedule, how much do you feel off - not your regular self, the next day [PhenX]; If you do not keep your regular sleep schedule, how much do you feel off - not your regular self, the next day:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",0
C3175971,"If you do not keep your regular sleep schedule, how much do you feel off - not your regular self, the next day",regular,"If you do not keep your regular sleep schedule, how much do you feel off - not your regular self, the next day",0
C3176194,Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX,insulin,Are you now taking insulin [PhenX]; Taking insulin PhenX; Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX,0
C3176195,Are you now taking insulin,insulin,Are you now taking insulin,0
C3176479,Was insulin your first diabetes medicine:Find:Pt:^Patient:Ord:PhenX,insulin,Was insulin your first diabetes medicine:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX; Was insulin your first diabetes medicine [PhenX]; Diabetes insulin PhenX,0
C3177005,Exclusion criteria for fasting serum insulin,insulin,Exclusion criteria for fasting serum insulin,0
C3177085,"How often do you remember your dreams - that is, dreams that occur during your regular sleep and not while napping",regular,"How often do you remember your dreams - that is, dreams that occur during your regular sleep and not while napping",0
C3177814,"IGF2BP2 protein, mouse",insulin,"IMP2 protein, mouse; insulin-like growth factor 2 mRNA binding protein 2, mouse; IMP-2 protein, mouse",0
C3179172,Insulin B Chain,insulin,"Chain, Insulin B",0
C3179576,"RXFP2 protein, mouse",insulin,"relaxin-insulin-like family peptide receptor 2, mouse",0
C3180727,"isophane insulin, insulin lispro drug combination 50:50",insulin,"insulin lispro - isophane insulin (50:50); insulin lispro, isophane insulin drug combination 50:50; isophane insulin - insulin lispro (50:50)",0
C3180742,"insulin, pork; isophane insulin, pork drug combination 30:70",insulin,"insulin, pork - isophane insulin, pork (30:70)",0
C3181697,"insulin-like growth factor 3, zebrafish",insulin,"IGF3 protein, zebrafish",0
C3195144,"BRIEF,BREATHABLE EXTRA ABSORBENT REGULAR ATTENDS",regular,"BRIEF,BREATHABLE EXTRA ABS REGUL ATTENDS",0
C3195149,"BRIEF,BREATHABLE REGULAR ATTENDS",regular,"BRIEF,BREATHABLE REG ATTENDS",0
C3211882,insulin glargine Injectable Product,insulin,Product containing insulin glargine in parenteral dose form (medicinal product form); Insulin glargine-containing product in parenteral dose form,0
C3211883,"insulin lispro / insulin lispro protamine, human Injectable Product",insulin,Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form); Insulin lispro protamine- and insulin lispro-containing product in parenteral dose form,0
C3211884,insulin lispro Injectable Product,insulin,Insulin lispro-containing product in parenteral dose form; Product containing insulin lispro in parenteral dose form (medicinal product form),0
C3211885,"insulin aspart protamine, human / insulin aspart, human Injectable Product",insulin,,0
C3211886,"insulin aspart, human Injectable Product",insulin,Product containing insulin aspart in parenteral dose form (medicinal product form); Insulin aspart-containing product in parenteral dose form,0
C3211887,"insulin glulisine, human Injectable Product",insulin,Insulin glulisine-containing product in parenteral dose form; Product containing insulin glulisine in parenteral dose form (medicinal product form),0
C3211894,"insulin, protamine zinc, human Injectable Product",insulin,,0
C3211896,"insulin, regular, beef Injectable Product",insulin,Bovine insulin soluble-containing product in parenteral dose form; Bovine regular insulin-containing product in parenteral dose form; Product containing bovine regular insulin in parenteral dose form (medicinal product form),0
C3212430,"insulin, regular, pork Injectable Product",insulin,Porcine regular insulin-containing product in parenteral dose form; Porcine insulin soluble-containing product in parenteral dose form; Product containing porcine regular insulin in parenteral dose form (medicinal product form),0
C3212431,"lente insulin, human Injectable Product",insulin,Human insulin soluble-containing product in parenteral dose form; Human regular insulin-containing product in parenteral dose form; Product containing human regular insulin in parenteral dose form (medicinal product form),0
C3212432,"lente insulin, pork Injectable Product",insulin,,0
C3215056,insulin detemir Injectable Product,insulin,,0
C3215057,"insulin human, rDNA origin Inhalant Product",insulin,,0
C3215058,"insulin, protamine zinc, beef Injectable Product",insulin,Product containing bovine insulin protamine zinc in parenteral dose form (medicinal product form); Bovine insulin protamine zinc-containing product in parenteral dose form,0
C3219089,"insulin, regular, human Injectable Product",insulin,,0
C3222105,Levemir Injectable Product,levemir,,0
C3225371,Humalog Injectable Product,humalog,HumaLOG Injectable Product,0
C3225373,Humalog Mix Injectable Product,humalog,HumaLOG Mix Injectable Product,0
C3225907,Ex-Lax Regular Strength Pills Oral Product,regular,,0
C3225908,Ex-Lax Regular Strength Pills Pill,regular,,0
C3229603,Lantus Injectable Product,lantus,,0
C3232035,NovoLog Injectable Product,novolog,NovoLOG Injectable Product,0
C3232036,NovoLog Mix Injectable Product,novolog,NovoLOG Mix Injectable Product,0
C3232041,Novolin Injectable Product,novolin,NovoLIN Injectable Product,0
C3232043,Novolin N Injectable Product,novolin,NovoLIN N Injectable Product,0
C3232044,Novolin R Injectable Product,novolin,NovoLIN R Injectable Product,0
C3244877,Psyllium 3400 MG Powder for Oral Suspension,regular,"Natural Fiber, 3.4 g/5.8 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 5.78 g ORAL POWDER [Meijer Natural Daily Fiber Sugar Free Berry Flavor]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Lidl Orange Smooth Fiber Powder Naturally and Artificially Flavored]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [meijer Natural Fiber]; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [Fiber Therapy Orange Smooth]; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [QC Natural Daily Fiber Sugar Free Orange Flavor]; Natural Vegetable, 3.4 g/7 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [Premier Value Orange Flavor]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER [Best Choice Fiber Therapy original coarse]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Fiber Therapy Orange Flavor]; psyllium 3.4 g/5.8 g oral powder for reconstitution; PSYLLIUM PWDR,ORAL PKT; psyllium 3.4 g/5.2 g oral powder for reconstitution; PSYLLIUM ORAL PWD PKT; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Best Choice Fiber Therapy Orange Flavor]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER, FOR SUSPENSION [Bulk-forming Laxative]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER [Discount Drug Mart Regular Flavor]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Publix Fiber Therapy Orange Smooth]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [up and up fiber therapy Natural Fiber]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Natural Orange Flavor Organic Natural Fiber]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER [Premier Value Fiber Therapy Original Coarse]; PSYLLIUM HUSK 3.4 g in 5.79 g ORAL POWDER [up and up fiber therapy]; psyllium 3.4 g/12 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [LIDL Orange Smooth Fiber Powder Sugar Free Naturally and Artificially Flavored]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER, FOR SUSPENSION [Fiber original texture]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER [Rite Aid multihealthFiber Natural Fiber]; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER, FOR SUSPENSION [Sunmark fiber Smooth Texture]; Psyllium Husk 3.4 g in 5.8 g ORAL POWDER [Leader Natural Fiber]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER [Ultra Organic Fiber Sugar Free]; psyllium 3.4 GM Powder for Oral Suspension; PSYLLIUM HUSK 3.4 g in 5.79 g ORAL POWDER [Topco Fiber Therapy Sugar Free]; psyllium 3.4 g/11 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER [Unflavored Organic Natural Fiber]; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER, FOR SUSPENSION [Health Mart fiber]; PSYLLIUM HUSK 3.4 g in 5.79 g ORAL POWDER [meijer fiber therapy]; Fiber Original Texture, 3.4 g/11 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER, FOR SUSPENSION [Rite Aid Fiber Therapy]; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [Discount Drug Mart Sugar Free]; PSYLLIUM HUSK 3.4 g in 7 g ORAL POWDER [Multihealth Fiber Therapy original coarse]; psyllium 3.4 g/7 g oral powder for reconstitution; Psyllium, 3.4 g/7 g oral powder for reconstitution; PSYLLIUM SF ORAL PWD; Daily Fiber Sugar-Free, 3.4 g/5.8 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [QC Fiber Therapy Orange Smooth]; PSYLLIUM HUSK 3.4 g in 5.79 g ORAL POWDER [Orange Smooth Fiber Therapy Sugar Free]; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [DG health Sugar Free]; Fiber Smooth Texture, 3.4 g/5.8 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 5.79 g ORAL POWDER [Daily Fiber Sugar Free]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Rite Aid Natural Fiber Orange Flavor]; PSYLLIUM HUSK 3.4 g in 11 g ORAL POWDER, FOR SUSPENSION [Original texture Orange flavor]; Natural Fiber Smooth Orange, 3.4 g/5.8 g oral powder for reconstitution; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [CAREONE Orange Flavored]; PSYLLIUM SUGAR FREE PWDR,ORAL; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER, FOR SUSPENSION [Smooth texture Orange flavor]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Discount Drug Mart Orange Flavor]; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER, FOR SUSPENSION [Quality Choice]; psyllium 3400 MG Powder for Oral Suspension; PSYLLIUM HUSK 3.4 g in 5.8 g ORAL POWDER [Publix Fiber Therapy Sugar Free]; PSYLLIUM HUSK 3.4 g in 12 g ORAL POWDER [Premier Value Fiber Therapy Orange Flavor]",0
C3252670,"insulin, B(1-29)-valyl-glycyl-leucyl-seryl-seryl-glycyl-glutaminyl-A(1-21)-A18Q-",insulin,"INS-A insulin; insulin, B(1-29)-VGLSSGQ-A(1-21)-A18Q-; B(1-29)-VGLSSGQ-A(1-21)-A18Q human insulin; insulin, B(1-29)-Val-Gly-Leu-Ser-Ser-Gly-Gln-A(1-21)-A18Q-",0
C3252671,"insulin, A8H,B25N,B27E,desB30-",insulin,"A8H,B25N,B27E,desB30-insulin; INS-B insulin; A8H,B25N,B27E,desB30 human insulin",0
C3253840,"insulin lispro, isophane insulin lispro drug combination (25:75)",insulin,,0
C3253841,"Ins2 protein, mouse",insulin,"insulin II protein, mouse; Mody4 protein, mouse",0
C3255481,ALUMINUM CHLOROHYDRATE 20 g in 103 mL TOPICAL LIQUID [Ban Roll-On Antiperspirant Deodorant Simple Clean],regular,ALUMINUM CHLOROHYDRATE 20 g in 103 mL TOPICAL LIQUID [Ban Roll-On Antiperspirant Deodorant Unscented]; ALUMINUM CHLOROHYDRATE 20 g in 103 mL TOPICAL LIQUID [Ban Roll-On Antiperspirant Deodorant Satin Breeze]; ALUMINUM CHLOROHYDRATE 20 g in 103 mL TOPICAL LIQUID [Ban Roll-On Antiperspirant Deodorant Powder Fresh]; ALUMINUM CHLOROHYDRATE 20 g in 103 mL TOPICAL LIQUID [Ban Roll-On Antiperspirant Deodorant Fresh Cotton]; ALUMINUM CHLOROHYDRATE 20 g in 103 mL TOPICAL LIQUID [Ban Roll-On Antiperspirant Deodorant Regular],0
C3259019,Do you need insulin:Hx:Pt:^Patient:Ord:PhenX,insulin,Need insulin PhenX; Do you need insulin [PhenX]; Do you need insulin:History:To identify measures at a point in time:^Patient:Ordinal:PhenX,0
C3259020,Do you need insulin,insulin,Do you need insulin,0
C3259040,Medical reason why you had or have to take this medication:Hx:Pt:^Patient:Nom:PhenX,regular,Medical reason why you had or have to take this medication [PhenX]; Regular med reason PhenX; Medical reason why you had or have to take this medication:History:To identify measures at a point in time:^Patient:Nominal:PhenX,0
C3259439,Exclusion criteria for fasting serum insulin:Find:Pt:^Patient:Nom:PhenX,insulin,Exclusion criteria serum insulin PhenX; Exclusion criteria for fasting serum insulin [PhenX]; Exclusion criteria for fasting serum insulin:Finding:To identify measures at a point in time:^Patient:Nominal:PhenX,0
C3261466,Respiratory syncytial virus Ag:PrThr:Pt:Nph:Ord:IA,NPH,RSV Ag IA Ql (Nph); Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunoassay; Respiratory syncytial virus Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immunoassay; RSV Ag Nph Ql IA,0
C3261686,I am able to do all of my regular family activities in the past 7D:Find:7D:^Patient:Ord:NeuroQol,regular,I am able to do all of my regular family activities in the past 7 days [NeuroQol]; I am able to do all of my regular family activities in the past 7D:Finding:7 days:^Patient:Ordinal:NeuroQol,0
C3261687,I am able to do all of my regular family activities in the past 7D,regular,I am able to do all of my regular family activities in the past 7 days; I am able to do all of my regular family activities in the past 7D,0
C3261690,I am able to do all of my regular activities with friends in the past 7D:Find:7D:^Patient:Ord:NeuroQol,regular,I am able to do all of my regular activities with friends in the past 7D:Finding:7 days:^Patient:Ordinal:NeuroQol; I am able to do all of my regular activities with friends in the past 7 days [NeuroQol],0
C3261691,I am able to do all of my regular activities with friends in the past 7D,regular,I am able to do all of my regular activities with friends in the past 7D; I am able to do all of my regular activities with friends in the past 7 days,0
C3261702,I have to limit my regular family activities in the past 7D:Find:7D:^Patient:Ord:NeuroQol,regular,I have to limit my regular family activities in the past 7 days [NeuroQol]; I have to limit my regular family activities in the past 7D:Finding:7 days:^Patient:Ordinal:NeuroQol,0
C3261703,I have to limit my regular family activities in the past 7D,regular,I have to limit my regular family activities in the past 7D; I have to limit my regular family activities in the past 7 days,0
C3261747,I am able to do all of my regular leisure activities in the past 7D:Find:7D:^Patient:Ord:NeuroQol,regular,I am able to do all of my regular leisure activities in the past 7 days [NeuroQol]; I am able to do all of my regular leisure activities in the past 7D:Finding:7 days:^Patient:Ordinal:NeuroQol,0
C3261748,I am able to do all of my regular leisure activities in the past 7D,regular,I am able to do all of my regular leisure activities in the past 7D; I am able to do all of my regular leisure activities in the past 7 days,0
C3261782,I have trouble doing my regular chores or tasks in the past 7D:Find:7D:^Patient:Ord:NeuroQol,regular,I have trouble doing my regular chores or tasks in the past 7 days [NeuroQol]; I have trouble doing my regular chores or tasks in the past 7D:Finding:7 days:^Patient:Ordinal:NeuroQol,0
C3261783,I have trouble doing my regular chores or tasks in the past 7D,regular,I have trouble doing my regular chores or tasks in the past 7 days; I have trouble doing my regular chores or tasks in the past 7D,0
C3261790,I am bothered by my limitations in regular family activities in the past 7D:Find:7D:^Patient:Ord:NeuroQol,regular,I am bothered by my limitations in regular family activities in the past 7 days [NeuroQol]; I am bothered by my limitations in regular family activities in the past 7D:Finding:7 days:^Patient:Ordinal:NeuroQol,0
C3261791,I am bothered by my limitations in regular family activities in the past 7D,regular,I am bothered by my limitations in regular family activities in the past 7 days; I am bothered by my limitations in regular family activities in the past 7D,0
C3261794,I am bothered by limitations in my regular activities with friends in the past 7D:Find:7D:^Patient:Ord:NeuroQol,regular,I am bothered by limitations in my regular activities with friends in the past 7D:Finding:7 days:^Patient:Ordinal:NeuroQol; I am bothered by limitations in my regular activities with friends in the past 7 days [NeuroQol],0
C3261795,I am bothered by limitations in my regular activities with friends in the past 7D,regular,I am bothered by limitations in my regular activities with friends in the past 7D; I am bothered by limitations in my regular activities with friends in the past 7 days,0
C3262345,Insulin^1.25H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^1.25H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1.25 Hr post Unsp challenge Qn; Insulin 1.25h p chal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --1.25 hours post XXX challenge,0
C3262346,Insulin^1.75H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 1.75 Hr post Unsp challenge Qn; Insulin [Units/volume] in Serum or Plasma --1.75 hours post XXX challenge; Insulin 1.75h p chal SerPl-aCnc; Insulin^1.75H post XXX challenge:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C3262403,"How many soda and sweetened drinks, regular, not diet, did you drink each D in past 7D:NRat:7D:^Patient:Qn:SAMHSA",regular,"How many soda and sweetened drinks, regular, not diet, did you drink each D in past 7D:Number=Count/Time:7 days:^Patient:Quantitative:SAMHSA; How many soda and sweetened drinks, regular, not diet, did you drink each day in past 7 days [SAMHSA]",0
C3262404,"How many soda and sweetened drinks, regular, not diet, did you drink each D in past 7D",regular,"How many soda and sweetened drinks, regular, not diet, did you drink each D in past 7D; How many soda and sweetened drinks, regular, not diet, did you drink each day in past 7 days",0
C3264857,"Paradigm Revel Insulin Pump, Blue",insulin,,0
C3264858,"Paradigm Revel Insulin Pump, Clear",insulin,,0
C3264859,"Paradigm Revel Insulin Pump, Pink",insulin,,0
C3264860,"Paradigm Revel Insulin Pump, Purple",insulin,,0
C3264861,"Paradigm Revel Insulin Pump, Smoke",insulin,,0
C3267438,V-Go Disposable Insulin Delivery Device 20 Un,insulin,,0
C3267439,V-Go Disposable Insulin Delivery Device 30 Un,insulin,,0
C3267440,V-Go Disposable Insulin Delivery Device 40 Un,insulin,,0
C3269463,regulation of cellular response to insulin stimulus,insulin,,0
C3269464,negative regulation of cellular response to insulin stimulus,insulin,down regulation of cellular response to insulin stimulus; downregulation of cellular response to insulin stimulus; down-regulation of cellular response to insulin stimulus,0
C3269465,positive regulation of cellular response to insulin stimulus,insulin,up-regulation of cellular response to insulin stimulus; activation of cellular response to insulin stimulus; upregulation of cellular response to insulin stimulus; up regulation of cellular response to insulin stimulus,0
C3271691,negative regulation of insulin receptor signaling pathway by insulin receptor internalization,insulin,negative regulation of insulin receptor signalling pathway by insulin receptor internalization,0
C3271692,agonist-stimulated insulin receptor internalization,insulin,,0
C3271693,positive regulation of insulin receptor signaling pathway by insulin receptor internalization,insulin,positive regulation of insulin receptor signalling pathway by insulin receptor internalization,0
C3271694,insulin receptor internalization,insulin,,0
C3271695,insulin receptor endocytosis,insulin,,0
C3271703,insulin receptor recycling,insulin,,0
C3271714,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,insulin,insulin receptor signaling pathway via PI3K cascade; insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade; insulin receptor signaling via PI3K; insulin receptor signalling pathway via phosphatidylinositol 3-kinase cascade,0
C3271980,glucose import in response to insulin stimulus,insulin,cellular glucose import in response to insulin stimulus,0
C3272173,inhibition of cellular response to insulin stimulus,insulin,,0
C3273630,SOCS1 wt Allele,SSI,Cytokine-Inducible SH2 Protein 1 Gene; TIP3; JAB; CISH1; SOCS1 wt Allele; Suppressor of Cytokine Signaling 1 wt Allele; STAT Induced SH3 Protein 1 Gene; SSI1; SSI-1; CIS1; SOCS-1,0
C3273731,SOCS3 wt Allele,SSI,SSI-3; SOCS-3; SOCS3 wt Allele; Cish3; SSI3; ATOD4; Suppressor of Cytokine Signaling 3 wt Allele; MGC71791; CIS3,0
C3275256,Suppressor of Cytokine Signaling 1,SSI,JAB; Suppressor of Cytokine Signaling 1; Tec-Interacting Protein 3; Cytokine-Inducible SH2 Protein 1; JAK-Binding Protein; SSI-1; STAT-Induced STAT Inhibitor 1; SOCS-1; SOCS1,0
C3275257,Suppressor of Cytokine Signaling 3,SSI,SSI-3; SOCS-3; CIS-3; STAT-Induced STAT Inhibitor 3; Cytokine-Inducible SH2 Protein 3; Suppressor of Cytokine Signaling 3,0
C3278636,Neonatal insulin-dependent diabetes mellitus,insulin,Neonatal insulin-dependent diabetes mellitus,0
C3280824,Insulin-like growth factor slightly low,insulin,,0
C3282002,Good Sense Antacid Regular Strength,regular,,0
C3467798,SCH 717454,insulin,"Immunoglobulin G1, Anti-(Human Insulin-Like Growth Factor I Receptor) (Human Monoclonal SCH 717454 Heavy Chain), Disulfide with Human Monoclonal SCH 717454 Light Chain, Dimer; Anti-IGF-1R Recombinant Monoclonal Antibody SCH 717454; SCH717454; SCH-717454; SCH 717454; Sch717454; anti-IGF-1R recombinant monoclonal antibody SCH 717454; immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human monoclonal SCH 717454 heavy chain), disulfide with human monoclonal SCH 717454 light chain, dimer",0
C3473047,"Aimsco Ultra-Thin II Insulin Syringes 1cc, 29",insulin,"Aimsco Ultra-Thin II Insulin Syringe 1cc, 29",0
C3473048,"Aimsco Ultra-Thin II Insulin Syringes 1cc, 30",insulin,"Aimsco Ultra-Thin II Insulin Syringe 1cc, 30",0
C3473317,Acetaminophen 325 MG Oral Tablet [Pharbetol],regular,"APAP 325 MG Oral Tablet [Pharbetol]; acetaminophen 325 MG Oral Tablet [Pharbetol]; Pharbetol Regular Strength 325 MG Oral Tablet; ACETAMINOPHEN 325 mg ORAL TABLET [Pharbetol]; Pharbetol, 325 mg oral tablet; Pharbetol 325 MG Oral Tablet; ACETAMINOPHEN 325 mg ORAL TABLET [Pharbetol Regular strength]",0
C3474547,"Aimsco Ultra-Thin II Insulin Syringes 0.5cc,",insulin,"Aimsco Ultra-Thin II Insulin Syringe 0.5cc,",0
C3481986,Insulin-like growth factor binding protein 1:PrThr:Pt:Vag:Ord,insulin,Insulin-like growth factor binding protein 1:Presence or Threshold:To identify measures at a point in time:Vagina:Ordinal; Insulin-like growth factor binding protein 1 [Presence] in Vaginal fluid; Insulin-like growth factor binding protein 1 Ql (Vag fld); IGF BP1 Vag Ql,0
C3490938,"Ilp5 protein, Drosophila",insulin,"Insulin-like peptide 5 protein, Drosophila; Dilp5 protein, Drosophila",0
C3491971,insulin degludec,insulin,"degludec; INSULIN DEGLUDEC; (1A-21A),(1B-29B)-Insulin (human), 29B-(N6-(N-(15-carboxy-1-oxopentadecyl)-L-gamma-glutamyl)-L-lysine)-; (1A-21A),(1B-29B)-insulin (human), 29B-(N6-(N-(15-carboxy-1- oxopentadecyl)-L-gamma- glutamyl)-L-lysine)-; Insulin degludec-containing product; Insulin degludec; INSULIN,DEGLUDEC,HUMAN/RDNA; insulin degludec; Insulin Degludec; Insulin degludec (substance); Insulina degludec; Degludec; Product containing insulin degludec (medicinal product)",0
C3492162,"insulin-like peptide 8, Drosophila",insulin,"Dilp8 protein, Drosophila; CG14059 protein, Drosophila",0
C3501748,biphasic human insulin 30,insulin,BHI 30,0
C3501839,insulin detemir 100 UNT/ML Pen Injector,insulin,,0
C3502494,"insulin isophane, human 100 UNT/ML Prefilled Syringe",insulin,,0
C3502925,"insulin, regular, human 100 UNT/ML Prefilled Syringe",insulin,,0
C3502990,"insulin isophane, human 100 UNT/ML Prefilled Syringe [Novolin N]",insulin,,0
C3502999,"Insulin Lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector",insulin,,0
C3503009,"Insulin Lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]",insulin,,0
C3503014,"insulin isophane, human 100 UNT/ML Prefilled Syringe [Humulin N]",insulin,,0
C3503015,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe [Humulin]",insulin,,0
C3503050,"Insulin Lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [Humalog Mix]",insulin,,0
C3503165,"Insulin Lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector",insulin,,0
C3503221,"3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector",insulin,"3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector; insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector; insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector; Insulin Aspart-Insulin Aspart Protamine FlexPen, 30 units-70 units/mL subcutaneous suspension; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Insulin Aspart Protamine and Insulin Aspart Mix 70/30]; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [.Insulin Aspart Protamine and Insulin Aspart]",0
C3503234,"insulin glulisine, human 100 UNT/ML Pen Injector [Apidra]",insulin,,0
C3503266,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe [Novolin]",insulin,,0
C3503329,"3 ML insulin aspart, human 100 UNT/ML Pen Injector",insulin,"3 ML insulin aspart, human 100 UNT/ML Pen Injector; insulin aspart 100 UNT/ML in 3 ML Pen Injector; Insulin Aspart FlexPen, 100 units/mL injectable solution; insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector; INSULIN,ASPART 100UN/ML NOVO FLEXPEN 3ML; INSULIN,ASPART,HUMAN 100U/ML,NOVOLOG,FLEXPEN,3ML; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Aspart]; INSULIN ASPART 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin Aspart]",0
C3503424,insulin detemir 100 UNT/ML Pen Injector [Levemir],insulin,,0
C3503457,Insulin Glargine 100 UNT/ML Pen Injector,insulin,,0
C3503458,Insulin Glargine 100 UNT/ML Pen Injector [Lantus],insulin,,0
C3503497,"insulin glulisine, human 100 UNT/ML Pen Injector",insulin,,0
C3503595,"insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe",insulin,,0
C3503635,"insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]",insulin,,0
C3503716,"insulin, regular, human 100 UNT/ML Prefilled Syringe [Novolin R]",insulin,,0
C3504188,Ambulatory insulin infusion pump,insulin,"Infusion Pumps, Insulin, Ambulatory; Ambulatory insulin infusion pump (physical object); Infusion Pumps, Ambulatory, Insulin; Insulin Infusion Pumps, Ambulatory",0
C3504189,"Infusion Pumps, Insulin, Implantable",insulin,"Insulin Infusion Pumps, Implantable",0
C3530263,Indian Health Service - Regular,regular,,0
C3531390,Blue Lizard Regular SPF 30+,regular,,0
C3532532,Complication associated with insulin pump,insulin,Complication associated with insulin pump (disorder),0
C3532679,On subcutaneous insulin for diabetes mellitus,insulin,On subcutaneous insulin for diabetes mellitus (finding),0
C3533232,High molecular weight insulin-like growth factor-II,insulin,Insulin-like growth factor-II.high molecular weight; High molecular weight insulin-like growth factor-II (substance),0
C3533512,Insulin^4.5H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --4.5 hours post 75 g glucose PO; Insulin 4.5 Hr post 75 g glucose PO Qn; Insulin^4.5 hours post 75 g glucose Oral:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 4.5h p 75 g Glc PO SerPl-aCnc,0
C3533696,Virus identified:Prid:Pt:Nph:Nom:Culture,NPH,Virus Nph Cult; Virus identified Cx Nom (Nph); Virus identified:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Culture; Virus identified in Nasopharynx by Culture,0
C3534035,Insulin-like growth factor-II.high molecular weight:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-II.high molecular weight [Mass/Vol]; Insulin-like growth factor-II.high molecular weight:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-II.high molecular weight [Mass/volume] in Serum or Plasma; Big IGF-II SerPl-mCnc,0
C3534783,Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis,SSI,,0
C3534784,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time",SSI,,0
C3534785,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time",SSI,,0
C3537196,CT-47098,NPH,NPH-007098; NPH007098,0
C3537640,"lente insulin, pork Injectable Suspension [Vetsulin]",insulin,,0
C3537655,"BD Insulin Syringe with Ultra-Fine Needle, 0.",insulin,,0
C3537656,"BD Insulin Syringe with Ultra-Fine Needle, 1m",insulin,,0
C3538421,NovoLog Mix,novolog,NovoLOG Mix,0
C3540677,Comfort EZ insulin Syr 0.5 ml,insulin,Comfort EZ Insulin Syr 0.5 ml,0
C3547574,insulin catabolic process,insulin,insulin breakdown; insulin degradation; insulin catabolism,0
C3547575,insulin metabolic process,insulin,insulin metabolism,0
C3549878,Enhanced insulin sensitivity,insulin,,0
C3555004,insulin degludec 100 UNT/ML Injectable Solution,insulin,"INSULIN DEGLUDEC 100 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Degludec]; insulin degludec 100 UNT/mL Injectable Solution; insulin degludec 100 UNT/ML Injectable Solution; INSULIN,DEGLUDEC HUMAN 100 UNIT/ML INJ; INSULIN,DEGLUDEC,HUMAN 100 UNIT/ML INJ",0
C3639411,Homeostatic Model Assessment of Insulin Resistance,insulin,,0
C3639886,WPAI:SHP v2.0 - Problem Affects Regular Daily Activity,regular,,0
C3642804,Comfort EZ Insulin Syr 0.3 ml,insulin,,0
C3642821,"BD Insulin Syringe 0.3cc 31g 15/64"" (UF)",insulin,,0
C3654241,Adenovirus B+E DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Adenovirus B+E deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Adenovirus B+E DNA [Presence] in Nasopharynx by NAA with probe detection; AdV B+E DNA Nph Ql NAA+probe; Adenovirus B+E DNA NAA+probe Ql (Nph),0
C3654242,Adenovirus C DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,AdV C DNA Nph Ql NAA+probe; Adenovirus C deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Adenovirus C DNA [Presence] in Nasopharynx by NAA with probe detection; Adenovirus C DNA NAA+probe Ql (Nph),0
C3654416,Insulin-like growth factor-I:Zscore:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I [Z-score]; Insulin-like growth factor-I [Z-score] in Serum or Plasma; IGF-I Z-score SerPl; Insulin-like growth factor-I:Z Score:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C3655022,Insulin^1H post 75 g glucose PO:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO; Insulin^1 hour post 75 g glucose Oral:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1h p 75 g Glc PO SerPl-sCnc; Insulin 1 Hr post 75 g glucose PO [Moles/Vol],0
C3655023,Insulin^2H post 75 g glucose PO:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin 2h p 75 g Glc PO SerPl-sCnc; Insulin [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO; Insulin^2 hours post 75 g glucose Oral:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2 Hr post 75 g glucose PO [Moles/Vol],0
C3655024,Insulin^3H post 75 g glucose PO:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^3 hours post 75 g glucose Oral:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO; Insulin 3h p 75 g Glc PO SerPl-sCnc; Insulin 3 Hr post 75 g glucose PO [Moles/Vol],0
C3655038,Respiratory syncytial virus Ag:PrThr:Pt:Nph:Ord:IA.rapid,NPH,Respiratory syncytial virus Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immunoassay.rapid; RSV Ag IA.rapid Ql (Nph); RSV Ag Nph Ql IA.rapid; Respiratory syncytial virus Ag [Presence] in Nasopharynx by Rapid immunoassay,0
C3657803,"IMP1 protein, mouse",insulin,"IGF2 mRNA-binding protein 1, mouse; insulin-like growth factor 2, binding protein 1 protein, mouse; IMP-1 protein, mouse",0
C3658013,"insulin degludec, insulin aspart drug combination",insulin,insulin degludec - insulin aspart; Insulin aspart- and insulin degludec-containing product; insulin degludec and insulin aspart; Insulin Aspart/ Insulin Degludec; Product containing insulin aspart and insulin degludec (medicinal product); insulin aspart-insulin degludec,0
C3658137,"insulin, lysyl(B31)-arginyl(B32)-",insulin,"insulin, Lys(B31)-Arg(B32)-; Lys(B31)-Arg(B32) human insulin",0
C3658197,"phIGFBP-1 protein, human",insulin,"phosphorylated insulin-like growth factor-binding protein, human",0
C3668534,INSULIN SYRINGE 1ML 30G 0.5IN SAFETY,insulin,INSULIN SYRINGE 1ML 30G 0.5IN SAFETY,0
C3668824,Serum insulin concentration below normal (finding),insulin,Serum insulin concentration below normal; Hypoinsulinemia; Serum insulin concentration below normal (finding),0
C3670603,Amended insulin glucose ratio elevated,insulin,AIGR elevated; AIGR increased; Amended insulin glucose ration increased; Amended insulin glucose ratio elevated (finding),0
C3687692,Porcine insulin zinc,insulin,Porcine insulin zinc (substance),0
C3690644,"IVD Test Reagent/Kits, Immunoassay, Autoimmune, Diabetes, Insulin Autoantibody",insulin,,0
C3690795,"IVD Test Reagent/Kits, Immunoassay, Endocrine, Insulin-Like Growth Factor Binding Protein 3",insulin,,0
C3690796,"IVD Test Reagent/Kits, Immunoassay, Endocrine, Insulin-Like Growth Factor Binding Protein 1",insulin,,0
C3690806,"IVD Test Reagent/Kits, Immunoassay, Endocrine Hormone, Insulin-Like Growth Factor II",insulin,,0
C3690807,"IVD Test Reagent/Kits, Immunoassay, Endocrine Hormone, Insulin-Like Growth Factor I",insulin,,0
C3691491,"IVD Test Reagent/Kits, Immunoassay, Diabetes, Insulin",insulin,,0
C3692059,Regular Tourniquet Cuffs,regular,,0
C3692621,Citracal Regular,regular,,0
C3699134,I was satisfied with my ability to do regular personal and household responsibilities in past 7D:Find:7D:^Patient:Ord:PROMIS,regular,I was satisfied with my ability to do regular personal and household responsibilities in past 7 days [PROMIS]; I was satisfied with my ability to do regular personal and household responsibilities in past 7D:Finding:7 days:^Patient:Ordinal:PROMIS,0
C3699193,I could get up from a regular toilet in past 7D:Find:7D:^Patient:Ord:PROMIS,regular,I could get up from a regular toilet in past 7 days [PROMIS]; I could get up from a regular toilet in past 7D:Finding:7 days:^Patient:Ordinal:PROMIS,0
C3711523,"insulin, CysA10-CysB4-desB30-",insulin,CysA10-CysB4-desB30-insulin; 4SS-insulin,0
C3712803,"IGF1 protein, human",insulin,"insulin like growth factor 1, human; IGF1; Somatomedin C; IGF-I; Insulin-Like Growth Factor 1; IGF-1 protein, human; Insulin-Like Growth Factor-I; IGF I; Somatomedin-C; MGF; IGF1 protein, human; IGF-I protein, human; Mechano Growth Factor; IGF-1; Insulin-Like Growth Factor I; IGFI protein, human",0
C3714296,Thin fluid,regular,Watery fluid; Normal fluid consistency; Regular fluid consistency; Thin fluid (substance),0
C3714501,Insulin Drug Class,insulin,INSULIN,0
C3714619,Insulin resistance syndrome,insulin,insulin resistance syndrome; Insulin resistance syndrome; Insulin Resistance Syndrome,0
C3714909,"{60 (Regular Insulin, Human 4 UNT Inhalant Powder [Afrezza]) / 30 (Regular Insulin, Human 8 UNT Inhalant Powder [Afrezza]) } Pack [Afrezza 90 - 60 (4 UNT), 30 (8 UNT)]",insulin,,0
C3714911,"{30 (Regular Insulin, Human 4 UNT Inhalant Powder [Afrezza]) / 60 (Regular Insulin, Human 8 UNT Inhalant Powder [Afrezza]) } Pack [Afrezza 90 - 30 (4 UNT), 60 (8 UNT)]",insulin,,0
C3809554,"Hyperglycemia, insulin-responsive, episodic",insulin,,0
C3810344,"Absence of insulin, glucagon, and somatostatin by pancreatic immunohistochemistry",insulin,,0
C3810452,Low or undetectable insulin,insulin,,0
C3813208,"Proinsulin, human",insulin,Proinsulin Human; Proinsulin; Insulin Precursor,0
C3814812,Putative Insulin-Like Growth Factor 2 Antisense Gene Protein,insulin,IGF2 Antisense Gene Protein 1; Putative Insulin-Like Growth Factor 2 Antisense Gene Protein; IGF2-AS1; PEG8/IGF2AS Protein; Putative Insulin-Like Growth Factor 2 Antisense Gene Protein 1,0
C3814813,IGF2-AS wt Allele,insulin,"IGF2AS; hCG_1995804; IGF2 Antisense RNA wt Allele; PEG8; IGF2, Antisense Gene; Insulin-Like Growth Factor II, Antisense Gene; IGF2-AS1; IGF2 Antisense RNA (Non-Protein Coding) Gene; Insulin-Like Growth Factor 2, Antisense Gene; IGF2-AS wt Allele; IGF2 Antisense RNA 1 (Non-Protein Coding) Gene; Insulin-Like Growth Factor 2 Antisense 1 (Non-Protein Coding) Gene",0
C3814868,"IDE wt Allele, Human",insulin,IDE wt Allele; INSULYSIN; Insulin-Degrading Enzyme wt Allele; RP11-366I13.1,0
C3815878,Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2-Like Protein 1,insulin,BAI1-Associated Protein 2-Like Protein 1; Insulin Receptor Tyrosine Kinase Substrate; BAIAP2L1; Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2-Like Protein 1,0
C3817287,"Bio-K+ Regular, oral delayed release capsule",regular,,0
C3817348,Bio-K+ Regular,regular,,0
C3818033,BENZOCAINE 100 mg in 1 g TOPICAL GEL [Orajel Instant Pain Relief Regular],regular,,0
C3818211,CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Health Mart Castor Oil],regular,CASTOR OIL 1 mg in 1 mL ORAL LIQUID; CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Humco Castor Oil]; CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Harris Teeter Castor Oil]; CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Rite Aid Castor Oil]; CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Sunmark Castor Oil]; CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Quality Choice Castor Oil]; CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Humco Castor Oil (Regular)]; CASTOR OIL 1 mg in 1 mL ORAL LIQUID [Premiere Value Castor Oil],0
C3824524,cellular response to insulin-like growth factor stimulus,insulin,cellular response to insulin-like growth factor,0
C3828466,Proinsulin to Insulin Ratio Measurement,insulin,,0
C3832023,INSULIN SYRINGE 1ML 31G 6MM,insulin,INSULIN SYRINGE 1ML 31G 6MM,0
C3832156,Quality Choice Insulin Syringe 29g x 0.5cc,insulin,,0
C3832157,Quality Choice Insulin Syringe 30g x 0.5cc,insulin,,0
C3832160,"ReliOn Insulin Syringe 0.3cc 29gx1/2""",insulin,,0
C3832161,"ReliOn Insulin Syringe 0.3cc 30gx5/16""",insulin,,0
C3832162,"ReliOn Insulin Syringe 0.3cc 31gx5/16""",insulin,,0
C3832163,"ReliOn Insulin Syringe 0.5cc 29gx1/2""",insulin,,0
C3832164,"ReliOn Insulin Syringe 0.5cc 30gx5/16""",insulin,,0
C3832165,"ReliOn Insulin Syringe 1cc 29gx1/2""",insulin,,0
C3832166,"ReliOn Insulin Syringe 1cc 30gx5/16""",insulin,,0
C3832167,"ReliOn Insulin Syringe 1cc 31gx5/16""",insulin,,0
C3832168,ReliOn Insulin Syringe 29g x 0.5cc,insulin,,0
C3832169,ReliOn Insulin Syringe 29g x 1cc,insulin,,0
C3832170,"ReliOn Insulin Syringe, 29g x 0.3cc",insulin,,0
C3832195,SM Insulin Syringe 30g 1cc,insulin,,0
C3832196,SM Insulin Syringe 31g 0.3cc,insulin,,0
C3832197,SM Insulin Syringe 31g 0.5cc,insulin,,0
C3832198,SM Insulin Syringe 31g 1cc,insulin,,0
C3832214,"Sunmark Insulin Syringe 31 g, 0.3cc",insulin,,0
C3832215,"Sunmark Insulin Syringe 31 g, 0.5cc",insulin,,0
C3832216,"Sunmark Insulin Syringe 31 g, 1cc",insulin,,0
C3832223,"SureComfort Insulin Syringe, 31 ga, 0.3cc",insulin,,0
C3832272,"Ultra Comfort Insulin Syringe, 31 g, 0.3cc",insulin,,0
C3832273,"Ultra Comfort Insulin Syringe, 31 g, 0.5cc",insulin,,0
C3832294,AIMSCO Insulin Syringe 0.3cc 31g,insulin,,0
C3832295,AIMSCO Insulin Syringe 0.5cc 31g,insulin,,0
C3832318,"Aimsco Insulin Syringes 0.5cc 28gx1/2""",insulin,,0
C3832319,"Aimsco Insulin Syringes 1cc 28gx1/2""",insulin,,0
C3832320,"Aimsco Ultra-Thin II Insulin Syringe 0.3cc,",insulin,"Aimsco Ultra-Thin II Insulin Syringes 0.3cc,",0
C3832335,"BD Insulin Syringe 0.5cc 29gx1/2""",insulin,,0
C3832342,"BD MF Insulin Syringe 28gx1/2""",insulin,,0
C3832351,"BD Regular Insulin Needle 19gx1""",insulin,,0
C3832385,"Clickfine Pen Insulin Syringes 31gx1/4""",insulin,,0
C3832386,"Clickfine Pen Insulin Syringes 31gx5/16""",insulin,,0
C3832417,"EasyTouch Insulin Syringe 0.3cc, 31gx5/16",insulin,,0
C3832418,"EasyTouch Insulin Syringe 0.5cc, 30gx5/16",insulin,,0
C3832419,"EasyTouch Insulin Syringe 0.5cc, 31gx5/16",insulin,,0
C3832420,"EasyTouch Insulin Syringe 1cc, 31gx5/16""",insulin,,0
C3832432,Equaline Insulin Syringe 29gx0.3cc,insulin,,0
C3832433,Equaline Insulin Syringe 29gx0.5cc,insulin,,0
C3832434,Equaline Insulin Syringe 29gx1cc,insulin,,0
C3832435,Equaline Insulin Syringe 30gx0.3cc,insulin,,0
C3832436,Equaline Insulin Syringe 30gx0.5cc,insulin,,0
C3832437,Equaline Insulin Syringe 30gx1cc,insulin,,0
C3832438,Equaline Insulin Syringe 31gx0.3cc,insulin,,0
C3832439,Equaline Insulin Syringe 31gx0.5cc,insulin,,0
C3832440,Equaline Insulin Syringe 31gx1cc,insulin,,0
C3832444,Family Pharmacy Insulin Syringe 31gx0.5cc,insulin,,0
C3832445,Family Pharmacy Insulin Syringe 31gx1cc,insulin,,0
C3832473,Insulin Pen Needle Blue 31g X 5 mm,insulin,,0
C3832476,"Insulin Syrines, UltiGuard 0.5cc 31gx5/16",insulin,,0
C3832477,"Insulin Syrines, UltiGuard 1cc 31gx5/16",insulin,,0
C3832481,"Insulin Syringe 0.3cc, 30 g",insulin,,0
C3832482,"Insulin Syringe 0.5cc 28gx1/2""",insulin,,0
C3832483,"Insulin Syringe 0.5cc 30g x 1/2""",insulin,,0
C3832484,"Insulin Syringe 1cc 27gx1/2""",insulin,,0
C3832485,"Insulin Syringe 1cc 29g x 1/2""",insulin,,0
C3832486,"Insulin Syringe 1cc 31g X 5/16""",insulin,,0
C3832487,"Insulin Syringe 30gx5/16"" 0.5cc",insulin,"Insulin Syringe, 0.5cc, 30gx5/16""",0
C3832498,"Insulin Syringe, 0.3cc 31gx5/16""",insulin,"Insulin Syringe, 0.3cc, 31gx5/16""",0
C3832499,"Insulin Syringe, 0.3cc, 29gx1/2""",insulin,,0
C3832500,"Insulin Syringe, 0.3cc, 30gx1/2""",insulin,,0
C3832501,"Insulin Syringe, 0.3cc, 30gx5/16""",insulin,,0
C3832503,"Insulin Syringe, 0.5cc 31gx5/16""",insulin,"Insulin Syringe, 0.5cc, 31gx5/16""",0
C3832504,"Insulin Syringe, 0.5cc, 30gx1/2""",insulin,,0
C3832505,"Insulin Syringe, 1cc, 30gx1/2""",insulin,,0
C3832506,"Insulin Syringe, 1cc, 30gx5/16""",insulin,,0
C3832507,"Insulin Syringe, 1cc, 31gx5/16""",insulin,,0
C3832508,"Insulin Syringe, UltiCare 1cc, 28gx1/2""",insulin,,0
C3832509,"Insulin Syringe, Ultic 0.5cc 29gx1/2""",insulin,,0
C3832510,"Insulin Syringe, Ultic 1cc 29gx1/2""",insulin,,0
C3832511,"Insulin Syringe, Ultiguard 0.3cc 29gx1/2""",insulin,,0
C3832512,"Insulin Syringe, Ultiguard 0.3cc 31gx5/16""",insulin,,0
C3832513,"Insulin Syringes 0.5cc, 29 g",insulin,,0
C3832557,Monoject Insulin Syringe 31gx1cc,insulin,,0
C3832593,"PV Insulin Syringe, 1cc, 29gx1/2""",insulin,,0
C3833500,"insulin, regular, human 4 UNT Inhalation Powder [Afrezza]",insulin,"afrezza 4 UNT Inhalation Powder; Afrezza 4 UNT Inhalation Powder; Afrezza, 4 units inhalation powder; INSULIN HUMAN 4 RESPIRATORY (INHALATION) POWDER, METERED [Afrezza]",0
C3833517,"insulin, regular, human 4 UNT Inhalation Powder",insulin,"INSULIN,HUMAN 4 UNIT X 90 INHL,ORAL,CARTRIDGE,KIT; regular insulin, human 4 UNT Inhalation Powder Cartridge; INSULIN 4 UNIT X 90 INHL KIT",0
C3833588,Levemir FlexTouch,levemir,,0
C3833613,BD Insulin Syringe 0.5cc 31g 8mm,insulin,,0
C3833614,BD Insulin Syringe 0.5cc 31g 6mm,insulin,,0
C3833615,BD Insulin Syringe 0.5cc 30g 12.7mm,insulin,,0
C3833617,BD Insulin Syringe 0.3cc 31g 8mm,insulin,,0
C3833618,BD Insulin Syringe 0.3cc 31g 8 mm,insulin,,0
C3833619,BD Insulin Syringe 0.3cc 31g 6mm,insulin,,0
C3833620,BD Insulin Syringe 0.3cc 30g 12.7mm,insulin,,0
C3833646,BD Insulin Syringe Half Unit 0.3cc 31g 8mm,insulin,,0
C3833648,BD Insulin Syringe 1cc 31g 8mm,insulin,,0
C3833649,BD Insulin Syringe 1cc 31g 8 mm,insulin,,0
C3833650,BD Insulin Syringe 1cc 31g 6mm,insulin,,0
C3833651,BD Insulin Syringe 1cc 30g 12.7mm,insulin,,0
C3834216,Afrezza,afrezza,Afrezza,0
C3834381,Afrezza Inhalant Product,afrezza,,0
C3834483,"insulin, regular, human Inhalant Product",insulin,,0
C3840687,"Adequate - sees fine detail, such as regular print in newspapers/books",regular,,0
C3840794,"ADEQUATE- sees fine detail, including regular print in newspaper/books",regular,"Adequate: Sees fine detail, including regular print in newspapers/books",0
C3842614,Engaged in a regular program of physical fitness five or more times per week,regular,,0
C3842615,Engaged in a regular program of physical fitness involving some kind of heavy physical activity at least three times per week,regular,,0
C3842622,No job or regular work,regular,,0
C3842788,Taking insulin,insulin,,0
C3843334,Regular (within 8 days),regular,,0
C3843667,Regular soda pop or other sugared beverages,regular,,0
C3843672,Regular pop,regular,,0
C3843706,"Yes, I stopped regular use",regular,,0
C3843899,A regular night shift,regular,,0
C3843900,A regular evening shift,regular,,0
C3843901,A regular daytime schedule,regular,,0
C3844473,"Able to independently plan and prepare all light meals for self or reheat delivered meals; or Is physically, cognitively, and mentally able to prepare light meals on a regular basis but has not routinely performed light meal preparation in the past.",regular,,0
C3844540,Regular nighttime,regular,,0
C3844541,Regular daytime,regular,,0
C3845139,Regular food: solids and liquids swallowed safely without supervision and without modified food or liquid consistency.,regular,,0
C3845187,Insulin Drip,insulin,,0
C3845421,"Able to independently drive a regular or adapted car, OR uses a regular or handicap-accessible public bus.",regular,,0
C3845422,"Unable to prepare light meals on a regular basis due to physical, cognitive, or mental limitations.",regular,,0
C3845684,"Impaired - sees large print, but not regular print in newspapers/books",regular,,0
C3845956,"Lying quietly, normal position, moves easily; regular, rhythmic respirations",regular,,0
C3848321,"insulin, regular, human 8 UNT Inhalation Powder [Afrezza]",insulin,"Afrezza, 8 units inhalation powder; INSULIN HUMAN 8 RESPIRATORY (INHALATION) POWDER, METERED [Afrezza]; Afrezza 8 UNT Inhalation Powder; afrezza 8 UNT Inhalation Powder",0
C3848698,"{30 (Regular Insulin, Human 4 UNT Inhalant Powder) / 60 (Regular Insulin, Human 8 UNT Inhalant Powder) } Pack",insulin,,0
C3848699,"{60 (Regular Insulin, Human 4 UNT Inhalant Powder) / 30 (Regular Insulin, Human 8 UNT Inhalant Powder) } Pack",insulin,,0
C3848737,"insulin, regular, human 8 UNT Inhalation Powder",insulin,"regular insulin, human 8 UNT Inhalation Powder Cartridge; INSULIN,HUMAN 8 UNIT X 90 INHL,ORAL,CARTRIDGE,KIT; INSULIN 8 UNIT X 90 INH KIT",0
C3855077,"insulin inhalation, rapid acting 8 units inhalation powder",insulin,,0
C3855086,Insulin Pen Needle D/P 31g X 8 mm,insulin,,0
C3855087,Insulin Pen Needle Red 29g X 12.7mm,insulin,,0
C3855088,"Insulin Syringe 0.3 mL, 31gx5/16""",insulin,,0
C3855089,"Insulin Syringe 0.5 mL, 31gx5/16""",insulin,,0
C3855095,"Insulin Syringe 1 mL, 31gx5/16""",insulin,,0
C3855096,Insulin Syringe Blue 28g X 1 mL,insulin,,0
C3855097,Insulin Syringe Brn 31g X 1 mL,insulin,,0
C3855098,Insulin Syringe D/G 28g X 1/2 mL,insulin,,0
C3855099,Insulin Syringe D/P 29g X 1/2 mL,insulin,,0
C3855100,Insulin Syringe L/G 31g X 1/2 mL,insulin,,0
C3855101,Insulin Syringe L/P 30g X 3/10 mL,insulin,,0
C3855102,Insulin Syringe Orange 31g X 3/10 mL,insulin,,0
C3855103,Insulin Syringe Pink 30g X 1mL,insulin,,0
C3855104,Insulin Syringe Red 29g X 1 mL,insulin,,0
C3855105,Insulin Syringe Teal 29g X 3/10 mL,insulin,,0
C3855106,Insulin Syringe Yellow 30g X 1/2 mL,insulin,,0
C3859780,NovoLOG FlexTouch,novolog,,0
C3860193,Insulin pen needle,insulin,,0
C3864728,caffeine 100 MG Oral Tablet [Jet-Alert],regular,"Jet-Alert 100 MG Oral Tablet; JET-ALERT 100 MG Oral Tablet; CAFFEINE 100 mg ORAL TABLET, COATED [JET ALERT Regular Strength]; Jet-Alert, 100 mg oral tablet",0
C3869753,Have Trouble Doing Regular Leisure Activities with Others,regular,Trouble Doing Regular Leisure Activities with Others; I have trouble doing all of my regular leisure activities with others; Have Trouble Doing All Regular Leisure Activities with Others,0
C3869945,Respiratory syncytial virus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Respiratory syncytial virus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; RSV RNA Nph Ql NAA+probe; Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection; RSV RNA NAA+probe Ql (Nph),0
C3869947,Parainfluenza virus 4 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,HPIV4 RNA Nph Ql NAA+probe; Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection; Parainfluenza virus 4 RNA NAA+probe Ql (Nph); Parainfluenza virus 4 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C3869948,Parainfluenza virus 3 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Parainfluenza virus 3 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection; HPIV3 RNA Nph Ql NAA+probe; Parainfluenza virus 3 RNA NAA+probe Ql (Nph),0
C3869949,Parainfluenza virus 2 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,HPIV2 RNA Nph Ql NAA+probe; Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection; Parainfluenza virus 2 RNA NAA+probe Ql (Nph); Parainfluenza virus 2 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C3869950,Parainfluenza virus 1 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Parainfluenza virus 1 RNA NAA+probe Ql (Nph); Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection; Parainfluenza virus 1 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; HPIV1 RNA Nph Ql NAA+probe,0
C3869954,Influenza virus B RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection; Influenza virus B ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; FLUBV RNA NAA+probe Ql (Nph); FLUBV RNA Nph Ql NAA+probe,0
C3869956,Influenza virus A RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Influenza virus A ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection; FLUAV RNA NAA+probe Ql (Nph); FLUAV RNA Nph Ql NAA+probe,0
C3869960,Enterovirus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Enterovirus RNA NAA+probe Ql (Nph); Enterovirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; EV RNA Nph Ql NAA+probe; Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection,0
C3869964,Adenovirus DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection; HAdV DNA Nph Ql NAA+probe; Adenovirus DNA NAA+probe Ql (Nph); Adenovirus deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C3870412,I have trouble doing all of my regular leisure activities with others:Find:Pt:^Patient:Ord:PROMIS,regular,I have trouble doing all of my regular leisure activities with others:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS; I have trouble doing all of my regular leisure activities with others [PROMIS],0
C3871401,"Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices",insulin,,0
C3871600,Pen Needle Insulin 33 gauge 4mm,insulin,,0
C3872402,"CARTRIDGE,ACCU-CHEK INSULIN,3.15ML",insulin,"CARTRIDGE,ACCU-CHEK INSULIN 3.15ML",0
C3872833,Insulin treatment stopped,insulin,Insulin treatment stopped (situation),0
C3873842,Insulin autoinjector,insulin,Insulin autoinjector (physical object),0
C3874266,Maternal history of non-insulin dependent diabetes mellitus,insulin,Maternal history of non-insulin dependent diabetes mellitus (situation),0
C3874273,Maternal history of insulin dependent diabetes mellitus,insulin,Maternal history of insulin dependent diabetes mellitus (situation),0
C3874722,Electronic insulin autoinjector,insulin,Electronic insulin autoinjector (physical object),0
C3874750,"Basic insulin autoinjector, replaceable-cartridge",insulin,"Basic insulin autoinjector, replaceable-cartridge (physical object)",0
C3875009,Insulin reactive hypoglycemia due to type 2 diabetes mellitus,insulin,Insulin reactive hypoglycemia due to type 2 diabetes mellitus (disorder); Insulin reactive hypoglycaemia in type 2 diabetes mellitus; Insulin reactive hypoglycaemia due to type 2 diabetes mellitus; Insulin reactive hypoglycemia in type 2 diabetes mellitus,0
C3875568,Insulin dose changed,insulin,Insulin dose changed (situation),0
C3875649,Invasive interstitial fluid glucose monitoring/insulin infusion system,insulin,Invasive interstitial fluid glucose monitoring/insulin infusion system (physical object),0
C3875803,Insulin infusion cannula introducer,insulin,Insulin infusion cannula introducer (physical object),0
C3875857,Insulin pen timer,insulin,Insulin pen timer (physical object),0
C3876069,Ambulatory insulin infusion pump cartridge filling device,insulin,Ambulatory insulin infusion pump cartridge filling device (physical object),0
C3876336,Ambulatory insulin infusion pump/blood glucose analyzer system,insulin,Ambulatory insulin infusion pump/blood glucose analyser system; Ambulatory insulin infusion pump/blood glucose analyzer system (physical object),0
C3877371,Insulin pen cartridge,insulin,Insulin pen cartridge (physical object),0
C3877559,"Insulin syringe, fixed-needle",insulin,"Insulin syringe, fixed-needle (physical object)",0
C3878443,Mechanical insulin infusion patch pump,insulin,Mechanical insulin infusion patch pump (physical object),0
C3879617,Electronic insulin infusion patch pump,insulin,Electronic insulin infusion patch pump (physical object),0
C3881242,Ambulatory insulin infusion pump reservoir,insulin,Ambulatory insulin infusion pump reservoir (physical object),0
C3881495,"Insulin syringe, retractable-needle",insulin,"Insulin syringe, retractable-needle (physical object)",0
C3882078,Insulin alarm,insulin,Insulin alarm (physical object),0
C3882781,"insulin inhalation, rapid acting 4 units- 8 units inhalation powder",insulin,,0
C3882782,"insulin inhalation, rapid acting 4 units inhalation powder",insulin,,0
C3888214,"3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector",insulin,"insulin isophane, human 70 UNT/ML / insulin, human UNT/ML per 3 ML Pen Injector; insulin isophane, human 70 UNT/ML / insulin, human UNT/ML in 3 ML Pen Injector",0
C3888215,NovoLOG Mix 70/30 FlexPen,novolog,,0
C3888216,Novolin 70/30 Innolet Suspension for Injection,novolin,,0
C3888219,"3 ML insulin isophane, human 100 UNT/ML Pen Injector",insulin,"insulin isophane U-100 per 3 ML Pen Injector; insulin isophane (NPH), human 100 UNT/ML per 3 ML Pen Injector; insulin isophane (NPH), human 100 UNT/mL in 3 mL Pen Injector",0
C3888220,3 ML insulin lispro 100 UNT/ML Pen Injector,insulin,"INSULIN,LISPRO,HUMAN 100/ML KWIKPEN 3ML; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Lispro KwikPen]; Insulin lispro 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin Lispro KwikPen]; insulin lispro 100 UNT/ML in 3 ML Pen Injector; insulin lispro 100 UNT/ML per 3 ML Pen Injector; Insulin Lispro KwikPen, 100 units/mL injectable solution; INSULIN,LISPRO,HUMAN 100 UNT/ML INJ,KWIKPEN,3ML",0
C3888221,3 ML insulin lispro 100 UNT/ML Pen Injector [Humalog],insulin,"INSULIN LISPRO 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog KwikPen]; Humalog Tempo Pen 100 UNT/ML per 3 ML Pen Injector; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog Tempo Pen]; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog KwikPen]; HumaLOG 100 UNT/ML in 3 ML Pen Injector; 3 ML insulin lispro 100 UNT/ML Pen Injector [Humalog]; 3 ML insulin lispro 100 UNT/ML Pen Injector [HumaLOG]; INSULIN LISPRO 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Humalog KwikPen]; Insulin lispro 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [Humalog KwikPen]; 3 ML Humalog 100 UNT/ML Pen Injector; HumaLOG KwikPen 100 UNT/ML per 3 ML Pen Injector; Humalog KwikPen 100 UNT/ML per 3 ML Pen Injector; HumaLOG KwikPen, 100 units/mL injectable solution; HumaLOG Tempo Pen 100 UNT/ML per 3 ML Pen Injector; 3 ML HumaLOG 100 UNT/ML Pen Injector",0
C3888222,3 ML insulin glargine 100 UNT/ML Pen Injector,insulin,"Insulin Glargine Solostar Pen, 100 units/mL subcutaneous solution; 3 ML insulin glargine 100 UNT/ML Pen Injector; insulin glargine 300 UNT per 3 ML Pen Injector; INSULIN,GLARGINE,HUMAN 100 UNIT/ML INJ,KWIKPEN,3ML; insulin analog, glargine 300 UNT Pen Injector; INSULIN,GLARGINE 100 UNT/ML 3ML SOLOSTAR; 3 ML insulin analog, glargine 100 UNT/ML Pen Injector; INSULIN,GLARGINE,HUMAN 100 UNIT/ML INJ,SOLOSTAR,3ML; INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Glargine Solostar]; insulin glargine 100 UNT/ML in 3 ML Pen Injector; INSULIN,GLARGINE 100 UNT/ML 3ML KWIKPEN",0
C3888224,3 ML insulin detemir 100 UNT/ML Pen Injector,insulin,"insulin detemir 100 UNT/ML in 3 ML Pen Injector; 3 ML insulin detemir 100 UNT/ML Pen Injector; INSULIN,DETEMIR,HUMAN 100 UNIT/ML INJ,FLEXTOUCH,3ML; INSULIN,DETEMIR 100UNIT/ML FLEXTOUCH 3ML",0
C3888225,"3 ML insulin glulisine, human 100 UNT/ML Pen Injector",insulin,"insulin, glulisine, human 100 UNT/ML per 3 ML Pen Injector; INSULIN,GLULISINE 100 UNIT/ML PEN 3ML; insulin glulisine 100 UNT/ML in 3 ML Pen Injector; INSULIN,GLULISINE,HUMAN 100 UNIT/ML INJ PEN 3ML",0
C3888227,"3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]",insulin,"3 ML NovoLOG 100 UNT/ML Pen Injector; 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLOG]; 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]; NovoLOG FlexPen 100 UNT/ML per 3 ML Pen Injector; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [NOVOLOG]; NovoLog FlexTouch 100 UNT/ML per 3 ML Pen Injector; NovoLOG FlexTouch 100 UNT/ML per 3 ML Pen Injector; NovoLOG 100 UNT/ML in 3 ML Pen Injector; Relion NovoLOG Flexpen, 100 units/mL injectable solution; NovoLog FlexPen 100 UNT/ML per 3 ML Pen Injector; NovoLOG FlexPen, 100 units/mL injectable solution; INSULIN ASPART 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [NOVOLOG]; 3 ML NovoLog 100 UNT/ML Pen Injector",0
C3888419,"{30 (Regular Insulin, Human 12 UNT Inhalant Powder [Afrezza]) / 60 (Regular Insulin, Human 8 UNT Inhalant Powder [Afrezza]) } Pack [Afrezza 90 - 60 (8 UNT), 30 (12 UNT)]",insulin,,0
C3889249,PDX1 wt Allele,insulin,"IPF1; Pancreatic and Duodenal Homeobox 1 wt Allele; Insulin Promoter Factor 1, Homeodomain Transcription Factor Gene; PDX1 wt Allele; STF-1; GSF; IDX-1; PDX-1; IUF1; PAGEN1; MODY4",0
C3890424,SOCS2 wt Allele,SSI,SSI-2; CIS2; SOCS2 wt Allele; Suppressor of Cytokine Signaling 2 wt Allele; STATI2; Cish2; SOCS-2; SSI2,0
C3892071,1.5 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo],insulin,"1.5 ML Toujeo 300 UNT/ML Pen Injector; Toujeo 300 UNT/ML in 1.5 ML Pen Injector; Toujeo 300 UNT/ML 1.5 ML Prefilled Pen; insulin glargine 300 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [TOUJEO]; INSULIN GLARGINE 300 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [TOUJEO]; Toujeo SoloStar, 300 units/mL subcutaneous solution",0
C3892516,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] / ECHINACEA ANGUSTIFOLIA 6 [hp_X] / SUS SCROFA HYPOTHALAMUS 6 [hp_X] / PORK LIVER 8 [hp_X] / PORK KIDNEY 8 [hp_X] / METHYLCOBALAMIN 8 [hp_X] / GAMBOGE 12 [hp_X] / GRAPHITE 12 [hp_X] / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] / PHYTOLACCA AMERICANA ROOT 12 [hp_X] / 7-KETO-DEHYDROEPIANDROSTERONE 30 [hp_X] / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] / GLUCAGON 30 [hp_X] / INSULIN PORK 30 [hp_X] / LACTIC ACID, L- 30 [hp_X] / PROTEUS VULGARIS 30 [hp_C] ORAL TABLET [Professional Weight Support]",insulin,,0
C3892930,1.5 ML insulin glargine 300 UNT/ML Pen Injector,insulin,"INSULIN,GLARGINE 300 UNT/ML1.5ML SOLOSTR; insulin glargine 300 UNT/ML per 1.5 ML Pen Injector; INSULIN,GLARGINE,HUMAN 300 UNIT/ML INJ,SOLOSTAR,1.5ML; insulin glargine 300 UNT/ML in 1.5 ML Pen Injector",0
C3892970,Toujeo,toujeo,,0
C3893029,insulin glargine 300 UNT/ML [Toujeo],insulin,,0
C3893079,Toujeo Injectable Product,toujeo,,0
C3893130,insulin glargine 300 UNT/ML,insulin,,0
C3893903,insulin receptor signaling pathway involved in dauer larval development,insulin,daf-2 receptor signaling pathway involved in dauer larval development; insulin receptor signalling pathway involved in dauer larval development,0
C3896180,response to insulin-like growth factor stimulus,insulin,,0
C3896726,Lung-targeted Immunomodulator QBKPN,SSI,lung-targeted immunomodulator QBKPN; QBKPN; SSI QBKPN; site-specific immunomodulator QBKPN; Site Specific Immunomodulator QBKPN,0
C3896773,S-707106,insulin,S-707106; Insulin Sensitizer S-707106,0
C3899052,GOSE - Social and Leisure Activities: Resume Regular Social and Leisure Activities,regular,,0
C3899054,GOSE - Social and Leisure Activities: Engage Regular Social and Leisure Activities Before Injury,regular,,0
C4012165,Low insulin-like growth factor-I (IGF1 147440) levels,insulin,,0
C4012176,Insulin-resistant diabetes mellitus in adulthood,insulin,,0
C4013230,Low to undetectable insulin levels in the presence of hyperglycemia,insulin,,0
C4013591,Low insulin-like growth factor-1 (IGF1) concentration,insulin,,0
C4014870,Elevated insulin,insulin,,0
C4015006,Inappropriate insulin secretion,insulin,,0
C4015208,Regular acanthosis,regular,,0
C4015267,Nonautoimmune insulin-dependent diabetes in second decade of life,insulin,,0
C4015535,Normal response to exogenously administered insulin,insulin,,0
C4016224,INSULIN-LIKE GROWTH FACTOR II POLYMORPHISM,insulin,,0
C4016701,"INSULIN RESISTANCE, SEVERE, DIGENIC",insulin,,0
C4016738,"INSULIN RESISTANCE, DIGENIC",insulin,,0
C4018035,"BRIEF,DERMADRY COMPLETE REGULAR ATTENDS",regular,"BRIEF,DERMADRY COMPLETE REGULAR ATTENDS",0
C4018038,"BRIEF,DERMADRY ADVANCED REGULAR ATTENDS",regular,"BRIEF,DERMADRY ADVANCED REGULAR ATTENDS",0
C4018150,insulin glargine 300 units/mL subcutaneous solution,insulin,,0
C4018243,Toujeo SoloStar,toujeo,,0
C4018317,Afrezza 4 unit (30)- 8 unit (60),afrezza,,0
C4018318,Afrezza 4 unit (60)- 8 unit (30),afrezza,,0
C4018333,"Comfort Assist Insulin Syringe 0.5cc 29g 0.5""",insulin,,0
C4018334,Comfort Assist Insulin Syringe 1cc 29g 0.5'',insulin,"Comfort Assist Insulin Syringe 1cc 29g 0.5""",0
C4019701,"Comfort Assist Insulin Syr 0.3cc 30g 0.3125""",insulin,,0
C4019702,"Comfort Assist Insulin Syr 0.3cc 31g 0.3125""",insulin,,0
C4019703,"Comfort Assist Insulin Syr 0.5cc 30g 0.3125""",insulin,,0
C4019704,"Comfort Assist Insulin Syr 0.5cc 31g 0.3125""",insulin,,0
C4019705,"Comfort Assist Insulin Syr 1cc 30g 0.3125""",insulin,,0
C4019706,Comfort Assist Insulin Syr 1cc 31g 0.3125',insulin,,0
C4019707,"Comfort Assist Insulin Syringe 0.3cc 29g 0.5""",insulin,,0
C4020137,insulin isophane-insulin regular,insulin,,0
C4020235,"insulin, regular, human 4 UNT",insulin,,0
C4020237,"insulin, regular, human 4 UNT [Afrezza]",insulin,,0
C4020238,"insulin, regular, human 8 UNT",insulin,,0
C4020239,"insulin, regular, human 8 UNT [Afrezza]",insulin,,0
C4026140,"insulin glulisine, human Pen Injector",insulin,,0
C4026141,"insulin glulisine, human Pen Injector [Apidra]",insulin,,0
C4026349,insulin lispro 200 UNT/ML,insulin,,0
C4026350,insulin lispro Pen Injector,insulin,,0
C4026351,3 ML insulin lispro 200 UNT/ML Pen Injector,insulin,"INSULIN,LISPRO,HUMAN 200/ML KWIKPEN 3ML; insulin lispro 200 UNT/ML in 3 ML Pen Injector; INSULIN,LISPRO,HUMAN 200 UNT/ML INJ,KWIKPEN,3ML; insulin lispro 200 units/mL subcutaneous solution",0
C4026352,insulin lispro 200 UNT/ML [Humalog],insulin,insulin lispro 200 UNT/ML [HumaLOG],0
C4026353,insulin lispro Pen Injector [Humalog],insulin,insulin lispro Pen Injector [HumaLOG],0
C4026354,3 ML insulin lispro 200 UNT/ML Pen Injector [Humalog],insulin,"3 ML HumaLOG 200 UNT/ML Pen Injector; 3 ML insulin lispro 200 UNT/ML Pen Injector [HumaLOG]; 3 ML Humalog 200 UNT/ML Pen Injector; HumaLOG KwikPen (Concentrated), 200 units/mL subcutaneous solution; HumaLOG 200 UNT/ML in 3 ML Pen Injector; Insulin lispro 200 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog KwikPen]; HumaLOG 600 UNT per 3 ML KwikPen; Humalog 600 UNT per 3 ML KwikPen",0
C4026490,insulin lispro Cartridge,insulin,,0
C4026491,insulin lispro Cartridge [Humalog],insulin,insulin lispro Cartridge [HumaLOG],0
C4026605,"insulin lispro / insulin lispro protamine, human Pen Injector",insulin,,0
C4026606,"insulin lispro / insulin lispro protamine, human Pen Injector [Humalog Mix]",insulin,"insulin lispro / insulin lispro protamine, human Pen Injector [HumaLOG Mix]",0
C4026661,"insulin aspart, human Cartridge",insulin,,0
C4026662,"insulin aspart, human Cartridge [NovoLog]",insulin,"insulin aspart, human Cartridge [NovoLOG]",0
C4026665,"insulin aspart, human Pen Injector",insulin,,0
C4026666,"insulin aspart, human Pen Injector [NovoLog]",insulin,"insulin aspart, human Pen Injector [NovoLOG]",0
C4026669,"insulin aspart protamine, human / insulin aspart, human Pen Injector",insulin,,0
C4026670,"insulin aspart protamine, human / insulin aspart, human Pen Injector [NovoLog Mix]",insulin,"insulin aspart protamine, human / insulin aspart, human Pen Injector [NovoLOG Mix]",0
C4026763,insulin glargine Pen Injector,insulin,,0
C4026764,insulin glargine Pen Injector [Lantus],insulin,,0
C4026766,insulin glargine Pen Injector [Toujeo],insulin,,0
C4026878,insulin isophane Injectable Product,insulin,Product containing isophane insulin in parenteral dose form (medicinal product form); Isophane insulin-containing product in parenteral dose form,0
C4026879,"insulin isophane / insulin, regular, human Injectable Product",insulin,Product containing human isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form); Human isophane insulin- and recombinant human soluble insulin-containing product in parenteral dose form; Human isophane insulin- and recombinant human regular insulin-containing product in parenteral dose form,0
C4026880,"insulin isophane / insulin, regular, pork Injectable Product",insulin,Porcine insulin soluble- and porcine isophane insulin-containing product; Product containing porcine isophane insulin and porcine regular insulin (medicinal product); Product containing porcine isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form); Isophane insulin- and porcine insulin soluble-containing product in parenteral dose form; Product containing isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form); Porcine isophane insulin- and porcine regular insulin-containing product; Isophane insulin- and porcine regular insulin-containing product in parenteral dose form; Porcine insulin soluble- and porcine isophane insulin-containing product in parenteral dose form; Porcine isophane insulin- and porcine regular insulin-containing product in parenteral dose form,0
C4027001,insulin detemir Pen Injector,insulin,,0
C4027002,insulin detemir Pen Injector [Levemir],insulin,,0
C4027095,"insulin isophane / insulin, regular, human Pen Injector",insulin,,0
C4027139,"insulin isophane / insulin, regular, human Pen Injector [Humulin]",insulin,"insulin isophane / insulin, regular, human Pen Injector [HumuLIN]",0
C4027143,insulin isophane Pen Injector,insulin,,0
C4027144,insulin isophane Pen Injector [Humulin N],insulin,insulin isophane Pen Injector [HumuLIN N],0
C4027165,"insulin, regular, human 12 UNT",insulin,,0
C4027166,"insulin, regular, human 12 UNT Inhalation Powder",insulin,"INSULIN 12 UNIT X 90 INH KIT; regular insulin, human 12 UNT Inhalation Powder Cartridge; INSULIN,HUMAN 12 UNIT X 90 INHL,ORAL,CARTRIDGE,KIT; insulin inhalation, rapid acting 12 units inhalation powder",0
C4027167,"insulin, regular, human 12 UNT [Afrezza]",insulin,,0
C4027168,"insulin, regular, human 12 UNT Inhalation Powder [Afrezza]",insulin,"Afrezza, 12 units inhalation powder; INSULIN HUMAN 12 RESPIRATORY (INHALATION) POWDER, METERED [Afrezza]; afrezza 12 UNT Inhalation Powder; Afrezza 12 UNT Inhalation Powder",0
C4032807,"{30 (Regular Insulin, Human 12 UNT Inhalant Powder) / 60 (Regular Insulin, Human 8 UNT Inhalant Powder) } Pack",insulin,,0
C4034474,"Yesterday, how many times did the patient drink any regular (not diet) sodas or soft drinks",regular,"Yesterday, how many times did the patient drink any regular (not diet) sodas or soft drinks",0
C4034806,I have trouble taking care of my regular personal responsibilities,regular,I have trouble taking care of my regular personal responsibilities,0
C4034820,I have trouble doing my regular daily work around the house,regular,I have trouble doing my regular daily work around the house,0
C4034827,I am satisfied with my ability to do regular personal responsibilities,regular,I am satisfied with my ability to do regular personal responsibilities,0
C4034828,Satisfied with Ability to do Regular Personal and Household Responsibilities,regular,I am satisfied with my ability to do regular personal and household responsibilities,0
C4034915,Have to Limit Regular Activities with Friends,regular,I have to limit my regular activities with friends,0
C4034918,Have Trouble Doing Regular Family Activities,regular,Have Trouble Doing All Regular Family Activities; Trouble Doing Regular Family Activities; I have trouble doing all of the family activities that I want to do,0
C4034920,Have to Limit Regular Activities with Family,regular,I have to limit my regular family activities,0
C4036716,Insulin-like growth factor-I^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I 3 Hr post Unsp challenge [Mass/Vol]; IGF-I 3h p chal SerPl-mCnc; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3 hours post XXX challenge; Insulin-like growth factor-I^3 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C4036717,Insulin-like growth factor-I^2.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I^2.5 hours post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin-like growth factor-I 2.5 Hr post Unsp challenge [Mass/Vol]; IGF-I 2.5h p chal SerPl-mCnc; Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge,0
C4036942,Parainfluenza virus 3 Ag:PrThr:Pt:Nph:Ord:IF,NPH,HPIV3 Ag Nph Ql IF; Parainfluenza virus 3 Ag [Presence] in Nasopharynx by Immunofluorescence; Parainfluenza virus 3 Ag IF Ql (Nph); Parainfluenza virus 3 Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence,0
C4036943,Parainfluenza virus 2 Ag:PrThr:Pt:Nph:Ord:IF,NPH,Parainfluenza virus 2 Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence; Parainfluenza virus 2 Ag IF Ql (Nph); Parainfluenza virus 2 Ag [Presence] in Nasopharynx by Immunofluorescence; HPIV2 Ag Nph Ql IF,0
C4036944,Respiratory syncytial virus Ag:PrThr:Pt:Nph:Ord:IF,NPH,Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence; RSV Ag IF Ql (Nph); Respiratory syncytial virus Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence; RSV Ag Nph Ql IF,0
C4037016,"Yesterday, how many times did the patient drink any regular (not diet) sodas or soft drinks:Num:1D:^Patient:Qn",regular,"Yesterday, how many times did the patient drink any regular (not diet) sodas or soft drinks:Number:1 day:^Patient:Quantitative; Yesterday, how many times did the patient drink any regular (not diet) sodas or soft drinks #",0
C4037259,Respiratory pathogens DNA & RNA 14 panel:-:Pt:Nph:-:Probe.amp.tar,NPH,Respiratory pathogens DNA and RNA 14 panel - Nasopharynx by NAA with probe detection; Respiratory pathogens DNA and RNA 14 panel NAA+probe (Nph); Respiratory pathogens deoxyribonucleic acid & ribonucleic acid 14 panel:-:To identify measures at a point in time:Naspopharynx:-:Probe.amp.tar; Resp path DNA+RNA 14 pnl Nph NAA+probe,0
C4037260,Influenza virus A H1 2009 pandemic RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Influenza virus A H1 2009 pandemic ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; FLUAV H1 2009 pand RNA NAA+probe Ql (Nph); Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with probe detection; FLUAV H1 2009 pand RNA Nph Ql NAA+probe,0
C4037261,Influenza virus A H3 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,FLUAV H3 RNA Nph Ql NAA+probe; Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with probe detection; Influenza virus A H3 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; FLUAV H3 RNA NAA+probe Ql (Nph),0
C4037262,Influenza virus A H1 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Influenza virus A H1 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; FLUAV H1 RNA Nph Ql NAA+probe; Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with probe detection; FLUAV H1 RNA NAA+probe Ql (Nph),0
C4037263,Rhinovirus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Rhinovirus RNA [Presence] in Nasopharynx by NAA with probe detection; Rhinovirus RNA Nph Ql NAA+probe; Rhinovirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Rhinovirus RNA NAA+probe Ql (Nph),0
C4037264,Human metapneumovirus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Human metapneumovirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; hMPV RNA Nph Ql NAA+probe; Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with probe detection; hMPV RNA NAA+probe Ql (Nph),0
C4037273,Human coronavirus 229E+OC43 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,HCoV 229E+OC43 RNA NAA+probe Ql (Nph); Human coronavirus 229E+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection; HCoV 229E+OC43 RNA Nph Ql NAA+probe; Human coronavirus 229E+OC43 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4037412,I have trouble taking care of my regular personal responsibilities:Find:Pt:^Patient:Ord:PROMIS,regular,I have trouble taking care of my regular personal responsibilities [PROMIS]; I have trouble taking care of my regular personal responsibilities:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS,0
C4037426,I have trouble doing my regular daily work around the house:Find:Pt:^Patient:Ord:PROMIS,regular,I have trouble doing my regular daily work around the house:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS; I have trouble doing my regular daily work around the house [PROMIS],0
C4037433,I am satisfied with my ability to do regular personal responsibilities:Find:Pt:^Patient:Ord:PROMIS,regular,I am satisfied with my ability to do regular personal responsibilities [PROMIS]; I am satisfied with my ability to do regular personal responsibilities:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS,0
C4037434,I am satisfied with my ability to do regular personal and household responsibilities:Find:Pt:^Patient:Ord:PROMIS,regular,I am satisfied with my ability to do regular personal and household responsibilities [PROMIS]; I am satisfied with my ability to do regular personal and household responsibilities:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS,0
C4037549,I have to limit my regular activities with friends:Find:Pt:^Patient:Ord:PROMIS,regular,I have to limit my regular activities with friends [PROMIS]; I have to limit my regular activities with friends:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS,0
C4037554,I have to limit my regular family activities:Find:Pt:^Patient:Ord:PROMIS,regular,I have to limit my regular family activities [PROMIS]; I have to limit my regular family activities:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS,0
C4037659,Respiratory syncytial virus B RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Respiratory syncytial virus B ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; RSV B RNA Nph Ql NAA+probe; Respiratory syncytial virus B RNA [Presence] in Nasopharynx by NAA with probe detection; RSV B RNA NAA+probe Ql (Nph),0
C4037660,Respiratory syncytial virus A RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,RSV A RNA NAA+probe Ql (Nph); RSV A RNA Nph Ql NAA+probe; Respiratory syncytial virus A RNA [Presence] in Nasopharynx by NAA with probe detection; Respiratory syncytial virus A ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4037855,Respiratory pathogens DNA & RNA 4 panel:-:Pt:Nph:-:Probe.amp.tar,NPH,Respiratory pathogens DNA and RNA 4 panel NAA+probe (Nph); Resp path 4 Pnl Nph NAA+probe; Respiratory pathogens DNA and RNA 4 panel - Nasopharynx by NAA with probe detection; Respiratory pathogens deoxyribonucleic acid & ribonucleic acid 4 panel:-:To identify measures at a point in time:Naspopharynx:-:Probe.amp.tar,0
C4039693,"Insulin-like growth factor binding protein 3, acid labile subunit",insulin,"Insulin-like growth factor binding protein 3, acid labile subunit (substance); Insulin-like growth factor binding protein 3.acid labile",0
C4040354,Long-term current use of insulin,insulin,Long-term current use of insulin (situation),0
C4041846,"Igf2 protein, rat",insulin,"insulin-like growth factor II carrier protein, rat; multiplication-stimulating activity carrier protein, rat; MCP protein, rat (multiplication-stimulating); IGF-II, rat; MSA carrier protein, rat; insulin-like growth factor II, rat",0
C4044495,"IGF1R protein, human",insulin,"Receptors, Insulin-Like-Growth Factor I; Antigen CD221; CD221; IGF1R protein, human; CD221 Antigen; EC 2.7.10.1; Insulin-Like Growth Factor I Receptor; Insulin-Like Growth Factor 1 Receptor; IGF-1R; IGF1R; IGF-I Receptor; Insulin-Like-Growth Factor I Receptor",0
C4046244,HumaLOG KwikPen (Concentrated),humalog,,0
C4046312,Syringes Insulin UtliCare .5cc 30g X 1/2,insulin,,0
C4046313,Syringes Insulin UltiCare 1cc 30g X 1/2,insulin,,0
C4046314,Syringes Insulin UltiCare .3cc 30g X 1/2,insulin,,0
C4046315,Syringes Insulin Safety 1cc 29g X 1/2,insulin,,0
C4046316,Syringes Insulin Safety 0.5cc 29g X 1/2,insulin,,0
C4047249,INSULIN SYRINGE 0.5ML 31G 6MM,insulin,INSULIN SYRINGE 0.5ML 31G 6MM,0
C4047972,Regular bowel action,regular,Regular bowel action (finding); Normal bowel action,0
C4049897,"Insulin-Like Growth Factor 1 Receptor Beta Chain, Human",insulin,IGF1R Beta; CD221 Antigen Beta Chain; IGF1R Beta Chain; IGF-IR Beta Chain; IGF-IR Beta; Insulin-Like Growth Factor 1 Receptor Beta Chain,0
C4049919,Insulin Sensitivity Measurement,insulin,Insulin Sensitivity Measurement,0
C4049994,Insulin Resistance Measurement,insulin,Insulin Resistance Measurement,0
C4050945,"WATER 1 mL in 1 mL INTRAVENOUS INJECTION, SOLUTION [Insulin Diluting Medium for NovoLog]",insulin,"DILUTING MEDIUM FOR NOVOLOG; WATER 1 mL in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Diluting Medium for NovoLog]; Insulin Diluting Medium for NovoLOG, diluent injectable solution",0
C4051173,"insulin inhalation, rapid acting 8 units-12 units inhalation powder",insulin,,0
C4051217,Afrezza 8 unit (60)- 12 unit (30),afrezza,,0
C4054829,Health Problems Affect Ability to do Regular Daily Activities other than Work at Job,regular,Health Problems Affect Ability to do Regular Daily Activities,0
C4055746,Comfort Assist Insulin Syr 0.3cc 30g 8 mm,insulin,,0
C4055766,Comfort Assist Insulin Syr 1cc 31g 8 mm,insulin,,0
C4055767,Comfort Assist Insulin Syr 1cc 30g 8 mm,insulin,,0
C4055768,Comfort Assist Insulin Syr 0.5cc 31g 8 mm,insulin,,0
C4055769,Comfort Assist Insulin Syr 0.5cc 30g 8 mm,insulin,,0
C4055770,Comfort Assist Insulin Syr 0.3cc 31g 8 mm,insulin,,0
C4055825,Lantus 100 UNT/ML includes Injectable Solution & Pen Injector,lantus,,0
C4055826,insulin detemir 100 UNT/ML includes Injectable Solution & Pen Injector,insulin,,0
C4056297,3 ML insulin degludec 200 UNT/ML Pen Injector [Tresiba],insulin,"Tresiba FlexTouch, 200 units/mL subcutaneous solution; INSULIN DEGLUDEC 200 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Tresiba]; Tresiba 200 UNT/ML in 3 ML Pen Injector; Tresiba 200 UNT/ML per 3 ML Pen Injector; 3 ML Tresiba 200 UNT/ML Pen Injector",0
C4056298,3 ML insulin degludec 100 UNT/ML Pen Injector [Tresiba],insulin,"3 ML Tresiba 100 UNT/ML Pen Injector; Tresiba FlexTouch, 100 units/mL subcutaneous solution; Tresiba 100 UNT/ML per 3 ML Pen Injector; INSULIN DEGLUDEC 100 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Tresiba]; 3 ML insulin degludec 100 UNT/ML Pen Injector [Tresiba]; Tresiba 100 UNT/ML in 3 ML Pen Injector",0
C4056537,Tresiba,tresiba,Tresiba,0
C4056561,3 ML insulin degludec 200 UNT/ML Pen Injector,insulin,"insulin degludec 200 UNT/ML in 3 ML Pen Injector; INSULIN,DEGLUDEC,HUMAN 200 UNIT/ML INJ,FLEXTOUCH,3ML; INSULIN,DEGLUDEC 200UNIT/ML FLEXTOUCH3ML; insulin degludec 200 UNT/ML per 3 ML Pen Injector; INSULIN DEGLUDEC 200 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Degludec]; Product containing precisely insulin degludec 200 unit/1 milliliter conventional release solution for injection (clinical drug); Insulin degludec 200 unit/mL solution for injection; insulin degludec 200 units/mL subcutaneous solution",0
C4056562,3 ML insulin degludec 100 UNT/ML Pen Injector,insulin,"insulin degludec 100 units/mL subcutaneous solution; INSULIN DEGLUDEC 100 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Degludec]; INSULIN,DEGLUDEC 100UNIT/ML FLEXTOUCH3ML; INSULIN,DEGLUDEC,HUMAN 100 UNIT/ML INJ,FLEXTOUCH,3ML; 3 ML insulin degludec 100 UNT/ML Pen Injector; insulin degludec 100 UNT/ML per 3 ML Pen Injector; insulin degludec 100 UNT/ML in 3 ML Pen Injector",0
C4056603,insulin degludec 200 UNT/ML [Tresiba],insulin,,0
C4056604,insulin degludec 100 UNT/ML [Tresiba],insulin,,0
C4056657,insulin degludec Pen Injector [Tresiba],insulin,,0
C4056701,Tresiba Injectable Product,tresiba,,0
C4056767,insulin degludec 200 UNT/ML,insulin,,0
C4056768,insulin degludec 100 UNT/ML,insulin,,0
C4056811,insulin degludec Pen Injector,insulin,,0
C4056841,insulin degludec Injectable Product,insulin,Insulin degludec-containing product in parenteral dose form; Product containing insulin degludec in parenteral dose form (medicinal product form),0
C4056887,"CARTRIDGE,T FLEX INSULIN,4.8ML",insulin,"CARTRIDGE,T FLEX INSULIN,4.8ML",0
C4056930,ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 0.19 g in 1 g TOPICAL STICK [Arrid Extra Extra Dry Regular],regular,,0
C4058549,Neo-Synephrine Cold and Sinus Regular Strength,regular,,0
C4058558,Tresiba FlexTouch,tresiba,,0
C4059165,insulin degludec / liraglutide,insulin,Product containing insulin degludec and liraglutide (medicinal product); Insulin Degludec/ Liraglutide; Insulin degludec- and liraglutide-containing product; insulin degludec-liraglutide; insulin degludec and liraglutide; INSULIN DEGLUDEC/LIRAGLUTIDE,0
C4059333,BD SafetyGlide Insulin Syringe 0.3 cc 31g 6mm,insulin,,0
C4059334,BD SafetyGlide Insulin Syringe 1 cc 31g 6mm,insulin,,0
C4059335,BD SafetyGlide Insulin Syringe 0.5 cc 31g 6mm,insulin,,0
C4068169,Are you able to use a regular computer mouse,regular,Are you able to use a regular computer mouse,0
C4069483,Influenza virus A & B identified:Prid:Pt:Nph:Nom:Shell vial culture,NPH,Influenza virus A & B identified:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Shell vial culture; Influenza virus A and B identified in Nasopharynx by Shell vial culture; FLUAV and FLUBV identified Shell vial culture Nom (Nph); FLUAV + FLUBV Nph Shell Vial Cult,0
C4070382,Somatotropin^1.5H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin 1.5 Hr post dose arginine+insulin [Mass/Vol]; GH 1.5h p Arg+Ins SerPl-mCnc; Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin; Somatotropin^1.5 hours post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C4070383,Somatotropin^1.25H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Mass/volume] in Serum or Plasma --1.25 hours post dose arginine+insulin; Somatotropin^1.25H post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 1.25 Hr post dose arginine+insulin [Mass/Vol]; GH 1.25h p Arg+Ins SerPl-mCnc,0
C4070384,Somatotropin^1H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^1 hour post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 1 Hr post dose arginine+insulin [Mass/Vol]; Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin; GH 1h p Arg+Ins SerPl-mCnc,0
C4070385,Somatotropin^45M post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^45M post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 45M p Arg+Ins SerPl-mCnc; Somatotropin 45 Min post dose arginine+insulin [Mass/Vol]; Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin,0
C4070386,Somatotropin^30M post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin; GH 30M p Arg+Ins SerPl-mCnc; Somatotropin 30 Min post dose arginine+insulin [Mass/Vol]; Somatotropin^30 minutes post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C4070387,Somatotropin^2.5H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,GH 2.5h p Arg+Ins SerPl-mCnc; Somatotropin 2.5 Hr post dose arginine+insulin [Mass/Vol]; Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin; Somatotropin^2.5 hours post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C4070388,Somatotropin^15M post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,GH 15M p Arg+Ins SerPl-mCnc; Somatotropin 15 Min post dose arginine+insulin [Mass/Vol]; Somatotropin^15 minutes post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin,0
C4070389,Somatotropin^2.25H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin [Mass/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin; Somatotropin^2.25H post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 2.25h p Arg+Ins SerPl-mCnc; Somatotropin 2.25 Hr post dose arginine+insulin [Mass/Vol],0
C4070390,Somatotropin^2H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Somatotropin^2 hours post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; GH 2h p Arg+Ins SerPl-mCnc; Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine+insulin; Somatotropin 2 Hr post dose arginine+insulin [Mass/Vol],0
C4070391,Glucose^1H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin; Glucose^1 hour post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 1 Hr post dose arginine+insulin [Mass/Vol]; Glucose 1h p Arg+Ins SerPl-mCnc,0
C4070392,Glucose^45M post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin; Glucose 45 Min post dose arginine+insulin [Mass/Vol]; Glucose 45M p Arg+Ins SerPl-mCnc; Glucose^45M post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C4070393,Glucose^30M post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin; Glucose^30 minutes post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Glucose 30 Min post dose arginine+insulin [Mass/Vol]; Glucose 30M p Arg+Ins SerPl-mCnc,0
C4070394,Glucose^15M post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,Glucose 15M p Arg+Ins SerPl-mCnc; Glucose 15 Min post dose arginine+insulin [Mass/Vol]; Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin; Glucose^15 minutes post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C4070517,Are you able to use a regular computer mouse:Find:Pt:^Patient:Ord:PROMIS,regular,Are you able to use a regular computer mouse [PROMIS]; Are you able to use a regular computer mouse:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS,0
C4070603,Respiratory pathogens DNA & RNA panel:-:Pt:Nph:-:Probe.amp.tar,NPH,Respiratory pathogens deoxyribonucleic acid & ribonucleic acid panel:-:To identify measures at a point in time:Naspopharynx:-:Probe.amp.tar; Resp path DNA+RNA Pnl Nph NAA+probe; Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with probe detection; Respiratory pathogens DNA and RNA panel NAA+probe (Nph),0
C4070604,Bordetella pertussis & Bordetella parapertussis panel:-:Pt:Nph:-,NPH,B. pertussis and B. parapertussis panel (Nph); Bordetella pertussis & Bordetella parapertussis panel:-:To identify measures at a point in time:Naspopharynx:-; B pert+parapert DNA+cult Pnl Nph; Bordetella pertussis and Bordetella parapertussis DNA and culture panel - Nasopharynx,0
C4072802,1.25 hours post dose arginine+insulin,insulin,1.25H post dose arginine+insulin,0
C4072896,Abnormal serum insulin-like growth factor 1 level,insulin,,0
C4072897,Decreased serum insulin-like growth factor 1,insulin,,0
C4073160,Abnormal insulin level,insulin,,0
C4073161,Abnormal circulating insulin level,insulin,,0
C4073423,3 ML insulin glargine 100 UNT/ML Pen Injector [Basaglar],insulin,"Basaglar 300 UNT per 3 ML Pen Injector; Basaglar KwikPen, 100 units/mL subcutaneous solution; Basaglar KwikPen 100 UNT/ML in 3 ML Pen Injector; Insulin glargine 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [BASAGLAR KwikPen]; 3 ML Basaglar 100 UNT/ML Pen Injector",0
C4073706,Comfort Assist Insulin Syringes 29g x 0.5cc,insulin,,0
C4073803,acetaminophen 325 MG Oral Capsule [Tylenol],regular,"APAP 325 MG Oral Capsule [Tylenol]; Tylenol 325 MG Oral Capsule; Tylenol Regular Strength 325 MG Oral Capsule; Acetaminophen 325 mg ORAL CAPSULE, LIQUID FILLED [Tylenol Regular Strength]; Tylenol, 325 mg oral capsule",0
C4073907,"3 ML insulin, regular, human 500 UNT/ML Pen Injector [Humulin R]",insulin,"3 ML insulin, regular, human 500 UNT/ML Pen Injector [HumuLIN R]; Insulin human 500 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humulin R U-500 KwikPen]; 3 ML Humulin R 500 UNT/ML Pen Injector; HumuLIN R KwikPen (Concentrated), human recombinant 500 units/mL subcutaneous solution; 3 ML HumuLIN R 500 UNT/ML Pen Injector; HumuLIN R (concentrated) 500 UNT/ML in 3 ML Pen Injector",0
C4074422,"3 ML insulin, regular, human 500 UNT/ML Pen Injector",insulin,"INSULIN,REGULAR,HUMAN CONCENTRATED 500 UNIT/ML INJ,KWIKPEN,3ML; regular insulin, human (concentrated) 500 UNT/ML in 3 ML Pen Injector; INSULIN CONC REG HUM 500 UNT/ML KWIKPEN",0
C4074520,"insulin, regular, human Pen Injector [Humulin R]",insulin,"insulin, regular, human Pen Injector [HumuLIN R]",0
C4074690,"insulin, regular, human Pen Injector",insulin,,0
C4078938,"insulin-like peptide, Sagmariasus verreauxi",insulin,,0
C4081008,Basaglar KwikPen,basaglar,,0
C4081042,Basaglar,basaglar,Basaglar,0
C4081043,insulin glargine 100 UNT/ML [Basaglar],insulin,,0
C4081044,insulin glargine Pen Injector [Basaglar],insulin,,0
C4081045,Basaglar Injectable Product,basaglar,,0
C4081811,Education about insulin administration site rotation,insulin,Education about insulin administration site rotation (procedure),0
C4081852,Education about insulin administration site location,insulin,Education about insulin administration site location (procedure),0
C4082284,"Mitogen-Activated Protein Kinase 3, human",insulin,"p44-ERK1; ERK1 protein, human; p44ERK1; MAPK 3; Insulin-Stimulated MAP2 Kinase; MAP Kinase 3; MAPK3; MAPK3 protein, human; p44; MAP Kinase Isoform p44; Extracellular Signal-Regulated Kinase 1; ERK-1; p44 (MAPK); p44MAPK; ERT2; P44ERK1 protein, human; Mitogen-Activated Protein Kinase 3; p44-MAPK; EC 2.7.11.24; mitogen-activated protein kinase 3, human; Microtubule-Associated Protein 2 Kinase; PRKM3 protein, human; p44MAPK protein, human",0
C4082285,"Insulin Receptor-Related Receptor, human",insulin,"insulin receptor related receptor, human; INSRR; IR-Related Receptor; Insulin Receptor-Related Receptor; EC 2.7.10.1; Insulin Receptor-Related Protein; INSRR protein, human; IRR",0
C4082566,"Insulin-Like Growth Factor-Binding Protein 2, human",insulin,"IGFBP-2 protein, human; Insulin-Like Growth Factor Binding Protein 2, 36kDa; IGFBP2 protein, human; insulin like growth factor binding protein 2, human; Insulin-Like Growth Factor Binding Protein 2 (36kD); IGF-Binding Protein 2; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor-Binding Protein 2; IBP-2 protein, human; IGFBP-2; IGF Binding Protein 2; IGFBP2",0
C4082567,"Insulin-Like Growth Factor-Binding Protein 4, human",insulin,"Insulin-Like Growth Factor Binding Protein 4; IGFBP4 protein, human; IGF-Binding Protein 4; IBP-4; IGF Binding Protein 4; insulin like growth factor binding protein 4, human; IGFBP4; Insulin-Like Growth Factor-Binding Protein 4; IGFBP-4",0
C4082568,"IGFBP5 protein, human",insulin,"IBP5 protein, human; IGF-Binding Protein 5; IGF Binding Protein 5; insulin like growth factor binding protein 5, human; IGFBP5; Insulin-Like Growth Factor Binding Protein 5; IBP-5; IGFBP-5; IGFBP5 protein, human; Insulin-Like Growth Factor-Binding Protein 5",0
C4083366,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-KETO-DEHYDROEPIANDROSTERONE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / GLUCAGON 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Weight Management Support]",insulin,,0
C4083762,insulin argine,insulin,INSULIN ARGINE; Insulin Argine,0
C4083931,Syringe Insulin 1cc 29GX1/2,insulin,,0
C4084163,INSULIN SYRINGE 1ML NEEDLELESS,insulin,INSULIN SYRINGE 1ML NEEDLELESS,0
C4086506,IGF2BP3 Autoantibody,insulin,IGF2 mRNA-Binding Protein 3 Autoantibody; Anti-Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Autoantibody; Anti-KOC Autoantibody; IGF-II mRNA-Binding Protein 3 Autoantibody; Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Autoantibody; IMP-3 Autoantibody; Anti-IGF-II mRNA-Binding Protein 3 Autoantibody; Anti-IMP3 Antibody; Anti-IGF2 mRNA-Binding Protein 3 Autoantibody; Anti-IMP-3 Autoantibody; KOC Autoantibody; Anti-IMP3 Autoantibody; Anti-IGF2BP3 Autoantibody,0
C4224483,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / GLUCAGON 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Weight Management]",insulin,,0
C4224484,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / GLUCAGON 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [WLP40]",insulin,,0
C4227726,Insulin administration required for glucose control,insulin,,0
C4229331,Low levels of insulin-like growth factor I,insulin,,0
C4237663,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / GLUCAGON 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Professional Weight Maintenance]",insulin,,0
C4237710,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / GLUCAGON 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Professional Weight Support]",insulin,,0
C4238498,INSULIN SYRINGE 1ML 30G 5/16IN SAFETY,insulin,INSULIN SYRINGE 1ML 30G 5/16IN SAFETY,0
C4238521,INSULIN SYRINGE 1ML 31G 5/16IN SAFETY,insulin,INSULIN SYRINGE 1ML 31G 5/16IN SAFETY,0
C4244544,Capillary network of dense regular collagenous tissue of skeletal ligament,regular,Capillary plexus of dense regular collagenous tissue of skeletal ligament,0
C4245840,Set of regular cardiac myocytes,regular,Set of regular cardiac muscle cells,0
C4255085,"{90 (Regular Insulin, Human 4 UNT Inhalant Powder [Afrezza]) / 90 (Regular Insulin, Human 8 UNT Inhalant Powder [Afrezza]) } Pack [Afrezza Titration Pack]",insulin,"Afrezza 4 unit (90)- 8 unit (90), 4 units- 8 units inhalation powder; {90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack]; Afrezza Titration Pack- 90 (4 UNT), 90 (8 UNT); afrezza 180 Inhalation Cartridge Titration Pack - 90 (4 UNT), 90 (8 UNT); Afrezza KIT",0
C4256422,Ulticare Insulin Syringe 1cc 31g,insulin,,0
C4256424,Syringe Insulin BD 1cc 29g 1/2'',insulin,,0
C4256425,Syringe Insulin BD 0.5cc 29g 1/2'',insulin,,0
C4256434,Syringe Insulin BD 0.3cc 29g 1/2'',insulin,,0
C4256452,"Monoject Insulin Syringe 0.5cc 30g 5/16""",insulin,,0
C4256457,"Comfort EZ Insulin Syr 0.3ml 30g 5/16""",insulin,,0
C4256458,"Comfort EZ Insulin Syr 0.3ml 30g 1/2""",insulin,,0
C4256627,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / GLUCAGON 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [HA2CG Evolution]",insulin,,0
C4264643,Influenza virus A M gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,FLUAV M gene NAA+probe Ql (Nph); Influenza virus A M gene [Presence] in Nasopharynx by NAA with probe detection; Influenza virus A M gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; FLUAV M gene Nph Ql NAA+probe,0
C4264743,Bordetella pertussis.pertussis toxin promoter region:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Bordetella pertussis.pertussis toxin promoter region:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; B. pertussis toxin promoter region NAA+non-probe Ql (Nph); Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection; B pert.PT Prmt Nph Ql NAA+non-probe,0
C4264744,Chlamydophila pneumoniae DNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Chlamydophila pneumoniae deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; C. pneumoniae DNA NAA+non-probe Ql (Nph); C pneum DNA Nph Ql NAA+non-probe; Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection,0
C4264745,Mycoplasma pneumoniae DNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,M. pneumoniae DNA NAA+non-probe Ql (Nph); Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection; Mycoplasma pneumoniae deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; M pneumo DNA Nph Ql NAA+non-probe,0
C4264746,Respiratory syncytial virus RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Respiratory syncytial virus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection; RSV RNA NAA+non-probe Ql (Nph); RSV RNA Nph Ql NAA+non-probe,0
C4264747,Rhinovirus+Enterovirus RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Rhinovirus+Enterovirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; RV+EV RNA Nph Ql NAA+non-probe; Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection; Rhinovirus+Enterovirus RNA NAA+non-probe Ql (Nph),0
C4264748,Parainfluenza virus 4 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Parainfluenza virus 4 RNA NAA+non-probe Ql (Nph); Parainfluenza virus 4 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection; HPIV4 RNA Nph Ql NAA+non-probe,0
C4264749,Parainfluenza virus 3 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,HPIV3 RNA Nph Ql NAA+non-probe; Parainfluenza virus 3 RNA NAA+non-probe Ql (Nph); Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection; Parainfluenza virus 3 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar,0
C4264750,Parainfluenza virus 2 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Parainfluenza virus 2 RNA NAA+non-probe Ql (Nph); HPIV2 RNA Nph Ql NAA+non-probe; Parainfluenza virus 2 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection,0
C4264751,Parainfluenza virus 1 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,HPIV1 RNA Nph Ql NAA+non-probe; Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection; Parainfluenza virus 1 RNA NAA+non-probe Ql (Nph); Parainfluenza virus 1 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar,0
C4264752,Influenza virus B RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Influenza virus B ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; FLUBV RNA Nph Ql NAA+non-probe; Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection; FLUBV RNA NAA+non-probe Ql (Nph),0
C4264753,Influenza virus A H3 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection; Influenza virus A H3 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; FLUAV H3 RNA NAA+non-probe Ql (Nph); FLUAV H3 RNA Nph Ql NAA+non-probe,0
C4264754,Influenza virus A H1 2009 pandemic RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection; FLUAV H1 2009 pan RNA Nph NAA+non-probe; FLUAV H1 2009 pand RNA NAA+non-probe Ql (Nph); Influenza virus A H1 2009 pandemic ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar,0
C4264755,Influenza virus A H1 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Influenza virus A H1 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; FLUAV H1 RNA NAA+non-probe Ql (Nph); Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection; FLUAV H1 RNA Nph Ql NAA+non-probe,0
C4264756,Influenza virus A RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Influenza virus A ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection; FLUAV RNA Nph Ql NAA+non-probe; FLUAV RNA NAA+non-probe Ql (Nph),0
C4264757,Human coronavirus NL63 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Human coronavirus NL63 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; HCoV NL63 RNA Nph Ql NAA+non-probe; Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection; HCoV NL63 RNA NAA+non-probe Ql (Nph),0
C4264758,Human coronavirus HKU1 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection; HCoV HKU1 RNA NAA+non-probe Ql (Nph); Human coronavirus HKU1 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; HCoV HKU1 RNA Nph Ql NAA+non-probe,0
C4264759,Adenovirus DNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection; Adenovirus deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; HAdV DNA Nph Ql NAA+non-probe; Adenovirus DNA NAA+non-probe Ql (Nph),0
C4264760,Respiratory pathogens DNA & RNA panel:-:Pt:Nph:-:Non-probe.amp.tar,NPH,Resp path DNA+RNA Pnl Nph NAA+non-probe; Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with non-probe detection; Respiratory pathogens deoxyribonucleic acid & ribonucleic acid panel:-:To identify measures at a point in time:Naspopharynx:-:Non-probe.amp.tar; Respiratory pathogens DNA and RNA panel NAA+non-probe (Nph),0
C4265421,Human metapneumovirus RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection; hMPV RNA NAA+non-probe Ql (Nph); hMPV RNA Nph Ql NAA+non-probe; Human metapneumovirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar,0
C4265422,Human coronavirus OC43 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection; HCoV OC43 RNA Nph Ql NAA+non-probe; Human coronavirus OC43 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; HCoV OC43 RNA NAA+non-probe Ql (Nph),0
C4265423,Human coronavirus 229E RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,HCoV 229E RNA NAA+non-probe Ql (Nph); Human coronavirus 229E ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; HCoV 229E RNA Nph Ql NAA+non-probe; Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection,0
C4265466,Somatotropin^1.75H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,insulin,GH 1.75h p Arg+Ins SerPl-mCnc; Somatotropin [Mass/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin; Somatotropin^1.75H post dose arginine+insulin:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Somatotropin 1.75 Hr post dose arginine+insulin [Mass/Vol],0
C4266110,Respiratory pathogens identified:Type:Pt:Nph:Nom:Probe.amp.tar,NPH,Respiratory pathogens identified NAA+probe Nom (Nph); Respiratory pathogens identified [Type] in Nasopharynx by NAA with probe detection; Respiratory pathogens identified:Type:To identify measures at a point in time:Naspopharynx:Nominal:Probe.amp.tar; Resp pathogens Nph NAA+probe,0
C4266111,Bordetella pertussis+parapertussis+bronchiseptica gidA gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,B per+par+bron gidA Nph Ql NAA+probe; B. pertussis+parapertussis+bronchiseptica gidA gene NAA+probe Ql (Nph); Bordetella pertussis+parapertussis+bronchiseptica gidA gene [Presence] in Nasopharynx by NAA with probe detection; Bordetella pertussis+parapertussis+bronchiseptica gidA gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4266112,Bordetella pertussis.pertussis toxin promoter region:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,B pert.PT Prmt Nph Ql NAA+probe; Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with probe detection; B. pertussis toxin promoter region NAA+probe Ql (Nph); Bordetella pertussis.pertussis toxin promoter region:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4266113,Bordetella holmesii fumC gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Bordetella holmesii fumC gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Bordetella holmesii fumC gene [Presence] in Nasopharynx by NAA with probe detection; B holmesii fumC Nph Ql NAA+probe; B. holmesii fumC gene NAA+probe Ql (Nph),0
C4266114,Respiratory syncytial virus B F gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Respiratory syncytial virus B F gene [Presence] in Nasopharynx by NAA with probe detection; RSV B F gene Nph Ql NAA+probe; Respiratory syncytial virus B F gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; RSV B F gene NAA+probe Ql (Nph),0
C4266115,Respiratory syncytial virus A 5' UTR RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,RSV A 5' UTR RNA Nph Ql NAA+probe; RSV A 5' UTR RNA NAA+probe Ql (Nph); Respiratory syncytial virus A 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection; Respiratory syncytial virus A 5' UTR ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4266116,Rhinovirus 5' UTR RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Rhinovirus 5' UTR RNA NAA+probe Ql (Nph); Rhinovirus 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection; Rhinovirus 5' UTR RNA Nph Ql NAA+probe; Rhinovirus 5' UTR ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4266117,Parainfluenza virus 4 P gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,HPIV4 P gene Nph Ql NAA+probe; Parainfluenza virus 4 P gene NAA+probe Ql (Nph); Parainfluenza virus 4 P gene [Presence] in Nasopharynx by NAA with probe detection; Parainfluenza virus 4 P gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4266118,Parainfluenza virus 3 NP gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Parainfluenza virus 3 NP gene NAA+probe Ql (Nph); Parainfluenza virus 3 NP gene [Presence] in Nasopharynx by NAA with probe detection; Parainfluenza virus 3 NP gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; HPIV3 NP gene Nph Ql NAA+probe,0
C4266119,Parainfluenza virus 2 L gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Parainfluenza virus 2 L gene [Presence] in Nasopharynx by NAA with probe detection; Parainfluenza virus 2 L gene NAA+probe Ql (Nph); Parainfluenza virus 2 L gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; HPIV2 L gene Nph Ql NAA+probe,0
C4266120,Parainfluenza virus 1 F gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Parainfluenza virus 1 F gene NAA+probe Ql (Nph); Parainfluenza virus 1 F gene [Presence] in Nasopharynx by NAA with probe detection; Parainfluenza virus 1 F gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; HPIV1 F gene Nph Ql NAA+probe,0
C4266121,Influenza virus B NS gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,FLUBV NS gene Nph Ql NAA+probe; Influenza virus B NS gene [Presence] in Nasopharynx by NAA with probe detection; FLUBV NS gene NAA+probe Ql (Nph); Influenza virus B NS gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4266122,Influenza virus A H3 HA gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Influenza virus A H3 HA gene [Presence] in Nasopharynx by NAA with probe detection; Influenza virus A H3 HA gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; FLUAV H3 HA gene NAA+probe Ql (Nph); FLUAV H3 HA gene Nph Ql NAA+probe,0
C4266123,Influenza virus A H1 HA gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,FLUAV H1 HA gene NAA+probe Ql (Nph); Influenza virus A H1 HA gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Influenza virus A H1 HA gene [Presence] in Nasopharynx by NAA with probe detection; FLUAV H1 HA gene Nph Ql NAA+probe,0
C4266124,Human metapneumovirus A+B L+N genes:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,hMPV A+B L+N genes Nph Ql NAA+probe; Human metapneumovirus A+B L+N genes:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Human metapneumovirus A+B L+N genes [Presence] in Nasopharynx by NAA with probe detection; hMPV A+B L+N genes NAA+probe Ql (Nph),0
C4266125,Adenovirus hexon gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Adenovirus hexon gene Nph Ql NAA+probe; Adenovirus hexon gene NAA+probe Ql (Nph); Adenovirus hexon gene [Presence] in Nasopharynx by NAA with probe detection; Adenovirus hexon gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C4271162,"ASCORBIC ACID 6 [hp_X] in 1 mL / PYRIDOXINE HYDROCHLORIDE 6 [hp_X] in 1 mL / RIBOFLAVIN 6 [hp_X] in 1 mL / LACTIC ACID, L- 6 [hp_X] in 1 mL / THIAMINE HYDROCHLORIDE 6 [hp_X] in 1 mL / ACETALDEHYDE 6 [hp_X] in 1 mL / PRASTERONE 6 [hp_X] in 1 mL / PHLORIZIN 6 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 8 [hp_X] in 1 mL / THIOCTIC ACID 8 [hp_X] in 1 mL / CITRIC ACID MONOHYDRATE 8 [hp_X] in 1 mL / FUMARIC ACID 8 [hp_X] in 1 mL / GLYOXAL TRIMER DIHYDRATE 8 [hp_X] in 1 mL / NADIDE 8 [hp_X] in 1 mL / PANTOTHENIC ACID 8 [hp_X] in 1 mL / INSULIN PORK 8 [hp_X] in 1 mL / PORK LIVER 10 [hp_X] in 1 mL / SUS SCROFA PANCREAS 10 [hp_X] in 1 mL / GLUCAGON 12 [hp_X] in 1 mL / BARIUM OXALATE 6 [hp_C] in 1 mL / ALLOXAN 6 [hp_C] in 1 mL / BERBERIS VULGARIS ROOT BARK 6 [hp_C] in 1 mL / HUMAN BREAST TUMOR CELL 6 [hp_C] in 1 mL / LYCOPODIUM CLAVATUM SPORE 6 [hp_C] in 1 mL / MOMORDICA BALSAMINA IMMATURE FRUIT 6 [hp_C] in 1 mL / PHOSPHORIC ACID 6 [hp_C] in 1 mL / PHOSPHORUS 6 [hp_C] in 1 mL / SYZYGIUM CUMINI SEED 6 [hp_C] in 1 mL / SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS 30 [hp_C] in 1 mL / GYMNEMA SYLVESTRE LEAF 30 [hp_C] in 1 mL / TRIGONELLA FOENUM-GRAECUM WHOLE 30 [hp_C] in 1 mL ORAL LIQUID [Glucoreg]",insulin,,0
C4271576,"{90 (Regular Insulin, Human 4 UNT Inhalant Powder) / 90 (Regular Insulin, Human 8 UNT Inhalant Powder) } Pack",insulin,"regular insulin, human 180 Inhalation Powder Titration Pack - 90 (4 UNT), 90 (8 UNT); INSULIN 4 UNIT X 90/8 UNIT X 90 INHL KIT; INSULIN,HUMAN 4 UNIT X 90/8 UNIT X 90 INHL,ORAL,CARTRIDGE,KIT; {90 (insulin, regular, human 4 UNT Inhalation Powder) / 90 (insulin, regular, human 8 UNT Inhalation Powder) } Pack",0
C4273587,Stuttering Severity Instrument for Children and Adults score,SSI,Stuttering Severity Instrument for Children and Adults score (observable entity); SSI (Stuttering Severity Instrument) for Children and Adults score,0
C4273932,IV insulin syringe,insulin,IV insulin syringe (physical object),0
C4275102,Assessment using Stuttering Severity Instrument for children and adults,SSI,Assessment using Stuttering Severity Instrument for children and adults (procedure); Assessment using SSI (Stuttering Severity Instrument) for children and adults,0
C4276402,"LINER,OSTOMY,BIODEGRADABLE REGULAR",regular,"LINER,OSTOMY BIODEGRADABLE REGULAR",0
C4276894,"Insig2 protein, rat",insulin,"Insig-2 protein, rat; insulin-induced gene 2 product, rat",0
C4276926,"Igf2bp1 protein, zebrafish",insulin,"insulin-like growth factor 2 mRNA-binding protein 1, zebrafish",0
C4276977,"IGFBP5-interacting protein, mouse",insulin,"IGFBP5 protein, mouse; insulin-like growth factor binding protein 5, mouse",0
C4277189,"IRTKS protein, mouse",insulin,"BAI1-associated protein 2-like 1 protein, mouse; insulin receptor tyrosine kinase substrate protein, mouse; BAIAP2L1 protein, mouse; brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1, mouse",0
C4277251,LY2963016 insulin glargine,insulin,LY IGlar,0
C4282172,"INSULIN,REGULAR,HUMAN BUFFERED",insulin,,0
C4282750,NOVOPEN ECHO INSULIN DELIVERY SYSTEM 3ML,insulin,NOVOPEN ECHO INSULIN DELIVERY SYSTEM 3ML,0
C4283304,long-(ARG3)insulin-like growth factor-I,insulin,LONG-(ARG3)INSULIN-LIKE GROWTH FACTOR-I,0
C4283637,Afrezza 4 unit (90)- 8 unit (90),afrezza,,0
C4283823,"{60 (Regular Insulin, Human 12 UNT Inhalant Powder [Afrezza]) / 60 (Regular Insulin, Human 4 UNT Inhalant Powder [Afrezza]) / 60 (Regular Insulin, Human 8 UNT Inhalant Powder [Afrezza]) } Pack [Afrezza 180 Titration Pack- 60 (4 UNT), 60 (8 UNT), 60 (12 UNT)]",insulin,"{60 (insulin, regular, human 12 UNT Inhalation Powder [Afrezza]) / 60 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 60 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza 180 Titration Pack- 60 (4 UNT), 60 (8 UNT), 60 (12 UNT)]; Afrezza Titration Pack, 4 units-8 units-12 units inhalation powder; Afrezza 180 Inhalation Cartridge Titration Pack - 60 (4 UNT), 60 (8 UNT), 60 (12 UNT); afrezza 180 Inhalation Cartridge Titration Pack - 60 (4 UNT), 60 (8 UNT), 60 (12 UNT); Afrezza KIT",0
C4284100,"3 ML insulin, regular, human 100 UNT/ML Pen Injector [Novolin R]",insulin,"3 ML NovoLIN R 100 UNT/ML Pen Injector; INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Novolin R]; INSULIN REGULAR NOVOLIN-R 100 U/ML PEN 3ML; 3 ML insulin, regular, human 100 UNT/ML Pen Injector [NovoLIN R]; NovoLIN R FlexPen, human recombinant 100 units/mL injectable solution; 3 ML Novolin R 100 UNT/ML Pen Injector; NovoLIN R 100 UNT/mL in 3 mL Pen Injector; INSULIN REG NOVOLIN-R 100UNIT/ML PEN 3ML; Novolin R 100 UNT/ML per 3 ML Pen Injector; Relion NovoLIN R 100 UNT/ML per 3 ML Pen Injector; ReliOn/NovoLIN R FlexPen, human recombinant 100 units/mL injectable solution; Relion Novolin R 100 UNT/ML per 3 ML Pen Injector; 3 ML insulin, regular, human 100 UNT/ML Pen Injector [Novolin R]; NovoLIN R 100 UNT/ML per 3 ML Pen Injector",0
C4284411,"{60 (Regular Insulin, Human 12 UNT Inhalant Powder) / 60 (Regular Insulin, Human 4 UNT Inhalant Powder) / 60 (Regular Insulin, Human 8 UNT Inhalant Powder) } Pack",insulin,"INSULIN,HUMAN 4 UNIT/8 UNIT/12 UNIT INHL,ORAL,TITRATION,KIT,180; {60 (insulin, regular, human 12 UNT Inhalation Powder) / 60 (insulin, regular, human 4 UNT Inhalation Powder) / 60 (insulin, regular, human 8 UNT Inhalation Powder) } Pack; regular insulin, human 180 Inhalation Powder Pack - 60 (4 UNT), 60 (8 UNT), 60 (12 UNT); INSULIN TITRATION ORAL INHL KIT 180; insulin inhalation, rapid acting 4 units-8 units-12 units inhalation powder",0
C4286339,"IVD Panels, Human Genetics, Metabolic Disorder, Diabetes, Diabetes Mellitus Type 2",insulin,Non-Insulin Dependent Diabetes Gene Panel Reagents; Diabetes Mellitus Type 2 Gene Panel Reagents; Adult-Onset Diabetes Gene Panel Reagents; Type 2 Diabetes Gene Panel Reagents,0
C4288926,IGF1R Positive,insulin,Insulin Like Growth Factor 1 Receptor Positive; CD221 Positive; IGFR Positive; IGF-1R Positive,0
C4290707,Insulin Syringe S/C 0.3cc 31g 6mm,insulin,,0
C4292626,BD Insulin Syringe U-500,insulin,,0
C4292822,3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua],insulin,"Soliqua 100/33 per 3 ML Pen Injector; Soliqua 100/33, 100 units-33 mcg/mL subcutaneous solution; INSULIN GLARGINE 100 U in 1 mL / LIXISENATIDE 33 ug in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Soliqua 100/33]; Soliqua 100/33 in 3 ML Pen Injector",0
C4293375,insulin glargine / lixisenatide,insulin,INSULIN GLARGINE/LIXISENATIDE; insulin glargine-lixisenatide; insulin glargine and lixisenatide; Insulin Glargine/ Lixisenatide,0
C4293382,3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector,insulin,"insulin glargine 100 UNT/ML / lixisenatide 33 MCG/ML in 3 ML Pen Injector; insulin glargine 100 UNT/ML / lixisenatide 33 MCG/ML per 3 ML Pen Injector; insulin glargine-lixisenatide 100 units-33 mcg/mL subcutaneous solution; INSULIN,GLARGINE 100UNIT/LIXISENATIDE 33MCG/ML INJ,SOLN,PEN; SOLIQUA 100UNIT/33MCG/ML INJ PEN 3ML",0
C4293405,insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML [Soliqua],insulin,,0
C4293447,insulin glargine / lixisenatide Pen Injector [Soliqua],insulin,,0
C4293577,insulin glargine / lixisenatide Pen Injector,insulin,,0
C4293608,insulin glargine / lixisenatide Injectable Product,insulin,,0
C4293738,3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector [Xultophy],insulin,"INSULIN DEGLUDEC 100 [iU] in 1 mL / LIRAGLUTIDE 3.6 mg in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Xultophy 100/3.6]; Xultophy 100/3.6 in 3 ML Pen Injector; Xultophy, 100 units-3.6 mg/mL subcutaneous solution; Xultophy (insulin degludec 100 UNT / liraglutide 3.6 MG/ML) per 3 ML Pen Injector",0
C4293770,3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector,insulin,"INSULIN,DEGLUDEC 100UNIT/LIRAGLUTIDE 3.6MG/ML INJ,SOLN,PEN; insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML in 3 ML Pen Injector; insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML per 3 ML Pen Injector; XULTOPHY 100UNIT/3.6MG/ML INJ PEN 3ML; insulin degludec-liraglutide 100 units-3.6 mg/mL subcutaneous solution",0
C4294627,insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML [Xultophy],insulin,,0
C4294643,insulin degludec / liraglutide Pen Injector [Xultophy],insulin,,0
C4294705,insulin degludec / liraglutide Pen Injector,insulin,,0
C4294715,insulin degludec / liraglutide Injectable Product,insulin,Insulin degludec- and liraglutide-containing product in parenteral dose form; Product containing insulin degludec and liraglutide in parenteral dose form (medicinal product form),0
C4301008,INSULIN/LIRAGLUTIDE,insulin,,0
C4301058,INSULIN SYRINGE 0.5ML 31G 6MM (U-500),insulin,INSULIN SYRINGE 0.5ML 31G 6MM (U-500),0
C4301288,"Ulticare Insulin Syringe and Needles, 1 cc x",insulin,,0
C4302207,Neonatal hyperglycemia due to insulin deficiency,insulin,Neonatal hyperglycaemia due to insulin deficiency; Neonatal hyperglycemia due to insulin deficiency (disorder),0
C4303474,Hyperinsulinism due to insulin receptor deficiency,insulin,Hyperinsulinism due to INSR (insulin receptor) deficiency; Hyperinsulinism due to insulin receptor deficiency (disorder),0
C4303621,Short fifth metacarpal insulin resistance syndrome,insulin,Short fifth metacarpal insulin resistance syndrome (disorder); Short fifth metacarpals-insulin resistance syndrome,0
C4303750,Insulin declined,insulin,Insulin declined (situation); Insulin refused,0
C4304605,Diabetic on non-insulin injectable medication,insulin,Diabetic on non-insulin injectable medication (finding),0
C4305258,Acanthosis nigricans and insulin resistance with muscle cramp and acral enlargement syndrome,insulin,Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome; Acanthosis nigricans and insulin resistance with muscle cramp and acral enlargement syndrome (disorder),0
C4306218,Minimed 630g Insulin Pump DS,insulin,,0
C4306799,INSULIN/LIXISENATIDE,insulin,,0
C4307476,"Insrr protein, mouse",insulin,"insulin receptor-related receptor, mouse",0
C4307477,"Insrr protein, rat",insulin,"insulin receptor-related receptor, rat",0
C4313258,Extreme insulin resistance,insulin,,0
C4313269,Markedly elevated fasting plasma insulin,insulin,,0
C4316071,"Supplies for external insulin infusion pump, syringe type cartridge, sterile, each",insulin,,0
C4316288,"Supplies for maintenance of insulin infusion catheter, per week",insulin,,0
C4316466,Education about insulin pump,insulin,Education about insulin pump (procedure),0
C4316869,B29-tetradecanoyl-Lys-B30-des-Ala-insulin,insulin,"Des-(B30)-insulin, Lys(B29)-tetradecanoyl; B29 tetradecanoyl Lys B30 des Ala insulin; 12C-Lys(B29)-DB30I; Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30); Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)",0
C4317916,Afrezza Titration Pack,afrezza,,0
C4321359,Reduced insulin like growth factor binding protein acid labile subunit level,insulin,Reduced insulin like growth factor binding protein acid labile subunit level; Decreased levels of acid labile subunit; Acid-labile subunit deficiency; Reduced insulin like growth factor binding protein acid labile subunit concentration,0
C4324242,Insulin Aspart Rapid-acting/ Insulin Aspart Protamine,insulin,,0
C4324257,Insulin Lispro Rapid-acting/ Insulin Lispro Protamine,insulin,,0
C4329216,2-Hour Postprandial Insulin,insulin,2 Hour Postprandial Insulin; 2h Postprandial Insulin; 2 hr Postprandial Insulin,0
C4330492,Insulin Receptor Mutation - Associated Insulin Resistance Syndromes,insulin,,0
C4331921,Obesity-Associated Insulin Resistance,insulin,,0
C4473559,"INSULIN COOLING CASE, LG",insulin,"INSULIN COOLING CASE, LG",0
C4473591,INSULIN SYRINGE 0.3ML 31G 6MM,insulin,INSULIN SYRINGE 0.3ML 31G 6MM,0
C4476922,Abnormal insulin like growth factor binding protein acid labile subunit level,insulin,,0
C4476924,Reduced insulin-like factor 3 level,insulin,Reduced plasma INSL3 level,0
C4476954,Abnormal response to insulin tolerance test,insulin,,0
C4476955,Impaired cortisol response to insulin stimulation test,insulin,,0
C4476958,Impaired growth-hormone response to insulin stimulation test,insulin,,0
C4476963,Excessive insulin response to glucagon test,insulin,,0
C4476973,Insulin receptor antibody positivity,insulin,,0
C4478045,0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector,insulin,"Insulin Lispro Junior KwikPen, 100 units/mL injectable solution; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Lispro Junior KwikPen]; insulin lispro 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses; insulin lispro 100 UNT/ML per 3 ML Pen Injector, 0.5 UNT Doses; INSULIN,LISPRO,HUMAN 100 UNT/ML INJ,JUNIOR KWIKPEN,3ML; INSULIN,LISPRO,HUM 100/ML JR KWIKPEN 3ML",0
C4478046,0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector [Humalog],insulin,"Humalog Junior KwikPen 100 UNT/ML per 3 ML Pen Injector; HumaLOG Junior 100 UNT/ML in 3 ML Pen Injector; 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector [HumaLOG]; 0.5 UNT Doses 3 ML HumaLOG 100 UNT/ML Pen Injector; HumaLOG Junior KwikPen, 100 units/mL injectable solution; HumaLOG Junior KwikPen 100 UNT/ML per 3 ML Pen Injector; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Humalog Junior KwikPen]; 0.5 UNT Doses 3 ML Humalog 100 UNT/ML Pen Injector",0
C4482407,"During the last 7D, on how many D did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ",regular,"During the last 7D, on how many D did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10M at a time:Number=Count/Time:7 days:^Patient:Quantitative:IPAQ; During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10 minutes at a time [IPAQ]",0
C4482408,"During the last 7D, on how many D did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10M at a time",regular,"During the last 7D, on how many D did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10M at a time; During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10 minutes at a time",0
C4482793,Bordetella pertussis+bronchiseptica+holmesii IS481 DNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,B. pertussis+bronchiseptica+holmesii IS481 DNA NAA+non-probe Ql (Nph); Bordetella pertussis+bronchiseptica+holmesii IS481 deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Nasopharynx by NAA with non-probe detection; B pert+bron+holm IS481 Nph NAA+non-Probe,0
C4489369,Regular food: solids and liquids swallowed safely without supervision or modified food consistency,regular,,0
C4519113,Bacillus calmette-guerin substrain danish 1331 live antigen,SSI,BCG SSI; BCG Substrain Danish 1331 Live Antigen; BCG SSI Strain; BCG (SSI strain); Bacillus Calmette-Guerin Substrain Danish 1331 Live Antigen,0
C4519461,"Insulin Pen Needles, 31g 1/4"" (6mm)",insulin,,0
C4519462,"Insulin Pen Needles, 31g 3/16"" (5mm)",insulin,,0
C4519463,"Insulin Pen Needles, 31g 5/16"" (8mm)",insulin,,0
C4519464,"Insulin Pen Needles, 32g 5/32"" (4mm)",insulin,,0
C4521518,"insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp]",insulin,"Fiasp 100 UNT/ML Injectable Solution; insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp]; INSULIN,ASPART,HUMAN FIASP 100 UN/ML INJ; Fiasp, 100 units/mL injectable solution; INSULIN,ASPART,HUMAN FIASP 100 UNT/ML INJ; Fiasp 100 UNT/mL Injectable Solution; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Fiasp]",0
C4521519,"3 ML insulin aspart, human 100 UNT/ML Pen Injector [Fiasp]",insulin,"3 ML insulin aspart, human 100 UNT/ML Pen Injector [Fiasp]; INSULIN,ASPART,HUMAN 100U/ML,FIASP,FLEXTOUCH,3ML; Fiasp 100 UNT/mL in 3 mL Pen Injector; 3 ML Fiasp 100 UNT/ML Pen Injector; INSULIN,ASPART 100UN/ML FIASP PEN 3ML; Fiasp FlexTouch, 100 units/mL injectable solution; INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Fiasp]",0
C4522142,3 ML insulin lispro 100 UNT/ML Pen Injector [Admelog],insulin,"INSULIN,LISPRO,HUMAN 100 UNT/ML INJ,ADMELOG SOLOSTAR,3ML; 3 ML insulin lispro 100 UNT/ML Pen Injector [Admelog]; INSULIN LISPRO 100 UNIT/ML SOLOSTAR 3ML; Admelog 100 UNT/ML per 3 ML Pen Injector; Admelog 100 UNT/ML in 3 ML Pen Injector; Admelog SoloStar, 100 units/mL injectable solution; INSULIN LISPRO 100 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [ADMELOG]",0
C4522143,insulin lispro 100 UNT/ML Injectable Solution [Admelog],insulin,"insulin lispro 100 UNT/ML Injectable Solution [Admelog]; Admelog 100 UNT/ML Injectable Solution; INSULIN LISPRO 100 U in 1 mL INTRAVENOUS INJECTION, SOLUTION [ADMELOG]; INSULIN LISPRO HUMAN 100 UNIT/ML ADMELOG; INSULIN,LISPRO,HUMAN 100 UNT/ML INJ,ADMELOG; Admelog, 100 units/mL injectable solution; INSULIN LISPRO 100 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [ADMELOG]",0
C4528168,IGF1 Positive,insulin,Insulin-Like Growth Factor I Positive; Somatomedin C Positive; IGF I Positive; Insulin-Like Growth Factor 1 Positive; IGF-1 Positive; IGF-I Positive,0
C4529885,Fiasp,fiasp,Fiasp,0
C4529886,"insulin aspart, human 100 UNT/ML [Fiasp]",insulin,,0
C4529887,"insulin aspart, human Injectable Solution [Fiasp]",insulin,,0
C4529888,Fiasp Injectable Product,fiasp,,0
C4529889,"insulin aspart, human Pen Injector [Fiasp]",insulin,,0
C4530128,"GLYCERIN 3 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 3 [hp_X] in 1 mL / TARAXACUM OFFICINALE 3 [hp_X] in 1 mL / ARSENIC TRIOXIDE 12 [hp_X] in 1 mL / NITRIC ACID 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / KEROSENE 12 [hp_X] in 1 mL / PHOSPHORIC ACID 12 [hp_X] in 1 mL / PHOSPHORUS 12 [hp_X] in 1 mL / ASPIRIN 12 [hp_X] in 1 mL / NITROGLYCERIN 12 [hp_X] in 1 mL / INSULIN PORK 12 [hp_X] in 1 mL / LITHIUM CARBONATE 12 [hp_X] in 1 mL / SUS SCROFA THYROID 12 [hp_X] in 1 mL / SALICYLIC ACID 12 [hp_X] in 1 mL / CORTICOTROPIN 12 [hp_X] in 1 mL / CORTISONE ACETATE 12 [hp_X] in 1 mL / EUGENOL 12 [hp_X] in 1 mL / STEARYL ALCOHOL 12 [hp_X] in 1 mL / XYLITOL 12 [hp_X] in 1 mL / ESTRONE 12 [hp_X] in 1 mL / BENZOIC ACID 12 [hp_X] in 1 mL / CHLORINE 12 [hp_X] in 1 mL / POTASSIUM SORBATE 12 [hp_X] in 1 mL / SORBITOL 12 [hp_X] in 1 mL / RESORCINOL 12 [hp_X] in 1 mL / BENZYL ALCOHOL 12 [hp_X] in 1 mL / LACTIC ACID, DL- 12 [hp_X] in 1 mL / ISOPROPYL PALMITATE 12 [hp_X] in 1 mL / BORIC ACID 12 [hp_X] in 1 mL / ACETIC ACID 12 [hp_X] in 1 mL / PHENYLBUTAZONE 12 [hp_X] in 1 mL / PETROLATUM 12 [hp_X] in 1 mL / LEAD 12 [hp_X] in 1 mL ORAL LIQUID [Homeoplex D]",insulin,,0
C4530768,HumaLOG Junior KwikPen,humalog,,0
C4530904,Fiasp FlexTouch,fiasp,,0
C4532917,Bordetella parapertussis IS1001 DNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,B parap IS1001 DNA Nph Ql NAA+non-probe; Bordetella parapertussis IS1001 deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; Bordetella parapertussis IS1001 DNA [Presence] in Nasopharynx by NAA with non-probe detection; B. parapertussis IS1001 DNA NAA+non-probe Ql (Nph),0
C4533028,Middle East respiratory syndrome coronavirus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Middle East respiratory syndrome coronavirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; MERS-CoV RNA NAA+probe Ql (Nph); MERS-CoV RNA Nph Ql NAA+probe; Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with probe detection,0
C4533531,Respiratory pathogens panel:-:Pt:Nph:-:IF,NPH,Respiratory pathogens panel IF (Nph); Respiratory pathogens panel:-:To identify measures at a point in time:Naspopharynx:-:Immune Fluorescence; Respiratory pathogens panel - Nasopharynx by Immunofluorescence; Respiratory path Pnl Nph IF,0
C4533543,Microscopic observation:Prid:Pt:Nph:Nom:Gram stain,NPH,Microscopic observation [Identifier] in Nasopharynx by Gram stain; Microscopic observation:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Gram stain; Gram Stn Nph; Microscopic observation Gram stain Nom (Nph),0
C4533623,Human metapneumovirus Ag:PrThr:Pt:Nph:Ord:IF,NPH,Human metapneumovirus Ag [Presence] in Nasopharynx by Immunofluorescence; Human metapneumovirus Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immune Fluorescence; hMPV Ag IF Ql (Nph); hMPV Ag Nph Ql IF,0
C4534372,Patient lives alone - regular daytime,regular,,0
C4534373,Patient lives alone - regular nighttime,regular,,0
C4534376,Patient lives with other person(s) in the home - regular daytime,regular,,0
C4534377,Patient lives with other person(s) in the home - regular nighttime,regular,,0
C4534381,"Patient lives in congregate situation (for example, assisted living, residential care home) - regular daytime",regular,,0
C4534382,"Patient lives in congregate situation (for example, assisted living, residential care home) - regular nighttime",regular,,0
C4535341,insulin lispro 100 UNT/ML [Admelog],insulin,,0
C4535342,insulin lispro Injectable Solution [Admelog],insulin,,0
C4535344,insulin lispro Pen Injector [Admelog],insulin,,0
C4538687,Elevated baseline insulin (recessive),insulin,,0
C4541356,"insulin aspart, human / insulin degludec Injectable Product",insulin,Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form); Insulin aspart- and insulin degludec-containing product in parenteral dose form,0
C4541358,"insulin aspart, human / insulin degludec",insulin,,0
C4541663,"Insulin Lispro, Recombinant 100 U/1 ML Injection Solution",insulin,,0
C4541719,INSULIN SYRINGE 0.3ML 31G 1/4IN,insulin,INSULIN SYRINGE 0.3ML 31G 1/4IN,0
C4541720,INSULIN SYRINGE 0.5ML 31G 1/4IN,insulin,INSULIN SYRINGE 0.5ML 31G 1/4IN,0
C4541721,INSULIN SYRINGE 1ML 31G 1/4IN,insulin,INSULIN SYRINGE 1ML 31G 1/4IN,0
C4542607,Outpatient IV Insulin Treatment,insulin,,0
C4544151,Insulin infusion rate,insulin,Insulin infusion rate (observable entity),0
C4548432,basal insulin peglispro,insulin,,0
C4548981,"insulin (ox), 8(A)-L-threonine-10(A)-L-isoleucine-",insulin,,0
C4549738,neutral protamine lispro insulin,insulin,NPL protamine lispro insulin,0
C4550894,Insulin tregopil,insulin,Insulin Tregopil,0
C4550895,Insulin peglispro,insulin,Insulin Peglispro,0
C4551912,ATTENDS REGULAR BRIEF LARGE,regular,Attends Brief Large; ATTENDS REGULAR BRIEF LARGE; Attends Briefs Large,0
C4551913,ATTENDS REGULAR BRIEF MEDIUM,regular,ATTENDS REGULAR BRIEF MEDIUM; Attends Briefs Medium; Attends Brief Medium,0
C4552087,"3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Novolin]",insulin,"3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [NovoLIN]; NovoLIN 70/30 in 3 ML Pen Injector; NovoLIN 70/30 per 3 ML Pen Injector; Novolin 70/30 per 3 ML Pen Injector; ReliOn/NovLIN 70/30 FlexPen, human recombinant 70 units-30 units/mL subcutaneous suspension; NovoLIN 70/30 FlexPen, human recombinant 70 units-30 units/mL subcutaneous suspension; INSULIN NOVOLIN 70/30 (NPH/REG) INJ PEN,3ML; 3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Novolin]; INSULIN NOVOLIN 70/30 INJ PEN 3ML; INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Novolin 70/30]",0
C4553513,IGF2BP2 wt Allele,insulin,IGF2BP2 wt Allele; VICKZ2; IMP-2; Insulin Like Growth Factor 2 mRNA Binding Protein 2 wt Allele; IMP2,0
C4553940,Insulin antagonist (disposition),insulin,Insulin antagonist (disposition); Insulin antagonist,0
C4555611,"VanishPoint 0.5mL U - 100"" Insulin 30G x",insulin,,0
C4555612,"VanishPoint 0.5mL U - 100"" Insulin 30G x 1/2""",insulin,,0
C4555613,"VanishPoint 0.5mL U - 100"" Insulin 30G x 3/16",insulin,,0
C4555614,"VanishPoint 0.5mL U - 100"" Insulin 30G x 5/1",insulin,,0
C4555616,"VanishPoint 1 mL U-100 Insulin 29G x 1/2""",insulin,,0
C4555617,"VanishPoint 1 mL U-100 Insulin 29G x 5/16""",insulin,,0
C4555618,"VanishPoint 1 mL U-100 Insulin 30G x 3/16""",insulin,,0
C4555619,"VanishPoint 1 mL U-100 Insulin 30G x 5/16""",insulin,,0
C4555671,InPen Blue (For Novolog),novolog,,0
C4555672,InPen Grey (For Humalog),humalog,,0
C4555673,InPen Grey (For Novolog),novolog,,0
C4555674,InPen Pink (For Humalog),humalog,,0
C4555675,InPen Pink (For Novolog),novolog,,0
C4556013,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 59 mL / ECHINACEA, UNSPECIFIED 6 [hp_X] in 59 mL / BOS TAURUS HYPOTHALAMUS 6 [hp_X] in 59 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 59 mL / PORK LIVER 8 [hp_X] in 59 mL / PORK KIDNEY 8 [hp_X] in 59 mL / METHYLCOBALAMIN 8 [hp_X] in 59 mL / SUS SCROFA PANCREAS 8 [hp_X] in 59 mL / SUS SCROFA STOMACH 8 [hp_X] in 59 mL / APC-356433 8 [hp_X] in 59 mL / APC-356434 8 [hp_X] in 59 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 59 mL / GAMBOGE 12 [hp_X] in 59 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 59 mL / GRAPHITE 12 [hp_X] in 59 mL / SODIUM CHLORIDE 12 [hp_X] in 59 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 59 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 59 mL / 7-KETO-DEHYDROEPIANDROSTERONE 30 [hp_X] in 59 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 59 mL / GLUCAGON 30 [hp_X] in 59 mL / INSULIN PORK 30 [hp_X] in 59 mL / LACTIC ACID, L- 30 [hp_X] in 59 mL / PROTEUS VULGARIS 30 [hp_C] in 59 mL Oral LIQUID [Weight Management]",insulin,,0
C4556100,InPen Blue (For Humalog),humalog,,0
C4688733,"SOLANUM DULCAMARA TOP 10 [hp_X] in 1 g / NITRIC ACID 10 [hp_X] in 1 g / THUJA OCCIDENTALIS LEAFY TWIG 10 [hp_X] in 1 g / ANTIMONY TRISULFIDE 12 [hp_X] in 1 g / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 g / SILICON DIOXIDE 12 [hp_X] in 1 g TOPICAL PASTE [HaloDerm Regular]",regular,,0
C4688827,3 ML insulin glargine 300 UNT/ML Pen Injector,insulin,"INSULIN,GLARGINE,HUMAN 300 UNIT/ML INJ,SOLOSTAR,3ML; insulin glargine 300 UNT/ML in 3 ML Pen Injector; INSULIN,GLARGINE 300 UNT/ML 3ML SOLOSTR; insulin glargine 300 UNT/ML per 3 ML Pen Injector",0
C4688828,3 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo],insulin,"Toujeo 300 UNT/ML per 3 ML Pen Injector; INSULIN GLARGINE 300 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [TOUJEO Max]; 3 ML Toujeo 300 UNT/ML Pen Injector; Toujeo Max 300 UNT/ML in 3 ML Pen Injector; Toujeo Max SoloStar, 300 units/mL subcutaneous solution; insulin glargine 300 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [TOUJEO Max]",0
C4689047,INSULIN SYRINGE 0.3ML 31G 6MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.3ML 31G 6MM (1/2 UNIT),0
C4689464,"VINCETOXICUM HIRUNDINARIA ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / GLUCAGON 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Metabolism Manager]",insulin,,0
C4691472,TechLITE Insulin Syringe 31 g X 6 mm 0.3 mL,insulin,,0
C4691473,TechLITE Insulin Syringe 31 g X 6 mm 0.5 mL,insulin,,0
C4691474,TechLITE Insulin Syringe 31 g X 6 mm 1 mL,insulin,,0
C4692193,Toujeo Max SoloStar,toujeo,,0
C4692511,Low serum glucose with inappropriately high insulin levels,insulin,,0
C4694157,ALUMINUM CHLOROHYDRATE 10 g in 100 g TOPICAL AEROSOL [Sure Antiperspirant Deodorant Regular],regular,,0
C4694365,"CARTRIDGE,T FLEX W/T:LOCK INSULIN,4.8ML",insulin,"CARTRIDGE,T FLEX W/T:LOCK INSULIN,4.8ML",0
C4694579,INSULIN SYRINGE 0.3ML 29G 12MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.3ML 29G 12MM (1/2 UNIT),0
C4694580,INSULIN SYRINGE 0.3ML 30G 12MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.3ML 30G 12MM (1/2 UNIT),0
C4694581,INSULIN SYRINGE 0.3ML 30G 8MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.3ML 30G 8MM (1/2 UNIT),0
C4694582,INSULIN SYRINGE 0.3ML 31G 6MM SAFETY,insulin,INSULIN SYRINGE 0.3ML 31G 6MM SAFETY,0
C4694583,INSULIN SYRINGE 0.3ML 31G 8MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.3ML 31G 8MM (1/2 UNIT),0
C4694584,INSULIN SYRINGE 0.5ML 29G 12MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.5ML 29G 12MM (1/2 UNIT),0
C4694585,INSULIN SYRINGE 0.5ML 30G 12MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.5ML 30G 12MM (1/2 UNIT),0
C4694586,INSULIN SYRINGE 0.5ML 30G 8MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.5ML 30G 8MM (1/2 UNIT),0
C4694587,INSULIN SYRINGE 0.5ML 31G 6MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.5ML 31G 6MM (1/2 UNIT),0
C4694588,INSULIN SYRINGE 0.5ML 31G 6MM SAFETY,insulin,INSULIN SYRINGE 0.5ML 31G 6MM SAFETY,0
C4694589,INSULIN SYRINGE 0.5ML 31G 8MM (1/2 UNIT MARKINGS),insulin,INSULIN SYR 0.5ML 31G 8MM (1/2 UNIT),0
C4694590,INSULIN SYRINGE 1ML 29G 12MM,insulin,INSULIN SYRINGE 1ML 29G 12MM,0
C4694591,INSULIN SYRINGE 1ML 30G 8MM,insulin,INSULIN SYRINGE 1ML 30G 8MM,0
C4694592,INSULIN SYRINGE 1ML 31G 6MM SAFETY,insulin,INSULIN SYRINGE 1ML 31G 6MM SAFETY,0
C4694593,INSULIN SYRINGE 1ML 31G 8MM,insulin,INSULIN SYRINGE 1ML 31G 8MM,0
C4695256,Bordetella sp identified:Prid:Pt:Nph:Nom:Organism specific culture,NPH,Bordetella Nph Cult; Bordetella sp identified Org specific cx Nom (Nph); Bordetella sp identified:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Organism specific culture; Bordetella sp identified in Nasopharynx by Organism specific culture,0
C4695257,Bordetella sp DNA:Prid:Pt:Nph:Nom:Probe.amp.tar,NPH,Bordetella sp DNA [Identifier] in Nasopharynx by NAA with probe detection; Bordetella sp DNA NAA+probe Nom (Nph); Bordetella DNA Nph NAA+probe; Bordetella sp deoxyribonucleic acid:Presence or Identity:To identify measures at a point in time:Naspopharynx:Nominal:Probe.amp.tar,0
C4695265,Adenovirus A+B+C+D+E+F DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Adenovirus A+B+C+D+E+F deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Adenovirus A+B+C+D+E+F DNA [Presence] in Nasopharynx by NAA with probe detection; HAdV A+B+C+D+E+F DNA Nph Ql NAA+probe; Adenovirus A+B+C+D+E+F DNA NAA+probe Ql (Nph),0
C4695476,"During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time:NRat:7D:^Patient:Qn:IPAQ",regular,"During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time:Number=Count/Time:7 days:^Patient:Quantitative:IPAQ; During the last 7 days, on how many days did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10 minutes at a time [IPAQ]",0
C4695477,"During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time",regular,"During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time; During the last 7 days, on how many days did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10 minutes at a time",0
C4695722,Bordetella holmesii hIS1001 DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Bordetella holmesii hIS1001 deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Bordetella holmesii hIS1001 DNA [Presence] in Nasopharynx by NAA with probe detection; B holm hIS1001 DNA Nph Ql NAA+probe; B. holmesii hIS1001 DNA NAA+probe Ql (Nph),0
C4695745,Adenovirus Ag:PrThr:Pt:Nph:Ord:IA,NPH,HAdV Ag Nph Ql IA; Adenovirus Antigen:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Immunoassay; Adenovirus Ag IA Ql (Nph); Adenovirus Ag [Presence] in Nasopharynx by Immunoassay,0
C4695839,Chlamydophila pneumoniae DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Chlamydophila pneumoniae deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; C. pneumoniae DNA NAA+probe Ql (Nph); Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection; C pneum DNA Nph Ql NAA+probe,0
C4695840,Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,HCoV 229E+HKU1+NL63+OC43 RNA NAA+probe Ql (Nph); Human coronavirus 229E+HKU1+NL63+OC43 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; HCoV 229E+HKU1+NL63+OC43 Nph Ql NAA+Pr; Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection,0
C4695842,Mycoplasma pneumoniae DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,M. pneumoniae DNA NAA+probe Ql (Nph); Mycoplasma pneumoniae deoxyribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection; M pneumo DNA Nph Ql NAA+probe,0
C4695843,Rhinovirus+enterovirus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection; Rhinovirus+enterovirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; RV+EV RNA Nph Ql NAA+probe; Rhinovirus+Enterovirus RNA NAA+probe Ql (Nph),0
C4696149,Middle east respiratory syndrome coronavirus RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detection; Middle east respiratory syndrome coronavirus ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; MERS-CoV RNA NAA+non-probe Ql (Nph); MERS-CoV RNA Nph Ql NAA+non-probe,0
C4696150,Parainfluenza virus 1+2+3+4 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,Parainfluenza virus 1+2+3+4 RNA [Presence] in Nasopharynx by NAA with non-probe detection; Parainfluenza virus 1+2+3+4 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; HPIV 1+2+3+4 RNA Nph Ql NAA+non-probe; Parainfluenza virus 1+2+3+4 RNA NAA+non-probe Ql (Nph),0
C4696152,Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,HCoV 229E+HKU1+NL63+OC43 Np Ql NAA+nonpr; HCoV 229E+HKU1+NL63+OC43 RNA NAA+non-probe Ql (Nph); Human coronavirus 229E+HKU1+NL63+OC43 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection,0
C4696305,I have trouble doing all of my regular leisure activities with others in the past 7D:Find:7D:^Patient:Ord:ADAPTABLE,regular,I have trouble doing all of my regular leisure activities with others in the past 7 days [ADAPTABLE]; I have trouble doing all of my regular leisure activities with others in the past 7D:Finding:7 days:^Patient:Ordinal:ADAPTABLE,0
C4696306,I have trouble doing all of my regular leisure activities with others in the past 7D,regular,I have trouble doing all of my regular leisure activities with others in the past 7 days; I have trouble doing all of my regular leisure activities with others in the past 7D,0
C4696652,Insulin.intact:ACnc:Pt:Ser:Qn:LC/MS/MS,insulin,Insulin intact Ser LC/MS/MS-aCnc; Insulin intact LC/MS/MS Qn (S); Insulin.intact:Arbitrary concentration:To identify measures at a point in time:Serum:Quantitative:LC/MS/MS; Insulin intact [Units/volume] in Serum by LC/MS/MS,0
C4696653,Insulin.intact,insulin,Insulin intact; Insulin.intact,0
C4703595,Increased proinsulin:insulin ratio,insulin,,0
C4704241,INSULIN SYRINGE 1ML 27G 12.7MM,insulin,INSULIN SYRINGE 1ML 27G 12.7MM,0
C4704408,"insulin isophane / insulin, regular, human Pen Injector [Novolin]",insulin,"insulin isophane / insulin, regular, human Pen Injector [NovoLIN]",0
C4708193,Remote control insulin infusion patch pump blood glucose analyzer,insulin,Remote control insulin infusion patch pump blood glucose analyzer (physical object); Remote control insulin infusion patch pump blood glucose analyser,0
C4708587,Bovine isophane insulin-containing product in parenteral dose form,insulin,Product containing bovine isophane insulin in parenteral dose form (medicinal product form),0
C4719131,BD Veo 6mm 0.3cc 31g 1/2 Unit Insulin Syringe,insulin,,0
C4719132,BD Veo 6mm 0.3cc 31g Insulin Syringe,insulin,,0
C4719133,BD Veo 6mm 0.5cc 31g Insulin Syringe,insulin,,0
C4719134,BD Veo 6mm 1cc 31g Insulin Syringe,insulin,,0
C4719136,"Insulin Syringes - 29G, 1/2cc, 1/2""",insulin,,0
C4719137,"Insulin Syringes - 30G, 1/2cc, 5/16""",insulin,,0
C4719138,"Insulin Syringes - 30G, 3/10cc, 5/16""",insulin,,0
C4719139,"Insulin Syringes - 31G, 1/2cc, 5/16""",insulin,,0
C4719140,"Insulin Syringes - 31G, 1cc, 5/16""",insulin,,0
C4719141,"Insulin Syringes - 31G, 3/10cc, 5/16""",insulin,,0
C4719151,"SOMATROPIN 12 [hp_X] in 1 mL / LONG-(ARG3)INSULIN-LIKE GROWTH FACTOR-I 12 [hp_X] in 1 mL / ARSENIC TRIOXIDE 6 [hp_X] in 1 mL / SAW PALMETTO 12 [hp_X] in 1 mL / PLATINUM 30 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / BOS TAURUS ADRENAL CORTEX 12 [hp_X] in 1 mL / BOS TAURUS PITUITARY GLAND, POSTERIOR 12 [hp_X] in 1 mL / THYROID, UNSPECIFIED 12 [hp_X] in 1 mL / BOS TAURUS HYPOTHALAMUS 12 [hp_X] in 1 mL SUBLINGUAL SOLUTION [D-136]",insulin,,0
C4721402,"INS protein, human",insulin,Insulin,0
C4721412,Malignant Pancreatic Insulinoma,insulin,"Pancreatic Insulin Producing Carcinoma; Beta cell tumor, malignant; Insulinoma, malignant; Malignant beta cell tumor; Malignant insulinoma (disorder); Pancreatic Beta Islet Cell Carcinoma; Insulinoma, malignant (morphologic abnormality); Malignant Insulinoma; carcinoma, pancreatic beta islet cell; insulin producing carcinoma; Malignant Pancreatic Insulinoma; insulin secreting carcinoma; pancreatic beta islet cell carcinoma; Beta-cell tumor, malignant; Beta cell tumour, malignant; Malignant beta cell tumour; islet cell, beta, pancreatic carcinoma; Malignant insulinoma; beta islet cell carcinoma, pancreatic",0
C4721874,human insulin,insulin,Human insulin; Insulin Human,0
C4722076,insulin degludec 100 UNT/ML Injectable Solution [Tresiba],insulin,"Tresiba 100 UNT/mL Injectable Solution; Tresiba 100 UNT/ML Injectable Solution; insulin degludec 100 UNT/ML Injectable Solution [Tresiba]; INSULIN DEGLUDEC 100 U in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Tresiba]; Tresiba, 100 units/mL subcutaneous solution",0
C4722704,"Immunoglobulin G1, Anti-(Human Insulin-like Growth Factor I) (Human Monoclonal PS05388 Heavy Chain), Disulfide with Human Monoclonal PS05388 Light Chain, Dimer",insulin,IGF ligand neutralizing antibody BI 836845,0
C4723465,"GLYCERIN 3 [hp_X] in 1 mL / TARAXACUM OFFICINALE 3 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 6 [hp_X] in 1 mL / ARSENIC TRIOXIDE 12 [hp_X] in 1 mL / NITRIC ACID 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / KEROSENE 12 [hp_X] in 1 mL / PHOSPHORIC ACID 12 [hp_X] in 1 mL / PHOSPHORUS 12 [hp_X] in 1 mL / ASPIRIN 12 [hp_X] in 1 mL / NITROGLYCERIN 12 [hp_X] in 1 mL / INSULIN PORK 12 [hp_X] in 1 mL / LITHIUM CARBONATE 12 [hp_X] in 1 mL / SUS SCROFA THYROID 12 [hp_X] in 1 mL / SALICYLIC ACID 12 [hp_X] in 1 mL / CORTICOTROPIN 12 [hp_X] in 1 mL / CORTISONE ACETATE 12 [hp_X] in 1 mL / EUGENOL 12 [hp_X] in 1 mL / STEARYL ALCOHOL 12 [hp_X] in 1 mL / XYLITOL 12 [hp_X] in 1 mL / ESTRONE 12 [hp_X] in 1 mL / BENZOIC ACID 12 [hp_X] in 1 mL / CHLORINE 12 [hp_X] in 1 mL / POTASSIUM SORBATE 12 [hp_X] in 1 mL / SORBITOL 12 [hp_X] in 1 mL / RESORCINOL 12 [hp_X] in 1 mL / BENZYL ALCOHOL 12 [hp_X] in 1 mL / LACTIC ACID, DL- 12 [hp_X] in 1 mL / ISOPROPYL PALMITATE 12 [hp_X] in 1 mL / BORIC ACID 12 [hp_X] in 1 mL / ACETIC ACID 12 [hp_X] in 1 mL / PHENYLBUTAZONE 12 [hp_X] in 1 mL / PETROLATUM 12 [hp_X] in 1 mL / LEAD 12 [hp_X] in 1 mL ORAL LIQUID [Chemstat]",insulin,,0
C4723626,"{90 (Regular Insulin, Human 12 UNT Inhalant Powder) / 90 (Regular Insulin, Human 8 UNT Inhalant Powder) } Pack",insulin,"INSULIN,HUMAN 8 UNIT X 90/12 UNIT X 90 INHL,ORAL,CARTRIDGE,KIT; {90 (insulin, regular, human 12 UNT Inhalation Powder) / 90 (insulin, regular, human 8 UNT Inhalation Powder) } Pack; INSULIN 8 UNIT X 90/12 UNIT X 90 INH KIT; regular insulin, human 180 Inhalation Cartridge Pack - 90 (8 UNT), 90 (12 UNT)",0
C4723720,"{90 (Regular Insulin, Human 12 UNT Inhalant Powder [Afrezza]) / 90 (Regular Insulin, Human 8 UNT Inhalant Powder [Afrezza]) } Pack [Afrezza 180 - 90 (8 UNT), 90 (12 UNT)]",insulin,"{90 (insulin, regular, human 12 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza 180 - 90 (8 UNT), 90 (12 UNT)]; afrezza 180 Inhalation Cartridge Pack - 90 (8 UNT), 90 (12 UNT); Afrezza 8 unit (90)- 12 unit (90), 8 units-12 units inhalation powder; Afrezza KIT; afrezza 180 Cartridge Pack - 90 (8 UNT), 90 (12 UNT)",0
C4724688,Regular use of birth control when got pregnant,regular,Regular use of birth control when got pregnant,0
C4724689,Regular use of birth control when got pregnant:Finding:Point in time:^Patient:Ordinal,regular,Regular use of BC when got preg; Regular use of birth control when got pregnant:Finding:To identify measures at a point in time:^Patient:Ordinal; Regular use of birth control when got pregnant; Regular use of birth control when got pregnant:Find:Pt:^Patient:Ord,0
C4725145,It is Very Important to Me to See My Regular Doctor,regular,,0
C4725609,Received High Quality Care From Regular Doctor,regular,Received High Quality Care From My Regular Doctor,0
C4725611,Regular Doctor was Informed About the Results of Test,regular,My Regular Doctor was Informed About the Results of the Test I Got,0
C4725897,IGF1R Negative,insulin,IGFR Negative; IGF-1R Negative; CD221 Negative; Insulin Like Growth Factor 1 Receptor Negative,0
C4733410,Humulin R Insulin,insulin,,0
C4733411,Regular Novolin R,regular,,0
C4734426,"ASCORBIC ACID 6 [hp_X] in 1 mL / PYRIDOXINE HYDROCHLORIDE 6 [hp_X] in 1 mL / RIBOFLAVIN 6 [hp_X] in 1 mL / LACTIC ACID, L- 6 [hp_X] in 1 mL / THIAMINE HYDROCHLORIDE 6 [hp_X] in 1 mL / PRASTERONE 6 [hp_X] in 1 mL / PHLORIZIN 6 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 8 [hp_X] in 1 mL / THIOCTIC ACID 8 [hp_X] in 1 mL / CITRIC ACID MONOHYDRATE 8 [hp_X] in 1 mL / FUMARIC ACID 8 [hp_X] in 1 mL / GLYOXAL TRIMER DIHYDRATE 8 [hp_X] in 1 mL / NADIDE 8 [hp_X] in 1 mL / PANTOTHENIC ACID 8 [hp_X] in 1 mL / ACETALDEHYDE 8 [hp_X] in 1 mL / INSULIN PORK 8 [hp_X] in 1 mL / PORK LIVER 10 [hp_X] in 1 mL / SUS SCROFA PANCREAS 10 [hp_X] in 1 mL / GLUCAGON 12 [hp_X] in 1 mL / BARIUM OXALATE 6 [hp_C] in 1 mL / ALLOXAN 6 [hp_C] in 1 mL / BERBERIS VULGARIS ROOT BARK 6 [hp_C] in 1 mL / HUMAN BREAST TUMOR CELL 6 [hp_C] in 1 mL / LYCOPODIUM CLAVATUM SPORE 6 [hp_C] in 1 mL / MOMORDICA BALSAMINA IMMATURE FRUIT 6 [hp_C] in 1 mL / PHOSPHORIC ACID 6 [hp_C] in 1 mL / PHOSPHORUS 6 [hp_C] in 1 mL / SYZYGIUM CUMINI SEED 6 [hp_C] in 1 mL / SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS 30 [hp_C] in 1 mL / GYMNEMA SYLVESTRE LEAF 30 [hp_C] in 1 mL / TRIGONELLA FOENUM-GRAECUM WHOLE 30 [hp_C] in 1 mL ORAL LIQUID [Glucoreg]",insulin,,0
C4735084,NovoLIN 70/30 FlexPen,novolin,,0
C4738752,Insulin porcine Ab.IgE/IgE.total,insulin,Insulin porcine Antibody.immunoglobulin E/immunoglobulin E.total; Insulin porcine Ab.IgE/IgE.total,0
C4738913,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel:-:Pt:Nph:-:Probe.amp.tar,NPH,C trach+GC pnl Nph NAA+probe; C. trachomatis and N. gonorrhoeae rRNA panel NAA+probe (Nph); Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Nasopharynx by NAA with probe detection; Chlamydia trachomatis & Neisseria gonorrhoeae ribosomal ribonucleic acid panel:-:To identify measures at a point in time:Naspopharynx:-:Probe.amp.tar,0
C4739210,Bordetella pertussis & Bordetella parapertussis DNA panel:-:Pt:Nph:-,NPH,Bordetella pertussis and Bordetella parapertussis DNA panel - Nasopharynx; B pert+parapert DNA Pnl Nph; B. pertussis and B. parapertussis DNA panel (Nph); Bordetella pertussis & Bordetella parapertussis deoxyribonucleic acid panel:-:To identify measures at a point in time:Naspopharynx:-,0
C4739506,"During the past Mo, how often did you drink regular soda or pop that contains sugar:NRat:1Mo:^Patient:Qn",regular,"During the past month, how often did you drink regular soda or pop that contains sugar; During the past Mo, how often did you drink regular soda or pop that contains sugar:NRat:1Mo:^Patient:Qn; During the past Mo, how often did you drink regular soda or pop that contains sugar:Number=Count/Time:1 month:^Patient:Quantitative",0
C4739507,"During the past month, how often did you drink regular soda or pop that contains sugar",regular,"During the past month, how often did you drink regular soda or pop that contains sugar; During the past Mo, how often did you drink regular soda or pop that contains sugar",0
C4739530,Insulin was taken in last 8H:Find:8H:^Patient:Ord,insulin,Insulin was taken in last 8H:Finding:8 hours:^Patient:Ordinal; Insulin was taken in last 8H 8 hour; Insulin taken in last 8H 8h,0
C4739531,Insulin was taken in last 8H,insulin,Insulin was taken in last 8H,0
C4739927,My child could get up from a regular toilet in past 7D:Find:7D:^Patient:Ord:PROMIS.PARENTPROXY,regular,My child could get up from a regular toilet in past 7 days [PROMIS.PARENTPROXY]; My child could get up from a regular toilet in past 7D:Finding:7 days:^Patient:Ordinal:PROMIS.PARENTPROXY,0
C4739928,My child could get up from a regular toilet in past 7D,regular,My child could get up from a regular toilet in past 7D; My child could get up from a regular toilet in past 7 days,0
C4742657,"IST-1 protein, C elegans",insulin,"insulin receptor substrate homolog protein, C elegans; IST1 protein, C elegans",0
C4742925,"Ide protein, mouse",insulin,"insulin-degrading enzyme, mouse; insulin degrading enzyme, mouse",0
C4745492,insulin degludec Injectable Solution,insulin,,0
C4745493,insulin degludec Injectable Solution [Tresiba],insulin,,0
C4745833,"insulin, regular, human Inhalation Powder",insulin,,0
C4745834,"insulin, regular, human Inhalation Powder [Afrezza]",insulin,,0
C4745848,"insulin human, rDNA origin 1 MG",insulin,,0
C4745849,"insulin human, rDNA origin Inhalation Powder",insulin,,0
C4745850,"insulin human, rDNA origin 1 MG [Exubera]",insulin,,0
C4745851,"insulin human, rDNA origin Inhalation Powder [Exubera]",insulin,,0
C4745852,"insulin human, rDNA origin 3 MG",insulin,,0
C4745853,"insulin human, rDNA origin 3 MG [Exubera]",insulin,,0
C4749449,Insulin infusion patch pump cartridge filling device,insulin,Insulin infusion patch pump cartridge filling device (physical object),0
C4750487,Human insulin zinc suspension crystalline-containing product in parenteral dose form,insulin,Product containing human insulin zinc suspension crystalline in parenteral dose form (medicinal product form),0
C4752180,Bovine insulin protamine zinc only product,insulin,Product containing only bovine insulin protamine zinc (medicinal product),0
C4752181,Bovine regular insulin only product,insulin,Bovine insulin soluble only product; Product containing only bovine regular insulin (medicinal product),0
C4753473,Human regular insulin only product,insulin,Human insulin soluble only product; Product containing only human regular insulin (medicinal product),0
C4753474,Human insulin zinc suspension crystalline only product,insulin,Product containing only human insulin zinc suspension crystalline (medicinal product),0
C4753603,Insulin aspart only product,insulin,Product containing only insulin aspart (medicinal product),0
C4753604,Insulin aspart and insulin degludec only product,insulin,Product containing only insulin aspart and insulin degludec (medicinal product),0
C4753605,Insulin degludec only product,insulin,Product containing only insulin degludec (medicinal product),0
C4753606,Insulin degludec and liraglutide only product,insulin,Product containing only insulin degludec and liraglutide (medicinal product),0
C4753607,Insulin detemir only product,insulin,Product containing only insulin detemir (medicinal product),0
C4753608,Insulin glargine only product,insulin,Product containing only insulin glargine (medicinal product),0
C4753609,Insulin glulisine only product,insulin,Product containing only insulin glulisine (medicinal product),0
C4753610,Insulin lispro protamine only product,insulin,Product containing only insulin lispro protamine (medicinal product),0
C4753680,Isophane insulin only product,insulin,Product containing only isophane insulin (medicinal product),0
C4753814,Insulin lispro only product,insulin,Product containing only insulin lispro (medicinal product),0
C4754518,Porcine regular insulin only product,insulin,Porcine insulin soluble only product; Product containing only porcine regular insulin (medicinal product),0
C4755674,Bovine insulin protamine zinc only product in parenteral dose form,insulin,Product containing only bovine insulin protamine zinc in parenteral dose form (medicinal product form),0
C4755675,Bovine regular insulin only product in parenteral dose form,insulin,Product containing only bovine regular insulin in parenteral dose form (medicinal product form); Bovine insulin soluble only product in parenteral dose form,0
C4756583,Human regular insulin only product in parenteral dose form,insulin,Human insulin soluble only product in parenteral dose form; Product containing only human regular insulin in parenteral dose form (medicinal product form),0
C4756584,Human insulin zinc suspension crystalline only product in parenteral dose form,insulin,Product containing only human insulin zinc suspension crystalline in parenteral dose form (medicinal product form),0
C4756687,Insulin aspart and insulin degludec only product in parenteral dose form,insulin,Product containing only insulin aspart and insulin degludec in parenteral dose form (medicinal product form),0
C4756688,Insulin aspart only product in parenteral dose form,insulin,Product containing only insulin aspart in parenteral dose form (medicinal product form),0
C4756689,Insulin degludec and liraglutide only product in parenteral dose form,insulin,Product containing only insulin degludec and liraglutide in parenteral dose form (medicinal product form),0
C4756690,Insulin degludec only product in parenteral dose form,insulin,Product containing only insulin degludec in parenteral dose form (medicinal product form),0
C4756691,Insulin glargine only product in parenteral dose form,insulin,Product containing only insulin glargine in parenteral dose form (medicinal product form),0
C4756692,Insulin glulisine only product in parenteral dose form,insulin,Product containing only insulin glulisine in parenteral dose form (medicinal product form),0
C4756731,Isophane insulin only product in parenteral dose form,insulin,Product containing only isophane insulin in parenteral dose form (medicinal product form),0
C4756851,Insulin lispro only product in parenteral dose form,insulin,Product containing only insulin lispro in parenteral dose form (medicinal product form),0
C4757373,Porcine regular insulin only product in parenteral dose form,insulin,Porcine insulin soluble only product in parenteral dose form; Product containing only porcine regular insulin in parenteral dose form (medicinal product form),0
C4758349,Insulin aspart 100 unit/mL solution for injection,insulin,Product containing precisely insulin aspart 100 unit/1 milliliter conventional release solution for injection (clinical drug),0
C4758912,Afrezza 8 unit (90)- 12 unit (90),afrezza,,0
C4759832,"Receptor, IGF Type 2",insulin,"Receptors, IGF 2; Receptor, Insulin-Like Growth Factor II; Receptor, Mannose-6-Phosphate; Receptors, Insulin Like Growth Factor II; IGF 2 Receptor; Receptor, IGF-II; Receptor, Insulin Like Growth Factor II; IGF Type 2 Receptor; Mannose-6-Phosphate Receptor; Mannose 6 Phosphate Receptor; Receptor, IGF II; IGF-2 Receptors; Receptor, Insulin-Like-Growth-Factor II; Receptor, Insulin Like Growth Factor Type 2; IGF-2 Receptor; Receptor, IGF Type 2; Receptors, Insulin-Like Growth Factor II; Receptor, Mannose 6 Phosphate; Insulin-Like-Growth-Factor II Receptor; Receptors, IGF-2; Insulin Like Growth Factor II Receptor; IGF-II Receptor; Receptor, IGF-2; IGF II Receptor; Receptor, Insulin-Like Growth Factor Type 2",0
C4763604,Age When Started using Smokeless Tobacco after Regular Use,regular,,0
C4765238,Insulin Lispro KwikPen,insulin,,0
C5056238,Adelges nr. japonicus NPH-2018,NPH,,0
C5142426,Current level of confidence I can maintain a regular exercise program,regular,Current level of confidence I can maintain a regular exercise program,0
C5142645,Insulin resistance score,insulin,Insulin resistance score,0
C5144366,Current level of confidence I can maintain a regular exercise program:Find:Pt:^Patient:Ord:PROMIS,regular,Current level of confidence I can maintain a regular exercise program:Finding:To identify measures at a point in time:^Patient:Ordinal:PROMIS; Current level of confidence I can maintain a regular exercise program [PROMIS],0
C5144730,Insulin resistance score:Score:Pt:Ser:Qn:Calculated.CardioIQ,insulin,Insulin resistance score Calculated.CardioIQ (S) [Score]; Insulin resist score Ser Calc.CardioIQ; Insulin resistance score in Serum by Calculated.CardioIQ; Insulin resistance score:Score:To identify measures at a point in time:Serum:Quantitative:Calculated.CardioIQ,0
C5146042,Corticotropin^1.5H post dose insulin IV,insulin,Corticotropin^1.5H post dose insulin IV,0
C5146046,Corticotropin^105M post dose insulin IV,insulin,Corticotropin^105M post dose insulin IV,0
C5146055,Corticotropin^15M post dose insulin IV,insulin,Corticotropin^15M post dose insulin IV,0
C5146058,Corticotropin^15M pre dose insulin IV,insulin,Corticotropin^15M pre dose insulin IV,0
C5146064,Corticotropin^1H post dose insulin IV,insulin,Corticotropin^1H post dose insulin IV,0
C5146073,Corticotropin^2.5H post dose insulin IV,insulin,Corticotropin^2.5H post dose insulin IV,0
C5146081,Corticotropin^2H post dose insulin IV,insulin,Corticotropin^2H post dose insulin IV,0
C5146091,Corticotropin^30M post dose insulin IV,insulin,Corticotropin^30M post dose insulin IV,0
C5146095,Corticotropin^30M pre dose insulin IV,insulin,Corticotropin^30M pre dose insulin IV,0
C5146099,Corticotropin^3H post dose insulin IV,insulin,Corticotropin^3H post dose insulin IV,0
C5146107,Corticotropin^45M post dose insulin IV,insulin,Corticotropin^45M post dose insulin IV,0
C5146120,Corticotropin^75M post dose insulin IV,insulin,Corticotropin^75M post dose insulin IV,0
C5146147,Corticotropin^pre dose insulin IV,insulin,Corticotropin^pre dose insulin IV,0
C5146166,Cortisol^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst,insulin,Cortisol^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C5146169,Cortisol^1.5H post dose insulin IV,insulin,Cortisol^1.5H post dose insulin IV,0
C5146192,Cortisol^15M post dose insulin IV,insulin,Cortisol^15M post dose insulin IV,0
C5146202,Cortisol^1H post 0.05-0.15 U insulin/kg IV post 12H CFst,insulin,Cortisol^1H post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C5146211,Cortisol^1H post dose insulin IV,insulin,Cortisol^1H post dose insulin IV,0
C5146213,Cortisol^1H post dose U/kg insulin IV,insulin,Cortisol^1H post dose U/kg insulin IV,0
C5146222,Cortisol^20M post dose insulin IV,insulin,Cortisol^20M post dose insulin IV,0
C5146241,Cortisol^2H post dose insulin IV,insulin,Cortisol^2H post dose insulin IV,0
C5146249,Cortisol^30M post 0.05-0.15 U insulin/kg IV post 12H CFst,insulin,Cortisol^30M post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C5146256,Cortisol^30M post dose insulin IV,insulin,Cortisol^30M post dose insulin IV,0
C5146258,Cortisol^30M post dose U/kg insulin IV,insulin,Cortisol^30M post dose U/kg insulin IV,0
C5146261,Cortisol^30M pre dose insulin IV,insulin,Cortisol^30M pre dose insulin IV,0
C5146276,Cortisol^45M post dose insulin IV,insulin,Cortisol^45M post dose insulin IV,0
C5146359,Cortisol^pre dose insulin IV,insulin,Cortisol^pre dose insulin IV,0
C5146918,Glucose^1.3H post dose insulin IV,insulin,Glucose^1.3H post dose insulin IV,0
C5146919,Glucose^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst,insulin,Glucose^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C5146928,Glucose^1.5H post dose insulin IV,insulin,Glucose^1.5H post dose insulin IV,0
C5146971,Glucose^15M post 0.1 U/kg insulin,insulin,Glucose^15M post 0.1 U/kg insulin,0
C5146974,Glucose^15M post dose arginine+insulin,insulin,Glucose^15M post dose arginine+insulin,0
C5146984,Glucose^15M pre dose insulin IV,insulin,Glucose^15M pre dose insulin IV,0
C5146995,Glucose^1H post 0.05-0.15 U insulin/kg IV post 12H CFst,insulin,Glucose^1H post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C5147002,Glucose^1H post dose arginine+insulin,insulin,Glucose^1H post dose arginine+insulin,0
C5147007,Glucose^1H post dose insulin IV,insulin,Glucose^1H post dose insulin IV,0
C5147011,Glucose^1H post dose U/kg insulin IV,insulin,Glucose^1H post dose U/kg insulin IV,0
C5147028,Glucose^2.5H post dose insulin IV,insulin,Glucose^2.5H post dose insulin IV,0
C5147064,Glucose^2H post dose insulin IV,insulin,Glucose^2H post dose insulin IV,0
C5147087,Glucose^30M post 0.05-0.15 U insulin/kg IV post 12H CFst,insulin,Glucose^30M post 0.05-0.15 U insulin/kg IV post 12H CFst,0
C5147088,Glucose^30M post 0.1 U/kg insulin,insulin,Glucose^30M post 0.1 U/kg insulin,0
C5147094,Glucose^30M post dose arginine+insulin,insulin,Glucose^30M post dose arginine+insulin,0
C5147100,Glucose^30M post dose insulin IV,insulin,Glucose^30M post dose insulin IV,0
C5147104,Glucose^30M post dose U/kg insulin IV,insulin,Glucose^30M post dose U/kg insulin IV,0
C5147120,Glucose^3H pre dose insulin IV,insulin,Glucose^3H pre dose insulin IV,0
C5147142,Glucose^45M post dose arginine+insulin,insulin,Glucose^45M post dose arginine+insulin,0
C5147241,Glucose^pre dose insulin IV,insulin,Glucose^pre dose insulin IV,0
C5147248,Glucose^pre or post dose insulin,insulin,Glucose^pre or post dose insulin,0
C5147569,Insulin^1.25H post XXX challenge,insulin,Insulin^1.25H post XXX challenge,0
C5147570,Insulin^1.3H post XXX challenge,insulin,Insulin^1.3H post XXX challenge,0
C5147571,Insulin^1.5H post 75 g glucose PO,insulin,Insulin^1.5H post 75 g glucose PO,0
C5147572,Insulin^1.5H post dose glucagon,insulin,Insulin^1.5H post dose glucagon,0
C5147573,Insulin^1.5H post dose glucose,insulin,Insulin^1.5H post dose glucose,0
C5147574,Insulin^1.5H post dose glucose IV,insulin,Insulin^1.5H post dose glucose IV,0
C5147575,Insulin^1.5H post dose TOLBUTamide IV,insulin,Insulin^1.5H post dose TOLBUTamide IV,0
C5147576,Insulin^1.5H post XXX challenge,insulin,Insulin^1.5H post XXX challenge,0
C5147577,Insulin^1.75H post XXX challenge,insulin,Insulin^1.75H post XXX challenge,0
C5147578,Insulin^10H post XXX challenge,insulin,Insulin^10H post XXX challenge,0
C5147579,Insulin^10M post dose glucagon,insulin,Insulin^10M post dose glucagon,0
C5147580,Insulin^10M post dose glucose,insulin,Insulin^10M post dose glucose,0
C5147581,Insulin^10M post dose glucose IV,insulin,Insulin^10M post dose glucose IV,0
C5147582,Insulin^10M post XXX challenge,insulin,Insulin^10M post XXX challenge,0
C5147583,Insulin^10M pre dose glucose,insulin,Insulin^10M pre dose glucose,0
C5147584,Insulin^10th specimen post XXX challenge,insulin,Insulin^10th specimen post XXX challenge,0
C5147585,Insulin^11H post XXX challenge,insulin,Insulin^11H post XXX challenge,0
C5147586,Insulin^11th specimen post XXX challenge,insulin,Insulin^11th specimen post XXX challenge,0
C5147587,Insulin^12H post XXX challenge,insulin,Insulin^12H post XXX challenge,0
C5147588,Insulin^12M post XXX challenge,insulin,Insulin^12M post XXX challenge,0
C5147589,Insulin^12th specimen post XXX challenge,insulin,Insulin^12th specimen post XXX challenge,0
C5147590,Insulin^13th specimen post XXX challenge,insulin,Insulin^13th specimen post XXX challenge,0
C5147591,Insulin^14th specimen post XXX challenge,insulin,Insulin^14th specimen post XXX challenge,0
C5147592,Insulin^15M post dose glucagon,insulin,Insulin^15M post dose glucagon,0
C5147593,Insulin^15M post dose glucose IV,insulin,Insulin^15M post dose glucose IV,0
C5147594,Insulin^15M post XXX challenge,insulin,Insulin^15M post XXX challenge,0
C5147595,Insulin^15M pre XXX challenge,insulin,Insulin^15M pre XXX challenge,0
C5147596,Insulin^15th specimen post XXX challenge,insulin,Insulin^15th specimen post XXX challenge,0
C5147597,Insulin^16H post XXX challenge,insulin,Insulin^16H post XXX challenge,0
C5147598,Insulin^19M post XXX challenge,insulin,Insulin^19M post XXX challenge,0
C5147599,Insulin^1D post XXX challenge,insulin,Insulin^1D post XXX challenge,0
C5147600,Insulin^1H post 75 g glucose PO,insulin,Insulin^1H post 75 g glucose PO,0
C5147601,Insulin^1H post dose glucagon,insulin,Insulin^1H post dose glucagon,0
C5147602,Insulin^1H post dose glucose,insulin,Insulin^1H post dose glucose,0
C5147603,Insulin^1H post dose glucose IV,insulin,Insulin^1H post dose glucose IV,0
C5147604,Insulin^1H post dose TOLBUTamide IV,insulin,Insulin^1H post dose TOLBUTamide IV,0
C5147605,Insulin^1H post XXX challenge,insulin,Insulin^1H post XXX challenge,0
C5147606,Insulin^1M post dose glucose IV,insulin,Insulin^1M post dose glucose IV,0
C5147607,Insulin^1M post XXX challenge,insulin,Insulin^1M post XXX challenge,0
C5147608,Insulin^1st specimen,insulin,Insulin^1st specimen,0
C5147609,Insulin^1st specimen post XXX challenge,insulin,Insulin^1st specimen post XXX challenge,0
C5147610,Insulin^2.3H post XXX challenge,insulin,Insulin^2.3H post XXX challenge,0
C5147611,Insulin^2.5H post 75 g glucose PO,insulin,Insulin^2.5H post 75 g glucose PO,0
C5147612,Insulin^2.5H post dose glucose,insulin,Insulin^2.5H post dose glucose,0
C5147613,Insulin^2.5H post dose glucose IV,insulin,Insulin^2.5H post dose glucose IV,0
C5147614,Insulin^2.5H post dose TOLBUTamide IV,insulin,Insulin^2.5H post dose TOLBUTamide IV,0
C5147615,Insulin^2.5H post XXX challenge,insulin,Insulin^2.5H post XXX challenge,0
C5147616,Insulin^2.6H post XXX challenge,insulin,Insulin^2.6H post XXX challenge,0
C5147617,Insulin^20H post XXX challenge,insulin,Insulin^20H post XXX challenge,0
C5147618,Insulin^20M post dose glucose,insulin,Insulin^20M post dose glucose,0
C5147619,Insulin^20M post XXX challenge,insulin,Insulin^20M post XXX challenge,0
C5147620,Insulin^22M post XXX challenge,insulin,Insulin^22M post XXX challenge,0
C5147621,Insulin^28H post XXX challenge,insulin,Insulin^28H post XXX challenge,0
C5147622,Insulin^2D post XXX challenge,insulin,Insulin^2D post XXX challenge,0
C5147623,Insulin^2H post 75 g glucose PO,insulin,Insulin^2H post 75 g glucose PO,0
C5147624,Insulin^2H post dose glucose,insulin,Insulin^2H post dose glucose,0
C5147625,Insulin^2H post dose glucose IV,insulin,Insulin^2H post dose glucose IV,0
C5147626,Insulin^2H post dose TOLBUTamide IV,insulin,Insulin^2H post dose TOLBUTamide IV,0
C5147627,Insulin^2H post XXX challenge,insulin,Insulin^2H post XXX challenge,0
C5147628,Insulin^2M post XXX challenge,insulin,Insulin^2M post XXX challenge,0
C5147629,Insulin^2nd specimen,insulin,Insulin^2nd specimen,0
C5147630,Insulin^2nd specimen post XXX challenge,insulin,Insulin^2nd specimen post XXX challenge,0
C5147631,Insulin^3.3H post XXX challenge,insulin,Insulin^3.3H post XXX challenge,0
C5147632,Insulin^3.5H post XXX challenge,insulin,Insulin^3.5H post XXX challenge,0
C5147633,Insulin^3.6H post XXX challenge,insulin,Insulin^3.6H post XXX challenge,0
C5147634,Insulin^30M post 75 g glucose PO,insulin,Insulin^30M post 75 g glucose PO,0
C5147635,Insulin^30M post dose glucagon,insulin,Insulin^30M post dose glucagon,0
C5147636,Insulin^30M post dose glucose,insulin,Insulin^30M post dose glucose,0
C5147637,Insulin^30M post dose glucose IV,insulin,Insulin^30M post dose glucose IV,0
C5147638,Insulin^30M post dose TOLBUTamide IV,insulin,Insulin^30M post dose TOLBUTamide IV,0
C5147639,Insulin^30M post XXX challenge,insulin,Insulin^30M post XXX challenge,0
C5147640,Insulin^30M pre XXX challenge,insulin,Insulin^30M pre XXX challenge,0
C5147641,Insulin^32H post XXX challenge,insulin,Insulin^32H post XXX challenge,0
C5147642,Insulin^36H post XXX challenge,insulin,Insulin^36H post XXX challenge,0
C5147643,Insulin^3D post XXX challenge,insulin,Insulin^3D post XXX challenge,0
C5147644,Insulin^3H post 75 g glucose PO,insulin,Insulin^3H post 75 g glucose PO,0
C5147645,Insulin^3H post dose glucose,insulin,Insulin^3H post dose glucose,0
C5147646,Insulin^3H post dose glucose IV,insulin,Insulin^3H post dose glucose IV,0
C5147647,Insulin^3H post dose TOLBUTamide IV,insulin,Insulin^3H post dose TOLBUTamide IV,0
C5147648,Insulin^3H post XXX challenge,insulin,Insulin^3H post XXX challenge,0
C5147649,Insulin^3M post dose glucose,insulin,Insulin^3M post dose glucose,0
C5147650,Insulin^3M post dose glucose IV,insulin,Insulin^3M post dose glucose IV,0
C5147651,Insulin^3M post XXX challenge,insulin,Insulin^3M post XXX challenge,0
C5147652,Insulin^3rd specimen,insulin,Insulin^3rd specimen,0
C5147653,Insulin^3rd specimen post XXX challenge,insulin,Insulin^3rd specimen post XXX challenge,0
C5147654,Insulin^4.5H post XXX challenge,insulin,Insulin^4.5H post XXX challenge,0
C5147655,Insulin^40H post XXX challenge,insulin,Insulin^40H post XXX challenge,0
C5147656,Insulin^40M post XXX challenge,insulin,Insulin^40M post XXX challenge,0
C5147657,Insulin^44H post XXX challenge,insulin,Insulin^44H post XXX challenge,0
C5147658,Insulin^45M post dose glucagon,insulin,Insulin^45M post dose glucagon,0
C5147659,Insulin^45M post dose glucose IV,insulin,Insulin^45M post dose glucose IV,0
C5147660,Insulin^45M post XXX challenge,insulin,Insulin^45M post XXX challenge,0
C5147661,Insulin^4H post 75 g glucose PO,insulin,Insulin^4H post 75 g glucose PO,0
C5147662,Insulin^4H post dose glucose IV,insulin,Insulin^4H post dose glucose IV,0
C5147663,Insulin^4H post XXX challenge,insulin,Insulin^4H post XXX challenge,0
C5147664,Insulin^4M post XXX challenge,insulin,Insulin^4M post XXX challenge,0
C5147665,Insulin^4th specimen,insulin,Insulin^4th specimen,0
C5147666,Insulin^4th specimen post XXX challenge,insulin,Insulin^4th specimen post XXX challenge,0
C5147667,Insulin^5.5H post XXX challenge,insulin,Insulin^5.5H post XXX challenge,0
C5147668,Insulin^50M post XXX challenge,insulin,Insulin^50M post XXX challenge,0
C5147669,Insulin^52H post XXX challenge,insulin,Insulin^52H post XXX challenge,0
C5147670,Insulin^56H post XXX challenge,insulin,Insulin^56H post XXX challenge,0
C5147671,Insulin^5H post 75 g glucose PO,insulin,Insulin^5H post 75 g glucose PO,0
C5147672,Insulin^5M post dose glucose,insulin,Insulin^5M post dose glucose,0
C5147673,Insulin^5M post dose glucose IV,insulin,Insulin^5M post dose glucose IV,0
C5147674,Insulin^5M post XXX challenge,insulin,Insulin^5M post XXX challenge,0
C5147675,Insulin^5M pre dose glucose,insulin,Insulin^5M pre dose glucose,0
C5147676,Insulin^5th specimen,insulin,Insulin^5th specimen,0
C5147677,Insulin^5th specimen post XXX challenge,insulin,Insulin^5th specimen post XXX challenge,0
C5147678,Insulin^60H post XXX challenge,insulin,Insulin^60H post XXX challenge,0
C5147679,Insulin^64H post XXX challenge,insulin,Insulin^64H post XXX challenge,0
C5147680,Insulin^68H post XXX challenge,insulin,Insulin^68H post XXX challenge,0
C5147681,Insulin^6H post 75 g glucose PO,insulin,Insulin^6H post 75 g glucose PO,0
C5147682,Insulin^6H post XXX challenge,insulin,Insulin^6H post XXX challenge,0
C5147683,Insulin^6M post dose glucagon,insulin,Insulin^6M post dose glucagon,0
C5147684,Insulin^6M post XXX challenge,insulin,Insulin^6M post XXX challenge,0
C5147685,Insulin^6th specimen,insulin,Insulin^6th specimen,0
C5147686,Insulin^6th specimen post XXX challenge,insulin,Insulin^6th specimen post XXX challenge,0
C5147687,Insulin^7.5H post XXX challenge,insulin,Insulin^7.5H post XXX challenge,0
C5147688,Insulin^70M post XXX challenge,insulin,Insulin^70M post XXX challenge,0
C5147689,Insulin^7H post 75 g glucose PO,insulin,Insulin^7H post 75 g glucose PO,0
C5147690,Insulin^7H post XXX challenge,insulin,Insulin^7H post XXX challenge,0
C5147691,Insulin^7M post dose glucose IV,insulin,Insulin^7M post dose glucose IV,0
C5147692,Insulin^7M pre dose glucose,insulin,Insulin^7M pre dose glucose,0
C5147693,Insulin^7th specimen,insulin,Insulin^7th specimen,0
C5147694,Insulin^7th specimen post XXX challenge,insulin,Insulin^7th specimen post XXX challenge,0
C5147695,Insulin^8M post XXX challenge,insulin,Insulin^8M post XXX challenge,0
C5147696,Insulin^8th specimen,insulin,Insulin^8th specimen,0
C5147697,Insulin^8th specimen post XXX challenge,insulin,Insulin^8th specimen post XXX challenge,0
C5147698,Insulin^9H post XXX challenge,insulin,Insulin^9H post XXX challenge,0
C5147699,Insulin^9th specimen post XXX challenge,insulin,Insulin^9th specimen post XXX challenge,0
C5147700,Insulin^baseline,insulin,Insulin^baseline,0
C5147701,Insulin^post 12H CFst,insulin,Insulin^post 12H CFst,0
C5147702,Insulin^post CFst,insulin,Insulin^post CFst,0
C5147703,Insulin^post meal,insulin,Insulin^post meal,0
C5147704,Insulin^pre 100 g glucose PO,insulin,Insulin^pre 100 g glucose PO,0
C5147705,Insulin^pre 75 g glucose PO,insulin,Insulin^pre 75 g glucose PO,0
C5147706,Insulin^pre dose glucagon,insulin,Insulin^pre dose glucagon,0
C5147707,Insulin^pre dose glucose,insulin,Insulin^pre dose glucose,0
C5147708,Insulin^pre dose TOLBUTamide IV,insulin,Insulin^pre dose TOLBUTamide IV,0
C5147709,Insulin^pre or post dose glucose,insulin,Insulin^pre or post dose glucose,0
C5147710,Insulin^pre or post XXX challenge,insulin,Insulin^pre or post XXX challenge,0
C5147711,Insulin^pre XXX challenge,insulin,Insulin^pre XXX challenge,0
C5147712,Insulin^pre-meal,insulin,Insulin^pre-meal,0
C5147713,Insulin-like growth factor binding protein 3^10M post XXX challenge,insulin,Insulin-like growth factor binding protein 3^10M post XXX challenge,0
C5147714,Insulin-like growth factor binding protein 3^15M post XXX challenge,insulin,Insulin-like growth factor binding protein 3^15M post XXX challenge,0
C5147715,Insulin-like growth factor binding protein 3^1H post XXX challenge,insulin,Insulin-like growth factor binding protein 3^1H post XXX challenge,0
C5147716,Insulin-like growth factor binding protein 3^1st specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^1st specimen post XXX challenge,0
C5147717,Insulin-like growth factor binding protein 3^20M post XXX challenge,insulin,Insulin-like growth factor binding protein 3^20M post XXX challenge,0
C5147718,Insulin-like growth factor binding protein 3^2H post XXX challenge,insulin,Insulin-like growth factor binding protein 3^2H post XXX challenge,0
C5147719,Insulin-like growth factor binding protein 3^2nd specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^2nd specimen post XXX challenge,0
C5147720,Insulin-like growth factor binding protein 3^3rd specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^3rd specimen post XXX challenge,0
C5147721,Insulin-like growth factor binding protein 3^45M post XXX challenge,insulin,Insulin-like growth factor binding protein 3^45M post XXX challenge,0
C5147722,Insulin-like growth factor binding protein 3^4th specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^4th specimen post XXX challenge,0
C5147723,Insulin-like growth factor binding protein 3^5th specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^5th specimen post XXX challenge,0
C5147724,Insulin-like growth factor binding protein 3^6th specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^6th specimen post XXX challenge,0
C5147725,Insulin-like growth factor binding protein 3^7th specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^7th specimen post XXX challenge,0
C5147726,Insulin-like growth factor binding protein 3^8th specimen post XXX challenge,insulin,Insulin-like growth factor binding protein 3^8th specimen post XXX challenge,0
C5147727,Insulin-like growth factor binding protein 3^baseline,insulin,Insulin-like growth factor binding protein 3^baseline,0
C5147728,Insulin-like growth factor^10th specimen post XXX challenge,insulin,Insulin-like growth factor^10th specimen post XXX challenge,0
C5147729,Insulin-like growth factor^11th specimen post XXX challenge,insulin,Insulin-like growth factor^11th specimen post XXX challenge,0
C5147730,Insulin-like growth factor^12th specimen post XXX challenge,insulin,Insulin-like growth factor^12th specimen post XXX challenge,0
C5147731,Insulin-like growth factor^13th specimen post XXX challenge,insulin,Insulin-like growth factor^13th specimen post XXX challenge,0
C5147732,Insulin-like growth factor^14th specimen post XXX challenge,insulin,Insulin-like growth factor^14th specimen post XXX challenge,0
C5147733,Insulin-like growth factor^1st specimen post XXX challenge,insulin,Insulin-like growth factor^1st specimen post XXX challenge,0
C5147734,Insulin-like growth factor^2nd specimen post XXX challenge,insulin,Insulin-like growth factor^2nd specimen post XXX challenge,0
C5147735,Insulin-like growth factor^3rd specimen post XXX challenge,insulin,Insulin-like growth factor^3rd specimen post XXX challenge,0
C5147736,Insulin-like growth factor^4th specimen post XXX challenge,insulin,Insulin-like growth factor^4th specimen post XXX challenge,0
C5147737,Insulin-like growth factor^5th specimen post XXX challenge,insulin,Insulin-like growth factor^5th specimen post XXX challenge,0
C5147738,Insulin-like growth factor^6th specimen post XXX challenge,insulin,Insulin-like growth factor^6th specimen post XXX challenge,0
C5147739,Insulin-like growth factor^7th specimen post XXX challenge,insulin,Insulin-like growth factor^7th specimen post XXX challenge,0
C5147740,Insulin-like growth factor^8th specimen post XXX challenge,insulin,Insulin-like growth factor^8th specimen post XXX challenge,0
C5147741,Insulin-like growth factor^9th specimen post XXX challenge,insulin,Insulin-like growth factor^9th specimen post XXX challenge,0
C5147742,Insulin-like growth factor-I^1.5H post XXX challenge,insulin,Insulin-like growth factor-I^1.5H post XXX challenge,0
C5147743,Insulin-like growth factor-I^10M post XXX challenge,insulin,Insulin-like growth factor-I^10M post XXX challenge,0
C5147744,Insulin-like growth factor-I^15M post XXX challenge,insulin,Insulin-like growth factor-I^15M post XXX challenge,0
C5147745,Insulin-like growth factor-I^1H post XXX challenge,insulin,Insulin-like growth factor-I^1H post XXX challenge,0
C5147746,Insulin-like growth factor-I^1st specimen post XXX challenge,insulin,Insulin-like growth factor-I^1st specimen post XXX challenge,0
C5147747,Insulin-like growth factor-I^2.5H post XXX challenge,insulin,Insulin-like growth factor-I^2.5H post XXX challenge,0
C5147748,Insulin-like growth factor-I^20M post XXX challenge,insulin,Insulin-like growth factor-I^20M post XXX challenge,0
C5147749,Insulin-like growth factor-I^2H post XXX challenge,insulin,Insulin-like growth factor-I^2H post XXX challenge,0
C5147750,Insulin-like growth factor-I^2nd specimen post XXX challenge,insulin,Insulin-like growth factor-I^2nd specimen post XXX challenge,0
C5147751,Insulin-like growth factor-I^30M post XXX challenge,insulin,Insulin-like growth factor-I^30M post XXX challenge,0
C5147752,Insulin-like growth factor-I^3H post XXX challenge,insulin,Insulin-like growth factor-I^3H post XXX challenge,0
C5147753,Insulin-like growth factor-I^3rd specimen post XXX challenge,insulin,Insulin-like growth factor-I^3rd specimen post XXX challenge,0
C5147754,Insulin-like growth factor-I^45M post XXX challenge,insulin,Insulin-like growth factor-I^45M post XXX challenge,0
C5147755,Insulin-like growth factor-I^4th specimen post XXX challenge,insulin,Insulin-like growth factor-I^4th specimen post XXX challenge,0
C5147756,Insulin-like growth factor-I^5th specimen post XXX challenge,insulin,Insulin-like growth factor-I^5th specimen post XXX challenge,0
C5147757,Insulin-like growth factor-I^6th specimen post XXX challenge,insulin,Insulin-like growth factor-I^6th specimen post XXX challenge,0
C5147758,Insulin-like growth factor-I^7th specimen post XXX challenge,insulin,Insulin-like growth factor-I^7th specimen post XXX challenge,0
C5147759,Insulin-like growth factor-I^8th specimen post XXX challenge,insulin,Insulin-like growth factor-I^8th specimen post XXX challenge,0
C5148659,Prolactin^1.5H post dose insulin IV,insulin,Prolactin^1.5H post dose insulin IV,0
C5148670,Prolactin^1H post dose insulin IV,insulin,Prolactin^1H post dose insulin IV,0
C5148689,Prolactin^30M post dose insulin IV,insulin,Prolactin^30M post dose insulin IV,0
C5148693,Prolactin^30M post dose U/kg insulin IV,insulin,Prolactin^30M post dose U/kg insulin IV,0
C5148702,Prolactin^45M post dose insulin IV,insulin,Prolactin^45M post dose insulin IV,0
C5148718,Prolactin^pre dose insulin IV,insulin,Prolactin^pre dose insulin IV,0
C5148884,Somatotropin^1.25H post dose arginine+insulin,insulin,Somatotropin^1.25H post dose arginine+insulin,0
C5148888,Somatotropin^1.5H post dose arginine+insulin,insulin,Somatotropin^1.5H post dose arginine+insulin,0
C5148893,Somatotropin^1.5H post dose insulin IV,insulin,Somatotropin^1.5H post dose insulin IV,0
C5148897,Somatotropin^1.75H post dose arginine+insulin,insulin,Somatotropin^1.75H post dose arginine+insulin,0
C5148926,Somatotropin^15M post dose arginine+insulin,insulin,Somatotropin^15M post dose arginine+insulin,0
C5148929,Somatotropin^15M post dose insulin IV,insulin,Somatotropin^15M post dose insulin IV,0
C5148936,Somatotropin^15M pre dose arginine+insulin,insulin,Somatotropin^15M pre dose arginine+insulin,0
C5148938,Somatotropin^15M pre dose insulin IV,insulin,Somatotropin^15M pre dose insulin IV,0
C5148954,Somatotropin^1H post dose arginine+insulin,insulin,Somatotropin^1H post dose arginine+insulin,0
C5148961,Somatotropin^1H post dose insulin IV,insulin,Somatotropin^1H post dose insulin IV,0
C5148971,Somatotropin^2.25H post dose arginine+insulin,insulin,Somatotropin^2.25H post dose arginine+insulin,0
C5148973,Somatotropin^2.5H post dose arginine+insulin,insulin,Somatotropin^2.5H post dose arginine+insulin,0
C5149000,Somatotropin^2H post dose arginine+insulin,insulin,Somatotropin^2H post dose arginine+insulin,0
C5149007,Somatotropin^2H post dose insulin IV,insulin,Somatotropin^2H post dose insulin IV,0
C5149021,Somatotropin^30M post dose arginine+insulin,insulin,Somatotropin^30M post dose arginine+insulin,0
C5149028,Somatotropin^30M post dose insulin IV,insulin,Somatotropin^30M post dose insulin IV,0
C5149070,Somatotropin^45M post dose arginine+insulin,insulin,Somatotropin^45M post dose arginine+insulin,0
C5149074,Somatotropin^45M post dose insulin IV,insulin,Somatotropin^45M post dose insulin IV,0
C5149093,Somatotropin^5M post dose arginine+insulin,insulin,Somatotropin^5M post dose arginine+insulin,0
C5149121,Somatotropin^pre dose arginine+insulin,insulin,Somatotropin^pre dose arginine+insulin,0
C5149127,Somatotropin^pre dose insulin IV,insulin,Somatotropin^pre dose insulin IV,0
C5149136,Somatotropin^pre or post dose insulin,insulin,Somatotropin^pre or post dose insulin,0
C5165783,Glucose/Insulin &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169374,Insulin &#x7C; Body fluid &#x7C; Chemistry - non-challenge,insulin,,0
C5169375,Insulin &#x7C; Serum or Plasma &#x7C; Chemistry - challenge,insulin,,0
C5169376,Insulin &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169377,Insulin &#x7C; Unknown substance &#x7C; Chemistry - non-challenge,insulin,,0
C5169378,Insulin Ab &#x7C; Serum &#x7C; Serology - non-micro,insulin,,0
C5169379,Insulin Ag &#x7C; Tissue and Smears &#x7C; Pathology,insulin,,0
C5169380,Insulin bovine Ab &#x7C; Serum &#x7C; Serology - non-micro,insulin,,0
C5169381,Insulin bovine Ab.IgE.RAST class &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169382,Insulin bovine IgE &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169383,Insulin bovine IgG4 &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169384,Insulin Free &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169385,Insulin Free+Bound &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169386,Insulin human Ab &#x7C; Serum &#x7C; Serology - non-micro,insulin,,0
C5169387,Insulin human Ab.IgE.RAST class &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169388,Insulin human IgE &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169389,Insulin human IgG4 &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169390,Insulin IgG &#x7C; Serum &#x7C; Serology - non-micro,insulin,,0
C5169391,Insulin intact &#x7C; Serum &#x7C; Chemistry - non-challenge,insulin,,0
C5169392,Insulin porcine Ab &#x7C; Serum &#x7C; Serology - non-micro,insulin,,0
C5169393,Insulin porcine Ab.IgE.RAST class &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169394,Insulin porcine Ab.IgE/IgE.total &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169395,Insulin porcine IgE &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169396,Insulin porcine IgG4 &#x7C; Serum &#x7C; Allergy,insulin,,0
C5169397,Insulin receptor Ab &#x7C; Serum &#x7C; Serology - non-micro,insulin,,0
C5169398,Insulin regular &#x7C; Dose &#x7C; Drug doses,insulin,,0
C5169399,Insulin renal clearance &#x7C; Urine &#x7C; Chemistry - non-challenge,insulin,,0
C5169400,Insulin XXX challenge panel &#x7C; Serum &#x7C; Challenge Bank Panels,insulin,,0
C5169401,Insulin.bound &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169402,Insulin.free and Insulin.total panel &#x7C; Serum or Plasma &#x7C; Chemistry Panels,insulin,,0
C5169403,Insulin-like growth factor &#x7C; Serum or Plasma &#x7C; Chemistry - challenge,insulin,,0
C5169404,Insulin-like growth factor &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169405,Insulin-like growth factor binding protein 1 &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169406,Insulin-like growth factor binding protein 1 &#x7C; Vaginal &#x7C; Chemistry - non-challenge,insulin,,0
C5169407,Insulin-like growth factor binding protein 2 &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169408,Insulin-like growth factor binding protein 3 &#x7C; Serum or Plasma &#x7C; Chemistry - challenge,insulin,,0
C5169409,Insulin-like growth factor binding protein 3 &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169410,Insulin-like growth factor binding protein 3 &#x7C; Urine &#x7C; Chemistry - non-challenge,insulin,,0
C5169411,Insulin-like growth factor binding protein 3.acid labile &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169412,Insulin-like growth factor-I &#x7C; Blood &#x7C; Chemistry - non-challenge,insulin,,0
C5169413,Insulin-like growth factor-I &#x7C; Serum or Plasma &#x7C; Chemistry - challenge,insulin,,0
C5169414,Insulin-like growth factor-I &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169415,Insulin-like growth factor-I receptor Ag &#x7C; Tissue and Smears &#x7C; Pathology,insulin,,0
C5169416,Insulin-like growth factor-II &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5169417,Insulin-like growth factor-II.high molecular weight &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5171105,Lipoprotein insulin resistance score &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5178249,Proinsulin/Insulin &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5184948,Vendor device model code &#x7C; Insulin delivery device &#x7C; Devices,insulin,,0
C5184962,Vendor device name &#x7C; Insulin delivery device &#x7C; Devices,insulin,,0
C5184993,Vendor serial number &#x7C; Insulin delivery device &#x7C; Devices,insulin,,0
C5185007,Vendor software version &#x7C; Insulin delivery device &#x7C; Devices,insulin,,0
C5186665,Insulin delivery device panel &#x7C; Patient &#x7C; Panel.devices,insulin,,0
C5187395,Glucose^15M post dose insulin IV,insulin,Glucose^15M post dose insulin IV,0
C5187401,Glucose^45M post dose insulin IV,insulin,Glucose^45M post dose insulin IV,0
C5187411,Insulin^1.6H post XXX challenge,insulin,Insulin^1.6H post XXX challenge,0
C5187415,Insulin^1M post dose glucose,insulin,Insulin^1M post dose glucose,0
C5187416,Insulin^2H post dose glucagon,insulin,Insulin^2H post dose glucagon,0
C5187417,Insulin^4.5H post 75 g glucose PO,insulin,Insulin^4.5H post 75 g glucose PO,0
C5187418,Insulin^5H post XXX challenge,insulin,Insulin^5H post XXX challenge,0
C5187419,Insulin^8H post XXX challenge,insulin,Insulin^8H post XXX challenge,0
C5187420,Insulin-like growth factor binding protein 1^pre or post XXX challenge,insulin,Insulin-like growth factor binding protein 1^pre or post XXX challenge,0
C5187426,Insulin-like growth factor-I^baseline,insulin,Insulin-like growth factor-I^baseline,0
C5188228,"insulin, regular, human 1 UNT/ML",insulin,,0
C5188229,"insulin, regular, human Injection",insulin,,0
C5188230,"100 ML insulin, regular, human 1 UNT/ML Injection",insulin,"regular insulin, human 100 UNT per 100 ML Injection; INSULIN REG HUMAN 1 UNIT/ML/SODIUM CHLORIDE 0.9% INJ,BAG,100ML; INSULIN REG HUMAN 1 UNT/ML/NS INJ 100ML; insulin regular human recombinant 1 unit/mL-NaCl 0.9% intravenous solution; regular insulin, human 100 UNT in 100 ML Injection",0
C5188232,"insulin, regular, human 1 UNT/ML [Myxredlin]",insulin,,0
C5188233,"insulin, regular, human Injection [Myxredlin]",insulin,,0
C5188235,"100 ML insulin, regular, human 1 UNT/ML Injection [Myxredlin]",insulin,"MYXREDLIN 100 UNT in 100 ML Injection; Myxredlin 100 UNT per 100 ML Injection; Myxredlin, human recombinant 1 unit/mL-NaCl 0.9% intravenous solution; 100 ML Myxredlin 1 UNT/ML Injection; INSULIN HUMAN 1.00 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [MYXREDLIN]",0
C5190989,Severe early-onset obesity insulin resistance syndrome due to SH2B1 deficiency,insulin,Severe early-onset obesity insulin resistance syndrome due to SH2B adaptor protein 1 deficiency; Severe early-onset obesity insulin resistance syndrome due to SH2B adaptor protein 1 deficiency (disorder); Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency,0
C5191345,Bovine isophane insulin 100 unit/mL suspension for injection,insulin,Product containing precisely bovine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug),0
C5191534,Isophane insulin- and recombinant human regular insulin-containing product in parenteral dose form,insulin,Product containing isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form); Isophane insulin- and recombinant human soluble insulin-containing product in parenteral dose form,0
C5192011,Isophane insulin- and recombinant human regular insulin-containing product,insulin,Isophane insulin- and recombinant human soluble insulin-containing product; Product containing isophane insulin and recombinant human regular insulin (medicinal product),0
C5192163,Isophane insulin and porcine regular insulin only product,insulin,Isophane insulin and porcine insulin soluble only product; Product containing only isophane insulin and porcine regular insulin (medicinal product),0
C5192164,Isophane insulin and porcine regular insulin only product in parenteral dose form,insulin,Isophane insulin and porcine insulin soluble only product in parenteral dose form; Product containing only isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form),0
C5192165,Isophane insulin and recombinant human regular insulin only product,insulin,Isophane insulin and recombinant human soluble insulin only product; Product containing only isophane insulin and recombinant human regular insulin (medicinal product),0
C5192166,Isophane insulin and recombinant human regular insulin only product in parenteral dose form,insulin,Isophane insulin and recombinant human soluble insulin only product in parenteral dose form; Product containing only isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form),0
C5194339,Late predisposition to type 2 (insulin resistant) diabetes,insulin,,0
C5194514,Low insulin-like growth factor 1 (in adults),insulin,,0
C5195879,"VINCETOXICUM HIRUNDINARIA ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / GAMBOGE 14 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Metabolism Manager]",insulin,,0
C5195881,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / GAMBOGE 14 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [HA2CG Evolution]",insulin,,0
C5196608,"Insra protein, zebrafish",insulin,"insulin receptor a protein, zebrafish",0
C5196609,"Insrb protein, zebrafish",insulin,"insulin receptor b protein, zebrafish",0
C5197539,"Igf1r protein, mouse",insulin,"insulin-like growth factor I receptor protein, mouse; IGF-1 receptor, mouse",0
C5197586,"Insr protein, rat",insulin,"insulin receptor protein, rat",0
C5201082,insulin aspart protamine / insulin aspart 70/30 includes Injectable Suspension & Pen Injector,insulin,,0
C5201196,"Immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human monoclonal heavy chain), disulfide with human monoclonal light chain, dimer",insulin,"immunoglobulin G1, anti-(human insulin-like growth factor I receptor)(human monoclonal heavy chain), disulfide with human monoclonal light chain, dimer; Immunoglobulin G1, Anti-(Human Insulin-like Growth Factor I Receptor)(Human Monoclonal Heavy Chain), Disulfide with Human Monoclonal Light Chain, Dimer; Immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human monoclonal heavy chain), disulfide with human monoclonal light chain, dimer",0
C5201262,"3 ML insulin aspart, human 100 UNT/ML Cartridge [Fiasp]",insulin,"INSULIN ASPART 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Fiasp]; Fiasp PenFill, 100 units/mL injectable solution; INSULIN,ASPART 100UN/ML FIASP PENFIL CTG; Fiasp 100 UNT/mL in 3 mL Cartridge; 3 ML insulin aspart, human 100 UNT/ML Cartridge [Fiasp]; Fiasp 100 UNT/ML per 3 ML Cartridge; 3 ML Fiasp 100 UNT/ML Cartridge; INSULIN,ASPART,HUMAN 100U/ML,FIASP,PENFILL CARTRIDGE,3ML",0
C5203219,"3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N]",insulin,"NovoLIN N 100 UNT/ML per 3 ML Pen Injector; NovoLIN N 100 UNT/mL in 3 mL Pen Injector; 3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N]; 3 ML Novolin N 100 UNT/ML Pen Injector; NovoLIN N FlexPen, human recombinant 100 units/mL subcutaneous suspension; 3 ML insulin isophane, human 100 UNT/ML Pen Injector [NovoLIN N]; Relion NovoLIN N 100 UNT/ML per 3 ML Pen Injector; Novolin N 100 UNT/ML per 3 ML Pen Injector; INSULIN HUMAN 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SUSPENSION [Novolin N]; ReliOn/NovoLIN N FlexPen, human recombinant 100 units/mL subcutaneous suspension; Relion Novolin N 100 UNT/ML per 3 ML Pen Injector; 3 ML NovoLIN N 100 UNT/ML Pen Injector",0
C5203973,Regular Smokeless Tobacco Use for Six Weeks or More,regular,,0
C5203976,Age When Quit using Smokeless Tobacco after Regular Use,regular,,0
C5204324,Was Insulin Administered During Surgery,insulin,,0
C5204728,Have a Regular Morning Routine in Our Home,regular,,0
C5205281,Regular Smokeless Tobacco Use for Six Weeks or More Positive,regular,,0
C5205282,Regular Smokeless Tobacco Use for Six Weeks or More Negative,regular,,0
C5205283,Regular Smokeless Tobacco Use for Six Weeks or More Unknown,regular,,0
C5205285,Never Quit using Smokeless Tobacco after Regular Use,regular,,0
C5205388,Unknown Age When Started using Smokeless Tobacco after Regular Use,regular,,0
C5206032,T1-DDS - Not Taking Insulin as I Should,insulin,,0
C5207295,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / GAMBOGE 14 [hp_X] in 1 mL / 7-KETO-DEHYDROEPIANDROSTERONE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Weight Management]",insulin,,0
C5207303,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / SUS SCROFA PANCREAS 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Professional Weight Support]",insulin,,0
C5207398,"EPINEPHRINE 30 [hp_C] in 1 mL / GLUTAMIC ACID 30 [hp_C] in 1 mL / MUCUNA PRURIENS SEED 30 [hp_C] in 1 mL / NIACINAMIDE 9 [hp_X] in 1 mL / SEROTONIN 30 [hp_C] in 1 mL / UBIDECARENONE 9 [hp_X] in 1 mL / CORTICOTROPIN 30 [hp_C] in 1 mL / ADENOSINE TRIPHOSPHATE 6 [hp_C] in 1 mL / INSULIN PORK 6 [hp_C] in 1 mL / SUS SCROFA PARATHYROID GLAND 6 [hp_C] in 1 mL / SUS SCROFA PITUITARY GLAND 6 [hp_C] in 1 mL / THIAMINE HYDROCHLORIDE 6 [hp_C] in 1 mL / THYROID, UNSPECIFIED 6 [hp_C] in 1 mL / ANHYDROUS CITRIC ACID 12 [hp_C] in 1 mL / HERRING SPERM DNA 12 [hp_C] in 1 mL / SACCHAROMYCES CEREVISIAE RNA 12 [hp_C] in 1 mL / ANACARDIUM OCCIDENTALE FRUIT 30 [hp_C] in 1 mL / ARSENIC TRIOXIDE 30 [hp_C] in 1 mL / ASPARTIC ACID 30 [hp_C] in 1 mL / BARIUM CARBONATE 30 [hp_C] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 30 [hp_C] in 1 mL / CLEMATIS RECTA FLOWERING TOP 30 [hp_C] in 1 mL / LYCOPODIUM CLAVATUM SPORE 30 [hp_C] in 1 mL / ANEMONE PULSATILLA 30 [hp_C] in 1 mL / DATURA STRAMONIUM 30 [hp_C] in 1 mL / SULFUR 30 [hp_C] in 1 mL ORAL LIQUID [FCS HP]",insulin,,0
C5207917,INSULIN SYRINGE 0.5ML 27G 0.5IN,insulin,INSULIN SYRINGE 0.5ML LOW DOSE 27G 0.5IN,0
C5209763,"ASCORBIC ACID 6 [hp_X] in 1 mL / PYRIDOXINE HYDROCHLORIDE 6 [hp_X] in 1 mL / RIBOFLAVIN 6 [hp_X] in 1 mL / LACTIC ACID, L- 6 [hp_X] in 1 mL / THIAMINE HYDROCHLORIDE 6 [hp_X] in 1 mL / PRASTERONE 6 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 8 [hp_X] in 1 mL / THIOCTIC ACID 8 [hp_X] in 1 mL / ANHYDROUS CITRIC ACID 8 [hp_X] in 1 mL / FUMARIC ACID 8 [hp_X] in 1 mL / NADIDE 8 [hp_X] in 1 mL / PANTOTHENIC ACID 8 [hp_X] in 1 mL / ACETALDEHYDE 8 [hp_X] in 1 mL / INSULIN PORK 8 [hp_X] in 1 mL / PORK LIVER 10 [hp_X] in 1 mL / SUS SCROFA PANCREAS 10 [hp_X] in 1 mL / PHLORIZIN 16 [hp_X] in 1 mL / BARIUM OXALATE 6 [hp_C] in 1 mL / ALLOXAN 6 [hp_C] in 1 mL / BERBERIS VULGARIS ROOT BARK 6 [hp_C] in 1 mL / HUMAN BREAST TUMOR CELL 6 [hp_C] in 1 mL / LYCOPODIUM CLAVATUM SPORE 6 [hp_C] in 1 mL / MOMORDICA BALSAMINA IMMATURE FRUIT 6 [hp_C] in 1 mL / PHOSPHORIC ACID 6 [hp_C] in 1 mL / PHOSPHORUS 6 [hp_C] in 1 mL / SYZYGIUM CUMINI SEED 6 [hp_C] in 1 mL / INSULIN HUMAN 12 [hp_C] in 1 mL / SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS 30 [hp_C] in 1 mL / GYMNEMA SYLVESTRE LEAF 30 [hp_C] in 1 mL / TRIGONELLA FOENUM-GRAECUM WHOLE 30 [hp_C] in 1 mL ORAL LIQUID [Glucoreg]",insulin,,0
C5209818,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / GAMBOGE 14 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [MFL 20/40]",insulin,,0
C5210009,"3 ML insulin, regular, human 100 UNT/ML Pen Injector",insulin,"insulin regular, human 100 UNT/1 mL in 3 mL Pen Injector; insulin regular, human 100 UNT/1 ML per 3 ML Pen Injector",0
C5210119,"insulin aspart, human Cartridge [Fiasp]",insulin,,0
C5210124,"insulin, regular, human Pen Injector [Novolin R]",insulin,"insulin, regular, human Pen Injector [NovoLIN R]",0
C5210125,insulin isophane Pen Injector [Novolin N],insulin,insulin isophane Pen Injector [NovoLIN N],0
C5210392,"INSULIN,REGULAR,HUMAN/SODIUM CHLORIDE",insulin,,0
C5210532,Fiasp PenFill,fiasp,,0
C5212149,Are you unemployed or without regular income:Find:Pt:^Patient:Ord:WellRx,regular,Are you unemployed or without regular income:Finding:To identify measures at a point in time:^Patient:Ordinal:WellRx; Are you unemployed or without regular income [WellRx],0
C5212150,Are you unemployed or without regular income,regular,Are you unemployed or without regular income,0
C5212234,Insulin^post meal:SCnc:Pt:Ser/Plas:Qn,insulin,Insulin^post meal:Substance Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Moles/volume] in Serum or Plasma --post meal; Insulin post meal [Moles/Vol]; Insulin p meal SerPl-sCnc,0
C5212331,Insulin sensitivity index:Ratio:Pt:Ser/Plas:Qn:Calculated,insulin,Ins Sens Index SerPl Calc-Rto; Insulin sensitivity index in Serum or Plasma by calculation; Insulin sensitivity index:Ratio:To identify measures at a point in time:Serum/Plasma:Quantitative:Calculated; Insulin sensitivity index Calc [Ratio],0
C5212332,Insulin sensitivity index,insulin,Insulin sensitivity index,0
C5212333,Insulin:ACnc:Stdy^mean:Ser/Plas:Qn,insulin,Insulin Qn (Stdy mean); Insulin [Units/volume] mean in Serum or Plasma; Insulin:Arbitrary concentration:Duration of the study^Mean of all of the values observed on the interval:Serum/Plasma:Quantitative; Insulin Mean SerPl-aCnc,0
C5212334,Glucose tolerance & insulin sensitivity 2H panel:-:-:Ser/Plas:-,insulin,Glucose tolerance and insulin sensitivity 2 hour panel; Glucose tolerance & insulin sensitivity 2H panel:-:-:Ser/Plas:-; Glucose tolerance & insulin sensitivity 2H panel:-:-:Serum/Plasma:-; GTT ISI 2h Pnl SerPl; Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma,0
C5212335,Glucose tolerance & insulin sensitivity 2H panel,insulin,Glucose tolerance and insulin sensitivity 2 hour panel; Glucose tolerance & insulin sensitivity 2H panel,0
C5213445,Glucose tolerance and insulin sensitivity 2 hour panel &#x7C; Serum or Plasma &#x7C; Challenge Bank Panels,insulin,,0
C5213549,Insulin sensitivity index &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5214488,Hypoglycemic (including insulin),insulin,,0
C5215445,Insulin Ab&#x7C;ACnc&#x7C;Pt&#x7C;ANYBldSerPl,insulin,,0
C5215446,Insulin^1.5H post 75 g glucose PO&#x7C;ACnc&#x7C;Pt&#x7C;ANYBldSerPl,insulin,,0
C5215447,Insulin-like growth factor-I&#x7C;ACnc&#x7C;Pt&#x7C;ANYBldSerPl,insulin,,0
C5215448,Insulin-like growth factor-I&#x7C;MCnc&#x7C;Pt&#x7C;ANYBldSerPl,insulin,,0
C5217003,Corticotropin^1.5H post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217007,Corticotropin^105M post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217014,Corticotropin^15M post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217017,Corticotropin^15M pre dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217022,Corticotropin^1H post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217028,Corticotropin^2.5H post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217031,Corticotropin^2H post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217037,Corticotropin^30M post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217044,Corticotropin^3H post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217050,Corticotropin^45M post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217056,Corticotropin^75M post dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217067,Corticotropin^pre dose insulin IV&#x7C;Pt&#x7C;Plas,insulin,,0
C5217437,Glucose^1.5H post dose insulin IV&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217480,Glucose^1H post dose insulin IV&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217525,Glucose^30M post dose insulin IV&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217544,Glucose^45M post dose insulin IV&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217589,Glucose^pre dose insulin IV&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217714,Insulin Ab&#x7C;Pt&#x7C;Ser,insulin,,0
C5217715,Insulin^10M post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217716,Insulin^15M post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217717,Insulin^1H post 75 g glucose PO&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217718,Insulin^20M post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217719,Insulin^2H post 75 g glucose PO&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217720,Insulin^2M post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217721,Insulin^2nd specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217722,Insulin^3H post 75 g glucose PO&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217723,Insulin^3rd specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217724,Insulin^45M post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217725,Insulin^4M post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217726,Insulin^4th specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217727,Insulin^5th specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217728,Insulin^7.5H post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217729,Insulin^7th specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217730,Insulin^8th specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217731,Insulin^9th specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217732,Insulin^baseline&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217733,Insulin&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217734,Insulin-like growth factor binding protein 3&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217735,Insulin-like growth factor^1st specimen post XXX challenge&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5217736,Insulin-like growth factor-I&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5221085,Insulin.free&#x7C;Pt&#x7C;Ser/Plas,insulin,,0
C5222450,Insulin Aspart Injection,insulin,,0
C5222451,Insulin Detemir Injection,insulin,,0
C5222452,Insulin Glargine Injection,insulin,,0
C5222453,Insulin Human Injection,insulin,,0
C5222454,Insulin Lispro Injection,insulin,,0
C5222455,Insulin Lispro Protamine Suspension and Insulin Lispro Injection,insulin,,0
C5222552,INSULIN SYRINGE 0.3ML 30G 12MM,insulin,INSULIN SYRINGE 0.3ML 30G 12MM,0
C5222553,INSULIN SYRINGE 0.3ML 31G 8MM,insulin,INSULIN SYRINGE 0.3ML 31G 8MM,0
C5222556,INSULIN SYRINGE 0.5ML 29G 12MM,insulin,INSULIN SYRINGE 0.5ML 29G 12MM,0
C5222557,INSULIN SYRINGE 0.5ML 29G 12MM SAFETY,insulin,INSULIN SYRINGE 0.5ML 29G 12MM SAFETY,0
C5222559,INSULIN SYRINGE 0.5ML 30G 12MM,insulin,INSULIN SYRINGE 0.5ML 30G 12MM,0
C5222560,INSULIN SYRINGE 0.5ML 30G 8MM,insulin,INSULIN SYRINGE 0.5ML 30G 8MM,0
C5222561,INSULIN SYRINGE 0.5ML 31G 8MM,insulin,INSULIN SYRINGE 0.5ML 31G 8MM,0
C5222562,INSULIN SYRINGE 0.5ML 32G 8MM,insulin,INSULIN SYRINGE 0.5ML 32G 8MM,0
C5222563,INSULIN SYRINGE 1ML 25G 16MM,insulin,INSULIN SYRINGE 1ML 25G 16MM,0
C5222564,INSULIN SYRINGE 1ML 28G 12MM,insulin,INSULIN SYRINGE 1ML 28G 12MM,0
C5222565,INSULIN SYRINGE 1ML 29G 12MM SAFETY,insulin,INSULIN SYRINGE 1ML 29G 12MM SAFETY,0
C5222566,INSULIN SYRINGE 1ML 30G 12MM,insulin,INSULIN SYRINGE 1ML 30G 12MM,0
C5224463,"insulin aspart, human 100 UNT/ML includes Cartridge, Pen Injector and Injectable Solution",insulin,,0
C5227952,Insulin Aspart FlexPen,insulin,,0
C5227953,Insulin Aspart PenFill,insulin,,0
C5227954,Insulin Aspart-Insulin Aspart Protamine FlexPen,insulin,,0
C5228171,Sensor 3 ML insulin glargine 100 UNT/ML Pen Injector [Basaglar],insulin,"Basaglar 100 UNT/ML per 3 ML Pen Injector with Sensor; Basaglar Tempo 100 UNT/ML in 3 ML Pen Injector; Insulin glargine 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [BASAGLAR Tempo Pen]; Basaglar 300 UNT per 3 ML Pen Injector with Sensor",0
C5228187,"CORTICOTROPIN 30 [hp_C] in 1 mL / GLUTAMIC ACID 30 [hp_C] in 1 mL / MUCUNA PRURIENS SEED 30 [hp_C] in 1 mL / SEROTONIN 30 [hp_C] in 1 mL / EPINEPHRINE 30 [hp_C] in 1 mL / NIACINAMIDE 8 [hp_X] in 1 mL / UBIDECARENONE 8 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE 6 [hp_C] in 1 mL / INSULIN PORK 6 [hp_C] in 1 mL / SUS SCROFA PARATHYROID GLAND 6 [hp_C] in 1 mL / SUS SCROFA PITUITARY GLAND 6 [hp_C] in 1 mL / THIAMINE HYDROCHLORIDE 6 [hp_C] in 1 mL / THYROID, UNSPECIFIED 6 [hp_C] in 1 mL / ANHYDROUS CITRIC ACID 12 [hp_C] in 1 mL / HERRING SPERM DNA 12 [hp_C] in 1 mL / SACCHAROMYCES CEREVISIAE RNA 12 [hp_C] in 1 mL / ANACARDIUM OCCIDENTALE FRUIT 30 [hp_C] in 1 mL / ARSENIC TRIOXIDE 30 [hp_C] in 1 mL / ASPARTIC ACID 30 [hp_C] in 1 mL / BARIUM CARBONATE 30 [hp_C] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 30 [hp_C] in 1 mL / CLEMATIS RECTA FLOWERING TOP 30 [hp_C] in 1 mL / LYCOPODIUM CLAVATUM SPORE 30 [hp_C] in 1 mL / ANEMONE PULSATILLA 30 [hp_C] in 1 mL / DATURA STRAMONIUM 30 [hp_C] in 1 mL / SULFUR 30 [hp_C] in 1 mL ORAL LIQUID [FCS CP]",insulin,,0
C5228611,Sensor 3 ML insulin glargine 100 UNT/ML Pen Injector,insulin,insulin glargine 100 UNT/ML per 3 ML Pen Injector with Sensor; insulin glargine 300 UNT per 3 ML Pen Injector with Sensor; insulin glargine 100 UNT/ML in 3 ML Pen Injector with Sensor,0
C5228919,INSULIN SYRINGE 0.3ML 29G 12MM,insulin,INSULIN SYRINGE 0.3ML 29G 12MM,0
C5228920,INSULIN SYRINGE 0.3ML 30G 8MM,insulin,INSULIN SYRINGE 0.3ML 30G 8MM,0
C5228921,INSULIN SYRINGE 0.5ML 28G 12MM,insulin,INSULIN SYRINGE 0.5ML 28G 12MM,0
C5228922,INSULIN SYRINGE 1ML 25G 25MM,insulin,INSULIN SYRINGE 1ML 25G 25MM,0
C5228923,INSULIN SYRINGE 1ML 28G 12MM DOUBLE SCALE,insulin,INSULIN SYRG 1ML 28G 12MM DOUBLE SCALE,0
C5228924,INSULIN SYRINGE 1ML 29G 12MM SAFETYGLIDE,insulin,INSULIN SYR 1ML 29G 12MM SAFETYGLIDE,0
C5228995,"Supplies for maintenance of insulin infusion pump with dosage rate adjustment using therapeutic continuous glucose sensing, per week",insulin,,0
C5229023,"External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing",insulin,,0
C5229299,Zinc insulin-containing product,insulin,Product containing zinc insulin (product),0
C5229519,Allergy to beef insulin,insulin,Allergy to beef insulin (finding); Bovine insulin allergy,0
C5229520,Allergy to pork insulin,insulin,Allergy to pork insulin (finding); Porcine insulin allergy,0
C5230545,Insulin dose,insulin,Insulin dose (observable entity),0
C5230546,Mean total daily insulin dose,insulin,Mean total daily insulin dose (observable entity),0
C5230548,Insulin sensitivity factor,insulin,Insulin sensitivity factor (observable entity); Correction factor; Insulin correction factor,0
C5230552,Insulin to carbohydrate ratio,insulin,Insulin/carbohydrate ratio; Insulin to carbohydrate ratio (observable entity),0
C5230588,Insulin dose at evening meal calculated by insulin to carbohydrate ratio,insulin,Insulin dose at dinner calculated by insulin to carbohydrate ratio; Insulin dose at evening meal calculated by insulin to carbohydrate ratio (observable entity); Insulin to carbohydrate ratio dose at dinner; Insulin to carbohydrate ratio dose at evening meal,0
C5230589,Insulin dose calculated by insulin sensitivity factor,insulin,Insulin dose calculated by insulin sensitivity factor (observable entity); Insulin sensitivity factor dose; High blood sugar correction dose,0
C5230590,Insulin dose calculated by insulin to carbohydrate ratio,insulin,Insulin to carbohydrate ratio insulin dose; Carbohydrate coverage insulin dose; Insulin dose calculated by insulin to carbohydrate ratio (observable entity),0
C5230591,Insulin dose at breakfast calculated by insulin to carbohydrate ratio,insulin,Insulin to carbohydrate ratio dose at breakfast; Insulin dose at breakfast calculated by insulin to carbohydrate ratio (observable entity),0
C5230592,Insulin dose at lunch calculated by insulin sensitivity factor,insulin,Insulin sensitivity factor dose at lunch; Insulin dose at lunch calculated by insulin sensitivity factor (observable entity),0
C5230593,Insulin dose at lunch calculated by insulin to carbohydrate ratio,insulin,Insulin dose at lunch calculated by insulin to carbohydrate ratio (observable entity); Insulin to carbohydrate ratio dose at lunch,0
C5230787,Human insulin zinc suspension crystalline 100 unit/mL suspension for injection,insulin,Product containing precisely human insulin zinc suspension crystalline 100 unit/1 milliliter conventional release suspension for injection (clinical drug),0
C5230822,Bovine isophane insulin only product,insulin,Product containing only bovine isophane insulin (medicinal product),0
C5230823,Bovine isophane insulin only product in parenteral dose form,insulin,Product containing only bovine isophane insulin in parenteral dose form (medicinal product form),0
C5230829,Human isophane insulin only product,insulin,Product containing only human isophane insulin (medicinal product),0
C5230831,Insulin aspart and insulin aspart protamine only product,insulin,Product containing only insulin aspart and insulin aspart protamine (medicinal product),0
C5230832,Insulin lispro and insulin lispro protamine only product,insulin,Product containing only insulin lispro and insulin lispro protamine (medicinal product),0
C5230840,Porcine isophane insulin only product,insulin,Product containing only porcine isophane insulin (medicinal product),0
C5230842,Human isophane insulin-containing product in parenteral dose form,insulin,Product containing human isophane insulin in parenteral dose form (medicinal product form),0
C5230845,Porcine isophane insulin-containing product in parenteral dose form,insulin,Product containing porcine isophane insulin in parenteral dose form (medicinal product form),0
C5231261,Regular shape of mass of abdomen,regular,Regular shape of mass of abdomen (finding),0
C5234326,NovoLIN N FlexPen,novolin,,0
C5234327,NovoLIN R FlexPen,novolin,,0
C5234912,Insulin-Like Growth Factor Binding Protein 7 Measurement,insulin,IGFBP7 Measurement; Insulin-Like Growth Factor Binding Protein 7 Measurement; Angiomodulin Measurement; IGFBP-7 Measurement,0
C5235455,Carbohydrate to Insulin Ratio Device Setting,insulin,,0
C5237049,Insulin-Producing,insulin,,0
C5237448,Insulin-Like Growth Factor Binding Protein Measurement,insulin,IGFBP Measurement,0
C5238097,Dalanated Insulin,insulin,,0
C5238440,"Extent that Arm, Shoulder, or Hand Problem Limited Work or Other Regular Activities",regular,,0
C5240705,Insulin post fasting and meal stimulation panel:-:Pt:Ser/Plas:-,insulin,Insulin post fasting and meal stimulation panel - Serum or Plasma; Insulin p Cfst + meal Pnl SerPl; Insulin post fasting and meal stimulation panel; Insulin post fasting and meal stimulation panel:-:To identify measures at a point in time:Serum/Plasma:-; Insulin post fasting and meal stimulation panel:-:Pt:Ser/Plas:-,0
C5240706,Insulin post fasting and meal stimulation panel,insulin,Insulin post fasting and meal stimulation panel,0
C5241310,3 ML insulin lispro-aabc 100 UNT/ML Cartridge [Lyumjev],insulin,"LYUMJEV 100 UNT/ML in 3 ML Cartridge; Lyumjev 100 UNT/ML per 3 ML Cartridge; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [LYUMJEV]; 3 ML insulin lispro-aabc 100 UNT/ML Cartridge [Lyumjev]; 3 ML Lyumjev 100 UNT/ML Cartridge",0
C5241311,insulin lispro-aabc 100 UNT/ML Injectable Solution [Lyumjev],insulin,"insulin lispro-aabc 100 UNT/ML Injectable Solution [Lyumjev]; Lyumjev, aabc 100 units/mL injectable solution; Lyumjev 100 UNT/ML Injectable Solution; LYUMJEV 100 UNT/ML Injectable Solution; INSULIN LISPRO-AABC 100 UNIT/ML LYUMJEV; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [LYUMJEV]; Insulin lispro 100 [iU] in 1 mL INTRAVENOUS INJECTION, SOLUTION [LYUMJEV]; INSULIN,LISPRO-AABC 100 UNIT/ML INJ,LYUMJEV",0
C5241352,3 ML insulin glargine 100 UNT/ML Pen Injector [Semglee],insulin,"INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [SEMGLEE]; 3 ML Semglee 100 UNT/ML Pen Injector; Semglee Prefilled Pen, 100 units/mL subcutaneous solution; Semglee 300 UNT in 3 mL Pen Injector; Semglee 300 UNT per 3 ML Pen Injector; 3 ML insulin glargine 100 UNT/ML Pen Injector [Semglee]",0
C5241353,insulin glargine 100 UNT/ML Injectable Solution [Semglee],insulin,"insulin glargine 100 UNT/ML Injectable Solution [Semglee]; INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [SEMGLEE]; Semglee 100 UNT/ML Injectable Solution",0
C5241746,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / GAMBOGE 14 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Weight Management]",insulin,,0
C5242431,"VINCETOXICUM HIRUNDINARIA ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA WHOLE 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / SUS SCROFA CEREBRUM 8 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / SUS SCROFA PANCREAS 8 [hp_X] in 1 mL / SUS SCROFA STOMACH 8 [hp_X] in 1 mL / APC-356433 8 [hp_X] in 1 mL / APC-356434 8 [hp_X] in 1 mL / OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / GAMBOGE 14 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [WLP40]",insulin,,0
C5244713,ReliOn/NovoLIN N FlexPen,novolin,,0
C5244714,ReliOn/NovoLIN R FlexPen,novolin,,0
C5244718,Insulin Lispro Protamine-Insulin Lispro Mix75/25 KwikPen,insulin,,0
C5244724,Insulin Lispro Junior KwikPen,insulin,,0
C5381381,SARS coronavirus 2 RNA:PrThr:Pt:Nph:Ord:Non-probe.amp.tar,NPH,SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection; SARS coronavirus 2 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Non-probe.amp.tar; SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Nph); SARS-CoV-2 RNA Nph Ql NAA+non-probe,0
C5381521,SARS coronavirus 2 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,SARS-CoV-2 RNA Nph Ql NAA+probe; SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Nph); SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection; SARS coronavirus 2 ribonucleic acid:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar,0
C5381522,SARS coronavirus 2 N gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,NPH,SARS-CoV-2 N gene Nph Ql NAA+probe; SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Nph); SARS coronavirus 2 N gene:Presence or Threshold:To identify measures at a point in time:Naspopharynx:Ordinal:Probe.amp.tar; SARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection,0
C5381594,Insulin^15M post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 15 Min post meal Qn; Insulin 15M p meal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --15 min post meal; Insulin^15 minutes post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C5381620,Insulin^1.5H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 1.5h p meal SerPl-aCnc; Insulin^1.5 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --1.5 hours post meal; Insulin 1.5 Hr post meal Qn,0
C5381621,Insulin^1H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --1 hour post meal; Insulin^1 hour post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 1 Hr post meal Qn; Insulin 1h p meal SerPl-aCnc,0
C5381622,Insulin^2.5H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 2.5 Hr post meal Qn; Insulin [Units/volume] in Serum or Plasma --2.5 hours post meal; Insulin^2.5 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2.5h p meal SerPl-aCnc,0
C5381623,Insulin^2H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 2h p meal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --2 hours post meal; Insulin^2 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 2 Hr post meal Qn,0
C5381624,Insulin^3.5H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 3.5h p meal SerPl-aCnc; Insulin^3.5 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --3.5 hours post meal; Insulin 3.5 Hr post meal Qn,0
C5381625,Insulin^30M post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin [Units/volume] in Serum or Plasma --30 min post meal; Insulin 30M p meal SerPl-aCnc; Insulin^30 minutes post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin 30 Min post meal Qn,0
C5381626,Insulin^3H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 3h p meal SerPl-aCnc; Insulin 3 Hr post meal Qn; Insulin [Units/volume] in Serum or Plasma --3 hours post meal; Insulin^3 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C5381627,Insulin^4.5H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^4.5 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --4.5 hours post meal; Insulin 4.5 Hr post meal Qn; Insulin 4.5h p meal SerPl-aCnc,0
C5381628,Insulin^4H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin^4 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative; Insulin [Units/volume] in Serum or Plasma --4 hours post meal; Insulin 4h p meal SerPl-aCnc; Insulin 4 Hr post meal Qn,0
C5381629,Insulin^5H post meal:ACnc:Pt:Ser/Plas:Qn,insulin,Insulin 5 Hr post meal Qn; Insulin 5h p meal SerPl-aCnc; Insulin [Units/volume] in Serum or Plasma --5 hours post meal; Insulin^5 hours post meal:Arbitrary concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C5381960,Regular night-time,regular,,0
C5382606,Insulin^1.5H post meal,insulin,Insulin^1.5H post meal,0
C5382607,Insulin^15M post meal,insulin,Insulin^15M post meal,0
C5382608,Insulin^1H post meal,insulin,Insulin^1H post meal,0
C5382609,Insulin^2.5H post meal,insulin,Insulin^2.5H post meal,0
C5382610,Insulin^2H post meal,insulin,Insulin^2H post meal,0
C5382611,Insulin^3.5H post meal,insulin,Insulin^3.5H post meal,0
C5382612,Insulin^30M post meal,insulin,Insulin^30M post meal,0
C5382613,Insulin^3H post meal,insulin,Insulin^3H post meal,0
C5382614,Insulin^4.5H post meal,insulin,Insulin^4.5H post meal,0
C5382615,Insulin^4H post meal,insulin,Insulin^4H post meal,0
C5382616,Insulin^5H post meal,insulin,Insulin^5H post meal,0
C5382937,Insulin post fasting and meal stimulation panel &#x7C; Serum or Plasma &#x7C; Challenge Bank Panels,insulin,,0
C5389884,insulin lispro-aabc,insulin,"INSULIN,LISPRO-AABC; insulin lispro-aabc",0
C5389888,3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev],insulin,"INSULIN,LISPRO-AABC 200 UNIT/ML INJ,LYUMJEV KWIKPEN 3ML; INSULIN LISPRO-AABC 200/ML KWIKPEN 3ML; Lyumjev 200 UNT/ML per 3 ML Pen Injector; Lyumjev KwikPen, aabc 200 units/mL subcutaneous solution; LYUMJEV 200 UNT/ML in 3 ML Pen Injector; Insulin lispro 200 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [LYUMJEV KwikPen]; 3 ML Lyumjev 200 UNT/ML Pen Injector",0
C5389889,3 ML insulin lispro-aabc 100 UNT/ML Pen Injector [Lyumjev],insulin,"3 ML Lyumjev 100 UNT/ML Pen Injector; LYUMJEV 100 UNT/ML per 3 ML Pen Injector; LYUMJEV 100 UNT/ML in 3 ML Pen Injector; INSULIN,LISPRO-AABC 100 UNIT/ML INJ,LYUMJEV KWIKPEN 3ML; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [LYUMJEV KwikPen]; Lyumjev KwikPen, aabc 100 units/mL injectable solution; INSULIN LISPRO-AABC 100/ML KWIKPEN 3ML",0
C5390116,insulin lispro-aabc 100 UNT/ML Injectable Solution,insulin,insulin lispro aabc 100 units/mL injectable solution; insulin lispro-aabc 100 UNT/ML Injectable Solution,0
C5390117,3 ML insulin lispro-aabc 200 UNT/ML Pen Injector,insulin,insulin lispro-aabc 200 UNT/ML per 3 ML Pen Injector; insulin lispro-aabc 200 UNT/ML in 3 ML Pen Injector,0
C5390377,0.5 UNT Doses 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector [Lyumjev],insulin,"LYUMJEV 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses; LYUMJEV 100 UNT/ML per 3 ML Pen Injector, 0.5 UNT Doses; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [LYUMJEV Junior KwikPen]",0
C5390378,Sensor 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector [Lyumjev],insulin,"Sensor 3 ML Lyumjev 100 UNT/ML Pen Injector; Insulin lispro 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [LYUMJEV Tempo Pen]; LYUMJEV 100 UNT/ML in 3 ML Pen Injector with Sensor; Lyumjev 100 UNT/ML per 3 ML Pen Injector with Sensor",0
C5390833,3 ML insulin lispro-aabc 100 UNT/ML Cartridge,insulin,insulin lispro-aabc 100 UNT per 3 ML Cartridge; insulin lispro-aabc 100 UNT in 3 ML Cartridge,0
C5390834,3 ML insulin lispro-aabc 100 UNT/ML Pen Injector,insulin,insulin lispro-aabc 100 UNT/ML per 3 ML Pen Injector; insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector,0
C5390835,0.5 UNT Doses 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector,insulin,"insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses; insulin lispro-aabc 100 UNT/ML per 3 ML Pen Injector, 0.5 UNT Doses",0
C5390950,Sensor 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector,insulin,insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector with Sensor; insulin lispro-aabc 100 UNT/ML per 3 ML Pen Injector with Sensor,0
C5390980,insulin glargine 100 UNT/ML [Semglee],insulin,,0
C5390988,insulin lispro-aabc 100 UNT/ML [Lyumjev],insulin,,0
C5390989,insulin lispro-aabc 200 UNT/ML [Lyumjev],insulin,,0
C5391018,insulin glargine Injectable Solution [Semglee],insulin,,0
C5391019,insulin glargine Pen Injector [Semglee],insulin,,0
C5391025,insulin lispro Injectable Solution [Lyumjev],insulin,,0
C5391026,insulin lispro Pen Injector [Lyumjev],insulin,,0
C5391027,insulin lispro Cartridge [Lyumjev],insulin,,0
C5391118,insulin lispro-aabc 100 UNT/ML,insulin,,0
C5391119,insulin lispro-aabc 200 UNT/ML,insulin,,0
C5391319,"Igf2r protein, mouse",insulin,"insulin-like growth factor 2 receptor protein, mouse",0
C5391879,"Igf1r protein, rat",insulin,"Igf1-r protein, rat; insulin-like growth factor 1 receptor, rat",0
C5393573,Negative insulin autoantibodies,insulin,,0
C5393957,Flat growth hormone response to clonidine or insulin-induced hypoglycemia,insulin,,0
C5394872,Regular insulin adverse reaction,insulin,Regular insulin adverse reaction (disorder); Soluble insulin adverse reaction,0
C5395235,Adverse reaction caused by human insulin,insulin,Adverse reaction caused by human insulin (disorder),0
C5395628,Administration of insulin using insulin pump,insulin,Administration of insulin using insulin pump (procedure),0
C5395629,Insulin pump education,insulin,Education about administration of insulin using insulin pump (procedure); Education about administration of insulin using insulin pump,0
C5396255,Active insulin time,insulin,Active insulin time (observable entity),0
C5396272,Insulin dose at evening meal calculated by insulin sensitivity factor,insulin,Insulin dose at evening meal calculated by insulin sensitivity factor (observable entity),0
C5396889,Basal insulin infusion rate,insulin,Basal insulin infusion rate (observable entity),0
C5396890,Bolus insulin infusion rate,insulin,Bolus insulin infusion rate (observable entity),0
C5397051,Adverse reaction to zinc insulin,insulin,Zinc insulin adverse reaction; Adverse reaction to zinc insulin (disorder),0
C5398346,insulin lispro aabc 200 units/mL subcutaneous solution,insulin,,0
C5398803,"CYNANCHUM VINCETOXICUM ROOT 6 [hp_X] in 1 mL / ECHINACEA ANGUSTIFOLIA WHOLE 6 [hp_X] in 1 mL / SUS SCROFA HYPOTHALAMUS 6 [hp_X] in 1 mL / PORK LIVER 8 [hp_X] in 1 mL / PORK KIDNEY 8 [hp_X] in 1 mL / METHYLCOBALAMIN 8 [hp_X] in 1 mL / GAMBOGE 12 [hp_X] in 1 mL / GRAPHITE 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 12 [hp_X] in 1 mL / 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 30 [hp_X] in 1 mL / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] in 1 mL / INSULIN PORK 30 [hp_X] in 1 mL / SUS SCROFA PANCREAS 30 [hp_X] in 1 mL / LACTIC ACID, L- 30 [hp_X] in 1 mL / PROTEUS VULGARIS 30 [hp_C] in 1 mL ORAL LIQUID [Professional Weight Maintenance]",insulin,,0
C5399831,"C-peptide, Human",insulin,Human proinsulin c-peptide; C-peptide; C Peptide; Proinsulin c-peptide; Proinsulin c-peptide (human); Human c-peptide; Insulin c-peptide; Human Proinsulin C-Peptide; C-Peptide; Proinsulin C-Peptide,0
C5400717,Insulin Isophane Liquid Injectable Suspension,insulin,Insulin Isophane Injectable Suspension,0
C5417303,"ALPHA 8 [hp_X] in 30 mL / CERVUS ELAPHUS VELVET 6 [hp_X] in 30 mL / PORK LIVER 6 [hp_X] in 30 mL / SOMATROPIN 12 [hp_X] in 30 mL / DALOTUZUMAB 12 [hp_X] in 30 mL / INSULIN-LIKE GROWTH FACTOR-2 12 [hp_X] in 30 mL / SUS SCROFA PITUITARY GLAND, POSTERIOR 5 [hp_C] in 30 mL ORAL SPRAY [HGH Plus]",insulin,,0
C5418418,Insulin Defalan (Bovine),insulin,,0
C5419683,Insulin Delivery Automation Mode,insulin,,0
C5420973,Insulin Efsitora Alfa,insulin,,0
C5421277,Insulin Defalan (Porcine),insulin,,0
C5421531,NHSN SSI Anatomic Site,SSI,,0
C5421532,NHSN SSI Location Type,SSI,,0
C5422077,ALUMINUM CHLOROHYDRATE 160 mg in 1 mL TOPICAL LIQUID [ARRID XX Roll On Antiperspirant Deodorant Regular],regular,,0
C5426904,Class &#x7C; Insulin delivery device &#x7C; Devices,insulin,,0
C5433207,Insulin Isophane Human and Insulin Human Injectable Suspension,insulin,,0
C5433208,Insulin Isophane Human Injectable Suspension,insulin,,0
C5434213,insulin icodec,insulin,Insulin Icodec,0
C5436940,"TYPE 1 DIABETES MELLITUS, INSULIN-DEPENDENT, 10",insulin,,0
C5439067,Porcine isophane insulin only product in parenteral dose form,insulin,Product containing only porcine isophane insulin in parenteral dose form (medicinal product form),0
C5439068,Insulin lispro and insulin lispro protamine only product in parenteral dose form,insulin,Product containing only insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form),0
C5439071,Human isophane insulin only product in parenteral dose form,insulin,Product containing only human isophane insulin in parenteral dose form (medicinal product form),0
C5439373,Human isophane insulin and recombinant human regular insulin only product in parenteral dose form,insulin,Human isophane insulin and recombinant human soluble insulin only product in parenteral dose form; Product containing only human isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form),0
C5439427,Human isophane insulin and recombinant human regular insulin only product,insulin,Product containing only human isophane insulin and recombinant human regular insulin (medicinal product); Human isophane insulin and recombinant human soluble insulin only product,0
C5439429,Porcine isophane insulin and porcine regular insulin only product in parenteral dose form,insulin,Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form; Product containing only porcine isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form),0
C5439430,Porcine isophane insulin and porcine regular insulin only product,insulin,Product containing only porcine isophane insulin and porcine regular insulin (medicinal product); Porcine insulin soluble and porcine isophane insulin only product,0
C5440355,ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [Arrid Extra Extra Dry - Cool Shower],regular,ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [UltraMax Invisible Solid - Cool Blast Antiperspirant Deodorant Cool Blast]; ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [UltraMax Invisible Solid - Unscented Antiperspirant Deodorant Unscented]; ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [UltraMax Invisible Solid - Active Sport Antiperspirant Deodorant Active Sport]; ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [UltraMax Invisible Solid - Powder Fresh Antiperspirant Deodorant Powder Fresh]; ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [UltraMax Invisible Solid - Fresh Antiperspirant Deodorant Fresh]; ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [Arrid Extra Extra Dry Regular Solid]; ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [Arrid Extra Extra Dry Ultra Fresh]; ALUMINUM CHLOROHYDRATE 0.19 g in 1 g TOPICAL STICK [Arrid Extra Extra Dry Unscented Solid],0
C5441715,"IDE protein, human",insulin,EC 3.4.24.56; Insulysin; Insulinase; Insulin-Degrading Enzyme; IDE; Abeta-Degrading Protease; Insulin Protease,0
C5442966,"Techlite Insulin Syringe 29g X 1/2"" 12mm 0.3",insulin,,0
C5442967,"Techlite Insulin Syringe 30g X 1/2"" 12mm 0.3",insulin,,0
C5443311,"GLYCERIN 3 [hp_X] in 1 mL / TARAXACUM OFFICINALE 3 [hp_X] in 1 mL / PHYTOLACCA AMERICANA ROOT 6 [hp_X] in 1 mL / ARSENIC TRIOXIDE 12 [hp_X] in 1 mL / NITRIC ACID 12 [hp_X] in 1 mL / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] in 1 mL / KEROSENE 12 [hp_X] in 1 mL / PHOSPHORIC ACID 12 [hp_X] in 1 mL / PHOSPHORUS 12 [hp_X] in 1 mL / ASPIRIN 12 [hp_X] in 1 mL / NITROGLYCERIN 12 [hp_X] in 1 mL / INSULIN HUMAN 12 [hp_X] in 1 mL / LITHIUM CARBONATE 12 [hp_X] in 1 mL / THYROID, PORCINE 12 [hp_X] in 1 mL / ACETIC ACID 12 [hp_X] in 1 mL / BENZOIC ACID 12 [hp_X] in 1 mL / BENZYL ALCOHOL 12 [hp_X] in 1 mL / BORIC ACID 12 [hp_X] in 1 mL / CHLORINE 12 [hp_X] in 1 mL / CORTISONE ACETATE 12 [hp_X] in 1 mL / EUGENOL 12 [hp_X] in 1 mL / ESTRONE 12 [hp_X] in 1 mL / ISOPROPYL PALMITATE 12 [hp_X] in 1 mL / LACTIC ACID, DL- 12 [hp_X] in 1 mL / POTASSIUM SORBATE 12 [hp_X] in 1 mL / PETROLATUM 12 [hp_X] in 1 mL / PHENYLBUTAZONE 12 [hp_X] in 1 mL / LEAD 12 [hp_X] in 1 mL / RESORCINOL 12 [hp_X] in 1 mL / SALICYLIC ACID 12 [hp_X] in 1 mL / STEARYL ALCOHOL 12 [hp_X] in 1 mL / SORBITOL 12 [hp_X] in 1 mL / XYLITOL 12 [hp_X] in 1 mL / CORTICOTROPIN 15 [hp_C] in 1 mL ORAL LIQUID [Chemstat]",insulin,,0
C5446508,MAPK3 Fusion Positive,insulin,P44ERK1 Fusion Positive; MAPK 3 Fusion Positive; P44MAPK Fusion Positive; ERK1 Fusion Positive; ERT2 Fusion Positive; PRKM3 Fusion Positive; Insulin-Stimulated MAP2 Kinase Fusion Positive; Microtubule-Associated Protein 2 Kinase Fusion Positive; Extracellular Signal-Regulated Kinase 1 Fusion Positive; p44-ERK1 Fusion Positive; ERK-1 Fusion Positive; p44-MAPK Fusion Positive; Mitogen-Activated Protein Kinase 3 Fusion Positive,0
C5448647,"TAPE STRIP,REGULAR ADHERING NU-HOPE#2304",regular,"TAPE STRIP,REGULAR ADHERING NU-HOPE#2304",0
C5448654,"POISE PAD,LIGHT ABSORB REGULAR COVERAGE",regular,"POISE PAD,LIGHT ABSORB REGULAR COVERAGE",0
C5452125,Insulin type:Prid:Pt:Ser/Plas:Nom:LC/MS/MS,insulin,Insulin type LC/MS/MS Nom; Insulin type [Identifier] in Serum or Plasma by LC/MS/MS; Insulin Type SerPl LC/MS/MS; Insulin type:Presence or Identity:To identify measures at a point in time:Serum/Plasma:Nominal:LC/MS/MS,0
C5452942,"In a setting with regular customer interaction (delivery, transport, retail, food service, restaurant, etc.)",regular,,0
C5493480,Lestodiplosis sp. 1 NPH-2020,NPH,,0
C5540128,NovoLog 100 UNT/ML Injectable Solution includes Cartridge,novolog,,0
C5543376,"Diabetes mellitus, insulin-dependent (early childhood-onset)",insulin,,0
C5550111,insulin glargine-yfgn 100 UNT/ML Injectable Solution [Semglee],insulin,"Semglee (insulin glargine-yfgn) 100 UNT/ML Injectable Solution; INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [SEMGLEE]; insulin glargine-yfgn 100 UNT/ML Injectable Solution [Semglee]; Semglee (Vial), yfgn 100 units/mL subcutaneous solution",0
C5550124,Antacid Regular Strength Cool Mint,regular,,0
C5550141,Relion NovoLOG,novolog,,0
C5550142,Relion NovoLOG Flexpen,novolog,,0
C5550143,Relion NovoLOG Mix 70/30,novolog,,0
C5550144,Relion NovoLOG Mix 70/30 FlexPen,novolog,,0
C5550535,3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector,insulin,"INSULIN,GLARGINE-YFGN 100UNIT/ML INJ PEN,3ML; INSULIN,GLARGINE-YFGN 100UNIT/ML PEN 3ML; insulin glargine-yfgn 300 UNT per 3 ML Pen Injector; insulin glargine-yfgn 300 UNT in 3 ML Pen Injector; INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Glargine]; insulin glargine-yfgn 100 UNT/ML per 3 ML Pen Injector; 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector; Insulin Glargine, yfgn 100 units/mL subcutaneous solution_#2",0
C5550536,insulin glargine-yfgn 100 UNT/ML Injectable Solution,insulin,"INSULIN,GLARGINE-YFGN 100UNIT/ML INJ; insulin glargine yfgn 100 units/mL subcutaneous solution; INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Insulin Glargine]; Insulin Glargine, yfgn 100 units/mL subcutaneous solution_#1; insulin glargine-yfgn 100 UNT/ML Injectable Solution",0
C5550555,insulin glargine-yfgn,insulin,"Insulin Glargine-yfgn; insulin glargine-yfgn; INSULIN GLARGINE-YFGN; INSULIN,GLARGINE-YFGN",0
C5550594,3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee],insulin,"Semglee (insulin glargine-yfgn) 300 UNT in 3 ML Pen Injector; 3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee]; INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [SEMGLEE]; Semglee (insulin glargine-yfgn) 100 UNT/ML per 3 ML Pen Injector; Semglee (insulin glargine-yfgn) 300 UNT per 3 ML Pen Injector; Semglee (Prefilled Pen), yfgn 100 units/mL subcutaneous solution",0
C5550611,insulin glargine-yfgn 100 UNT/ML [Semglee],insulin,,0
C5550690,insulin glargine-yfgn 100 UNT/ML,insulin,,0
C5550911,Insulin-like Growth Factor-1 Receptor Interactions,insulin,IGF-1R Interactions; Insulin-like Growth Factor-1 Receptor Interactions [MoA]; IGF Type 1 Receptor Interactions; IGF-1 Receptor Interactions,0
C5550912,Insulin-like Growth Factor-1 Receptor Inhibitors,insulin,IGF-1R Inhibitors; Insulin-like Growth Factor-1 Receptor Inhibitors [MoA],0
C5550928,Insulin-like Growth Factor-1 Receptor Inhibitor,insulin,IGF-1R Inhibitor; Insulin-like Growth Factor-1 Receptor Inhibitor [EPC],0
C5551838,"Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7 days",regular,"Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7 days; Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7D",0
C5551839,"Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7D:Find:7D:^Patient:Ord",regular,"Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7D:Find:7D:^Patient:Ord; Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7 days; Lvl eye prbs afct daily non wk activ 7D; Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7D:Finding:7 days:^Patient:Ordinal",0
C5552803,Injected Insulin Diabetes Therapy,insulin,Injected Insulin Diabetes Therapy; Therapeutic Insulin Injection; Insulin Injection; Injected Insulin Therapy; Injected Insulin,0
C5553275,"Care Touch U-100 Insulin Syringes, 28g 5/16""",insulin,,0
C5553276,"Care Touch U-100 Insulin Syringes, 29g 5/16""",insulin,,0
C5553277,"Care Touch U-100 Insulin Syringes, 30g 5/16""",insulin,,0
C5553278,"Care Touch U-100 Insulin Syringes, 31g 5/16""",insulin,,0
C5557338,Have Participated in Regular Exercise Program,regular,Have Participated in Regular Exercise Program Such as Stretching or Strengthening Exercises Swimming or Other Regular Exercise Program,0
C5557367,Allogeneic Human Stem Cell-derived Pancreatic Islet Cells VX-880,insulin,Allogeneic Human Stem Cell-derived Islet Cells VX-880; STx 02; VX 880; VX-880; VX880; Allogeneic Human Stem Cell-derived Beta Cells VX-880; Allogeneic Stem Cell-derived Fully Differentiated Insulin-producing Pancreatic Islet Cells VX-880; STx02; STx-02,0
C5558657,"Insulin Glargine, yfgn 100 units/mL subcutaneous solution",insulin,,0
C5561694,Insulin Dosing Software,insulin,,0
C5561695,Insulin Infusion Software,insulin,,0
C5561877,"Software, Infusion Pump System, Control/Programming, Glucose/Insulin",insulin,,0
C5563352,Low serum insulin-like growth factor I (IGF1),insulin,,0
C5564171,insulin glargine-aglr,insulin,"Insulin Glargine-aglr; Glargine-aglr, Insulin",0
C5564172,insulin glargine-aglr 100 UNT/ML,insulin,,0
C5564173,3 ML insulin glargine-aglr 100 UNT/ML Pen Injector,insulin,insulin glargine-aglr 300 UNT in 3 ML Pen Injector; insulin glargine-aglr 300 UNT per 3 ML Pen Injector,0
C5564176,insulin glargine-aglr 100 UNT/ML [Rezvoglar],insulin,,0
C5564178,insulin glargine Pen Injector [Rezvoglar],insulin,,0
C5564179,3 ML insulin glargine-aglr 100 UNT/ML Pen Injector [Rezvoglar],insulin,"Insulin glargine 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Rezvoglar KwikPen]; REZVOGLAR (insulin glargine-aglr) 100 UNT/ML in 3 ML Pen Injector; 3 ML Rezvoglar 100 UNT/ML Pen Injector; Rezvoglar KwikPen (insulin glargine-aglr) 300 UNT per 3 ML Pen Injector",0
C5567376,Insulin degludec 100 unit/mL solution for injection,insulin,Product containing precisely insulin degludec 100 unit/1 milliliter conventional release solution for injection (clinical drug),0
C5570793,10: Eye problem(s) completely prevented me from doing my regular activities,regular,,0
C5571050,Regular (no modifications),regular,,0
C5573412,CHROMIUM 6 [hp_X] in 59 mL / LYCOPODIUM CLAVATUM SPORE 6 [hp_X] in 59 mL / VANADIUM 6 [hp_X] in 59 mL / PANCRELIPASE AMYLASE 6 [hp_X] in 59 mL / INSULIN GLULISINE 12 [hp_X] in 59 mL / PHOSPHORIC ACID 30 [hp_X] in 59 mL / URANYL NITRATE HEXAHYDRATE 30 [hp_X] in 59 mL / RADIUM BROMIDE 60 [hp_X] in 59 mL ORAL LIQUID [DNA Insulin Drops 2019],insulin,,0
C5573474,".GAMMA.-AMINOBUTYRIC ACID 3 [hp_X] in 59 mL / GINKGO 3 [hp_X] in 59 mL / BOS TAURUS BRAIN 6 [hp_X] in 59 mL / BOS TAURUS HYPOTHALAMUS 6 [hp_X] in 59 mL / BEEF KIDNEY 6 [hp_X] in 59 mL / BEEF LIVER 6 [hp_X] in 59 mL / BOS TAURUS PANCREAS 6 [hp_X] in 59 mL / SUS SCROFA PINEAL GLAND 6 [hp_X] in 59 mL / SILVER NITRATE 30 [hp_X] in 59 mL / AMARYLLIS BELLADONNA WHOLE 30 [hp_X] in 59 mL / COFFEA ARABICA SEED, ROASTED 30 [hp_X] in 59 mL / PHOSPHORUS 30 [hp_X] in 59 mL / AMBERGRIS 30 [hp_X] in 59 mL / BARIUM CARBONATE 30 [hp_X] in 59 mL / BARIUM CHLORIDE DIHYDRATE 30 [hp_X] in 59 mL / INSULIN GLULISINE 30 [hp_X] in 59 mL / LYCOPODIUM CLAVATUM SPORE 30 [hp_X] in 59 mL / GONORRHEAL URETHRAL SECRETION HUMAN 30 [hp_X] in 59 mL / DATURA STRAMONIUM 30 [hp_X] in 59 mL / THUJA OCCIDENTALIS LEAF 30 [hp_X] in 59 mL / BOVINE TUBERCULIN 30 [hp_X] in 59 mL / VERATRUM ALBUM ROOT 30 [hp_X] in 59 mL ORAL LIQUID [Attention Deficit Mild Drops 2146]",insulin,,0
C5573475,".GAMMA.-AMINOBUTYRIC ACID 3 [hp_X] in 59 mL / GINKGO 3 [hp_X] in 59 mL / BOS TAURUS BRAIN 6 [hp_X] in 59 mL / BOS TAURUS HYPOTHALAMUS 6 [hp_X] in 59 mL / BEEF KIDNEY 6 [hp_X] in 59 mL / BEEF LIVER 6 [hp_X] in 59 mL / BOS TAURUS PANCREAS 6 [hp_X] in 59 mL / SUS SCROFA PINEAL GLAND 6 [hp_X] in 59 mL / SILVER NITRATE 30 [hp_X] in 59 mL / COFFEA ARABICA SEED, ROASTED 30 [hp_X] in 59 mL / LYCOPODIUM CLAVATUM SPORE 30 [hp_X] in 59 mL / AMARYLLIS BELLADONNA WHOLE 60 [hp_X] in 59 mL / PHOSPHORUS 60 [hp_X] in 59 mL / AMBERGRIS 60 [hp_X] in 59 mL / BARIUM CARBONATE 60 [hp_X] in 59 mL / BARIUM CHLORIDE DIHYDRATE 60 [hp_X] in 59 mL / BUFO BUFO CUTANEOUS GLAND 60 [hp_X] in 59 mL / HYOSCYAMUS NIGER 60 [hp_X] in 59 mL / GONORRHEAL URETHRAL SECRETION HUMAN 60 [hp_X] in 59 mL / DATURA STRAMONIUM 60 [hp_X] in 59 mL / LYCOSA TARANTULA 60 [hp_X] in 59 mL / THUJA OCCIDENTALIS LEAF 60 [hp_X] in 59 mL / BOVINE TUBERCULIN 60 [hp_X] in 59 mL / VERATRUM ALBUM ROOT 60 [hp_X] in 59 mL / INSULIN GLULISINE 60 [hp_X] in 59 mL ORAL LIQUID [Attention Deficit Severe Drops 2147]",insulin,,0
C5573674,TRILLIUM ERECTUM ROOT 1 [hp_X] in 118 mL / FENUGREEK SEED 3 [hp_X] in 118 mL / GYMNEMA SYLVESTRE LEAF 3 [hp_X] in 118 mL / PHOSPHORIC ACID 3 [hp_X] in 118 mL / RHUS AROMATICA ROOT BARK 3 [hp_X] in 118 mL / SYZYGIUM CUMINI SEED 3 [hp_X] in 118 mL / SILVER NITRATE 6 [hp_X] in 118 mL / CHIONANTHUS VIRGINICUS BARK 6 [hp_X] in 118 mL / PHOSPHORUS 6 [hp_X] in 118 mL / ZINC 6 [hp_X] in 118 mL / BOS TAURUS PANCREAS 6 [hp_X] in 118 mL / CHROMIUM 8 [hp_X] in 118 mL / SULFUR 8 [hp_X] in 118 mL / VANADIUM 8 [hp_X] in 118 mL / LYCOPODIUM CLAVATUM SPORE 8 [hp_X] in 118 mL / HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE 12 [hp_X] in 118 mL / INSULIN GLULISINE 30 [hp_X] in 118 mL / URANYL NITRATE HEXAHYDRATE 30 [hp_X] in 118 mL ORAL LIQUID [Pancreas DB Liquescence 3037],insulin,,0
C5574971,Insulin Glargine 100 UNT/ML includes Injectable Solution & Prefilled Pen,insulin,,0
C5575508,IGFALS wt Allele,insulin,"Insulin-Like Growth Factor-Binding Protein, Acid-Labile Subunit Gene; IGFBP, Soluble Gene; IGFALS wt Allele; ACLSD; Insulin Like Growth Factor Binding Protein Acid Labile Subunit wt Allele; Insulin-Like Growth Factor Binding Protein, Acid Labile Subunit Gene; ALS",0
C5576884,INSULIN GLARGINE 9 [hp_X] in 29.5 mL ORAL LIQUID [Insulin 1556],insulin,,0
C5577303,Good Sense Antacid And Gas Relief Regular Strength,regular,,0
C5577306,Good Sense Advanced Antacid Regular Strength,regular,,0
C5577373,"VINCETOXICUM HIRUNDINARIA ROOT 6 [hp_X] / ECHINACEA, UNSPECIFIED 6 [hp_X] / SUS SCROFA HYPOTHALAMUS 6 [hp_X] / PORK LIVER 8 [hp_X] / PORK KIDNEY 8 [hp_X] / METHYLCOBALAMIN 8 [hp_X] / GAMBOGE 12 [hp_X] / GRAPHITE 12 [hp_X] / STRYCHNOS NUX-VOMICA SEED 12 [hp_X] / PHYTOLACCA AMERICANA ROOT 12 [hp_X] / 7-KETO-DEHYDROEPIANDROSTERONE 30 [hp_X] / ADENOSINE TRIPHOSPHATE DISODIUM 30 [hp_X] / INSULIN HUMAN 30 [hp_X] / SUS SCROFA PANCREAS 30 [hp_X] / LACTIC ACID, L- 30 [hp_X] / PROTEUS VULGARIS 30 [hp_C] ORAL TABLET [Professional Weight Support]",insulin,,0
C5577539,"MENTHOL, UNSPECIFIED FORM 85 mg in 1 mL TOPICAL GEL [Cryofreeze Roll-On Extra Strength]",regular,"MENTHOL, UNSPECIFIED FORM 85 mg in 1 mL TOPICAL GEL [Cryofreeze Roll-On Regular Strength]",0
C5578456,T Flex Insulin Pump Cartridge For T Flex Pump,insulin,,0
C5578457,"T Slim Insulin Pump Cartridge, T Lock",insulin,,0
C5578458,"T Slim X2 Basal-IQ 6.4, Insulin Pump-Dexcom",insulin,,0
C5578459,"T Slim X2 Control-IQ 7.4,Insulin Pump-Dexcom",insulin,,0
C5669515,IGF-1R Inhibition,insulin,CD221 Inhibition; IGF1R Inhibition; Insulin-Like Growth Factor 1 Receptor Inhibition,0
C5669517,Diabetes Is Controlled by Insulin,insulin,Insulin Controlled Diabetes; Insulin-Controlled Diabetes,0
C5669649,Insulin Sudelidec,insulin,,0
C5670276,Intact Insulin Measurement,insulin,,0
C5671118,Anti-insulin antibody positivity,insulin,Insulin autoantibodies; Anti-insulin antibody positivity; IAA positivity,0
C5673381,Insulin Glargine Solostar Pen,insulin,,0
C5676778,Increased insulin like growth factor binding protein acid labile subunit concentration,insulin,Increased circulating IGFALS contration,0
C5678740,UltiGuard Safe Pack Insulin Syringes 31gx8mm,insulin,Ultiguard Safe Pack Insulin Syringes 31gx8mm,0
C5678741,"Ultiguard Safe Pack Insulin Syringes 30gx1/2""",insulin,,0
C5679586,Rare diabetes mellitus type 1,insulin,Rare insulin-dependent diabetes mellitus,0
C5679587,Rare diabetes mellitus type 2,insulin,Rare insulin-independent diabetes mellitus,0
C5679694,Hyperinsulinism due to INSR deficiency,insulin,Hyperinsulinemic hypoglycemia due to insulin receptor deficiency; Hyperinsulinemic hypoglycemia due to INSR deficiency,0
C5680478,Rare insulin-resistance syndrome,insulin,,0
C5681181,"Microcephalic primordial dwarfism, insulin resistance syndrome",insulin,"Microcephalic primordial dwarfism-insulin resistance syndrome; Microcephalic primordial dwarfism, insulin resistance syndrome (disorder)",0
C5688289,Regular wide QRS complex tachycardia,regular,Regular wide complex tachycardia; Regular wide QRS complex tachycardia (disorder),0
C5688580,Provision of snack between regular meals,regular,Provision of snack between regular meals (procedure); Giving snack between meals; Giving of snack,0
C5689510,Insulin-like growth factor-I^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,insulin,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge; IGF-I sp9 p chal SerPl-mCnc; Insulin-like growth factor-I 9th specimen post Unsp challenge [Mass/Vol]; Insulin-like growth factor-I^9th specimen post XXX challenge:Mass Concentration:To identify measures at a point in time:Serum/Plasma:Quantitative,0
C5690133,Insulin-like growth factor-I^9th specimen post XXX challenge,insulin,Insulin-like growth factor-I^9th specimen post XXX challenge,0
C5690200,Insulin type &#x7C; Serum or Plasma &#x7C; Chemistry - non-challenge,insulin,,0
C5690720,Insulin Secretagogues,insulin,"Insulin Secretogogue; Secretogogue, Insulin; Secretogogues, Insulin; Insulin Secretogogues",0
C0202076,"17 Hydroxyprogesterone measurement, amniotic fluid",continuous insulin infusion,"17 Hydroxyprogesterone measurement, amniotic fluid; 17 Hydroxyprogesterone measurement, amniotic fluid (procedure)",0
C0201982,"Cystine measurement, quantitative",intermediate-acting insulin,"Cystine measurement, quantitative (procedure); Cystine measurement, quantitative",0
C0201985,Base excess measurement,long-acting insulin,"base excess test; Base Excess Measurement; actual base excess; Delta base, blood (procedure); Delta base, blood; Actual base excess; BE - Base excess; Base excess; base excess; Base excess - observation",0
C0037595,"Soil Pollutants, Radioactive",no change in insulin dose,"Radioactive Soil Pollutants; Pollutants, Radioactive Soil",0
